Citrus Sinensis ID: 007254
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 611 | 2.2.26 [Sep-21-2011] | |||||||
| Q8RWW0 | 744 | Receptor-like serine/thre | no | no | 0.296 | 0.243 | 0.453 | 3e-42 | |
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.292 | 0.252 | 0.467 | 6e-42 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.294 | 0.25 | 0.451 | 8e-42 | |
| Q9LK03 | 717 | Proline-rich receptor-lik | no | no | 0.330 | 0.281 | 0.436 | 2e-41 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.320 | 0.300 | 0.450 | 2e-41 | |
| Q9ZNQ8 | 633 | Proline-rich receptor-lik | no | no | 0.294 | 0.284 | 0.456 | 5e-41 | |
| Q9C660 | 762 | Proline-rich receptor-lik | no | no | 0.306 | 0.245 | 0.439 | 1e-40 | |
| Q3EDL4 | 472 | Probable serine/threonine | no | no | 0.299 | 0.387 | 0.448 | 2e-40 | |
| Q9SGY7 | 718 | Putative proline-rich rec | no | no | 0.292 | 0.249 | 0.442 | 2e-40 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.294 | 0.253 | 0.445 | 3e-40 |
| >sp|Q8RWW0|ALE2_ARATH Receptor-like serine/threonine-protein kinase ALE2 OS=Arabidopsis thaliana GN=ALE2 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 174 bits (440), Expect = 3e-42, Method: Compositional matrix adjust.
Identities = 87/192 (45%), Positives = 125/192 (65%), Gaps = 11/192 (5%)
Query: 407 ATCRL----FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKIL-KPSEDVI 461
ATC L F +L AT F A+ ++G+GG +VY+G + DG E+AVK+L + +++
Sbjct: 328 ATCALSVKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKLLTRDNQNRD 387
Query: 462 KEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWS 521
+EF+ E+E+++ LHH+N++ L+G C E L+Y+ + GS+E +LH D W
Sbjct: 388 REFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLHEGTLD-----WD 442
Query: 522 ERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581
R K+A+G A L YLH S RVIHRD K+SN+LL DDF P++SDFGLA+ A+ S HI
Sbjct: 443 ARLKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI 502
Query: 582 TCTDVAGTFGYV 593
+ T V GTFGYV
Sbjct: 503 S-TRVMGTFGYV 513
|
Required during the differentiation of the protoderm into shoots epidermis and cuticle. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 172 bits (437), Expect = 6e-42, Method: Compositional matrix adjust.
Identities = 86/184 (46%), Positives = 124/184 (67%), Gaps = 5/184 (2%)
Query: 411 LFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILK-PSEDVIKEFVLEIE 469
LF+Y++L+ AT+ F ENL+G+GG VYKG LPDG+ +AVK LK +EF E+E
Sbjct: 364 LFSYEELVKATNGFSQENLLGEGGFGCVYKGILPDGRVVAVKQLKIGGGQGDREFKAEVE 423
Query: 470 IITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG 529
++ +HH++++S++G C + LL+YD++S L +LHG K + W+ R K+A G
Sbjct: 424 TLSRIHHRHLVSIVGHCISGDRRLLIYDYVSNNDLYFHLHGEK---SVLDWATRVKIAAG 480
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 589
A L YLH R+IHRD+KSSNILL D+F+ ++SDFGLA+ A ++HIT T V GT
Sbjct: 481 AARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSDFGLARLALDCNTHIT-TRVIGT 539
Query: 590 FGYV 593
FGY+
Sbjct: 540 FGYM 543
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 172 bits (436), Expect = 8e-42, Method: Compositional matrix adjust.
Identities = 83/184 (45%), Positives = 127/184 (69%), Gaps = 4/184 (2%)
Query: 412 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKP-SEDVIKEFVLEIEI 470
F+Y++L T F +N++G+GG VYKG L DGK +AVK LK S +EF E+EI
Sbjct: 359 FSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREFKAEVEI 418
Query: 471 ITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGV 530
I+ +HH++++SL+G+C D + LL+Y+++S +LE +LHG K WS+R ++A+G
Sbjct: 419 ISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHG--KGLPVLEWSKRVRIAIGS 476
Query: 531 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 590
A+ L YLH ++IHRD+KS+NILL D++E Q++DFGLA+ T+ +H++ T V GTF
Sbjct: 477 AKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLNDTTQTHVS-TRVMGTF 535
Query: 591 GYVV 594
GY+
Sbjct: 536 GYLA 539
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 171 bits (432), Expect = 2e-41, Method: Compositional matrix adjust.
Identities = 90/206 (43%), Positives = 131/206 (63%), Gaps = 4/206 (1%)
Query: 390 DSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKEL 449
D + LP GL FNY++L AT+ F NL+G+GG V+KG L +GKE+
Sbjct: 320 DQSVLPPPSPGLALGLGIYQGTFNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEV 379
Query: 450 AVKILKP-SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENL 508
AVK LK S +EF E+ II+ +HH+++++L+G+C D LLVY+F+ +LE +L
Sbjct: 380 AVKQLKEGSSQGEREFQAEVGIISRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFHL 439
Query: 509 HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568
HG K WS R K+A+G A+ L YLH ++IHRD+K+SNIL+ FE +++DF
Sbjct: 440 HG--KGRPTMEWSSRLKIAVGSAKGLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADF 497
Query: 569 GLAKWASTSSSHITCTDVAGTFGYVV 594
GLAK AS +++H++ T V GTFGY+
Sbjct: 498 GLAKIASDTNTHVS-TRVMGTFGYLA 522
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 170 bits (431), Expect = 2e-41, Method: Compositional matrix adjust.
Identities = 91/202 (45%), Positives = 131/202 (64%), Gaps = 6/202 (2%)
Query: 394 LPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKI 453
LP GL +S + F Y++L AT+ F NL+G+GG V+KG LP GKE+AVK
Sbjct: 252 LPPPSPGLVLGFSKST--FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQ 309
Query: 454 LKP-SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNK 512
LK S +EF E+EII+ +HH++++SL+G+C LLVY+F+ +LE +LHG
Sbjct: 310 LKAGSGQGEREFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHG-- 367
Query: 513 KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
K WS R K+A+G A+ L YLH ++IHRD+K+SNIL+ FE +++DFGLAK
Sbjct: 368 KGRPTMEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAK 427
Query: 573 WASTSSSHITCTDVAGTFGYVV 594
AS +++H++ T V GTFGY+
Sbjct: 428 IASDTNTHVS-TRVMGTFGYLA 448
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZNQ8|PERK4_ARATH Proline-rich receptor-like protein kinase PERK4 OS=Arabidopsis thaliana GN=PERK4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 169 bits (428), Expect = 5e-41, Method: Compositional matrix adjust.
Identities = 84/184 (45%), Positives = 124/184 (67%), Gaps = 4/184 (2%)
Query: 412 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKP-SEDVIKEFVLEIEI 470
F YQ+L +AT F NL+G+GG V+KG LP GKE+AVK LK S +EF E++I
Sbjct: 272 FTYQELAAATGGFTDANLLGQGGFGYVHKGVLPSGKEVAVKSLKAGSGQGEREFQAEVDI 331
Query: 471 ITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGV 530
I+ +HH+ ++SL+G+C D +LVY+F+ +LE +LHG K+ +S R ++A+G
Sbjct: 332 ISRVHHRYLVSLVGYCIADGQRMLVYEFVPNKTLEYHLHG--KNLPVMEFSTRLRIALGA 389
Query: 531 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 590
A+ L YLH R+IHRD+KS+NILL +F+ ++DFGLAK S +++H++ T V GTF
Sbjct: 390 AKGLAYLHEDCHPRIIHRDIKSANILLDFNFDAMVADFGLAKLTSDNNTHVS-TRVMGTF 448
Query: 591 GYVV 594
GY+
Sbjct: 449 GYLA 452
|
Required during abscisic acid (ABA)-mediated activation of Ca(2+) channels. Regulates ABA signaling pathways. Modulates the expression of genes related to cell elongation and ABA signaling during root growth. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 168 bits (425), Expect = 1e-40, Method: Compositional matrix adjust.
Identities = 84/191 (43%), Positives = 123/191 (64%), Gaps = 4/191 (2%)
Query: 405 YSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILK-PSEDVIKE 463
+ + LF+Y++L+ AT+ F ENL+G+GG +VYKG LPD + +AVK LK +E
Sbjct: 411 FGQSRELFSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLKIGGGQGDRE 470
Query: 464 FVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER 523
F E++ I+ +HH+N++S++G+C +N LL+YD++ +L +LH W+ R
Sbjct: 471 FKAEVDTISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNLYFHLHAAGT--PGLDWATR 528
Query: 524 YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 583
K+A G A L YLH R+IHRD+KSSNILL ++F +SDFGLAK A ++HIT
Sbjct: 529 VKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAKLALDCNTHIT- 587
Query: 584 TDVAGTFGYVV 594
T V GTFGY+
Sbjct: 588 TRVMGTFGYMA 598
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3EDL4|Y1154_ARATH Probable serine/threonine-protein kinase At1g01540 OS=Arabidopsis thaliana GN=At1g01540 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 167 bits (424), Expect = 2e-40, Method: Compositional matrix adjust.
Identities = 83/185 (44%), Positives = 121/185 (65%), Gaps = 2/185 (1%)
Query: 410 RLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVK-ILKPSEDVIKEFVLEI 468
R + ++L +AT+ EN+IG+GG VY+G L DG ++AVK +L KEF +E+
Sbjct: 140 RWYTLRELEAATNGLCEENVIGEGGYGIVYRGILTDGTKVAVKNLLNNRGQAEKEFKVEV 199
Query: 469 EIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM 528
E+I + HKN++ LLG+C E +LVYDF+ G+LE+ +HG+ D + W R + +
Sbjct: 200 EVIGRVRHKNLVRLLGYCVEGAYRMLVYDFVDNGNLEQWIHGDVGDVSPLTWDIRMNIIL 259
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 588
G+A+ L YLH G +V+HRD+KSSNILL + ++SDFGLAK + SS++T T V G
Sbjct: 260 GMAKGLAYLHEGLEPKVVHRDIKSSNILLDRQWNAKVSDFGLAKLLGSESSYVT-TRVMG 318
Query: 589 TFGYV 593
TFGYV
Sbjct: 319 TFGYV 323
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 167 bits (423), Expect = 2e-40, Method: Compositional matrix adjust.
Identities = 81/183 (44%), Positives = 123/183 (67%), Gaps = 4/183 (2%)
Query: 412 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKP-SEDVIKEFVLEIEI 470
F Y++L T F ++G+GG VYKG L +GK +A+K LK S + +EF E+EI
Sbjct: 358 FTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAEGYREFKAEVEI 417
Query: 471 ITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGV 530
I+ +HH++++SL+G+C + + L+Y+F+ +L+ +LHG K+ WS R ++A+G
Sbjct: 418 ISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHG--KNLPVLEWSRRVRIAIGA 475
Query: 531 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 590
A+ L YLH ++IHRD+KSSNILL D+FE Q++DFGLA+ T+ SHI+ T V GTF
Sbjct: 476 AKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLARLNDTAQSHIS-TRVMGTF 534
Query: 591 GYV 593
GY+
Sbjct: 535 GYL 537
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 167 bits (422), Expect = 3e-40, Method: Compositional matrix adjust.
Identities = 82/184 (44%), Positives = 123/184 (66%), Gaps = 4/184 (2%)
Query: 412 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILK-PSEDVIKEFVLEIEI 470
F Y++L T F N++G+GG VYKG L DGK +AVK LK S +EF E+EI
Sbjct: 341 FTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVEI 400
Query: 471 ITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGV 530
I+ +HH++++SL+G+C D+ LL+Y+++ +LE +LHG K W+ R ++A+G
Sbjct: 401 ISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHG--KGRPVLEWARRVRIAIGS 458
Query: 531 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 590
A+ L YLH ++IHRD+KS+NILL D+FE Q++DFGLAK ++ +H++ T V GTF
Sbjct: 459 AKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQTHVS-TRVMGTF 517
Query: 591 GYVV 594
GY+
Sbjct: 518 GYLA 521
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 611 | ||||||
| 255558560 | 758 | ATP binding protein, putative [Ricinus c | 0.959 | 0.773 | 0.704 | 0.0 | |
| 224066793 | 738 | predicted protein [Populus trichocarpa] | 0.921 | 0.762 | 0.687 | 0.0 | |
| 224082346 | 697 | predicted protein [Populus trichocarpa] | 0.849 | 0.744 | 0.659 | 0.0 | |
| 449523137 | 756 | PREDICTED: uncharacterized LOC101203034 | 0.924 | 0.747 | 0.648 | 0.0 | |
| 449463428 | 756 | PREDICTED: uncharacterized protein LOC10 | 0.924 | 0.747 | 0.648 | 0.0 | |
| 356547275 | 736 | PREDICTED: uncharacterized protein LOC10 | 0.921 | 0.764 | 0.624 | 0.0 | |
| 356515943 | 743 | PREDICTED: probable receptor-like serine | 0.913 | 0.751 | 0.615 | 0.0 | |
| 356507630 | 750 | PREDICTED: probable receptor-like serine | 0.914 | 0.745 | 0.611 | 0.0 | |
| 302141759 | 732 | unnamed protein product [Vitis vinifera] | 0.873 | 0.729 | 0.632 | 0.0 | |
| 42563282 | 794 | adenine nucleotide alpha hydrolases-doma | 0.932 | 0.717 | 0.575 | 0.0 |
| >gi|255558560|ref|XP_002520305.1| ATP binding protein, putative [Ricinus communis] gi|223540524|gb|EEF42091.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 828 bits (2138), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 427/606 (70%), Positives = 490/606 (80%), Gaps = 20/606 (3%)
Query: 1 MKMVQQEGDVISSGAGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVD 60
MKM+Q SG RTV+VGVKLD+ SRELLTWA+VKVAQPGDTVIALHVL NN IVD
Sbjct: 1 MKMIQHAEKKGGSGC-RTVMVGVKLDSESRELLTWAMVKVAQPGDTVIALHVLGNNEIVD 59
Query: 61 RDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIV 120
R+GKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKICRG+SIRKILVREA+SYSAT IV
Sbjct: 60 REGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKICRGSSIRKILVREAKSYSATNIIV 119
Query: 121 GTAKNHHTIRSTTSLAKYCAKKLSKDCSVLAVNNGKVVFQKEGCPSTAGESKGTEDHRRN 180
G A+ HHTIRS TS+AKYCAKKLSKDC VLAV+NGKVVFQKEG + G+S G+ED +R
Sbjct: 120 GAARTHHTIRSPTSVAKYCAKKLSKDCLVLAVHNGKVVFQKEGSTAKTGDSHGSEDDQRK 179
Query: 181 SLLDVIHRSISMSKITGQKNSKVVTDDGSSITSKPVDDLG-GSVMNLEQALVKARSDCSG 239
+++ HRSIS+SK NSKV+++ G I P +G G+ QALVKAR + G
Sbjct: 180 GFVNIFHRSISLSK-----NSKVISESG--INEAPKYVVGEGNEQTFHQALVKARPNSLG 232
Query: 240 SAAKRNCSICGPVRNLPDGSCSQSEEESPSDGGAGDESLAIVPVQNVEAASTSITMLVRQ 299
S K+NC++CG V N D SC+QS E+S D G ++SLA+VPV VE S+S L+ Q
Sbjct: 233 SIMKQNCTVCGAVGNSLDESCNQSAEKSSGDNGGDNKSLALVPVSKVEGRSSSFRSLIAQ 292
Query: 300 LPESRPGWPLLRRAIFPDRRAPDRSSLRKISVVQWALRLPTRQ-PSYLANSDVKQITYDP 358
+PE +PGWPLLRRAI P +A DRSSLR+ISVVQWA+RLP+RQ S ++N D KQ
Sbjct: 293 VPELKPGWPLLRRAILPGGQASDRSSLRQISVVQWAMRLPSRQLSSSISNLDHKQ----N 348
Query: 359 GDNESINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLL 418
G+ + +L+G+SGAIV VG + ++ P S DH++ +LP ELEG HEKYSATCRLF YQ+LL
Sbjct: 349 GEGQP-SLDGESGAIVAVGTDALTIPPSPDHNA-KLPIELEGFHEKYSATCRLFQYQELL 406
Query: 419 SATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKN 478
SATSNFLAE L+GKGGSSQVYKGCLPDGKELAVKILKPSEDV+KEFVLEIEIITTL+HKN
Sbjct: 407 SATSNFLAEYLVGKGGSSQVYKGCLPDGKELAVKILKPSEDVLKEFVLEIEIITTLNHKN 466
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
IISLLGFCFE N LLLVYDFLSRGSLEENLHGN+KDP AF W ERYKVA+GVAEAL YLH
Sbjct: 467 IISLLGFCFEYNKLLLVYDFLSRGSLEENLHGNRKDPLAFNWYERYKVAVGVAEALNYLH 526
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILN 598
+G+AQ VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI CTDVAGTFGY L
Sbjct: 527 TGTAQPVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIICTDVAGTFGY----LA 582
Query: 599 PIAFLF 604
P F++
Sbjct: 583 PEYFMY 588
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224066793|ref|XP_002302218.1| predicted protein [Populus trichocarpa] gi|222843944|gb|EEE81491.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 769 bits (1985), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 404/588 (68%), Positives = 468/588 (79%), Gaps = 25/588 (4%)
Query: 18 TVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSV 77
TV+VGVKLD+ SRELLTWALVKVAQPGDTVIALHVL +N IVDR+GKSSLLSLVKAFDSV
Sbjct: 8 TVIVGVKLDSMSRELLTWALVKVAQPGDTVIALHVLGSNEIVDREGKSSLLSLVKAFDSV 67
Query: 78 LAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTSLAK 137
LAVYEGFCNLKQVDLKLKICRG+S RKILVRE +SY+ATK IVG AKNH +I S+TS+AK
Sbjct: 68 LAVYEGFCNLKQVDLKLKICRGSSTRKILVREVKSYAATKVIVGAAKNHPSIWSSTSVAK 127
Query: 138 YCAKKLSKDCSVLAVNNGKVVFQKEGCPSTAGESKGTEDHRRNSLLDVIHRSISMSKITG 197
YCAKKL KDCSVLAVNNGKVVFQ+E P+T+G T+DH + SLL V+HR+IS K +
Sbjct: 128 YCAKKLPKDCSVLAVNNGKVVFQRERSPNTSG----TKDHSK-SLLSVVHRTISSEKKSR 182
Query: 198 QKNSKVVTDDGSSITSKPVDDLGGSVMNLEQALVKARSDCSGSAAKRNCSICGPVRNLPD 257
+ N + +G S + D + LE+AL+KARS+ S K NCS+CG D
Sbjct: 183 ELNES--SANGGSKDDQDSDQI------LEKALMKARSNSLESIMKENCSVCGSATIFAD 234
Query: 258 GSCSQSEEESPSDGGAGDESLAIVPVQNVEAASTSITMLVRQLPESRPGWPLLRRAIFPD 317
S ++S E S SD G D+SLA+VPV +E ++S++ L+RQ+PE +PGWPLL RA+ PD
Sbjct: 235 DSSNESAEASSSDNGGDDKSLALVPVPRLEEPTSSVSTLIRQVPELKPGWPLLCRAVLPD 294
Query: 318 RRAPDRSSLRKISVVQW-ALRLPTRQPSYLANSDVKQITYDPGDNESINLNGDSGAIVPV 376
++ + S +R++ VVQW L L T NSD KQ D G+++ NL+G+SGAIV V
Sbjct: 295 KKESNISLVRQVCVVQWEQLSLST------VNSDHKQDGSDKGEDK-FNLDGESGAIVAV 347
Query: 377 GNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSS 436
G E ++P + H+S PKELEGLHEKYSATCRLF YQ+LLSATSNFLAENLIGKGGSS
Sbjct: 348 GMETATAPHTPHHNSRSPPKELEGLHEKYSATCRLFQYQELLSATSNFLAENLIGKGGSS 407
Query: 437 QVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496
QVYKGCL DGKELAVKILKPSEDV+KEFVLEIEIITTLHHKNIISLLGFCFED NLLLVY
Sbjct: 408 QVYKGCLSDGKELAVKILKPSEDVLKEFVLEIEIITTLHHKNIISLLGFCFEDKNLLLVY 467
Query: 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 556
DFL RGSLE+NL+GNKKDP FGW+ERYKVA+GVAEAL+YLHS SAQ VIHRDVKSSNIL
Sbjct: 468 DFLPRGSLEDNLYGNKKDPLTFGWNERYKVALGVAEALDYLHSCSAQPVIHRDVKSSNIL 527
Query: 557 LSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNPIAFLF 604
LSDDFEPQLSDFGLAKWA TSSSHI CTDVAGTFGY L P F++
Sbjct: 528 LSDDFEPQLSDFGLAKWAPTSSSHIICTDVAGTFGY----LAPEYFMY 571
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224082346|ref|XP_002306655.1| predicted protein [Populus trichocarpa] gi|222856104|gb|EEE93651.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 736 bits (1899), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 388/588 (65%), Positives = 442/588 (75%), Gaps = 69/588 (11%)
Query: 18 TVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSV 77
TV+VGVKLD SRELLTWALVKVAQPGDTVIALH+L NN IVDR+GKSSLLSLVKAFD+V
Sbjct: 8 TVIVGVKLDPASRELLTWALVKVAQPGDTVIALHILDNNEIVDREGKSSLLSLVKAFDNV 67
Query: 78 LAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTSLAK 137
LAVYEGFCNLKQVDLKLKICRG+SIR+ILVREA+SY+ATK IVG +NH +I +TS+AK
Sbjct: 68 LAVYEGFCNLKQVDLKLKICRGSSIRRILVREAKSYTATKVIVGATRNHLSIWPSTSVAK 127
Query: 138 YCAKKLSKDCSVLAVNNGKVVFQKEGCPSTAGESKGTEDHRRNSLLDVIHRSISMSKITG 197
YCAKKL KDCSVLA NNGKVVFQ+E P+ G + S S++ I
Sbjct: 128 YCAKKLPKDCSVLAFNNGKVVFQRERTPNNTG-----------------NFSCSLASIM- 169
Query: 198 QKNSKVVTDDGSSITSKPVDDLGGSVMNLEQALVKARSDCSGSAAKRNCSICGPVRNLPD 257
++N V GS + KP DD
Sbjct: 170 KENCSVC---GSVM--KPADD--------------------------------------- 185
Query: 258 GSCSQSEEESPSDGGAGDESLAIVPVQNVEAASTSITMLVRQLPESRPGWPLLRRAIFPD 317
SC+QS E S D D+SLA+VPV VE ++S++ L+ Q+PE +PGWPLLR ++ P+
Sbjct: 186 -SCNQSAEASCGDRDGDDKSLALVPVPRVEEPTSSVSTLIGQVPELKPGWPLLRSSVLPN 244
Query: 318 RRAPDRSSLRKISVVQWALRLPTRQPSY-LANSDVKQITYDPGDNESINLNGDSGAIVPV 376
R+ +RS +R+ISVVQWA+RLP+RQ S NSD KQ D G+ E +NL+G+SGAIV V
Sbjct: 245 RKTSNRSLVRQISVVQWAMRLPSRQLSLSTVNSDHKQDVSDKGE-EQLNLDGESGAIVAV 303
Query: 377 GNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSS 436
G E ++PLS DH+S LPKELEGLHEKYSATCRLF Q+LLSATSNFLAENLIGKGGSS
Sbjct: 304 GMETATAPLSPDHNSRSLPKELEGLHEKYSATCRLFQCQELLSATSNFLAENLIGKGGSS 363
Query: 437 QVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496
QVYKGCLPDGKELAVKILKPSEDV+KEFV EIEIITTL HKNIISLLGFCFE NLLLVY
Sbjct: 364 QVYKGCLPDGKELAVKILKPSEDVLKEFVQEIEIITTLSHKNIISLLGFCFEGKNLLLVY 423
Query: 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 556
DFLSRGSLEENLHGNKKDP AFGW+ERYKVA+G+AEAL+YLHS SAQ VIHRDVKSSNIL
Sbjct: 424 DFLSRGSLEENLHGNKKDPRAFGWNERYKVALGIAEALDYLHSCSAQPVIHRDVKSSNIL 483
Query: 557 LSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNPIAFLF 604
LSDDFEPQLSDFGLAKWA TSSSHI C DVAGTFGY L P F++
Sbjct: 484 LSDDFEPQLSDFGLAKWAPTSSSHIICNDVAGTFGY----LAPEYFMY 527
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449523137|ref|XP_004168581.1| PREDICTED: uncharacterized LOC101203034 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 728 bits (1879), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 386/595 (64%), Positives = 460/595 (77%), Gaps = 30/595 (5%)
Query: 15 AGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAF 74
+ RTV+VG+KLD+HSRELLTWALVKVAQPGD VIALHVL N+ IV++DGKSSLLSLVKAF
Sbjct: 17 SARTVLVGMKLDSHSRELLTWALVKVAQPGDLVIALHVLGNHEIVNQDGKSSLLSLVKAF 76
Query: 75 DSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTS 134
D+VLAVYEGFCNLKQVDLKLKICRG S RKILVREA+SY AT IVGTA+ HH IRS+TS
Sbjct: 77 DTVLAVYEGFCNLKQVDLKLKICRGESARKILVREAKSYRATNLIVGTARKHHKIRSSTS 136
Query: 135 LAKYCAKKLSKDCSVLAVNNGKVVFQKEGCPSTAGESKGTEDHRRNSLLDVIHRSISMSK 194
+AKYCAKKL KD VLAV+NGKV+F++EGCP G+ G E+ R ++LL ++ S S
Sbjct: 137 VAKYCAKKLPKDFWVLAVHNGKVIFEREGCPVATGDCHGNEEQRHSNLLAAVYGSAGSSP 196
Query: 195 ITGQKNSKVVTDDG-SSITSKPVDDLGGSVMNLEQALVKARSDCSGSAAKRNCSICGPVR 253
KV + + S+ ++ D+LG N +Q KA S K+NCSICG
Sbjct: 197 -------KVQSGESFGSLLARDRDNLGIG-KNSDQEFEKA---LSVGTDKQNCSICGSES 245
Query: 254 NLPDGSCSQSEEESPSDGGAGDESLAIVPVQNVEAASTSITMLVRQLPESRPGWPLLR-- 311
+ QS E S SDG DESLA+VPVQ VE AS+SIT L++QLPE +PGWPLLR
Sbjct: 246 SF----VEQSAEISSSDGEKHDESLALVPVQIVEVASSSITKLIKQLPEVKPGWPLLRHV 301
Query: 312 -RAIFPDRRAP-DRSSLRKISVVQWALRLPTRQPSYLANSDVKQITYDPGDNESINLNGD 369
++ R+A DRS ++ISVVQWA++LP+R P Y A D K T D +S+ L+G+
Sbjct: 302 DQSCESGRQASSDRSLAKQISVVQWAMKLPSRSPLYPAALDYKSNTSD----QSLGLDGE 357
Query: 370 SGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENL 429
+GA+V VG+E V SPLS+D D+ LPKELEG HEKYS+TCRLFNY +LL+ATSNFL ENL
Sbjct: 358 NGAMVLVGSEPVPSPLSSDSDTETLPKELEGFHEKYSSTCRLFNYHELLTATSNFLPENL 417
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 489
IGKGGSSQV++GCLPDGKE+AVKILK SEDV+KEFV+E+EIIT+L HKNIISLLGFCFE+
Sbjct: 418 IGKGGSSQVFRGCLPDGKEVAVKILKTSEDVLKEFVMEVEIITSLSHKNIISLLGFCFEN 477
Query: 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 549
+ LLVYDFLSRG LEE LHGN+K+P FGWSERYKVA+GVAEAL+YLH AQ VIHRD
Sbjct: 478 SKFLLVYDFLSRGCLEEILHGNRKNPNTFGWSERYKVAVGVAEALDYLHL-DAQHVIHRD 536
Query: 550 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNPIAFLF 604
VKSSNILLSDDFEPQLSDFGLAK S++SSH+TCTDVAGTFGY L P F++
Sbjct: 537 VKSSNILLSDDFEPQLSDFGLAK-RSSNSSHVTCTDVAGTFGY----LAPEYFMY 586
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449463428|ref|XP_004149436.1| PREDICTED: uncharacterized protein LOC101203034 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 728 bits (1879), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 386/595 (64%), Positives = 460/595 (77%), Gaps = 30/595 (5%)
Query: 15 AGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAF 74
+ RTV+VG+KLD+HSRELLTWALVKVAQPGD VIALHVL N+ IV++DGKSSLLSLVKAF
Sbjct: 17 SARTVLVGMKLDSHSRELLTWALVKVAQPGDLVIALHVLGNHEIVNQDGKSSLLSLVKAF 76
Query: 75 DSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTS 134
D+VLAVYEGFCNLKQVDLKLKICRG S RKILVREA+SY AT IVGTA+ HH IRS+TS
Sbjct: 77 DTVLAVYEGFCNLKQVDLKLKICRGESARKILVREAKSYRATNLIVGTARKHHKIRSSTS 136
Query: 135 LAKYCAKKLSKDCSVLAVNNGKVVFQKEGCPSTAGESKGTEDHRRNSLLDVIHRSISMSK 194
+AKYCAKKL KD VLAV+NGKV+F++EGCP G+ G E+ R ++LL ++ S S
Sbjct: 137 VAKYCAKKLPKDFWVLAVHNGKVIFEREGCPVATGDCHGNEEQRHSNLLAAVYGSAGSSP 196
Query: 195 ITGQKNSKVVTDDG-SSITSKPVDDLGGSVMNLEQALVKARSDCSGSAAKRNCSICGPVR 253
KV + + S+ ++ D+LG N +Q KA S K+NCSICG
Sbjct: 197 -------KVQSGESFGSLLARDRDNLGIG-KNSDQEFEKA---LSVGTDKQNCSICGSES 245
Query: 254 NLPDGSCSQSEEESPSDGGAGDESLAIVPVQNVEAASTSITMLVRQLPESRPGWPLLR-- 311
+ QS E S SDG DESLA+VPVQ VE AS+SIT L++QLPE +PGWPLLR
Sbjct: 246 SF----VEQSAEISSSDGEKHDESLALVPVQIVEVASSSITKLIKQLPEVKPGWPLLRHV 301
Query: 312 -RAIFPDRRAP-DRSSLRKISVVQWALRLPTRQPSYLANSDVKQITYDPGDNESINLNGD 369
++ R+A DRS ++ISVVQWA++LP+R P Y A D K T D +S+ L+G+
Sbjct: 302 DQSCESGRQASSDRSLAKQISVVQWAMKLPSRSPLYPAALDYKSNTSD----QSLGLDGE 357
Query: 370 SGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENL 429
+GA+V VG+E V SPLS+D D+ LPKELEG HEKYS+TCRLFNY +LL+ATSNFL ENL
Sbjct: 358 NGAMVLVGSEPVPSPLSSDSDTETLPKELEGFHEKYSSTCRLFNYHELLTATSNFLPENL 417
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 489
IGKGGSSQV++GCLPDGKE+AVKILK SEDV+KEFV+E+EIIT+L HKNIISLLGFCFE+
Sbjct: 418 IGKGGSSQVFRGCLPDGKEVAVKILKTSEDVLKEFVMEVEIITSLSHKNIISLLGFCFEN 477
Query: 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 549
+ LLVYDFLSRG LEE LHGN+K+P FGWSERYKVA+GVAEAL+YLH AQ VIHRD
Sbjct: 478 SKFLLVYDFLSRGCLEEILHGNRKNPNTFGWSERYKVAVGVAEALDYLHL-DAQHVIHRD 536
Query: 550 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNPIAFLF 604
VKSSNILLSDDFEPQLSDFGLAK S++SSH+TCTDVAGTFGY L P F++
Sbjct: 537 VKSSNILLSDDFEPQLSDFGLAK-RSSNSSHVTCTDVAGTFGY----LAPEYFMY 586
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356547275|ref|XP_003542041.1| PREDICTED: uncharacterized protein LOC100797280 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 724 bits (1869), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 379/607 (62%), Positives = 449/607 (73%), Gaps = 44/607 (7%)
Query: 1 MKMVQ--QEGDVISSGAG-RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNA 57
MKM+ G SGAG RTVVVG+K+D+HS ELLTWAL KVAQPGD V+ALHVL N+
Sbjct: 1 MKMLPPPTAGGASHSGAGDRTVVVGMKMDSHSTELLTWALFKVAQPGDVVLALHVLGNDE 60
Query: 58 IVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATK 117
IV+R+GKSSL SLVKAFDS+LAVYEGFCNLKQVDLK KICRG+S+R+ILVREA +YSAT
Sbjct: 61 IVNREGKSSLFSLVKAFDSILAVYEGFCNLKQVDLKFKICRGSSVRRILVREANAYSATH 120
Query: 118 FIVGTAKNHHTIRSTTSLAKYCAKKLSKDCSVLAVNNGKVVFQKEGCPSTAGESKGTEDH 177
IVG+++ H IR S+A+YCAKKL KDC VLAV+NGK+VF++EG P+T E KG +
Sbjct: 121 IIVGSSQGLHIIRPCISVARYCAKKLPKDCWVLAVDNGKIVFKREGSPATRAELKGLDQD 180
Query: 178 RRNSLLDVIHRSISMSKITGQKNSKVVTDDGSSITSKPVDDLGGSVMNLEQALVKARSDC 237
+ LL IHR+IS K SKV+ DDG+ I K G+ + +L KA D
Sbjct: 181 HKTRLLGSIHRTIS-------KGSKVLDDDGTGIHEKGC----GNGEYSDHSLAKAFLDS 229
Query: 238 SGSAAKRNCSICGPVRNLPDGSCSQSEEESPSDGGAGDESLAIVPVQNVEAASTSITMLV 297
K+ CSIC SEEES D + LAIVPVQ +AAS
Sbjct: 230 KEFVEKKRCSICA------------SEEESCGDASDENNPLAIVPVQTNDAAS------- 270
Query: 298 RQLPESRPGWPLLRRAIFPDRRAPDRSSLRKISVVQWALRLPTRQPSYLANSDVKQITYD 357
+PGWPLLR+ I D++ ++S LR+ISVVQWA++LP+R SY A+ D K D
Sbjct: 271 ------KPGWPLLRKTIASDKKCSEKSLLRQISVVQWAMQLPSRDLSYAAHQDHKANNCD 324
Query: 358 PGDNESINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDL 417
++ + L+ SGA+VPV EI ++ S + +S +PKELEGLHEKYS+TCRLF YQ+L
Sbjct: 325 QNKDQFLALDSKSGALVPVDAEIGTAS-SPERNSRSIPKELEGLHEKYSSTCRLFEYQEL 383
Query: 418 LSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK 477
+ ATSNFL ENLIGKGGSSQVY+GCLPDGKELAVKILKPS+DV+KEFVLEIEIITTL+HK
Sbjct: 384 VLATSNFLPENLIGKGGSSQVYRGCLPDGKELAVKILKPSDDVLKEFVLEIEIITTLNHK 443
Query: 478 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
NIISLLGFCFED NLLLVYDFLSRGSLEENLHGNKK+P FGW+ERYKVAMGVAEALEYL
Sbjct: 444 NIISLLGFCFEDGNLLLVYDFLSRGSLEENLHGNKKNPLVFGWTERYKVAMGVAEALEYL 503
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLIL 597
H+ Q VIHRDVKSSN+LLS+DFEPQLSDFGLAKWASTSSSHI CTDVAGTFGY+
Sbjct: 504 HNNEGQSVIHRDVKSSNVLLSEDFEPQLSDFGLAKWASTSSSHIICTDVAGTFGYMA--- 560
Query: 598 NPIAFLF 604
P F++
Sbjct: 561 -PEYFMY 566
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356515943|ref|XP_003526656.1| PREDICTED: probable receptor-like serine/threonine-protein kinase At5g57670-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 694 bits (1792), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 367/596 (61%), Positives = 435/596 (72%), Gaps = 38/596 (6%)
Query: 15 AGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAF 74
GRTV+VGVK+D+ S+ELLTWALVKVA PGDTV+ALHVL NN V+ DGKSSLLSLVKAF
Sbjct: 10 GGRTVLVGVKMDSPSKELLTWALVKVAHPGDTVVALHVLGNNETVNGDGKSSLLSLVKAF 69
Query: 75 DSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTS 134
DSVLA Y+GFCNLKQVDLKLKICRG+S++K LVREA YSAT +VGT H IRS+T
Sbjct: 70 DSVLAAYKGFCNLKQVDLKLKICRGSSVKKTLVREANGYSATHVVVGTTHGLHKIRSSTV 129
Query: 135 LAKYCAKKLSKDCSVLAVNNGKVVFQKEGCPSTAGESKGTEDHRRNSLLDVIHRSISMSK 194
+AK+CAKKLSKDC VLAVNNGKVVF+++ P + E +G + H RN LL IH ++
Sbjct: 130 VAKHCAKKLSKDCCVLAVNNGKVVFKRDSSPPSVAELQGVDRHNRNGLLGSIHWTLG--- 186
Query: 195 ITGQKNSKVVTDDGSSITSK-----PVDDLGGSVMNLEQALVKARSDCSGSAAKRNCSIC 249
KN KV++DD S + + P+ D +L K + + +CSIC
Sbjct: 187 ----KNRKVLSDDSSGMDADEKKTGPISD---------HSLAKFFLESKETVRNPSCSIC 233
Query: 250 GPVRNLPDGSCSQSEEESPSDGGAGDESLAIVPVQNVEAASTSITMLVRQLPESRPGWPL 309
G LPD S QS E D G + SLA+VPVQ AA T E +PGWPL
Sbjct: 234 GTTLALPDPSFYQSAEGVSGDEGR-ENSLAMVPVQPTVAAKT----------ELKPGWPL 282
Query: 310 LRRAIFPDRRAPDRSSLR-KISVVQWALRLPTRQPSYLANSDVKQITYDPGDNESINLNG 368
L I DR++ RS +ISVVQWA+RLP+R SY + D K D G ++ L+
Sbjct: 283 LDGRILSDRQSAGRSLFHLQISVVQWAMRLPSRNLSYAVDRDEKSKICDQGQDQPAALDS 342
Query: 369 DSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAEN 428
+SGA+V V E+ ++ S +++S +PKELEGLHEKYS+TCRLF YQ+L+SATSNFL EN
Sbjct: 343 ESGALVLVDAELGTAS-SPENNSGNIPKELEGLHEKYSSTCRLFEYQELVSATSNFLHEN 401
Query: 429 LIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE 488
LIGKGGSSQVY+GCLPDGKELAVKIL PS+DV+ EF+LEIEIITTLHHKNIISLLGFCFE
Sbjct: 402 LIGKGGSSQVYRGCLPDGKELAVKILNPSDDVLSEFLLEIEIITTLHHKNIISLLGFCFE 461
Query: 489 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHR 548
+ LLLVYDFLSRGSLEENLHGNKK+ FGWSERYKVA+GVAEAL+YLHS Q VIHR
Sbjct: 462 NGKLLLVYDFLSRGSLEENLHGNKKNSLVFGWSERYKVAVGVAEALDYLHSKDDQPVIHR 521
Query: 549 DVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNPIAFLF 604
DVKSSN+LLS++FEPQLSDFGLAKWAST SSHITCTDVAGTFGY L P F++
Sbjct: 522 DVKSSNVLLSENFEPQLSDFGLAKWASTLSSHITCTDVAGTFGY----LAPEYFMY 573
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356507630|ref|XP_003522567.1| PREDICTED: probable receptor-like serine/threonine-protein kinase At5g57670-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 686 bits (1770), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 364/595 (61%), Positives = 438/595 (73%), Gaps = 36/595 (6%)
Query: 15 AGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAF 74
GRTVVVGVK+D+ +ELLTWALVKVA P DTV+ALHVL ++ V+ GKSSLLSLVKAF
Sbjct: 17 GGRTVVVGVKMDSPCKELLTWALVKVAHPRDTVVALHVLGSHETVNGVGKSSLLSLVKAF 76
Query: 75 DSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTS 134
DSVLAVY+GFCNLKQVDLKLKICRG+S++K LVREA YSAT +VGT H IRS+T
Sbjct: 77 DSVLAVYKGFCNLKQVDLKLKICRGSSVKKSLVREANGYSATHIVVGTTHGLHKIRSSTV 136
Query: 135 LAKYCAKKLSKDCSVLAVNNGKVVFQKEGCPSTAGESKGTEDHRRNSLLDVIHRSISMSK 194
+AKYCAKKLSKDC VLAVNNGKVVF+++ P + E +G + H RN L+ I ++
Sbjct: 137 VAKYCAKKLSKDCCVLAVNNGKVVFKRDSSPPSVTELQGIDRHNRNGLIGSIQWTLG--- 193
Query: 195 ITGQKNSKVVTDDGSSITSKPVDDLGGSVMNLEQALVKARSDCSGSAAKRNCSICGPVRN 254
K++KV++DD S + + + G V + +L K + + +CSICG
Sbjct: 194 ----KSTKVLSDDNSGMEAD--EKKTGQVS--DHSLAKLFLESKETVRNPSCSICGTTLA 245
Query: 255 LPDGSCSQSEEESPSDGGAGDE----SLAIVPVQNVEAASTSITMLVRQLPESRPGWPLL 310
LPD SC QS +DG +GD+ SLAIVPVQ AA T E +PGWPLL
Sbjct: 246 LPDSSCYQS-----ADGVSGDDGRENSLAIVPVQPSVAAIT----------EMKPGWPLL 290
Query: 311 RRAIFPDRRAPDRSSLR-KISVVQWALRLPTRQPSYLANSDVKQITYDPGDNESINLNGD 369
R I DR++ DR + +ISVVQWA+RLP+R SY + + K D G ++ L+ +
Sbjct: 291 HRGILLDRQSADRLLMHPQISVVQWAMRLPSRNLSYAVDCNEKPNICDQGQDQHAALDSE 350
Query: 370 SGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENL 429
SGA+VPV E+ ++ L +H+S +PKELEGLHEKYS+TCRLF YQ+L+ ATSNFL NL
Sbjct: 351 SGALVPVDAELGTASL-PEHNSGNIPKELEGLHEKYSSTCRLFEYQELVLATSNFLPGNL 409
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 489
IGKGGSSQVY+GCLPDGKELAVKILKPS++V+ EF+LEIEIITTLHHKNIISLLGFCFE+
Sbjct: 410 IGKGGSSQVYRGCLPDGKELAVKILKPSDNVLSEFLLEIEIITTLHHKNIISLLGFCFEN 469
Query: 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 549
LLLVYDFLSRGSLEENLHGNKK FGWSERYKVA+G+AEAL+YLHS Q VIHRD
Sbjct: 470 GKLLLVYDFLSRGSLEENLHGNKKISLVFGWSERYKVAVGIAEALDYLHSKDDQPVIHRD 529
Query: 550 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNPIAFLF 604
VKSSN+LLS+DFEPQL DFGLAKWAST SSHITCTDVAGTFGY L P F++
Sbjct: 530 VKSSNVLLSEDFEPQLCDFGLAKWASTLSSHITCTDVAGTFGY----LAPEYFMY 580
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302141759|emb|CBI18962.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 681 bits (1758), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 370/585 (63%), Positives = 435/585 (74%), Gaps = 51/585 (8%)
Query: 24 KLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEG 83
KLD+ SRELLTWALVKVAQPGD VIALHVL +N + S +V +F AVYEG
Sbjct: 25 KLDSQSRELLTWALVKVAQPGDRVIALHVLGHNEMGVCRNCGSRWEIVASF----AVYEG 80
Query: 84 FCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTSLAKYCAKKL 143
FCNLKQVDLKLKICRG+SI KILVRE +SY A+K IVGTA+NHH IRS+ ++AKYCAKKL
Sbjct: 81 FCNLKQVDLKLKICRGSSIGKILVREVKSYVASKVIVGTARNHHAIRSSAAVAKYCAKKL 140
Query: 144 SKDCSVLAVNNGKVVFQKEGCPSTAGESKGTEDHRRNSLLDVIHRSISMSKITGQKNSKV 203
KDCSVLAVNNGKVVFQ+E T +S+ E+HRRN LL I +S+S K SK
Sbjct: 141 PKDCSVLAVNNGKVVFQREASMRTTVDSQEKEEHRRNGLLGGIQQSVS-------KKSKA 193
Query: 204 VTDDGSSITSKPVDDLGGSVMNLEQALVKARSDCSGSAAKRNCSICGP--VRNLPDG--S 259
+ G + +IC P ++L G S
Sbjct: 194 LNH--------------------------------GKVNEEPSTICDPSACQSLELGLNS 221
Query: 260 CSQSEEESPSDGGAGDESLAIVPVQNVEAASTSITMLVRQLPESRPGWPLLRRAIFPDRR 319
CSQS E S D D+SLAIVPVQ +EA+S+SI++L+R+LPE RPGWPLLRRAI PDR+
Sbjct: 222 CSQSIEGSSGDSHHEDDSLAIVPVQKLEASSSSISLLIRELPELRPGWPLLRRAILPDRQ 281
Query: 320 APDRSSLRKISVVQWALRLPTRQPSYLANSDVKQITYDPGDNESINLNGDSGAIVPVGNE 379
+SS+R+ISVVQWA+RLP+R A+ D + + D ++ S NL+G+SGAIVPVG
Sbjct: 282 TSTKSSVRQISVVQWAMRLPSRNFPSAASLDNIESSCDGDEDLSTNLDGESGAIVPVGTV 341
Query: 380 IVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVY 439
S+P S ST+L KELEGLHEKYSATCRLF +Q+L SATSNF+ ENLIGKGGSS+VY
Sbjct: 342 NASAPPSPSRSSTKLAKELEGLHEKYSATCRLFKFQELFSATSNFMPENLIGKGGSSRVY 401
Query: 440 KGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499
+GCL DGKELAVKILK S+D++KEF+LEIEII+TLHHKNIISLLGFCFE+NNLLLVYDFL
Sbjct: 402 RGCLSDGKELAVKILKQSDDILKEFLLEIEIISTLHHKNIISLLGFCFENNNLLLVYDFL 461
Query: 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD 559
SRGSLEENL+GNKKD AFGWSERYKVA+GVAEAL+YLH GSAQ VIH DVKSSNILL+D
Sbjct: 462 SRGSLEENLYGNKKDLFAFGWSERYKVAVGVAEALDYLHCGSAQAVIHGDVKSSNILLAD 521
Query: 560 DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNPIAFLF 604
DFEPQLSDFGLAKWASTSSSHITC+DVAGTFGY+ P F++
Sbjct: 522 DFEPQLSDFGLAKWASTSSSHITCSDVAGTFGYMA----PEYFMY 562
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|42563282|ref|NP_177852.2| adenine nucleotide alpha hydrolases-domain containing protein kinase [Arabidopsis thaliana] gi|332197836|gb|AEE35957.1| adenine nucleotide alpha hydrolases-domain containing protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 669 bits (1726), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 360/626 (57%), Positives = 447/626 (71%), Gaps = 56/626 (8%)
Query: 2 KMVQQEGDVISS----GAGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNA 57
+M++ GD SS GRT++VGVKLD SRELLTWALVKVA+PGDTVIALH+L N
Sbjct: 29 EMIETGGDKQSSVEEGCGGRTILVGVKLDAPSRELLTWALVKVAEPGDTVIALHILGNE- 87
Query: 58 IVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATK 117
IVDR G SSLLSLV+ FDSVL VYEGFCNLKQVDLKLK+CRG+S RKILVREA+S+SATK
Sbjct: 88 IVDRAGNSSLLSLVRTFDSVLDVYEGFCNLKQVDLKLKLCRGSSARKILVREAKSFSATK 147
Query: 118 FIVGTAKNHHTIRSTTSLAKYCAKKLSKDCSVLAVNNGKVVFQKEGCPS-TAGESK---- 172
+VG +K+HH IRS+ S+AKY AKKLSKDC V+AVNNGK++FQKEG PS T +S+
Sbjct: 148 VLVGISKSHHAIRSSASVAKYIAKKLSKDCWVIAVNNGKILFQKEGSPSSTINQSQVVEE 207
Query: 173 --------GTEDHRRNSLLDVIHRSISMSKITGQKNSKVVTDDGSSITSKPVDDLGGSVM 224
G ED RR +LL+V+ RS++++K T KVV+ SK ++
Sbjct: 208 TVIGFGYIGKEDVRRITLLNVLQRSVTLNKTT-----KVVSHSEEDSNSKEEEEDQACGQ 262
Query: 225 NLEQALVKARSDCSGSAAKRNCSICG-----PVRNLPDGSCS-QSEEESPSDGGAGDESL 278
NL Q L AR + NCS+CG P G S S+ + D ++++
Sbjct: 263 NLRQVLAAARLE--------NCSVCGFDSLSPNDTTTPGKLSGASDFDRSEDDDECNKAM 314
Query: 279 AIVPVQNVEAASTSITMLVRQLPESRPGWPLLRRAIFPDRRAPDRSSLRKISVVQWALRL 338
IVPV E + S+TMLVR+LPE RPGWPLLRRA+ + KI VVQWAL+L
Sbjct: 315 EIVPVNGSEDSGGSVTMLVRKLPEPRPGWPLLRRAV---STLGQSVTPHKIPVVQWALKL 371
Query: 339 PTRQPSYLANSDVKQITYDPGDNESINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKEL 398
P R D KQ+ YD ++ LN A+VP G +++ D+ +LP+EL
Sbjct: 372 PPR--------DTKQLGYDSSEDNLSTLN----ALVPFGINSITNKSIPDNSPRKLPEEL 419
Query: 399 EGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE 458
EGL+E++S+TCR F Y++L+S TSNF A+N IGKGGSS+V++GCL +G+ +AVKILK +E
Sbjct: 420 EGLYERFSSTCRFFKYKELVSVTSNFSADNFIGKGGSSRVFRGCLSNGRVVAVKILKQTE 479
Query: 459 DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAF 518
DV+ +FV EIEIITTLHHKNIISLLGFCFED+NLLLVY++LSRGSLEENLHGNKKDP AF
Sbjct: 480 DVLNDFVAEIEIITTLHHKNIISLLGFCFEDHNLLLVYNYLSRGSLEENLHGNKKDPLAF 539
Query: 519 GWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578
WSERYKVA+GVAEAL+YLH+ ++Q VIHRDVKSSNILLSDDFEPQLSDFGLA+WAS S+
Sbjct: 540 CWSERYKVAVGVAEALDYLHNTASQPVIHRDVKSSNILLSDDFEPQLSDFGLARWASIST 599
Query: 579 SHITCTDVAGTFGYVVLILNPIAFLF 604
+HI C+DVAGTFGY L P F++
Sbjct: 600 THIICSDVAGTFGY----LAPEYFMY 621
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 611 | ||||||
| TAIR|locus:2195975 | 794 | AT1G77280 [Arabidopsis thalian | 0.934 | 0.719 | 0.571 | 1.6e-166 | |
| TAIR|locus:2026957 | 756 | AT1G21590 [Arabidopsis thalian | 0.927 | 0.75 | 0.557 | 1.1e-158 | |
| TAIR|locus:2160801 | 705 | AT5G63940 [Arabidopsis thalian | 0.587 | 0.509 | 0.533 | 5.8e-137 | |
| TAIR|locus:2059919 | 617 | AT2G16750 [Arabidopsis thalian | 0.294 | 0.291 | 0.556 | 6e-70 | |
| TAIR|locus:2172555 | 579 | AT5G57670 [Arabidopsis thalian | 0.292 | 0.309 | 0.464 | 2e-49 | |
| TAIR|locus:504954886 | 1113 | AT5G56890 [Arabidopsis thalian | 0.307 | 0.168 | 0.447 | 6.2e-44 | |
| TAIR|locus:2044420 | 392 | AT2G18890 [Arabidopsis thalian | 0.338 | 0.528 | 0.447 | 2.2e-43 | |
| TAIR|locus:2012325 | 466 | AT1G09440 [Arabidopsis thalian | 0.397 | 0.521 | 0.412 | 5.2e-42 | |
| TAIR|locus:2156050 | 552 | AT5G37790 [Arabidopsis thalian | 0.463 | 0.512 | 0.373 | 1.1e-41 | |
| TAIR|locus:2077730 | 512 | AT3G59110 [Arabidopsis thalian | 0.296 | 0.353 | 0.486 | 1.4e-41 |
| TAIR|locus:2195975 AT1G77280 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1620 (575.3 bits), Expect = 1.6e-166, P = 1.6e-166
Identities = 347/607 (57%), Positives = 435/607 (71%)
Query: 2 KMVQQEGDVISS---GAG-RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNA 57
+M++ GD SS G G RT++VGVKLD SRELLTWALVKVA+PGDTVIALH+L N
Sbjct: 29 EMIETGGDKQSSVEEGCGGRTILVGVKLDAPSRELLTWALVKVAEPGDTVIALHILGNE- 87
Query: 58 IVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATK 117
IVDR G SSLLSLV+ FDSVL VYEGFCNLKQVDLKLK+CRG+S RKILVREA+S+SATK
Sbjct: 88 IVDRAGNSSLLSLVRTFDSVLDVYEGFCNLKQVDLKLKLCRGSSARKILVREAKSFSATK 147
Query: 118 FIVGTAKNHHTIRSTTSLAKYCAKKLSKDCSVLAVNNGKVVFQKEGCPS-TAGESKGTED 176
+VG +K+HH IRS+ S+AKY AKKLSKDC V+AVNNGK++FQKEG PS T +S+ E+
Sbjct: 148 VLVGISKSHHAIRSSASVAKYIAKKLSKDCWVIAVNNGKILFQKEGSPSSTINQSQVVEE 207
Query: 177 HRRN----SLLDVIHRSISMSKITGQKNSKVVTDDGSSITSKPVDDLGGSVMNLEQALVK 232
DV R I++ + Q++ V + + + S +D +QA +
Sbjct: 208 TVIGFGYIGKEDV--RRITLLNVL-QRS--VTLNKTTKVVSHSEEDSNSKEEEEDQACGQ 262
Query: 233 ARSDCSGSAAKRNCSICG-----PVRNLPDGSCS-QSEEESPSDGGAGDESLAIVPVQNV 286
+A NCS+CG P G S S+ + D ++++ IVPV
Sbjct: 263 NLRQVLAAARLENCSVCGFDSLSPNDTTTPGKLSGASDFDRSEDDDECNKAMEIVPVNGS 322
Query: 287 EAASTSITMLVRQLPESRPGWPLLRRAIFPDRRAPDRSSLRKISVVQWALRLPTRQPSYL 346
E + S+TMLVR+LPE RPGWPLLRRA+ + KI VVQWAL+LP R
Sbjct: 323 EDSGGSVTMLVRKLPEPRPGWPLLRRAV---STLGQSVTPHKIPVVQWALKLPPR----- 374
Query: 347 ANSDVKQITYDPGDNESINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYS 406
D KQ+ YD ++ LN A+VP G +++ D+ +LP+ELEGL+E++S
Sbjct: 375 ---DTKQLGYDSSEDNLSTLN----ALVPFGINSITNKSIPDNSPRKLPEELEGLYERFS 427
Query: 407 ATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVL 466
+TCR F Y++L+S TSNF A+N IGKGGSS+V++GCL +G+ +AVKILK +EDV+ +FV
Sbjct: 428 STCRFFKYKELVSVTSNFSADNFIGKGGSSRVFRGCLSNGRVVAVKILKQTEDVLNDFVA 487
Query: 467 EIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKV 526
EIEIITTLHHKNIISLLGFCFED+NLLLVY++LSRGSLEENLHGNKKDP AF WSERYKV
Sbjct: 488 EIEIITTLHHKNIISLLGFCFEDHNLLLVYNYLSRGSLEENLHGNKKDPLAFCWSERYKV 547
Query: 527 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV 586
A+GVAEAL+YLH+ ++Q VIHRDVKSSNILLSDDFEPQLSDFGLA+WAS S++HI C+DV
Sbjct: 548 AVGVAEALDYLHNTASQPVIHRDVKSSNILLSDDFEPQLSDFGLARWASISTTHIICSDV 607
Query: 587 AGTFGYV 593
AGTFGY+
Sbjct: 608 AGTFGYL 614
|
|
| TAIR|locus:2026957 AT1G21590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1546 (549.3 bits), Expect = 1.1e-158, P = 1.1e-158
Identities = 332/596 (55%), Positives = 424/596 (71%)
Query: 7 EGDVISSGAGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSS 66
E V++ G G TV+VGVK D S ELL WALVKVA+PGDTVIALHVL N IVDR SS
Sbjct: 3 ENGVVTGG-GHTVMVGVKFDESSNELLDWALVKVAEPGDTVIALHVLGNE-IVDRADNSS 60
Query: 67 LLSLVKAFDSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNH 126
L+S+VK FDSVL VYEGFC LKQ++LKLK+ RG+S RKILV+EA+ SA+K +VG ++
Sbjct: 61 LVSIVKNFDSVLEVYEGFCKLKQLELKLKLSRGSSTRKILVKEAKMCSASKVVVGISRRF 120
Query: 127 HTIRSTTSLAKYCAKKLSKDCSVLAVNNGKVVFQKEGCPSTAGESKGTEDHRRNSLLDVI 186
HTI S+ S+AKY A+K++KDC VLAV+NGKV+FQK+G S SKG D RRN+L
Sbjct: 121 HTIHSSVSVAKYLARKVAKDCWVLAVDNGKVMFQKDGSSSIIHHSKGKSDARRNTL---- 176
Query: 187 HRSISMSKITGQKNSKVVTDDGSSITSKPVDDLGGSVMNLEQALVKARSDCSGSAAKRNC 246
S +T +KN+KVV S + + ++ + +L ++LV A C G NC
Sbjct: 177 -SSFFQMPVTLRKNTKVVNH--SEVEEEEAEEDHSNGQSLRRSLVYA---CLG-----NC 225
Query: 247 SICGPVRNLPD-GSCSQSEE-ESPSDGGAG-DESLAIVPVQNVEAASTSITMLVRQLPES 303
S+ + +LP G+ S+S D A +++A+VP + E + ITMLV++LPE
Sbjct: 226 SV-RDMNSLPTPGNLSRSSSCNGDQDDNADLHKAMALVPAKFPEDLTPFITMLVKELPEF 284
Query: 304 RPGWPLLRRAIFPD--RRAPDRSSLRKISVVQWALRLPTRQPSYLANSDVKQITYDPGDN 361
RPGWPLL R D AP SS RKI VVQW L+LP R S + +SD KQI +D ++
Sbjct: 285 RPGWPLLCRVASSDVLASAPRSSSFRKIPVVQWVLKLPARTNSVVGSSDTKQIGFDSSES 344
Query: 362 ES----INLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDL 417
E + N + AIVP + IV L DH S P+ +EGL + S +C+ F Y++L
Sbjct: 345 EENDKLSSSNVERQAIVPDESMIVKCSL--DHSSGRFPENVEGLQARISTSCQFFTYKEL 402
Query: 418 LSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK 477
+S TSNF A+N IGKGGSS+V++G LP+G+E+AVKILK +E V+K+FV EI+IITTLHHK
Sbjct: 403 VSVTSNFCADNFIGKGGSSRVFRGYLPNGREVAVKILKRTECVLKDFVAEIDIITTLHHK 462
Query: 478 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
N+ISLLG+CFE+NNLLLVY++LSRGSLEENLHGNKKD AF W+ERYKVA+G+AEAL+YL
Sbjct: 463 NVISLLGYCFENNNLLLVYNYLSRGSLEENLHGNKKDLVAFRWNERYKVAVGIAEALDYL 522
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYV 593
H+ + Q VIHRDVKSSNILLSDDFEPQLSDFGLAKWAS S++ I C+DVAGTFGY+
Sbjct: 523 HNDAPQPVIHRDVKSSNILLSDDFEPQLSDFGLAKWASESTTQIICSDVAGTFGYL 578
|
|
| TAIR|locus:2160801 AT5G63940 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 922 (329.6 bits), Expect = 5.8e-137, Sum P(2) = 5.8e-137
Identities = 201/377 (53%), Positives = 259/377 (68%)
Query: 221 GSVMNLEQALVKARSDCSGSAAKRNCSICGPVRNLPDGS-CSQSEE-ESPSDGGAGDESL 278
G MN+ +LV D + AAK S P R + S+S +SP G D L
Sbjct: 169 GPQMNIP-SLVCGSPDIAIEAAKIGNSF-SPARTSSRWTRTSRSSSLQSPDSLGV-DNLL 225
Query: 279 AIVPVQNVEAASTSITMLVRQLPESRPGWPLLRRAIFPDRRAPDRSSLRKISVVQWALRL 338
A+VPVQ E S S+ ES PGW LR +R++ + S +K +V+QW RL
Sbjct: 226 ALVPVQTNETDSGSL--------ESGPGWHFLRGLYGNNRKSWTKVSAKK-AVLQWVSRL 276
Query: 339 PTRQPSYLANSDVKQITYDPGDNE--SINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPK 396
R + D K+ D G +E S +++G+ +I G+E++ SPLS S +P+
Sbjct: 277 RGRHSETVIYLDRKRS--DSGCDEDCSSSIDGEDVSISRFGSELMQSPLSPFIGSNNIPE 334
Query: 397 ELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKP 456
ELEGLHEKYS+TCRLF Y+++LS TSNF +ENL+G+GG+S VY+G LPDG+ELAVKILKP
Sbjct: 335 ELEGLHEKYSSTCRLFTYEEVLSITSNFASENLVGEGGNSYVYRGDLPDGRELAVKILKP 394
Query: 457 SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPA 516
DV+KEF+LEIE+IT++HHKNI+SL GFCFE+NNL+LVYD+L RGSLEENLHGN+KD
Sbjct: 395 CLDVLKEFILEIEVITSVHHKNIVSLFGFCFENNNLMLVYDYLPRGSLEENLHGNRKDAK 454
Query: 517 AFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576
FGW ERYKVA+GVAEAL+YLH+ VIHRDVKSSN+LL+DDFEPQLSDFG A AS+
Sbjct: 455 KFGWMERYKVAVGVAEALDYLHNTHDPEVIHRDVKSSNVLLADDFEPQLSDFGFASLASS 514
Query: 577 SSSHITCTDVAGTFGYV 593
+S H+ D+AGTFGY+
Sbjct: 515 TSQHVAGGDIAGTFGYL 531
|
|
| TAIR|locus:2059919 AT2G16750 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 512 (185.3 bits), Expect = 6.0e-70, Sum P(2) = 6.0e-70
Identities = 103/185 (55%), Positives = 132/185 (71%)
Query: 410 RLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS-EDVIKEFVLEI 468
R F+Y L +ATS+F ENLIGKGG ++VYKG L DGK +AVKILKPS ++ +KEFV E+
Sbjct: 263 RWFSYDVLKTATSDFSLENLIGKGGCNEVYKGFLEDGKGVAVKILKPSVKEAVKEFVHEV 322
Query: 469 EIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM 528
I+++L H NI L+G C N+L+ VY+ S+GSLEE L G W ER K+A+
Sbjct: 323 SIVSSLSHSNISPLIGVCVHYNDLISVYNLSSKGSLEETLQGKH----VLRWEERLKIAI 378
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 588
G+ EAL+YLH+ + VIHRDVKSSN+LLSD+FEPQLSDFGL+ W S S + DV G
Sbjct: 379 GLGEALDYLHNQCSNPVIHRDVKSSNVLLSDEFEPQLSDFGLSMWGSKSCRYTIQRDVVG 438
Query: 589 TFGYV 593
TFGY+
Sbjct: 439 TFGYL 443
|
|
| TAIR|locus:2172555 AT5G57670 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 405 (147.6 bits), Expect = 2.0e-49, Sum P(2) = 2.0e-49
Identities = 86/185 (46%), Positives = 115/185 (62%)
Query: 412 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKIL-KPSEDVIKE--FVLEI 468
F Y ++ AT++F N++G GG S+VY+G L DG+ +AVK L K S D+ KE F+ E+
Sbjct: 255 FTYNEISKATNDFHQGNIVGIGGYSEVYRGDLWDGRRIAVKRLAKESGDMNKEKEFLTEL 314
Query: 469 EIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM 528
II+ + H N LLG C E L LV+ F G+L LH N+ + W RYK+A+
Sbjct: 315 GIISHVSHPNTALLLGCCVE-KGLYLVFRFSENGTLYSALHENEN--GSLDWPVRYKIAV 371
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 588
GVA L YLH R+IHRD+KSSN+LL D+EPQ++DFGLAKW +H V G
Sbjct: 372 GVARGLHYLHKRCNHRIIHRDIKSSNVLLGPDYEPQITDFGLAKWLPNKWTHHAVIPVEG 431
Query: 589 TFGYV 593
TFGY+
Sbjct: 432 TFGYL 436
|
|
| TAIR|locus:504954886 AT5G56890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 451 (163.8 bits), Expect = 6.2e-44, Sum P(2) = 6.2e-44
Identities = 86/192 (44%), Positives = 128/192 (66%)
Query: 405 YSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDV-IKE 463
++ + + F +++ AT+NF ++G+GG +VY+G DG ++AVK+LK + +E
Sbjct: 704 FTLSAKTFTASEIMKATNNFDESRVLGEGGFGRVYEGVFDDGTKVAVKVLKRDDQQGSRE 763
Query: 464 FVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER 523
F+ E+E+++ LHH+N+++L+G C ED N LVY+ + GS+E +LHG K + W R
Sbjct: 764 FLAEVEMLSRLHHRNLVNLIGICIEDRNRSLVYELIPNGSVESHLHGIDKASSPLDWDAR 823
Query: 524 YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA--STSSSHI 581
K+A+G A L YLH S+ RVIHRD KSSNILL +DF P++SDFGLA+ A + HI
Sbjct: 824 LKIALGAARGLAYLHEDSSPRVIHRDFKSSNILLENDFTPKVSDFGLARNALDDEDNRHI 883
Query: 582 TCTDVAGTFGYV 593
+ T V GTFGYV
Sbjct: 884 S-TRVMGTFGYV 894
|
|
| TAIR|locus:2044420 AT2G18890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 458 (166.3 bits), Expect = 2.2e-43, P = 2.2e-43
Identities = 97/217 (44%), Positives = 139/217 (64%)
Query: 382 SSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKG 441
SSPL+ ST+ + + + + F++Q++ AT+ F +ENL+G+GG ++VYKG
Sbjct: 28 SSPLAAS--STKCVEGFQETDQFQRPKWKCFSFQEIYDATNGFSSENLVGRGGFAEVYKG 85
Query: 442 CL-PDGKELAVKIL----KPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496
L +G+E+AVK + + E KEF++EI I + H N++SLLG C DN L LV+
Sbjct: 86 ILGKNGEEIAVKRITRGGRDDERREKEFLMEIGTIGHVSHPNVLSLLGCCI-DNGLYLVF 144
Query: 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 556
F SRGSL LH + P W RYK+A+G A+ L YLH G +R+IHRD+KSSN+L
Sbjct: 145 IFSSRGSLASLLHDLNQAPLE--WETRYKIAIGTAKGLHYLHKGCQRRIIHRDIKSSNVL 202
Query: 557 LSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYV 593
L+ DFEPQ+SDFGLAKW + SH + + GTFG++
Sbjct: 203 LNQDFEPQISDFGLAKWLPSQWSHHSIAPIEGTFGHL 239
|
|
| TAIR|locus:2012325 AT1G09440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 445 (161.7 bits), Expect = 5.2e-42, P = 5.2e-42
Identities = 103/250 (41%), Positives = 144/250 (57%)
Query: 345 YLANSDVKQITYDPGDNESINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEK 404
+L N ++++ + G + S + +G G + V N SS +T P L GL E
Sbjct: 83 FLLNLEMEK-NRENGLSSSRSGSGKEGYLC-VANRSTSSLYEM---ATPSPSPLSGLPES 137
Query: 405 YSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVK-ILKPSEDVIKE 463
+ F +DL AT+ F EN+IG+GG VY+G L +G +AVK IL KE
Sbjct: 138 HLGWGHWFTLRDLEIATNRFSKENVIGEGGYGVVYRGELVNGSLVAVKKILNHLGQAEKE 197
Query: 464 FVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER 523
F +E++ I + HKN++ LLG+C E N +LVY++++ G+LEE LHG K W R
Sbjct: 198 FRVEVDAIGHVRHKNLVRLLGYCIEGTNRILVYEYMNNGNLEEWLHGAMKHHGYLTWEAR 257
Query: 524 YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 583
KV G ++AL YLH +V+HRD+KSSNIL+ D F ++SDFGLAK SH+T
Sbjct: 258 MKVLTGTSKALAYLHEAIEPKVVHRDIKSSNILIDDRFNAKISDFGLAKLLGDGKSHVT- 316
Query: 584 TDVAGTFGYV 593
T V GTFGYV
Sbjct: 317 TRVMGTFGYV 326
|
|
| TAIR|locus:2156050 AT5G37790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 442 (160.7 bits), Expect = 1.1e-41, P = 1.1e-41
Identities = 114/305 (37%), Positives = 164/305 (53%)
Query: 302 ESRPGWPLLRRAIFPDRRAPD----RSSLRKISVVQWAL-RLPTRQPSYLANSDVKQITY 356
E+ W L A P+ PD SS R Q L ++ +PS A+S + ++
Sbjct: 93 ENNKAWLLAETA--PENMNPDPHSVHSSFRFSLCSQIELEKMKGEEPSLSASSSCRNLSV 150
Query: 357 DPGDNESINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQD 416
G + +N ++G GN +TD + LE + T F+Y +
Sbjct: 151 SGGSTTVLMVNLENGVKETTGN-------ATDDLRWTRARSLEKSISPVANTLVRFSYGE 203
Query: 417 LLSATSNFLAENLIGKGGSSQVYKGCLPDGKE-LAVKIL-KPSEDVIKEFVLEIEIITTL 474
+++AT NF ++G+G S V++G + + LA+K L K ++ K F E+ I ++L
Sbjct: 204 IVAATRNFSKGRVLGRGACSYVFRGKIGMWRTALAIKRLDKEDKESPKSFCRELMIASSL 263
Query: 475 HHKNIISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDP---AAFG--WSERYKVAM 528
H NI+ LLGFC + + L LVY ++S GSLE LH KK AAFG WS RYKVA+
Sbjct: 264 HSSNIVPLLGFCIDPEEGLFLVYKYVSGGSLEHYLHDKKKKKGVKAAFGLPWSARYKVAL 323
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 588
G+A+A+ YLH+G+ Q V+HRD+K SNILLS P+L DFGLA W + S C V G
Sbjct: 324 GIADAIAYLHNGTEQCVVHRDIKPSNILLSSKKIPKLCDFGLATWTAAPSVPFLCKTVKG 383
Query: 589 TFGYV 593
TFGY+
Sbjct: 384 TFGYL 388
|
|
| TAIR|locus:2077730 AT3G59110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 441 (160.3 bits), Expect = 1.4e-41, P = 1.4e-41
Identities = 89/183 (48%), Positives = 121/183 (66%)
Query: 412 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVK-ILKPSEDVIKEFVLEIEI 470
F +DL AT+ F AEN+IG+GG VYKG L +G ++AVK +L KEF +E+E
Sbjct: 178 FTLRDLQLATNRFAAENVIGEGGYGVVYKGRLINGNDVAVKKLLNNLGQAEKEFRVEVEA 237
Query: 471 ITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGV 530
I + HKN++ LLG+C E N +LVY++++ G+LE+ LHG + W R K+ +G
Sbjct: 238 IGHVRHKNLVRLLGYCIEGVNRMLVYEYVNSGNLEQWLHGAMGKQSTLTWEARMKILVGT 297
Query: 531 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 590
A+AL YLH +V+HRD+K+SNIL+ DDF +LSDFGLAK + SHIT T V GTF
Sbjct: 298 AQALAYLHEAIEPKVVHRDIKASNILIDDDFNAKLSDFGLAKLLDSGESHIT-TRVMGTF 356
Query: 591 GYV 593
GYV
Sbjct: 357 GYV 359
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | estExt_fgenesh4_pg.C_LG_II0708 | hypothetical protein (739 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 611 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-37 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-36 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-34 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-33 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-33 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-33 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-30 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-30 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-24 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-24 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-22 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 9e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-20 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-19 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-19 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-19 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-19 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-18 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-18 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-18 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-17 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-17 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 9e-17 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-16 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-16 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-16 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-16 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-15 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-15 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-15 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-15 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-15 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 9e-15 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-14 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-14 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-14 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-14 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-14 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 8e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-14 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 9e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-13 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-13 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-13 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-13 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-13 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-13 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-12 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-12 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-12 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-12 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-12 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-12 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-12 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-12 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-12 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 8e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-12 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 9e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-11 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-11 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-11 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-11 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-11 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-11 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-11 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-11 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-10 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-10 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-10 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-10 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-10 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-10 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-10 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 8e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-10 | |
| cd01989 | 146 | cd01989, STK_N, The N-terminal domain of Eukaryoti | 8e-10 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 9e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-09 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-09 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-09 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-09 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-09 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-09 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-09 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-08 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-08 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-08 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-08 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-08 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-08 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-08 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-08 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-08 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-08 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-08 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 9e-08 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-07 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-07 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-07 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-07 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-07 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-07 | |
| cd00293 | 130 | cd00293, USP_Like, Usp: Universal stress protein f | 6e-07 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-07 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-07 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-07 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-07 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 8e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 9e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-06 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-06 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-06 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-06 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-06 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-06 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-06 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-06 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-06 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-06 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-06 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-06 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-06 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-06 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 8e-06 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-06 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 9e-06 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-05 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-05 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-05 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-05 | |
| pfam00582 | 139 | pfam00582, Usp, Universal stress protein family | 2e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-05 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-05 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-05 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-05 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-05 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-05 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 8e-05 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-05 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 8e-05 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 9e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-04 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-04 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-04 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-04 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-04 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-04 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-04 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-04 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 4e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-04 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 7e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-04 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-04 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 0.001 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.001 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 0.001 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 0.001 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.001 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 0.001 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 0.001 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 0.002 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 0.002 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.002 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.002 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 0.002 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 0.002 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.002 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 0.002 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.002 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.003 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 0.003 | |
| pfam03109 | 117 | pfam03109, ABC1, ABC1 family | 0.003 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.004 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 4e-37
Identities = 61/168 (36%), Positives = 96/168 (57%), Gaps = 12/168 (7%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
+G+GG VY GK++A+KI+K S +++E + EIEI+ L+H NI+ L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
++N+L LV ++ GSL++ L N+ E ++ + + E LEYLHS +I
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK---LSEDEILRILLQILEGLEYLHS---NGII 114
Query: 547 HRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYV 593
HRD+K NILL SD+ + +L+DFGL+K +S + GT Y+
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSK--LLTSDKSLLKTIVGTPAYM 160
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 4e-36
Identities = 59/168 (35%), Positives = 83/168 (49%), Gaps = 13/168 (7%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL---EIEIITTLHHKNIISLLGF 485
+G G VYK GK +AVKILK + K+ EI I+ L H NI+ L+
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
+ ++L LV ++ G L + L E K+A+ + LEYLHS +
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRGGP----LSEDEAKKIALQILRGLEYLHS---NGI 119
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYV 593
IHRD+K NILL ++ +++DFGLAK SSS T GT Y+
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSS--LTTFVGTPWYM 165
|
Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 8e-34
Identities = 57/150 (38%), Positives = 86/150 (57%), Gaps = 12/150 (8%)
Query: 430 IGKGGSSQVYKGCL---PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIISL 482
+G+G +VYKG L DGKE+ AVK LK SE I+EF+ E I+ L H NI+ L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
LG C E+ L++V +++ G L + L K P S+ A+ +A +EYL S
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLR--KNRPKELSLSDLLSFALQIARGMEYLES--- 121
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+ IHRD+ + N L+ ++ ++SDFGL++
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSR 151
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 1e-33
Identities = 52/150 (34%), Positives = 80/150 (53%), Gaps = 13/150 (8%)
Query: 430 IGKGGSSQVYKGCL----PDGKEL-AVKILKP--SEDVIKEFVLEIEIITTLHHKNIISL 482
+G+G +VYKG L K AVK LK SE I+EF+ E I+ L H N++ L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
LG C E+ L +V +++ G L L N+ S+ A+ +A +EYL S
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP---KLSLSDLLSFALQIARGMEYLES--- 120
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+ IHRD+ + N L+ ++ ++SDFGL++
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSR 150
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 2e-33
Identities = 51/172 (29%), Positives = 82/172 (47%), Gaps = 19/172 (11%)
Query: 428 NLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDV--IKEFVLEIEIITTLHHKNIISLLG 484
+G+G +VY GK +A+K++K + + + EI+I+ L H NI+ L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDP---AAFGWSERYKVAMGVAEALEYLHSGS 541
+++ L LV ++ G L + L + A F + + ALEYLHS
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQ-------ILSALEYLHS-- 115
Query: 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYV 593
+ ++HRD+K NILL +D +L+DFGLA+ T GT Y+
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLAR---QLDPGEKLTTFVGTPEYM 163
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 8e-33
Identities = 59/167 (35%), Positives = 90/167 (53%), Gaps = 15/167 (8%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFCF 487
IGKGG +VYK GKE+A+K++K KE ++ EI+I+ H NI+ G
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRV 545
+ + L +V +F S GSL++ L + +E V + + LEYLHS +
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQ-----TLTESQIAYVCKELLKGLEYLHS---NGI 119
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 592
IHRD+K++NILL+ D E +L DFGL+ S + + T + GT +
Sbjct: 120 IHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT---MVGTPYW 163
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 49/150 (32%), Positives = 85/150 (56%), Gaps = 13/150 (8%)
Query: 430 IGKGGSSQVYKGCL---PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIISL 482
+G+G +VYKG L +G E AVK LK SE+ +EF+ E I+ L H NI+ L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
LG C + L +V +++ G L + L + + + ++A+ +A+ +EYL S
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE---KLTLKDLLQMALQIAKGMEYLES--- 120
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+ +HRD+ + N L++++ ++SDFGL++
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSR 150
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 7e-30
Identities = 50/156 (32%), Positives = 83/156 (53%), Gaps = 14/156 (8%)
Query: 428 NLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIIS 481
+G+G +VYKG L DGK AVK LK SE+ K+F+ E ++ L H N++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 482 LLGFCFEDNNLLLVYDFLSRGSL-----EENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
LLG C E+ L LV +++ G L + + + + A+ +A+ +EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
L S ++ +HRD+ + N L+ +D ++SDFGL++
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSR 153
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 7e-28
Identities = 55/175 (31%), Positives = 82/175 (46%), Gaps = 21/175 (12%)
Query: 428 NLIGKGGSSQVYKGCLPD-GKELAVK---ILKPSEDVIKEFVLEIEIITTLHHKNIISLL 483
L+G+G VY D G+ +AVK + SE+ ++ EI I+++L H NI+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 484 GFCF--EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSE----RYKVAMGVAEALEYL 537
G E N L + +++S GSL L K P E +Y + E L YL
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLP------EPVIRKY-TRQ-ILEGLAYL 117
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 592
HS ++HRD+K +NIL+ D +L+DFG AK + V GT +
Sbjct: 118 HS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYW 169
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 52/147 (35%), Positives = 84/147 (57%), Gaps = 6/147 (4%)
Query: 429 LIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE 488
IGKG V G G+++AVK LK + F+ E ++TTL H N++ LLG +
Sbjct: 13 TIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 489 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHR 548
N L +V +++++GSL + L + A +++ A+ V E +EYL + +HR
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEE---KNFVHR 126
Query: 549 DVKSSNILLSDDFEPQLSDFGLAKWAS 575
D+ + N+L+S+D ++SDFGLAK AS
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAKEAS 153
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 56/166 (33%), Positives = 81/166 (48%), Gaps = 19/166 (11%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE 488
IG+G S +VYK GKE+A+K ++ + + + EI I+ H NI+ +
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYD-SYL 85
Query: 489 DNNLL-LVYDFLSRGSLEENLHGNKKD----PAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
+ L +V +++ GSL + + N A+ V V + LEYLHS Q
Sbjct: 86 VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAY-------VCREVLQGLEYLHS---Q 135
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 589
VIHRD+KS NILLS D +L+DFG A A + V GT
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFA--AQLTKEKSKRNSVVGT 179
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 48/160 (30%), Positives = 77/160 (48%), Gaps = 15/160 (9%)
Query: 428 NLIGKGGSSQVYKGCLP-----DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNII 480
+G+G +V G+++AVK L S E +F EIEI+ TL H+NI+
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 481 SLLGFCFED--NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
G C + +L L+ ++L GSL + L ++ + + + ++YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLG 126
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578
S QR IHRD+ + NIL+ + ++SDFGLAK
Sbjct: 127 S---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK 163
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 6e-24
Identities = 52/171 (30%), Positives = 83/171 (48%), Gaps = 13/171 (7%)
Query: 423 NFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKN 478
N+ +LIG+G VYKG L G +A+K + E+ +K + EI+++ L H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
I+ +G ++L ++ ++ GSL + + F S V + L YLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGP----FPESLVAVYVYQVLQGLAYLH 116
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 589
Q VIHRD+K++NIL + D +L+DFG+A + V GT
Sbjct: 117 E---QGVIHRDIKAANILTTKDGVVKLADFGVA--TKLNDVSKDDASVVGT 162
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 98.7 bits (244), Expect = 3e-22
Identities = 58/180 (32%), Positives = 87/180 (48%), Gaps = 16/180 (8%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHK 477
++ +G+G +VY D K +A+K+L ++ F+ EI+I+ +L H
Sbjct: 1 SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 478 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
NI+ L F ++ +L LV +++ GSLE+ L SE + + ALEYL
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLK-KIGRKGPLSESEALFILAQILSALEYL 117
Query: 538 HSGSAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKWASTSSSH----ITCTDVAGTFGY 592
HS + +IHRD+K NILL D +L DFGLAK S + GT GY
Sbjct: 118 HS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
|
Length = 384 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 9e-21
Identities = 46/161 (28%), Positives = 81/161 (50%), Gaps = 21/161 (13%)
Query: 430 IGKGGSSQVYKG-----CLPDGKEL-AVKILK--PSEDVIKEFVLEIEIITTLHHKNIIS 481
+G+G +V+ G + KEL AVK LK S D K+F E E++T H+NI+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENL--HG--------NKKDPAAFGWSERYKVAMGVA 531
G C E + ++V++++ G L + L HG S+ ++A+ +A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 532 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+ YL ++Q +HRD+ + N L+ D ++ DFG+++
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 48/169 (28%), Positives = 80/169 (47%), Gaps = 17/169 (10%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
IG G ++ VY CLP+ +++A+K + K V E E++ ++ +H N++
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSV-DELRKEVQAMSQCNHPNVVKYYTS 67
Query: 486 CFEDNNLLLVYDFLSRGSLEENL-HGNKKDPAAFGWSERYKVAM--GVAEALEYLHSGSA 542
+ L LV +LS GSL + + + G E + V + LEYLHS
Sbjct: 68 FVVGDELWLVMPYLSGGSLLDIMKSSYPRG----GLDEAIIATVLKEVLKGLEYLHS--- 120
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS--SSHITCTDVAGT 589
IHRD+K+ NILL +D +++DFG++ + + GT
Sbjct: 121 NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGT 169
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 3e-20
Identities = 54/171 (31%), Positives = 87/171 (50%), Gaps = 18/171 (10%)
Query: 421 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL--------KPSEDVIKEFVLEIEII 471
NF E IGKG S VYK CL DG+ +A+K + K +D +KE I+++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKE----IDLL 56
Query: 472 TTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVA 531
L H N+I L E+N L +V + G L + KK +K + +
Sbjct: 57 KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116
Query: 532 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS--TSSSH 580
ALE++HS +R++HRD+K +N+ ++ +L D GL ++ S T+++H
Sbjct: 117 SALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH 164
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 45/151 (29%), Positives = 76/151 (50%), Gaps = 11/151 (7%)
Query: 424 FLAENLIGKGGSSQVYKG-CLPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNII 480
F IGKG +VYK + +A+K+ L+ +ED I++ EI+ ++ I
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
G + + L ++ ++ GS + L K D + R V LEYLH
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILRE-----VLLGLEYLHE- 116
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571
+ IHRD+K++NILLS++ + +L+DFG++
Sbjct: 117 --EGKIHRDIKAANILLSEEGDVKLADFGVS 145
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 59/176 (33%), Positives = 86/176 (48%), Gaps = 21/176 (11%)
Query: 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKE----FVL-EIEIITTL- 474
+F +IG+G S V KE A+KIL + +IKE +V E E++T L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQ-LIKEKKVKYVKIEKEVLTRLN 59
Query: 475 HHKNIISLLGFCFEDN-NLLLVYDFLSRGSLEE--NLHGNKKDPAAFGWSERYKVAMGVA 531
H II L + F+D NL V ++ G L + +G+ + R+ A +
Sbjct: 60 GHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCT-----RFYAAE-IL 112
Query: 532 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 587
ALEYLHS + +IHRD+K NILL D +++DFG AK +SS + A
Sbjct: 113 LALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDA 165
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 47/153 (30%), Positives = 81/153 (52%), Gaps = 8/153 (5%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIK--EFVLEIEIITTLHHKNI 479
F E +G G +V++G + +A+KILK S+D++K +F E++ + L HK++
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILK-SDDLLKQQDFQKEVQALKRLRHKHL 64
Query: 480 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 539
ISL C + ++ + + +GSL L + + +A VAE + YL
Sbjct: 65 ISLFAVCSVGEPVYIITELMEKGSLLAFL--RSPEGQVLPVASLIDMACQVAEGMAYLEE 122
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
Q IHRD+ + NIL+ +D +++DFGLA+
Sbjct: 123 ---QNSIHRDLAARNILVGEDLVCKVADFGLAR 152
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 87.9 bits (219), Expect = 2e-19
Identities = 49/172 (28%), Positives = 83/172 (48%), Gaps = 13/172 (7%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKN 478
+ IGKG +VY DGK +K + SE ++ + E++I+ L+H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
II E L +V ++ G L + + KK+ F + + + AL+YLH
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 590
S ++++HRD+K NI L+ + +L DFG++K S++ D+A T
Sbjct: 121 S---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST------VDLAKTV 163
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 5e-18
Identities = 45/167 (26%), Positives = 82/167 (49%), Gaps = 21/167 (12%)
Query: 430 IGKGGSSQVYKGCL-PDGKELAVKILK--PSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
+G+G S VYK P GK A+K + E+ K+ + E++ + + ++ G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQR 544
+++ + +V +++ GSL + L KK E +A + + L+YLH+
Sbjct: 69 YKEGEISIVLEYMDGGSLADLL---KKVG---KIPEPVLAYIARQILKGLDYLHTKR--H 120
Query: 545 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT-DVAGTF 590
+IHRD+K SN+L++ E +++DFG+ S + T D TF
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGI-------SKVLENTLDQCNTF 160
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 5e-18
Identities = 50/149 (33%), Positives = 86/149 (57%), Gaps = 8/149 (5%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 489
IGKG V G G ++AVK +K ++ + F+ E ++T L H N++ LLG E+
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIK-NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 71
Query: 490 N-NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHR 548
L +V +++++GSL + L + + G K ++ V EA+EYL + + +HR
Sbjct: 72 KGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126
Query: 549 DVKSSNILLSDDFEPQLSDFGLAKWASTS 577
D+ + N+L+S+D ++SDFGL K AS++
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASST 155
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 7e-18
Identities = 43/149 (28%), Positives = 78/149 (52%), Gaps = 8/149 (5%)
Query: 424 FLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISL 482
F +G+G VYK G+ +A+K++ P E+ ++E + EI I+ I+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDLQEIIKEISILKQCDSPYIVKY 63
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
G F++ +L +V ++ GS+ + + K E + + LEYLHS
Sbjct: 64 YGSYFKNTDLWIVMEYCGAGSVSDIMKITNK---TLTEEEIAAILYQTLKGLEYLHS--- 117
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLA 571
+ IHRD+K+ NILL+++ + +L+DFG++
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVS 146
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 8e-18
Identities = 53/170 (31%), Positives = 90/170 (52%), Gaps = 18/170 (10%)
Query: 422 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL--------KPSEDVIKEFVLEIEIIT 472
+NF E IG+G S+VY+ CL D K +A+K + K +D +KE I+++
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKE----IDLLK 57
Query: 473 TLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE 532
L+H N+I L EDN L +V + G L + + KK +K + +
Sbjct: 58 QLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117
Query: 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS--TSSSH 580
A+E++HS +RV+HRD+K +N+ ++ +L D GL ++ S T+++H
Sbjct: 118 AVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH 164
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 1e-17
Identities = 46/155 (29%), Positives = 78/155 (50%), Gaps = 23/155 (14%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKE-----FVLEIEIITTLHHKNIISLL 483
IG+G QVYK G+ +A+K ++ + KE + EI+++ L H NI+ L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENE--KEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 484 GFCFED--NNLLLVYDFLS---RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
++ +V++++ G L+ K F S+ + E L+YLH
Sbjct: 65 EIVTSKGKGSIYMVFEYMDHDLTGLLD---SPEVK----FTESQIKCYMKQLLEGLQYLH 117
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573
S ++HRD+K SNIL+++D +L+DFGLA+
Sbjct: 118 S---NGILHRDIKGSNILINNDGVLKLADFGLARP 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 44/155 (28%), Positives = 71/155 (45%), Gaps = 11/155 (7%)
Query: 428 NLIGKGGSSQVYKGC-LPDGKELAVKILK---PSEDVIKEFVLEIEIITTLHHKNIISLL 483
N IG G +VY L G+ +AVK ++ IKE E++++ L H N++
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 484 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
G + + ++ S G+LEE L + Y + + E L YLHS
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHV--IRVYTLQL--LEGLAYLHS---H 118
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578
++HRD+K +NI L + +L DFG A ++
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-17
Identities = 48/153 (31%), Positives = 82/153 (53%), Gaps = 18/153 (11%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKIL------KPSEDVIKEFVLEIEIITTLHHKNIIS 481
L+G G VY+G L DG AVK + + ++ +K+ EI +++ L H NI+
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYLHS 539
LG E++NL + + + GSL + L +G+ +P ++ + + LEYLH
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQ------ILLGLEYLHD 120
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+ +HRD+K +NIL+ + +L+DFG+AK
Sbjct: 121 ---RNTVHRDIKGANILVDTNGVVKLADFGMAK 150
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 3e-17
Identities = 41/125 (32%), Positives = 66/125 (52%), Gaps = 8/125 (6%)
Query: 450 AVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEEN 507
AVK LK D++ +F+ E I+ +L H+N+I L G + L++V + GSL +
Sbjct: 27 AVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVL-THPLMMVTELAPLGSLLDR 85
Query: 508 LHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSD 567
L + Y A+ +A + YL S +R IHRD+ + NILL+ D + ++ D
Sbjct: 86 LRKDALGHFLISTLCDY--AVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGD 140
Query: 568 FGLAK 572
FGL +
Sbjct: 141 FGLMR 145
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 5e-17
Identities = 52/144 (36%), Positives = 86/144 (59%), Gaps = 10/144 (6%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKE-FVLEIEIITTLHHKNIISLLGFCFE 488
IG+G V +G G+++AVK +K DV + F+ E ++T LHHKN++ LLG
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNIKC--DVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 489 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHR 548
N L +V + +S+G+L L + A + + ++ VAE +EYL S ++++HR
Sbjct: 71 -NGLYIVMELMSKGNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLES---KKLVHR 124
Query: 549 DVKSSNILLSDDFEPQLSDFGLAK 572
D+ + NIL+S+D ++SDFGLA+
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 7e-17
Identities = 53/171 (30%), Positives = 76/171 (44%), Gaps = 24/171 (14%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFC 486
+IG+G +VYK G+ +A+KI+ ED +E E I+ +H NI + G
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYG-A 71
Query: 487 F-------EDNNLLLVYDFLSRGS---LEENLH--GNKKDPAAFGWSERYKVAMGVAEAL 534
F D+ L LV + GS L + L G + + R L
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR-----ETLRGL 126
Query: 535 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCT 584
YLH +VIHRD+K NILL+ + E +L DFG+ A+ ST T
Sbjct: 127 AYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI 174
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 7e-17
Identities = 48/152 (31%), Positives = 78/152 (51%), Gaps = 14/152 (9%)
Query: 429 LIGKGGSSQVYKGC---LPD--GKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISL 482
+GKG V L D G+ +AVK L+ S + +++F EIEI+ +L H NI+
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 483 LGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
G C+ NL LV ++L GSL + L ++ + A + + +EYL
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYL--- 124
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
++R +HRD+ + NIL+ + ++ DFGL K
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTK 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 9e-17
Identities = 53/169 (31%), Positives = 89/169 (52%), Gaps = 25/169 (14%)
Query: 424 FLAENLIGKGGSSQVYKGCL--PDGKE----LAVKILKPSE--DVIKEFVLEIEIITTLH 475
FL E +G+G +VYKG L P+ + +A+K LK + V +EF E E+++ L
Sbjct: 9 FLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQ 66
Query: 476 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYK-------- 525
H NI+ LLG C ++ +++++L+ G L E L + D A E K
Sbjct: 67 HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126
Query: 526 --VAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+A+ +A +EYL S+ +HRD+ + N L+ + ++SDFGL++
Sbjct: 127 LHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 1e-16
Identities = 55/176 (31%), Positives = 82/176 (46%), Gaps = 28/176 (15%)
Query: 430 IGKGGSSQVY----KGCLPDGKELAVKILKPSEDVIKEFVL----EIEIITTLHHKNIIS 481
+GKG +V K GK A+K+LK + + ++ V E I++ ++H I+
Sbjct: 1 LGKGSFGKVLLVRKKD---TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 482 LLGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE---ALEYL 537
L + F+ L LV ++ G L +L + + Y AE ALEYL
Sbjct: 58 LH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSE--ERARFY-----AAEIVLALEYL 109
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYV 593
HS +I+RD+K NILL D +L+DFGLAK S+ S GT Y+
Sbjct: 110 HS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTFCGTPEYL 160
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 53/160 (33%), Positives = 85/160 (53%), Gaps = 17/160 (10%)
Query: 430 IGKGGSSQVYKGCLPDGKEL-AVKILK-PSEDVIKEFVLEIEIITTLHHKNIISLLGFCF 487
+G G +VYK + A KI++ SE+ +++F++EI+I++ H NI+ L F
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 488 EDNNLLLVYDFLSRGSL----EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
+N L ++ +F G+L E G + + V + EAL +LHS
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRY-------VCRQMLEALNFLHS---H 122
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHIT 582
+VIHRD+K+ NILL+ D + +L+DFG+ AK ST T
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT 162
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 52/144 (36%), Positives = 81/144 (56%), Gaps = 10/144 (6%)
Query: 446 GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLLVYDFLSR 501
G+++AVK LKP + I + EIEI+ L+H+NI+ G C ED N + L+ +FL
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92
Query: 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 561
GSL+E L NK ++ K A+ + + ++YL GS Q V HRD+ + N+L+ +
Sbjct: 93 GSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYL--GSRQYV-HRDLAARNVLVESEH 146
Query: 562 EPQLSDFGLAKWASTSSSHITCTD 585
+ ++ DFGL K T + T D
Sbjct: 147 QVKIGDFGLTKAIETDKEYYTVKD 170
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 47/150 (31%), Positives = 80/150 (53%), Gaps = 16/150 (10%)
Query: 430 IGKGGSSQVYKGCL--PDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
+G G S V K L P GK +AVK L+ +E + K+ + E++I+ + I+ G
Sbjct: 9 LGAGNSGVVSK-VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGW-SERY--KVAMGVAEALEYLHSGSA 542
+ + ++ + +++ GSL++ L G ER K+A+ V + L YLH
Sbjct: 68 FYNNGDISICMEYMDGGSLDKIL------KEVQGRIPERILGKIAVAVLKGLTYLHE--K 119
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
++IHRDVK SNIL++ + +L DFG++
Sbjct: 120 HKIIHRDVKPSNILVNSRGQIKLCDFGVSG 149
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 52/172 (30%), Positives = 81/172 (47%), Gaps = 14/172 (8%)
Query: 446 GKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLLVYDFLSR 501
G+ +AVK LK + + EI I+ TL+H+NI+ G C E L L+ +++
Sbjct: 33 GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPL 92
Query: 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 561
GSL + L +K ++ A + E + YLHS Q IHRD+ + N+LL +D
Sbjct: 93 GSLRDYLPKHK-----LNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDR 144
Query: 562 EPQLSDFGLAKWASTSSSHITCTDVAGT--FGYVVLILNPIAFLFMFNCWFF 611
++ DFGLAK + + + F Y V L F + + W F
Sbjct: 145 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSF 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 48/173 (27%), Positives = 85/173 (49%), Gaps = 40/173 (23%)
Query: 429 LIGKGGSSQVYKG------CLPDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNI 479
+G+G QV K + +AVK+LK E + + V E+E++ + HKNI
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 480 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNK--------------------KDPAAFG 519
I+LLG C ++ L +V ++ + G+L + L + KD +F
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 520 WSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+ VA +E+L S ++ IHRD+ + N+L+++D +++DFGLA+
Sbjct: 139 YQ--------VARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLAR 180
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 4e-16
Identities = 47/149 (31%), Positives = 77/149 (51%), Gaps = 14/149 (9%)
Query: 430 IGKGGSSQVYKGC--LPDGKEL--AVKILKPSEDVI--KEFVLEIEIITTLHHKNIISLL 483
+G G V KG + GKE+ AVK LK KEF+ E ++ L H I+ L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 484 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
G C + L+LV + G L + L ++ P S+ ++A VA + YL S +
Sbjct: 63 GVCKGEP-LMLVMELAPLGPLLKYLKKRREIPV----SDLKELAHQVAMGMAYLES---K 114
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+HRD+ + N+LL + + ++SDFG+++
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSR 143
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 5e-16
Identities = 43/147 (29%), Positives = 72/147 (48%), Gaps = 14/147 (9%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCF 487
IG G VYK + G+ +A+K++K D + EI ++ H NI++ G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL---EYLHSGSAQR 544
+ L +V ++ GSL++ + G ++A E L YLH
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIYQVTR------GPLSELQIAYVCRETLKGLAYLHE---TG 121
Query: 545 VIHRDVKSSNILLSDDFEPQLSDFGLA 571
IHRD+K +NILL++D + +L+DFG++
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 6e-16
Identities = 45/143 (31%), Positives = 74/143 (51%), Gaps = 5/143 (3%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 489
+G G +V++G + +AVK LKP K+F+ E +I+ L H +I L C +
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73
Query: 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 549
+ +V + + GSL E L G A + +A VA + YL AQ IHRD
Sbjct: 74 EPIYIVTELMKYGSLLEYLQGGAG--RALKLPQLIDMAAQVASGMAYLE---AQNYIHRD 128
Query: 550 VKSSNILLSDDFEPQLSDFGLAK 572
+ + N+L+ ++ +++DFGLA+
Sbjct: 129 LAARNVLVGENNICKVADFGLAR 151
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 2e-15
Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 19/151 (12%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILK--PSEDVIKEFVL-EIEIITTLHHKNIISLLGF 485
+G+G VYK G+ +A+K ++ E+ I L EI ++ L H NI+ LL
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDV 66
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHG--NKKDPAAFGWSERY-KVAMG-VAEALEYLHSGS 541
+ L LV+++ + +L +K+ S K M + L Y HS
Sbjct: 67 IHTERKLYLVFEYC-----DMDLKKYLDKRPGPL---SPNLIKSIMYQLLRGLAYCHS-- 116
Query: 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
R++HRD+K NIL++ D +L+DFGLA+
Sbjct: 117 -HRILHRDLKPQNILINRDGVLKLADFGLAR 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 49/157 (31%), Positives = 80/157 (50%), Gaps = 23/157 (14%)
Query: 428 NLIGKGGSSQVYKGCL--PDGKEL--AVKILKPSEDV--IKEFVLEIEIITTLHHKNIIS 481
+IGKG VY G L DG+++ AVK L D+ +++F+ E I+ H N++S
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 482 LLGFCFEDNNL-LLVYDFLSRGSLEENLHGNKKDPA-----AFGWSERYKVAMGVAEALE 535
LLG C L+V ++ G L + +P FG + VA+ +E
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFG--------LQVAKGME 112
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
YL S ++ +HRD+ + N +L + F +++DFGLA+
Sbjct: 113 YLAS---KKFVHRDLAARNCMLDESFTVKVADFGLAR 146
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 3e-15
Identities = 48/159 (30%), Positives = 82/159 (51%), Gaps = 14/159 (8%)
Query: 425 LAENLIGKGGSSQVYKGCLPDGKEL-AVKILK-PSEDVIKEFVLEIEIITTLHHKNIISL 482
L E GK ++ Y C K L AVK LK S++ K+F E E++T L H++I+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD---------PAAFGWSERYKVAMGVAEA 533
G C E + L++V++++ G L + L + D PA S+ +A +A
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+ YL S Q +HRD+ + N L+ ++ ++ DFG+++
Sbjct: 133 MVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMSR 168
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 54/170 (31%), Positives = 87/170 (51%), Gaps = 18/170 (10%)
Query: 422 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL--------KPSEDVIKEFVLEIEIIT 472
+NF E IG+G S+VY+ CL DG +A+K + K D IKE I+++
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKE----IDLLK 57
Query: 473 TLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE 532
L+H N+I EDN L +V + G L + KK +K + +
Sbjct: 58 QLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117
Query: 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS--TSSSH 580
ALE++HS +RV+HRD+K +N+ ++ +L D GL ++ S T+++H
Sbjct: 118 ALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH 164
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 3e-15
Identities = 46/147 (31%), Positives = 75/147 (51%), Gaps = 10/147 (6%)
Query: 429 LIGKGGSSQVYKGCLPDGKELAVKILK---PSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
IGKG VYKG L E+AVK + P + K F+ E EI+ H NI+ L+G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRK-FLQEAEILKQYDHPNIVKLIGV 60
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
C + + +V + + GSL L K + ++++ A +EYL S +
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKK---NRLTVKKLLQMSLDAAAGMEYLES---KNC 114
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAK 572
IHRD+ + N L+ ++ ++SDFG+++
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 4e-15
Identities = 50/165 (30%), Positives = 82/165 (49%), Gaps = 21/165 (12%)
Query: 428 NLIGKGGSSQVYKGCLPDGKELAVK--ILKPS-----EDVIKEFVLEIEIITTLHHKNII 480
++GKG VY G G+ +AVK L S E ++ E++++ +L H NI+
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLH 538
LG C +DN + + +F+ GS+ L N+ P +Y ++ GVA YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSIL--NRFGPLPEPVFCKYTKQILDGVA----YLH 119
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK---WASTSSSH 580
+ V+HRD+K +N++L + +L DFG A+ W +H
Sbjct: 120 NNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTH 161
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 6e-15
Identities = 47/151 (31%), Positives = 83/151 (54%), Gaps = 22/151 (14%)
Query: 430 IGKGGSSQVYK------GCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLL 483
+G G +VYK G L K + K SE+ ++++++EIEI+ T +H I+ LL
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDYMVEIEILATCNHPYIVKLL 75
Query: 484 GFCFEDNNLLLVYDFLSRGSLEE---NLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
G + D L ++ +F G+++ L +P + + + EAL+YLHS
Sbjct: 76 GAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEP------QIQVICRQMLEALQYLHS- 128
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571
++IHRD+K+ N+LL+ D + +L+DFG++
Sbjct: 129 --MKIIHRDLKAGNVLLTLDGDIKLADFGVS 157
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 9e-15
Identities = 38/155 (24%), Positives = 79/155 (50%), Gaps = 12/155 (7%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNII 480
++ ++ +G G +VY+G +AVK LK ++EF+ E ++ + H N++
Sbjct: 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 65
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYL 537
LLG C + ++ +F++ G+L + L + + +A ++ A+EYL
Sbjct: 66 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYL 120
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+ IHRD+ + N L+ ++ +++DFGL++
Sbjct: 121 EKKN---FIHRDLAARNCLVGENHLVKVADFGLSR 152
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 9e-15
Identities = 48/173 (27%), Positives = 83/173 (47%), Gaps = 16/173 (9%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKIL--KPSEDVIKEFVLEIEIITTLHHKNI 479
+ + +G+G V K L + + A+K + P+ D+ K+ + E+EI + I
Sbjct: 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYI 61
Query: 480 ISLLGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
+ G + +++ + ++ GSL+ KK G K+A V + L YL
Sbjct: 62 VKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 590
HS +++IHRD+K SNILL+ + +L DFG++ S +AGTF
Sbjct: 122 HS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS--------LAGTF 163
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 1e-14
Identities = 53/173 (30%), Positives = 86/173 (49%), Gaps = 16/173 (9%)
Query: 423 NFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSE-----DVIKEFVL-EIEIITTLH 475
+ +G+G + VYK G+ +A+K +K E D I L EI+++ L
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 476 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVA-EAL 534
H NII LL +N+ LV++F+ LE+ + KD + K M + L
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFME-TDLEKVI----KDKSIVLTPADIKSYMLMTLRGL 115
Query: 535 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 587
EYLHS ++HRD+K +N+L++ D +L+DFGLA+ + + +T V
Sbjct: 116 EYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVT 165
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 50/169 (29%), Positives = 80/169 (47%), Gaps = 14/169 (8%)
Query: 429 LIGKGGSSQVYKGC--LPDGKELAVKILKPSED--VIKEFVL-EIEIITTLHHKNIISLL 483
++G+G V K C G+ +A+K K SED +K+ L E++++ L H+NI++L
Sbjct: 8 VVGEGAYGVVLK-CRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 484 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
L LV++++ R LE + P + +A+ Y HS
Sbjct: 67 EAFRRKGRLYLVFEYVERTLLEL----LEASPGGLPPDAVRSYIWQLLQAIAYCHS---H 119
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 592
+IHRD+K NIL+S+ +L DFG A+ A + TD T Y
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFAR-ALRARPASPLTDYVATRWY 167
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 38/143 (26%), Positives = 74/143 (51%), Gaps = 6/143 (4%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 489
IG G V+ G + +++A+K ++ ++F+ E +++ L H ++ L G C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER 71
Query: 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 549
+ + LV++F+ G L + L + F + + V E + YL S + VIHRD
Sbjct: 72 SPICLVFEFMEHGCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLESSN---VIHRD 125
Query: 550 VKSSNILLSDDFEPQLSDFGLAK 572
+ + N L+ ++ ++SDFG+ +
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTR 148
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 42/143 (29%), Positives = 76/143 (53%), Gaps = 5/143 (3%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 489
+G G +V+ G ++AVK LKP + F+ E +I+ L H ++ L C E+
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEE 73
Query: 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 549
+ +V +++S+GSL + L + + +A +AE + YL S + IHRD
Sbjct: 74 EPIYIVTEYMSKGSLLDFLK--SGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRD 128
Query: 550 VKSSNILLSDDFEPQLSDFGLAK 572
+ + NIL+ ++ +++DFGLA+
Sbjct: 129 LAARNILVGENLVCKIADFGLAR 151
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 46/160 (28%), Positives = 80/160 (50%), Gaps = 17/160 (10%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKPSE--DVIKEFVL-EIEIITTLHHKNIISLLGF 485
IG+G VYK G+ +A+K +K + I + L EI+++ L+H NII LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSE---RYKVAMGVAEALEYLHSGSA 542
+L LV++F+ + +L+ KD G E + + + + L + HS
Sbjct: 67 FRHKGDLYLVFEFM-----DTDLYKLIKD-RQRGLPESLIKSYLYQ-LLQGLAFCHS--- 116
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 582
++HRD+K N+L++ + +L+DFGLA+ + T
Sbjct: 117 HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYT 156
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 6e-14
Identities = 46/152 (30%), Positives = 80/152 (52%), Gaps = 12/152 (7%)
Query: 427 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 480
E +IG G +V +G L P KE+ A+K LK S+ +F+ E I+ H NII
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
L G + ++++ +++ GSL++ L N F + + G+A ++YL
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYL--- 122
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
S +HRD+ + NIL++ + ++SDFGL++
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSR 154
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 7e-14
Identities = 50/164 (30%), Positives = 90/164 (54%), Gaps = 21/164 (12%)
Query: 427 ENLIGKGGSSQVYKGCLP-DGKEL--AVKILK--PSEDVIKEFVLEIEIITTL-HHKNII 480
E++IG+G QV + + DG ++ A+K+LK SE+ ++F E+E++ L HH NII
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNK---KDPA---------AFGWSERYKVAM 528
+LLG C L + ++ G+L + L ++ DPA + + A
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
VA ++YL S ++ IHRD+ + N+L+ ++ +++DFGL++
Sbjct: 127 DVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 7e-14
Identities = 46/154 (29%), Positives = 86/154 (55%), Gaps = 16/154 (10%)
Query: 427 ENLIGKGGSSQVYKGCL--PDGKE--LAVKILKP--SEDVIKEFVLEIEIITTLHHKNII 480
+ +IG G +V++G L P KE +A+K LKP +E ++F+ E I+ H NII
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM--GVAEALEYLH 538
L G + +++ +++ G+L++ L + + +++ V M G+A ++YL
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-----VGMLRGIAAGMKYL- 123
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
S +HRD+ + NIL++ + E ++SDFGL++
Sbjct: 124 --SDMNYVHRDLAARNILVNSNLECKVSDFGLSR 155
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 8e-14
Identities = 53/156 (33%), Positives = 84/156 (53%), Gaps = 23/156 (14%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFC 486
++G G QVYKG + G+ A+K++ +ED +E LEI ++ HH+NI + G
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 487 FE------DNNLLLVYDFLSRGS---LEENLHGN--KKDPAAFGWSERYKVAMGVAEALE 535
+ D+ L LV +F GS L +N GN K+D A+ + + L
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY-------ICREILRGLA 135
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571
+LH A +VIHRD+K N+LL+++ E +L DFG++
Sbjct: 136 HLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVS 168
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 9e-14
Identities = 42/139 (30%), Positives = 77/139 (55%), Gaps = 18/139 (12%)
Query: 449 LAVKILK--PSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSRGSLE 505
+AVK+LK ++ + + + E+E++ + HKNII+LLG C ++ L ++ ++ ++G+L
Sbjct: 47 VAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLR 106
Query: 506 ENLH------------GNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSS 553
E L K + + A VA +EYL S +R IHRD+ +
Sbjct: 107 EFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAAR 163
Query: 554 NILLSDDFEPQLSDFGLAK 572
N+L+++D +++DFGLA+
Sbjct: 164 NVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 9e-14
Identities = 46/147 (31%), Positives = 74/147 (50%), Gaps = 10/147 (6%)
Query: 429 LIGKGGSSQVYKGCLPDGKELAVKILK---PSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
L+GKG +V+KG L D +AVK K P E IK F+ E I+ H NI+ L+G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIK-FLSEARILKQYDHPNIVKLIGV 60
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
C + + +V + + G L K + + K A+ A + YL S +
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDE---LKTKQLVKFALDAAAGMAYLES---KNC 114
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAK 572
IHRD+ + N L+ ++ ++SDFG+++
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 43/140 (30%), Positives = 80/140 (57%), Gaps = 18/140 (12%)
Query: 448 ELAVKILKP--SEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504
++AVK+LK +E + + + E+E++ + HKNII+LLG C +D L ++ ++ S+G+L
Sbjct: 52 KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 111
Query: 505 EENLHGNKKDPAAFGWS------------ERYKVAMGVAEALEYLHSGSAQRVIHRDVKS 552
E L + + ++ + A VA +EYL S ++ IHRD+ +
Sbjct: 112 REYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAA 168
Query: 553 SNILLSDDFEPQLSDFGLAK 572
N+L+++D +++DFGLA+
Sbjct: 169 RNVLVTEDNVMKIADFGLAR 188
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 52/179 (29%), Positives = 84/179 (46%), Gaps = 23/179 (12%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSE----DVIKEFVLEIEIITTLHHK 477
+F +IGKG +V D K++ A+K + + ++ + E I+ L+H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 478 NIISLLGFCFEDN-NLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEA 533
+++L + F+D N+ LV D L G L +L K + F E + A
Sbjct: 61 FLVNLW-YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICE-------IVLA 112
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 592
LEYLHS + +IHRD+K NILL + ++DF +A + + T +GT GY
Sbjct: 113 LEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL---TTSTSGTPGY 165
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 47/164 (28%), Positives = 79/164 (48%), Gaps = 21/164 (12%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILK---PSEDVIKEFVLEIEIITTLHH---KNIIS 481
LIG+G VY+G +P G+ +A+KI+ P +DV + E+ +++ L NI
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDV-SDIQREVALLSQLRQSQPPNITK 66
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK--VAMGVAEALEYLHS 539
G + L ++ ++ GS+ + E+Y + V AL+Y+H
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIA-------EKYISVIIREVLVALKYIHK 119
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHIT 582
VIHRD+K++NIL+++ +L DFG+ A SS T
Sbjct: 120 VG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST 160
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 51/164 (31%), Positives = 88/164 (53%), Gaps = 21/164 (12%)
Query: 427 ENLIGKGGSSQVYKGCL-PDGKEL--AVKILK--PSEDVIKEFVLEIEIITTL-HHKNII 480
+++IG+G QV K + DG + A+K +K S+D ++F E+E++ L HH NII
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNK---KDPA---------AFGWSERYKVAM 528
+LLG C L L ++ G+L + L ++ DPA + A
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
VA ++YL S ++ IHRD+ + NIL+ +++ +++DFGL++
Sbjct: 132 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 51/171 (29%), Positives = 83/171 (48%), Gaps = 19/171 (11%)
Query: 429 LIGKGGSSQVYKGC--LPDGKELAVKIL------KPSEDVIKEFVLEIEIITTLHHKNII 480
L+G+G +VY C + G+ELAVK + ++ + EI+++ L H+ I+
Sbjct: 9 LLGQGAFGRVYL-CYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 481 SLLGFCFEDNNLLLVY-DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 539
G C D+ L ++ +++ GS+++ L K A + K + E +EYLHS
Sbjct: 68 QYYG-CLRDDETLSIFMEYMPGGSVKDQL----KAYGALTETVTRKYTRQILEGVEYLHS 122
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT-CTDVAGT 589
++HRD+K +NIL +L DFG +K T S T V GT
Sbjct: 123 ---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGT 170
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 46/153 (30%), Positives = 78/153 (50%), Gaps = 14/153 (9%)
Query: 424 FLAENLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNII 480
FL E +G G V+ G ++A+K+++ SED +F+ E +++ L H N++
Sbjct: 8 FLKE--LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLSHPNLV 62
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
L G C + + +V ++++ G L L K G + V EA+EYL S
Sbjct: 63 QLYGVCTKQRPIFIVTEYMANGCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLESN 119
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573
IHRD+ + N L+ +D ++SDFGLA++
Sbjct: 120 G---FIHRDLAARNCLVGEDNVVKVSDFGLARY 149
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 50/169 (29%), Positives = 80/169 (47%), Gaps = 15/169 (8%)
Query: 429 LIGKGGSSQVYKGCL--PDGKELAVKILKPSED---VIKEFVLEIEIITTLHHKNIISLL 483
L+G+G V K C G+ +A+K SED V K + EI ++ L H+N+++L+
Sbjct: 8 LVGEGSYGMVMK-CKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66
Query: 484 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
L LV++F+ L++ +K P S K + +E+ HS
Sbjct: 67 EVFRRKKRLYLVFEFVDHTVLDDL----EKYPNGLDESRVRKYLFQILRGIEFCHS---H 119
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 592
+IHRD+K NIL+S +L DFG A+ + ++ TD T Y
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFAR--TLAAPGEVYTDYVATRWY 166
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 43/144 (29%), Positives = 80/144 (55%), Gaps = 8/144 (5%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVK--ILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCF 487
+G G +VYK + LA I SE+ ++++++EI+I+ + H NI+ LL +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 547
+NNL ++ +F + G+++ + ++ + V EAL YLH ++IH
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELER---PLTEPQIRVVCKQTLEALNYLHE---NKIIH 126
Query: 548 RDVKSSNILLSDDFEPQLSDFGLA 571
RD+K+ NIL + D + +L+DFG++
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 4e-13
Identities = 48/143 (33%), Positives = 74/143 (51%), Gaps = 10/143 (6%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFCF 487
IG+G S VY + G+E+A+K + + KE ++ EI ++ H NI++ L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 547
+ L +V ++L+ GSL + + D V +ALE+LHS +VIH
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALEFLHS---NQVIH 138
Query: 548 RDVKSSNILLSDDFEPQLSDFGL 570
RD+KS NILL D +L+DFG
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGF 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 46/141 (32%), Positives = 79/141 (56%), Gaps = 22/141 (15%)
Query: 449 LAVKILK--PSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSRGSLE 505
+AVK+LK ++ + + V E+E++ + HKNII+LLG C +D L ++ ++ S+G+L
Sbjct: 47 VAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLR 106
Query: 506 ENLHGNKKDPAAFGWS--------------ERYKVAMGVAEALEYLHSGSAQRVIHRDVK 551
E L + P +S + A VA +EYL S Q+ IHRD+
Sbjct: 107 EYLRARR--PPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLA 161
Query: 552 SSNILLSDDFEPQLSDFGLAK 572
+ N+L+++D +++DFGLA+
Sbjct: 162 ARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-13
Identities = 49/168 (29%), Positives = 86/168 (51%), Gaps = 12/168 (7%)
Query: 427 ENLIGKGGSSQVYKGCL--PDGKE--LAVKILKP--SEDVIKEFVLEIEIITTLHHKNII 480
E +IG G +V +G L P +E +A+K LK +E ++F+ E I+ H NII
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
L G + ++++ +F+ G+L+ L N F + + G+A ++YL
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQND---GQFTVIQLVGMLRGIAAGMKYL--- 122
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 588
S +HRD+ + NIL++ + ++SDFGL+++ +S T T G
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLG 170
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 53/163 (32%), Positives = 89/163 (54%), Gaps = 21/163 (12%)
Query: 428 NLIGKGGSSQVYKGCLP-DGKEL--AVKILK--PSEDVIKEFVLEIEIITTL-HHKNIIS 481
++IG+G QV K + DG + A+K +K S+D ++F E+E++ L HH NII+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNK---KDPA-------AFGWSER--YKVAMG 529
LLG C L L ++ G+L + L ++ DPA A S + A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
VA ++YL S ++ IHRD+ + NIL+ +++ +++DFGL++
Sbjct: 121 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 6e-13
Identities = 45/169 (26%), Positives = 80/169 (47%), Gaps = 29/169 (17%)
Query: 430 IGKGGSSQVYK----GCLPDGKEL--AVKILK--PSEDVIKEFVLEIEIITTLHHKNIIS 481
IG+G +V++ G LP AVK+LK S D+ +F E ++ H NI+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNK------------------KDPAAFGWSER 523
LLG C + L++++++ G L E L +P +E+
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 524 YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+A VA + YL S ++ +HRD+ + N L+ ++ +++DFGL++
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 178
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 9e-13
Identities = 38/129 (29%), Positives = 71/129 (55%), Gaps = 12/129 (9%)
Query: 448 ELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504
++A+K++K SED EF+ E +++ L H+ ++ L G C + + +V +++S G L
Sbjct: 30 DVAIKMIKEGSMSED---EFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCL 86
Query: 505 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 564
L + K S+ ++ V E + YL S ++ IHRD+ + N L+ D +
Sbjct: 87 LNYLREHGKRFQP---SQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVK 140
Query: 565 LSDFGLAKW 573
+SDFGL+++
Sbjct: 141 VSDFGLSRY 149
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 46/143 (32%), Positives = 80/143 (55%), Gaps = 26/143 (18%)
Query: 449 LAVKILK--PSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSRGSLE 505
+AVK+LK +E + + V E+E++ + HKNII+LLG C +D L ++ ++ S+G+L
Sbjct: 50 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 109
Query: 506 ENLHGNKKDPAAFGW----------------SERYKVAMGVAEALEYLHSGSAQRVIHRD 549
E L + + + S Y+VA G +EYL S Q+ IHRD
Sbjct: 110 EYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARG----MEYLAS---QKCIHRD 162
Query: 550 VKSSNILLSDDFEPQLSDFGLAK 572
+ + N+L++++ +++DFGLA+
Sbjct: 163 LAARNVLVTENNVMKIADFGLAR 185
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 40/141 (28%), Positives = 79/141 (56%), Gaps = 20/141 (14%)
Query: 449 LAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEE 506
+AVKIL+P +++ +F+ E++I++ L NII LLG C +++ L ++ +++ G L +
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 507 NL----------HGNKKDPAA-----FGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVK 551
L +GN P A +S VA+ +A ++YL S+ +HRD+
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLA 165
Query: 552 SSNILLSDDFEPQLSDFGLAK 572
+ N L+ ++ +++DFG+++
Sbjct: 166 TRNCLVGENLTIKIADFGMSR 186
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 45/162 (27%), Positives = 78/162 (48%), Gaps = 17/162 (10%)
Query: 425 LAENLIGKGGSSQVYKGCLPDGKEL-AVKILK-PSEDVIKEFVLEIEIITTLHHKNIISL 482
L E GK ++ Y K L AVK LK P+ K+F E E++T L H++I+
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDP------------AAFGWSERYKVAMGV 530
G C + + L++V++++ G L + L + D G S+ +A +
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 531 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
A + YL S Q +HRD+ + N L+ + ++ DFG+++
Sbjct: 133 ASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSR 171
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 47/145 (32%), Positives = 78/145 (53%), Gaps = 11/145 (7%)
Query: 430 IGKGGSSQVYKGCLPDGKEL-AVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
IGKG +VYKG KE+ A+KI L+ +ED I++ EI +++ I G
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
+ L ++ ++L GS + L P + + + + L+YLHS +R I
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLL-----KPGPLEETYIATILREILKGLDYLHS---ERKI 123
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLA 571
HRD+K++N+LLS+ + +L+DFG+A
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVA 148
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 48/156 (30%), Positives = 82/156 (52%), Gaps = 14/156 (8%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILK---PSEDVIKEFVLEIEIITTLHHKN 478
NF IG+G VYK G+ +A+K ++ +E V + EI ++ L+H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD--PAAFGWSERYKVAMGVAEALEY 536
I+ LL +N L LV++FL + L++ + + P S +++ G+A +
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLA----F 115
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
HS RV+HRD+K N+L++ + +L+DFGLA+
Sbjct: 116 CHS---HRVLHRDLKPQNLLINTEGAIKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 59/201 (29%), Positives = 94/201 (46%), Gaps = 22/201 (10%)
Query: 401 LHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYK-GCLPDGKELAVKILKPSED 459
L+ + + + L T + IGKG +VYK DG AVKIL P D
Sbjct: 1 LYGLFPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD 60
Query: 460 VIKEFVLEIEIITTL-HHKNIISLLGFCFEDNN-----LLLVYDFLSRGSLEENLHG--- 510
V +E E I+ +L +H N++ G ++ + L LV + + GS+ E + G
Sbjct: 61 VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLI 120
Query: 511 --NKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568
+ D A + + G L++LH+ R+IHRDVK +NILL+ + +L DF
Sbjct: 121 CGQRLDEAMISY-----ILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDF 172
Query: 569 GLAKWASTSSSHITCTDVAGT 589
G++ A +S+ + GT
Sbjct: 173 GVS--AQLTSTRLRRNTSVGT 191
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 53/180 (29%), Positives = 88/180 (48%), Gaps = 20/180 (11%)
Query: 402 HEKYSATCRLF-NYQDLLSATSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKP 456
HE++ A +L + D +F+ IG+G + V C+ GK++AVK +
Sbjct: 4 HEQFRAALQLVVSPGDPREYLDSFIK---IGEGSTGIV---CIATEKHTGKQVAVKKMDL 57
Query: 457 SEDVIKEFVL-EIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDP 515
+ +E + E+ I+ HH+N++ + + L +V +FL G+L + + + +
Sbjct: 58 RKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE 117
Query: 516 AAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575
V + V AL YLH+ Q VIHRD+KS +ILL+ D +LSDFG S
Sbjct: 118 EQIA-----TVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVS 169
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 48/150 (32%), Positives = 80/150 (53%), Gaps = 15/150 (10%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSED--VIKEFVLEIEIITTLHHKNIISLLGF 485
IG+G VYKG G+ +A+K I SE+ V + EI ++ L H NI+ L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 486 CFEDNNLLLVYDFLSRGSLE---ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
+++ L L+++FLS L+ ++L + A S Y++ G+ + HS
Sbjct: 68 LMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGIL----FCHS--- 119
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+RV+HRD+K N+L+ + +L+DFGLA+
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLAR 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 43/161 (26%), Positives = 76/161 (47%), Gaps = 21/161 (13%)
Query: 430 IGKGGSSQVY----KGCLPDGKEL--AVKILKP-SEDVIKEFVLEIEIITTLHHKNIISL 482
+G+G +V+ LP+ ++ AVK LK SE ++F E E++T L H++I+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD-----------PAAFGWSERYKVAMGVA 531
G C E LL+V++++ G L L + D P + +A +A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 532 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+ YL S +HRD+ + N L+ ++ DFG+++
Sbjct: 133 SGMVYLAS---LHFVHRDLATRNCLVGQGLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 46/151 (30%), Positives = 77/151 (50%), Gaps = 13/151 (8%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFC 486
L+G G QVYKG + G+ A+K++ + D +E EI ++ HH+NI + G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 487 FE------DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
+ D+ L LV +F GS+ + + K + W + + L +LH
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLHQ- 129
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571
+VIHRD+K N+LL+++ E +L DFG++
Sbjct: 130 --HKVIHRDIKGQNVLLTENAEVKLVDFGVS 158
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 39/161 (24%), Positives = 77/161 (47%), Gaps = 20/161 (12%)
Query: 430 IGKGGSSQVYKGC-LPDGK----ELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISL 482
+G G VYKG +P+G+ +A+K+L+ KE + E ++ ++ H +++ L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAA---FGWSERYKVAMGVAEALEYLHS 539
LG C + L+ + G L + + +K + + W + +A+ + YL
Sbjct: 75 LGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYL-- 125
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580
+R++HRD+ + N+L+ +++DFGLAK
Sbjct: 126 -EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE 165
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 45/145 (31%), Positives = 80/145 (55%), Gaps = 11/145 (7%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
IGKG +V+KG K +A+KI L+ +ED I++ EI +++ + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
+D L ++ ++L GS + L +P ++ + + + L+YLHS ++ I
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLHS---EKKI 123
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLA 571
HRD+K++N+LLS+ E +L+DFG+A
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFGVA 148
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 4e-12
Identities = 43/161 (26%), Positives = 76/161 (47%), Gaps = 21/161 (13%)
Query: 430 IGKG--GSSQVYK----GCLPDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIIS 481
+GKG G + +Y+ L KE+ + L E D + E I I++ L H NII+
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNE----IVILSLLQHPNIIA 63
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM--GVAEALEYLHS 539
+DN LL+ ++ + G+L + + ++ F E + + A+ Y+H
Sbjct: 64 YYNHFMDDNTLLIEMEYANGGTLYDKI--VRQKGQLF--EEEMVLWYLFQIVSAVSYIHK 119
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580
++HRD+K+ NI L+ +L DFG++K + S
Sbjct: 120 AG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM 157
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 5e-12
Identities = 37/147 (25%), Positives = 80/147 (54%), Gaps = 13/147 (8%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 489
+G G +V+ G + ++AVK LKP ++ F+ E ++ TL H ++ L ++
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73
Query: 490 NNLLLVYDFLSRGSLEENLHGNKKD----PAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
+ ++ +++++GSL + L ++ P +S + +AE + Y+ +
Sbjct: 74 EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ------IAEGMAYIER---KNY 124
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAK 572
IHRD++++N+L+S+ +++DFGLA+
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLAR 151
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 45/147 (30%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVK-ILKPSED--VIKEFVLEIEIITTLHHKNIISLLGF 485
IG+G VYK G+ +A+K I +ED V + EI ++ L+H NI+ LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
+N L LV++FL L+ + + + + + Y HS RV
Sbjct: 67 VHSENKLYLVFEFLD---LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---HRV 120
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAK 572
+HRD+K N+L+ + +L+DFGLA+
Sbjct: 121 LHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 6e-12
Identities = 46/154 (29%), Positives = 77/154 (50%), Gaps = 7/154 (4%)
Query: 423 NFLAENLIGKGGSSQVYK-GCLPDGKELAVKILKPSEDVIKE---FVLEIEIITTLHHKN 478
+F +GKG VYK L D + A+K + KE V EI I+ +++H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
IIS + N L +V ++ G L + + KK E +++ + + L+ LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
Q+++HRD+KS+NILL + ++ D G++K
Sbjct: 121 E---QKILHRDLKSANILLVANDLVKIGDLGISK 151
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 7e-12
Identities = 37/147 (25%), Positives = 75/147 (51%), Gaps = 14/147 (9%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 489
+G+G +V+ G +A+K LKP + F+ E +++ L H+ ++ L E+
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 73
Query: 490 NNLLLVYDFLSRGSLEENLHGNK----KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
+ +V +++S+GSL + L G + P + + M E + Y
Sbjct: 74 P-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY--------- 123
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAK 572
+HRD++++NIL+ ++ +++DFGLA+
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 8e-12
Identities = 47/159 (29%), Positives = 79/159 (49%), Gaps = 18/159 (11%)
Query: 429 LIGKGGSSQVYKGCL--PDGKEL--AVKILKP---SEDVIKEFVLEIEIITTLHHKNIIS 481
++G+G V +G L DG +L AVK +K + I+EF+ E + H N++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 482 LLGFCFEDNNL------LLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEA 533
L+G CFE ++L +++ F+ G L L ++ P K + +A
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+EYL S + IHRD+ + N +L +D ++DFGL+K
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 8e-12
Identities = 45/146 (30%), Positives = 74/146 (50%), Gaps = 18/146 (12%)
Query: 430 IGKGGSSQVYKGCLP----DGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLG 484
IG+G + V C+ G+++AVK + + +E + E+ I+ H NI+ +
Sbjct: 27 IGEGSTGIV---CIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYS 83
Query: 485 FCFEDNNLLLVYDFLSRGSLEENL-HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
+ L +V +FL G+L + + H + V + V +AL +LH+ Q
Sbjct: 84 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI------ATVCLAVLKALSFLHA---Q 134
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFG 569
VIHRD+KS +ILL+ D +LSDFG
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDFG 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 9e-12
Identities = 43/160 (26%), Positives = 76/160 (47%), Gaps = 19/160 (11%)
Query: 428 NLIGKGGSSQVYKGCL----PDGKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNI 479
+G G +VY+G D EL V + SE +F++E I++ +H+NI
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 480 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNK---KDPAAFGWSERYKVAMGVAEALEY 536
+ L+G FE ++ + ++ G L+ L N+ + P++ + A VA+ +Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAK 572
L IHRD+ + N LL+ P ++DFG+A+
Sbjct: 132 LEE---NHFIHRDIAARNCLLTCK-GPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 44/156 (28%), Positives = 74/156 (47%), Gaps = 13/156 (8%)
Query: 429 LIGKGGSSQVYKGCLPDGK----ELAVKILK--PSEDVIKEFVLEIEIITTLHHKNIISL 482
IG+G VY+G + +AVK K S V ++F+ E I+ H +I+ L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
+G +N + +V + G L L NK + + + ++ AL YL S
Sbjct: 73 IGVI-TENPVWIVMELAPLGELRSYLQVNKY---SLDLASLILYSYQLSTALAYLES--- 125
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578
+R +HRD+ + N+L+S +L DFGL+++ S
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 39/143 (27%), Positives = 77/143 (53%), Gaps = 6/143 (4%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 489
+G+G +V+ G ++A+K LKP + + F+ E +I+ L H ++ L E+
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEE 73
Query: 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 549
+ +V +F+ +GSL + L + D + +A +A+ + Y+ IHRD
Sbjct: 74 P-IYIVTEFMGKGSLLDFL--KEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRD 127
Query: 550 VKSSNILLSDDFEPQLSDFGLAK 572
++++NIL+ D+ +++DFGLA+
Sbjct: 128 LRAANILVGDNLVCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 47/143 (32%), Positives = 76/143 (53%), Gaps = 10/143 (6%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFCF 487
IG+G S V+ + G+E+A+K + + KE ++ EI ++ L + NI++ L
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 547
+ L +V ++L+ GSL + + D A V +ALE+LH A +VIH
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTETCMDEAQIA-----AVCRECLQALEFLH---ANQVIH 138
Query: 548 RDVKSSNILLSDDFEPQLSDFGL 570
RD+KS N+LL D +L+DFG
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGF 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 48/158 (30%), Positives = 70/158 (44%), Gaps = 8/158 (5%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKE---FVLEIEIITTLHHKNIISLLGF 485
IGKG V K DGK L K + KE V E+ I+ L H NI+
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 486 CFEDNN--LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA- 542
+ +N L +V ++ G L + + KK+ +++ + AL H+ S
Sbjct: 68 IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDP 127
Query: 543 -QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579
V+HRD+K +NI L + +L DFGLAK SS
Sbjct: 128 GNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS 165
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 48/156 (30%), Positives = 74/156 (47%), Gaps = 19/156 (12%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVK-------ILKPSEDVIKEFV----LEIEIITTLHH 476
LIGKG +VY + G+ +AVK I + K+ V EIE + L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 477 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
NI+ LGF + L + +++ GS+ L + F V E L Y
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL----RTYGRFEEQLVRFFTEQVLEGLAY 123
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
LHS + ++HRD+K+ N+L+ D ++SDFG++K
Sbjct: 124 LHS---KGILHRDLKADNLLVDADGICKISDFGISK 156
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 40/162 (24%), Positives = 72/162 (44%), Gaps = 13/162 (8%)
Query: 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVK---ILKPSEDVIKEFVLEIEIITTLHHKN 478
+F N IGKG V+K D + A+K + K + +E + E ++ L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER--YKVAMGVAEALEY 536
II + L +V ++ G L + L + P E ++ + + L +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPL----PEDQVWRFFIQILLGLAH 116
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578
LHS ++++HRD+KS N+ L ++ D G+AK S ++
Sbjct: 117 LHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 49/173 (28%), Positives = 83/173 (47%), Gaps = 17/173 (9%)
Query: 422 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILK--PSEDVIKEFVL-EIEIITTLHHK 477
+ F N IG+G VY+ G+ +A+K ++ D I L EI ++ L H
Sbjct: 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHP 66
Query: 478 NIISLLGFCFED--NNLLLVYDFLSR--GSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 533
NI+ L +++ LV ++ + SL +N+ P F S+ + + +
Sbjct: 67 NIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNM------PTPFSESQVKCLMLQLLRG 120
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV 586
L+YLH +IHRD+K SN+LL+D +++DFGLA+ + +T V
Sbjct: 121 LQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 5e-11
Identities = 45/162 (27%), Positives = 75/162 (46%), Gaps = 20/162 (12%)
Query: 428 NLIGKGGSSQVYKGC----LPDGKE---LAVKILK--PSEDVIKEFVLEIEIITTLHHKN 478
N +G G +VY+G L G +AVK L+ ++ KEF+ E +++ +H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD---PAAFGWSERYKVAMGVAEALE 535
I+ LLG C + ++ + + G L L + + P E + + VA+
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 536 YLHSGSAQRVIHRDVKSSNILLSD-----DFEPQLSDFGLAK 572
YL IHRD+ + N L+S+ D ++ DFGLA+
Sbjct: 121 YLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 5e-11
Identities = 43/142 (30%), Positives = 69/142 (48%), Gaps = 6/142 (4%)
Query: 452 KILKPSEDVIKEFVLEIEIIT-TLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHG 510
K + + I + V E+ II L H NI+ E++ L +V D + L E+ +
Sbjct: 43 KDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNS 102
Query: 511 NKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570
K+ F + + + + AL YLH +R++HRD+ +NI+L +D + ++DFGL
Sbjct: 103 LKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGL 160
Query: 571 AKWASTSSSHITCTDVAGTFGY 592
AK S T V GT Y
Sbjct: 161 AKQKQPESK---LTSVVGTILY 179
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 5e-11
Identities = 45/172 (26%), Positives = 81/172 (47%), Gaps = 22/172 (12%)
Query: 428 NLIGKGGSSQVYKGC-LPDGKELAVKIL--KPSEDVIKEFVLEIEIITTLHHKNIISLLG 484
N IG G VYK P G+ A+K++ + V ++ EIEI+ ++H N++
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSA 542
+ + ++ +F+ GSLE E++ VA + + YLH
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLE----------GTHIADEQFLADVARQILSGIAYLHR--- 186
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAK-WASTSSSHITCTDVAGTFGYV 593
+ ++HRD+K SN+L++ +++DFG+++ A T C GT Y+
Sbjct: 187 RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP---CNSSVGTIAYM 235
|
Length = 353 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 42/143 (29%), Positives = 73/143 (51%), Gaps = 6/143 (4%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 489
+G G +V+ G ++AVK LKP + F+ E +I+ L H ++ L E+
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEE 73
Query: 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 549
+ +V +++S+GSL + L + A +A VA + Y+ IHRD
Sbjct: 74 P-IYIVTEYMSKGSLLDFL--KDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRD 127
Query: 550 VKSSNILLSDDFEPQLSDFGLAK 572
++S+NIL+ D +++DFGLA+
Sbjct: 128 LRSANILVGDGLVCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 39/138 (28%), Positives = 75/138 (54%), Gaps = 21/138 (15%)
Query: 449 LAVKILKPSEDVIK----EFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504
+AVK+L+ DV K +F+ EI+I++ L + NII LLG C D+ L ++ +++ G L
Sbjct: 47 VAVKMLRA--DVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL 104
Query: 505 EENL----------HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSN 554
+ L H N + + + +A+ +A ++YL S +HRD+ + N
Sbjct: 105 NQFLSQREIESTFTHAN--NIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRN 159
Query: 555 ILLSDDFEPQLSDFGLAK 572
L+ + + +++DFG+++
Sbjct: 160 CLVGNHYTIKIADFGMSR 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 6e-11
Identities = 46/151 (30%), Positives = 72/151 (47%), Gaps = 19/151 (12%)
Query: 430 IGKGGSSQVYKGC--LPDGKELAVKILKPSED--VIKEFVL-EIEIITTLHHKNIISLLG 484
IG+G V+K C G+ +A+K SED VIK+ L EI ++ L H N+++L+
Sbjct: 9 IGEGSYGVVFK-CRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 485 FCFEDNNLLLVYDFLSR---GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
L LV+++ LE+N G + K+ +A+ + H
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK-------KIIWQTLQAVNFCH--- 117
Query: 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
IHRDVK NIL++ + +L DFG A+
Sbjct: 118 KHNCIHRDVKPENILITKQGQIKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 8e-11
Identities = 46/143 (32%), Positives = 74/143 (51%), Gaps = 10/143 (6%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFCF 487
IG+G S VY + G+E+A++ + + KE ++ EI ++ + NI++ L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 547
+ L +V ++L+ GSL + + D V +ALE+LHS +VIH
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALEFLHS---NQVIH 139
Query: 548 RDVKSSNILLSDDFEPQLSDFGL 570
RD+KS NILL D +L+DFG
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGF 162
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 8e-11
Identities = 42/157 (26%), Positives = 74/157 (47%), Gaps = 16/157 (10%)
Query: 429 LIGKGGSSQVY----KGCLPDGKEL--AVKIL--KPSEDVIKEFVLEIEIITTLHHKNII 480
+G+G +V+ KG +G E VK L E++ EF E+++ L HKN++
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK-----DPAAFGWSERYKVAMGVAEALE 535
LLG C E ++ ++ G L++ L K P ++ + +A ++
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+L S R +HRD+ + N L+S E ++S L+K
Sbjct: 132 HL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK 165
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 8e-11
Identities = 53/164 (32%), Positives = 80/164 (48%), Gaps = 31/164 (18%)
Query: 428 NLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKE-----FVLEIEIITTLHHKNIISL 482
IG+G QVYK D EL V + K D KE + EI+I+ L+H+NI++L
Sbjct: 13 GQIGEGTYGQVYKARDKDTGEL-VALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNL 71
Query: 483 ----------LGFCFEDNNLLLVYDFLSR---GSLEENL-HGNKKDPAAFGWSERYKVAM 528
L F + LV++++ G LE L H ++ +F K +
Sbjct: 72 KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSF-----MKQLL 126
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
E L Y H + +HRD+K SNILL++ + +L+DFGLA+
Sbjct: 127 ---EGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLAR 164
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 8e-11
Identities = 54/171 (31%), Positives = 82/171 (47%), Gaps = 17/171 (9%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCF 487
IGKG +V+K +G + AVKIL P D+ +E E I+ L H N++ G +
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85
Query: 488 EDN-----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK---VAMGVAEALEYLHS 539
+ + L LV + + GS+ + + G K ER + +A + EAL L
Sbjct: 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKR------GERMEEPIIAYILHEALMGLQH 139
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 590
+ IHRDVK +NILL+ + +L DFG++ TS+ T V F
Sbjct: 140 LHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSA-QLTSTRLRRNTSVGTPF 189
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 8e-11
Identities = 46/143 (32%), Positives = 74/143 (51%), Gaps = 10/143 (6%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFCF 487
IG+G S VY + G+E+A+K + + KE ++ EI ++ + NI++ L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 547
+ L +V ++L+ GSL + + D V +AL++LHS +VIH
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALDFLHS---NQVIH 138
Query: 548 RDVKSSNILLSDDFEPQLSDFGL 570
RD+KS NILL D +L+DFG
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGF 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 9e-11
Identities = 44/158 (27%), Positives = 75/158 (47%), Gaps = 16/158 (10%)
Query: 423 NFLAENLIGKGGSSQVYKGC-LPDGKELAVKILK-------PSEDVIKEFVLEIEIITTL 474
+L +G G S Y+ + G +AVK + E+V++ EI ++ L
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 475 HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL 534
+H +II +LG ED++ L ++++ GS+ L AF + + L
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS----KYGAFKEAVIINYTEQLLRGL 116
Query: 535 EYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLA 571
YLH ++IHRDVK +N+L+ S +++DFG A
Sbjct: 117 SYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAA 151
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 50/181 (27%), Positives = 83/181 (45%), Gaps = 30/181 (16%)
Query: 430 IGKGGSSQVY---KGCLPDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISL 482
I KG +V+ K G A+K++K + ++ + + + E +I++ ++ L
Sbjct: 1 ISKGAYGRVFLAKKKST--GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 483 LGFCFE-DNNLLLVYDFLSRG---SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
+ F+ NL LV ++L G SL EN+ +D A +E + ALEYLH
Sbjct: 59 Y-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAE-------IVLALEYLH 110
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT------CTDVAGTFGY 592
S +IHRD+K NIL+ + +L+DFGL+K + GT Y
Sbjct: 111 S---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDY 167
Query: 593 V 593
+
Sbjct: 168 I 168
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 40/130 (30%), Positives = 71/130 (54%), Gaps = 12/130 (9%)
Query: 448 ELAVKILKPSEDVIKEFVL--EIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504
++AVK+LKP+ + L E++I++ L +H+NI++LLG C +L++ ++ G L
Sbjct: 67 KVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDL 126
Query: 505 EENLHGNKKDPAAFG--WSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE 562
L ++ S Y+VA G + +L S + IHRD+ + N+LL+
Sbjct: 127 LNFLRRKRESFLTLEDLLSFSYQVAKG----MAFLASKNC---IHRDLAARNVLLTHGKI 179
Query: 563 PQLSDFGLAK 572
++ DFGLA+
Sbjct: 180 VKICDFGLAR 189
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 44/156 (28%), Positives = 81/156 (51%), Gaps = 24/156 (15%)
Query: 429 LIGKGGSSQVYKGC-LPDGKEL----AVKILK----PSEDVIKEFVLEIEIITTLHHKNI 479
++G G VYKG +P+G+ + A+KIL P +V EF+ E I+ ++ H ++
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV--EFMDEALIMASMDHPHL 71
Query: 480 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAA---FGWSERYKVAMGVAEALEY 536
+ LLG C + LV + G L + +H +K + + W + +A+ + Y
Sbjct: 72 VRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMY 124
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
L +R++HRD+ + N+L+ +++DFGLA+
Sbjct: 125 LEE---RRLVHRDLAARNVLVKSPNHVKITDFGLAR 157
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 50/172 (29%), Positives = 85/172 (49%), Gaps = 14/172 (8%)
Query: 402 HEKYSATCRLF-NYQDLLSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSED 459
HE++ A ++ + D + NF+ IG+G + V + GK +AVK + +
Sbjct: 2 HEQFRAALQMVVDPGDPRTYLDNFIK---IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ 58
Query: 460 VIKEFVL-EIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAF 518
+E + E+ I+ H+N++ + + L +V +FL G+L + + + +
Sbjct: 59 QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI 118
Query: 519 GWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570
V + V +AL LH AQ VIHRD+KS +ILL+ D +LSDFG
Sbjct: 119 A-----AVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGF 162
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 44/148 (29%), Positives = 80/148 (54%), Gaps = 17/148 (11%)
Query: 430 IGKGGSSQVYKGCLPDGKEL-AVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
IGKG +V+KG +++ A+KI L+ +ED I++ EI +++ + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE---ALEYLHSGSAQ 543
+ L ++ ++L GS + L D +++A + E L+YLHS +
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLRAGPFD--------EFQIATMLKEILKGLDYLHS---E 120
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLA 571
+ IHRD+K++N+LLS+ + +L+DFG+A
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKLADFGVA 148
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 33/159 (20%), Positives = 71/159 (44%), Gaps = 21/159 (13%)
Query: 430 IGKGGSSQVYKGCLPD------GKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIIS 481
+G+G VY+G +A+K + S EF+ E ++ + +++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 482 LLGFCFEDNNLLLVYDFLSRGSL--------EENLHGNKKDPAAFGWSERYKVAMGVAEA 533
LLG L+V + +++G L E + P + ++A +A+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPP--TLQKFIQMAAEIADG 131
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+ YL A++ +HRD+ + N ++++D ++ DFG+ +
Sbjct: 132 MAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 47/157 (29%), Positives = 81/157 (51%), Gaps = 12/157 (7%)
Query: 422 SNFLAENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLH 475
S E +IG G +V G L P +E+ A+K LK +E ++F+ E I+
Sbjct: 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD 63
Query: 476 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 535
H NII L G + +++V +++ GSL+ L +K F + + G+A ++
Sbjct: 64 HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFL---RKHDGQFTVIQLVGMLRGIASGMK 120
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
YL S +HRD+ + NIL++ + ++SDFGL++
Sbjct: 121 YL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSR 154
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 48/175 (27%), Positives = 88/175 (50%), Gaps = 26/175 (14%)
Query: 418 LSATSNFLAENLIGKGGSSQVYKGCL-----PDGKELAVKILK--PSEDVIKEFVLEIEI 470
LSA F+ E +G+ ++YKG L + +A+K LK + EF E +
Sbjct: 4 LSAV-RFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASL 60
Query: 471 ITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENL-----H---GNKKD-----PAA 517
+ LHH NI+ LLG ++ + +++++L++G L E L H G D ++
Sbjct: 61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120
Query: 518 FGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+ +A+ +A +EYL S+ +H+D+ + NIL+ + ++SD GL++
Sbjct: 121 LDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (150), Expect = 4e-10
Identities = 41/147 (27%), Positives = 71/147 (48%), Gaps = 40/147 (27%)
Query: 446 GKELAVK-ILKPSEDVI--KEFVLEIEIITTLHHKNIISLLGF-------CFEDNNLLLV 495
G+++A+K I +D+I K + EI+++ L H+NII LL F D + +V
Sbjct: 25 GRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFND--VYIV 82
Query: 496 YDFL---------SRGSLEENLHGNKKDPAAFGWSERYKVAM-GVAEALEYLHSGSAQRV 545
+ + S L + + + + + L+YLHS + V
Sbjct: 83 TELMETDLHKVIKSPQPLTD---------------DHIQYFLYQILRGLKYLHSAN---V 124
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAK 572
IHRD+K SNIL++ + + ++ DFGLA+
Sbjct: 125 IHRDLKPSNILVNSNCDLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 4e-10
Identities = 43/180 (23%), Positives = 86/180 (47%), Gaps = 35/180 (19%)
Query: 423 NFLAENLIGKGGSSQVYKGC------LPDGKELAVKILK----PSEDVIKEFVLEIEIIT 472
N + +G+G +V K +AVK+LK SE +++ + E ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSE--LRDLLSEFNLLK 58
Query: 473 TLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK-DPAAFGWSERYK------ 525
++H ++I L G C +D LLL+ ++ GSL L ++K P+ G
Sbjct: 59 QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118
Query: 526 -----VAMG--------VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+ MG ++ ++YL + +++HRD+ + N+L+++ + ++SDFGL++
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 52/175 (29%), Positives = 87/175 (49%), Gaps = 20/175 (11%)
Query: 402 HEKYSATCRLFNYQ-DLLSATSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKP 456
HE++ A R+ Q D S N++ IG+G + V C+ G+++AVK++
Sbjct: 3 HEQFKAALRMVVDQGDPRSLLENYIK---IGEGSTGIV---CIAREKHSGRQVAVKMMDL 56
Query: 457 SEDVIKEFVL-EIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDP 515
+ +E + E+ I+ H+N++ + L ++ +FL G+L + + + +
Sbjct: 57 RKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNE 116
Query: 516 AAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570
V V +AL YLHS Q VIHRD+KS +ILL+ D +LSDFG
Sbjct: 117 EQIA-----TVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGF 163
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 5e-10
Identities = 40/161 (24%), Positives = 73/161 (45%), Gaps = 14/161 (8%)
Query: 406 SATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEF 464
S + D+LS+ EN+I +G YKG + +G + VK + +
Sbjct: 677 SKVSKSITINDILSSLKE---ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSE 733
Query: 465 VLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY 524
+ ++ L H NI+ L+G C + L+++++ +L E L W R
Sbjct: 734 IADMG---KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRR 783
Query: 525 KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQL 565
K+A+G+A+AL +LH + V+ ++ I++ EP L
Sbjct: 784 KIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL 824
|
Length = 968 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 6e-10
Identities = 49/159 (30%), Positives = 80/159 (50%), Gaps = 22/159 (13%)
Query: 428 NLIGKGGSSQVYKGC-LPDGKELAVK-ILKP-SEDVIKEFVL-EIEI---ITTLHHKNII 480
IG+G VYK L G+ +A+K + P SE+ I L EI + + + H NI+
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 481 SLLGFC-----FEDNNLLLVYDFLSRGSLEENLHGN-KKDPAAFGWSERYKVAMG-VAEA 533
LL C + L LV++ + +++L K P E K M +
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHV-----DQDLATYLSKCPKPGLPPETIKDLMRQLLRG 119
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+++LHS R++HRD+K NIL++ D + +++DFGLA+
Sbjct: 120 VDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLAR 155
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 7e-10
Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 22/157 (14%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVK---ILKPSED-------VIKEFVLEIEIITTLHHK 477
LIG G VY G G+ +AVK + S ++ EI ++ L H+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 478 NIISLLGFCFEDNNLLLVYDFLSRGSLEE--NLHGNKKDPAAFGWSERYKVAMGVAEALE 535
NI+ LG + ++L + +++ GS+ N +G ++ + + + + L
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQ------ILKGLN 120
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
YLH+ + +IHRD+K +NIL+ + ++SDFG++K
Sbjct: 121 YLHN---RGIIHRDIKGANILVDNKGGIKISDFGISK 154
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 7e-10
Identities = 39/146 (26%), Positives = 72/146 (49%), Gaps = 9/146 (6%)
Query: 430 IGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFC 486
IG+G +V+ G L D +AVK + + D+ +F+ E I+ H NI+ L+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
+ + +V + + G L + + E ++ A +EYL S + I
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFL---RTEGPRLKVKELIQMVENAAAGMEYLES---KHCI 116
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLAK 572
HRD+ + N L+++ ++SDFG+++
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR 142
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 8e-10
Identities = 50/168 (29%), Positives = 82/168 (48%), Gaps = 18/168 (10%)
Query: 430 IGKGGSSQVYKGCLPDGK---ELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLG 484
+G G V KG K ++A+K+LK + V E + E EI+ L + I+ ++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSE-RYKVAMGVAEALEYLHSGSAQ 543
C E L+LV + S G L + L G K + E ++V+MG ++YL +
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMG----MKYLEG---K 114
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG 591
+HRD+ + N+LL + ++SDFGL+K S+ A + G
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK----ARSAG 158
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 8e-10
Identities = 46/153 (30%), Positives = 77/153 (50%), Gaps = 15/153 (9%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILK--PSED--VIKEFVLEIEIITTLHHKNIISLLG 484
IG G VYK + G+ A+K++K P ED V+++ EI ++ H NI++ G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQ---EIIMMKDCKHSNIVAYFG 73
Query: 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 544
+ L + +F GSL++ H S+ V+ + L YLHS
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDIYHVT----GPLSESQIAYVSRETLQGLYYLHSKGK-- 127
Query: 545 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577
+HRD+K +NILL+D+ +L+DFG++ + +
Sbjct: 128 -MHRDIKGANILLTDNGHVKLADFGVSAQITAT 159
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 8e-10
Identities = 37/107 (34%), Positives = 60/107 (56%), Gaps = 25/107 (23%)
Query: 475 HHKNIISLLGFCFEDNN--LLLVYDFLS-------RGSLEENLHGNKKDPAAFGWSERYK 525
H NI+ LL +N+ + LV++++ R ++ E++H +RY
Sbjct: 65 DHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVH------------KRY- 111
Query: 526 VAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+ + +AL+Y+HSG VIHRD+K SNILL+ D +L+DFGLA+
Sbjct: 112 IMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR 155
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|238947 cd01989, STK_N, The N-terminal domain of Eukaryotic Serine Threonine kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 8e-10
Identities = 37/146 (25%), Positives = 62/146 (42%), Gaps = 8/146 (5%)
Query: 18 TVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHV-LANNAIVDRDGKSSLLSLVKA--- 73
+V V V D S+ L WAL +A G T++ +HV +I GK + S K
Sbjct: 1 SVAVAVDKDKKSKNALKWALDNLATKGQTIVLVHVHPPITSIPSSSGKLEVASAYKQEED 60
Query: 74 --FDSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRS 131
+L Y FC+ K V + + + K +V + TK ++G + ++H
Sbjct: 61 KEAKELLLPYRCFCSRKGVQCEDVVLEDDDVAKAIVEYVADHGITKLVMGASSDNHFSMK 120
Query: 132 T--TSLAKYCAKKLSKDCSVLAVNNG 155
+ +A K+ C+V V+ G
Sbjct: 121 FKKSDVASSVLKEAPDFCTVYVVSKG 146
|
The Serine Threonine kinases are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. The N-terminal domain is homologous to the USP family which has a ATP binding fold. The N-terminal domain is predicted to be involved in ATP binding. Length = 146 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 9e-10
Identities = 46/132 (34%), Positives = 72/132 (54%), Gaps = 13/132 (9%)
Query: 446 GKELAVKILKPSEDVIK----EFVL-EIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500
GK A+KIL ++K E VL E I+ ++ H +++L G +D+NL LV +++
Sbjct: 26 GKYYALKILS-KAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVP 84
Query: 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD 560
G L +L + + P + Y A V ALEYLHS +++RD+K N+LL D
Sbjct: 85 GGELFSHLRKSGRFPE--PVARFY--AAQVVLALEYLHS---LDIVYRDLKPENLLLDSD 137
Query: 561 FEPQLSDFGLAK 572
+++DFG AK
Sbjct: 138 GYIKITDFGFAK 149
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 38/135 (28%), Positives = 71/135 (52%), Gaps = 16/135 (11%)
Query: 449 LAVKILKPSEDVIK----EFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504
+AVK+L+ ED K +F+ EI+I++ L NII LL C + L ++ +++ G L
Sbjct: 49 VAVKMLR--EDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL 106
Query: 505 EENL-------HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557
+ L K D +S +A +A ++YL S+ +HRD+ + N L+
Sbjct: 107 NQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLV 163
Query: 558 SDDFEPQLSDFGLAK 572
++ +++DFG+++
Sbjct: 164 GKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 45/157 (28%), Positives = 73/157 (46%), Gaps = 12/157 (7%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKIL----KPSEDVIKEFVLEIEIITTLHHKNIISLLG 484
IG G VY + + +A+K + K S + ++ + E+ + L H N I G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 544
++ LV ++ GS + L +KK E + G + L YLHS
Sbjct: 83 CYLREHTAWLVMEY-CLGSASDILEVHKK---PLQEVEIAAICHGALQGLAYLHS---HE 135
Query: 545 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581
IHRD+K+ NILL++ +L+DFG A S ++S +
Sbjct: 136 RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV 172
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 43/146 (29%), Positives = 76/146 (52%), Gaps = 14/146 (9%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
+G G VYK L + LAVK+ L + ++ K+ + E+EI+ II G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
F +N + + +F+ GSL+ ++ + G ++A+ V + L YL S +++
Sbjct: 69 FVENRISICTEFMDGGSLD--VYRKIPEHV-LG-----RIAVAVVKGLTYLWS---LKIL 117
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLAK 572
HRDVK SN+L++ + +L DFG++
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVST 143
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 48/150 (32%), Positives = 76/150 (50%), Gaps = 21/150 (14%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILK--PSED--VIKEFVLEIEIITTLHHKNIISLLG 484
+G G VYK L G+ AVKI+K P +D +I++ EI ++ H NI++ G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQ---EIFMVKECKHCNIVAYFG 73
Query: 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE---YLHSGS 541
L + ++ GSL++ H G ++A E L+ YLHS
Sbjct: 74 SYLSREKLWICMEYCGGGSLQDIYH-------VTGPLSELQIAYVCRETLQGLAYLHSKG 126
Query: 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571
+HRD+K +NILL+D+ + +L+DFG+A
Sbjct: 127 K---MHRDIKGANILLTDNGDVKLADFGVA 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 42/160 (26%), Positives = 74/160 (46%), Gaps = 12/160 (7%)
Query: 424 FLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLL 483
F+ E +G G V+ G ++A+K + ++F+ E +++ L H ++ L
Sbjct: 8 FMKE--LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLY 65
Query: 484 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
G C + L +V +F+ G L L+ ++ + V E +EYL S
Sbjct: 66 GVCTQQKPLYIVTEFMENGCL---LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS-- 120
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWA----STSSS 579
IHRD+ + N L+S ++SDFG+ ++ TSSS
Sbjct: 121 -FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS 159
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 48/153 (31%), Positives = 77/153 (50%), Gaps = 22/153 (14%)
Query: 430 IGKGGSSQVYKGCLPDGKEL-AVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLG 484
+G+GG QV+ D E+ A+K +K S + ++ + E +I+TT + ++ LL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL- 67
Query: 485 FCFED-NNLLLVYDFLSRG---SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS- 539
+ F+D L L +++ G +L NL +D A F Y M EA++ LH
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARF-----YMAEM--FEAVDALHEL 120
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
G IHRD+K N L+ +L+DFGL+K
Sbjct: 121 G----YIHRDLKPENFLIDASGHIKLTDFGLSK 149
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 3e-09
Identities = 45/160 (28%), Positives = 77/160 (48%), Gaps = 11/160 (6%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEF--VLEIEIITTLHHKNIISLLGFC 486
+G+G + VYKG +GK +A+K+++ E+ F + E ++ L H NI+ L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
L LV++++ + K P + L Y+H + ++
Sbjct: 73 HTKETLTLVFEYVHTDLCQYM----DKHPGGLHPENVKLFLFQLLRGLSYIHQ---RYIL 125
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV 586
HRD+K N+L+SD E +L+DFGLA+ A + SH +V
Sbjct: 126 HRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEV 164
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 3e-09
Identities = 45/165 (27%), Positives = 74/165 (44%), Gaps = 34/165 (20%)
Query: 430 IGKGGSSQVYKGCL---PDGKELAVKILKPSEDVIKEF----VLEIEIITTLHHKNIISL 482
IG+G +VYK DGKE A+K K ++ EI ++ L H+N++SL
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 483 LGFCFEDNN--LLLVYDFLSRGSLEENL---------HGNKKDPAAFGWSERYKVAMGVA 531
+ E + + L++D+ E +L P + S +++ GV
Sbjct: 68 VEVFLEHADKSVYLLFDYA-----EHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVH 122
Query: 532 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAK 572
YLHS V+HRD+K +NIL+ + + + D GLA+
Sbjct: 123 ----YLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 44/145 (30%), Positives = 72/145 (49%), Gaps = 20/145 (13%)
Query: 430 IGKGGSSQVYKGCLPD-----------GKELAV--KILKPSE-DVIKEFVLEIEIITTLH 475
+G+G +Q+Y G L KE+ V K+L PS D+ F ++ +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 476 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 535
HK+I+ L G C D ++V +F+ G L+ +H K D W ++KVA +A AL
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH-RKSDVLTTPW--KFKVAKQLASALS 119
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDD 560
YL + ++H +V + NILL+ +
Sbjct: 120 YLED---KDLVHGNVCTKNILLARE 141
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 39/150 (26%), Positives = 80/150 (53%), Gaps = 14/150 (9%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
E +G G +V+ ++AVK +KP ++ F+ E ++ TL H ++ L
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 70
Query: 487 FEDNNLLLVYDFLSRGSLEENL---HGNKKD-PAAFGWSERYKVAMGVAEALEYLHSGSA 542
++ + ++ +F+++GSL + L G+K+ P +S + +AE + ++
Sbjct: 71 TKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAFIEQ--- 120
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+ IHRD++++NIL+S +++DFGLA+
Sbjct: 121 RNYIHRDLRAANILVSASLVCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 44/150 (29%), Positives = 76/150 (50%), Gaps = 17/150 (11%)
Query: 430 IGKGGSSQVYKGCLPDGKELA----VKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
IG+G V+K + E+ V++ E V + EI ++ L HKNI+ L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 486 CFEDNNLLLVYDFLSRGSLE---ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
D L LV+++ + L+ ++ +G DP S +++ G+A + HS
Sbjct: 68 LHSDKKLTLVFEYCDQ-DLKKYFDSCNG-DIDPEIVK-SFMFQLLKGLA----FCHS--- 117
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
V+HRD+K N+L++ + E +L+DFGLA+
Sbjct: 118 HNVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 5e-09
Identities = 40/147 (27%), Positives = 73/147 (49%), Gaps = 11/147 (7%)
Query: 430 IGKGGSSQVYK-GCLPDGKELAVK--ILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGF 485
IG+G V+K G+ +A+K L+ E I L EI+ + H ++ LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
+ +LV +++ L E L +++ P + Y + + + Y+H A +
Sbjct: 68 FPHGSGFVLVMEYMPS-DLSEVLR-DEERPLPEAQVKSY--MRMLLKGVAYMH---ANGI 120
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAK 572
+HRD+K +N+L+S D +++DFGLA+
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 6e-09
Identities = 52/162 (32%), Positives = 75/162 (46%), Gaps = 26/162 (16%)
Query: 429 LIGKGGSSQVY----KGCLPDGKELAVKILKPSEDV----IKEFVLEIEIITTLHHKNII 480
L+GKG +V+ KG GK A+K+L E + +K + E EI+ TL H +
Sbjct: 8 LLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLP 64
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLH---GN--KKDPAAFGWSERYKVAMGVAEALE 535
+L + L LV D+ G L L G ++ A F +E V ALE
Sbjct: 65 TLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAE-------VLLALE 117
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577
YLH +++RD+K NILL + LSDF L+K +
Sbjct: 118 YLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 20/153 (13%)
Query: 429 LIGKGGSSQVYKGC-LPDGKEL----AVKIL--KPSEDVIKEFVLEIEIITTLHHKNIIS 481
L+G G V+KG +P+G + A+K + + +E + + +L H I+
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK--DPAAF-GWSERYKVAMGVAEALEYLH 538
LLG C +L LV GSL +++ ++ DP W + +A+ + YL
Sbjct: 74 LLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIAKGMYYLE 126
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571
R++HR++ + NILL D Q++DFG+A
Sbjct: 127 E---HRMVHRNLAARNILLKSDSIVQIADFGVA 156
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 8e-09
Identities = 45/148 (30%), Positives = 78/148 (52%), Gaps = 31/148 (20%)
Query: 446 GKELAVKILKPSEDVI---KEFVLEIEIITTLHHKNIISLL------GFCFEDNNLLLVY 496
GK++A+K + + DV K + E++I+ H NII++ G F+D + +V
Sbjct: 30 GKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD--VYVVM 87
Query: 497 DFLSRGSLEENLHGNKKDPAAFGWSER------YKVAMGVAEALEYLHSGSAQRVIHRDV 550
D L L +H ++ +E Y++ G L+Y+HS + VIHRD+
Sbjct: 88 D-LMESDLHHIIHSDQP------LTEEHIRYFLYQLLRG----LKYIHSAN---VIHRDL 133
Query: 551 KSSNILLSDDFEPQLSDFGLAKWASTSS 578
K SN+L+++D E ++ DFG+A+ S+S
Sbjct: 134 KPSNLLVNEDCELRIGDFGMARGLSSSP 161
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 38/131 (29%), Positives = 68/131 (51%), Gaps = 8/131 (6%)
Query: 445 DGKELAVK---ILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501
DGK+ +K I K S +E E+ +++ + H NI+ E+ NL +V D+
Sbjct: 24 DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEG 83
Query: 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 561
G L + + N + F + + + AL+++H ++++HRD+KS NI L+ D
Sbjct: 84 GDLYKKI--NAQRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDG 138
Query: 562 EPQLSDFGLAK 572
+L DFG+A+
Sbjct: 139 TIKLGDFGIAR 149
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 35/145 (24%), Positives = 73/145 (50%), Gaps = 10/145 (6%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 489
+G G +V+ G ++A+K LK + F+ E ++ L H ++ L ++
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQE 73
Query: 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG--VAEALEYLHSGSAQRVIH 547
+ ++ +++ GSL + L K P + + M +AE + ++ + IH
Sbjct: 74 P-IYIITEYMENGSLVDFL----KTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIH 125
Query: 548 RDVKSSNILLSDDFEPQLSDFGLAK 572
RD++++NIL+S+ +++DFGLA+
Sbjct: 126 RDLRAANILVSETLCCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 51/164 (31%), Positives = 84/164 (51%), Gaps = 27/164 (16%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKE-FVL----EIEIITTLHHKNIISL 482
IG+G +V+K + +A+K +L +E KE F + EI+I+ L H+N+++L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENE---KEGFPITALREIKILQLLKHENVVNL 76
Query: 483 LGFCFED----NN----LLLVYDFLSRGSLEENLHGNKKDPAA-FGWSERYKVAMGVAEA 533
+ C N LV++F E +L G + F SE KV +
Sbjct: 77 IEICRTKATPYNRYKGSFYLVFEFC-----EHDLAGLLSNKNVKFTLSEIKKVMKMLLNG 131
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577
L Y+H +++HRD+K++NIL++ D +L+DFGLA+ S S
Sbjct: 132 LYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAFSLS 172
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 48/176 (27%), Positives = 81/176 (46%), Gaps = 35/176 (19%)
Query: 420 ATSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPSEDVI--KEFVLEIEII 471
+T F+ E +G+ +VYKG L + +A+K LK + +EF E +
Sbjct: 5 STVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMR 62
Query: 472 TTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENL-----H---GNKKD--------- 514
+ L H NI+ LLG ++ L +++ + S L E L H G+ D
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 515 PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570
PA F + +A +E+L S+ V+H+D+ + N+L+ D ++SD GL
Sbjct: 123 PADF-----VHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGL 170
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 48/161 (29%), Positives = 77/161 (47%), Gaps = 22/161 (13%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKE-----FVLEIEIITTLH 475
+F +IG+G +V+ D ++ A+K+L+ S D+IK E +I+
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKS-DMIKRNQIAHVRAERDILADAD 59
Query: 476 HKNIISLLGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE-- 532
I+ L + F+D +L LV +++ G L L +KD + Y +AE
Sbjct: 60 SPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLL--IRKDVFPEETARFY-----IAELV 111
Query: 533 -ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
AL+ +H IHRD+K NIL+ D +L+DFGL K
Sbjct: 112 LALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCK 149
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 50/167 (29%), Positives = 80/167 (47%), Gaps = 20/167 (11%)
Query: 424 FLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPS--------EDVIKEFVLEIEIITTL 474
F+ + IG G VY E+ AVK + S +D+IKE ++ + L
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKE----VKFLQQL 78
Query: 475 HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL 534
H N I G +++ LV ++ GS + L +KK E + G + L
Sbjct: 79 KHPNTIEYKGCYLKEHTAWLVMEY-CLGSASDLLEVHKK---PLQEVEIAAITHGALQGL 134
Query: 535 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581
YLHS +IHRD+K+ NILL++ + +L+DFG A +S ++S +
Sbjct: 135 AYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV 178
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 42/163 (25%), Positives = 82/163 (50%), Gaps = 19/163 (11%)
Query: 424 FLAENLIGKGGSSQVYKGCLPDGK-----ELAVKILK--PSEDVIKEFVLEIEIITTLHH 476
+L+ +G +++ G L D K E+ VK +K SE + + E ++ L H
Sbjct: 8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSH 67
Query: 477 KNIISLLGFCFEDNNL-LLVYDFLSRGSLEENL----HGNKKDPAAFGWSERYKVAMG-- 529
+NI+ +L C ED ++Y +++ G+L+ L G +P A S + V M
Sbjct: 68 QNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL--STQQLVHMAIQ 125
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+A + YLH + VIH+D+ + N ++ ++ + +++D L++
Sbjct: 126 IACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSR 165
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 43/149 (28%), Positives = 71/149 (47%), Gaps = 14/149 (9%)
Query: 430 IGKGGSSQVYKG---CLPDGKELAVKILKPSED---VIKEFVLEIEIITTLHHKNIISLL 483
+G G V KG K +AVKILK + + E + E ++ L + I+ ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 484 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
G C E + +LV + G L + L NK ++V+MG ++YL +
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMG----MKYLEETN-- 115
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+HRD+ + N+LL ++SDFGL+K
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSK 143
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 44/144 (30%), Positives = 73/144 (50%), Gaps = 11/144 (7%)
Query: 431 GKGGSSQVYKGCLPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE 488
G GGS K +P G +A K+ + V K+ + E++I+ I+S G
Sbjct: 16 GNGGSVSKVKH-IPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN 74
Query: 489 DNNLLLVYDFLSRGSLEENLH-GNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 547
+NN+ + +F+ GSL+ G G K+A+ V E L YL++ R++H
Sbjct: 75 ENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYLYN--VHRIMH 127
Query: 548 RDVKSSNILLSDDFEPQLSDFGLA 571
RD+K SNIL++ + +L DFG++
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVS 151
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 44/153 (28%), Positives = 75/153 (49%), Gaps = 22/153 (14%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFV--LEIEIITTL-HHKNIISLLGF 485
IG+G S+V K GK A+K +K +++ EI+ + L H NI+ L+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66
Query: 486 CFE--DNNLLLVYDFLSRGSLEENLH---GNKKDPAAFGWSERYKVAM-GVAEALEYLHS 539
F+ L LV++ + + NL+ +K P +R K M + ++L+++H
Sbjct: 67 LFDRKTGRLALVFELM-----DMNLYELIKGRKRPLP---EKRVKSYMYQLLKSLDHMH- 117
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+ HRD+K NIL+ DD +L+DFG +
Sbjct: 118 --RNGIFHRDIKPENILIKDD-ILKLADFGSCR 147
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 47/151 (31%), Positives = 71/151 (47%), Gaps = 21/151 (13%)
Query: 429 LIGK----GGSSQVYKGCLPDGKELAVKILKPSEDVIKEFV-LEIEIITT--LHHKNIIS 481
LIGK + K P +AVK + ++ L+ EIIT+ L H NI+
Sbjct: 5 LIGKCFEDLMIVHLAK-HKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 482 LLGFCF-EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSE---RYKVAMGVAEALEYL 537
+ F D+ L +V ++ GS E+ L + + G E + + V AL+Y+
Sbjct: 64 YV-TSFIVDSELYVVSPLMAYGSCEDLLKTHFPE----GLPELAIAF-ILKDVLNALDYI 117
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568
HS + IHR VK+S+ILLS D + LS
Sbjct: 118 HS---KGFIHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 40/150 (26%), Positives = 70/150 (46%), Gaps = 14/150 (9%)
Query: 429 LIGKGGSSQVYKGCLPDGKE-LAVKILKPSEDVIK----EFVL-EIEIITTLHHKNIISL 482
+G G +V+ + A+K++ +VI+ + V E ++ + H II L
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIP-EVIRLKQEQHVHNEKRVLKEVSHPFIIRL 66
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
+ L ++ +++ G L L + + F S A + ALEYLHS
Sbjct: 67 FWTEHDQRFLYMLMEYVPGGELFSYLRNSGR----FSNSTGLFYASEIVCALEYLHS--- 119
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+ +++RD+K NILL + +L+DFG AK
Sbjct: 120 KEIVYRDLKPENILLDKEGHIKLTDFGFAK 149
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 36/157 (22%), Positives = 80/157 (50%), Gaps = 17/157 (10%)
Query: 430 IGKGGSSQVY----KGCLPDGKE--LAVKILKPSEDVIK--EFVLEIEIITTLHHKNIIS 481
+G+G VY KG + D E +A+K + + + + EF+ E ++ + +++
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDP------AAFGWSERYKVAMGVAEALE 535
LLG + L++ + ++RG L+ L + + A + ++A +A+ +
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
YL +A + +HRD+ + N ++++DF ++ DFG+ +
Sbjct: 134 YL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 45/162 (27%), Positives = 78/162 (48%), Gaps = 24/162 (14%)
Query: 422 SNFLAENLIGKGGSSQV----YKGCLPDGKELAVKILKPSEDV----IKEFVLEIEIITT 473
S+F +G G +V +KG G+ A+K LK E + ++ E I+
Sbjct: 18 SDFEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILME 74
Query: 474 LHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDP---AAFGWSERYKVAMGV 530
L H I++++ ++N + + +F+ G L +L + P A F +E +
Sbjct: 75 LSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAE-------L 127
Query: 531 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
A EYLHS + +I+RD+K N+LL + +++DFG AK
Sbjct: 128 VLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK 166
|
Length = 329 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 40/158 (25%), Positives = 80/158 (50%), Gaps = 14/158 (8%)
Query: 422 SNFLAENLIGKGGSSQVYKGC-LPDGKEL----AVKILK--PSEDVIKEFVLEIEIITTL 474
+ F ++G G VYKG +P+G+++ A+K L+ S KE + E ++ ++
Sbjct: 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 66
Query: 475 HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL 534
+ ++ LLG C + + L+ + G L + + +K + G + +A+ +
Sbjct: 67 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGM 122
Query: 535 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
YL +R++HRD+ + N+L+ +++DFGLAK
Sbjct: 123 NYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 47/164 (28%), Positives = 77/164 (46%), Gaps = 18/164 (10%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPD-GKELAVKILK---PSEDVIKE---FVLEIEIITTLH 475
N+ L+G+G +VY D G+ELAVK + S++ KE EI+++ L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 476 HKNIISLLGFCFED---NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE 532
H I+ G C D L + +++ GS+++ L K A + + + +
Sbjct: 63 HDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQL----KAYGALTENVTRRYTRQILQ 117
Query: 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576
+ YLHS ++HRD+K +NIL +L DFG +K T
Sbjct: 118 GVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 44/160 (27%), Positives = 76/160 (47%), Gaps = 25/160 (15%)
Query: 430 IGKGGSSQVYKGCL---PD------GKELAV--KILKPSEDVIKEFVLEIEIITTLHHKN 478
+G+G + +YKG L D G+E++V K+L F +++ L HK+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
++ L G C D N ++V +++ G L+ LH K + + W + VA +A AL YL
Sbjct: 63 LVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSL-HW--KLDVAKQLASALHYLE 118
Query: 539 SGSAQRVIHRDVKSSNILL---SDDFEPQ----LSDFGLA 571
++++H +V NIL+ + LSD G+
Sbjct: 119 D---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 5e-08
Identities = 48/159 (30%), Positives = 76/159 (47%), Gaps = 20/159 (12%)
Query: 429 LIGKGGSSQVYKGC--LPDGKELAVKILK---PSEDVIKE---FVLEIEIITTLHHKNII 480
L+G+G +VY C + G+ELA K ++ S + KE EI+++ L H+ I+
Sbjct: 9 LLGQGAFGRVYL-CYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 481 SLLGFCFEDN---NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
G C D L + +++ GS+++ L K A S K + E + YL
Sbjct: 68 QYYG-CLRDRAEKTLTIFMEYMPGGSVKDQL----KAYGALTESVTRKYTRQILEGMSYL 122
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576
HS ++HRD+K +NIL +L DFG +K T
Sbjct: 123 HS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.5 bits (132), Expect = 5e-08
Identities = 43/155 (27%), Positives = 73/155 (47%), Gaps = 26/155 (16%)
Query: 430 IGKGGSSQVYKGCLPDGKEL-AVKILK---PS-EDVIKEFVLEIEIITTL-HHKNIISLL 483
+G G VY + EL A+K +K S E+ + + E++ + L H NI+ L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN--LREVKSLRKLNEHPNIVKLK 64
Query: 484 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER------YKVAMGVAEALEYL 537
E++ L V++++ E NL+ KD +SE Y++ G L ++
Sbjct: 65 EVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSIIYQILQG----LAHI 115
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
H HRD+K N+L+S +++DFGLA+
Sbjct: 116 HK---HGFFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 5e-08
Identities = 47/172 (27%), Positives = 82/172 (47%), Gaps = 17/172 (9%)
Query: 429 LIGKGGSSQVYKGCL--PDGKELAVKILKPSEDVIKEFVL----EIEIITTLHHKNIISL 482
++G+G V+ C D K + +K + P E + K+ L E +++ L H NII
Sbjct: 7 VVGRGAFGIVHL-CRRKADQKLVIIKQI-PVEQMTKDERLAAQNECQVLKLLSHPNIIEY 64
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
ED L++V ++ G+L E + K+ + + + AL ++H
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYI--QKRCNSLLDEDTILHFFVQILLALHHVH---T 119
Query: 543 QRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYV 593
+ ++HRD+K+ NILL ++ DFG++K S+ S T V GT Y+
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT---VVGTPCYI 168
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 47/164 (28%), Positives = 78/164 (47%), Gaps = 16/164 (9%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPD-GKELAVKILK---PSEDVIKE---FVLEIEIITTL 474
+N+ L+G+G +VY D G+ELAVK ++ S + KE EI+++ L
Sbjct: 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61
Query: 475 HHKNIISLLGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE 532
H+ I+ G + + L + + + GS+++ L K A + K + E
Sbjct: 62 LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL----KSYGALTENVTRKYTRQILE 117
Query: 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576
+ YLHS ++HRD+K +NIL +L DFG +K T
Sbjct: 118 GVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 7e-08
Identities = 45/149 (30%), Positives = 77/149 (51%), Gaps = 14/149 (9%)
Query: 430 IGKGGSSQVYKGCLPDGKEL-AVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
+G+G + VYKG E+ A+K L E + EI ++ L H+NI+ L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 487 FEDNNLLLVYDFLSRGSLEE--NLHGNKKD-PAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
+N L+LV++++ L++ + HG + S Y++ G+A + H
Sbjct: 68 HTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIA----FCHE---N 119
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
RV+HRD+K N+L++ E +L+DFGLA+
Sbjct: 120 RVLHRDLKPQNLLINKRGELKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 7e-08
Identities = 47/158 (29%), Positives = 77/158 (48%), Gaps = 22/158 (13%)
Query: 430 IGKGGSSQVYKG--CLPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
+G+G + VYKG L G+ +A+K L+ E + E ++ L H NI++L
Sbjct: 13 LGEGSYATVYKGRSKL-TGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 486 CFEDNNLLLVYDFLSRGSLEENL--HGNKKDPA---AFGWSERYKVAMGVAEALEYLHSG 540
L LV+++L L++ + G F +++ G L Y H
Sbjct: 72 IHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLF----LFQLLRG----LAYCHQ- 121
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578
+RV+HRD+K N+L+S+ E +L+DFGLA+ S S
Sbjct: 122 --RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (129), Expect = 9e-08
Identities = 51/176 (28%), Positives = 69/176 (39%), Gaps = 28/176 (15%)
Query: 418 LSATSNFLAE-------NLI-GKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIE 469
LS FL LI GK G V K P K KI+K K F IE
Sbjct: 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKH-KPTQKLFVQKIIKA-----KNFN-AIE 58
Query: 470 I-ITTL--HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKV 526
+ L + N I L +L+ D++ G L + L K +E K+
Sbjct: 59 PMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK----LSEAEVKKI 114
Query: 527 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ--LSDFGLAKWASTSSSH 580
+ EAL LH +IH D+K N+L D + + L D+GL K T S +
Sbjct: 115 IRQLVEALNDLHK---HNIIHNDIKLENVLY-DRAKDRIYLCDYGLCKIIGTPSCY 166
|
Length = 267 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 9e-08
Identities = 48/171 (28%), Positives = 76/171 (44%), Gaps = 17/171 (9%)
Query: 430 IGKGGSSQVYKGC--LPDGKELAVKILKPSEDVIKE----FVLEIEIITTLHHKNIISLL 483
+GKGG +V C GK A K L ++ + E +I+ + + I+SL
Sbjct: 1 LGKGGFGEVC-ACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL- 58
Query: 484 GFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
+ FE ++L LV ++ G L+ H F + A + LE+LH
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLK--YHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ--- 113
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYV 593
+R+++RD+K N+LL D ++SD GLA AGT GY+
Sbjct: 114 RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYM 161
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 38/127 (29%), Positives = 65/127 (51%), Gaps = 7/127 (5%)
Query: 455 KPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD 514
K S + ++ + E++ + + H N I G ++ LV ++ GS + L +KK
Sbjct: 63 KQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY-CLGSASDLLEVHKKP 121
Query: 515 PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574
E + G + L YLHS +IHRD+K+ NILL++ + +L+DFG A A
Sbjct: 122 LQEV---EIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIA 175
Query: 575 STSSSHI 581
S ++S +
Sbjct: 176 SPANSFV 182
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 23/47 (48%), Positives = 35/47 (74%), Gaps = 2/47 (4%)
Query: 525 KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571
K+A+ + +ALEYLHS VIHRDVK SN+L++ + + +L DFG++
Sbjct: 107 KIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGIS 151
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 40/124 (32%), Positives = 59/124 (47%), Gaps = 11/124 (8%)
Query: 458 EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAA 517
+D+IKE + + L H N I G ++ LV ++ GS + L +KK
Sbjct: 60 QDIIKE----VRFLQKLRHPNTIQYRGCYLREHTAWLVMEY-CLGSASDLLEVHKKPLQE 114
Query: 518 FGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577
E V G + L YLHS +IHRDVK+ NILLS+ +L DFG A + +
Sbjct: 115 V---EIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168
Query: 578 SSHI 581
+ +
Sbjct: 169 NXFV 172
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 42/160 (26%), Positives = 77/160 (48%), Gaps = 20/160 (12%)
Query: 429 LIGKGGSSQVYKGCLP----DGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNII 480
++GKG V + L +++AVK+LK S D I+EF+ E + H N+I
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSD-IEEFLREAACMKEFDHPNVI 64
Query: 481 SLLGFCFEDNNL------LLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAE 532
L+G +++ F+ G L L ++ ++P + + +A
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+EYL S++ IHRD+ + N +L+++ ++DFGL+K
Sbjct: 125 GMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 54/174 (31%), Positives = 81/174 (46%), Gaps = 31/174 (17%)
Query: 430 IGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI--------- 479
IGKG QVY+ D + A+K+L KE V + E+ T+ +NI
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSK-----KEIVAKKEVAHTIGERNILVRTLLDES 55
Query: 480 --ISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
I L F F+ D++L LV D++S G L +L + ++ +A V ALE+
Sbjct: 56 PFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSED---RAKFYIAELVL-ALEH 111
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 590
LH +++RD+K NILL L DFGL+K +++T TF
Sbjct: 112 LHK---YDIVYRDLKPENILLDATGHIALCDFGLSK------ANLTDNKTTNTF 156
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 49/157 (31%), Positives = 78/157 (49%), Gaps = 24/157 (15%)
Query: 429 LIGKGGSSQVYKGCLPDGKEL----AVKILKPSEDVIKE-----FVLEIEIITTLHHKNI 479
++GKGG +V++ G + A+K+LK + V + E I+ + H I
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 480 ISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNK---KDPAAFGWSERYKVAMGVAEALE 535
+ L+ + F+ L L+ ++LS G L +L +D A F SE ++ ALE
Sbjct: 63 VDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSE-------ISLALE 114
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+LH Q +I+RD+K NILL +L+DFGL K
Sbjct: 115 HLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCK 148
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 44/174 (25%), Positives = 80/174 (45%), Gaps = 35/174 (20%)
Query: 419 SATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKE-FVL----EIEII 471
S ++ +G+G +VYK + G+ +A+K IL +E K+ F + EI+I+
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE---KDGFPITALREIKIL 61
Query: 472 TTLHHKNIISLLGFCFE-----DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKV 526
L H N++ L+ E VY ++ +L G ++P K+
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTP--YMDHDLSGLLENP-------SVKL 112
Query: 527 AMG--------VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+ E + YLH ++HRD+K++NIL+ + +++DFGLA+
Sbjct: 113 TESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLAR 163
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 48/153 (31%), Positives = 72/153 (47%), Gaps = 21/153 (13%)
Query: 430 IGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIE-----IITTLHHKNIISLL 483
IGKG +V DGK AVK+L+ + K+ I ++ + H ++ L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 484 GFCFED-NNLLLVYDFLSRGSLEENLHGNKKDP---AAFGWSERYKVAMGVAEALEYLHS 539
+ F+ + L V D+++ G L +L + P A F +E +A AL YLHS
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAE-------IASALGYLHS 114
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+I+RD+K NILL L+DFGL K
Sbjct: 115 ---LNIIYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 41/153 (26%), Positives = 77/153 (50%), Gaps = 19/153 (12%)
Query: 429 LIGKGGSSQVYKGCLP-DGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLL 483
++GKG +V L G+ AVK+LK +D ++ + E I++ + ++ L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 484 GFCFED-NNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHS 539
CF+ + L V +F++ G L ++ +++ A F +E + AL +LH
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE-------ITSALMFLHD 114
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+ +I+RD+K N+LL + +L+DFG+ K
Sbjct: 115 ---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 42/151 (27%), Positives = 76/151 (50%), Gaps = 17/151 (11%)
Query: 429 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSE--DVIKEFVL-EIEIITTLHHKNIISLLG 484
++G+G V K + KE+ A+K K SE + +KE L E++++ TL +NI+ L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 485 FCFEDNNLLLVYDFLSRGSLE---ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
L LV++++ + LE E +G + KV + + ++ +H
Sbjct: 68 AFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPE----------KVRSYIYQLIKAIHWCH 117
Query: 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
++HRD+K N+L+S + +L DFG A+
Sbjct: 118 KNDIVHRDIKPENLLISHNDVLKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 10/162 (6%)
Query: 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKI--LKPSEDVIKEFVLEIEIITTLHH 476
A +++L +G+G + VYKG +G+ +A+K+ +K E V + E ++ L H
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62
Query: 477 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
NI+ L L V++++ L + + + P + L Y
Sbjct: 63 ANIVLLHDIIHTKETLTFVFEYM-HTDLAQYM---IQHPGGLHPYNVRLFMFQLLRGLAY 118
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578
+H Q ++HRD+K N+L+S E +L+DFGLA+ S S
Sbjct: 119 IHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 48/155 (30%), Positives = 84/155 (54%), Gaps = 22/155 (14%)
Query: 429 LIGKGGSSQVY---KGCLPDGKEL-AVKILKPSEDVIKEFV---LEIEIITTLHHKNIIS 481
++G+G +V+ K PD +L A+K+LK + +++ V +E +I+ ++H I+
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 482 LLGFCFE-DNNLLLVYDFLSRGSLEENLHGN---KKDPAAFGWSERYKVAMGVAEALEYL 537
L + F+ + L L+ DFL G L L ++ F +E +A AL++L
Sbjct: 63 L-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE-------LALALDHL 114
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
HS +I+RD+K NILL ++ +L+DFGL+K
Sbjct: 115 HSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK 146
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 48/153 (31%), Positives = 76/153 (49%), Gaps = 22/153 (14%)
Query: 430 IGKGGSSQVY---KGCLPDGKELAVKILKPSEDVIKEFV----LEIEIITTLHHKNIISL 482
I +G +VY K + K AVK++K ++ + K V E + + I+ L
Sbjct: 12 ISRGAFGKVYLGRKKN--NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHL 69
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLH--GNKKDPAAFGW-SERYKVAMGVAEALEYLHS 539
NN+ LV ++L G ++ LH G + A + SE VA AL+YLH
Sbjct: 70 YYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISE-------VALALDYLHR 122
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+IHRD+K N+L+S++ +L+DFGL+K
Sbjct: 123 HG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 43/151 (28%), Positives = 79/151 (52%), Gaps = 14/151 (9%)
Query: 430 IGKGGSSQVYKG--CLPDGKELAVKI-LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
+G+G + VYKG L D +I L+ E + E+ ++ L H NI++L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 487 FEDNNLLLVYDFLSRGSLEENLH--GNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 544
+ +L LV+++L + L++ L GN + + V + + + L L+ ++
Sbjct: 74 HTEKSLTLVFEYLDK-DLKQYLDDCGNSIN--------MHNVKLFLFQLLRGLNYCHRRK 124
Query: 545 VIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575
V+HRD+K N+L+++ E +L+DFGLA+ S
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKS 155
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 44/149 (29%), Positives = 72/149 (48%), Gaps = 12/149 (8%)
Query: 430 IGKGGSSQVY------KGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLL 483
+GKGG +V G L K+L K LK + V E I+ +H + I+SL
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMV-EKRILAKVHSRFIVSL- 58
Query: 484 GFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
+ F+ +L LV ++ G L +++ ++ F + LE+LH
Sbjct: 59 AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ--- 115
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLA 571
+R+I+RD+K N+LL +D ++SD GLA
Sbjct: 116 RRIIYRDLKPENVLLDNDGNVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 45/153 (29%), Positives = 71/153 (46%), Gaps = 19/153 (12%)
Query: 430 IGKGGSSQVYKGCLPDG---KELAVKILKPSEDVIKE--FVLEIEIITTLHHKNIISLLG 484
IG G +V G + G ++ VK L+ S V ++ F+ E + +L H N++ LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKK------DPAAFGWSERYKVAMGVAEALEYLH 538
C E LLV +F G L+ L +K DP ++A +A L +LH
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTL-----QRMACEIALGLLHLH 117
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571
+ IH D+ N LL+ D ++ D+GL+
Sbjct: 118 KNN---FIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 43/131 (32%), Positives = 71/131 (54%), Gaps = 13/131 (9%)
Query: 446 GKELAVK-ILKP-SEDVI-KEFVLEIEIITTLHHKNIISLLG-FCFEDNNLLLVYDFLSR 501
G+ +A+K I+KP S V+ K E++++ L H+NIISL F ++ V + L
Sbjct: 35 GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGT 94
Query: 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 561
L L + F Y++ G L+Y+HS V+HRD+K SNIL++++
Sbjct: 95 -DLHRLLTSRPLEKQ-FIQYFLYQILRG----LKYVHSAG---VVHRDLKPSNILINENC 145
Query: 562 EPQLSDFGLAK 572
+ ++ DFGLA+
Sbjct: 146 DLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 5e-07
Identities = 41/151 (27%), Positives = 74/151 (49%), Gaps = 14/151 (9%)
Query: 429 LIGKGGSSQVYKGC-LPDGKEL----AVKILK--PSEDVIKEFVLEIEIITTLHHKNIIS 481
++G G VYKG +PDG+ + A+K+L+ S KE + E ++ + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
LLG C + + LV + G L + + NK G + + +A+ + YL
Sbjct: 74 LLGICLT-STVQLVTQLMPYGCLLDYVRENKD---RIGSQDLLNWCVQIAKGMSYLEE-- 127
Query: 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
R++HRD+ + N+L+ +++DFGLA+
Sbjct: 128 -VRLVHRDLAARNVLVKSPNHVKITDFGLAR 157
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|238182 cd00293, USP_Like, Usp: Universal stress protein family | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 6e-07
Identities = 27/137 (19%), Positives = 47/137 (34%), Gaps = 9/137 (6%)
Query: 18 TVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSV 77
++V V S L WA + G ++ LHV+ + L +A +
Sbjct: 1 RILVAVDGSEESERALRWAARLARRLGAELVLLHVVDPPPSSAAELAELLEEEARA---L 57
Query: 78 LAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRST--TSL 135
L V ++ + G IL A+ A ++G+ +R S+
Sbjct: 58 LEALREALAEAGVKVETVVLEGDPAEAIL-EAAEELGADLIVMGSRG-RSGLRRLLLGSV 115
Query: 136 AKYCAKKLSKDCSVLAV 152
A+ + C VL V
Sbjct: 116 AERVLRHAP--CPVLVV 130
|
The universal stress protein Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae Usp reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, athough Usp lacks ATP-binding activity. Length = 130 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 6e-07
Identities = 46/172 (26%), Positives = 73/172 (42%), Gaps = 41/172 (23%)
Query: 424 FLAENL-----IGKGGSSQVYKGCLPD-GKELAVKILKPSED--VIKEFVLEIEIITTLH 475
F AE+L IG+G V K G +AVK ++ + D K +++++++
Sbjct: 1 FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS 60
Query: 476 H-KNIISLLG---------FCFE------DNNLLLVYDFLSRGSLEENLHGNKKDPAAFG 519
I+ G C E D VY+ L + + E + G
Sbjct: 61 DCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVL-KSVIPEEILG--------- 110
Query: 520 WSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571
K+A+ +AL YL ++IHRDVK SNILL + +L DFG++
Sbjct: 111 -----KIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGIS 155
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 6e-07
Identities = 41/148 (27%), Positives = 69/148 (46%), Gaps = 9/148 (6%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKIL--KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
++GKG VY L +A+K + + S V + EI + + L H+NI+ LG
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYV-QPLHEEIALHSYLKHRNIVQYLGS 73
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
E+ + + + GSL L +K P + E L+YLH ++
Sbjct: 74 DSENGFFKIFMEQVPGGSLSALLR-SKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQI 129
Query: 546 IHRDVKSSNILLSD-DFEPQLSDFGLAK 572
+HRD+K N+L++ ++SDFG +K
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTSK 157
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 6e-07
Identities = 42/153 (27%), Positives = 77/153 (50%), Gaps = 12/153 (7%)
Query: 430 IGKGGSSQVYKGCLPDGKEL-AVK--ILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
+G+G + V+KG + L A+K L+ E + E+ ++ L H NI++L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-GVAEALEYLHSGSAQRV 545
D +L LV+++L +++L D K+ + + L Y H ++V
Sbjct: 74 HTDKSLTLVFEYL-----DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR---RKV 125
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578
+HRD+K N+L+++ E +L+DFGLA+ S +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPT 158
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 7e-07
Identities = 36/149 (24%), Positives = 72/149 (48%), Gaps = 12/149 (8%)
Query: 427 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 480
E ++G G ++ +GCL P +EL A+ L+ S+ + F+ E + H NI+
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
L G N +++V +++S G+L+ L +K + + G+A ++YL
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFL---RKHEGQLVAGQLMGMLPGLASGMKYL--- 123
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFG 569
S +H+ + + +L++ D ++S F
Sbjct: 124 SEMGYVHKGLAAHKVLVNSDLVCKISGFR 152
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 36/131 (27%), Positives = 63/131 (48%), Gaps = 16/131 (12%)
Query: 450 AVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEEN 507
AVK+L+P ++F+ E++I++ L NI LLG C D L ++ +++ G L +
Sbjct: 50 AVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQF 109
Query: 508 LHGNKKDPAAFGWSERYK-------VAMGV--AEALEYLHSGSAQRVIHRDVKSSNILLS 558
L K G + K + M A + YL S +HRD+ + N L+
Sbjct: 110 LQ--KHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVG 164
Query: 559 DDFEPQLSDFG 569
++ +++DFG
Sbjct: 165 KNYTIKIADFG 175
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 8e-07
Identities = 45/148 (30%), Positives = 67/148 (45%), Gaps = 9/148 (6%)
Query: 430 IGKGGSSQVYKGCLPDGKELA---VKILKPSEDVIKE--FVLEIEIITTLHHKNIISLLG 484
IG G +V G G A VK L+ S ++ F+ E++ L+H N++ LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSE-RYKVAMGVAEALEYLHSGSAQ 543
C E LLV +F G L+ L N+ A + ++A VA L +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD-- 120
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLA 571
IH D+ N L+ D ++ D+GLA
Sbjct: 121 -FIHSDLALRNCQLTADLSVKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 9e-07
Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 23/154 (14%)
Query: 430 IGKGGSSQVYKGCLPDGKE-LAVKILK---PSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
IG+G VYK E +A+K ++ E V + EI ++ + H NI+ L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER------YKVAMGVAEALEYLHS 539
+ L LV+++ L+ +L + F + R Y++ G+A Y HS
Sbjct: 70 VHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA----YCHS 120
Query: 540 GSAQRVIHRDVKSSNILLSDDFEP-QLSDFGLAK 572
RV+HRD+K N+L+ +L+DFGLA+
Sbjct: 121 ---HRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
|
Length = 294 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 54/190 (28%), Positives = 85/190 (44%), Gaps = 56/190 (29%)
Query: 411 LFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPD----GKELAVKIL-KPSEDVI---- 461
L YQ+L IG G V C G+ +A+K L +P ++V
Sbjct: 15 LKRYQNL----------KPIGSGAQGIV---CAAYDTVTGQNVAIKKLSRPFQNVTHAKR 61
Query: 462 --KEFVLEIEIITTLHHKNIISLLGFCF-------EDNNLLLVYDFLSRGSLEENLHGNK 512
+E VL + ++HKNII LL F E ++ LV + + +L + + +
Sbjct: 62 AYRELVL----MKLVNHKNIIGLLN-VFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDL 115
Query: 513 KDPAAFGWSER-----YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSD 567
ER Y++ G+ ++LHS +IHRD+K SNI++ D ++ D
Sbjct: 116 D-------HERMSYLLYQMLCGI----KHLHSAG---IIHRDLKPSNIVVKSDCTLKILD 161
Query: 568 FGLAKWASTS 577
FGLA+ A TS
Sbjct: 162 FGLARTAGTS 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 49/164 (29%), Positives = 85/164 (51%), Gaps = 31/164 (18%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 481
NFL ++GKG +V EL A+KILK +DVI + + ++ T+ K +++
Sbjct: 3 NFLM--VLGKGSFGKVMLAERKGTDELYAIKILK--KDVI---IQDDDVECTMVEKRVLA 55
Query: 482 LLG---F------CFED-NNLLLVYDFLSRGSLEENLH--GNKKDP-AAFGWSERYKVAM 528
L G F CF+ + L V ++++ G L ++ G K+P A F +E
Sbjct: 56 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAE------ 109
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+A L +LHS + +I+RD+K N++L + +++DFG+ K
Sbjct: 110 -IAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 1e-06
Identities = 43/159 (27%), Positives = 72/159 (45%), Gaps = 34/159 (21%)
Query: 430 IGKGGSSQVYKGCL-PDGKELAVKILKPSEDV---IKEFV-LEIEIITTLHHKNIISLLG 484
+G GG +V + + A+K +K V +E + E EI+ +H I+ L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 485 FCFEDNN---LLL-------VYDFL-SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 533
F+D +L+ ++ L RG +E ++ R+ +A V A
Sbjct: 61 -TFKDKKYIYMLMEYCLGGELWTILRDRGLFDE-------------YTARFYIAC-VVLA 105
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
EYLH+ + +I+RD+K N+LL + +L DFG AK
Sbjct: 106 FEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAK 141
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 43/158 (27%), Positives = 79/158 (50%), Gaps = 29/158 (18%)
Query: 429 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEIEIITTLHHKNIISL----- 482
++GKG +V L EL AVK+LK +DVI + + ++ T+ K +++L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLK--KDVI---LQDDDVECTMTEKRVLALAGKHP 56
Query: 483 ----LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDP---AAFGWSERYKVAMGVAEAL 534
L CF+ + L V ++++ G L ++ + + A F Y A + L
Sbjct: 57 FLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARF-----Y--AAEIVLGL 109
Query: 535 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
++LH + +I+RD+K N+LL + +++DFG+ K
Sbjct: 110 QFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 1e-06
Identities = 31/111 (27%), Positives = 56/111 (50%), Gaps = 15/111 (13%)
Query: 467 EIEIITTLHHKNIISLLGFCFEDN--NLLLVYDFLSRGSLEENLHG---NKKDPAAFGWS 521
EI I+ L H NI+++ N + +V +++ E +L K P F S
Sbjct: 54 EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYV-----EHDLKSLMETMKQP--FLQS 106
Query: 522 ERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
E + + + + +LH ++HRD+K+SN+LL++ ++ DFGLA+
Sbjct: 107 EVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 43/154 (27%), Positives = 71/154 (46%), Gaps = 19/154 (12%)
Query: 449 LAVKILKPSEDVIKEFVL------------EIEIITTLHHKNIISLLGFCFEDNNLLLVY 496
+A + P E V+ +FV+ E+ + H I+ D+ LLL+
Sbjct: 85 VATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144
Query: 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 556
++ S G L + + K+ F E + + AL+ +HS ++++HRD+KS+NI
Sbjct: 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIF 201
Query: 557 LSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 590
L +L DFG +K S S S DVA +F
Sbjct: 202 LMPTGIIKLGDFGFSKQYSDSVS----LDVASSF 231
|
Length = 478 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 48/179 (26%), Positives = 82/179 (45%), Gaps = 41/179 (22%)
Query: 422 SNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL----EIEIITTLHH 476
+ + IG+G V P G ++A+K + P E F EI+I+ H
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQT--FCQRTLREIKILRRFKH 62
Query: 477 KNIISLLGF----CFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER-------- 523
+NII +L FE N++ +V + + E +L+ K ++
Sbjct: 63 ENIIGILDIIRPPSFESFNDVYIVQELM-----ETDLYKLIK-------TQHLSNDHIQY 110
Query: 524 --YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580
Y++ G L+Y+HS + V+HRD+K SN+LL+ + + ++ DFGLA+ A H
Sbjct: 111 FLYQILRG----LKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH 162
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 34/98 (34%), Positives = 52/98 (53%), Gaps = 9/98 (9%)
Query: 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSS 553
LV D+ + G L + + K F E + + V A+ ++HS + +IHRD+KS+
Sbjct: 116 LVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSA 172
Query: 554 NILLSDDFEPQLSDFGLAK-WASTSSSHITCTDVAGTF 590
NILL + +L DFG +K +A+T S DV TF
Sbjct: 173 NILLCSNGLVKLGDFGFSKMYAATVSD-----DVGRTF 205
|
Length = 496 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 47/158 (29%), Positives = 73/158 (46%), Gaps = 16/158 (10%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFVL----EIEIITTLHH 476
+F + +IG+G +V D G A+K L+ SE + KE V E +I+ +
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 477 KNIISLLGFC-FED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL 534
++ L + F+D N L L+ ++L G + L KKD + Y +AE +
Sbjct: 61 PWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLM--KKDTFTEEETRFY-----IAETI 111
Query: 535 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+ S IHRD+K N+LL +LSDFGL
Sbjct: 112 LAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCT 149
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 21/156 (13%)
Query: 446 GKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFE-DNNLLLVYDFLS 500
GK A+KILK ++D + + E ++ H + SL + F+ + L V ++++
Sbjct: 20 GKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL-KYSFQTKDRLCFVMEYVN 78
Query: 501 RGSLEENLHGNK---KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557
G L +L + +D F +E + AL+YLHSG ++++RD+K N++L
Sbjct: 79 GGELFFHLSRERVFSEDRTRFYGAE-------IVSALDYLHSG---KIVYRDLKLENLML 128
Query: 558 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYV 593
D +++DFGL K T ++ T GT Y+
Sbjct: 129 DKDGHIKITDFGLCKEGITDAA--TMKTFCGTPEYL 162
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 36/157 (22%), Positives = 75/157 (47%), Gaps = 17/157 (10%)
Query: 430 IGKGGSSQVYKGCLPD------GKELAVKILKPSEDVIK--EFVLEIEIITTLHHKNIIS 481
+G+G VY+G D +AVK + S + + EF+ E ++ +++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPA------AFGWSERYKVAMGVAEALE 535
LLG + L+V + ++ G L+ L + + E ++A +A+ +
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
YL +A++ +HRD+ + N +++ DF ++ DFG+ +
Sbjct: 134 YL---NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 39/147 (26%), Positives = 73/147 (49%), Gaps = 13/147 (8%)
Query: 430 IGKGGSSQVYK-GCLPDGKELAVKIL----KPSEDVIKEFVLEIEIITTLHHKNIISLLG 484
+G G V+K P G +A K++ KP+ + + + E++++ + I+ G
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPA--IRNQIIRELQVLHECNSPYIVGFYG 70
Query: 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 544
+ D + + + + GSL++ L + P KV++ V + L YL +
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLRE--KHK 124
Query: 545 VIHRDVKSSNILLSDDFEPQLSDFGLA 571
++HRDVK SNIL++ E +L DFG++
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVS 151
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 36/132 (27%), Positives = 67/132 (50%), Gaps = 12/132 (9%)
Query: 444 PDGKELAVKIL----KPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499
P G +A K++ KP+ + + + E++++ + I+ G + D + + + +
Sbjct: 28 PSGLIMARKLIHLEIKPA--IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 85
Query: 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD 559
GSL++ L K+ P KV++ V L YL +++HRDVK SNIL++
Sbjct: 86 DGGSLDQVLKEAKRIPEEI----LGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNS 139
Query: 560 DFEPQLSDFGLA 571
E +L DFG++
Sbjct: 140 RGEIKLCDFGVS 151
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 35/133 (26%), Positives = 62/133 (46%), Gaps = 14/133 (10%)
Query: 446 GKELAVKILKPSEDV----IKEFVLEIEIITTLHHKNIISLLGFCFED-NNLLLVYDFLS 500
G A+K+LK S+ + + E I+ ++ L + F+ + L LV ++L+
Sbjct: 21 GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN 80
Query: 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR-VIHRDVKSSNILLSD 559
G + W+++Y V +E LH QR +IHRD+K N+L+
Sbjct: 81 GGDCASLI--KTLGGLPEDWAKQY--IAEVVLGVEDLH----QRGIIHRDIKPENLLIDQ 132
Query: 560 DFEPQLSDFGLAK 572
+L+DFGL++
Sbjct: 133 TGHLKLTDFGLSR 145
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 38/157 (24%), Positives = 74/157 (47%), Gaps = 17/157 (10%)
Query: 430 IGKGGSSQVYKGCLPDGK---ELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLL 483
+G+G V +G L ++AVK +K + +++F+ E + H N++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 484 GFCFEDN------NLLLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALE 535
G C + + +++ F+ G L L ++ P K +A +E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
YL S++ IHRD+ + N +L+++ ++DFGL+K
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 41/157 (26%), Positives = 73/157 (46%), Gaps = 30/157 (19%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILKPS--EDVIKEFVLEIEIITTLHH-KNIISLLG 484
IG G QVYK G +AVK ++ + ++ K +++++++ H I+ G
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYG 81
Query: 485 FCFEDNNLLLVYDFLS----------RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL 534
+ D+++ + + +S +G + E++ G K+ + + +AL
Sbjct: 82 YFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILG--------------KMTVAIVKAL 127
Query: 535 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571
YL VIHRDVK SNILL +L DFG++
Sbjct: 128 HYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGIS 162
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 50/172 (29%), Positives = 78/172 (45%), Gaps = 41/172 (23%)
Query: 423 NFLAENLIGKGGSSQVY----KGCLPDGKELAVKILKP--------------SEDVIKEF 464
NF ++G G +V+ G GK A+K+LK +E + E
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 465 VLEIEIITTLHHKNIISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER 523
V + TLH + F+ D L L+ D+++ G L +L+ + F SE
Sbjct: 61 VRRCPFLVTLH---------YAFQTDTKLHLILDYVNGGELFTHLYQREH----FTESE- 106
Query: 524 YKVAMGVAE---ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
V + +AE AL++LH +I+RD+K NILL + L+DFGL+K
Sbjct: 107 --VRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSK 153
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 30/115 (26%), Positives = 58/115 (50%), Gaps = 9/115 (7%)
Query: 465 VLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY 524
+ E+ ++ L H NI++L + L LV+++L + +L +
Sbjct: 51 IREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL-----DSDLKQYLDNCGNLMSMHNV 105
Query: 525 KVAM-GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578
K+ M + L Y H ++++HRD+K N+L+++ E +L+DFGLA+ S +
Sbjct: 106 KIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 4e-06
Identities = 42/170 (24%), Positives = 77/170 (45%), Gaps = 42/170 (24%)
Query: 423 NFLAENLIGKGGSSQV----YKGCLPDGKELAVKILKPSEDVIKEFVLE----------- 467
LA ++G+G +V YK G+ A+K LK K ++
Sbjct: 2 RCLA--VLGRGHFGKVLLAEYK---KTGELYAIKALK------KGDIIARDEVESLMCEK 50
Query: 468 --IEIITTLHHKNIISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY 524
E + H +++L CF+ ++++ V ++ + G L ++H + +SE
Sbjct: 51 RIFETANSERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDV-------FSEPR 102
Query: 525 KV--AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
V A V L+YLH ++++RD+K N+LL + +++DFGL K
Sbjct: 103 AVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCK 149
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 38/135 (28%), Positives = 70/135 (51%), Gaps = 19/135 (14%)
Query: 446 GKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN-LLLVYDFLS 500
G+ A+KIL+ ++D + V E ++ H ++ L + F+ ++ L V ++ +
Sbjct: 20 GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP-FLTALKYAFQTHDRLCFVMEYAN 78
Query: 501 RGSLEENLHGNK---KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557
G L +L + ++ A F +E + ALEYLHS + V++RD+K N++L
Sbjct: 79 GGELFFHLSRERVFTEERARFYGAE-------IVSALEYLHS---RDVVYRDIKLENLML 128
Query: 558 SDDFEPQLSDFGLAK 572
D +++DFGL K
Sbjct: 129 DKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 6e-06
Identities = 40/159 (25%), Positives = 79/159 (49%), Gaps = 8/159 (5%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIK--EFVLEIEIITTLHHKNIISLLGFC 486
+GKG VYK P G +A+K ++ D K + ++E++I+ I+ G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
F + + + +++ GSL++ L+ ++ V + L++L +I
Sbjct: 69 FIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNII 125
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLAK--WASTSSSHITC 583
HRDVK +N+L++ + + +L DFG++ AS + ++I C
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGC 164
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 6e-06
Identities = 39/134 (29%), Positives = 65/134 (48%), Gaps = 17/134 (12%)
Query: 446 GKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNIISLL--GFCFEDNNLLLVYDFL 499
G E+A+K+L+ E F E + L+H NI++LL G L V++++
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS- 558
+L E L + PA E ++ + V +AL H Q ++HRD+K NI++S
Sbjct: 62 PGRTLREVLAADGALPAG----ETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQ 114
Query: 559 DDFEP--QLSDFGL 570
P ++ DFG+
Sbjct: 115 TGVRPHAKVLDFGI 128
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 7e-06
Identities = 40/135 (29%), Positives = 67/135 (49%), Gaps = 19/135 (14%)
Query: 446 GKELAVKILKPSEDVIKEFV----LEIEIITTLHHKNIISLLGFCFEDNN-LLLVYDFLS 500
GK A+KILK + K+ V E ++ H + +L + F+ ++ L V ++ +
Sbjct: 20 GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL-KYSFQTHDRLCFVMEYAN 78
Query: 501 RGSLEENLHGNK---KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557
G L +L + +D A F +E + AL YLHS V++RD+K N++L
Sbjct: 79 GGELFFHLSRERVFSEDRARFYGAE-------IVSALGYLHS---CDVVYRDLKLENLML 128
Query: 558 SDDFEPQLSDFGLAK 572
D +++DFGL K
Sbjct: 129 DKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 8e-06
Identities = 19/44 (43%), Positives = 29/44 (65%), Gaps = 3/44 (6%)
Query: 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576
L+Y+HS +IHRD+K SNI +++D E ++ DFGLA+
Sbjct: 130 GLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDD 170
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 8e-06
Identities = 51/176 (28%), Positives = 81/176 (46%), Gaps = 25/176 (14%)
Query: 429 LIGKGGSSQVYKGC--LPDGKELAVKILKPSEDVIKE---FVLEIEIITTLHHKN---II 480
+IG+GG +VY GC GK A+K L +K+ L I+ +L I
Sbjct: 1 IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 481 SLLGFCFED-NNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYL 537
+ + F + L + D ++ G L +L HG F +E A + LE++
Sbjct: 60 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG------VFSEAEMRFYAAEIILGLEHM 113
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYV 593
H+ + V++RD+K +NILL + ++SD GLA S H + GT GY+
Sbjct: 114 HN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYM 162
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 8e-06
Identities = 51/176 (28%), Positives = 84/176 (47%), Gaps = 25/176 (14%)
Query: 429 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEIEIITTLHHKNIISL----- 482
++GKG +V L E+ A+K+LK +DVI + + ++ T+ K I++L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLK--KDVI---LQDDDVDCTMTEKRILALAAKHP 56
Query: 483 ----LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
L CF+ + L V ++++ G L + ++K F A V AL +L
Sbjct: 57 FLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK----FDEPRSRFYAAEVTLALMFL 112
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYV 593
H VI+RD+K NILL + +L+DFG+ K + +T T GT Y+
Sbjct: 113 HRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTTTFCGTPDYI 163
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 9e-06
Identities = 51/176 (28%), Positives = 80/176 (45%), Gaps = 25/176 (14%)
Query: 429 LIGKGGSSQVYKGC--LPDGKELAVKILKPSEDVIKE---FVLEIEIITTLHHKN---II 480
+IG+GG +VY GC GK A+K L +K+ L I+ +L I
Sbjct: 1 IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 481 SLLGFCFED-NNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYL 537
+ + F + L + D ++ G L +L HG F E A + LE++
Sbjct: 60 VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG------VFSEKEMRFYATEIILGLEHM 113
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYV 593
H+ + V++RD+K +NILL + ++SD GLA S H + GT GY+
Sbjct: 114 HN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYM 162
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 37/152 (24%), Positives = 73/152 (48%), Gaps = 18/152 (11%)
Query: 430 IGKGGSSQVY--------KGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 481
IG+G ++Y + C+ +L +K E KE +L + + H NI++
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVIL----LAKMKHPNIVT 63
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
E+ L +V ++ G L + + N++ F + + ++ L+++H
Sbjct: 64 FFASFQENGRLFIVMEYCDGGDLMKRI--NRQRGVLFSEDQILSWFVQISLGLKHIHD-- 119
Query: 542 AQRVIHRDVKSSNILLSDD-FEPQLSDFGLAK 572
++++HRD+KS NI LS + +L DFG+A+
Sbjct: 120 -RKILHRDIKSQNIFLSKNGMVAKLGDFGIAR 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 44/157 (28%), Positives = 74/157 (47%), Gaps = 21/157 (13%)
Query: 430 IGKGGSSQVYKGC-LPDGKELA----VKILKPSEDVIKEFVLEIEII---TTLHHKNIIS 481
IG+G +V+K L +G V++ E + + E+ ++ T H N++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 482 LLGFCF-----EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-GVAEALE 535
L C + L LV++ + + L L K P +E K M + L+
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL---DKVPEPGVPTETIKDMMFQLLRGLD 124
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+LHS RV+HRD+K NIL++ + +L+DFGLA+
Sbjct: 125 FLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 39/163 (23%), Positives = 74/163 (45%), Gaps = 28/163 (17%)
Query: 428 NLIGKGGSSQVYKGC-LPDGKELAVKILKPSE---DVIKE----------FVL--EIEII 471
+G+G +V K GK +A+K +K E DV K+ F E++I+
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 472 TTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK--VAMG 529
+ H+NI+ L+ E + + LV D ++ L++ + + +E + +
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIR------LTESQVKCILLQ 127
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+ L LH +HRD+ +NI ++ +++DFGLA+
Sbjct: 128 ILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLAR 167
|
Length = 335 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 32/112 (28%), Positives = 56/112 (50%), Gaps = 7/112 (6%)
Query: 467 EIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKV 526
E +I+ ++H ++L G +++ L LV +F+ G L NK+ P G ++
Sbjct: 81 ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQI 140
Query: 527 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578
+ EYL S +++RD+K N+LL D +++DFG AK T +
Sbjct: 141 VL----IFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT 185
|
Length = 340 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 38/140 (27%), Positives = 70/140 (50%), Gaps = 16/140 (11%)
Query: 427 ENLIGKGGSSQVYKGC---LPDGKEL-----AVKILKPSEDVIKEFVLE-IEIITTLHHK 477
E+L G+G ++++KG + D EL +K+L S E E +++ L HK
Sbjct: 1 ESL-GQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHK 59
Query: 478 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
+++ G C + ++V +++ GSL+ L KK+ S + +VA +A AL +L
Sbjct: 60 HLVLNYGVCVCGDESIMVQEYVKFGSLDTYL---KKNKNLINISWKLEVAKQLAWALHFL 116
Query: 538 HSGSAQRVIHRDVKSSNILL 557
+ + H +V + N+LL
Sbjct: 117 ED---KGLTHGNVCAKNVLL 133
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 40/153 (26%), Positives = 77/153 (50%), Gaps = 32/153 (20%)
Query: 446 GKELAVK-ILKPSEDVI--KEFVLEIEIITTLHHKNIISLLGFC-------FEDNNLLLV 495
+++A+K I ++ I K + EI+++ L H+N+I++ F D + +V
Sbjct: 30 NEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND--VYIV 87
Query: 496 YDFLSRGSLEENLHGNKKDPAAFGWSER------YKVAMGVAEALEYLHSGSAQRVIHRD 549
Y+ + + +LH + S+ Y++ G L+Y+HS + V+HRD
Sbjct: 88 YELM-----DTDLHQIIRSSQTL--SDDHCQYFLYQLLRG----LKYIHSAN---VLHRD 133
Query: 550 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 582
+K SN+LL+ + + ++ DFGLA+ S +T
Sbjct: 134 LKPSNLLLNANCDLKICDFGLARTTSEKGDFMT 166
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|216006 pfam00582, Usp, Universal stress protein family | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-05
Identities = 23/138 (16%), Positives = 48/138 (34%), Gaps = 4/138 (2%)
Query: 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDS 76
+ ++V V S L WAL + G +I LHV+ + +
Sbjct: 3 KRILVAVDGSEESERALEWALELAKRRGAELILLHVIDPEPSGAASEALEEEEEEELEEE 62
Query: 77 VLAVYEGFCNLKQVDLKLK-ICRGTSIRKILVREAQSYSATKFIVGT-AKNHHTIRSTTS 134
+ + ++ + RG + ++ A+ A ++G+ ++ S
Sbjct: 63 EAEAEALAAAAEAGGVVVEVVVRGGDPAEAILEVAEEEDADLIVMGSRGRSGLRRLLLGS 122
Query: 135 LAKYCAKKLSKDCSVLAV 152
+A+ + C VL V
Sbjct: 123 VAEKVLRHAP--CPVLVV 138
|
The universal stress protein UspA is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. UspA enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae UspA reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, though UspA lacks ATP-binding activity. Length = 139 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 41/160 (25%), Positives = 78/160 (48%), Gaps = 19/160 (11%)
Query: 421 TSNFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKP----SEDVIKEFVLEIEIITTLH 475
NFL ++GKG +V EL A+KILK +D ++ ++E ++
Sbjct: 1 DFNFLM--VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD 58
Query: 476 HKNIISLLGFCFED-NNLLLVYDFLSRGSLEENLH--GNKKDPAAFGWSERYKVAMGVAE 532
++ L CF+ + L V ++++ G L ++ G K+P A + A ++
Sbjct: 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY------AAEISV 112
Query: 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
L +LH + +I+RD+K N++L + +++DFG+ K
Sbjct: 113 GLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 33/144 (22%), Positives = 67/144 (46%), Gaps = 12/144 (8%)
Query: 447 KELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEE 506
KE+ V L P+E V + E ++++ L H I+ E + ++ ++ L+
Sbjct: 34 KEIPVGELNPNETV--QANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDC 91
Query: 507 NLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 566
L K ++ + + + + Y+H +R++HRD+K+ NI L ++ ++
Sbjct: 92 KLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKNNL-LKIG 147
Query: 567 DFGLAKWASTSSSHITCTDVAGTF 590
DFG+++ S D+A TF
Sbjct: 148 DFGVSRLLMGS------CDLATTF 165
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 53/174 (30%), Positives = 80/174 (45%), Gaps = 21/174 (12%)
Query: 429 LIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVI------KEFVLEIEII-TTLHHKNII 480
+IGKG +V DGK AVK+L+ + ++ K + E ++ + H ++
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQ--KKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59
Query: 481 SLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 539
L + F+ L V DF++ G L +L + P R+ A +A AL YLHS
Sbjct: 60 GL-HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP---RARFYAAE-IASALGYLHS 114
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYV 593
+++RD+K NILL L+DFGL K S T T GT Y+
Sbjct: 115 ---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TTTTFCGTPEYL 163
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 42/155 (27%), Positives = 77/155 (49%), Gaps = 23/155 (14%)
Query: 429 LIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLG--- 484
++GKG +V+ L + A+K LK +DV+ +++ ++ T+ K ++SL
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALK--KDVV---LMDDDVECTMVEKRVLSLAWEHP 56
Query: 485 -----FC-FE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
+C F+ NL V ++L+ G L ++ K F A + L++L
Sbjct: 57 FLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK----FDLPRATFYAAEIICGLQFL 112
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
HS + +++RD+K NILL D +++DFG+ K
Sbjct: 113 HS---KGIVYRDLKLDNILLDTDGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 50/177 (28%), Positives = 81/177 (45%), Gaps = 25/177 (14%)
Query: 430 IGKGGSSQVYKGCLPD-GKELAVKILK--PSED-----VIKEFVLEIEIITTLHHKNIIS 481
IG G VYK P G +A+K ++ +ED ++E L ++ + H NI+
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVAL-LKRLEAFDHPNIVR 66
Query: 482 LLGFCF-----EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-GVAEALE 535
L+ C + + LV++ + + L L K P +E K M L+
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQ-DLRTYL---DKVPPPGLPAETIKDLMRQFLRGLD 122
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 592
+LH A ++HRD+K NIL++ + +L+DFGLA+ S + T V T Y
Sbjct: 123 FLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR---IYSCQMALTPVVVTLWY 173
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 48/178 (26%), Positives = 84/178 (47%), Gaps = 16/178 (8%)
Query: 423 NFLAENLIGKG--GSSQVYKGCLPDGKELAVKILKPSEDVIKEFVL----EIEIITTLHH 476
+F ++L+G+G G QV + G A+K++K S + +E V E +I++ +
Sbjct: 2 DFDVKSLVGRGHFGEVQVVRE-KATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 477 KNIISLLGFCFEDN-NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 535
I L + F+D NL LV ++ G L +L +D ++ Y +AE +
Sbjct: 61 PWIPQLQ-YAFQDKDNLYLVMEYQPGGDLL-SLLNRYEDQFDEDMAQFY-----LAELVL 113
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYV 593
+HS +HRD+K N+L+ +L+DFG A T++ + GT Y+
Sbjct: 114 AIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAA-RLTANKMVNSKLPVGTPDYI 170
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 46/163 (28%), Positives = 82/163 (50%), Gaps = 29/163 (17%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 481
NFL ++GKG +V EL A+KILK +DV+ + + ++ T+ K +++
Sbjct: 3 NFLM--VLGKGSFGKVMLAERKGTDELYAIKILK--KDVV---IQDDDVECTMVEKRVLA 55
Query: 482 LLG---------FCFED-NNLLLVYDFLSRGSLEENLH--GNKKDPAAFGWSERYKVAMG 529
L G CF+ + L V ++++ G L + G K+P A + A
Sbjct: 56 LSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFY------AAE 109
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+A L +LHS + +I+RD+K N++L + +++DFG+ K
Sbjct: 110 IAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 41/137 (29%), Positives = 68/137 (49%), Gaps = 20/137 (14%)
Query: 446 GKELAVKIL-KPSEDVI--KEFVLEIEIITTLHHKNIISLLGF-----CFEDNNLLLVYD 497
G +AVK L +P + +I K E+ ++ + H+N+I LL E+ N + +
Sbjct: 42 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 101
Query: 498 FLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNI 555
L L + K D F Y++ G L+Y+HS +IHRD+K SN+
Sbjct: 102 HLMGADLNNIVKCQKLTDDHVQF---LIYQILRG----LKYIHSAD---IIHRDLKPSNL 151
Query: 556 LLSDDFEPQLSDFGLAK 572
+++D E ++ DFGLA+
Sbjct: 152 AVNEDCELKILDFGLAR 168
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 5e-05
Identities = 44/163 (26%), Positives = 76/163 (46%), Gaps = 23/163 (14%)
Query: 423 NFLAENLIGKGGSSQVY---KGCLPD-GKELAVKILKPSEDVIKEFVLE-----IEIITT 473
NF ++G G +V+ K D GK A+K+L+ + V K +E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 474 LHHKNIISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGN---KKDPAAFGWSERYKVAMG 529
+ + L + F+ + L L+ D++S G + +L+ +D F E
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGE------- 113
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+ ALE+LH +++RD+K NILL + L+DFGL+K
Sbjct: 114 IILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSK 153
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 6e-05
Identities = 45/189 (23%), Positives = 79/189 (41%), Gaps = 68/189 (35%)
Query: 447 KELAVKILK----PSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNN-LLLVYDFLS 500
+ +AVK+LK SE K + E++I+ + HH N+++LLG C + L+++ ++
Sbjct: 38 RTVAVKMLKEGATASEY--KALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCK 95
Query: 501 RGSLEENLHGNK--------------------------------KDPAAFGW-------- 520
G+L L + + A+ G+
Sbjct: 96 FGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSD 155
Query: 521 -------SERYKV----------AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 563
E YK + VA +E+L S ++ IHRD+ + NILLS++
Sbjct: 156 VEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVV 212
Query: 564 QLSDFGLAK 572
++ DFGLA+
Sbjct: 213 KICDFGLAR 221
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 6e-05
Identities = 41/156 (26%), Positives = 75/156 (48%), Gaps = 25/156 (16%)
Query: 429 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEIEII-TTLHHKNIISLLG-- 484
++GKG +V L E A+K LK K+ VLE + + T+ + +++L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALK------KDVVLEDDDVECTMVERRVLALAWEH 55
Query: 485 ------FC-FEDN-NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
FC F+ +L V ++L+ G L ++ + + F + A + L++
Sbjct: 56 PFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR----FDEARARFYAAEIICGLQF 111
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
LH + +I+RD+K N+LL D +++DFG+ K
Sbjct: 112 LHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 6e-05
Identities = 20/43 (46%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+ E L YLH AQR+IHRDVK+ NI ++D + + D G A+
Sbjct: 166 ILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQ 205
|
Length = 357 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 7e-05
Identities = 34/123 (27%), Positives = 62/123 (50%), Gaps = 18/123 (14%)
Query: 454 LKPSEDVIKEFVLEIEIITTLHHKN---IISLLGFCFEDNNLLLVYDFLSRGSLEENLHG 510
+KP+ + + + E+++ LH N I+ G + D + + + + GSL++ L
Sbjct: 38 IKPA--IRNQIIRELKV---LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK 92
Query: 511 NKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568
+ P E K+++ V L YL +++HRDVK SNIL++ E +L DF
Sbjct: 93 AGRIP------ENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDF 144
Query: 569 GLA 571
G++
Sbjct: 145 GVS 147
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 8e-05
Identities = 33/148 (22%), Positives = 57/148 (38%), Gaps = 15/148 (10%)
Query: 429 LIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS--LLGFC 486
L+ G +++VY D +KI E E+ I+ L K + +L
Sbjct: 5 LLKGGLTNRVYLLGTKDED-YVLKINPSREKGAD-REREVAILQLLARKGLPVPKVLASG 62
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
D L+ +++ +L+E K+D +A +AE L LH +
Sbjct: 63 ESDGWSYLLMEWIEGETLDEVSEEEKED-----------IAEQLAELLAKLHQLPLLVLC 111
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLAKWA 574
H D+ NIL+ D + D+ A +
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 8e-05
Identities = 40/140 (28%), Positives = 70/140 (50%), Gaps = 19/140 (13%)
Query: 458 EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNK----K 513
ED KE VL + + H NI++ D +L +V ++ G L + + +
Sbjct: 43 EDSRKEAVL----LAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFP 98
Query: 514 DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573
+ W ++ +GV +++H +RV+HRD+KS NI L+ + + +L DFG A+
Sbjct: 99 EDTILQWF--VQMCLGV----QHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARL 149
Query: 574 ASTSSSHITCTDVAGTFGYV 593
++ ++ CT V GT YV
Sbjct: 150 LTSPGAY-ACTYV-GTPYYV 167
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 8e-05
Identities = 39/133 (29%), Positives = 65/133 (48%), Gaps = 13/133 (9%)
Query: 446 GKELAVKILKPSEDVIKEFV-----LEIEIITTLHHKNIISLLGFCFE-DNNLLLVYDFL 499
GK A+K+LK + V K E +++ + + L + F+ D L L+ D++
Sbjct: 28 GKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYI 87
Query: 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD 559
+ G L +L ++ F E + + ALE+LH +I+RD+K NILL
Sbjct: 88 NGGELFTHLSQRER----FKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDS 140
Query: 560 DFEPQLSDFGLAK 572
+ L+DFGL+K
Sbjct: 141 NGHVVLTDFGLSK 153
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 9e-05
Identities = 38/135 (28%), Positives = 70/135 (51%), Gaps = 18/135 (13%)
Query: 446 GKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN-LLLVYDFLS 500
G+ A+KILK ++D + + E ++ H ++ L + F+ ++ L V ++ +
Sbjct: 20 GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP-FLTALKYSFQTHDRLCFVMEYAN 78
Query: 501 RGSLEENLHGNK---KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557
G L +L + +D A F +E + AL+YLHS + V++RD+K N++L
Sbjct: 79 GGELFFHLSRERVFSEDRARFYGAE-------IVSALDYLHS--EKNVVYRDLKLENLML 129
Query: 558 SDDFEPQLSDFGLAK 572
D +++DFGL K
Sbjct: 130 DKDGHIKITDFGLCK 144
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 37/135 (27%), Positives = 67/135 (49%), Gaps = 8/135 (5%)
Query: 446 GKELAVKIL-KP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF-LSR 501
G ++A+K L +P SE K E+ ++ + H+N+I LL D +L +DF L
Sbjct: 40 GAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVM 99
Query: 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 561
+ +L G + + + L+Y+H+ +IHRD+K N+ +++D
Sbjct: 100 PFMGTDL-GKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDC 155
Query: 562 EPQLSDFGLAKWAST 576
E ++ DFGLA+ +
Sbjct: 156 ELKILDFGLARQTDS 170
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 18/40 (45%), Positives = 29/40 (72%), Gaps = 3/40 (7%)
Query: 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
L+Y+HS + V+HRD+K N+L++ D E ++ DFGLA+
Sbjct: 117 GLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 37/122 (30%), Positives = 62/122 (50%), Gaps = 26/122 (21%)
Query: 467 EIEIITTLHHKNIISLLGF------CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGW 520
E+ ++ ++HKNIISLL E ++ LV + + +L + +H
Sbjct: 70 ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHMELD------- 121
Query: 521 SER-----YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575
ER Y++ G+ ++LHS +IHRD+K SNI++ D ++ DFGLA+ A
Sbjct: 122 HERMSYLLYQMLCGI----KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174
Query: 576 TS 577
T+
Sbjct: 175 TN 176
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 32/91 (35%), Positives = 45/91 (49%), Gaps = 9/91 (9%)
Query: 480 ISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
I L + F+D+ L +V +++ G L NL N P W+ Y V AL+ +H
Sbjct: 105 IVQLHYAFQDDKYLYMVMEYMPGGDLV-NLMSNYDIPEK--WARFY--TAEVVLALDAIH 159
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569
S IHRDVK N+LL +L+DFG
Sbjct: 160 S---MGFIHRDVKPDNMLLDKSGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 46/154 (29%), Positives = 74/154 (48%), Gaps = 14/154 (9%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFV----LEIEIITTLHHK 477
+F + +IG+G +V D G A+KIL+ ++ + KE V E +I+
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 478 NIISLLGFCFEDN-NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
++ + + F+D NL L+ +FL G + L KKD ++ Y +AE +
Sbjct: 62 WVVKMF-YSFQDKLNLYLIMEFLPGGDMMTLLM--KKDTLTEEETQFY-----IAETVLA 113
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570
+ S IHRD+K N+LL +LSDFGL
Sbjct: 114 IDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 45/154 (29%), Positives = 75/154 (48%), Gaps = 14/154 (9%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFVLEI----EIITTLHHK 477
+F + +IG+G +V D G A+KIL+ ++ + KE V I +I+
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61
Query: 478 NIISLLGFCFEDN-NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
++ + + F+D NL L+ +FL G + L KKD + ++ Y +AE +
Sbjct: 62 WVVKMF-YSFQDKRNLYLIMEFLPGGDMMTLLM--KKDTLSEEATQFY-----IAETVLA 113
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570
+ + IHRD+K N+LL +LSDFGL
Sbjct: 114 IDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 41/156 (26%), Positives = 67/156 (42%), Gaps = 17/156 (10%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISL--LGF 485
+G+G VYK DGK+ LK E + EI ++ L H N+I+L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 486 CFEDNNLLLVYDFLSRG-----SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
D + L++D+ NKK P S + + + + YLH
Sbjct: 69 SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKK-PMQLPRSMVKSLLYQILDGIHYLH-- 125
Query: 541 SAQRVIHRDVKSSNILL----SDDFEPQLSDFGLAK 572
A V+HRD+K +NIL+ + +++D G A+
Sbjct: 126 -ANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 53/204 (25%), Positives = 85/204 (41%), Gaps = 18/204 (8%)
Query: 396 KELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKG--GSSQVYKGCLPDGKELAVKI 453
K ++ +Y T + +DL ++ +IG+G G Q+ + K A+K+
Sbjct: 19 KNIDNFLNRYKDT--INKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTR-KVYAMKL 75
Query: 454 LKPSEDVIKE---FVLEIEIITTLHHKNIISLLGFCFEDNNLL-LVYDFLSRGSLEENLH 509
L E + + F E I + + L + F+D+ L +V +++ G L NL
Sbjct: 76 LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLM 134
Query: 510 GNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569
N P W+ Y V AL+ +HS IHRDVK N+LL +L+DFG
Sbjct: 135 SNYDVPEK--WARFYTAE--VVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFG 187
Query: 570 LAKWASTSSSHITCTDVAGTFGYV 593
+ C GT Y+
Sbjct: 188 TCM-KMNKEGMVRCDTAVGTPDYI 210
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 43/171 (25%), Positives = 78/171 (45%), Gaps = 32/171 (18%)
Query: 430 IGKGGSSQVYKGCLPD-GKELAVKILKPSEDV-IKEFVLEIEIITTLHHKNII------- 480
+G G + V+ D K +AVK + ++ +K + EI+II L H NI+
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 481 -------SLLGFCFEDNNLLLVYDFLS---RGSLEENLHGNKKDPAAFGWSERYKVAMGV 530
+G E N++ +V +++ LE+ + Y++ G
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFM-----YQLLRG- 126
Query: 531 AEALEYLHSGSAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKWASTSSSH 580
L+Y+HS + V+HRD+K +N+ ++ +D ++ DFGLA+ SH
Sbjct: 127 ---LKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSH 171
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 45/159 (28%), Positives = 79/159 (49%), Gaps = 31/159 (19%)
Query: 429 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLE---IEIITTLHH-----KNI 479
+IG+G ++V L + + A+K++K KE V + I+ + T H N
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIK------KELVNDDEDIDWVQTEKHVFETASNH 55
Query: 480 ISLLGF--CFE-DNNLLLVYDFLSRGSLEENLHGNKKDP---AAFGWSERYKVAMGVAEA 533
L+G CF+ ++ L V +F+S G L ++ +K P A F +E ++ A
Sbjct: 56 PFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAE-------ISLA 108
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
L +LH +I+RD+K N+LL + +L+D+G+ K
Sbjct: 109 LNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 37/128 (28%), Positives = 59/128 (46%), Gaps = 10/128 (7%)
Query: 467 EIEIITTLHHKNIISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK 525
E +I+ ++ + ++SL + +E + L LV ++ G L+ H A F
Sbjct: 50 EKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLK--FHIYHMGEAGFEEGRAVF 106
Query: 526 VAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD 585
A + LE LH +R+++RD+K NILL D ++SD GLA T
Sbjct: 107 YAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKG 160
Query: 586 VAGTFGYV 593
GT GY+
Sbjct: 161 RVGTVGYM 168
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 23/150 (15%)
Query: 445 DGKELAVKILKPSED---VIKEFVLEIEIITTLHHKNIISLLGF-------CFEDNNLLL 494
DGK +A+K + K E++++ H N++S L FE+ + +
Sbjct: 24 DGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEE--IYV 81
Query: 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-GVAEALEYLHSGSAQRVIHRDVKSS 553
V + + + +LH P S+ KV + + L+YLHS ++HRD+K
Sbjct: 82 VTELM-----QSDLHKIIVSPQPLS-SDHVKVFLYQILRGLKYLHSA---GILHRDIKPG 132
Query: 554 NILLSDDFEPQLSDFGLA-KWASTSSSHIT 582
N+L++ + ++ DFGLA S H+T
Sbjct: 133 NLLVNSNCVLKICDFGLARVEEPDESKHMT 162
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 48/155 (30%), Positives = 73/155 (47%), Gaps = 23/155 (14%)
Query: 429 LIGKGGSSQVY---KGCLPDGKELAVKILKPSEDVIKEFVLEIE-----IITTLHHKNII 480
+IGKG +V + DG AVK+L+ + K+ I ++ L H ++
Sbjct: 2 VIGKGSFGKVLLAKRKS--DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 481 SLLGFCFED-NNLLLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYL 537
L + F+ L V D+++ G L +L + +P A R+ A VA A+ YL
Sbjct: 60 GL-HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRA-----RFYAAE-VASAIGYL 112
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
HS +I+RD+K NILL L+DFGL K
Sbjct: 113 HS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 52/198 (26%), Positives = 94/198 (47%), Gaps = 32/198 (16%)
Query: 429 LIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISL----- 482
++GKG +V L G+ AVK LK +DV+ +++ ++ T+ K +++L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALK--KDVV---LIDDDVECTMVEKRVLALAWENP 56
Query: 483 ----LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE---AL 534
L F+ +L V +FL+ G L ++ +D F + Y+ AE L
Sbjct: 57 FLTHLYCTFQTKEHLFFVMEFLNGGDLMFHI----QDKGRF---DLYRATFYAAEIVCGL 109
Query: 535 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVV 594
++LHS + +I+RD+K N++L D +++DFG+ K + + GT Y+
Sbjct: 110 QFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYIA 164
Query: 595 -LILNPIAFLFMFNCWFF 611
IL + + F + W F
Sbjct: 165 PEILQGLKYTFSVDWWSF 182
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 35/148 (23%), Positives = 62/148 (41%), Gaps = 19/148 (12%)
Query: 431 GKGGSSQVYKGCLPDGKELAVKILKPSEDVIK--EFVLEIEIITTLHHKNIISLLGFCFE 488
GK S++Y + VK LK + + EF+ + + L H NI+ LG C E
Sbjct: 9 GKVLLSEIYTD--TGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE 66
Query: 489 DNNLLLVYDFLSRGSL------EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
LLV+++ G L E+ N + ++A +A + ++H
Sbjct: 67 AIPYLLVFEYCELGDLKSYLSQEQWHRRNSQL------LLLQRMACEIAAGVTHMHK--- 117
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGL 570
+H D+ N L+ D ++ D+G+
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (102), Expect = 3e-04
Identities = 42/163 (25%), Positives = 68/163 (41%), Gaps = 31/163 (19%)
Query: 447 KELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN--LLLVYDFLSRGSL 504
K ++ + LK E + V+E+ ++ L HKNI+ + N L ++ +F G L
Sbjct: 44 KAISYRGLKEREK--SQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDL 101
Query: 505 EENLHGNKKDPAAFGWSERY---KVAMGVAEALEYLHS----GSAQRVIHRDVKSSNILL 557
N+ K FG E + + + AL Y H+ + +RV+HRD+K NI L
Sbjct: 102 SRNIQKCYK---MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFL 158
Query: 558 SDDFE-----------------PQLSDFGLAKWASTSSSHITC 583
S ++ DFGL+K S +C
Sbjct: 159 STGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSC 201
|
Length = 1021 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 4e-04
Identities = 37/115 (32%), Positives = 60/115 (52%), Gaps = 12/115 (10%)
Query: 467 EIEIITTLHHKNIISLLGFCFEDNNLLLVYD-FLSRGSLEENLHG---NKKDPAAFGWSE 522
E+ ++ ++HKNIISLL +L D +L ++ NL + D +
Sbjct: 66 ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL- 124
Query: 523 RYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577
Y++ G+ ++LHS +IHRD+K SNI++ D ++ DFGLA+ A TS
Sbjct: 125 LYQMLCGI----KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 44/159 (27%), Positives = 68/159 (42%), Gaps = 23/159 (14%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISL--LGF 485
+G+G VYK DGK+ LK E + EI ++ L H N+ISL +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 486 CFEDNNLLLVYDFLSRG-----SLEENLHGNKKD---PAAFGWSERYKVAMGVAEALEYL 537
D + L++D+ NKK P S Y++ G+ YL
Sbjct: 69 SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI----HYL 124
Query: 538 HSGSAQRVIHRDVKSSNILL----SDDFEPQLSDFGLAK 572
H A V+HRD+K +NIL+ + +++D G A+
Sbjct: 125 H---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 34/108 (31%), Positives = 60/108 (55%), Gaps = 11/108 (10%)
Query: 467 EIEIITTLHHKNIISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK 525
E +I+ ++ + ++SL + +E + L LV ++ G L+ +++ N +P G+ E
Sbjct: 50 EKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIY-NMGNP---GFDEERA 104
Query: 526 V--AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571
V A + LE LH +R+++RD+K NILL D ++SD GLA
Sbjct: 105 VFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 32/112 (28%), Positives = 56/112 (50%), Gaps = 9/112 (8%)
Query: 457 SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPA 516
+ +++ E+ + +H NI+ DN L +V F++ GS ++ + + D
Sbjct: 39 TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMD-- 96
Query: 517 AFGWSERY--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 566
G SE + GV +AL+Y+H +HR VK+S+IL+S D + LS
Sbjct: 97 --GMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLS 143
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 5e-04
Identities = 21/48 (43%), Positives = 31/48 (64%), Gaps = 6/48 (12%)
Query: 528 MGVAE---ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
M AE ALEYLH+ ++HRD+K N+L++ +L+DFGL+K
Sbjct: 105 MYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSK 149
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 6e-04
Identities = 31/110 (28%), Positives = 51/110 (46%), Gaps = 18/110 (16%)
Query: 467 EIEIITTLHHKNIISLLGFCFEDNNLLLV-----YDFLSRGSLEENLHGNKKDPAAFGWS 521
EI+I+ T+ H+ II+L+ + + +V D + + ++ P
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFT--------YVDRSGPLPL--E 185
Query: 522 ERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571
+ + + EAL YLH + +IHRDVK+ NI L + L DFG A
Sbjct: 186 QAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAA 232
|
Length = 392 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 7e-04
Identities = 19/41 (46%), Positives = 30/41 (73%), Gaps = 3/41 (7%)
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574
L+Y+HS +IHRD+K SN+ +++D E ++ DFGLA+ A
Sbjct: 131 LKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQA 168
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 7e-04
Identities = 32/100 (32%), Positives = 46/100 (46%), Gaps = 16/100 (16%)
Query: 471 ITTLHHKNIISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG 529
ITTLH + F+D N L LV D+ G L L +D + Y
Sbjct: 63 ITTLH---------YAFQDENYLYLVMDYYVGGDLL-TLLSKFEDRLPEDMARFY----- 107
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569
+AE + +HS +HRD+K N+LL + +L+DFG
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG 147
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 8e-04
Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 20/158 (12%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFV----LEIEIITTLHH 476
S F+ IG G +V D L A+K L+ ++ +++ E +I+ +
Sbjct: 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADN 60
Query: 477 KNIISLLGFCFED-NNLLLVYDFLSRG---SLEENLHGNKKDPAAFGWSERYKVAMGVAE 532
+ ++ L + F+D +NL V D++ G SL L ++D A F +E +
Sbjct: 61 EWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAE-------LTC 112
Query: 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570
A+E +H IHRD+K NIL+ D +L+DFGL
Sbjct: 113 AIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 8e-04
Identities = 31/108 (28%), Positives = 58/108 (53%), Gaps = 11/108 (10%)
Query: 467 EIEIITTLHHKNIISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK 525
E +I+ ++ + +++L + +E + L LV ++ G L+ +++ N +P G+ E
Sbjct: 50 EKQILEKVNSQFVVNL-AYAYETKDALCLVLTIMNGGDLKFHIY-NMGNP---GFEEERA 104
Query: 526 V--AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571
+ A + LE LH + ++RD+K NILL D ++SD GLA
Sbjct: 105 LFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 9e-04
Identities = 20/45 (44%), Positives = 30/45 (66%), Gaps = 3/45 (6%)
Query: 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577
+++LHS +IHRD+K SNI++ D ++ DFGLA+ A TS
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 47/156 (30%), Positives = 74/156 (47%), Gaps = 26/156 (16%)
Query: 446 GKELAVKIL-KP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF-LSR 501
G+++A+K L +P SE K E+ ++ + H+N+I LL + DF L
Sbjct: 40 GEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM 99
Query: 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAE---ALEYLHSGSAQRVIHRDVKSSNILLS 558
++ +L P SE KV V + L+Y+HS +IHRD+K N+ ++
Sbjct: 100 PYMQTDLQKIMGHP----LSED-KVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVN 151
Query: 559 DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVV 594
+D E ++ DFGLA+ A A GYVV
Sbjct: 152 EDCELKILDFGLARHAD-----------AEMTGYVV 176
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 51/160 (31%), Positives = 74/160 (46%), Gaps = 24/160 (15%)
Query: 423 NFLAENLIGKGGSSQV---YKGCLPDGKELAVKILKPSE----DVIKEFVLEIEIITTLH 475
+F +IGKG +V K GK A+K L SE D + E +++
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQK--KDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD 59
Query: 476 HKNIISLLGFCFEDNNLL-LVYDFLSRGSLEENLHGNKKDPAAFGWSE---RYKVAMGVA 531
++SL + F+D L L+ +FL G L L K D +SE R+ +A V
Sbjct: 60 SPWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTML--IKYDT----FSEDVTRFYMAECVL 112
Query: 532 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571
A+E +H IHRD+K NIL+ +LSDFGL+
Sbjct: 113 -AIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 24/61 (39%), Positives = 37/61 (60%), Gaps = 4/61 (6%)
Query: 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA-STSSSHITCTDVAGTFG 591
AL+Y+H+ + V HRD+K NIL + D + ++ DFGLA+ A + + + I TD T
Sbjct: 115 ALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171
Query: 592 Y 592
Y
Sbjct: 172 Y 172
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 27/88 (30%), Positives = 48/88 (54%), Gaps = 8/88 (9%)
Query: 486 CFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 544
CF+ + L LV ++++ G L ++ +K P R+ A + AL +LH +
Sbjct: 64 CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHA---RFYAAE-ICIALNFLHE---RG 116
Query: 545 VIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+I+RD+K N+LL D +L+D+G+ K
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 34/107 (31%), Positives = 48/107 (44%), Gaps = 30/107 (28%)
Query: 471 ITTLHHKNIISLLGFCFED-NNLLLVYDFLSRGSL-------EENLHGNKKDPAAFGWSE 522
IT LH + F+D NNL LV D+ G L E+ L +D A F
Sbjct: 63 ITNLH---------YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRL---PEDMARF---- 106
Query: 523 RYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569
Y +AE + + S +HRD+K N+LL + +L+DFG
Sbjct: 107 -Y-----LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFG 147
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 38/112 (33%), Positives = 53/112 (47%), Gaps = 13/112 (11%)
Query: 485 FC-FEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
FC F+D+ L +V +++ G L NL N P W++ Y V AL+ +HS
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLV-NLMSNYDVPEK--WAKFYTAE--VVLALDAIHS--- 160
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLA-KWASTSSSHITCTDVAGTFGYV 593
+IHRDVK N+LL +L+DFG K T C GT Y+
Sbjct: 161 MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVR--CDTAVGTPDYI 210
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 36/132 (27%), Positives = 63/132 (47%), Gaps = 9/132 (6%)
Query: 445 DGKELAVKILK---PSEDVIKEFVLEIEIITTLHHKNIISLL-GFCFEDNNLLLVYDFLS 500
DGK+ +K L S K E ++++ L H NI++ + ED L +V F
Sbjct: 24 DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCE 83
Query: 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD 560
G L L K ++ + + +A AL+YLH + ++HRD+K+ N+ L+
Sbjct: 84 GGDLYHKLKEQKGK--LLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRT 138
Query: 561 FEPQLSDFGLAK 572
++ D G+A+
Sbjct: 139 NIIKVGDLGIAR 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.002
Identities = 46/163 (28%), Positives = 71/163 (43%), Gaps = 29/163 (17%)
Query: 429 LIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVI------KEFVLEIEIITTLHHKNIIS 481
LIGKGG +VY P + +A+K K ED+ K F+ E +I L H I+
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALK--KIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENL------------HGNKKDPAAFGWSERYKVAMG 529
+ C + + + ++ +L+ L K AF S +K+
Sbjct: 67 VYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF-LSIFHKICAT 125
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+ EY+HS + V+HRD+K NILL E + D+G A
Sbjct: 126 I----EYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAI 161
|
Length = 932 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 49/155 (31%), Positives = 74/155 (47%), Gaps = 23/155 (14%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVK------ILKPSEDVIKEFVLEIEII-TTLHHKNII 480
+IGKG +V + K AVK ILK E+ K + E ++ + H ++
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEE--KHIMSERNVLLKNVKHPFLV 59
Query: 481 SLLGFCFED-NNLLLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYL 537
L F F+ + L V D+++ G L +L + +P A R+ A +A AL YL
Sbjct: 60 GL-HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA-----RFYAAE-IASALGYL 112
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
HS +++RD+K NILL L+DFGL K
Sbjct: 113 HS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 17/43 (39%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
VA+ +++L +++ IHRDV + N+LL+D ++ DFGLA+
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR 260
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 19/43 (44%), Positives = 31/43 (72%), Gaps = 3/43 (6%)
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
VA+ +E+L S ++ IHRD+ + NILLS++ ++ DFGLA+
Sbjct: 188 VAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLAR 227
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 29/108 (26%), Positives = 49/108 (45%), Gaps = 10/108 (9%)
Query: 465 VLEIEIITTLHHKNIISLLG-FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER 523
E I+ ++H +II L G F + L++ + + L L + +
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY--KTDLYCYLAAKRNIAIC----DI 184
Query: 524 YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571
+ V A++YLH R+IHRD+K+ NI ++ + L DFG A
Sbjct: 185 LAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAA 229
|
Length = 391 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 26/88 (29%), Positives = 49/88 (55%), Gaps = 8/88 (9%)
Query: 486 CFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 544
CF+ ++ L V ++++ G L ++ +K P R+ A ++ AL YLH +
Sbjct: 64 CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA---RFYSAE-ISLALNYLHE---RG 116
Query: 545 VIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+I+RD+K N+LL + +L+D+G+ K
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 23/64 (35%), Positives = 37/64 (57%), Gaps = 3/64 (4%)
Query: 526 VAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD 585
VA + A++Y+H + +IHRD+K+ N+L++ + L DFG A +A S S
Sbjct: 265 VARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321
Query: 586 VAGT 589
+AGT
Sbjct: 322 IAGT 325
|
Length = 461 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 32/108 (29%), Positives = 59/108 (54%), Gaps = 11/108 (10%)
Query: 467 EIEIITTLHHKNIISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK 525
E I+ ++ + ++SL + +E + L LV ++ G L+ +++ N +P G+ E+
Sbjct: 50 EKRILEKVNSRFVVSL-AYAYETKDALCLVLTIMNGGDLKFHIY-NMGNP---GFDEQRA 104
Query: 526 V--AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571
+ A + LE L +R+++RD+K NILL D ++SD GLA
Sbjct: 105 IFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 39/137 (28%), Positives = 62/137 (45%), Gaps = 21/137 (15%)
Query: 444 PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC-FEDNNLLLV--YDFLS 500
P + L K +K + EI + L+H+NI+ + E N ++ YDF
Sbjct: 190 PKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF-- 247
Query: 501 RGSLEENLHGNKKDPAAFGWSER------YKVAMGVAEALEYLHSGSAQRVIHRDVKSSN 554
+L+ D AF W +R + + A+EY+H +++IHRD+K N
Sbjct: 248 ------DLYSFMYD-EAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLEN 297
Query: 555 ILLSDDFEPQLSDFGLA 571
I L+ D + L DFG A
Sbjct: 298 IFLNCDGKIVLGDFGTA 314
|
Length = 501 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 24/67 (35%), Positives = 39/67 (58%), Gaps = 8/67 (11%)
Query: 446 GKE-----LAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYD 497
GKE +AVK+LK S D + + E++I++ L HKNI++LLG C +L++ +
Sbjct: 63 GKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITE 122
Query: 498 FLSRGSL 504
+ G L
Sbjct: 123 YCCYGDL 129
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 49/171 (28%), Positives = 75/171 (43%), Gaps = 17/171 (9%)
Query: 430 IGKGGSSQV------YKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLL 483
+GKGG +V G + K+L K LK K +LE EI+ ++ I++L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGE-KMALLEKEILEKVNSPFIVNL- 58
Query: 484 GFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
+ FE +L LV ++ G L+ H + + + +LHS
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLK--YHIYNVGERGLEMERVIHYSAQITCGILHLHS--- 113
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYV 593
+++RD+K N+LL D +LSD GLA T T AGT GY+
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRAGTNGYM 161
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|111949 pfam03109, ABC1, ABC1 family | Back alignment and domain information |
|---|
Score = 37.6 bits (88), Expect = 0.003
Identities = 18/70 (25%), Positives = 35/70 (50%), Gaps = 7/70 (10%)
Query: 437 QVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496
QV++ L DG+E+AVK+ +P V K +++++ K + +L F +L +
Sbjct: 26 QVHRAVLKDGEEVAVKVQRP--GVKKRIRSDLKLL-----KFLAKILKKFFPGFDLDWLV 78
Query: 497 DFLSRGSLEE 506
D + +E
Sbjct: 79 DEFRKSLPQE 88
|
This family includes ABC1 from yeast and AarF from E. coli. These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex and E. coli AarF is required for ubiquinone production. It has been suggested that members of the ABC1 family are novel chaperonins. These proteins are unrelated to the ABC transporter proteins. Length = 117 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 19/43 (44%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
VA +E+L S ++ IHRD+ + NILLS++ ++ DFGLA+
Sbjct: 183 VARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLAR 222
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 44/159 (27%), Positives = 72/159 (45%), Gaps = 24/159 (15%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVK--ILKPSEDVIKEFVL-EIEIITTLHHKN-IISLLG 484
IG+G +VYK GK +A+K L+ E+ I L EI ++ L I+ LL
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68
Query: 485 FCFEDNN-----LLLVYDFLSRGSLEENLHGNKKD-----PAAFGWSERYKVAMGVAEAL 534
+ L LV+++L L++ + N + PA S Y++ GVA
Sbjct: 69 VEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA--- 124
Query: 535 EYLHSGSAQRVIHRDVKSSNILLSDDFEP-QLSDFGLAK 572
+ H V+HRD+K N+L+ +++D GL +
Sbjct: 125 -HCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 611 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.98 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.98 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.98 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.98 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.98 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.98 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.98 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.97 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.97 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.97 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.97 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.97 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.97 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.97 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.97 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.97 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.97 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.97 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.97 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.97 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.97 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.97 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.97 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.97 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.97 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.97 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.97 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.97 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.97 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.97 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.97 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.97 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.97 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.97 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.97 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.97 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.97 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.97 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.97 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.97 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.97 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.97 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.96 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.96 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.96 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.96 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.96 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.96 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.96 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.96 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.96 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.96 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.96 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.96 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.96 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.96 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.96 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.96 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.96 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.96 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.96 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.96 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.96 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.96 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.96 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.96 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.96 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.96 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.96 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.96 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.96 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.96 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.96 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.96 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.96 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.96 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.96 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.96 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.96 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.96 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.96 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.96 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.96 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.96 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.96 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.96 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.96 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.96 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.96 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.96 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.96 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.96 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.96 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.95 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.95 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.95 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.95 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.95 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.95 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.95 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.95 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.95 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.95 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.95 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.95 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.95 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.95 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.95 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.95 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.95 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.95 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.95 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.95 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.95 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.95 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.95 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.95 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.95 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.95 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.95 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.95 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.95 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.95 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.95 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.95 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.95 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.95 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.95 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.95 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.95 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.95 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.95 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.95 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.95 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.95 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.95 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.95 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.95 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.95 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.95 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.95 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.95 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.95 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.95 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.95 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.95 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.95 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.95 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.94 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.94 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.94 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.94 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.94 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.94 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.94 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.94 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.94 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.94 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.94 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.94 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.94 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.94 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.94 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.94 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.94 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.94 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.94 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.94 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.94 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.94 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.94 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.94 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.94 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.94 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.94 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.94 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.94 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.94 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.94 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.93 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.93 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.93 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.93 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.93 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.93 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.93 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.93 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.93 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.93 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.93 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.93 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.93 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.93 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.93 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.92 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.92 | |
| cd01989 | 146 | STK_N The N-terminal domain of Eukaryotic Serine T | 99.92 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.92 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.92 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.92 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.91 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.91 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.91 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.91 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.9 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.9 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.9 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.89 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.89 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.89 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.88 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.88 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.87 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.87 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.85 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.81 | |
| PRK15456 | 142 | universal stress protein UspG; Provisional | 99.81 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.8 | |
| PRK15005 | 144 | universal stress protein F; Provisional | 99.79 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.78 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.77 | |
| PRK15118 | 144 | universal stress global response regulator UspA; P | 99.76 | |
| PRK09982 | 142 | universal stress protein UspD; Provisional | 99.76 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.76 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.76 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.76 | |
| PF00582 | 140 | Usp: Universal stress protein family; InterPro: IP | 99.75 | |
| cd01988 | 132 | Na_H_Antiporter_C The C-terminal domain of a subfa | 99.75 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.74 | |
| cd01987 | 124 | USP_OKCHK USP domain is located between the N-term | 99.74 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.74 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.72 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.71 | |
| PRK10116 | 142 | universal stress protein UspC; Provisional | 99.69 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.67 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.66 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.66 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.62 | |
| cd00293 | 130 | USP_Like Usp: Universal stress protein family. The | 99.61 | |
| PRK11175 | 305 | universal stress protein UspE; Provisional | 99.61 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.56 | |
| PRK11175 | 305 | universal stress protein UspE; Provisional | 99.55 | |
| COG0589 | 154 | UspA Universal stress protein UspA and related nuc | 99.55 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.51 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.51 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.48 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.46 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.39 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.38 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.37 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.3 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.29 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.25 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.24 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.21 | |
| PRK12652 | 357 | putative monovalent cation/H+ antiporter subunit E | 99.19 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.14 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.07 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.97 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.92 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.89 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.85 | |
| PRK10490 | 895 | sensor protein KdpD; Provisional | 98.82 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.82 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.78 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.78 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.71 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.63 | |
| COG2205 | 890 | KdpD Osmosensitive K+ channel histidine kinase [Si | 98.6 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.5 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.45 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.41 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.4 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.39 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.35 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.33 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.27 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.2 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.17 | |
| cd01984 | 86 | AANH_like Adenine nucleotide alpha hydrolases supe | 98.07 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.05 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.98 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.98 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.91 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.91 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.91 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.82 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.78 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.66 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.65 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.55 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.53 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.52 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.51 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.49 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 97.22 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 97.18 | |
| PLN02236 | 344 | choline kinase | 96.99 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.95 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.89 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.86 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.84 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.82 | |
| TIGR02432 | 189 | lysidine_TilS_N tRNA(Ile)-lysidine synthetase, N-t | 96.64 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=371.85 Aligned_cols=199 Identities=45% Similarity=0.785 Sum_probs=180.7
Q ss_pred cccccChHHHHHhcCCCccceeecccCceEEEEEEecCCCEEEEEEecCChhH-HHHHHHHHHHHHhcCCCCeeeEEEEE
Q 007254 408 TCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDV-IKEFVLEIEIITTLHHKNIISLLGFC 486 (611)
Q Consensus 408 ~~~~~~~~~l~~~~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~-~~~~~~Ei~il~~l~HpnIv~l~~~~ 486 (611)
..+.|++.++..+|++|...+.||+|+||.||+|.+.+|+.||||.+...... .++|..|+++|.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56789999999999999999999999999999999999999999988875544 67799999999999999999999999
Q ss_pred EeCC-eEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEE
Q 007254 487 FEDN-NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQL 565 (611)
Q Consensus 487 ~~~~-~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL 565 (611)
.+.+ +.+||||||++|+|+++|+..... .++|..|++||.++|+||+|||..+..+||||||||+|||||+++++||
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 9988 599999999999999999876433 7899999999999999999999988779999999999999999999999
Q ss_pred EeeccccccCC-CCCceeecCC-ccCCCcccceecc-CCCcCcceEEeC
Q 007254 566 SDFGLAKWAST-SSSHITCTDV-AGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 566 ~DFGlA~~~~~-~~~~~~~~~~-~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+|||||+..+. ..... +. .||++|+||||.. ...+.++|||||
T Consensus 219 sDFGLa~~~~~~~~~~~---~~~~gt~gY~~PEy~~~g~lt~KsDVySF 264 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSVS---TTVMGTFGYLAPEYASTGKLTEKSDVYSF 264 (361)
T ss_pred cCccCcccCCcccccee---eecCCCCccCChhhhccCCcCcccccccc
Confidence 99999988876 33221 22 8999999999997 788999999997
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=335.23 Aligned_cols=182 Identities=26% Similarity=0.442 Sum_probs=163.2
Q ss_pred hcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 495 (611)
...+|...+.||.|+||+||+|.++ ++..||||.+.+. ....+.+..||.||+.++|||||.|++++..++++|||
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 3567888888999999999999965 7899999998654 35667788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCC------CcEEEEeec
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD------FEPQLSDFG 569 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~------~~vKL~DFG 569 (611)
||||.||+|.++|++++ .++...+..++.|++.||+|||+ ++||||||||+||||+.. -.+||+|||
T Consensus 88 MEyC~gGDLs~yi~~~~----~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRG----RLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred EEeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 99999999999998875 48899999999999999999999 999999999999999865 458999999
Q ss_pred cccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 570 LAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 570 lA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
||+.+.+.. ...+.+|++-|||||+.. .+|+.++|+||+
T Consensus 161 fAR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSi 200 (429)
T KOG0595|consen 161 FARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSI 200 (429)
T ss_pred hhhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHH
Confidence 999998643 334689999999999885 999999999984
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=330.86 Aligned_cols=181 Identities=28% Similarity=0.425 Sum_probs=157.8
Q ss_pred cCCCccceeecccCceEEEEEEe-cCCCEEEEEEecCChh--------HHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCe
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSED--------VIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 491 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~~~--------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 491 (611)
.+.|.+.+.||+|+||.|-+|.. ++|+.||||++++... ......+|++||++|+|||||+++++|...++
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 45677889999999999999984 5899999999976421 22345699999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCC---CcEEEEee
Q 007254 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD---FEPQLSDF 568 (611)
Q Consensus 492 ~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~---~~vKL~DF 568 (611)
.||||||+.||+|.+++-.++. +.......+++|++.||.|||+ +||+||||||+||||..+ ..+||+||
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk~----l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANKY----LREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred eEEEEEEecCccHHHHHHhccc----cccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEeccc
Confidence 9999999999999999987653 6667778899999999999999 999999999999999876 78999999
Q ss_pred ccccccCCCCCceeecCCccCCCcccceecc----CCCcCcceEEeC
Q 007254 569 GLAKWASTSSSHITCTDVAGTFGYVVLILNP----IAFLFMFNCWFF 611 (611)
Q Consensus 569 GlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~----~~~~~~sDiWSL 611 (611)
|||+...+.. .+.+.|||+.|+|||++. ..++.++|||||
T Consensus 324 GlAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSl 367 (475)
T KOG0615|consen 324 GLAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSL 367 (475)
T ss_pred chhhccccce---ehhhhcCCccccChhheecCCeecccchheeeec
Confidence 9999887533 567899999999999874 445668999997
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=328.93 Aligned_cols=182 Identities=27% Similarity=0.385 Sum_probs=163.9
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 495 (611)
.++|.+.++||+|+||+||.+..+ +++.+|+|++++.. ........|..||..++||+||.|+-.|++.+++|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 567899999999999999999854 78999999998753 3456788899999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
+||+.||.|..+|++.+ .|++..+..++.+|+.||.|||+ ++||||||||+|||||.+|+++|+|||||+..-
T Consensus 104 ld~~~GGeLf~hL~~eg----~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG----RFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EeccCCccHHHHHHhcC----CcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 99999999999998765 49999999999999999999999 999999999999999999999999999999655
Q ss_pred CCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 576 TSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.... ...+++||+.|||||++. ..|+.++|+|||
T Consensus 177 ~~~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsL 211 (357)
T KOG0598|consen 177 KDGD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSL 211 (357)
T ss_pred cCCC--ccccccCCccccChHHHhcCCCCcccchHhH
Confidence 4432 223589999999999876 999999999997
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=320.24 Aligned_cols=176 Identities=24% Similarity=0.413 Sum_probs=160.0
Q ss_pred cceeecccCceEEEEEEec-CCCEEEEEEecC--ChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCe-EEEEEEcCCC
Q 007254 426 AENLIGKGGSSQVYKGCLP-DGKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN-LLLVYDFLSR 501 (611)
Q Consensus 426 ~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-~~lV~Ey~~~ 501 (611)
..+.||+|+.|+|||+.++ +++.+|+|.+.. +....+++.+|++|++..+||+||.+||+|...+. ++|+||||++
T Consensus 83 ~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDg 162 (364)
T KOG0581|consen 83 RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDG 162 (364)
T ss_pred hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCC
Confidence 4678999999999999865 789999999943 45678999999999999999999999999999995 9999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCce
Q 007254 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (611)
Q Consensus 502 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~ 581 (611)
|+|+.++...+ .+++...-+|+.+|++||.|||. .++||||||||+|||++..|++||||||-++.+..+
T Consensus 163 GSLd~~~k~~g----~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---- 232 (364)
T KOG0581|consen 163 GSLDDILKRVG----RIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---- 232 (364)
T ss_pred CCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----
Confidence 99999997653 48899999999999999999994 288999999999999999999999999999988775
Q ss_pred eecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 582 TCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 582 ~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.+.+.+||..|||||-+. ..|+.++|||||
T Consensus 233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSL 263 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISGESYSVKSDIWSL 263 (364)
T ss_pred hcccccccccccChhhhcCCcCCcccceecc
Confidence 456789999999999776 899999999998
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=336.36 Aligned_cols=181 Identities=29% Similarity=0.464 Sum_probs=165.5
Q ss_pred CCCccceeecccCceEEEEEEe-cCCCEEEEEEecC----ChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~----~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
..|...++||+|||+.||.+.. .+|+.||+|++.+ .....+.+.+||+|.+.|+|||||+++++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4578889999999999999996 7999999999976 4456788999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
|+|.+|+|..++.+.+ .+++.++..++.||+.||.|||+ ++|||||||..|+||+++.++||+|||||..+..
T Consensus 98 ELC~~~sL~el~Krrk----~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRK----PLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHhcC----CCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999998553 59999999999999999999999 9999999999999999999999999999999885
Q ss_pred CCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 577 SSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
... ...+.||||.|+|||++. ..+++.+||||+
T Consensus 171 ~~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSl 204 (592)
T KOG0575|consen 171 DGE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSL 204 (592)
T ss_pred ccc--ccceecCCCcccChhHhccCCCCCchhhhhh
Confidence 532 234689999999999887 899999999996
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=304.66 Aligned_cols=179 Identities=25% Similarity=0.364 Sum_probs=163.5
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 495 (611)
.++|...+.||.|+||.|.+++.+ +|..+|+|+|++.. .+.+...+|..+|+.+.||++++|++.|.+.+++|||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 457888999999999999999865 68899999998764 3455677899999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
|||++||.|..+|++.++ |+...+..+|.||+.||+|||+ .+|++|||||+|||||.+|.+||+|||+|+++.
T Consensus 123 meyv~GGElFS~Lrk~~r----F~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSGR----FSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred EeccCCccHHHHHHhcCC----CCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 999999999999987754 8999999999999999999999 999999999999999999999999999999998
Q ss_pred CCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 576 TSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.. +-+.|||+.|+|||.+. +.|+.++|.|||
T Consensus 196 ~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWal 227 (355)
T KOG0616|consen 196 GR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWAL 227 (355)
T ss_pred Cc-----EEEecCCccccChHHhhcCCCCcchhHHHH
Confidence 75 23579999999999776 999999999997
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=313.31 Aligned_cols=188 Identities=28% Similarity=0.404 Sum_probs=165.7
Q ss_pred CCCccceeecccCceEEEEEE-ecCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEE-EEEeCCe-EEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLG-FCFEDNN-LLLV 495 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~-~~~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~-~~~~~~~-~~lV 495 (611)
.+|.++++||.|.||.|||+. +.+|+.||.|.++-. ......++.|+.+|+.|+|||||++++ .|.+++. ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 357788999999999999996 669999999999853 356778999999999999999999999 4555555 8999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-CCeEecCCCCCCEEEcCCCcEEEEeecccccc
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA-QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~-~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~ 574 (611)
||||.+|+|...++..+.....+++..+++++.|+++||.++|..-+ .-|+||||||.||+|+.+|.+||+||||++++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999999998777777789999999999999999999998322 34999999999999999999999999999999
Q ss_pred CCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 575 STSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 575 ~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
....+. ..+.+|||.||+||.+. ..|+++||||||
T Consensus 179 ~s~~tf--A~S~VGTPyYMSPE~i~~~~Y~~kSDiWsl 214 (375)
T KOG0591|consen 179 SSKTTF--AHSLVGTPYYMSPERIHESGYNFKSDIWSL 214 (375)
T ss_pred cchhHH--HHhhcCCCcccCHHHHhcCCCCcchhHHHH
Confidence 876553 34689999999999886 999999999996
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=317.04 Aligned_cols=179 Identities=31% Similarity=0.506 Sum_probs=156.9
Q ss_pred cceeecccCceEEEEEEecCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-eEEEEEEcCCC
Q 007254 426 AENLIGKGGSSQVYKGCLPDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN-NLLLVYDFLSR 501 (611)
Q Consensus 426 ~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~lV~Ey~~~ 501 (611)
..+.||+|+||+||+|.+.....||||++...+ ...++|.+|+.+|.+++|||||+++|+|.+.. .++||||||++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 345699999999999999544449999998643 33679999999999999999999999999877 79999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC-eEecCCCCCCEEEcCCC-cEEEEeeccccccCCCCC
Q 007254 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR-VIHRDVKSSNILLSDDF-EPQLSDFGLAKWASTSSS 579 (611)
Q Consensus 502 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~-IvHrDLKp~NILl~~~~-~vKL~DFGlA~~~~~~~~ 579 (611)
|+|.++|+.. ....++|..++.++.+||+||.|||+ .+ ||||||||+|||++.++ .+||+|||+++......
T Consensus 125 GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 125 GSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 9999999874 23569999999999999999999999 55 99999999999999998 99999999999876542
Q ss_pred ceeecCCccCCCcccceecc---CCCcCcceEEeC
Q 007254 580 HITCTDVAGTFGYVVLILNP---IAFLFMFNCWFF 611 (611)
Q Consensus 580 ~~~~~~~~GT~~Y~aPE~~~---~~~~~~sDiWSL 611 (611)
..++...||+.|||||++. ..|+.++|||||
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySF 232 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSF 232 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhH
Confidence 2345589999999999876 369999999997
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=310.79 Aligned_cols=187 Identities=22% Similarity=0.270 Sum_probs=163.3
Q ss_pred HHhcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeE
Q 007254 418 LSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 492 (611)
Q Consensus 418 ~~~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 492 (611)
....++|.++..||+|+||.||+|..+ +|..+|+|+|++++ ...+....|-+||...+.|+||+||..|++..++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 346789999999999999999999854 79999999999875 4566788899999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccc
Q 007254 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~ 572 (611)
||||||++||++..+|.+.. .|+...+.+++.+++.||+-||+ .|+|||||||+|+|||..|++||+|||||.
T Consensus 217 YLiMEylPGGD~mTLL~~~~----~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKD----TLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred EEEEEecCCccHHHHHHhcC----cCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccc
Confidence 99999999999999997654 58899999999999999999999 999999999999999999999999999985
Q ss_pred ccCC-----------------------CCC----ce------------------eecCCccCCCcccceecc-CCCcCcc
Q 007254 573 WAST-----------------------SSS----HI------------------TCTDVAGTFGYVVLILNP-IAFLFMF 606 (611)
Q Consensus 573 ~~~~-----------------------~~~----~~------------------~~~~~~GT~~Y~aPE~~~-~~~~~~s 606 (611)
-+.. ... .. ....++|||.|||||++. ..|+..+
T Consensus 290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c 369 (550)
T KOG0605|consen 290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC 369 (550)
T ss_pred hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence 3211 000 00 011389999999999876 8899999
Q ss_pred eEEeC
Q 007254 607 NCWFF 611 (611)
Q Consensus 607 DiWSL 611 (611)
|+|||
T Consensus 370 DwWSL 374 (550)
T KOG0605|consen 370 DWWSL 374 (550)
T ss_pred cHHHH
Confidence 99997
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=311.63 Aligned_cols=186 Identities=30% Similarity=0.388 Sum_probs=164.2
Q ss_pred HhcCCCccceeecccCceEEEEEEe-cCCCEEEEEEecCC----hhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeE
Q 007254 419 SATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 492 (611)
Q Consensus 419 ~~~~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~----~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 492 (611)
....+|..++.||+|+|++|++|.. .+++.||||++.+. +...+-...|-++|..| .||.|++||..|.+...+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 3457899999999999999999984 47999999999764 33455677899999999 899999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccc
Q 007254 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~ 572 (611)
|+|+||+++|+|.++|++.+ .|+......++.+|+.||+|||+ .|||||||||+|||||.|+++||+|||-|+
T Consensus 150 YFvLe~A~nGdll~~i~K~G----sfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYG----SFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred EEEEEecCCCcHHHHHHHhC----cchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccc
Confidence 99999999999999998765 48899999999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCCc-----------eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 573 WASTSSSH-----------ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 573 ~~~~~~~~-----------~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.++..... ..+.+++||-.|++||++. ...++++|||+|
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAl 273 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWAL 273 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHH
Confidence 88643211 1235699999999999987 777999999987
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=307.21 Aligned_cols=182 Identities=30% Similarity=0.410 Sum_probs=160.2
Q ss_pred CCCccceeecccCceEEEEEE-ecCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CeEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLLV 495 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~-~~~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lV 495 (611)
+.|..++.||+|.||.||+|. ..+|+.||+|.++.+ +.....+.+||.||++|+||||++|.+...+. +.+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 345667889999999999998 458999999999764 34567889999999999999999999999876 789999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
+|||+. ||.-++.... ..|+..++.+|+.|++.||+|||. ++|+|||||.+|||||++|.+||+|||||+++.
T Consensus 197 FeYMdh-DL~GLl~~p~---vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPG---VKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred Eecccc-hhhhhhcCCC---cccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeecc
Confidence 999977 8988886532 469999999999999999999999 999999999999999999999999999999887
Q ss_pred CCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 576 TSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
..... ..+..+-|+-|.+||++. ..|+.++|+||.
T Consensus 270 ~~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~ 306 (560)
T KOG0600|consen 270 PSGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSV 306 (560)
T ss_pred CCCCc-ccccceEEeeccChHHhcCCcccccceeehhh
Confidence 65433 255678899999999876 899999999983
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=315.35 Aligned_cols=183 Identities=22% Similarity=0.373 Sum_probs=161.0
Q ss_pred HhcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCeE
Q 007254 419 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNL 492 (611)
Q Consensus 419 ~~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~ 492 (611)
...++|.++++||+|+||+|+++.++ +++.+|||++|++. +.....+.|..|+.... ||++++|+..|++.+++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 45678999999999999999999975 68899999999864 45677788988888775 99999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccc
Q 007254 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~ 572 (611)
|+||||+.||++....+. ..|+...+..|+.+|+.||.|||+ ++|||||||.+|||||.+|++||+||||+|
T Consensus 445 ~fvmey~~Ggdm~~~~~~-----~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIHT-----DVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEecCCCcEEEEEec-----ccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEeccccccc
Confidence 999999999995443332 359999999999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 573 WASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 573 ~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
....... ...+++||+.|||||++. ..|+.++|+|||
T Consensus 517 e~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~l 554 (694)
T KOG0694|consen 517 EGMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGL 554 (694)
T ss_pred ccCCCCC--ccccccCChhhcChhhhccCcccchhhHHHH
Confidence 7653332 445799999999999887 999999999997
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=291.74 Aligned_cols=181 Identities=25% Similarity=0.341 Sum_probs=157.4
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 497 (611)
+.|..+..+|+|+||.||||..+ +|+.||||++..++ ...+-.++||.+|++|+|+|+|.|+.+|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 34667788999999999999865 79999999997654 345567899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCC
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~ 577 (611)
||+. ++.+-|... +..++...+.+|++|++.|+.|+|+ +++|||||||+||||+.++.+||||||+|+.+...
T Consensus 82 ~~dh-TvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 82 YCDH-TVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred ecch-HHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 9977 444555433 3458889999999999999999999 88999999999999999999999999999998864
Q ss_pred CCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 578 SSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 578 ~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
.. ..++.+.|..|.|||++. .+|..++||||+
T Consensus 155 gd--~YTDYVATRWYRaPELLvGDtqYG~pVDiWAi 188 (396)
T KOG0593|consen 155 GD--NYTDYVATRWYRAPELLVGDTQYGKPVDIWAI 188 (396)
T ss_pred cc--hhhhhhhhhhccChhhhcccCcCCCcccchhh
Confidence 43 346789999999999875 899999999984
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=301.61 Aligned_cols=184 Identities=24% Similarity=0.344 Sum_probs=161.0
Q ss_pred HhcCCCccceeecccCceEEEEEEe-cCCCEEEEEEecCC----h--hHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCC
Q 007254 419 SATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----E--DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDN 490 (611)
Q Consensus 419 ~~~~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~----~--~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~ 490 (611)
...++|.+.+.||+|+||+|+.|.. .+|..||||++.+. . ...+.+.+|+.+++.++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3467899999999999999999975 47899999987653 1 23556668999999999 999999999999999
Q ss_pred eEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCC-CcEEEEeec
Q 007254 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDFG 569 (611)
Q Consensus 491 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~-~~vKL~DFG 569 (611)
.+|+||||+.||+|.+.+...+ .+.+.++.+++.|++.|++|||+ ++|+||||||+||||+.+ +.+||+|||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g----~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKG----RLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcC----CCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 9999999999999999998743 47789999999999999999999 999999999999999999 999999999
Q ss_pred cccccCCCCCceeecCCccCCCcccceecc-CC-C-cCcceEEeC
Q 007254 570 LAKWASTSSSHITCTDVAGTFGYVVLILNP-IA-F-LFMFNCWFF 611 (611)
Q Consensus 570 lA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~-~-~~~sDiWSL 611 (611)
++.... .......+.+||+.|+|||++. .. | ..++|||||
T Consensus 167 ~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~ 209 (370)
T KOG0583|consen 167 LSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSL 209 (370)
T ss_pred cccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhh
Confidence 999875 2223556789999999999886 34 6 589999996
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=304.51 Aligned_cols=180 Identities=29% Similarity=0.429 Sum_probs=163.6
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecC---ChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 497 (611)
++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+ .+...+.+.+|++|++.|+|||||.++++|++..++++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888899999999999999854 789999999865 34567889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCC
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~ 577 (611)
|+.| +|..+|...+ .+++..+..|+.+++.||.|||+ .+|+|||+||.||||+.++.+|+||||||+.....
T Consensus 82 ~a~g-~L~~il~~d~----~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG----KLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hhhh-hHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 9977 9999997654 49999999999999999999999 99999999999999999999999999999988775
Q ss_pred CCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 578 SSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 578 ~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.. ..+.+.||+-|||||+.. ..|+..+|+|||
T Consensus 154 t~--vltsikGtPlYmAPElv~e~pyd~~sDlWsl 186 (808)
T KOG0597|consen 154 TS--VLTSIKGTPLYMAPELVEEQPYDHTSDLWSL 186 (808)
T ss_pred ce--eeeeccCcccccCHHHHcCCCccchhhHHHH
Confidence 43 446799999999999775 889999999997
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=301.17 Aligned_cols=180 Identities=24% Similarity=0.419 Sum_probs=158.0
Q ss_pred cceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCCHH
Q 007254 426 AENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLE 505 (611)
Q Consensus 426 ~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~ 505 (611)
..+.||+|-||.||.|.+.....||+|.++........|.+|++||++|+|+|||+|+++|..++.+|||||||+.|+|.
T Consensus 210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl 289 (468)
T KOG0197|consen 210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLL 289 (468)
T ss_pred HHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHH
Confidence 45789999999999999977779999999988777789999999999999999999999999988999999999999999
Q ss_pred HHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCceeecC
Q 007254 506 ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD 585 (611)
Q Consensus 506 ~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 585 (611)
++|+.. ....+...+...++.|||+||+||++ +++|||||.++|||++++..+||+|||||+...++... ....
T Consensus 290 ~yLr~~--~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~-~~~~ 363 (468)
T KOG0197|consen 290 DYLRTR--EGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT-ASEG 363 (468)
T ss_pred HHhhhc--CCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCcee-ecCC
Confidence 999862 23568889999999999999999999 99999999999999999999999999999955543322 2222
Q ss_pred CccCCCcccceecc-CCCcCcceEEeC
Q 007254 586 VAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 586 ~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
..-..-|.|||.+. ..++.+||||||
T Consensus 364 ~kfPIkWtAPEa~~~~~FS~kSDVWSF 390 (468)
T KOG0197|consen 364 GKFPIKWTAPEALNYGKFSSKSDVWSF 390 (468)
T ss_pred CCCCceecCHHHHhhCCcccccceeeh
Confidence 33345699999876 999999999998
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=289.66 Aligned_cols=186 Identities=26% Similarity=0.414 Sum_probs=163.8
Q ss_pred cCCCccceeecccCceEEEEEE-ecCCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~-~~~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 497 (611)
.++|.+.+.||.|..++||+|. .+.+..||||++..+. ...+.+.+|+..|+.++||||+.++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 4567888999999999999997 5678999999998654 347889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCC
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~ 577 (611)
||.+|++.+++...-. ..|.+..+..|..++++||.|||+ +|-||||||+.||||+.+|.+||+|||.+-.+-.+
T Consensus 105 fMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 9999999999976533 458899999999999999999999 99999999999999999999999999987766554
Q ss_pred CC-cee-ecCCccCCCcccceecc---CCCcCcceEEeC
Q 007254 578 SS-HIT-CTDVAGTFGYVVLILNP---IAFLFMFNCWFF 611 (611)
Q Consensus 578 ~~-~~~-~~~~~GT~~Y~aPE~~~---~~~~~~sDiWSL 611 (611)
.. ... ..+.+||++|||||++. ..|++++|||||
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSf 218 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSF 218 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhh
Confidence 32 212 26789999999999842 999999999997
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=275.01 Aligned_cols=180 Identities=26% Similarity=0.388 Sum_probs=158.9
Q ss_pred CCCccceeecccCceEEEEEEe-cCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 497 (611)
.+|...+.||+|.||.||+|+. .+|+.||||.++..+ ......++||..|+.++|+||+.|+++|...+++.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 3577788999999999999985 589999999998753 234567899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCC
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~ 577 (611)
||+. +|+..++.+. ..++-.++..++.+++.||+|||. +.|+||||||.|+||+.+|.+||+|||||+.+...
T Consensus 82 fm~t-dLe~vIkd~~---i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKN---IILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhcccc---cccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9976 9999997543 468889999999999999999999 99999999999999999999999999999988754
Q ss_pred CCceeecCCccCCCcccceecc--CCCcCcceEEe
Q 007254 578 SSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWF 610 (611)
Q Consensus 578 ~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWS 610 (611)
..... ..+-|.-|.|||++. ..|+..+||||
T Consensus 155 ~~~~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWa 187 (318)
T KOG0659|consen 155 NRIQT--HQVVTRWYRAPELLFGSRQYGTGVDMWA 187 (318)
T ss_pred Ccccc--cceeeeeccChHHhccchhcCCcchhhh
Confidence 43322 237899999999876 99999999998
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=282.42 Aligned_cols=182 Identities=24% Similarity=0.309 Sum_probs=159.2
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCChh---HHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CCeEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSED---VIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLL 494 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~l 494 (611)
.++|..++.|++|+||.||+|.++ +++.||+|.++.+.+ ..-.-++||.+|.+.+|||||.+-.+..- -+.+||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 345777899999999999999964 789999999987542 23456799999999999999999988764 357999
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccccc
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~ 574 (611)
|||||+. +|..++...+ ..|...++..++.|++.||+|||. ..|+||||||+|+|+++.|.+||+|||||+.+
T Consensus 155 VMe~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eHHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhh
Confidence 9999976 9999998765 469999999999999999999999 99999999999999999999999999999998
Q ss_pred CCCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 575 STSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 575 ~~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
..... .++..+-|+-|.|||++. ..|++++||||+
T Consensus 228 gsp~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSv 264 (419)
T KOG0663|consen 228 GSPLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSV 264 (419)
T ss_pred cCCcc--cCcceEEEeeecCHHHhcCCcccCcchhhhhH
Confidence 76533 345678899999999876 999999999995
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=293.03 Aligned_cols=183 Identities=25% Similarity=0.300 Sum_probs=156.5
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
++|.+.+.||+|+||.||++... +|+.||||++.+.. .....+.+|++++..++||||++++++|.+.+++||||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47888999999999999999854 78999999987532 34567888999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
||+++|+|.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+||||+.++.+||+|||+|+....
T Consensus 81 E~~~gg~L~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIKYD----TFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9999999999997543 48889999999999999999999 9999999999999999999999999999964321
Q ss_pred CCCc---------------------------------------------eeecCCccCCCcccceecc-CCCcCcceEEe
Q 007254 577 SSSH---------------------------------------------ITCTDVAGTFGYVVLILNP-IAFLFMFNCWF 610 (611)
Q Consensus 577 ~~~~---------------------------------------------~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWS 610 (611)
.... ......+||+.|+|||++. ..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 0000 0011357999999999876 78999999999
Q ss_pred C
Q 007254 611 F 611 (611)
Q Consensus 611 L 611 (611)
|
T Consensus 234 l 234 (377)
T cd05629 234 L 234 (377)
T ss_pred c
Confidence 7
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=286.86 Aligned_cols=179 Identities=23% Similarity=0.396 Sum_probs=161.6
Q ss_pred CCccceeecccCceEEEEEEe-cCCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 007254 423 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 497 (611)
+|.+.+.||+|.||+|-++.. ..|+.||||.++++ +..+-.+.+||+||+.|+||||+.+|.+|...+.+.||||
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME 133 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME 133 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence 466678899999999999985 58999999999875 3456678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCC
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~ 577 (611)
|..+|.|.+++..+. .++..++..++.||..|+.|+|+ .+++|||||.+|||||.++++||+||||+.++...
T Consensus 134 YaS~GeLYDYiSer~----~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 134 YASGGELYDYISERG----SLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred ecCCccHHHHHHHhc----cccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 999999999998775 48999999999999999999999 99999999999999999999999999999988764
Q ss_pred CCceeecCCccCCCcccceecc-CCC-cCcceEEeC
Q 007254 578 SSHITCTDVAGTFGYVVLILNP-IAF-LFMFNCWFF 611 (611)
Q Consensus 578 ~~~~~~~~~~GT~~Y~aPE~~~-~~~-~~~sDiWSL 611 (611)
. ..+++||++-|-+||+.+ ..| ...+|.|||
T Consensus 207 k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsL 239 (668)
T KOG0611|consen 207 K---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSL 239 (668)
T ss_pred c---HHHHhcCCcccCCccccCCCCCCCCccchhhH
Confidence 3 345789999999999887 555 789999997
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=298.84 Aligned_cols=180 Identities=26% Similarity=0.415 Sum_probs=162.0
Q ss_pred CCCccceeecccCceEEEEEE-ecCCCEEEEEEecCChhHHH-HHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 007254 422 SNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIK-EFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~-~~~g~~vAVK~lk~~~~~~~-~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 499 (611)
..|..-..||+|+.|.||.+. ..+++.||||.+....+..+ -+++|+.+|+..+|+|||.+++.|...+.++.|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 346666889999999999997 45789999999987765444 4679999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~ 579 (611)
+||+|.+.+... .+++.++..|+.+++.||+|||. ++|||||||.+||||+.+|.+||+|||||..+.....
T Consensus 353 ~ggsLTDvVt~~-----~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 353 EGGSLTDVVTKT-----RMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred CCCchhhhhhcc-----cccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 999999998654 38899999999999999999999 9999999999999999999999999999998877554
Q ss_pred ceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 580 HITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 580 ~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
...+.+||+.|||||+.. ..|++++|||||
T Consensus 425 --KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSL 455 (550)
T KOG0578|consen 425 --KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSL 455 (550)
T ss_pred --ccccccCCCCccchhhhhhcccCccccchhh
Confidence 446789999999999887 999999999998
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=292.20 Aligned_cols=183 Identities=23% Similarity=0.308 Sum_probs=158.5
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
++|.+.+.||+|+||.||+|... +|+.||||+++... .....+.+|+++|..++||||++++++|.+.+++||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47889999999999999999865 68999999997542 34566788999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
||+++|+|.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+||||+.++.+||+|||+++.+..
T Consensus 81 E~~~~g~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMKKD----TFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 9999999999997543 48999999999999999999999 8999999999999999999999999999976532
Q ss_pred CCCc------------------------------------eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 577 SSSH------------------------------------ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~~------------------------------------~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.... ......+||+.|+|||+.. ..++.++|||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 225 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSL 225 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecc
Confidence 2100 0112357999999999875 788999999997
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=292.83 Aligned_cols=183 Identities=22% Similarity=0.312 Sum_probs=158.4
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
++|.+.+.||+|+||+||++... +++.||||++++.. .....+..|+.++..++||||+++++.+.+.+.+||||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47888999999999999999854 68999999997642 34467788999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
||+++|+|.+++.... .+++.++..++.|++.||.|||+ ++|+||||||+||||+.++.+||+|||+|+.+..
T Consensus 81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMKKD----TLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 9999999999997643 48899999999999999999999 9999999999999999999999999999986542
Q ss_pred CCC---------------------------------ceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 577 SSS---------------------------------HITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~---------------------------------~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
... .......+||+.|+|||+.. ..++.++|||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSl 222 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSL 222 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhh
Confidence 110 00112468999999999875 789999999997
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=293.09 Aligned_cols=182 Identities=21% Similarity=0.301 Sum_probs=156.5
Q ss_pred CCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 497 (611)
+|...+.||+|+||+||+|... +++.||||+++... .....+.+|+++++.++||||+++++++.+.+++|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 6888999999999999999854 78899999997532 345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCC
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~ 577 (611)
|+++|+|.+++.+.. .+++..+..++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+++.+...
T Consensus 82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIRME----VFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 999999999997643 48889999999999999999999 89999999999999999999999999998643210
Q ss_pred CC---------------------------------------------ceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 578 SS---------------------------------------------HITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 578 ~~---------------------------------------------~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.. .......+||+.|+|||+.. ..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 00112467999999999876 778999999997
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=291.04 Aligned_cols=189 Identities=23% Similarity=0.386 Sum_probs=157.9
Q ss_pred hcCCCccceeecccCceEEEEEEe------cCCCEEEEEEecCCh--hHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC-
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPSE--DVIKEFVLEIEIITTL-HHKNIISLLGFCFED- 489 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~------~~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~- 489 (611)
..++|.+.+.||+|+||.||+|.. .+++.||||+++... .....+.+|+.++..+ +||||++++++|...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 346788999999999999999974 235689999997642 4456789999999999 899999999998764
Q ss_pred CeEEEEEEcCCCCCHHHHHhcCCC--------------------------------------------------------
Q 007254 490 NNLLLVYDFLSRGSLEENLHGNKK-------------------------------------------------------- 513 (611)
Q Consensus 490 ~~~~lV~Ey~~~gsL~~~L~~~~~-------------------------------------------------------- 513 (611)
+.+++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 468999999999999999875321
Q ss_pred --CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCceeecCCccCCC
Q 007254 514 --DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG 591 (611)
Q Consensus 514 --~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~ 591 (611)
....+++.++..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...............+|+.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 01358899999999999999999999 8999999999999999999999999999987654433333334567889
Q ss_pred cccceecc-CCCcCcceEEeC
Q 007254 592 YVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 592 Y~aPE~~~-~~~~~~sDiWSL 611 (611)
|+|||+.. ..++.++|||||
T Consensus 242 y~aPE~~~~~~~~~~sDiwsl 262 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSF 262 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHH
Confidence 99999775 778999999996
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=297.36 Aligned_cols=181 Identities=23% Similarity=0.327 Sum_probs=160.4
Q ss_pred cCCCccceeecccCceEEEEEE-ecCCCEEEEEEecCChhHHHHH--HHHHHHHHhcC-CCCeeeEEEEEEeCC-eEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEF--VLEIEIITTLH-HKNIISLLGFCFEDN-NLLLV 495 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~-~~~g~~vAVK~lk~~~~~~~~~--~~Ei~il~~l~-HpnIv~l~~~~~~~~-~~~lV 495 (611)
.++|...+.||.|.||.||+|. ..+|..||||.+|+.....++. ++|+..|++|+ ||||++|.+++.+.+ .+|||
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 4578888999999999999998 4589999999998765333333 58999999999 999999999999988 99999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
||||+. +|.+++..+. ..|+...+..|+.||+.||+|+|+ +|+.|||+||+|||+..+..+||+||||||.+.
T Consensus 89 fE~Md~-NLYqLmK~R~---r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDRN---RLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred HHhhhh-hHHHHHhhcC---CcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccccccc
Confidence 999966 9999997653 579999999999999999999999 999999999999999988899999999999887
Q ss_pred CCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 576 TSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
.... .+..+.|.-|.|||++. ..|+.++||||+
T Consensus 162 SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~ 196 (538)
T KOG0661|consen 162 SKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAV 196 (538)
T ss_pred cCCC---cchhhhcccccchHHhhhccccCCchHHHHH
Confidence 6554 35678999999999876 889999999985
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=282.85 Aligned_cols=187 Identities=24% Similarity=0.427 Sum_probs=159.3
Q ss_pred CCCccceeecccCceEEEEEEecC-----------------CCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLPD-----------------GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISL 482 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~~-----------------g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l 482 (611)
++|.+.+.||+|+||.||+|.+.+ +..||+|+++.. .....+|.+|+++|..++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578889999999999999997532 347999999864 3456789999999999999999999
Q ss_pred EEEEEeCCeEEEEEEcCCCCCHHHHHhcCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEe
Q 007254 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKK---------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 547 (611)
Q Consensus 483 ~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~---------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvH 547 (611)
+++|.+.+..++||||+++|+|.+++..... ....++|..+..++.||+.||.|||+ .+|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccc
Confidence 9999999999999999999999998864321 12357899999999999999999999 89999
Q ss_pred cCCCCCCEEEcCCCcEEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 548 RDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 548 rDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
|||||+||||+.++.+||+|||+++.+.............+|+.|+|||+.. ..++.++|||||
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 226 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAF 226 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHH
Confidence 9999999999999999999999998765543333334456788999999865 789999999997
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=281.35 Aligned_cols=185 Identities=25% Similarity=0.356 Sum_probs=156.5
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC--eEEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN--NLLLVY 496 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~~lV~ 496 (611)
..+|...+.||+|+||.||++... +|...|||.+.... ...+.+.+|+.+|..|+|||||+.+|...... .+++.|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 345677899999999999999965 58999999886542 22567889999999999999999999855444 689999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcC-CCcEEEEeeccccccC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWAS 575 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~-~~~vKL~DFGlA~~~~ 575 (611)
||+++|+|.+++.+.+. .|+...+.+++.||++||.|||+ ++||||||||+||||+. ++.+||+|||+++...
T Consensus 96 Ey~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 99999999999987643 48999999999999999999999 99999999999999999 7999999999999877
Q ss_pred CCC-CceeecCCccCCCcccceeccCCC--cCcceEEeC
Q 007254 576 TSS-SHITCTDVAGTFGYVVLILNPIAF--LFMFNCWFF 611 (611)
Q Consensus 576 ~~~-~~~~~~~~~GT~~Y~aPE~~~~~~--~~~sDiWSL 611 (611)
... .........||+.|||||+..... .+++|||||
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSl 208 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSL 208 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhc
Confidence 411 112234689999999999887443 349999997
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=287.01 Aligned_cols=179 Identities=25% Similarity=0.349 Sum_probs=159.4
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 495 (611)
.++|.+.+.||+|+||.||+|... +++.||||+++... .....+.+|+.++..++||||+++++++.+.+.+|+|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 467888999999999999999865 68999999997643 3456788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
|||+.+|+|.+.+.... .+++..+..++.|++.||.|||+ .+|+||||||+||||+.++.+||+|||+++...
T Consensus 97 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAG----RFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred EcCCCCChHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 99999999999997643 47889999999999999999999 899999999999999999999999999998775
Q ss_pred CCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 576 TSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
... ....||+.|+|||+.. ..++.++|||||
T Consensus 170 ~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 201 (329)
T PTZ00263 170 DRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTM 201 (329)
T ss_pred CCc-----ceecCChhhcCHHHHcCCCCCCcceeech
Confidence 432 2357999999999875 778999999997
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-32 Score=278.06 Aligned_cols=180 Identities=25% Similarity=0.319 Sum_probs=156.9
Q ss_pred CccceeecccCceEEEEEEe-cCCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 424 FLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 424 f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
|...+.||+|+||.||++.. .+|+.||||++.... .....+.+|++++..++|+||++++++|.+.+.+++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 67789999999999999985 479999999987542 2334678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
+++|+|...+..... ..+++..+..++.|++.||.|||+ .+|+||||||+|||+++++.+||+|||++.......
T Consensus 82 ~~~g~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 82 MNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred cCCCcHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 999999988864322 358999999999999999999999 999999999999999999999999999998765432
Q ss_pred CceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 579 SHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
. .....||+.|+|||+.. ..|+.++|||||
T Consensus 157 ~---~~~~~g~~~y~aPE~~~~~~~~~~~Dvwsl 187 (285)
T cd05631 157 T---VRGRVGTVGYMAPEVINNEKYTFSPDWWGL 187 (285)
T ss_pred e---ecCCCCCCCccCHhhhcCCCCCcccCchhH
Confidence 2 23467999999999876 789999999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-32 Score=285.10 Aligned_cols=178 Identities=25% Similarity=0.371 Sum_probs=159.2
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
++|.+.+.||+|+||.||+|... +++.||||+++... .....+..|++++..++||||+++++++...++.||||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46889999999999999999975 68999999997642 34567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
||+++|+|.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG----VLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 9999999999997543 48899999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 577 SSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......||+.|+|||+.. ..++.++|||||
T Consensus 154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 184 (333)
T cd05600 154 -----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSL 184 (333)
T ss_pred -----ccCCcccCccccChhHhcCCCCCCccceecc
Confidence 223568999999999876 789999999997
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-32 Score=290.32 Aligned_cols=182 Identities=21% Similarity=0.279 Sum_probs=155.9
Q ss_pred CCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 497 (611)
+|...+.||+|+||.||+|... +++.||+|++.... .....+.+|+++++.++||||+++++.|.+.+++|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999864 78899999997643 345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCC
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~ 577 (611)
|+++|+|.+.+.+.. .+++..+..++.||+.||.|||+ .+||||||||+||||+.++.+||+|||+|......
T Consensus 82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIRMG----IFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 999999999997543 47888899999999999999999 89999999999999999999999999998532110
Q ss_pred C---------------------------------------------CceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 578 S---------------------------------------------SHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 578 ~---------------------------------------------~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
. ........+||+.|+|||++. ..|+.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 000112357999999999875 789999999997
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-32 Score=289.66 Aligned_cols=183 Identities=22% Similarity=0.276 Sum_probs=156.1
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
++|.+.+.||+|+||.||++... +++.||||++.+.. .....+.+|+++|..++||||+++++.|.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47889999999999999999854 68999999997532 23566889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
||+++|+|.+++.... .++...+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+|..+..
T Consensus 81 E~~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 81 DYIPGGDMMSLLIRLG----IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 9999999999997643 47888889999999999999999 8999999999999999999999999999853210
Q ss_pred CC-----------------------------------------CceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 577 SS-----------------------------------------SHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~-----------------------------------------~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.. .........||+.|+|||+.. ..++.++|||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 230 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 230 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeec
Confidence 00 000112357999999999876 778999999997
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-32 Score=284.15 Aligned_cols=175 Identities=26% Similarity=0.326 Sum_probs=153.2
Q ss_pred eeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCC
Q 007254 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 502 (611)
Q Consensus 428 ~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 502 (611)
+.||+|+||.||++... +|+.||||++++.. .....+.+|+.+++.++||||+++++++...+++|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 78999999998642 34567788999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCcee
Q 007254 503 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 582 (611)
Q Consensus 503 sL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~ 582 (611)
+|.+.+.... .+++..+..++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+|+....... .
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~ 151 (323)
T cd05571 81 ELFFHLSRER----VFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--T 151 (323)
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--c
Confidence 9999987543 48899999999999999999999 8999999999999999999999999999986433222 2
Q ss_pred ecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 583 CTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 583 ~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.....||+.|+|||+.. ..++.++|||||
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 181 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 181 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCccc
Confidence 23467999999999876 778999999997
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=279.12 Aligned_cols=183 Identities=27% Similarity=0.387 Sum_probs=157.5
Q ss_pred CCccceeecccCceEEEEEEe-cCCCEEEEEEecCChh---HHHHHHHHHHHHHhcCCCC-eeeEEEEEEeCC------e
Q 007254 423 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSED---VIKEFVLEIEIITTLHHKN-IISLLGFCFEDN------N 491 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~~~---~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~------~ 491 (611)
.|...+.||+|+||+||+|+. .+|+.||+|.++...+ .....++|+.+|+.|+|+| |+.|++++.+.+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 455567799999999999985 4899999999987543 5677889999999999999 999999999877 8
Q ss_pred EEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccc
Q 007254 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (611)
Q Consensus 492 ~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA 571 (611)
+++||||++. +|..++.........++-..+..++.||++||+|||+ ++|+||||||+||||+++|.+||+|||+|
T Consensus 92 l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccchH
Confidence 9999999966 9999998665322356668899999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 572 KWASTSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 572 ~~~~~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
+...-... ..+..++|.-|.|||++. ..|+..+||||+
T Consensus 168 ra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~ 207 (323)
T KOG0594|consen 168 RAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSL 207 (323)
T ss_pred HHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhH
Confidence 96653332 245688999999999775 679999999996
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-32 Score=289.87 Aligned_cols=187 Identities=22% Similarity=0.267 Sum_probs=160.8
Q ss_pred HHHHhcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 007254 416 DLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN 490 (611)
Q Consensus 416 ~l~~~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 490 (611)
.+....++|.+.+.||+|+||.||++... +++.+|+|++++.. .....+.+|+.+++.++||||+++++++.+.+
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 33445678999999999999999999865 68899999997532 23456788999999999999999999999999
Q ss_pred eEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecc
Q 007254 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (611)
Q Consensus 491 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGl 570 (611)
++|+||||+++|+|.+++... .+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~ 188 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGT 188 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEeccc
Confidence 999999999999999998643 37888999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCceeecCCccCCCcccceecc-----CCCcCcceEEeC
Q 007254 571 AKWASTSSSHITCTDVAGTFGYVVLILNP-----IAFLFMFNCWFF 611 (611)
Q Consensus 571 A~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-----~~~~~~sDiWSL 611 (611)
|+...... ...+....||+.|+|||+.. ..++.++|||||
T Consensus 189 a~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSl 233 (370)
T cd05621 189 CMKMDETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV 233 (370)
T ss_pred ceecccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEee
Confidence 98775432 22334678999999999864 237899999997
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-33 Score=270.96 Aligned_cols=183 Identities=28% Similarity=0.426 Sum_probs=161.8
Q ss_pred hcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 494 (611)
+.++|.+++.||+|.||.||.|+.+ ++-.||+|++.++. ....++.+|++|-+.|+||||+++|++|.+....||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 3568899999999999999999854 67889999997754 346788899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccccc
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~ 574 (611)
++||..+|+|...|+..+. ..|+......+..|+|.||.|+|. .+||||||||+|+|++.++.+||+|||.+-..
T Consensus 100 ilEya~~gel~k~L~~~~~--~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRM--KRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEEecCCchHHHHHHhccc--ccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 9999999999999984432 347778888899999999999999 89999999999999999999999999998765
Q ss_pred CCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 575 STSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 575 ~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+.+ ...+.+||+.|++||+.. ..++..+|+|+|
T Consensus 175 p~~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~l 208 (281)
T KOG0580|consen 175 PSN----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSL 208 (281)
T ss_pred CCC----CceeeecccccCCHhhcCCCCccchhhHHHH
Confidence 532 335689999999999876 889999999985
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-32 Score=281.62 Aligned_cols=178 Identities=24% Similarity=0.296 Sum_probs=158.0
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
++|.+.+.||+|+||.||+|... +|+.||+|+++... .....+.+|+++++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888999999999999999865 68999999997532 34566889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
||+++|+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRNSG----RFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 9999999999997553 48899999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 577 SSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.. ....||+.|+|||+.. ..++.++|||||
T Consensus 154 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 184 (291)
T cd05612 154 RT-----WTLCGTPEYLAPEVIQSKGHNKAVDWWAL 184 (291)
T ss_pred Cc-----ccccCChhhcCHHHHcCCCCCchhhHHHH
Confidence 22 2357999999999775 778999999996
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=284.68 Aligned_cols=183 Identities=21% Similarity=0.314 Sum_probs=158.0
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
++|...+.||+|+||.||++... +++.||||+++... .....+..|+.++..++||||+++++.+.+.+++||||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999865 68999999997532 34567888999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
||+++|+|.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+||||+.++.+||+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMKKD----TLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 9999999999997543 48899999999999999999999 9999999999999999999999999999976532
Q ss_pred CCC---------------------------------ceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 577 SSS---------------------------------HITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~---------------------------------~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
... .......+||+.|+|||+.. ..++.++|||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSl 222 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSL 222 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccc
Confidence 110 00112468999999999875 889999999997
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-32 Score=283.61 Aligned_cols=186 Identities=30% Similarity=0.392 Sum_probs=154.8
Q ss_pred HhcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh---------------hHHHHHHHHHHHHHhcCCCCeeeE
Q 007254 419 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---------------DVIKEFVLEIEIITTLHHKNIISL 482 (611)
Q Consensus 419 ~~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~---------------~~~~~~~~Ei~il~~l~HpnIv~l 482 (611)
...++|.+...||+|.||.|-+|... +++.||||++.+.+ .-.+...+||.||++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34678999999999999999999854 79999999996532 113578899999999999999999
Q ss_pred EEEEEe--CCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCC
Q 007254 483 LGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD 560 (611)
Q Consensus 483 ~~~~~~--~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~ 560 (611)
+.+.-+ .+++|||+|||..|.+...- .+...++..++++|+.+++.||+|||. ++||||||||+|+||+++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCC
Confidence 999864 46899999999998885533 222339999999999999999999999 999999999999999999
Q ss_pred CcEEEEeeccccccCCC---CCceeecCCccCCCcccceeccC-----CCcCcceEEeC
Q 007254 561 FEPQLSDFGLAKWASTS---SSHITCTDVAGTFGYVVLILNPI-----AFLFMFNCWFF 611 (611)
Q Consensus 561 ~~vKL~DFGlA~~~~~~---~~~~~~~~~~GT~~Y~aPE~~~~-----~~~~~sDiWSL 611 (611)
|.+||+|||.+...+.. .........+||+.|+|||+... ..+++.|||||
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWal 305 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWAL 305 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhh
Confidence 99999999999876432 12223335899999999998753 34789999996
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=281.36 Aligned_cols=175 Identities=26% Similarity=0.360 Sum_probs=153.4
Q ss_pred eeecccCceEEEEEEec-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCC
Q 007254 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 502 (611)
Q Consensus 428 ~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 502 (611)
+.||+|+||.||++... +|+.||||++++. ......+.+|+.+++.++||||+++++++...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999864 7899999999763 234567889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCcee
Q 007254 503 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 582 (611)
Q Consensus 503 sL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~ 582 (611)
+|...+.... .+++.++..++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~ 151 (328)
T cd05593 81 ELFFHLSRER----VFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--T 151 (328)
T ss_pred CHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc--c
Confidence 9998886543 48899999999999999999999 8999999999999999999999999999986443222 2
Q ss_pred ecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 583 CTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 583 ~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.....||+.|+|||+.. ..++.++|||||
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 181 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 181 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCcccc
Confidence 23568999999999875 788999999997
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=281.60 Aligned_cols=175 Identities=26% Similarity=0.349 Sum_probs=152.8
Q ss_pred eeecccCceEEEEEEec-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCC
Q 007254 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 502 (611)
Q Consensus 428 ~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 502 (611)
+.||+|+||.||++... +|+.||+|+++.. ......+.+|+.+++.++||||++++++|...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999864 7899999999763 234567788999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCcee
Q 007254 503 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 582 (611)
Q Consensus 503 sL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~ 582 (611)
+|...+.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~ 151 (323)
T cd05595 81 ELFFHLSRER----VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--T 151 (323)
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--c
Confidence 9998886543 48899999999999999999999 8999999999999999999999999999986433221 2
Q ss_pred ecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 583 CTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 583 ~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.....||+.|+|||+.. ..++.++|||||
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 181 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 181 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhh
Confidence 23468999999999875 788999999997
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=280.41 Aligned_cols=179 Identities=26% Similarity=0.340 Sum_probs=150.7
Q ss_pred CCccceeecccCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-----eEEEEE
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN-----NLLLVY 496 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~~lV~ 496 (611)
.|...+++|.|+||.||+|.+. +++.||||..-++.... .+|++||+.++|||||+|.-+|.... ++.|||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k---nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK---NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC---cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 3556799999999999999865 67899999887665432 25999999999999999999887432 467899
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCC-CcEEEEeeccccccC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDFGLAKWAS 575 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~-~~vKL~DFGlA~~~~ 575 (611)
|||+. +|.+.++........++...+.-+..||++||.|||+ .+|+||||||.|||+|.+ |.+||||||-|+.+.
T Consensus 102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 99987 9999887543334567788889999999999999999 999999999999999977 899999999999987
Q ss_pred CCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 576 TSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
....+. +...|..|.|||++. ..|+.++||||.
T Consensus 178 ~~epni---SYicSRyYRaPELifga~~Yt~~IDiWSa 212 (364)
T KOG0658|consen 178 KGEPNI---SYICSRYYRAPELIFGATEYTTSIDIWSA 212 (364)
T ss_pred cCCCce---eEEEeccccCHHHHcCccccCceeEEhhh
Confidence 766542 245688999999886 999999999993
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=278.57 Aligned_cols=173 Identities=25% Similarity=0.310 Sum_probs=152.0
Q ss_pred ecccCceEEEEEEec-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCCH
Q 007254 430 IGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504 (611)
Q Consensus 430 IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 504 (611)
||+|+||.||+|... +++.||+|+++.. ......+..|+.++..++||||++++++|.+.+.+|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999865 6889999999753 23456788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCceeec
Q 007254 505 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 584 (611)
Q Consensus 505 ~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~ 584 (611)
.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~ 151 (312)
T cd05585 81 FHHLQREG----RFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTN 151 (312)
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--ccc
Confidence 99997543 48899999999999999999999 9999999999999999999999999999986543222 223
Q ss_pred CCccCCCcccceecc-CCCcCcceEEeC
Q 007254 585 DVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 585 ~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
...||+.|+|||+.. ..++.++|||||
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 179 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTL 179 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceech
Confidence 568999999999876 778999999997
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=284.51 Aligned_cols=179 Identities=24% Similarity=0.327 Sum_probs=157.6
Q ss_pred cCCCccceeecccCceEEEEEEecC--CCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLPD--GKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~~--g~~vAVK~lk~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 494 (611)
.++|.+.+.||+|+||.||+|.+.. +..||+|.+... ......+.+|+.++..++||||+++++++.+.+.+|+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 4578889999999999999998543 368999998653 2345678899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccccc
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~ 574 (611)
||||+++|+|.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 109 v~Ey~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK----RFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 999999999999997653 48899999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 575 STSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 575 ~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.... ....||+.|+|||+.. ..++.++|||||
T Consensus 182 ~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 214 (340)
T PTZ00426 182 DTRT-----YTLCGTPEYIAPEILLNVGHGKAADWWTL 214 (340)
T ss_pred CCCc-----ceecCChhhcCHHHHhCCCCCccccccch
Confidence 5422 2468999999999875 778999999997
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=279.91 Aligned_cols=183 Identities=22% Similarity=0.269 Sum_probs=159.9
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
++|.+.+.||+|+||.||++... +|+.||+|+++... ...+.+.+|+.++..++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46889999999999999999864 78999999998643 35567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
||+++|+|.+++.+.. ..+++..+..++.|++.||.|||+ .+|+||||||+||||+.++.+||+|||++..+..
T Consensus 81 e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRYE---DQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 9999999999997652 358999999999999999999999 9999999999999999999999999999987765
Q ss_pred CCCceeecCCccCCCcccceecc-------CCCcCcceEEeC
Q 007254 577 SSSHITCTDVAGTFGYVVLILNP-------IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~~~~~~~~~GT~~Y~aPE~~~-------~~~~~~sDiWSL 611 (611)
.... ......||+.|+|||+.. ..++.++|||||
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Diwsl 195 (330)
T cd05601 155 NKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSL 195 (330)
T ss_pred CCce-eeecccCCccccCHHHhccccccccCCCCCcceeecc
Confidence 4322 233467999999999763 467899999997
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=285.39 Aligned_cols=189 Identities=23% Similarity=0.265 Sum_probs=162.2
Q ss_pred hHHHHHhcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Q 007254 414 YQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFE 488 (611)
Q Consensus 414 ~~~l~~~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 488 (611)
..++....++|.+.+.||+|+||.||++... +++.+|+|++.+.. .....+.+|+.++..++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4445566789999999999999999999865 68899999986532 234567889999999999999999999999
Q ss_pred CCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEee
Q 007254 489 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568 (611)
Q Consensus 489 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DF 568 (611)
.+++|+||||+++|+|.+++... .++...+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeC
Confidence 99999999999999999998643 37788889999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCceeecCCccCCCcccceecc-----CCCcCcceEEeC
Q 007254 569 GLAKWASTSSSHITCTDVAGTFGYVVLILNP-----IAFLFMFNCWFF 611 (611)
Q Consensus 569 GlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-----~~~~~~sDiWSL 611 (611)
|+|+....... .......||+.|+|||++. ..++.++|||||
T Consensus 187 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSl 233 (371)
T cd05622 187 GTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV 233 (371)
T ss_pred CceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeeh
Confidence 99987754322 2234578999999999864 238899999997
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=278.16 Aligned_cols=176 Identities=25% Similarity=0.337 Sum_probs=152.2
Q ss_pred eeecccCceEEEEEEec-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCC
Q 007254 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 502 (611)
Q Consensus 428 ~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 502 (611)
+.||+|+||.||++... +|+.||+|++++. ......+..|++++..++||||+++++++...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999854 7899999999763 234567788999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCcee
Q 007254 503 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 582 (611)
Q Consensus 503 sL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~ 582 (611)
+|...+.... .+++..+..++.||+.||.|||+ ..+|+||||||+||||+.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (325)
T cd05594 81 ELFFHLSRER----VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--T 152 (325)
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--c
Confidence 9999886543 48999999999999999999995 15899999999999999999999999999986543222 2
Q ss_pred ecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 583 CTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 583 ~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.....||+.|+|||+.. ..++.++|||||
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 182 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 182 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccc
Confidence 23467999999999875 788999999997
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=282.79 Aligned_cols=183 Identities=24% Similarity=0.360 Sum_probs=161.0
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
++|.+.+.||+|+||.||+|... +|+.||||+++... .....+..|++++..++||||+++++++.+.+++|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47889999999999999999865 78999999997642 34567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
||+++|+|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+||||+.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 999999999999765 358899999999999999999999 9999999999999999999999999999987654
Q ss_pred CC---------------------------CceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 577 SS---------------------------SHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~---------------------------~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.. .........||+.|+|||+.. ..++.++|||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 216 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSL 216 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEec
Confidence 33 011233567999999999875 788999999997
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=277.85 Aligned_cols=183 Identities=21% Similarity=0.223 Sum_probs=158.0
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
++|.+.+.||+|+||.||++... +++.||+|++++.. .....+.+|+.++..++|+||+.+++++.+.++.||||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47889999999999999999865 68899999997532 23455788999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
||+++|+|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 81 Ey~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKFE---DRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 9999999999997532 258899999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCceeecCCccCCCcccceecc------CCCcCcceEEeC
Q 007254 577 SSSHITCTDVAGTFGYVVLILNP------IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~~~~~~~~~GT~~Y~aPE~~~------~~~~~~sDiWSL 611 (611)
.... ......||+.|+|||+.. ..++.++|||||
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSl 194 (331)
T cd05624 155 DGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSL 194 (331)
T ss_pred CCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEee
Confidence 3321 223467999999999764 457899999997
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=285.57 Aligned_cols=184 Identities=23% Similarity=0.262 Sum_probs=158.4
Q ss_pred HhcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEE
Q 007254 419 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (611)
Q Consensus 419 ~~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 493 (611)
...++|.+.+.||+|+||.||++... +++.||+|++++.. .....+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 45678999999999999999999865 68899999997532 23455788999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccc
Q 007254 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (611)
Q Consensus 494 lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~ 573 (611)
+||||+++|+|.+++... .++...+..++.|++.||.|||+ .+|+||||||+||||+.++.+||+|||+++.
T Consensus 120 lv~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 999999999999998653 36778888999999999999999 8999999999999999999999999999987
Q ss_pred cCCCCCceeecCCccCCCcccceecc-----CCCcCcceEEeC
Q 007254 574 ASTSSSHITCTDVAGTFGYVVLILNP-----IAFLFMFNCWFF 611 (611)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~Y~aPE~~~-----~~~~~~sDiWSL 611 (611)
...... .......||+.|+|||+.. ..++.++|||||
T Consensus 192 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSl 233 (370)
T cd05596 192 MDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV 233 (370)
T ss_pred ccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeeh
Confidence 654322 1234568999999999764 348999999997
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=277.97 Aligned_cols=181 Identities=23% Similarity=0.302 Sum_probs=155.5
Q ss_pred CCccceeecccCceEEEEEEe----cCCCEEEEEEecCCh-----hHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeE
Q 007254 423 NFLAENLIGKGGSSQVYKGCL----PDGKELAVKILKPSE-----DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 492 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~----~~g~~vAVK~lk~~~-----~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 492 (611)
+|.+.+.||+|+||.||++.. .+++.||+|++++.. ...+.+..|+.++..+ +||||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478899999999999999874 368899999997532 3346678899999999 599999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccc
Q 007254 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~ 572 (611)
|+||||+++|+|.+.+.... .+++.++..++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD----NFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 99999999999999987543 48899999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 573 WASTSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 573 ~~~~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
........ ......||+.|+|||+.. ..++.++|||||
T Consensus 154 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl 193 (332)
T cd05614 154 EFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSL 193 (332)
T ss_pred cccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccc
Confidence 75433221 223468999999999875 457899999997
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=274.73 Aligned_cols=185 Identities=26% Similarity=0.291 Sum_probs=160.8
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
++|...+.||+|.-|+||++.+. ++..+|+|++.+.. ....+...|-+||..++||+++.||..|..+++.||||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 45667789999999999999976 46899999998753 45677888999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
|||+||+|..++++... ..|+...+..++.+|+.||+|||- .|||+|||||+||||-++|++.|+||-|+...+.
T Consensus 157 eyCpGGdL~~LrqkQp~--~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPG--KRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred ecCCCccHHHHHhhCCC--CccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 99999999999986543 679999999999999999999999 9999999999999999999999999999865421
Q ss_pred CC---------------------------------C---------------------ceeecCCccCCCcccceecc-CC
Q 007254 577 SS---------------------------------S---------------------HITCTDVAGTFGYVVLILNP-IA 601 (611)
Q Consensus 577 ~~---------------------------------~---------------------~~~~~~~~GT~~Y~aPE~~~-~~ 601 (611)
.. . ......++||-.|+|||++. +.
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 00 0 01223478999999999987 99
Q ss_pred CcCcceEEeC
Q 007254 602 FLFMFNCWFF 611 (611)
Q Consensus 602 ~~~~sDiWSL 611 (611)
.+.++|+|+|
T Consensus 312 HgsAVDWWtf 321 (459)
T KOG0610|consen 312 HGSAVDWWTF 321 (459)
T ss_pred CCchhhHHHH
Confidence 9999999986
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=277.38 Aligned_cols=183 Identities=22% Similarity=0.254 Sum_probs=157.5
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
++|.+.+.||+|+||.||++... +++.||||++++.+ ...+.+.+|+.++..++|+||+.++++|.+.+++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47889999999999999999864 68999999997532 23456888999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
||+++|+|.+++.+.. ..+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 9999999999997532 358899999999999999999999 9999999999999999999999999999977654
Q ss_pred CCCceeecCCccCCCcccceecc------CCCcCcceEEeC
Q 007254 577 SSSHITCTDVAGTFGYVVLILNP------IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~~~~~~~~~GT~~Y~aPE~~~------~~~~~~sDiWSL 611 (611)
.... ......||+.|+|||++. ..++.++|||||
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diwsl 194 (331)
T cd05597 155 DGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSL 194 (331)
T ss_pred CCCc-cccceeccccccCHHHHhhccccccCCCCcceeehh
Confidence 3321 222357999999999864 457889999997
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=276.11 Aligned_cols=180 Identities=22% Similarity=0.293 Sum_probs=154.8
Q ss_pred CCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEEE
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
+|.+.+.||+|+||.||+|... +++.||||++++.. .....+..|..++..+ +|++|+.+++++.+.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5788899999999999999865 67899999997642 2345567788888877 5899999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
||+++|+|.+.+.... .+++.++..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQVG----RFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 9999999999986543 48899999999999999999999 8999999999999999999999999999986543
Q ss_pred CCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 577 SSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
... ......||+.|+|||+.. ..++.++|||||
T Consensus 154 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 187 (323)
T cd05616 154 DGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAF 187 (323)
T ss_pred CCC--ccccCCCChhhcCHHHhcCCCCCCccchhch
Confidence 221 223568999999999876 789999999997
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=275.77 Aligned_cols=180 Identities=22% Similarity=0.303 Sum_probs=154.7
Q ss_pred CCccceeecccCceEEEEEEec-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCC-CeeeEEEEEEeCCeEEEEE
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHK-NIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~----~~~~~~~~~Ei~il~~l~Hp-nIv~l~~~~~~~~~~~lV~ 496 (611)
+|.+.+.||+|+||.||+|... +++.||||++++. ......+..|++++..+.|+ +|+.+++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5788999999999999999865 6789999999763 23456788899999999765 5888999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
||+++|+|.+.+.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQVG----KFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 9999999999987543 48899999999999999999999 8999999999999999999999999999975432
Q ss_pred CCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 577 SSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
... ......||+.|+|||+.. ..++.++|||||
T Consensus 154 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 187 (324)
T cd05587 154 GGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAF 187 (324)
T ss_pred CCC--ceeeecCCccccChhhhcCCCCCcccchhhh
Confidence 221 223467999999999876 778999999997
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=292.33 Aligned_cols=185 Identities=23% Similarity=0.304 Sum_probs=159.5
Q ss_pred CccceeecccCceEEEEEEec-C-CCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 007254 424 FLAENLIGKGGSSQVYKGCLP-D-GKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (611)
Q Consensus 424 f~~~~~IG~G~fG~Vyk~~~~-~-g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 500 (611)
|.+.+.||+|+||.||+|... + ++.||+|.+.... .....+.+|+.+|..++||||++++++|...+++||||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 778899999999999999854 4 6788999876544 344567789999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCc
Q 007254 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (611)
Q Consensus 501 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~ 580 (611)
+|+|.+.|.........+++.++..++.|++.||.|||+ ++||||||||+||||+.++.+||+|||+|+........
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 999999886543333468899999999999999999999 89999999999999999999999999999987654333
Q ss_pred eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 581 ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 581 ~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......+||+.|+|||+.. ..++.++|||||
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~sl 257 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSL 257 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHH
Confidence 3344578999999999876 779999999996
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=275.42 Aligned_cols=175 Identities=27% Similarity=0.362 Sum_probs=151.1
Q ss_pred eeecccCceEEEEEEe----cCCCEEEEEEecCCh-----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 428 NLIGKGGSSQVYKGCL----PDGKELAVKILKPSE-----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 428 ~~IG~G~fG~Vyk~~~----~~g~~vAVK~lk~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
+.||+|+||.||++.. .+++.||||+++... .....+..|+++|+.++||||++++++|...+.+|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999975 357899999997532 2345677899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
+++|+|.+.+.... .+.+..+..++.|++.||.|||+ .+|+||||||+||||+.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLEREG----IFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 99999999987543 47888889999999999999999 899999999999999999999999999998643322
Q ss_pred CceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 579 SHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
. ......||+.|+|||+.. ..++.++|||||
T Consensus 155 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 186 (323)
T cd05584 155 T--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSL 186 (323)
T ss_pred C--cccccCCCccccChhhccCCCCCCcceeccc
Confidence 2 223467999999999875 778999999997
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=275.62 Aligned_cols=183 Identities=23% Similarity=0.245 Sum_probs=157.2
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
++|.+.+.||+|+||.||++... +++.+|+|++.+.. .....+.+|+.++..++|+||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47888999999999999999865 57889999996532 23445788999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
||+++|+|.+++.+.. ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 ey~~~g~L~~~l~~~~---~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 9999999999997532 258899999999999999999999 9999999999999999999999999999986644
Q ss_pred CCCceeecCCccCCCcccceecc------CCCcCcceEEeC
Q 007254 577 SSSHITCTDVAGTFGYVVLILNP------IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~~~~~~~~~GT~~Y~aPE~~~------~~~~~~sDiWSL 611 (611)
.... ......||+.|+|||+.. ..++.++|||||
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSl 194 (332)
T cd05623 155 DGTV-QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSL 194 (332)
T ss_pred CCcc-eecccccCccccCHHHHhccccCCCCCCCcCCEEee
Confidence 3221 223467999999999763 468999999997
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=276.99 Aligned_cols=175 Identities=23% Similarity=0.367 Sum_probs=152.0
Q ss_pred eeecccCceEEEEEEec-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 007254 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 501 (611)
Q Consensus 428 ~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~----~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 501 (611)
+.||+|+||.||++... +++.||||++++. ......+..|+.++..+ +||||++++++|.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999865 6889999999863 23456688899999988 799999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCce
Q 007254 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (611)
Q Consensus 502 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~ 581 (611)
|+|.+++...+ .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-- 151 (329)
T cd05588 81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-- 151 (329)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCCC--
Confidence 99998886543 48999999999999999999999 9999999999999999999999999999975332211
Q ss_pred eecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 582 TCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 582 ~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......||+.|+|||+.. ..+++++|||||
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 182 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWAL 182 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceech
Confidence 223568999999999876 788999999997
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=275.90 Aligned_cols=175 Identities=22% Similarity=0.362 Sum_probs=151.3
Q ss_pred eeecccCceEEEEEEec-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 007254 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 501 (611)
Q Consensus 428 ~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~----~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 501 (611)
+.||+|+||.||++... +++.||+|++++. ......+..|+.++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 6889999999763 23456678899988876 799999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCce
Q 007254 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (611)
Q Consensus 502 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~ 581 (611)
|+|...+.... .+++..+..++.|++.||.|||+ .+|+||||||+||||+.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-- 151 (329)
T cd05618 81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-- 151 (329)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--
Confidence 99998886543 48899999999999999999999 8999999999999999999999999999986433221
Q ss_pred eecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 582 TCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 582 ~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......||+.|+|||+.. ..++.++|||||
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 182 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWAL 182 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecc
Confidence 223468999999999876 788999999997
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=285.71 Aligned_cols=183 Identities=31% Similarity=0.450 Sum_probs=155.4
Q ss_pred cCCCccceeecccCceEEEEEEecC--C--CE-EEEEEecC----ChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCe
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLPD--G--KE-LAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 491 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~~--g--~~-vAVK~lk~----~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 491 (611)
-++-...+.||+|+||.||+|.+.. + .. ||||..+. .....++|++|.++|+.++|||||++||++.....
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 3445556899999999999998653 2 23 89999884 24678999999999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccc
Q 007254 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (611)
Q Consensus 492 ~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA 571 (611)
+|||||+|+||+|.++|++.+. .+++.++..++.+.+.||+|||+ +++|||||..+|+|++.++.+||+||||+
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccc
Confidence 9999999999999999987643 58999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 572 KWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 572 ~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+.......... .-.-..-|+|||.+. ..|++++|||||
T Consensus 310 ~~~~~~~~~~~--~~klPirWLAPEtl~~~~~s~kTDV~sf 348 (474)
T KOG0194|consen 310 RAGSQYVMKKF--LKKLPIRWLAPETLNTGIFSFKTDVWSF 348 (474)
T ss_pred cCCcceeeccc--cccCcceecChhhhccCccccccchhhe
Confidence 87652111100 112346799999876 889999999997
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=274.57 Aligned_cols=175 Identities=26% Similarity=0.366 Sum_probs=151.3
Q ss_pred eeecccCceEEEEEEec-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 007254 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 501 (611)
Q Consensus 428 ~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~----~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 501 (611)
+.||+|+||.||+|... +++.||||++++. ......+..|++++..+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36899999999999865 6889999999764 23455677899998866 799999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCce
Q 007254 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (611)
Q Consensus 502 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~ 581 (611)
|+|...+.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-- 151 (321)
T cd05591 81 GDLMFQIQRSR----KFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-- 151 (321)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCc--
Confidence 99999887543 48899999999999999999999 8999999999999999999999999999986543222
Q ss_pred eecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 582 TCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 582 ~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......||+.|+|||+.. ..++.++|||||
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 182 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWAL 182 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceech
Confidence 233567999999999876 788999999997
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=283.20 Aligned_cols=188 Identities=24% Similarity=0.389 Sum_probs=158.1
Q ss_pred cCCCccceeecccCceEEEEEEe------cCCCEEEEEEecCCh--hHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCe
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPSE--DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNN 491 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~------~~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 491 (611)
.++|.+.+.||+|+||.||+|.. .++..||||+++... ...+.+.+|+.+|..+ +||||++++++|.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 34688889999999999999963 246689999998643 3456788999999999 89999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhcCCC----------------------------------------------------------
Q 007254 492 LLLVYDFLSRGSLEENLHGNKK---------------------------------------------------------- 513 (611)
Q Consensus 492 ~~lV~Ey~~~gsL~~~L~~~~~---------------------------------------------------------- 513 (611)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999865321
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCc
Q 007254 514 -------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (611)
Q Consensus 514 -------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~ 580 (611)
....++|..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 01257899999999999999999999 89999999999999999999999999999877654332
Q ss_pred eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 581 ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 581 ~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.......++..|+|||+.. ..++.++|||||
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~sl 302 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSY 302 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHH
Confidence 2222345677899999875 788999999996
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=275.52 Aligned_cols=178 Identities=22% Similarity=0.371 Sum_probs=152.0
Q ss_pred CccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHH---HhcCCCCeeeEEEEEEeCCeEEEE
Q 007254 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEII---TTLHHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 424 f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il---~~l~HpnIv~l~~~~~~~~~~~lV 495 (611)
|.+.+.||+|+||.||+|... +|+.||||++++.. ...+.+.+|+.++ +.++||||+++++++.+.+++|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567899999999999999864 78999999997542 3345666776665 566899999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
|||+++|+|...+... .+++..+..++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHTD-----VFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 9999999999888542 48999999999999999999999 899999999999999999999999999997643
Q ss_pred CCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 576 TSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.... ......||+.|+|||+.. ..++.++|||||
T Consensus 153 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl 187 (324)
T cd05589 153 GFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGL 187 (324)
T ss_pred CCCC--cccccccCccccCHhHhcCCCCCcccchhhH
Confidence 3221 223578999999999876 778999999997
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=269.38 Aligned_cols=177 Identities=27% Similarity=0.356 Sum_probs=153.5
Q ss_pred ecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCCH
Q 007254 430 IGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504 (611)
Q Consensus 430 IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 504 (611)
||+|+||+||++... +|+.||+|.+.... .....+..|+++++.++|+||+++++++...+++|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999864 78999999987542 2345678899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCceeec
Q 007254 505 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 584 (611)
Q Consensus 505 ~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~ 584 (611)
...+.........+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++..+..... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 98886543344568999999999999999999999 8999999999999999999999999999987654332 223
Q ss_pred CCccCCCcccceecc-CCCcCcceEEeC
Q 007254 585 DVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 585 ~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
...||+.|+|||+.. ..++.++|||||
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~Dvwsl 183 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFAL 183 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHH
Confidence 468999999999876 788999999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=280.07 Aligned_cols=180 Identities=26% Similarity=0.379 Sum_probs=161.2
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCeEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLL 494 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~l 494 (611)
...|.+.+.||.|.||.||++..+ +|+.+|+|++++.. .....+.+|+.||+.+. |||||.++++|.+.+.+++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 446777899999999999999965 59999999997653 24568889999999998 9999999999999999999
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCC----CcEEEEeecc
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD----FEPQLSDFGL 570 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~----~~vKL~DFGl 570 (611)
|||++.||.|.+.+... .++...+..++.|++.++.|||+ .+|+||||||+|+|+... +.+|++|||+
T Consensus 114 vmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 99999999999999765 28999999999999999999999 999999999999999643 4799999999
Q ss_pred ccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 571 AKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 571 A~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
|.+... .....+++||+.|+|||+.. ..|+..+||||+
T Consensus 186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~ 224 (382)
T KOG0032|consen 186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSI 224 (382)
T ss_pred ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHH
Confidence 999887 22456789999999999988 999999999995
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=272.89 Aligned_cols=175 Identities=27% Similarity=0.352 Sum_probs=152.6
Q ss_pred eeecccCceEEEEEEe----cCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 007254 428 NLIGKGGSSQVYKGCL----PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (611)
Q Consensus 428 ~~IG~G~fG~Vyk~~~----~~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 500 (611)
+.||+|+||.||++.. .+|+.||+|+++... .....+..|+++|..++||||+++++++.+.+.+|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 368899999997643 234567789999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCc
Q 007254 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (611)
Q Consensus 501 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~ 580 (611)
+|+|.+.+... ..+++.++..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~- 153 (318)
T cd05582 82 GGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK- 153 (318)
T ss_pred CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence 99999998654 248999999999999999999999 8999999999999999999999999999987654322
Q ss_pred eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 581 ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 581 ~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......||+.|+|||+.. ..++.++|||||
T Consensus 154 -~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl 184 (318)
T cd05582 154 -KAYSFCGTVEYMAPEVVNRRGHTQSADWWSF 184 (318)
T ss_pred -ceecccCChhhcCHHHHcCCCCCCccceecc
Confidence 223468999999999876 778999999997
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=283.67 Aligned_cols=183 Identities=27% Similarity=0.384 Sum_probs=163.5
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCe-EEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN-LLLVY 496 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-~~lV~ 496 (611)
++|...++||+|+||.++....+ +++.+++|.+... +......++|+.++++++|||||.+++.|.+++. +||||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56778899999999999988754 6789999998653 3455678899999999999999999999998887 99999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
+||+||+|.+.+.+.+ ...|+...++.++.|++.|+.|||+ ..|+|||||+.||+++.++.|||.|||+|+.+..
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999998765 3569999999999999999999998 8999999999999999999999999999999876
Q ss_pred CCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 577 SSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
... ...+++||+.||+||++. ..|++++|||||
T Consensus 159 ~~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsL 192 (426)
T KOG0589|consen 159 EDS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSL 192 (426)
T ss_pred chh--hhheecCCCcccCHHHhCCCCCCccCcchhh
Confidence 542 234689999999999886 999999999997
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=273.39 Aligned_cols=175 Identities=23% Similarity=0.361 Sum_probs=149.3
Q ss_pred eeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHh-cCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 007254 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITT-LHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (611)
Q Consensus 428 ~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 501 (611)
+.||+|+||.||+|... +++.||||+++... .....+..|..++.. .+||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999864 68899999998642 334556667777765 4899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCce
Q 007254 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (611)
Q Consensus 502 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~ 581 (611)
|+|...+.... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+|+.......
T Consensus 81 g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~-- 151 (316)
T cd05592 81 GDLMFHIQSSG----RFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG-- 151 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC--
Confidence 99999987543 48889999999999999999999 8999999999999999999999999999986543221
Q ss_pred eecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 582 TCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 582 ~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......||+.|+|||+.. ..++.++|||||
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 182 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSF 182 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhH
Confidence 223568999999999876 778999999997
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=274.10 Aligned_cols=175 Identities=25% Similarity=0.391 Sum_probs=151.4
Q ss_pred eeecccCceEEEEEEec-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 007254 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 501 (611)
Q Consensus 428 ~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~----~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 501 (611)
+.||+|+||.||+|... +++.||||++++. ......+..|+.++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999865 6889999999753 23456778899998876 699999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCce
Q 007254 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (611)
Q Consensus 502 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~ 581 (611)
|+|.+.+.... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~i~~~~----~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-- 151 (320)
T cd05590 81 GDLMFHIQKSR----RFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-- 151 (320)
T ss_pred chHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--
Confidence 99999887553 48899999999999999999999 8999999999999999999999999999986433221
Q ss_pred eecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 582 TCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 582 ~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......||+.|+|||+.. ..++.++|||||
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 182 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAM 182 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhh
Confidence 223468999999999876 788999999997
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=281.93 Aligned_cols=187 Identities=25% Similarity=0.409 Sum_probs=157.3
Q ss_pred CCCccceeecccCceEEEEEEec------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 492 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 492 (611)
++|.+.+.||+|+||.||+|... +++.||||+++.. ......+.+|+++++.+ +|+||++++++|.+.+.+
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 46888899999999999998742 3457999999764 34456788999999999 899999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhcCCC-----------------------------------------------------------
Q 007254 493 LLVYDFLSRGSLEENLHGNKK----------------------------------------------------------- 513 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~~----------------------------------------------------------- 513 (611)
|+||||+++|+|.+++.....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 999999999999999864321
Q ss_pred -------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCceeecCC
Q 007254 514 -------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV 586 (611)
Q Consensus 514 -------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 586 (611)
....+++.++.+++.||+.||.|||+ ++|+||||||+|||+++++.+||+|||+++..............
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 11247899999999999999999999 89999999999999999999999999999876554333333334
Q ss_pred ccCCCcccceecc-CCCcCcceEEeC
Q 007254 587 AGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 587 ~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.+++.|+|||+.. ..++.++|||||
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSl 300 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSY 300 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHH
Confidence 5677899999775 789999999996
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=273.06 Aligned_cols=175 Identities=30% Similarity=0.389 Sum_probs=149.0
Q ss_pred eeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHH-HHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 007254 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIE-IITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (611)
Q Consensus 428 ~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 501 (611)
+.||+|+||.||+|... +|+.||+|++++.. .....+..|.. +++.++||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46899999999999854 78999999997532 33455666665 46789999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCce
Q 007254 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (611)
Q Consensus 502 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~ 581 (611)
|+|...+.... .+++..+..++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-- 151 (325)
T cd05604 81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-- 151 (325)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--
Confidence 99998886543 48899999999999999999999 8999999999999999999999999999986432221
Q ss_pred eecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 582 TCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 582 ~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......||+.|+|||+.. ..++.++|||||
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 182 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCL 182 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccc
Confidence 223568999999999876 778999999997
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=270.48 Aligned_cols=182 Identities=22% Similarity=0.372 Sum_probs=156.1
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 497 (611)
.++|.+.+.||.|+||.||+|... +++.||+|+++... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 357888999999999999999865 78999999987532 334567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCC
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~ 577 (611)
|+++ +|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~~-~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 84 YLDS-DLKQYLDNCG---NLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred CCCc-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 9975 8998886543 357889999999999999999999 99999999999999999999999999999865432
Q ss_pred CCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 578 SSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 578 ~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
.. ......||+.|+|||+.. ..++.++|||||
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl 190 (288)
T cd07871 157 TK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGV 190 (288)
T ss_pred Cc--cccCceecccccChHHhcCCcccCcHHHHHHH
Confidence 21 223467899999999764 668999999996
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=272.47 Aligned_cols=175 Identities=29% Similarity=0.388 Sum_probs=149.0
Q ss_pred eeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHH-HHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 007254 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIE-IITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (611)
Q Consensus 428 ~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 501 (611)
+.||+|+||+||+|... +|+.||||++.+.. ....++..|.. +++.++||||+++++.+.+.+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999865 78999999997532 23345556655 46789999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCce
Q 007254 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (611)
Q Consensus 502 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~ 581 (611)
|+|...+.... .+++..+..++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~-- 151 (323)
T cd05575 81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK-- 151 (323)
T ss_pred CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--
Confidence 99999987543 48899999999999999999999 8999999999999999999999999999986433221
Q ss_pred eecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 582 TCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 582 ~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......||+.|+|||+.. ..++.++|||||
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 182 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCL 182 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCcccccccc
Confidence 233567999999999875 778999999997
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=271.72 Aligned_cols=182 Identities=25% Similarity=0.386 Sum_probs=155.8
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 497 (611)
.++|.+.+.||+|+||.||+|... +++.||||+++... .....+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999965 78999999997543 234567789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCC
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~ 577 (611)
|+. ++|.+.+.... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDKHP---GGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 995 58888876542 347889999999999999999999 89999999999999999999999999999865432
Q ss_pred CCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 578 SSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 578 ~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
.. ......||+.|+|||+.. ..++.++|||||
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl 190 (303)
T cd07869 157 SH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGV 190 (303)
T ss_pred Cc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHH
Confidence 21 223467899999999764 568999999996
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=283.58 Aligned_cols=178 Identities=28% Similarity=0.409 Sum_probs=159.6
Q ss_pred CCccceeecccCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHHHhcC-C-----CCeeeEEEEEEeCCeEEEE
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLH-H-----KNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~-H-----pnIv~l~~~~~~~~~~~lV 495 (611)
+|.++++||+|.||+|-+|.+. +++.||||++|+......+...|+.||..|+ | -|+|+++++|...+++|||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 7889999999999999999854 7999999999999888888999999999997 4 4999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCC--CcEEEEeeccccc
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD--FEPQLSDFGLAKW 573 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~--~~vKL~DFGlA~~ 573 (611)
+|++.. +|.++|..++. ..|+...+..++.||+.||.+||+ .+|||+||||+||||.+- ..+||+|||.|..
T Consensus 267 fELL~~-NLYellK~n~f--~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 267 FELLST-NLYELLKNNKF--RGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred ehhhhh-hHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecccccc
Confidence 999954 99999987765 458899999999999999999999 999999999999999754 4799999999988
Q ss_pred cCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 574 ASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
...... +...+..|.|||++. ..|+.+.|||||
T Consensus 341 ~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSL 374 (586)
T KOG0667|consen 341 ESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSL 374 (586)
T ss_pred cCCcce-----eeeeccccccchhhccCCCCCccceeeh
Confidence 766432 456788999999887 999999999998
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=272.18 Aligned_cols=175 Identities=28% Similarity=0.368 Sum_probs=148.3
Q ss_pred eeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHH-HHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 007254 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIE-IITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (611)
Q Consensus 428 ~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 501 (611)
+.||+|+||.||+|... +|+.||+|++.+.. .....+..|+. +++.++||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999865 68899999997532 23345556654 67889999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCce
Q 007254 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (611)
Q Consensus 502 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~ 581 (611)
|+|...+.... .+++..+..++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-- 151 (321)
T cd05603 81 GELFFHLQRER----CFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-- 151 (321)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--
Confidence 99998886543 47888889999999999999999 8999999999999999999999999999986433221
Q ss_pred eecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 582 TCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 582 ~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......||+.|+|||+.. ..++.++|||||
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 182 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCL 182 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCccccc
Confidence 233567999999999875 778999999997
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=278.65 Aligned_cols=196 Identities=23% Similarity=0.254 Sum_probs=168.3
Q ss_pred cccccChHHHHHhcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeE
Q 007254 408 TCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISL 482 (611)
Q Consensus 408 ~~~~~~~~~l~~~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l 482 (611)
.+.+-.++-.....+.|..-++||+||||.||-+... +|+.+|.|.+.+.. ....-.+.|-.||..++.++||.|
T Consensus 171 FlQWK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVsl 250 (591)
T KOG0986|consen 171 FLQWKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSL 250 (591)
T ss_pred HHHHHHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEE
Confidence 3344344443444567888899999999999998754 89999999886532 233456789999999999999999
Q ss_pred EEEEEeCCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCc
Q 007254 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE 562 (611)
Q Consensus 483 ~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~ 562 (611)
--+|.+.+.+||||..|+||+|.-+|.+... +.|+...+..++.+|++||++||+ .+||+|||||+|||||+.|+
T Consensus 251 aYAfeTkd~LClVLtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~Gh 325 (591)
T KOG0986|consen 251 AYAFETKDALCLVLTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGH 325 (591)
T ss_pred eeeecCCCceEEEEEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCC
Confidence 9999999999999999999999998876643 679999999999999999999999 99999999999999999999
Q ss_pred EEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 563 PQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 563 vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
++|+|+|||..++..... ...+||.||||||++. +.|+++.|+|||
T Consensus 326 vRISDLGLAvei~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~l 372 (591)
T KOG0986|consen 326 VRISDLGLAVEIPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSL 372 (591)
T ss_pred eEeeccceEEecCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHH
Confidence 999999999998876643 2359999999999876 889999999997
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=272.39 Aligned_cols=175 Identities=22% Similarity=0.350 Sum_probs=151.8
Q ss_pred eeecccCceEEEEEEec-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 007254 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 501 (611)
Q Consensus 428 ~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~----~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 501 (611)
+.||+|+||.||++... +++.||+|++++. ....+.+..|+.++..+ +||||+.+++++.+.+++|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999864 6789999999864 23456788999999888 699999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCce
Q 007254 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (611)
Q Consensus 502 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~ 581 (611)
|+|...+...+ .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-- 151 (327)
T cd05617 81 GDLMFHMQRQR----KLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-- 151 (327)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--
Confidence 99999886543 48999999999999999999999 8999999999999999999999999999986432221
Q ss_pred eecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 582 TCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 582 ~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......||+.|+|||+.. ..++.++|||||
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 182 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWAL 182 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehh
Confidence 223568999999999875 788999999997
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=268.57 Aligned_cols=182 Identities=24% Similarity=0.318 Sum_probs=156.1
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 497 (611)
++|.+.+.||+|+||.||++... +++.||||+++... .....+.+|+++++.++||||++++++|...+.+|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46889999999999999999975 68899999997642 345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCC
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~ 577 (611)
|++++.+....... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEEMP----NGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 99987776544322 358899999999999999999999 89999999999999999999999999999887543
Q ss_pred CCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 578 SSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 578 ~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.. .......||+.|+|||+.. ..++.++|||||
T Consensus 154 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl 187 (287)
T cd07848 154 SN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSV 187 (287)
T ss_pred cc-ccccccccccccCCcHHHcCCCCCCchhHHhH
Confidence 22 1223467999999999775 778999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=272.76 Aligned_cols=175 Identities=25% Similarity=0.400 Sum_probs=150.1
Q ss_pred eeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHh-cCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 007254 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITT-LHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (611)
Q Consensus 428 ~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 501 (611)
+.||+|+||.||+|... +|+.||+|++++.. .....+..|..++.. ++||||+++++++.+.+++|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999865 68899999998642 334566778888875 4899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCce
Q 007254 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (611)
Q Consensus 502 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~ 581 (611)
|+|...+.... .+++.++..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~i~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 151 (316)
T cd05620 81 GDLMFHIQDKG----RFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-- 151 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--
Confidence 99999987543 48899999999999999999999 8999999999999999999999999999975432211
Q ss_pred eecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 582 TCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 582 ~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......||+.|+|||+.. ..++.++|||||
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 182 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSF 182 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhh
Confidence 234578999999999876 788999999997
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=272.89 Aligned_cols=180 Identities=21% Similarity=0.294 Sum_probs=154.2
Q ss_pred CCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCeEEEEE
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~ 496 (611)
+|...+.||+|+||.||+|... +|+.||+|++++.. ...+.+..|+.++..+. |++|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677899999999999999864 78999999997632 34566788999998886 577888999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
||+++|+|.+++.... .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQVG----KFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 9999999999986543 48999999999999999999999 8999999999999999999999999999986443
Q ss_pred CCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 577 SSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
... ......||+.|+|||+.. ..++.++|||||
T Consensus 154 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 187 (323)
T cd05615 154 DGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAY 187 (323)
T ss_pred CCc--cccCccCCccccCHHHHcCCCCCCccchhhh
Confidence 221 223467999999999876 778999999997
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=290.67 Aligned_cols=191 Identities=23% Similarity=0.282 Sum_probs=163.0
Q ss_pred HHhcCCCccceeecccCceEEEEEEe-cCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC---
Q 007254 418 LSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN--- 490 (611)
Q Consensus 418 ~~~~~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--- 490 (611)
....++|.+.+.||+|+||+||+|.. .+|+.||||+++.. ......+.+|+.++..++|+||++++..+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 34457899999999999999999985 47999999998653 345667889999999999999999988775432
Q ss_pred -----eEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEE
Q 007254 491 -----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQL 565 (611)
Q Consensus 491 -----~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL 565 (611)
.+++||||+++|+|.+.|.........+++..+..++.|++.||.|||+ .+|+||||||+||||+.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEE
Confidence 3789999999999999997654444578999999999999999999999 89999999999999999999999
Q ss_pred EeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 566 SDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 566 ~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+|||+++.+.............||+.|+|||+.. ..|+.++|||||
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSl 231 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSL 231 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHH
Confidence 9999998776543333334578999999999876 779999999996
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=272.04 Aligned_cols=175 Identities=27% Similarity=0.357 Sum_probs=147.5
Q ss_pred eeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHH-HHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 007254 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIE-IITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (611)
Q Consensus 428 ~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 501 (611)
+.||+|+||.||+|... +++.||+|++.... .....+..|.. +++.++||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999865 67889999997532 22334455544 56889999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCce
Q 007254 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (611)
Q Consensus 502 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~ 581 (611)
|+|.+.+.... .+.+..+..++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-- 151 (325)
T cd05602 81 GELFYHLQRER----CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-- 151 (325)
T ss_pred CcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--
Confidence 99999997543 47788888999999999999999 8999999999999999999999999999986433221
Q ss_pred eecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 582 TCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 582 ~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......||+.|+|||+.. ..++.++|||||
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 182 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCL 182 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccc
Confidence 233568999999999776 778999999997
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=265.34 Aligned_cols=181 Identities=25% Similarity=0.323 Sum_probs=156.8
Q ss_pred CCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 497 (611)
+|...+.||+|+||.||++... +++.||||++.... .....+.+|+.+++.++||||+++++.+.+.+.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4777899999999999999864 78999999997542 233567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCC
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~ 577 (611)
|+++|+|.+.+..... ..+++..+..++.|++.||.|||+ .+|+||||||+||++++++.++|+|||+++.....
T Consensus 81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNMGN--PGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 9999999988865322 358999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 578 SSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 578 ~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.. .....||+.|+|||+.. ..++.++|||||
T Consensus 156 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~ 187 (285)
T cd05605 156 ET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGL 187 (285)
T ss_pred Cc---cccccCCCCccCcHHhcCCCCCccccchhH
Confidence 22 23457999999999875 778999999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=280.55 Aligned_cols=188 Identities=23% Similarity=0.394 Sum_probs=158.8
Q ss_pred cCCCccceeecccCceEEEEEEec------CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCe
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNN 491 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~ 491 (611)
.++|.+.+.||+|+||.||+|... .+..||||+++... .....|.+|+++|..+. ||||++++++|.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 467888999999999999999742 23479999997643 34567999999999996 9999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhcCCC----------------------------------------------------------
Q 007254 492 LLLVYDFLSRGSLEENLHGNKK---------------------------------------------------------- 513 (611)
Q Consensus 492 ~~lV~Ey~~~gsL~~~L~~~~~---------------------------------------------------------- 513 (611)
+|||||||++|+|.++|.....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999998865321
Q ss_pred ----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcC
Q 007254 514 ----------------------------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD 559 (611)
Q Consensus 514 ----------------------------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~ 559 (611)
....+++.++..++.|++.||.|||+ .+|+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeC
Confidence 01248899999999999999999999 89999999999999999
Q ss_pred CCcEEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 560 DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 560 ~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
++.+||+|||+++...............|++.|+|||+.. ..++.++|||||
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSl 325 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSY 325 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHH
Confidence 9999999999998765443333334456788999999775 778999999996
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-32 Score=280.00 Aligned_cols=180 Identities=27% Similarity=0.404 Sum_probs=160.6
Q ss_pred CCccceeecccCceEEEEEEe-cCCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 007254 423 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 499 (611)
.|...++||+|+||.||+|.. .+++.||+|++... ++...++.+|+.+|.+++++||.++|+.|..+..++++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 355668899999999999985 47899999999875 356788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~ 579 (611)
.||++.+.|.... .+.+.....|+.+++.||.|||. ++.+|||||+.|||+..+|.+||+|||.+-.+.....
T Consensus 94 ~gGsv~~lL~~~~----~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 94 GGGSVLDLLKSGN----ILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred cCcchhhhhccCC----CCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 9999999997553 24666677789999999999999 8999999999999999999999999999988876543
Q ss_pred ceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 580 HITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 580 ~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
...+++||+.|||||++. ..|+.++|||||
T Consensus 167 --rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSL 197 (467)
T KOG0201|consen 167 --RRKTFVGTPFWMAPEVIKQSGYDTKADIWSL 197 (467)
T ss_pred --ccccccccccccchhhhccccccchhhhhhh
Confidence 336899999999999887 799999999997
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=279.92 Aligned_cols=178 Identities=20% Similarity=0.246 Sum_probs=153.6
Q ss_pred hcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
..++|.+.+.||+|+||.||++... +++.||+|.... ..+.+|+++|+.++||||++++++|...+..|+||||
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 3467999999999999999999864 788999997542 3567899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
+. ++|..++.... .+++.++..++.||+.||.|||+ .+||||||||+||||+.++.+||+|||+|+......
T Consensus 165 ~~-~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 165 YK-TDLYCYLAAKR----NIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred CC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 95 68988886543 48899999999999999999999 899999999999999999999999999997643322
Q ss_pred CceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 579 SHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
. .......||+.|+|||+.. ..|+.++|||||
T Consensus 237 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 269 (391)
T PHA03212 237 A-NKYYGWAGTIATNAPELLARDPYGPAVDIWSA 269 (391)
T ss_pred c-cccccccCccCCCChhhhcCCCCCcHHHHHHH
Confidence 1 1223568999999999876 789999999996
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=270.92 Aligned_cols=175 Identities=24% Similarity=0.376 Sum_probs=149.8
Q ss_pred eeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHh-cCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 007254 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITT-LHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (611)
Q Consensus 428 ~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 501 (611)
+.||+|+||.||+|... +++.||||+++... .....+..|..++.. ++||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 67899999998642 334566778888876 5999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCce
Q 007254 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (611)
Q Consensus 502 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~ 581 (611)
|+|.+++.... .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 151 (316)
T cd05619 81 GDLMFHIQSCH----KFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-- 151 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--
Confidence 99999997542 48899999999999999999999 8999999999999999999999999999986432221
Q ss_pred eecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 582 TCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 582 ~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......||+.|+|||+.. ..++.++|||||
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 182 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSF 182 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhH
Confidence 223467999999999875 778999999996
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=270.95 Aligned_cols=181 Identities=23% Similarity=0.357 Sum_probs=159.1
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 497 (611)
.++|.+.+.||+|+||.||++... +|..+|+|+++.. ......+.+|+++|+.++||||+++++++...+.+++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 467899999999999999999865 6889999999764 3456789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCC
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~ 577 (611)
|+++|+|.+++.... .+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK----RIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 999999999997643 488999999999999999999971 36999999999999999999999999999876543
Q ss_pred CCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 578 SSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 578 ~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
. .....||+.|+|||+.. ..++.++|||||
T Consensus 158 ~----~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl 188 (331)
T cd06649 158 M----ANSFVGTRSYMSPERLQGTHYSVQSDIWSM 188 (331)
T ss_pred c----cccCCCCcCcCCHhHhcCCCCCchHhHHHH
Confidence 2 23457999999999876 778999999996
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=270.02 Aligned_cols=184 Identities=22% Similarity=0.422 Sum_probs=157.2
Q ss_pred cCCCccceeecccCceEEEEEEec-CCC----EEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGK----ELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~----~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 493 (611)
..+|...+.||+|+||.||+|.+. +++ .||+|+++.. .....++.+|+.+++.++||||++++++|... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 356889999999999999999854 344 4899999754 34567899999999999999999999999764 578
Q ss_pred EEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccc
Q 007254 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (611)
Q Consensus 494 lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~ 573 (611)
+|+||+++|+|.+++.... ..+++..+..++.||+.||.|||+ .+|+||||||+|||+++++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 85 LITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeeecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEcccccccc
Confidence 9999999999999997643 358899999999999999999999 8999999999999999999999999999998
Q ss_pred cCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 574 ASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
..............+|+.|+|||+.. ..++.++|||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~sl 197 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSY 197 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHH
Confidence 76554443433445678899999876 788999999996
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=272.06 Aligned_cols=181 Identities=23% Similarity=0.390 Sum_probs=153.0
Q ss_pred CCccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----CeEE
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NNLL 493 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~~ 493 (611)
+|.+.+.||+|+||.||+|... +|+.||||.++.. .....++.+|+++++.++||||+++++++... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788899999999999999864 7899999998753 23446788999999999999999999998643 3589
Q ss_pred EEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccc
Q 007254 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (611)
Q Consensus 494 lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~ 573 (611)
+||||+. ++|.+.+.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKAND----DLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHhcc----cCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 68998886543 48999999999999999999999 8999999999999999999999999999986
Q ss_pred cCCCC-CceeecCCccCCCcccceecc---CCCcCcceEEeC
Q 007254 574 ASTSS-SHITCTDVAGTFGYVVLILNP---IAFLFMFNCWFF 611 (611)
Q Consensus 574 ~~~~~-~~~~~~~~~GT~~Y~aPE~~~---~~~~~~sDiWSL 611 (611)
..... .........||+.|+|||+.. ..++.++|||||
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSl 194 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSI 194 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHH
Confidence 54322 222234578999999999864 678999999996
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=259.97 Aligned_cols=185 Identities=21% Similarity=0.405 Sum_probs=161.9
Q ss_pred cCCCccceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 500 (611)
.++|.+.+.||+|+||.||+|...+++.||+|.++......+.+.+|+.+++.++|+||+++++++...+..++||||++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 35788899999999999999998888899999998766667889999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCc
Q 007254 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (611)
Q Consensus 501 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~ 580 (611)
+|+|.+++.... ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 85 ~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 85 KGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 999999997542 2458899999999999999999999 89999999999999999999999999999877653321
Q ss_pred eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 581 ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 581 ~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......++..|+|||+.. ..++.++|||||
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 190 (261)
T cd05072 160 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSF 190 (261)
T ss_pred -ccCCCccceecCCHHHhccCCCChhhhhhhh
Confidence 122345678899999775 778999999997
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=260.51 Aligned_cols=180 Identities=29% Similarity=0.475 Sum_probs=156.9
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecC------Ch---hHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCC
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP------SE---DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDN 490 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~------~~---~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 490 (611)
++|...+.||.|..+.|-+++.+ +|+++|+|++.. .+ ...+.-.+|++||+++ .||+|+.|.++|..+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 45666788999999999998854 789999999853 11 2344556799999998 5999999999999999
Q ss_pred eEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecc
Q 007254 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (611)
Q Consensus 491 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGl 570 (611)
.+++|+|+|+.|.|.++|... ..+++++..+|+.|+.+|++|||. +.||||||||+|||++++.++||+|||+
T Consensus 97 F~FlVFdl~prGELFDyLts~----VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSK----VTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred hhhhhhhhcccchHHHHhhhh----eeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccce
Confidence 999999999999999999765 358999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCceeecCCccCCCcccceecc-------CCCcCcceEEeC
Q 007254 571 AKWASTSSSHITCTDVAGTFGYVVLILNP-------IAFLFMFNCWFF 611 (611)
Q Consensus 571 A~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-------~~~~~~sDiWSL 611 (611)
|..++... .....|||++|+|||.+. ..|+..+|+|++
T Consensus 170 a~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~ 214 (411)
T KOG0599|consen 170 ACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWAC 214 (411)
T ss_pred eeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHH
Confidence 99988765 345689999999999652 789999999984
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=266.22 Aligned_cols=184 Identities=24% Similarity=0.364 Sum_probs=160.0
Q ss_pred hcCCCccceeecccCceEEEEEEec-CCCEEEEEEecC---ChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-----CC
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFE-----DN 490 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~~ 490 (611)
....|...+.||+|+||.|+.+... +|+.||||.+.. .....++-.+|+.+|+.++|+||+.+++++.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3455666789999999999999864 899999999873 33457888999999999999999999999865 35
Q ss_pred eEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecc
Q 007254 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (611)
Q Consensus 491 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGl 570 (611)
.+|+|+|+| +.+|...++... .++...+..+.+|+++||.|+|+ .+|+||||||+|+|++.+..+||+||||
T Consensus 100 DvYiV~elM-etDL~~iik~~~----~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQ----DLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCc----cccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccc
Confidence 699999999 559999987653 38888999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 571 AKWASTSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 571 A~~~~~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
|+..........++..+-|..|.|||+.. ..|+.++||||.
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSv 214 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSV 214 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhh
Confidence 99987654445667888999999999775 999999999994
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=275.46 Aligned_cols=176 Identities=24% Similarity=0.412 Sum_probs=149.1
Q ss_pred CCccceeecccCceEEEEEEec-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 499 (611)
+|...+.||+|+||.||+|... +|+.||||++... ......+.+|+++++.++|+||+++++++...+.+|+||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 3445678999999999999865 7899999999653 345678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~ 579 (611)
++|+|.... .+.+..+..++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+++.+.....
T Consensus 155 ~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 155 DGGSLEGTH--------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 999986432 24567788899999999999999 8999999999999999999999999999987654322
Q ss_pred ceeecCCccCCCcccceecc------CCCcCcceEEeC
Q 007254 580 HITCTDVAGTFGYVVLILNP------IAFLFMFNCWFF 611 (611)
Q Consensus 580 ~~~~~~~~GT~~Y~aPE~~~------~~~~~~sDiWSL 611 (611)
.+....||+.|+|||++. ..+++++|||||
T Consensus 224 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Dvwsl 259 (353)
T PLN00034 224 --PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSL 259 (353)
T ss_pred --cccccccCccccCccccccccccCcCCCcchhHHHH
Confidence 233568999999999763 234579999996
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-30 Score=268.76 Aligned_cols=173 Identities=28% Similarity=0.324 Sum_probs=147.0
Q ss_pred ecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhc---CCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 007254 430 IGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTL---HHKNIISLLGFCFEDNNLLLVYDFLSR 501 (611)
Q Consensus 430 IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 501 (611)
||+|+||.||+|... +++.||||++.+.. .....+..|..++..+ +||||+.+++++.+.+.+|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999865 68999999996532 2334556677777765 699999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCce
Q 007254 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (611)
Q Consensus 502 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~ 581 (611)
|+|...+.... .+++..+..++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-- 151 (330)
T cd05586 81 GELFWHLQKEG----RFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-- 151 (330)
T ss_pred ChHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--
Confidence 99999987543 48899999999999999999999 8999999999999999999999999999976433221
Q ss_pred eecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 582 TCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 582 ~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
.....+||+.|+|||+.. ..++.++|||||
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dvwsl 183 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSL 183 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceecc
Confidence 233568999999999765 458999999997
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=259.04 Aligned_cols=183 Identities=21% Similarity=0.349 Sum_probs=159.3
Q ss_pred CCCccceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 501 (611)
++|.+.+.||+|+||.||++.+.++..+|+|.++.......+|.+|+++++.++||||++++++|.+.+..++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 45778899999999999999988888999999887655567889999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCce
Q 007254 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (611)
Q Consensus 502 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~ 581 (611)
|+|.+++.... ..++|..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 84 ~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05114 84 GCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT- 156 (256)
T ss_pred CcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence 99999987543 248899999999999999999999 89999999999999999999999999999876543221
Q ss_pred eecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 582 TCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 582 ~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......+++.|+|||+.. ..++.++|||||
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~ 187 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSF 187 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHH
Confidence 122345667899999875 788999999996
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=292.47 Aligned_cols=189 Identities=26% Similarity=0.435 Sum_probs=161.6
Q ss_pred hcCCCccceeecccCceEEEEEEec------CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCe
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 491 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 491 (611)
.+.+....+.||+|+||+||+|... +...||||.||... +...+|.+|+++|..|+|||||+|+|+|.+++.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 3455566788999999999999743 34579999998754 478899999999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhcCCCC----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCC
Q 007254 492 LLLVYDFLSRGSLEENLHGNKKD----------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 561 (611)
Q Consensus 492 ~~lV~Ey~~~gsL~~~L~~~~~~----------~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~ 561 (611)
+|+|+|||..|||.++|..+... +..++..+.+.||.|||.||.||-+ +.+|||||..+|+|+.++.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---Ccccccchhhhhceeccce
Confidence 99999999999999999754421 3448999999999999999999999 8899999999999999999
Q ss_pred cEEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 562 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 562 ~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.|||+||||++-+-....+.......-..-||+||-++ .+||++||||||
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~ 691 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSF 691 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhh
Confidence 99999999999766544433222334456799999777 999999999997
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=263.03 Aligned_cols=189 Identities=19% Similarity=0.355 Sum_probs=159.0
Q ss_pred hcCCCccceeecccCceEEEEEEec------CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCe
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 491 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 491 (611)
..++|.+.+.||+|+||.||+|.+. ++..||||.++... ....+|.+|+.+++.++||||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567999999999999999998753 35679999986543 345678999999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhcCCCC------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEE
Q 007254 492 LLLVYDFLSRGSLEENLHGNKKD------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQL 565 (611)
Q Consensus 492 ~~lV~Ey~~~gsL~~~L~~~~~~------~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL 565 (611)
.++||||+++|+|.+++...... ...++|..+..++.|++.||.|||+ .+++||||||+|||+++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEE
Confidence 99999999999999998753321 2347889999999999999999999 89999999999999999999999
Q ss_pred EeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 566 SDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 566 ~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+|||+++...............+++.|+|||+.. ..++.++|||||
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 207 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 207 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHH
Confidence 9999998765443322222345688899999876 778999999996
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=268.99 Aligned_cols=175 Identities=22% Similarity=0.344 Sum_probs=151.5
Q ss_pred eeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 007254 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 501 (611)
Q Consensus 428 ~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 501 (611)
+.||+|+||.||++... +++.||||++++.. .....+..|++++..+ +||||+++++++.+.+++|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999865 67899999998642 3456678899999888 699999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCce
Q 007254 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (611)
Q Consensus 502 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~ 581 (611)
|+|...+.... .+++.++..++.|++.||.|||+ .+|+||||||+|||+++++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 151 (318)
T cd05570 81 GDLMFHIQRSG----RFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-- 151 (318)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--
Confidence 99999887543 48999999999999999999999 8999999999999999999999999999976433221
Q ss_pred eecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 582 TCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 582 ~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......||+.|+|||+.. ..++.++|||||
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl 182 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWAL 182 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhH
Confidence 223457999999999876 788999999996
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-30 Score=259.01 Aligned_cols=186 Identities=25% Similarity=0.400 Sum_probs=161.3
Q ss_pred hcCCCccceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 499 (611)
..++|.+.+.||+|+||.||+|.+.+++.||+|.++......+++.+|+.+++.++||||+++++++...+.+|+||||+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 34678889999999999999999877889999999876655678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~ 579 (611)
++++|.+++.... ...++|..+..++.+++.||.|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 84 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 84 KYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred cCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 9999999997643 2458999999999999999999999 8999999999999999999999999999988764322
Q ss_pred ceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 580 HITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 580 ~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
. ......++..|+|||+.. ..++.++|||||
T Consensus 159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 190 (261)
T cd05068 159 E-AREGAKFPIKWTAPEAALYNRFSIKSDVWSF 190 (261)
T ss_pred c-ccCCCcCceeccCccccccCCCCchhhHHHH
Confidence 1 112233356899999876 788999999996
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=299.73 Aligned_cols=190 Identities=23% Similarity=0.240 Sum_probs=169.5
Q ss_pred hHHHHHhcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Q 007254 414 YQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFE 488 (611)
Q Consensus 414 ~~~l~~~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 488 (611)
..++....++|.+.++||+|+||.|..+..+ +++.||+|++++.+ .....|..|-+||..-+.+.|+.|+-+|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 4456677889999999999999999999864 78999999998743 235678999999999999999999999999
Q ss_pred CCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEee
Q 007254 489 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568 (611)
Q Consensus 489 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DF 568 (611)
.+++|+|||||+||+|..+|.+.. .++...+.+|+.+|+.||+-||+ .|+|||||||+|||||..|++||+||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccc
Confidence 999999999999999999997653 48888999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCceeecCCccCCCcccceecc------CCCcCcceEEeC
Q 007254 569 GLAKWASTSSSHITCTDVAGTFGYVVLILNP------IAFLFMFNCWFF 611 (611)
Q Consensus 569 GlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~------~~~~~~sDiWSL 611 (611)
|-|-.+..++ ...+...+|||.|++||++. ..|+..+|+|||
T Consensus 220 GsClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSl 267 (1317)
T KOG0612|consen 220 GSCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSL 267 (1317)
T ss_pred hhHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhh
Confidence 9998887655 34667899999999999763 578999999996
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=279.88 Aligned_cols=188 Identities=26% Similarity=0.472 Sum_probs=160.3
Q ss_pred HHHHHhcCCCccceeecccCceEEEEEEecCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCe
Q 007254 415 QDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 491 (611)
Q Consensus 415 ~~l~~~~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 491 (611)
+++.+-.+.+.+...||+|.||+||+|.|.. .||||+|+-+ .+..+.|.+|+.++++-+|.||+.+.|+|.....
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 4444555667788999999999999999843 5999999753 4688999999999999999999999999988776
Q ss_pred EEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccc
Q 007254 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (611)
Q Consensus 492 ~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA 571 (611)
.||.-+|+|.+|+.+|+..+ ..|...+...|+.||+.||.|||. ++|||||||..||+|.+++.|||+||||+
T Consensus 463 -AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred -eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccce
Confidence 99999999999999998654 468889999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCCceeecCCccCCCcccceecc----CCCcCcceEEeC
Q 007254 572 KWASTSSSHITCTDVAGTFGYVVLILNP----IAFLFMFNCWFF 611 (611)
Q Consensus 572 ~~~~~~~~~~~~~~~~GT~~Y~aPE~~~----~~~~~~sDiWSL 611 (611)
..-..-..........|..+|||||++- ..|++.+|||||
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaF 579 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAF 579 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhh
Confidence 6332211112233467899999999763 889999999997
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-30 Score=262.77 Aligned_cols=181 Identities=24% Similarity=0.383 Sum_probs=150.6
Q ss_pred CCCccceeecccCceEEEEEEec--CCCEEEEEEecCCh---hHHHHHHHHHHHHHhc---CCCCeeeEEEEEEe-----
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP--DGKELAVKILKPSE---DVIKEFVLEIEIITTL---HHKNIISLLGFCFE----- 488 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~--~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~----- 488 (611)
++|.+.+.||+|+||.||+|... +++.||||.++... .....+.+|+.+++.+ +||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999863 46889999987532 2344566788777766 69999999999862
Q ss_pred CCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEee
Q 007254 489 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568 (611)
Q Consensus 489 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DF 568 (611)
...+++||||+. ++|.+++..... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccc
Confidence 456899999996 599998875432 348899999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 569 GLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 569 GlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
|+++...... ......||+.|+|||+.. ..++.++|||||
T Consensus 155 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl 195 (290)
T cd07862 155 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSV 195 (290)
T ss_pred cceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHH
Confidence 9998765432 223567999999999775 788999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-30 Score=269.25 Aligned_cols=181 Identities=23% Similarity=0.372 Sum_probs=158.4
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 497 (611)
.++|.+.+.||+|+||.||++... +++.+|+|+++.. ......+.+|+++++.++||||++++++|.+.+++|+|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 467889999999999999999865 6889999998754 3455778999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCC
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~ 577 (611)
|+++|+|.+++.... .+++..+..++.+++.||.|||+ ..+|+||||||+|||+++++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 84 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999999997543 47889999999999999999996 147999999999999999999999999999866443
Q ss_pred CCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 578 SSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 578 ~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
. .....||+.|+|||+.. ..++.++|+|||
T Consensus 158 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 188 (333)
T cd06650 158 M----ANSFVGTRSYMSPERLQGTHYSVQSDIWSM 188 (333)
T ss_pred c----cccCCCCccccCHHHhcCCCCCcHHHHHHH
Confidence 2 13457999999999876 678999999996
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=261.08 Aligned_cols=184 Identities=18% Similarity=0.338 Sum_probs=156.3
Q ss_pred cCCCccceeecccCceEEEEEEec----CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~----~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 494 (611)
.++|.+.+.||+|+||.||+|.+. .+..||+|.++... .....|.+|+.++..++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356888999999999999999753 35689999998643 445678999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccccc
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~ 574 (611)
||||+++|+|.+++.... ..++|.+++.++.|++.||.|||+ .+++||||||+||||+.++.+||+|||++...
T Consensus 84 v~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 999999999999997542 358999999999999999999999 89999999999999999999999999988764
Q ss_pred CCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 575 STSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 575 ~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
..... .......+|..|+|||+.. ..++.++|||||
T Consensus 158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 194 (266)
T cd05064 158 KSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSF 194 (266)
T ss_pred cccch-hcccCCCCceeecCHHHHhhCCccchhHHHHH
Confidence 33221 1112234578899999765 889999999996
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=279.10 Aligned_cols=180 Identities=21% Similarity=0.298 Sum_probs=159.1
Q ss_pred cCCCccceeecccCceEEEEEEe-cCCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 495 (611)
.+-|..++.||+|+.|.|-+|.. .+|+.+|||++.+. ......+.+||-||+.+.|||+++||+++.+..++|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 35578889999999999999985 48999999999764 23455677899999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
.||+++|.|+++|.+++ .|+..++.+++.||+.|+.|+|. .+|+||||||+|+||+..+.+||+|||+|..-.
T Consensus 91 lEyv~gGELFdylv~kG----~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~ 163 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKG----PLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEV 163 (786)
T ss_pred EEecCCchhHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeeccc
Confidence 99999999999998765 48899999999999999999999 999999999999999999999999999997654
Q ss_pred CCCCceeecCCccCCCcccceecc-CCC-cCcceEEe
Q 007254 576 TSSSHITCTDVAGTFGYVVLILNP-IAF-LFMFNCWF 610 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~~-~~~-~~~sDiWS 610 (611)
+.. ...+-||.+.|.|||+.. +.| ..++||||
T Consensus 164 ~gk---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWS 197 (786)
T KOG0588|consen 164 PGK---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWS 197 (786)
T ss_pred CCc---cccccCCCcccCCchhhcCCCCCCCccccch
Confidence 433 234579999999999886 555 89999998
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-30 Score=261.81 Aligned_cols=188 Identities=24% Similarity=0.416 Sum_probs=160.3
Q ss_pred cCCCccceeecccCceEEEEEEec------CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 492 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 492 (611)
.++|.+.+.||+|+||.||+|... +++.||||+++... +..+.+.+|+++|+.++|+||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 356788899999999999999753 34789999997643 3467899999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhcCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCc
Q 007254 493 LLVYDFLSRGSLEENLHGNKK----------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE 562 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~~----------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~ 562 (611)
++||||+++|+|.+++..... ....+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCe
Confidence 999999999999999976431 23458899999999999999999999 89999999999999999999
Q ss_pred EEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 563 PQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 563 vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+||+|||+++...............+++.|+|||+.. ..++.++|||||
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 210 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSF 210 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHH
Confidence 9999999998764433222233456788999999875 888999999996
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=260.54 Aligned_cols=180 Identities=24% Similarity=0.296 Sum_probs=156.3
Q ss_pred CccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 424 f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
|...+.||+|+||+||++... +++.+|+|++.... .....+.+|+++|+.++|+||+.+++++...+.+|+||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 666789999999999999864 78999999997543 2345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
+++|+|.+.+..... ..+++..+..++.|++.||.|||+ .+|+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMGN--PGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 999999988865432 358999999999999999999999 899999999999999999999999999998765432
Q ss_pred CceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 579 SHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
. .....||+.|+|||+.. ..++.++|+|||
T Consensus 157 ~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~sl 187 (285)
T cd05632 157 S---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGL 187 (285)
T ss_pred c---ccCCCCCcCccChHHhcCCCCCcccchHHH
Confidence 2 23467999999999875 778999999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-30 Score=269.65 Aligned_cols=177 Identities=25% Similarity=0.382 Sum_probs=152.8
Q ss_pred cceeecccCceEEEEEEe-cCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 007254 426 AENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (611)
Q Consensus 426 ~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 501 (611)
..++||+|-||+||-|.. ++|+.||||++.+- ......+..|+.||.+++||.||.|...|++.+.+|.|||-+.|
T Consensus 568 ~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 568 ADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred hHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 368999999999999985 48999999999652 34557888999999999999999999999999999999999966
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCC---CcEEEEeeccccccCCCC
Q 007254 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD---FEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 502 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~---~~vKL~DFGlA~~~~~~~ 578 (611)
.-|+-.|...+ ..++.....++..||+.||.|||. ++|||+||||+||||.+. -++||||||+|+.+++..
T Consensus 648 DMLEMILSsEk---gRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks 721 (888)
T KOG4236|consen 648 DMLEMILSSEK---GRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS 721 (888)
T ss_pred hHHHHHHHhhc---ccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence 44444554333 458888889999999999999999 999999999999999754 369999999999998754
Q ss_pred CceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 579 SHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
...+++||+.|+|||++. +.|+..-||||.
T Consensus 722 ---FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSV 752 (888)
T KOG4236|consen 722 ---FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSV 752 (888)
T ss_pred ---hhhhhcCCccccCHHHHhhccccccccceee
Confidence 345799999999999875 999999999983
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-31 Score=262.73 Aligned_cols=182 Identities=25% Similarity=0.315 Sum_probs=161.0
Q ss_pred cCCCccceeecccCceEEEEEEe-cCCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 495 (611)
.++|..+++||+|.||+|-++.- .+|+.+|+|+|++.- +....-+.|-++|..-+||++..|--.|+..+++|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 45778889999999999999984 489999999999853 3334456788999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
|||..||.|.-+|.+.+ .|+......+-.+|+.||.|||+ ++||+||||.+|+|||.||++||+||||++..-
T Consensus 247 MeyanGGeLf~HLsrer----~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRER----VFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEccCceEeeehhhhh----cccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhcc
Confidence 99999999999997654 58888889999999999999999 999999999999999999999999999999765
Q ss_pred CCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 576 TSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.... .+.+++||+.|+|||++. ..|..++|.|-+
T Consensus 320 ~~g~--t~kTFCGTPEYLAPEVleDnDYgraVDWWG~ 354 (516)
T KOG0690|consen 320 KYGD--TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGV 354 (516)
T ss_pred cccc--eeccccCChhhcCchhhccccccceeehhhh
Confidence 4433 456799999999999987 999999999964
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=262.15 Aligned_cols=188 Identities=24% Similarity=0.418 Sum_probs=160.6
Q ss_pred cCCCccceeecccCceEEEEEEec------CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 493 (611)
..+|.+.+.||+|+||+||++... ++..+|+|.++... ...+.+.+|++++..++||||++++++|...+.++
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 357888999999999999999742 34568999987643 45678999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhcCCC---------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEE
Q 007254 494 LVYDFLSRGSLEENLHGNKK---------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 564 (611)
Q Consensus 494 lV~Ey~~~gsL~~~L~~~~~---------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vK 564 (611)
+||||+++++|.+++..... ....+++..+..++.|++.||.|||+ .+|+||||||+|||+++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEE
Confidence 99999999999999875431 22358999999999999999999999 8999999999999999999999
Q ss_pred EEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 565 LSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 565 L~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
|+|||+++...............|++.|+|||+.. ..++.++|||||
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwsl 208 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSL 208 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHH
Confidence 99999998775543333334456788999999876 778999999996
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=259.01 Aligned_cols=174 Identities=26% Similarity=0.317 Sum_probs=150.3
Q ss_pred ecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCCH
Q 007254 430 IGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504 (611)
Q Consensus 430 IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 504 (611)
||+|+||.||++... +|+.||+|.+.... .....+..|+++++.++||||+++++++....++|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999864 68999999986532 2234566799999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCceeec
Q 007254 505 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 584 (611)
Q Consensus 505 ~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~ 584 (611)
.+.+..... ..+++..+..++.|++.||.|||+ .+|+||||||+|||+++++.++|+|||++....... ...
T Consensus 81 ~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~ 152 (277)
T cd05607 81 KYHIYNVGE--RGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TIT 152 (277)
T ss_pred HHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eee
Confidence 988865432 348899999999999999999999 999999999999999999999999999998765432 223
Q ss_pred CCccCCCcccceecc-CCCcCcceEEeC
Q 007254 585 DVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 585 ~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
...||+.|+|||+.. ..++.++|||||
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 180 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAM 180 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHH
Confidence 467999999999875 679999999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=256.63 Aligned_cols=185 Identities=25% Similarity=0.419 Sum_probs=159.6
Q ss_pred cCCCccceeecccCceEEEEEEec----CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~----~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 494 (611)
.++|.+.+.||+|+||.||+|.+. +...||||.++... ....+|..|+.++..++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 357889999999999999999864 24579999987643 455788999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccccc
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~ 574 (611)
||||+++|+|.+++.... ..+++.++..++.|++.||.|||+ .+|+||||||+|||+++++.++|+|||+++..
T Consensus 83 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 83 ITEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEcCCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 999999999999997543 368999999999999999999999 89999999999999999999999999999987
Q ss_pred CCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 575 STSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 575 ~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.............+++.|+|||+.. ..++.++|||||
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~sl 194 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSF 194 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHH
Confidence 6333333333345678899999876 788999999996
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=259.48 Aligned_cols=180 Identities=26% Similarity=0.346 Sum_probs=156.1
Q ss_pred CccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 424 f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
|...+.||+|+||.||++... +++.||||.+.... .....+..|+.+++.++|+||+.+++.+.+.+.+|+||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999865 78999999986532 2345677899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
+++|+|.+.+..... ..+++.++..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 82 MNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred cCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 999999998865432 358899999999999999999999 999999999999999999999999999998765433
Q ss_pred CceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 579 SHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
. .....||+.|+|||+.. ..++.++|||||
T Consensus 157 ~---~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl 187 (285)
T cd05630 157 T---IKGRVGTVGYMAPEVVKNERYTFSPDWWAL 187 (285)
T ss_pred c---ccCCCCCccccChHHHcCCCCCCccccHHH
Confidence 2 23457999999999876 778999999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-31 Score=278.10 Aligned_cols=175 Identities=26% Similarity=0.364 Sum_probs=154.5
Q ss_pred CccceeecccCceEEEEEEe-cCCCEEEEEEecC----ChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 424 FLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 424 f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~----~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
|..++.||.|+||-||-+.. .+.+.||||.+.- +.+...+++.|+..|..++|||++.+-|+|......||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 55567899999999999985 4788999999964 345678899999999999999999999999998889999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
|- |+-.++|.-.+ .++..-++..|+.+.+.||.|||+ ++.||||||..||||++.|.|||+|||.|....+..
T Consensus 108 Cl-GSAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn 180 (948)
T KOG0577|consen 108 CL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN 180 (948)
T ss_pred Hh-ccHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCchh
Confidence 94 57777776554 358888899999999999999999 899999999999999999999999999998776543
Q ss_pred CceeecCCccCCCcccceecc----CCCcCcceEEeC
Q 007254 579 SHITCTDVAGTFGYVVLILNP----IAFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~~~~~~~GT~~Y~aPE~~~----~~~~~~sDiWSL 611 (611)
+++|||.|||||++. .+|+=++|||||
T Consensus 181 ------sFvGTPywMAPEVILAMDEGqYdgkvDvWSL 211 (948)
T KOG0577|consen 181 ------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 211 (948)
T ss_pred ------cccCCccccchhHheeccccccCCccceeec
Confidence 479999999999874 899999999997
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=260.14 Aligned_cols=190 Identities=26% Similarity=0.420 Sum_probs=160.5
Q ss_pred HhcCCCccceeecccCceEEEEEEec------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC
Q 007254 419 SATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED 489 (611)
Q Consensus 419 ~~~~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 489 (611)
...++|...+.||+|+||.||++... ....+|+|.++.. .....++.+|++++..+ +|+||++++++|...
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 34567888999999999999999853 2367999998764 24456788999999999 899999999999999
Q ss_pred CeEEEEEEcCCCCCHHHHHhcCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE
Q 007254 490 NNLLLVYDFLSRGSLEENLHGNK------------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557 (611)
Q Consensus 490 ~~~~lV~Ey~~~gsL~~~L~~~~------------~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl 557 (611)
+.++++|||+++|+|..++.... .....+++..++.++.|++.||.|||+ .+|+||||||+|||+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEE
Confidence 99999999999999999997532 223468999999999999999999999 899999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 558 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 558 ~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
++++.+||+|||+++.+.............+++.|+|||+.. ..++.++|||||
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 220 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 220 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeeh
Confidence 999999999999999876543333333345678899999765 788999999997
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=260.14 Aligned_cols=187 Identities=27% Similarity=0.451 Sum_probs=158.8
Q ss_pred CCCccceeecccCceEEEEEEecC------CCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLPD------GKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~~------g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 493 (611)
++|.+.+.||+|+||.||+|.... .+.||+|.++... .....|.+|+.++..++||||+++++++...+..|
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467888999999999999998542 2579999997543 45667899999999999999999999999989999
Q ss_pred EEEEcCCCCCHHHHHhcCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCC
Q 007254 494 LVYDFLSRGSLEENLHGNKKD------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 561 (611)
Q Consensus 494 lV~Ey~~~gsL~~~L~~~~~~------------~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~ 561 (611)
++|||+++|+|.+++...... ...+++.++..++.|++.||.|||. .+|+||||||+|||+++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCC
Confidence 999999999999999754221 1458899999999999999999999 8999999999999999999
Q ss_pred cEEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 562 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 562 ~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.+||+|||+++...............+|+.|+|||+.. ..++.++|||||
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~sl 212 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSF 212 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHH
Confidence 99999999998765433332334456789999999765 788999999996
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=279.81 Aligned_cols=179 Identities=23% Similarity=0.280 Sum_probs=154.4
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 499 (611)
...|.+.+.||+|+||.||++... +++.||||... ...+.+|+++|+.++|+||+++++++...+..||||||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 457888999999999999999865 57899999643 234568999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~ 579 (611)
. ++|..++.... ..++|.++..|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+++.......
T Consensus 243 ~-~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 243 R-SDLYTYLGARL---RPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred C-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 5 68888886432 358999999999999999999999 8999999999999999999999999999987754433
Q ss_pred ceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 580 HITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 580 ~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
........||+.|+|||+.. ..++.++|||||
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSl 348 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSA 348 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHH
Confidence 22233568999999999876 779999999996
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=258.61 Aligned_cols=187 Identities=24% Similarity=0.379 Sum_probs=157.7
Q ss_pred CCCccceeecccCceEEEEEEe-----cCCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~-----~~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 494 (611)
++|.+.+.||+|+||.||+|.+ .+++.||+|.++... .....|.+|+++++.++||||+++++++...+..|+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4678889999999999999974 256789999997533 345678899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCC
Q 007254 495 VYDFLSRGSLEENLHGNKK-------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 561 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~-------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~ 561 (611)
||||+++|+|.+++..... ....+++.+...++.|++.||.|||+ .+|+||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence 9999999999999864321 12347899999999999999999999 8999999999999999999
Q ss_pred cEEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 562 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 562 ~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.+||+|||+++...............++..|+|||+.. ..++.++|+|||
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 212 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSF 212 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHH
Confidence 99999999998765433222233455788899999875 778999999996
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=256.06 Aligned_cols=183 Identities=24% Similarity=0.399 Sum_probs=157.7
Q ss_pred CCCccceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 501 (611)
.+|.+.+.||+|+||.||++.+.++..+|+|+++........|.+|+++++.++||||+++++++...+..|+||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 35778899999999999999987777899999976554556788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCce
Q 007254 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (611)
Q Consensus 502 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~ 581 (611)
++|.+++.... ..++|..+..++.|++.||.|||+ .+|+||||||+||++++++.+||+|||+++........
T Consensus 84 ~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~- 156 (256)
T cd05059 84 GCLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT- 156 (256)
T ss_pred CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceeccccccc-
Confidence 99999997543 258999999999999999999999 89999999999999999999999999999876543221
Q ss_pred eecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 582 TCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 582 ~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......++..|+|||+.. ..++.++|||||
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~sl 187 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSF 187 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHH
Confidence 112233456899999775 788999999996
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=258.92 Aligned_cols=188 Identities=22% Similarity=0.374 Sum_probs=161.0
Q ss_pred cCCCccceeecccCceEEEEEEecC-----------------CCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeee
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLPD-----------------GKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIIS 481 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~~-----------------g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~ 481 (611)
.++|.+.+.||+|+||.||++.... +..||+|.+.... ...+.+.+|++++..++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578889999999999999987532 2468999997653 45678899999999999999999
Q ss_pred EEEEEEeCCeEEEEEEcCCCCCHHHHHhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCC
Q 007254 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK-------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSN 554 (611)
Q Consensus 482 l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~-------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~N 554 (611)
++++|...+.+++||||+++++|.+++..... ....+++..++.++.|++.||.|||+ .+|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhc
Confidence 99999999999999999999999999976542 12358999999999999999999999 899999999999
Q ss_pred EEEcCCCcEEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 555 ILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 555 ILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
|+++.++.++|+|||+++...............+|+.|+|||+.. ..++.++|||||
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 218 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAF 218 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhh
Confidence 999999999999999998765543333334566788999999876 689999999997
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=260.38 Aligned_cols=173 Identities=19% Similarity=0.320 Sum_probs=150.4
Q ss_pred ceeecccCceEEEEEEecCCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEe----CCeEEEEEEc
Q 007254 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFE----DNNLLLVYDF 498 (611)
Q Consensus 427 ~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~lV~Ey 498 (611)
...||+|++|.||+|.+ +|+.||||.++... ...+.|.+|+.+|..++||||+++++++.+ ..++++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36799999999999998 78999999997643 235778899999999999999999999977 4578999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
+++|+|.+++.... .++|.....++.+++.||.|||+. .+++||||||+|||+++++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 104 CTRGYLREVLDKEK----DLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177 (283)
T ss_pred CCCCcHHHHHhhCC----CCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence 99999999997643 488999999999999999999971 378899999999999999999999999998765432
Q ss_pred CceeecCCccCCCcccceecc---CCCcCcceEEeC
Q 007254 579 SHITCTDVAGTFGYVVLILNP---IAFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~~~~~~~GT~~Y~aPE~~~---~~~~~~sDiWSL 611 (611)
....||..|+|||+.. ..++.++|||||
T Consensus 178 -----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~Sl 208 (283)
T PHA02988 178 -----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSL 208 (283)
T ss_pred -----ccccCcccccCHHHhhhccccccchhhhhHH
Confidence 2357899999999875 588999999997
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=259.05 Aligned_cols=193 Identities=25% Similarity=0.379 Sum_probs=162.1
Q ss_pred hHHHHHhcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCCCeeeEEEEEE----
Q 007254 414 YQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCF---- 487 (611)
Q Consensus 414 ~~~l~~~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~---- 487 (611)
++.+..+.++|.+.+.||+|+||.||++... +++.+|+|+++........+..|+.+++.+ +||||++++++|.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 3445567889999999999999999999864 688999999876555556788899999999 6999999999984
Q ss_pred -eCCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEE
Q 007254 488 -EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 566 (611)
Q Consensus 488 -~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~ 566 (611)
..+.+++||||+++|+|.+++.........+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEEEc
Confidence 3457899999999999999886433333468899999999999999999999 899999999999999999999999
Q ss_pred eeccccccCCCCCceeecCCccCCCcccceecc------CCCcCcceEEeC
Q 007254 567 DFGLAKWASTSSSHITCTDVAGTFGYVVLILNP------IAFLFMFNCWFF 611 (611)
Q Consensus 567 DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~------~~~~~~sDiWSL 611 (611)
|||+++....... ......||+.|+|||+.. ..++.++|||||
T Consensus 167 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~sl 215 (286)
T cd06638 167 DFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSL 215 (286)
T ss_pred cCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhH
Confidence 9999987654321 223457999999999753 457899999996
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=268.65 Aligned_cols=187 Identities=24% Similarity=0.408 Sum_probs=156.8
Q ss_pred CCCccceeecccCceEEEEEEec------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC-Ce
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED-NN 491 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~-~~ 491 (611)
++|.+.+.||+|+||.||+|... +++.||+|+++.. ....+.+..|++++..+ +|+||++++++|... ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 46888999999999999999632 3578999999753 23456788999999999 899999999988754 57
Q ss_pred EEEEEEcCCCCCHHHHHhcCCCC---------------------------------------------------------
Q 007254 492 LLLVYDFLSRGSLEENLHGNKKD--------------------------------------------------------- 514 (611)
Q Consensus 492 ~~lV~Ey~~~gsL~~~L~~~~~~--------------------------------------------------------- 514 (611)
++++|||+++|+|.+.+......
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 89999999999999988643211
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCceeecCCccCCCccc
Q 007254 515 PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVV 594 (611)
Q Consensus 515 ~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~a 594 (611)
...++|..+..++.||+.||.|||+ .+|+||||||+||||++++.+||+|||+++.+.............+++.|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 1258999999999999999999999 8999999999999999999999999999998755443333345567889999
Q ss_pred ceecc-CCCcCcceEEeC
Q 007254 595 LILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 595 PE~~~-~~~~~~sDiWSL 611 (611)
||+.. ..++.++|||||
T Consensus 244 PE~~~~~~~~~~~Di~Sl 261 (337)
T cd05054 244 PESIFDKVYTTQSDVWSF 261 (337)
T ss_pred cHHhcCCCCCccccHHHH
Confidence 99775 889999999996
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=255.90 Aligned_cols=183 Identities=23% Similarity=0.377 Sum_probs=158.8
Q ss_pred CCCccceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 501 (611)
++|.+.+.||+|+||.||++...++..+|||.++........|.+|+.++..++||||++++++|.+.+.+++||||+.+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 45778899999999999999887777899999987655557899999999999999999999999988899999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCce
Q 007254 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (611)
Q Consensus 502 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~ 581 (611)
|+|.+++.... ..++|..++.++.|++.||.|||+ .+|+|+||||+|||++.++.+||+|||+++....... .
T Consensus 84 ~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~ 156 (256)
T cd05113 84 GCLLNYLREHG---KRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-T 156 (256)
T ss_pred CcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCce-e
Confidence 99999987543 258999999999999999999999 8999999999999999999999999999987654322 1
Q ss_pred eecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 582 TCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 582 ~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......++..|++||+.. ..++.++|||||
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~sl 187 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAF 187 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHH
Confidence 222345678899999876 778999999996
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=277.96 Aligned_cols=181 Identities=22% Similarity=0.319 Sum_probs=149.2
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--------Ce
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED--------NN 491 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--------~~ 491 (611)
..+|.+.+.||+|+||.||+|... +++.||||++..... ...+|+.+|+.++||||+++++++... ..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ---YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 467999999999999999999864 788999998865432 234699999999999999999987532 25
Q ss_pred EEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCC-cEEEEeecc
Q 007254 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGL 570 (611)
Q Consensus 492 ~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~-~vKL~DFGl 570 (611)
+++||||+++ +|.+.+.........+++..+..++.||+.||.|||+ .+||||||||+||||+.++ .+||+|||+
T Consensus 142 l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 142 LNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred EEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeecccc
Confidence 7899999975 7777765433334568999999999999999999999 8999999999999999664 799999999
Q ss_pred ccccCCCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 571 AKWASTSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 571 A~~~~~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
|+.+..... .....||+.|+|||+.. ..|+.++|||||
T Consensus 218 a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSl 257 (440)
T PTZ00036 218 AKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSL 257 (440)
T ss_pred chhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHH
Confidence 987754332 23467899999999764 578999999996
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-30 Score=280.46 Aligned_cols=181 Identities=29% Similarity=0.423 Sum_probs=156.5
Q ss_pred CccceeecccCceEEEEEE-ecCCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC------eEEE
Q 007254 424 FLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN------NLLL 494 (611)
Q Consensus 424 f~~~~~IG~G~fG~Vyk~~-~~~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------~~~l 494 (611)
|...+.||+||||.||+|+ ..+|+.||||.+++.. ...+...+|+++|++|+|+|||+++++-.+.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 3445789999999999999 4589999999998742 34567889999999999999999999865433 4689
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEc--CCCc--EEEEeecc
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS--DDFE--PQLSDFGL 570 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~--~~~~--vKL~DFGl 570 (611)
|||||.||||...|.+-. +-..++..+...+...++.||.|||. .+||||||||.||++- .+|. -||+|||.
T Consensus 95 vmEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 999999999999997653 34569999999999999999999998 8999999999999984 3343 59999999
Q ss_pred ccccCCCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 571 AKWASTSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 571 A~~~~~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
||.++++. .+++++||..|++||+.. ..|+..+|.|||
T Consensus 171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~ 210 (732)
T KOG4250|consen 171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSF 210 (732)
T ss_pred cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhh
Confidence 99999876 567899999999999776 789999999997
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=290.17 Aligned_cols=187 Identities=22% Similarity=0.301 Sum_probs=158.5
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
++|.+.+.||+|+||.||+|... +|+.||||+++.. ....++|.+|+++++.++||||+++++++.+.+..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999865 6899999999753 234578999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeec
Q 007254 497 DFLSRGSLEENLHGNKK-------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~-------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFG 569 (611)
||++||+|.+++..... ....+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998864211 12346788889999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCC----------------ceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 570 LAKWASTSSS----------------HITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 570 lA~~~~~~~~----------------~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+|+....... .......+||+.|+|||+.. ..++.++|||||
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSL 217 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYAL 217 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHH
Confidence 9987621110 01112367999999999875 778999999996
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=260.51 Aligned_cols=187 Identities=22% Similarity=0.389 Sum_probs=157.0
Q ss_pred CCCccceeecccCceEEEEEEecC-------------C--CEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLPD-------------G--KELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLG 484 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~~-------------g--~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~ 484 (611)
++|.+.+.||+|+||.||++.... + ..||+|.++.. ......|.+|+++++.++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578889999999999999987532 2 25899999764 344567999999999999999999999
Q ss_pred EEEeCCeEEEEEEcCCCCCHHHHHhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEE
Q 007254 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKK--------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 556 (611)
Q Consensus 485 ~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~--------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NIL 556 (611)
++...+..++||||+++++|.+++..... ....++|..+..++.|++.||.|||+ .+++||||||+|||
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEE
Confidence 99999999999999999999999864321 11347899999999999999999999 89999999999999
Q ss_pred EcCCCcEEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 557 LSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 557 l~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+++++.+||+|||++................+++.|+|||+.. ..++.++|||||
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSl 217 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAF 217 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHH
Confidence 9999999999999998765443322333455678999999765 778999999997
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=256.53 Aligned_cols=188 Identities=18% Similarity=0.326 Sum_probs=159.5
Q ss_pred cCCCccceeecccCceEEEEEEec------CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 492 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 492 (611)
.++|.+.+.||+|+||.||+|... ++..||+|.+.... .....+.+|+.++..++||||+++++++...+..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 457888999999999999999864 24689999987653 3456788999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhcCCCC------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEE
Q 007254 493 LLVYDFLSRGSLEENLHGNKKD------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 566 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~~~------~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~ 566 (611)
|+||||+++|+|.+++...... ...++|..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEEC
Confidence 9999999999999999754321 2347899999999999999999999 899999999999999999999999
Q ss_pred eeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 567 DFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 567 DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
|||+++.+.............+|..|+|||+.. ..++.++|||||
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 207 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSF 207 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHH
Confidence 999998765543222223456788999999775 778999999997
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=271.43 Aligned_cols=182 Identities=25% Similarity=0.381 Sum_probs=160.9
Q ss_pred hcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 495 (611)
.+..|.+...||+|.|++|.++... ++..||||++.++. ..+..+.+|+++|+.|+|||||+|+.+......+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 4567889999999999999999854 79999999998753 3445589999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
|||+.+|.++++|.++.. +...++..++.|+..|++|||. +.|||||||++||||+.+.++||+||||+..+.
T Consensus 134 ~eya~~ge~~~yl~~~gr----~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGR----MKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEeccCchhHHHHHhccc----chhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeec
Confidence 999999999999987764 4447788899999999999999 999999999999999999999999999999887
Q ss_pred CCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 576 TSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
... ...+.+|++.|.|||+.. ....+.+|+|||
T Consensus 207 ~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wsl 241 (596)
T KOG0586|consen 207 YGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSL 241 (596)
T ss_pred ccc---cccccCCCCCccChHhhcCcccCCcceehhhh
Confidence 433 345689999999999775 555899999997
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-30 Score=273.20 Aligned_cols=187 Identities=24% Similarity=0.411 Sum_probs=163.7
Q ss_pred hcCCCccceeecccCceEEEEEEecCCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 497 (611)
..+...+.+.||+|-||.|.+|....+..||||.++... ...++|..||.+|.+|+||||+.|+|+|..++.+++|+|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 345567789999999999999999778999999999865 567899999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCC
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~ 577 (611)
||++|+|.++|..+...+ +.......|+.||+.||.||.+ .++|||||.++|+|++.++++||+|||+++-+-..
T Consensus 616 YmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccC
Confidence 999999999998764322 4455667799999999999999 89999999999999999999999999999966555
Q ss_pred CCceeecCCccCCCcccceec-cCCCcCcceEEeC
Q 007254 578 SSHITCTDVAGTFGYVVLILN-PIAFLFMFNCWFF 611 (611)
Q Consensus 578 ~~~~~~~~~~GT~~Y~aPE~~-~~~~~~~sDiWSL 611 (611)
..+......+-...|||||-+ ..+++.+||+|+|
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWaf 725 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAF 725 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccccchhhhhhh
Confidence 555444456667889999965 5999999999986
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=255.32 Aligned_cols=184 Identities=22% Similarity=0.420 Sum_probs=159.6
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 500 (611)
.+|.+.+.||+|+||.||+|.+. +++.||+|+++.+.....++.+|+++++.++||||++++++|...+.+++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 45778899999999999999865 68899999998776667789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCc
Q 007254 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (611)
Q Consensus 501 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~ 580 (611)
+++|.+++..... ..+++..+..++.|++.||.|||+ .+++||||||+|||+++++.+||+|||++.........
T Consensus 86 ~~~L~~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 86 YGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999975432 458999999999999999999999 89999999999999999999999999999877543221
Q ss_pred eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 581 ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 581 ~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......++..|+|||+.. ..++.++|||||
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 191 (263)
T cd05052 161 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAF 191 (263)
T ss_pred -ccCCCCCccccCCHHHhccCCCCchhHHHHH
Confidence 112234567899999775 888999999996
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=267.13 Aligned_cols=179 Identities=26% Similarity=0.322 Sum_probs=152.3
Q ss_pred hcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-----
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN----- 490 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----- 490 (611)
..++|.+.+.||+|+||.||++... +|+.||||+++.. ......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3578999999999999999999864 6899999999753 344667889999999999999999999986543
Q ss_pred -eEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeec
Q 007254 491 -NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569 (611)
Q Consensus 491 -~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFG 569 (611)
.+|+||||+.+ +|...+.. .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCC
Confidence 57999999965 66666642 37788999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 570 LAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 570 lA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+++...... ......||+.|+|||+.. ..++.++|||||
T Consensus 169 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl 208 (359)
T cd07876 169 LARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSV 208 (359)
T ss_pred CccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHH
Confidence 998654322 223468999999999876 789999999996
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=270.45 Aligned_cols=180 Identities=21% Similarity=0.315 Sum_probs=154.0
Q ss_pred CCccceeecccCceEEEEEEe-cCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-----eEE
Q 007254 423 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN-----NLL 493 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~~ 493 (611)
+|.+.+.||+|+||.||++.. .+|+.||||++... ....+++.+|+++++.++||||+++++++...+ .+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999986 47899999998753 234577899999999999999999999998766 799
Q ss_pred EEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccc
Q 007254 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (611)
Q Consensus 494 lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~ 573 (611)
+||||+. ++|.+.+... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+|+.
T Consensus 81 lv~e~~~-~~l~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP----QPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999996 5888877543 358999999999999999999999 8999999999999999999999999999987
Q ss_pred cCCCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 574 ASTSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
....... ......||+.|+|||+.. ..++.++|||||
T Consensus 153 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl 191 (372)
T cd07853 153 EEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSV 191 (372)
T ss_pred cccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhH
Confidence 6543221 234467899999999875 558999999996
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-31 Score=263.28 Aligned_cols=179 Identities=26% Similarity=0.395 Sum_probs=160.7
Q ss_pred CccceeecccCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCC
Q 007254 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 502 (611)
Q Consensus 424 f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 502 (611)
|.+...||+|+||.||++..+ .|+.+|||.+..+. .+.+++.||.||.....|++|++||.|+....+++|||||-.|
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG 113 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG 113 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence 456788999999999999865 79999999887544 4688999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCcee
Q 007254 503 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 582 (611)
Q Consensus 503 sL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~ 582 (611)
++.+.++-++ ..++..++..|+...+.||+|||. ..-||||||..||||+.+|.+||+|||.|..+.+.- ..
T Consensus 114 SiSDI~R~R~---K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--AK 185 (502)
T KOG0574|consen 114 SISDIMRARR---KPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--AK 185 (502)
T ss_pred cHHHHHHHhc---CCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhH--Hh
Confidence 9999987543 469999999999999999999998 788999999999999999999999999998876532 24
Q ss_pred ecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 583 CTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 583 ~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
..++.||+.|||||++. ..|+..+|||||
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSL 215 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSL 215 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhh
Confidence 45789999999999887 999999999997
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=272.86 Aligned_cols=179 Identities=22% Similarity=0.286 Sum_probs=155.1
Q ss_pred cCCCccceeecccCceEEEEEEec---CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP---DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~---~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 497 (611)
..+|.+.+.||+|+||.||++... +++.||+|.+.... .+.+|+++|+.++||||+++++++...+.+|+|||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~----~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK----TPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc----cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 346889999999999999999753 46789999887543 34579999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCC
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~ 577 (611)
|+. ++|.+++... ..++|.++..++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+++.....
T Consensus 167 ~~~-~~l~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 167 KYK-CDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hcC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 995 6888888433 358999999999999999999999 89999999999999999999999999999877654
Q ss_pred CCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 578 SSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 578 ~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
..........||+.|+|||+.. ..|+.++|||||
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 273 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSA 273 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHH
Confidence 4433444578999999999876 789999999996
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=262.00 Aligned_cols=181 Identities=23% Similarity=0.386 Sum_probs=154.7
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
++|.+.+.||+|+||.||+|... +++.||+|.++... .....+.+|+++++.++||||+++++++...+..|+||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57888999999999999999865 68899999987542 3345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
+++ +|.+.+.... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDDCG---NIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 975 8888876543 357889999999999999999999 899999999999999999999999999998654332
Q ss_pred CceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 579 SHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
. ......||+.|+|||+.. ..++.++|||||
T Consensus 159 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl 191 (309)
T cd07872 159 K--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGV 191 (309)
T ss_pred c--ccccccccccccCCHHHhCCCCCCcHHHHHHH
Confidence 2 223457899999999764 568999999996
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=252.08 Aligned_cols=178 Identities=24% Similarity=0.383 Sum_probs=150.8
Q ss_pred eeecccCceEEEEEEec-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCCH
Q 007254 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504 (611)
Q Consensus 428 ~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 504 (611)
+.||+|+||.||+|.+. +++.+|+|.+... .+....+.+|+++++.++||||++++++|...+..|+||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36899999999999864 7899999988653 34567899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCceeec
Q 007254 505 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 584 (611)
Q Consensus 505 ~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~ 584 (611)
.+++.... ..++|.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++.............
T Consensus 81 ~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRTEG---PRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 99986542 358899999999999999999999 899999999999999999999999999998655322111111
Q ss_pred CCccCCCcccceecc-CCCcCcceEEeC
Q 007254 585 DVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 585 ~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
...++..|+|||+.. ..++.++|||||
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 182 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSF 182 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHH
Confidence 223456799999875 778999999996
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=254.14 Aligned_cols=185 Identities=28% Similarity=0.439 Sum_probs=160.1
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecC----ChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~----~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
++|.+.+.||+|+||.||+|... +++.||||.++. .......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57889999999999999999854 789999998864 2344567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
||+++|+|.+++.........+++..+..++.|++.||.|||+ .+|+|+||||+|||++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998886543333468899999999999999999999 8999999999999999999999999999987764
Q ss_pred CCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 577 SSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
... ......|++.|+|||+.. ..++.++|+|||
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~sl 192 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSL 192 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHH
Confidence 332 122457899999999875 778999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=260.43 Aligned_cols=188 Identities=27% Similarity=0.431 Sum_probs=158.8
Q ss_pred cCCCccceeecccCceEEEEEEec--------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP--------DGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED 489 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~--------~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 489 (611)
.++|.+.+.||+|+||.||++... ++..||+|.++.. .....++.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 456788899999999999999631 3457999998753 34567889999999999 899999999999999
Q ss_pred CeEEEEEEcCCCCCHHHHHhcCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE
Q 007254 490 NNLLLVYDFLSRGSLEENLHGNKKD------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557 (611)
Q Consensus 490 ~~~~lV~Ey~~~gsL~~~L~~~~~~------------~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl 557 (611)
+..|+||||+++|+|.+++...... ...++|.++..++.||+.||.|||+ .+|+||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEEE
Confidence 9999999999999999999764321 2358899999999999999999999 899999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 558 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 558 ~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+.++.+||+|||+++...............++..|+|||+.. ..++.++|||||
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 225 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 225 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHH
Confidence 999999999999999876544333333445678899999775 778999999996
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=258.25 Aligned_cols=189 Identities=20% Similarity=0.333 Sum_probs=157.6
Q ss_pred hcCCCccceeecccCceEEEEEEec------CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCe
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 491 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 491 (611)
..++|.+.+.||+|+||.||+|..+ .+..||+|.++... .....+.+|+.+++.++||||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4568899999999999999999743 24579999987543 334568889999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhcCCCC------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEE
Q 007254 492 LLLVYDFLSRGSLEENLHGNKKD------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQL 565 (611)
Q Consensus 492 ~~lV~Ey~~~gsL~~~L~~~~~~------~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL 565 (611)
.|+||||+++|+|.+++...... ...+.+..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEE
Confidence 99999999999999999753221 2346788889999999999999999 89999999999999999999999
Q ss_pred EeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 566 SDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 566 ~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+|||+++...............+++.|+|||+.. ..++.++|+|||
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dvwsl 207 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSF 207 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHH
Confidence 9999998765433322223345678899999875 778999999996
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=271.50 Aligned_cols=188 Identities=24% Similarity=0.416 Sum_probs=157.6
Q ss_pred cCCCccceeecccCceEEEEEEec------CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCe
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNN 491 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~ 491 (611)
.++|.+.+.||+|+||.||+|.+. .++.||||+++... .....+..|+.+|..+. ||||++++++|...+.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 345777899999999999999853 34689999998642 33457889999999997 9999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhcCCC----------------------------------------------------------
Q 007254 492 LLLVYDFLSRGSLEENLHGNKK---------------------------------------------------------- 513 (611)
Q Consensus 492 ~~lV~Ey~~~gsL~~~L~~~~~---------------------------------------------------------- 513 (611)
+++||||+++|+|.++++..+.
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 9999999999999999975421
Q ss_pred ------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE
Q 007254 514 ------------------------------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557 (611)
Q Consensus 514 ------------------------------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl 557 (611)
....++|..+..++.|++.||.|||+ .+|+||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEEE
Confidence 11357888999999999999999998 899999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 558 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 558 ~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
++++.+||+|||+++...............|+..|+|||+.. ..++.++|||||
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 327 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSF 327 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHH
Confidence 999999999999998764433222223456788999999775 778999999996
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=254.79 Aligned_cols=184 Identities=21% Similarity=0.397 Sum_probs=157.6
Q ss_pred cCCCccceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 500 (611)
.++|.+.+.||+|+||.||+|.+.++..||+|+++......+.|.+|+++++.++||||+++++++. .+..|+||||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 3568899999999999999998776678999999876555578899999999999999999999875 456899999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCc
Q 007254 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (611)
Q Consensus 501 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~ 580 (611)
+|+|.+++.... ...++|..+..++.|++.||.|||+ .+|+||||||+||++++++.+||+|||+++........
T Consensus 84 ~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 84 KGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999999997542 2357899999999999999999999 89999999999999999999999999999876543321
Q ss_pred eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 581 ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 581 ~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......++..|++||+.. ..++.++|||||
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dvwsl 189 (262)
T cd05071 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 189 (262)
T ss_pred -cccCCcccceecCHhHhccCCCCchhhHHHH
Confidence 122345778899999875 778999999996
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=253.76 Aligned_cols=181 Identities=25% Similarity=0.312 Sum_probs=150.4
Q ss_pred eeecccCceEEEEEEec---CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCC
Q 007254 428 NLIGKGGSSQVYKGCLP---DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 502 (611)
Q Consensus 428 ~~IG~G~fG~Vyk~~~~---~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 502 (611)
+.||+|+||.||+|.+. ++..+|+|.++... .....+.+|+.+++.++||||+++++++.+...+++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 35899999999999854 34579999987653 34457889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCce
Q 007254 503 SLEENLHGNKK-DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (611)
Q Consensus 503 sL~~~L~~~~~-~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~ 581 (611)
+|.+++..... ....+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999975432 22356788888999999999999999 899999999999999999999999999998655433322
Q ss_pred eecCCccCCCcccceeccC--------CCcCcceEEeC
Q 007254 582 TCTDVAGTFGYVVLILNPI--------AFLFMFNCWFF 611 (611)
Q Consensus 582 ~~~~~~GT~~Y~aPE~~~~--------~~~~~sDiWSL 611 (611)
......|+..|+|||+... .++.++|||||
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diwsl 195 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSL 195 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHH
Confidence 3334568899999997641 35889999996
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-29 Score=251.43 Aligned_cols=185 Identities=28% Similarity=0.431 Sum_probs=161.9
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
++|.+.+.||+|+||.||+|... +|+.||+|.++.. ......+.+|+++++.++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 67899999999999999999976 8999999988642 234678899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
||+++|+|..++.........+++.++..++.+++.||.|||+ .+|+||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999987644444568999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 577 SSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.... .....|++.|+|||+.. ..++.++|||||
T Consensus 159 ~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~sl 192 (267)
T cd08224 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSL 192 (267)
T ss_pred CCcc--cceecCCccccCHHHhccCCCCchhcHHHH
Confidence 3322 22357899999999765 778999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=253.17 Aligned_cols=183 Identities=24% Similarity=0.405 Sum_probs=157.3
Q ss_pred CCCccceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 501 (611)
++|.+.+.||+|+||.||+|...++..+|+|.++........+.+|+.+++.++|+||+++++++. .+..|+||||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~ 84 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSK 84 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCC
Confidence 467888999999999999999888889999999876555677999999999999999999999885 4568999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCce
Q 007254 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (611)
Q Consensus 502 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~ 581 (611)
++|.+++..... ..+++..+..++.+++.||.|||+ .+|+||||||+||++++++.++|+|||++.........
T Consensus 85 ~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05070 85 GSLLDFLKDGEG--RALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc-
Confidence 999999975432 358999999999999999999999 89999999999999999999999999999876543321
Q ss_pred eecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 582 TCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 582 ~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......++..|+|||+.. ..++.++|||||
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 189 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 189 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHH
Confidence 112234677899999875 778999999996
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=252.29 Aligned_cols=184 Identities=20% Similarity=0.364 Sum_probs=159.3
Q ss_pred cCCCccceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 500 (611)
.++|.+.+.||+|+||.||+|...+++.||+|.+.........+.+|+.+++.++|+||+++++++ ..+..++||||+.
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~~ 83 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYME 83 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcCC
Confidence 356888999999999999999988899999999987665567899999999999999999999987 4567899999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCc
Q 007254 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (611)
Q Consensus 501 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~ 580 (611)
+|+|.+++..... ..+++.++..++.|++.||.|||+ .+++||||||+||++++++.++|+|||++.........
T Consensus 84 ~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 84 NGSLVDFLKTPEG--IKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 9999999875432 458999999999999999999999 89999999999999999999999999999877643221
Q ss_pred eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 581 ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 581 ~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......+++.|+|||+.. ..++.++|||||
T Consensus 159 -~~~~~~~~~~y~~pe~~~~~~~~~~~Di~sl 189 (260)
T cd05067 159 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSF 189 (260)
T ss_pred -cccCCcccccccCHHHhccCCcCcccchHHH
Confidence 122345678899999875 778999999996
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=256.81 Aligned_cols=183 Identities=22% Similarity=0.381 Sum_probs=154.8
Q ss_pred CCCccceeecccCceEEEEEEec-CCC----EEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGK----ELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~----~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 494 (611)
++|.+.+.||+|+||.||+|.+. +++ .+++|.+.... ....++..|+.++..++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 46778899999999999999864 454 47788775432 34567888899999999999999999885 456789
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccccc
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~ 574 (611)
++||+++|+|.+++.... ..++|..+..++.||+.||.|||+ .+++||||||+|||++.++.+||+|||+++.+
T Consensus 86 i~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR---DSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 999999999999997543 358999999999999999999999 89999999999999999999999999999987
Q ss_pred CCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 575 STSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 575 ~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.............|++.|++||+.. ..++.++|||||
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~sl 197 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSY 197 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHH
Confidence 6544434445567889999999875 779999999996
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-29 Score=252.17 Aligned_cols=185 Identities=24% Similarity=0.419 Sum_probs=154.6
Q ss_pred CccceeecccCceEEEEEEec-C---CCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCe-----
Q 007254 424 FLAENLIGKGGSSQVYKGCLP-D---GKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN----- 491 (611)
Q Consensus 424 f~~~~~IG~G~fG~Vyk~~~~-~---g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~----- 491 (611)
|.+.+.||+|+||.||+|.+. + +..||+|.++.. ......+.+|+++++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567789999999999999864 2 367999999754 2345688999999999999999999999876554
Q ss_pred -EEEEEEcCCCCCHHHHHhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEee
Q 007254 492 -LLLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568 (611)
Q Consensus 492 -~~lV~Ey~~~gsL~~~L~~~~--~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DF 568 (611)
.++||||+++|+|..++.... .....+++..+..++.|++.||.|||+ .+|+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence 799999999999999885432 223468999999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 569 GLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 569 GlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
|+++...............+++.|+|||+.. ..++.++|||||
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~Sl 201 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAF 201 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHH
Confidence 9998776544332222345678899999876 778999999997
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=257.57 Aligned_cols=187 Identities=21% Similarity=0.365 Sum_probs=157.0
Q ss_pred CCCccceeecccCceEEEEEEec-----------------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-----------------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISL 482 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-----------------~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l 482 (611)
++|.+.+.||+|+||.||++... ++..+|+|+++.. .....+|.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56888999999999999998532 2346899999764 3456789999999999999999999
Q ss_pred EEEEEeCCeEEEEEEcCCCCCHHHHHhcCCCC-------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCE
Q 007254 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD-------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNI 555 (611)
Q Consensus 483 ~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~-------~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NI 555 (611)
++++...+..++||||+++|+|.+++...... ...+++.++..++.|++.||.|||+ .+|+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheE
Confidence 99999999999999999999999998764321 1347889999999999999999999 8999999999999
Q ss_pred EEcCCCcEEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 556 LLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 556 Ll~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
||+.++.++|+|||+++.+.............+++.|++||+.. ..++.++|||||
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSl 218 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAF 218 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHH
Confidence 99999999999999998765433322223345578899999754 789999999997
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=254.42 Aligned_cols=180 Identities=27% Similarity=0.314 Sum_probs=148.1
Q ss_pred eecccCceEEEEEEecC---CCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCC
Q 007254 429 LIGKGGSSQVYKGCLPD---GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGS 503 (611)
Q Consensus 429 ~IG~G~fG~Vyk~~~~~---g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 503 (611)
.||+|+||.||+|...+ ...+|+|.+... ......|.+|+.+++.++||||+++++.|.+.+.+|+||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 346888887643 2445678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCcee
Q 007254 504 LEENLHGNKKD-PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 582 (611)
Q Consensus 504 L~~~L~~~~~~-~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~ 582 (611)
|.+++...... ...+++.....++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999765422 2335688889999999999999999 8999999999999999999999999999976543322222
Q ss_pred ecCCccCCCcccceecc--------CCCcCcceEEeC
Q 007254 583 CTDVAGTFGYVVLILNP--------IAFLFMFNCWFF 611 (611)
Q Consensus 583 ~~~~~GT~~Y~aPE~~~--------~~~~~~sDiWSL 611 (611)
.....+++.|+|||+.. ..++.++|||||
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diwsl 195 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSL 195 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHH
Confidence 23456778899999742 467889999996
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=256.96 Aligned_cols=187 Identities=23% Similarity=0.405 Sum_probs=159.8
Q ss_pred CCCccceeecccCceEEEEEEec------CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 494 (611)
.+|.+.+.||+|+||.||+|... ++..+++|.++... ...+.+.+|+++++.++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46788899999999999999742 35679999987654 445778999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCc
Q 007254 495 VYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE 562 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~ 562 (611)
||||+++++|.+++..... ....++|..+..++.|++.||.|||. ++|+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCc
Confidence 9999999999999975432 12358999999999999999999999 89999999999999999999
Q ss_pred EEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 563 PQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 563 vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
++|+|||+++...............|++.|+|||+.. ..++.++|||||
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 211 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSF 211 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHH
Confidence 9999999998765543333334566789999999776 788999999996
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=266.53 Aligned_cols=177 Identities=20% Similarity=0.306 Sum_probs=152.3
Q ss_pred hcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
...+|.+.+.||+|+||.||+|... +++.||+|+..... ...|+.+++.++||||+++++++...+..|+||||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~-----~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT-----TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc-----cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 3457999999999999999999865 57889999865432 34689999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
+. |+|.+++.... ..++|.++..++.||+.||.|||. .+||||||||+|||++.++.+||+|||+++......
T Consensus 139 ~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 139 YS-SDLYTYLTKRS---RPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred cC-CcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 95 58888886432 358999999999999999999999 899999999999999999999999999998644322
Q ss_pred CceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 579 SHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......||+.|+|||+.. ..|+.++|||||
T Consensus 212 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 242 (357)
T PHA03209 212 ---AFLGLAGTVETNAPEVLARDKYNSKADIWSA 242 (357)
T ss_pred ---ccccccccccccCCeecCCCCCCchhhHHHH
Confidence 123467999999999876 789999999996
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-30 Score=272.08 Aligned_cols=170 Identities=29% Similarity=0.447 Sum_probs=149.5
Q ss_pred ccceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCCH
Q 007254 425 LAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504 (611)
Q Consensus 425 ~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 504 (611)
..++-||.|+.|.||+|.+ .++.||||+++.-. ..+|.-|++|+||||+.+.|+|...-.+|||||||..|-|
T Consensus 127 sELeWlGSGaQGAVF~Grl-~netVAVKKV~elk------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhhccCcccceeeeec-cCceehhHHHhhhh------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 3457799999999999999 56889999776322 1478889999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCceeec
Q 007254 505 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 584 (611)
Q Consensus 505 ~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~ 584 (611)
.+.|.... .+.-.....+..+||.||.|||. +.|||||||.-||||+.+..+||+|||.++...+..+ .-
T Consensus 200 ~~VLka~~----~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST---kM 269 (904)
T KOG4721|consen 200 YEVLKAGR----PITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKST---KM 269 (904)
T ss_pred HHHHhccC----ccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhhhh---hh
Confidence 99997654 35666777889999999999999 8899999999999999999999999999998887654 33
Q ss_pred CCccCCCcccceecc-CCCcCcceEEeC
Q 007254 585 DVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 585 ~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.++||..|||||++- +.-++++|||||
T Consensus 270 SFaGTVaWMAPEvIrnePcsEKVDIwSf 297 (904)
T KOG4721|consen 270 SFAGTVAWMAPEVIRNEPCSEKVDIWSF 297 (904)
T ss_pred hhhhhHhhhCHHHhhcCCcccccceehh
Confidence 589999999999986 778999999997
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=265.41 Aligned_cols=188 Identities=24% Similarity=0.415 Sum_probs=155.8
Q ss_pred cCCCccceeecccCceEEEEEEe------cCCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC-C
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED-N 490 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~------~~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~-~ 490 (611)
.++|.+.+.||+|+||.||+|.. .+++.||||+++.. ......+.+|+.++..+ +||||++++++|... +
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35788999999999999999973 35789999999764 24456788999999999 689999999988654 5
Q ss_pred eEEEEEEcCCCCCHHHHHhcCCCC--------------------------------------------------------
Q 007254 491 NLLLVYDFLSRGSLEENLHGNKKD-------------------------------------------------------- 514 (611)
Q Consensus 491 ~~~lV~Ey~~~gsL~~~L~~~~~~-------------------------------------------------------- 514 (611)
.+++||||+++|+|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 689999999999999998653210
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCceeecCCc
Q 007254 515 -------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 587 (611)
Q Consensus 515 -------~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 587 (611)
...++|..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++...............
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 1247899999999999999999999 899999999999999999999999999998765433322333455
Q ss_pred cCCCcccceecc-CCCcCcceEEeC
Q 007254 588 GTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 588 GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+++.|+|||+.. ..++.++|||||
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~sl 267 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSF 267 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHH
Confidence 678899999765 788999999996
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=252.92 Aligned_cols=185 Identities=22% Similarity=0.382 Sum_probs=151.9
Q ss_pred CccceeecccCceEEEEEEecC-CC--EEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC------Ce
Q 007254 424 FLAENLIGKGGSSQVYKGCLPD-GK--ELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED------NN 491 (611)
Q Consensus 424 f~~~~~IG~G~fG~Vyk~~~~~-g~--~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~~ 491 (611)
|.+.+.||+|+||.||+|.+.. +. .+|+|.++.. ......+..|+++++.++||||++++++|... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3467889999999999998753 33 6899998754 34567889999999999999999999988542 24
Q ss_pred EEEEEEcCCCCCHHHHHhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeec
Q 007254 492 LLLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569 (611)
Q Consensus 492 ~~lV~Ey~~~gsL~~~L~~~~--~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFG 569 (611)
.+++|||+.+|+|.+++.... .....++|.....++.|++.||.|||+ .+|+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCC
Confidence 789999999999998874321 223458999999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 570 LAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 570 lA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+++...............+++.|++||+.. ..++.++|||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~sl 200 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSF 200 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHH
Confidence 999876543222222345678899999876 778999999996
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=256.64 Aligned_cols=186 Identities=23% Similarity=0.420 Sum_probs=156.2
Q ss_pred CCccceeecccCceEEEEEEec------CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 494 (611)
+|.+.+.||+|+||.||+|... ....+|+|.+.... ....++.+|+.+++.++||||+++++.|...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677899999999999999852 23579999887543 345678999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhcCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCC
Q 007254 495 VYDFLSRGSLEENLHGNKK--------------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSN 554 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~--------------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~N 554 (611)
||||+.+|+|.+++..... ....+++..++.++.|++.||.|||+ .+|+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhhe
Confidence 9999999999999864321 12358899999999999999999999 899999999999
Q ss_pred EEEcCCCcEEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 555 ILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 555 ILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
|||++++.+||+|||+++...............++..|+|||+.. ..++.++|||||
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~sl 215 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSF 215 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHH
Confidence 999999999999999998765443332333456678899999765 778999999996
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=252.73 Aligned_cols=181 Identities=25% Similarity=0.382 Sum_probs=156.9
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 499 (611)
++|.+.+.||+|+||.||+|... +++.||+|+++... .....+.+|+.+++.++||||+++++++...+..|+||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46778899999999999999864 68899999997654 33456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~ 579 (611)
++++|.+++.... .+++.++..++.|++.||.|||+ .+|+|+||||+||+++.++.+||+|||++........
T Consensus 89 ~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 89 GGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred CCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 9999999986543 48899999999999999999999 8999999999999999999999999999976643221
Q ss_pred ceeecCCccCCCcccceec----cCCCcCcceEEeC
Q 007254 580 HITCTDVAGTFGYVVLILN----PIAFLFMFNCWFF 611 (611)
Q Consensus 580 ~~~~~~~~GT~~Y~aPE~~----~~~~~~~sDiWSL 611 (611)
......||+.|+|||+. ...++.++|+|||
T Consensus 162 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSl 195 (267)
T cd06645 162 --KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAV 195 (267)
T ss_pred --ccccccCcccccChhhhccccCCCCCchhhhHHH
Confidence 22345799999999975 2558899999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=254.88 Aligned_cols=184 Identities=26% Similarity=0.438 Sum_probs=161.3
Q ss_pred cCCCccceeecccCceEEEEEEecCCCEEEEEEecCChh-HHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSED-VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 499 (611)
..+|...+.||.|+||.||+|...+++.+|+|+++.... ....+..|+.+++.++||||+++++++.+.+..++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 456888899999999999999988899999999987653 5677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~ 579 (611)
++|+|.+++..... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 85 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 85 EKGSLLAFLRSPEG--QVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ccCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999976432 458999999999999999999999 8999999999999999999999999999987754322
Q ss_pred ceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 580 HITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 580 ~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......++..|++||+.. ..++.++|||||
T Consensus 160 --~~~~~~~~~~~~~PE~~~~~~~~~~~Diwsl 190 (261)
T cd05148 160 --LSSDKKIPYKWTAPEAASHGTFSTKSDVWSF 190 (261)
T ss_pred --cccCCCCceEecCHHHHccCCCCchhhHHHH
Confidence 122445678899999765 788999999996
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=254.81 Aligned_cols=184 Identities=23% Similarity=0.429 Sum_probs=156.3
Q ss_pred cCCCccceeecccCceEEEEEEec-CCC----EEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGK----ELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~----~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 493 (611)
.++|...+.||+|+||.||+|.+. +|+ .||+|+++.. ......+.+|+.++..+.||||+.++++|.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 457888899999999999999853 454 4899998753 3456788899999999999999999999975 4578
Q ss_pred EEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccc
Q 007254 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (611)
Q Consensus 494 lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~ 573 (611)
++|||+++|+|.+++.... ..+++.++..++.|++.||.|||+ .+|+||||||+|||+++++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENK---DRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceee
Confidence 9999999999999997542 358999999999999999999999 8999999999999999999999999999998
Q ss_pred cCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 574 ASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+.............+++.|++||... ..++.++|||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl 197 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSY 197 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHH
Confidence 86544433333445678899999875 778999999996
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=259.18 Aligned_cols=188 Identities=27% Similarity=0.433 Sum_probs=156.4
Q ss_pred cCCCccceeecccCceEEEEEEec--------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP--------DGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED 489 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~--------~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 489 (611)
.++|.+.+.||+|+||.||++... ++..+|+|+++.. .....++..|++++..+ +||||++++++|...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 357889999999999999999742 2357999999864 34456788999999999 799999999999999
Q ss_pred CeEEEEEEcCCCCCHHHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE
Q 007254 490 NNLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557 (611)
Q Consensus 490 ~~~~lV~Ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl 557 (611)
+..|+||||+++|+|.+++..... ....++|.++..++.|++.||.|||+ .+++||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEE
Confidence 999999999999999999976432 11358999999999999999999999 899999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 558 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 558 ~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+.++.+||+|||+++...............+++.|+|||+.. ..++.++|+|||
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 228 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 228 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHH
Confidence 999999999999998765432211111223457899999765 778999999996
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=259.78 Aligned_cols=180 Identities=23% Similarity=0.380 Sum_probs=146.4
Q ss_pred ceeecccCceEEEEEEec---CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CCeEEEEEEcCCC
Q 007254 427 ENLIGKGGSSQVYKGCLP---DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLLVYDFLSR 501 (611)
Q Consensus 427 ~~~IG~G~fG~Vyk~~~~---~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lV~Ey~~~ 501 (611)
.+.||+|+||.||+|... +++.||+|.++... ....+.+|+.+|+.++||||+++++++.. ...+|+||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE- 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence 468999999999999854 56789999997643 23456789999999999999999999864 457899999995
Q ss_pred CCHHHHHhcCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE----cCCCcEEEEeecccc
Q 007254 502 GSLEENLHGNK-----KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL----SDDFEPQLSDFGLAK 572 (611)
Q Consensus 502 gsL~~~L~~~~-----~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl----~~~~~vKL~DFGlA~ 572 (611)
++|.+++.... .....+++..+..++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||+|+
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 58888775322 122358899999999999999999999 899999999999999 456789999999998
Q ss_pred ccCCCCCc-eeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 573 WASTSSSH-ITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 573 ~~~~~~~~-~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
........ .......||+.|+|||+.. ..++.++|||||
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 202 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAI 202 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHH
Confidence 77543221 2234578999999999775 568999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=254.16 Aligned_cols=185 Identities=26% Similarity=0.424 Sum_probs=158.2
Q ss_pred hcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC------Ce
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFED------NN 491 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~------~~ 491 (611)
+.+.|.+.+.||+|+||.||+|... +++.||+|++.........+..|+.++..+ +|+||++++++|... ..
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 4567888899999999999999864 688999999977655567788999999998 699999999999753 46
Q ss_pred EEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccc
Q 007254 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (611)
Q Consensus 492 ~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA 571 (611)
+|+||||+.+|+|.+++..... ..++|..+..++.|++.||.|||+ .+|+||||||+||++++++.+||+|||++
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 8999999999999999876432 358899999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCceeecCCccCCCcccceecc------CCCcCcceEEeC
Q 007254 572 KWASTSSSHITCTDVAGTFGYVVLILNP------IAFLFMFNCWFF 611 (611)
Q Consensus 572 ~~~~~~~~~~~~~~~~GT~~Y~aPE~~~------~~~~~~sDiWSL 611 (611)
........ ......||+.|+|||+.. ..++.++|||||
T Consensus 159 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~sl 202 (272)
T cd06637 159 AQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSL 202 (272)
T ss_pred eecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHH
Confidence 87654322 233567999999999763 468899999996
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=254.40 Aligned_cols=178 Identities=28% Similarity=0.385 Sum_probs=158.4
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
++|.+.+.||+|+||.||++... +++.||+|+++... .....+.+|+++++.++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888999999999999999865 68999999997642 34567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
||+++++|.+.+.... .+++..+..++.|++.||.|||+ .+|+|+||+|+|||++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~~~----~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRKSG----RFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 9999999999997653 48899999999999999999999 9999999999999999999999999999987765
Q ss_pred CCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 577 SSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
. .....||+.|+|||+.. ..++.++|||||
T Consensus 154 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 184 (290)
T cd05580 154 R-----TYTLCGTPEYLAPEIILSKGYGKAVDWWAL 184 (290)
T ss_pred C-----CCCCCCCccccChhhhcCCCCCccccHHHH
Confidence 4 22457999999999765 678899999996
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=256.81 Aligned_cols=186 Identities=22% Similarity=0.329 Sum_probs=156.6
Q ss_pred CCccceeecccCceEEEEEEec------CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 494 (611)
+|.+.+.||+|+||.||+|... +++.||+|+++... .....|..|+.++..++||||+++++++.+.+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4667788999999999999853 35789999997643 345678899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhcCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCc
Q 007254 495 VYDFLSRGSLEENLHGNK------------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE 562 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~------------~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~ 562 (611)
++||+.+++|.+++.... .....+++..+..++.|++.||.|||+ .+|+||||||+|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCc
Confidence 999999999999985321 112358899999999999999999999 89999999999999999999
Q ss_pred EEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 563 PQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 563 vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+||+|||+++...............+++.|+|||+.. ..++.++|||||
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 212 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSY 212 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHH
Confidence 9999999998765443322334456788999999875 778999999996
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=248.68 Aligned_cols=183 Identities=27% Similarity=0.402 Sum_probs=157.4
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh------hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 494 (611)
++|...+.||+|+||.||++... +++.||+|.++... .....+.+|+++++.++||||+++++++.+.+.+++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57889999999999999999854 78999999986532 234578899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccccc
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~ 574 (611)
||||+++++|.+.+.... .+++..+..++.|++.||.|||. .+|+||||||+||+++.++.++|+|||+++..
T Consensus 82 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG----ALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 999999999999987543 47889999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCCce-eecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 575 STSSSHI-TCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 575 ~~~~~~~-~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
....... ......|++.|+|||+.. ..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 193 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSV 193 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHH
Confidence 5422111 113457899999999876 668999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-29 Score=254.56 Aligned_cols=180 Identities=24% Similarity=0.383 Sum_probs=149.5
Q ss_pred CCccceeecccCceEEEEEEec-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhc---CCCCeeeEEEEEEe-----CC
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTL---HHKNIISLLGFCFE-----DN 490 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~-----~~ 490 (611)
+|.+.+.||+|+||.||+|... +|+.||+|.++... .....+.+|+++++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999865 78999999987532 2234556777777665 79999999999864 34
Q ss_pred eEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecc
Q 007254 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (611)
Q Consensus 491 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGl 570 (611)
.+++||||+.+ +|.+++..... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCc
Confidence 58999999974 89888865432 358999999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 571 AKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 571 A~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
++...... ......||+.|+|||+.. ..++.++|||||
T Consensus 155 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl 193 (288)
T cd07863 155 ARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSV 193 (288)
T ss_pred cccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhH
Confidence 98765432 223467899999999875 778999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-29 Score=251.46 Aligned_cols=186 Identities=25% Similarity=0.438 Sum_probs=161.9
Q ss_pred hcCCCccceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 499 (611)
..++|.+.+.||+|+||.||++.+.+++.+|||.+.......+++.+|+.+++.++|+||+++++++.....+++||||+
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 35678999999999999999999877889999999877666678999999999999999999999999888999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~ 579 (611)
++++|.+++..... ..+++..+..++.+++.||.|||+ .+|+|+||||+||+|++++.+||+|||+++.......
T Consensus 84 ~~~~L~~~i~~~~~--~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 84 SKGSLLDFLKSGEG--KKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred CCCCHHHHHhcccc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 99999999976432 358999999999999999999999 8999999999999999999999999999987754221
Q ss_pred ceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 580 HITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 580 ~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
. ......++..|+|||+.. ..++.++|||||
T Consensus 159 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl 190 (261)
T cd05034 159 T-AREGAKFPIKWTAPEAANYGRFTIKSDVWSF 190 (261)
T ss_pred h-hhhccCCCccccCHHHhccCCcCchhHHHHH
Confidence 1 112334567899999876 778999999996
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=254.49 Aligned_cols=189 Identities=21% Similarity=0.366 Sum_probs=161.0
Q ss_pred hcCCCccceeecccCceEEEEEEecC-----CCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-CCe
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLPD-----GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFE-DNN 491 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~~-----g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~ 491 (611)
..++|.+.+.||+|+||.||+|.... +..|++|.++.. ......+.+|+.+++.++||||+++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35678899999999999999998755 688999998754 3456778899999999999999999999876 467
Q ss_pred EEEEEEcCCCCCHHHHHhcCCCCC----CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEe
Q 007254 492 LLLVYDFLSRGSLEENLHGNKKDP----AAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSD 567 (611)
Q Consensus 492 ~~lV~Ey~~~gsL~~~L~~~~~~~----~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~D 567 (611)
.++++||+++|+|.+++....... ..+++.++..++.|++.||.|||+ .+++||||||+|||+++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECC
Confidence 899999999999999997653321 468999999999999999999999 8999999999999999999999999
Q ss_pred eccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 568 FGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 568 FGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
||+++.+.....+.......++..|+|||+.. ..++.++|||||
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~sl 205 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSF 205 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHh
Confidence 99998765544333333456788899999775 778999999997
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=252.66 Aligned_cols=183 Identities=30% Similarity=0.475 Sum_probs=156.0
Q ss_pred CCccceeecccCceEEEEEEe-----cCCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CeEE
Q 007254 423 NFLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLL 493 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~-----~~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~ 493 (611)
.|.+.+.||+|+||.||++.+ .++..||+|.++.. ......+.+|+++++.++||||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 467789999999999999974 35788999999754 34557899999999999999999999999875 5689
Q ss_pred EEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccc
Q 007254 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (611)
Q Consensus 494 lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~ 573 (611)
+||||+++++|.+++.... ..++|.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 85 lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEccCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCccccc
Confidence 9999999999999986542 358999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCCcee-ecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 574 ASTSSSHIT-CTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 574 ~~~~~~~~~-~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......... .....|+..|+|||+.. ..++.++|||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~sl 198 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSF 198 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhh
Confidence 765432221 22456788899999765 778999999997
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-31 Score=254.84 Aligned_cols=180 Identities=28% Similarity=0.409 Sum_probs=155.6
Q ss_pred cCCCccceeecccCceEEEEEEe-cCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
+++|.+.+.||+|.|+.||++.. .+|+.+|+|+++.. ....+++.+|+.|-+.|+||||++|.+.+.+.+..|||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 45677788999999999999874 58999999998643 235567888999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCC---CcEEEEeeccccc
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD---FEPQLSDFGLAKW 573 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~---~~vKL~DFGlA~~ 573 (611)
|+|.||+|..-+-.+ ..+++..+..++.||++||.|+|. ++|||||+||+|+||.+. --+||+|||+|..
T Consensus 90 e~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred ecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEE
Confidence 999999998766543 357888889999999999999999 999999999999999643 4589999999999
Q ss_pred cCCCCCceeecCCccCCCcccceecc-CCCcCcceEEe
Q 007254 574 ASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWF 610 (611)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWS 610 (611)
+.... .....+|||+|||||+.. ..|+..+|||+
T Consensus 163 l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~ 197 (355)
T KOG0033|consen 163 VNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWA 197 (355)
T ss_pred eCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhh
Confidence 88322 334679999999999886 99999999997
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=251.11 Aligned_cols=181 Identities=25% Similarity=0.375 Sum_probs=156.7
Q ss_pred CCCccceeecccCceEEEEEEe-cCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 007254 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 499 (611)
++|.+.+.||+|+||.||+|.. .+++.||+|+++... .....+.+|+.++..++||||+++++++...+.+|+||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4688899999999999999986 478899999997543 34456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~ 579 (611)
++++|.+.+.... .+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 89 ~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 89 GGGSLQDIYHVTG----PLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 9999999986542 48899999999999999999999 8999999999999999999999999999987653321
Q ss_pred ceeecCCccCCCcccceecc----CCCcCcceEEeC
Q 007254 580 HITCTDVAGTFGYVVLILNP----IAFLFMFNCWFF 611 (611)
Q Consensus 580 ~~~~~~~~GT~~Y~aPE~~~----~~~~~~sDiWSL 611 (611)
......|++.|+|||+.. ..++.++|+|||
T Consensus 162 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~ 195 (267)
T cd06646 162 --KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAV 195 (267)
T ss_pred --ccCccccCccccCHhHcccccCCCCcchhhHHHH
Confidence 123457899999999763 457889999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=252.05 Aligned_cols=175 Identities=26% Similarity=0.407 Sum_probs=153.2
Q ss_pred CCCccceeecccCceEEEEEEe-cCCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
++|.+.+.||+|+||.||+|.. .+++.||+|++... ......+.+|++++..++||||++++++|...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3577789999999999999985 47889999998654 34456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
+++|+|..+. .+++..+..++.|++.||.|||+ .+|+|+||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~ 149 (279)
T cd06619 81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI 149 (279)
T ss_pred CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc
Confidence 9999996542 36788889999999999999999 999999999999999999999999999998765432
Q ss_pred CceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 579 SHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.....||..|+|||+.. ..++.++|+|||
T Consensus 150 ----~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 179 (279)
T cd06619 150 ----AKTYVGTNAYMAPERISGEQYGIHSDVWSL 179 (279)
T ss_pred ----ccCCCCChhhcCceeecCCCCCCcchHHHH
Confidence 23468999999999876 778999999996
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=265.35 Aligned_cols=180 Identities=24% Similarity=0.313 Sum_probs=153.2
Q ss_pred HhcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----
Q 007254 419 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED----- 489 (611)
Q Consensus 419 ~~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~----- 489 (611)
...++|...+.||+|+||.||++... +++.||||+++.. ......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34578999999999999999999854 6889999999753 34457788999999999999999999998643
Q ss_pred -CeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEee
Q 007254 490 -NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568 (611)
Q Consensus 490 -~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DF 568 (611)
..+|+||||+++ +|.+.+.. .+++..+..++.|++.||.|||+ .+|+||||||+||||+.++.+||+||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Df 163 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeC
Confidence 357999999965 67676642 37888999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 569 GLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 569 GlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
|+++...... ......||..|+|||+.. ..++.++|||||
T Consensus 164 g~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Diwsl 204 (355)
T cd07874 164 GLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSV 204 (355)
T ss_pred cccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHH
Confidence 9998765432 223468999999999875 778999999996
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=247.96 Aligned_cols=182 Identities=24% Similarity=0.343 Sum_probs=159.4
Q ss_pred CCccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
+|.+.+.||+|+||.||++... +++.|++|.+... ......+.+|+++++.++||||+++++++.+.+..|+||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999865 7899999998653 34567889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
+++++|.+++.... ...+++..+..++.+++.||.|||+ .+|+|+||||+||+++.++.++|+|||+++......
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 99999999997642 2458899999999999999999999 899999999999999999999999999998776543
Q ss_pred CceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 579 SHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.. .....|++.|+|||+.. ..++.++|+|||
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 187 (256)
T cd08529 156 NF--ANTIVGTPYYLSPELCEDKPYNEKSDVWAL 187 (256)
T ss_pred ch--hhccccCccccCHHHhcCCCCCCccchHHH
Confidence 22 23457899999999875 778999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-29 Score=253.34 Aligned_cols=180 Identities=22% Similarity=0.282 Sum_probs=147.4
Q ss_pred eecccCceEEEEEEecCC---CEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCC
Q 007254 429 LIGKGGSSQVYKGCLPDG---KELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGS 503 (611)
Q Consensus 429 ~IG~G~fG~Vyk~~~~~g---~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 503 (611)
.||+|+||.||+|...++ ..+++|.++... ...+.|.+|+.+++.++||||+++++.|.+....|+||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999975433 346677766532 456789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCceee
Q 007254 504 LEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 583 (611)
Q Consensus 504 L~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~ 583 (611)
|.+++.+.......+.+.....++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999997654333456777888999999999999999 89999999999999999999999999998654322211122
Q ss_pred cCCccCCCcccceecc--------CCCcCcceEEeC
Q 007254 584 TDVAGTFGYVVLILNP--------IAFLFMFNCWFF 611 (611)
Q Consensus 584 ~~~~GT~~Y~aPE~~~--------~~~~~~sDiWSL 611 (611)
....|++.|+|||+.. ..++.++|||||
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diwsl 194 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWAL 194 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHH
Confidence 3467899999999863 345789999996
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=247.99 Aligned_cols=181 Identities=28% Similarity=0.466 Sum_probs=158.2
Q ss_pred eeecccCceEEEEEEecC----CCEEEEEEecCChh--HHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 007254 428 NLIGKGGSSQVYKGCLPD----GKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (611)
Q Consensus 428 ~~IG~G~fG~Vyk~~~~~----g~~vAVK~lk~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 501 (611)
+.||+|+||.||+|.... +..||+|+++.... ....+.+|++++..++|+||+++++++.+.+..++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999998653 78999999987643 367889999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCC-----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 502 GSLEENLHGNKKD-----PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 502 gsL~~~L~~~~~~-----~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
++|.+++...... ...+++.++..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999765221 2568999999999999999999999 9999999999999999999999999999998776
Q ss_pred CCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 577 SSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
...........+++.|+|||+.. ..++.++|||||
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 193 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSF 193 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHH
Confidence 54333344567899999999775 688999999996
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=254.94 Aligned_cols=181 Identities=34% Similarity=0.540 Sum_probs=153.0
Q ss_pred cceeecccCceEEEEEEec-----CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 426 AENLIGKGGSSQVYKGCLP-----DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 426 ~~~~IG~G~fG~Vyk~~~~-----~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
..+.||.|.||.||+|.+. .+..|+||.++.. ....+.|.+|+++++.++||||++++|+|...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4678999999999999976 2568999999763 34578999999999999999999999999988889999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
+++|+|.++|.... ...+++.++..++.|++.||.|||+ .+|+|+||+++|||+++++.+||+|||++.......
T Consensus 83 ~~~g~L~~~L~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSKN--KEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp -TTEBHHHHHHHTC--TTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccc--ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 99999999998762 2458999999999999999999999 889999999999999999999999999998874433
Q ss_pred CceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 579 SHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.........+...|+|||+.. ..++.++|||||
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysf 191 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSF 191 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccc
Confidence 333334566788999999876 778999999997
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=275.85 Aligned_cols=184 Identities=18% Similarity=0.287 Sum_probs=150.9
Q ss_pred HHHHhcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCC------CCeeeEEEEEEe
Q 007254 416 DLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHH------KNIISLLGFCFE 488 (611)
Q Consensus 416 ~l~~~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~H------pnIv~l~~~~~~ 488 (611)
++...+++|.+.+.||+|+||+||+|... +++.||||+++........+..|++++..++| .+++.++++|..
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 33445788999999999999999999864 68899999997655445566678888777755 458899998875
Q ss_pred C-CeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCC------
Q 007254 489 D-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF------ 561 (611)
Q Consensus 489 ~-~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~------ 561 (611)
. +++|+|||++ +++|.+++.... .+++..+..|+.||+.||.|||.. .+||||||||+||||+.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHG----PFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccc
Confidence 4 5789999998 778988886543 489999999999999999999961 4899999999999998765
Q ss_pred ----------cEEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 562 ----------EPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 562 ----------~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.+||+|||++...... ....+||+.|+|||++. ..|+.++|||||
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSl 331 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSM 331 (467)
T ss_pred cccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHH
Confidence 4999999998653322 23578999999999876 789999999996
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=257.79 Aligned_cols=188 Identities=25% Similarity=0.441 Sum_probs=156.3
Q ss_pred cCCCccceeecccCceEEEEEEec--------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP--------DGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED 489 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~--------~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 489 (611)
.++|.+.+.||+|+||.||++... ....+|+|.++.. ......+..|+++++.+ +||||++++++|...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 356788999999999999998642 2457999998753 24466788999999999 699999999999999
Q ss_pred CeEEEEEEcCCCCCHHHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE
Q 007254 490 NNLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557 (611)
Q Consensus 490 ~~~~lV~Ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl 557 (611)
+.+|+||||+++|+|.+++..... ....++|.++..++.|++.||.|||+ .+|+||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEE
Confidence 999999999999999999975421 12458999999999999999999999 899999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 558 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 558 ~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
++++.+||+|||+++...............+++.|+|||+.. ..++.++|||||
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl 222 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSF 222 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHH
Confidence 999999999999998776433222222234557899999765 778999999996
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=250.93 Aligned_cols=184 Identities=27% Similarity=0.470 Sum_probs=156.0
Q ss_pred CCCccceeecccCceEEEEEEec-CC---CEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DG---KELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g---~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 495 (611)
++|.+.+.||+|+||.||+|.+. ++ ..||||.++.. .....+|..|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 45778899999999999999864 33 36999999763 44567899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
|||+++|+|.+++.... ..+++.++..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++...
T Consensus 84 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccc
Confidence 99999999999987543 358999999999999999999999 899999999999999999999999999998776
Q ss_pred CCCCceeecC-Ccc--CCCcccceecc-CCCcCcceEEeC
Q 007254 576 TSSSHITCTD-VAG--TFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~-~~G--T~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.......... ..| +..|+|||+.. ..++.++|||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dvwsl 197 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSY 197 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhh
Confidence 5432222111 222 45799999876 788999999996
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=256.54 Aligned_cols=180 Identities=22% Similarity=0.357 Sum_probs=157.2
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
++|.+.+.||+|+||.||++... ++..+|+|.++.. .....++.+|++++..++||||++++++|.+.+++|+||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46889999999999999999854 6889999998754 34556788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
+++++|.+++.... .+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKKAG----RIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 99999999997553 48899999999999999999996 1489999999999999999999999999998664432
Q ss_pred CceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 579 SHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
. ....|+..|+|||+.. ..++.++|||||
T Consensus 155 ~----~~~~~~~~~~aPE~~~~~~~~~~~Diwsl 184 (308)
T cd06615 155 A----NSFVGTRSYMSPERLQGTHYTVQSDIWSL 184 (308)
T ss_pred c----ccCCCCcCccChhHhcCCCCCccchHHHH
Confidence 2 2457899999999765 678999999996
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=262.95 Aligned_cols=178 Identities=22% Similarity=0.322 Sum_probs=152.6
Q ss_pred hcCCCccceeecccCceEEEEEEe-cCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC------
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFED------ 489 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------ 489 (611)
..++|.+.+.||+|+||.||+|.. .+++.||||+++... .....+.+|+.+|+.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 457889999999999999999985 478899999997642 3346678999999999999999999987543
Q ss_pred CeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeec
Q 007254 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569 (611)
Q Consensus 490 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFG 569 (611)
...|++||++ +++|.+.+... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKCQ-----KLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCc
Confidence 4579999998 77998877532 48899999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 570 LAKWASTSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 570 lA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
+++...... ....||+.|+|||+.. ..++.++|||||
T Consensus 164 ~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 202 (343)
T cd07878 164 LARQADDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSV 202 (343)
T ss_pred cceecCCCc-----CCccccccccCchHhcCCccCCchhhhHhH
Confidence 998765432 3457999999999865 568999999996
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=289.02 Aligned_cols=190 Identities=24% Similarity=0.319 Sum_probs=157.8
Q ss_pred HhcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CCeE
Q 007254 419 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNL 492 (611)
Q Consensus 419 ~~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~ 492 (611)
...++|.+.+.||+|+||.||++... ++..||+|++... ......|..|+.+|..|+||||++++++|.. .+.+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 45678999999999999999999865 6788999998753 3456788999999999999999999999864 3579
Q ss_pred EEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC----CCCeEecCCCCCCEEEcCC--------
Q 007254 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS----AQRVIHRDVKSSNILLSDD-------- 560 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~----~~~IvHrDLKp~NILl~~~-------- 560 (611)
||||||+++|+|.++|.........+++..++.|+.||+.||.|||... ..+||||||||+||||+.+
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 9999999999999999764333346999999999999999999999832 1459999999999999643
Q ss_pred ---------CcEEEEeeccccccCCCCCceeecCCccCCCcccceecc---CCCcCcceEEeC
Q 007254 561 ---------FEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP---IAFLFMFNCWFF 611 (611)
Q Consensus 561 ---------~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~---~~~~~~sDiWSL 611 (611)
+.+||+|||+++.+..... .....||+.|+|||++. ..++.++|||||
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSL 229 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWAL 229 (1021)
T ss_pred ccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHH
Confidence 3489999999987654322 23467999999999764 558999999997
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=276.97 Aligned_cols=181 Identities=25% Similarity=0.411 Sum_probs=156.0
Q ss_pred CCccceeecccCceEEEEEEecC-CCEEEEEEecC-ChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 007254 423 NFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKP-SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~~-g~~vAVK~lk~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 500 (611)
.|.+...||.|+||+||++..++ +-..|.|++.. +++.+.+|+-||+||....||+||+|++.|+..+.++|+.|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 46677889999999999998654 44557788864 55778999999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCc
Q 007254 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (611)
Q Consensus 501 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~ 580 (611)
||-....+-... ..|...++..|+++++.||.|||+ +.|||||||..|||++-+|.++|+|||.+-.... +-
T Consensus 113 GGAVDaimlEL~---r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~ 184 (1187)
T KOG0579|consen 113 GGAVDAIMLELG---RVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TR 184 (1187)
T ss_pred CchHhHHHHHhc---cccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchh--HH
Confidence 999988876543 468999999999999999999999 9999999999999999999999999998754322 22
Q ss_pred eeecCCccCCCcccceecc------CCCcCcceEEeC
Q 007254 581 ITCTDVAGTFGYVVLILNP------IAFLFMFNCWFF 611 (611)
Q Consensus 581 ~~~~~~~GT~~Y~aPE~~~------~~~~~~sDiWSL 611 (611)
....++.||+.|||||+.. ..|++++|||||
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSl 221 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSL 221 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhh
Confidence 2345689999999999753 789999999997
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=252.25 Aligned_cols=184 Identities=27% Similarity=0.433 Sum_probs=155.1
Q ss_pred CCCccceeecccCceEEEEEEe-----cCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CCeEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLL 493 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~-----~~g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~ 493 (611)
.+|.+.+.||+|+||.||++.. .++..||+|.++... ...+.|.+|++++..++||||+++++++.. ...++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4678889999999999999974 257899999997654 456788999999999999999999998754 34689
Q ss_pred EEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccc
Q 007254 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (611)
Q Consensus 494 lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~ 573 (611)
+||||+++|+|.+++.... ..++|..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCccccc
Confidence 9999999999999997543 348999999999999999999999 8999999999999999999999999999998
Q ss_pred cCCCCCceee-cCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 574 ASTSSSHITC-TDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 574 ~~~~~~~~~~-~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.......... ....++..|+|||+.. ..++.++|||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 197 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSF 197 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHH
Confidence 7654432222 1223455699999875 778999999996
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=251.39 Aligned_cols=179 Identities=33% Similarity=0.491 Sum_probs=155.6
Q ss_pred CccceeecccCceEEEEEEec-CCCEEEEEEecCChhH---HHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 007254 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDV---IKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (611)
Q Consensus 424 f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 499 (611)
|.+.+.||+|+||+||++... +++.+|+|++...... .....+|+.+++.++||||+++++++.....+++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567899999999999999976 5678999999876532 223456999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~ 579 (611)
.+++|.+++... ..+++.++..++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~-- 151 (260)
T PF00069_consen 81 PGGSLQDYLQKN----KPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN-- 151 (260)
T ss_dssp TTEBHHHHHHHH----SSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTST--
T ss_pred cccccccccccc----cccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc--
Confidence 999999999833 248999999999999999999999 89999999999999999999999999999865222
Q ss_pred ceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 580 HITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 580 ~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
........||..|+|||+.. ..++.++|||||
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 185 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSL 185 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccc
Confidence 22445678999999999865 888999999996
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=280.56 Aligned_cols=188 Identities=27% Similarity=0.335 Sum_probs=154.6
Q ss_pred cCCCccceeecccCceEEEEEEecCC-CEEEEEEec-CChhHHHHHHHHHHHHHhcC-CCCeeeEEEE-EEe------CC
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLPDG-KELAVKILK-PSEDVIKEFVLEIEIITTLH-HKNIISLLGF-CFE------DN 490 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~~g-~~vAVK~lk-~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~-~~~------~~ 490 (611)
.-+..+.+.|.+|||+.||.|.+..+ ..||+|.+- .++..++.+.+||++|+.|. |+|||.+++. ... .-
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 34567889999999999999997765 999999874 46678899999999999997 9999999993 321 13
Q ss_pred eEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecc
Q 007254 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (611)
Q Consensus 491 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGl 570 (611)
.++|+||||.||.|-+++..+.. ..|++.++++|++++++|+.+||... .+|||||||-+||||+.++..||||||-
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccc
Confidence 57999999999999999986544 33999999999999999999999843 7899999999999999999999999998
Q ss_pred ccccCCCCC-cee------ecCCccCCCcccceecc----CCCcCcceEEeC
Q 007254 571 AKWASTSSS-HIT------CTDVAGTFGYVVLILNP----IAFLFMFNCWFF 611 (611)
Q Consensus 571 A~~~~~~~~-~~~------~~~~~GT~~Y~aPE~~~----~~~~~~sDiWSL 611 (611)
|.-.....+ ... .....-|+.|.|||++. ..+++++|||+|
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWAL 244 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWAL 244 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHH
Confidence 864332221 100 01234599999999874 788999999997
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-29 Score=264.59 Aligned_cols=179 Identities=23% Similarity=0.305 Sum_probs=152.8
Q ss_pred hcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC------
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED------ 489 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------ 489 (611)
..++|.+.+.||+|+||.||++... +++.||||++... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578999999999999999999864 6889999999753 34456788999999999999999999987543
Q ss_pred CeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeec
Q 007254 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569 (611)
Q Consensus 490 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFG 569 (611)
..+|+||||+++ +|...+.. .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCC
Confidence 357999999965 77777642 37888999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 570 LAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 570 lA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+++...... ......||..|+|||+.. ..++.++|||||
T Consensus 172 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl 211 (364)
T cd07875 172 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSV 211 (364)
T ss_pred CccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhH
Confidence 998765432 223467999999999875 788999999996
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-29 Score=251.98 Aligned_cols=185 Identities=28% Similarity=0.431 Sum_probs=160.5
Q ss_pred CCCccceeecccCceEEEEEEe-cCCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
++|.+.+.||+|+||.||++.. .+++.+|||.+... .....++.+|+.+++.++||||++++++|.+.+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999985 48899999988652 234568899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
||+++++|.+++.........+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999887543334568999999999999999999999 8999999999999999999999999999987765
Q ss_pred CCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 577 SSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.... .....|+..|+|||+.. ..++.++|+|||
T Consensus 159 ~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~sl 192 (267)
T cd08229 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSL 192 (267)
T ss_pred CCcc--cccccCCcCccCHHHhcCCCccchhhHHHH
Confidence 4322 22457999999999875 778999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=253.24 Aligned_cols=195 Identities=28% Similarity=0.396 Sum_probs=164.1
Q ss_pred cChHHHHHhcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC
Q 007254 412 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFED 489 (611)
Q Consensus 412 ~~~~~l~~~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 489 (611)
+...++..++++|.+.+.||+|+||.||++... +++.+|+|++.........+..|+.++..+ +||||++++++|...
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 445566667899999999999999999999864 788999999987655566788899999999 899999999998754
Q ss_pred -----CeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEE
Q 007254 490 -----NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 564 (611)
Q Consensus 490 -----~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vK 564 (611)
+..|+||||+++|+|.+++.........+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEE
Confidence 36899999999999999886543333468999999999999999999999 8999999999999999999999
Q ss_pred EEeeccccccCCCCCceeecCCccCCCcccceecc------CCCcCcceEEeC
Q 007254 565 LSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP------IAFLFMFNCWFF 611 (611)
Q Consensus 565 L~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~------~~~~~~sDiWSL 611 (611)
|+|||++........ ......|++.|+|||+.. ..++.++|||||
T Consensus 169 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~sl 219 (291)
T cd06639 169 LVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSL 219 (291)
T ss_pred Eeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHH
Confidence 999999987654322 123457899999999763 236899999996
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=249.87 Aligned_cols=183 Identities=22% Similarity=0.407 Sum_probs=157.0
Q ss_pred CCCccceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 501 (611)
++|.+...||+|+||.||++.+..+..+|+|.+.........+.+|+.+++.++||||+++++++. .+..++||||+.+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCC
Confidence 457888999999999999999877778999998876656678899999999999999999999875 4678999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCce
Q 007254 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (611)
Q Consensus 502 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~ 581 (611)
|+|.+++.... ...++|..+..++.|++.||.|||+ .+|+||||||+||++++++.++|+|||++.........
T Consensus 85 ~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05069 85 GSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence 99999997543 2458899999999999999999999 89999999999999999999999999999876543221
Q ss_pred eecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 582 TCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 582 ~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......+++.|+|||+.. ..++.++|||||
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~sl 189 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 189 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHH
Confidence 122345778899999876 778999999996
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=248.44 Aligned_cols=184 Identities=21% Similarity=0.392 Sum_probs=159.6
Q ss_pred cCCCccceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 500 (611)
.++|.+.+.||+|+||.||++.+..+..+|+|.++........|.+|+++++.++|+||+++++++.+ ...+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA 83 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence 45788899999999999999987778889999998776666789999999999999999999999887 78899999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCc
Q 007254 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (611)
Q Consensus 501 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~ 580 (611)
+|+|.+++.... ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 84 KGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 999999997643 2458899999999999999999999 89999999999999999999999999999876543221
Q ss_pred eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 581 ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 581 ~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......+++.|+|||+.. ..++.++|+|||
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl 189 (260)
T cd05073 159 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSF 189 (260)
T ss_pred -cccCCcccccccCHhHhccCCcCccccchHH
Confidence 122345678899999876 778999999996
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=257.01 Aligned_cols=185 Identities=23% Similarity=0.394 Sum_probs=157.6
Q ss_pred CCCccceeecccCceEEEEEEec------CCCEEEEEEecCCh--hHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 492 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 492 (611)
++|.+.+.||+|+||.||++... ++..||||.++... .....+.+|+.+++.+ +||||++++++|...+.+
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 46888999999999999999741 34579999987643 4456789999999999 799999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccc
Q 007254 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~ 572 (611)
|+||||+.+|+|.++++.... ..+++.++..++.+++.||.|||+ .+|+|+||||+|||++.++.+||+|||+++
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCcccc
Confidence 999999999999999975432 348999999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 573 WASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 573 ~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
...............+++.|+|||+.. ..++.++|||||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl 229 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSY 229 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHH
Confidence 776543322223345678899999765 778999999996
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=250.45 Aligned_cols=184 Identities=24% Similarity=0.392 Sum_probs=156.7
Q ss_pred CCCccceeecccCceEEEEEEec-C---CCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-D---GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~---g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 495 (611)
++|.+.+.||+|+||.||+|... + +..+|+|.++.. ......|..|+.++..++||||+++++++.+.+..|+|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 57888999999999999999853 2 337999998764 34467889999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
|||+++|+|.+++.... ..+++.++..++.|++.||.|||+ ++|+||||||+|||++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRKHD---GQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 99999999999997543 358999999999999999999999 899999999999999999999999999998876
Q ss_pred CCCCcee-ecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 576 TSSSHIT-CTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~-~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
....... .....++..|++||+.. ..++.++|+|||
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~sl 195 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSY 195 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHH
Confidence 5432221 12233467899999876 788999999996
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=252.89 Aligned_cols=188 Identities=24% Similarity=0.369 Sum_probs=156.8
Q ss_pred cCCCccceeecccCceEEEEEEec------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 492 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 492 (611)
+++|.+.+.||+|+||.||+|.+. .+..||+|.++.. ......|..|+.+++.++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 467889999999999999999864 3567999988753 23456789999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCC---cEEEE
Q 007254 493 LLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF---EPQLS 566 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~~---~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~---~vKL~ 566 (611)
++||||+++|+|.+++..... ....++|..+..++.||+.||.|||+ .+++||||||+|||++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEec
Confidence 999999999999999976532 22358999999999999999999999 8999999999999998764 59999
Q ss_pred eeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 567 DFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 567 DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
|||+++...............+++.|+|||+.. ..++.++|||||
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl 207 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSF 207 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHH
Confidence 999998774433222222334467899999875 779999999996
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-28 Score=245.44 Aligned_cols=182 Identities=19% Similarity=0.317 Sum_probs=158.2
Q ss_pred CCccceeecccCceEEEEEEec-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 499 (611)
+|.+.+.||.|+||.||++... +++.+|+|.++.. ....+.+..|+.+++.++|+||+++++.+.+.+.+|+||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999864 7899999998643 345677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~ 579 (611)
++|+|.+++..... ..+++..+..++.|++.||.|||+ .+|+|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 81 DGGDLMQKIKLQRG--KLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 99999998865332 357889999999999999999999 8999999999999999999999999999987654332
Q ss_pred ceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 580 HITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 580 ~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......|++.|+|||+.. ..++.++|+|||
T Consensus 156 --~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~sl 186 (255)
T cd08219 156 --YACTYVGTPYYVPPEIWENMPYNNKSDIWSL 186 (255)
T ss_pred --ccccccCCccccCHHHHccCCcCchhhhhhh
Confidence 223467999999999876 778999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=248.40 Aligned_cols=182 Identities=24% Similarity=0.399 Sum_probs=157.1
Q ss_pred CCccceeecccCceEEEEEEecCCCEEEEEEecCCh-------hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 007254 423 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~-------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 495 (611)
+|...+.||+|+||.||+|...+|+.+|||.++... .....+.+|+++++.++|+||++++++|.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999998889999999986431 2345688999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
|||+++++|.+++.+.. .+++..+..++.|++.||.|||+ .+|+|+||+|+||++++++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNRFG----PLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 99999999999996543 47899999999999999999999 899999999999999999999999999998764
Q ss_pred CCCCc----eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 576 TSSSH----ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~----~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
..... .......||+.|+|||+.. ..++.++|+|||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~sl 194 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSI 194 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHH
Confidence 32111 1123457999999999876 778999999996
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=252.98 Aligned_cols=187 Identities=23% Similarity=0.397 Sum_probs=158.3
Q ss_pred CCCccceeecccCceEEEEEEec------CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 494 (611)
.+|...+.||+|+||.||++... ++..+|+|.++... .....|.+|+++++.++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46777899999999999999632 45689999887543 456789999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhcCCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcE
Q 007254 495 VYDFLSRGSLEENLHGNKKD-----------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 563 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~-----------~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~v 563 (611)
||||+++|+|.+++...... ...+++..+..++.|++.||.|||+ .+|+||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCE
Confidence 99999999999999754321 1358999999999999999999999 899999999999999999999
Q ss_pred EEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 564 QLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 564 KL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
||+|||+++...............+++.|+|||+.. ..++.++|||||
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 210 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSF 210 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHH
Confidence 999999998765433322233455678999999776 778999999996
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=255.50 Aligned_cols=185 Identities=26% Similarity=0.450 Sum_probs=153.6
Q ss_pred cCCCccceeecccCceEEEEEEec-CCC--EEEEEEecCC--hhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGK--ELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLL 494 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~--~vAVK~lk~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l 494 (611)
.++|.+.+.||+|+||.||+|.+. ++. .+|+|.++.. ......+.+|++++..+ +||||+++++++.+.+..|+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 467888999999999999999864 454 4577777643 34556788999999999 89999999999999999999
Q ss_pred EEEcCCCCCHHHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCc
Q 007254 495 VYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE 562 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~ 562 (611)
||||+++|+|.+++..... ....+++.++..++.|++.||.|||+ ++|+||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCc
Confidence 9999999999999975431 12358999999999999999999999 99999999999999999999
Q ss_pred EEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 563 PQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 563 vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+||+|||+++...... ......+++.|+|||+.. ..++.++|||||
T Consensus 163 ~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 209 (303)
T cd05088 163 AKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSY 209 (303)
T ss_pred EEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhh
Confidence 9999999997432211 111223467899999876 678999999997
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=285.99 Aligned_cols=188 Identities=26% Similarity=0.449 Sum_probs=159.4
Q ss_pred cCCCccceeecccCceEEEEEEec--CCC----EEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP--DGK----ELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 492 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~--~g~----~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 492 (611)
..+-...+.||+|+||.||.|... +|. .||||.+++. .....+|++|..+|+.++|||||+++|+|.+.+..
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 344566789999999999999864 343 4899999875 56788999999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeec
Q 007254 493 LLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~~---~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFG 569 (611)
+|++|||++|+|..+|+..+. .+..++-.+.+.++.+||+|+.||++ +++|||||..+|+||+....+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccc
Confidence 999999999999999987632 24568899999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 570 LAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 570 lA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
||+-+-............-..-|||||.+. ..++.++|||||
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsF 890 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSF 890 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhh
Confidence 999554433322222212235699999887 889999999997
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=245.76 Aligned_cols=177 Identities=24% Similarity=0.407 Sum_probs=151.9
Q ss_pred eeecccCceEEEEEEecCCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCCHH
Q 007254 428 NLIGKGGSSQVYKGCLPDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLE 505 (611)
Q Consensus 428 ~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~ 505 (611)
++||+|+||.||+|...+++.+|+|.++... .....+.+|++++..++||||++++++|...+..++||||+++|+|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3689999999999998888999999987643 34457889999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCceeecC
Q 007254 506 ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD 585 (611)
Q Consensus 506 ~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 585 (611)
+++.... ..+.|..+..++.+++.||.|||+ .+++||||||+||+++.++.+||+|||++......... ....
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~ 153 (250)
T cd05085 81 SFLRKKK---DELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGL 153 (250)
T ss_pred HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccc-cCCC
Confidence 9986543 347899999999999999999999 89999999999999999999999999999865443221 1122
Q ss_pred CccCCCcccceecc-CCCcCcceEEeC
Q 007254 586 VAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 586 ~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
..+++.|+|||+.. ..++.++|||||
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~sl 180 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSY 180 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHH
Confidence 34567899999876 778999999996
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=246.93 Aligned_cols=180 Identities=31% Similarity=0.504 Sum_probs=159.0
Q ss_pred cCCCccceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 500 (611)
.++|.+.+.||.|+||.||+|.. .|+.||+|.++......+++..|+.+++.++|+||+++++++.+.+..++||||++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 35788899999999999999987 57899999998776667889999999999999999999999998899999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCc
Q 007254 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (611)
Q Consensus 501 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~ 580 (611)
+++|.+++..... ..++|..+..++.|++.||.|||. .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 84 ~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 84 KGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 9999999975432 358999999999999999999999 9999999999999999999999999999988743221
Q ss_pred eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 581 ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 581 ~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
...++..|+|||+.. ..++.++|||||
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~sl 185 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSF 185 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHH
Confidence 234577899999775 778999999996
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=261.79 Aligned_cols=181 Identities=19% Similarity=0.292 Sum_probs=157.7
Q ss_pred CCCccceeecccCceEEEEEEe-cCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 497 (611)
+-|..++.||+|.|..|-++.. -+|..||||++.+.. -....+.+|++.|+.++|||||+||.+..+...+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 4466678899999999999873 489999999997643 445678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEc-CCCcEEEEeeccccccCC
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~-~~~~vKL~DFGlA~~~~~ 576 (611)
+=++|+|+++|-++. ..+.+..+.+|+.||+.|+.|+|+ ..+|||||||+|+++- .-|-+||+||||+..+.+
T Consensus 98 LGD~GDl~DyImKHe---~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHE---EGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred ecCCchHHHHHHhhh---ccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 999999999998664 368899999999999999999999 9999999999999875 568899999999977665
Q ss_pred CCCceeecCCccCCCcccceecc-CCC-cCcceEEeC
Q 007254 577 SSSHITCTDVAGTFGYVVLILNP-IAF-LFMFNCWFF 611 (611)
Q Consensus 577 ~~~~~~~~~~~GT~~Y~aPE~~~-~~~-~~~sDiWSL 611 (611)
.. ..++.+|.+.|-|||++. ..| .+++|||||
T Consensus 172 G~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSL 205 (864)
T KOG4717|consen 172 GK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSL 205 (864)
T ss_pred cc---hhhcccchhhccCchhhhcCccCCcchhhhHH
Confidence 43 345689999999999876 555 679999997
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-28 Score=250.35 Aligned_cols=182 Identities=25% Similarity=0.413 Sum_probs=157.2
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 499 (611)
+.|.+.+.||.|+||.||+|... +++.+++|++.... .....+.+|+.+++.++||||+++++.+..++.+|+||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56788899999999999999865 58999999997654 55778899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~ 579 (611)
++++|..++.... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 92 ~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 92 PGGAVDAIMLELD---RGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred CCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 9999988876432 358999999999999999999999 8999999999999999999999999999876443221
Q ss_pred ceeecCCccCCCcccceecc------CCCcCcceEEeC
Q 007254 580 HITCTDVAGTFGYVVLILNP------IAFLFMFNCWFF 611 (611)
Q Consensus 580 ~~~~~~~~GT~~Y~aPE~~~------~~~~~~sDiWSL 611 (611)
......|++.|+|||+.. ..++.++|+|||
T Consensus 166 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~sl 201 (292)
T cd06644 166 --RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSL 201 (292)
T ss_pred --ccceecCCccccCceeeccccccCCCCCchhhhHhH
Confidence 223457899999999862 457889999996
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=250.73 Aligned_cols=180 Identities=29% Similarity=0.441 Sum_probs=151.7
Q ss_pred CccceeecccCceEEEEEEe-----cCCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CeEEE
Q 007254 424 FLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLL 494 (611)
Q Consensus 424 f~~~~~IG~G~fG~Vyk~~~-----~~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~l 494 (611)
|...+.||+|+||+||++.. .+++.||+|.++... .....|.+|+++|+.++||||++++++|... ..+++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37789999999999988653 367899999997643 3567788999999999999999999998753 46899
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccccc
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~ 574 (611)
||||+++|+|.+++... .++|.++..++.|++.||.|||+ .+|+||||||+|||+++++.+||+|||+++..
T Consensus 86 v~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 99999999999999653 38999999999999999999999 89999999999999999999999999999877
Q ss_pred CCCCCcee-ecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 575 STSSSHIT-CTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 575 ~~~~~~~~-~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
........ .....++..|++||+.. ..++.++|||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~sl 196 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSF 196 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHH
Confidence 65332211 12234567799999775 778999999996
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-28 Score=248.89 Aligned_cols=180 Identities=25% Similarity=0.429 Sum_probs=155.3
Q ss_pred CccceeecccCceEEEEEEec-CCCEEEEEEecCC-hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 007254 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (611)
Q Consensus 424 f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 501 (611)
|.+.+.||+|+||.||+|... ++..+++|.+... ....+.+.+|+++++.++||||++++++|...+..|+||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 456788999999999999865 5788999998764 35567889999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCce
Q 007254 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (611)
Q Consensus 502 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~ 581 (611)
|+|...+.+.. ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++........
T Consensus 87 ~~l~~~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-- 158 (282)
T cd06643 87 GAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-- 158 (282)
T ss_pred CcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccccc--
Confidence 99998886532 358999999999999999999999 8999999999999999999999999999976543221
Q ss_pred eecCCccCCCcccceecc------CCCcCcceEEeC
Q 007254 582 TCTDVAGTFGYVVLILNP------IAFLFMFNCWFF 611 (611)
Q Consensus 582 ~~~~~~GT~~Y~aPE~~~------~~~~~~sDiWSL 611 (611)
......||+.|+|||+.. ..++.++|||||
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~sl 194 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSL 194 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhH
Confidence 223467999999999862 457889999996
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=253.81 Aligned_cols=188 Identities=23% Similarity=0.418 Sum_probs=158.4
Q ss_pred cCCCccceeecccCceEEEEEEec------CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 492 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 492 (611)
.++|.+.+.||+|+||.||++... ++..||+|+++... ....+|.+|+.++..++||||++++++|...+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467888999999999999999853 46789999987643 4457799999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhcCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCC
Q 007254 493 LLVYDFLSRGSLEENLHGNKK------------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSN 554 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~~------------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~N 554 (611)
++||||+++|+|.+++..... ....+++.+++.++.|++.||.|||. .+++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhh
Confidence 999999999999999974321 12357899999999999999999999 899999999999
Q ss_pred EEEcCCCcEEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 555 ILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 555 ILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
||++.++.++|+|||++..+.............+++.|+|||+.. ..++.++|||||
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 218 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAY 218 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHH
Confidence 999999999999999998664432222222344577899999865 889999999996
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=249.47 Aligned_cols=183 Identities=22% Similarity=0.446 Sum_probs=156.3
Q ss_pred CCCccceeecccCceEEEEEEec-CCC----EEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGK----ELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~----~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 494 (611)
.+|.+.+.||+|+||.||+|.+. +|. .+|+|.++... .....+.+|+.++..++||||++++++|.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 56788899999999999999864 343 68999887653 455788999999999999999999999987 78899
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccccc
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~ 574 (611)
||||+++|+|.+++.... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 86 v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK---DNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEecCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 999999999999997643 248999999999999999999999 99999999999999999999999999999987
Q ss_pred CCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 575 STSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 575 ~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.............+++.|+|||+.. ..++.++|+|||
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl 197 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSY 197 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHH
Confidence 6544333333334567899999775 788999999996
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=258.94 Aligned_cols=188 Identities=27% Similarity=0.427 Sum_probs=157.1
Q ss_pred cCCCccceeecccCceEEEEEEec--------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP--------DGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED 489 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~--------~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 489 (611)
..+|.+.+.||+|+||.||++... .+..||+|.++.. .....++.+|+++++.+ +||||++++++|...
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 346888999999999999999742 1236899998753 34567899999999999 799999999999999
Q ss_pred CeEEEEEEcCCCCCHHHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE
Q 007254 490 NNLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557 (611)
Q Consensus 490 ~~~~lV~Ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl 557 (611)
+.++++|||+++|+|.+++..... ....++|.++..++.|++.||.|||. .+|+||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEE
Confidence 999999999999999999975421 12358899999999999999999999 899999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 558 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 558 ~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+.++.+||+|||+++...............+++.|+|||+.. ..++.++|||||
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 222 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 222 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHH
Confidence 999999999999998765533222223344567899999775 778999999997
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=266.69 Aligned_cols=182 Identities=23% Similarity=0.333 Sum_probs=155.4
Q ss_pred CCCccceeecccCceEEEEEEe-cCCCEEEEEEecCChh----HHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSED----VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~~~----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
.-|..++.||-|+||.|.+++. ++...+|+|.|++.+. .......|.+||...+++.||+||-.|.+.+++|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 4477889999999999999984 4677899999987653 2334567999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccc---c
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK---W 573 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~---~ 573 (611)
||++||++..+|.+.+ .|.+..+.+++.++.+|+++.|+ .|+|||||||+|||||.+|++||+|||||. |
T Consensus 709 dYIPGGDmMSLLIrmg----IFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMG----IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred eccCCccHHHHHHHhc----cCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeecccccccee
Confidence 9999999999998764 58899999999999999999999 999999999999999999999999999985 2
Q ss_pred cCC-----CCCce--------------------------------eecCCccCCCcccceecc-CCCcCcceEEe
Q 007254 574 AST-----SSSHI--------------------------------TCTDVAGTFGYVVLILNP-IAFLFMFNCWF 610 (611)
Q Consensus 574 ~~~-----~~~~~--------------------------------~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWS 610 (611)
-.+ ...|. .....+||+.|+|||++. ..|+..+|+||
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws 856 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWS 856 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhH
Confidence 111 01110 111378999999999887 99999999998
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=247.83 Aligned_cols=171 Identities=23% Similarity=0.378 Sum_probs=147.6
Q ss_pred eeecccCceEEEEEEecC-C----------CEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 428 NLIGKGGSSQVYKGCLPD-G----------KELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 428 ~~IG~G~fG~Vyk~~~~~-g----------~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
+.||+|+||.||+|.+.+ + ..+++|+++........|.+|+.+++.++||||+++++++.. +..++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 368999999999999753 3 257888887665447889999999999999999999999988 7789999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCC-------cEEEEeec
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-------EPQLSDFG 569 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~-------~vKL~DFG 569 (611)
||+++|+|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||
T Consensus 80 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 80 EYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 9999999999997643 258899999999999999999999 8999999999999999887 79999999
Q ss_pred cccccCCCCCceeecCCccCCCcccceecc-C--CCcCcceEEeC
Q 007254 570 LAKWASTSSSHITCTDVAGTFGYVVLILNP-I--AFLFMFNCWFF 611 (611)
Q Consensus 570 lA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~--~~~~~sDiWSL 611 (611)
++...... ....++..|+|||+.. . .++.++|||||
T Consensus 154 ~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~sl 192 (259)
T cd05037 154 IPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSF 192 (259)
T ss_pred cccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHH
Confidence 99876541 2346788899999875 3 68999999996
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-28 Score=248.23 Aligned_cols=183 Identities=23% Similarity=0.354 Sum_probs=153.6
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh--hHHHHHHHHHHH-HHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEI-ITTLHHKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~--~~~~~~~~Ei~i-l~~l~HpnIv~l~~~~~~~~~~~lV~E 497 (611)
++|.+.+.||+|+||.||++... +|+.||+|.++... ....++..|+.+ ++.++||||+++++++...+.+|+|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47888999999999999999865 79999999997643 334566667765 677799999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC-CeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ-RVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~-~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
|++ |+|.+++.........+++..+..++.|++.||.|||+ . +++||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 68888886543334568999999999999999999998 5 899999999999999999999999999987654
Q ss_pred CCCceeecCCccCCCcccceecc-----CCCcCcceEEeC
Q 007254 577 SSSHITCTDVAGTFGYVVLILNP-----IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~~~~~~~~~GT~~Y~aPE~~~-----~~~~~~sDiWSL 611 (611)
... .+...||..|+|||+.. ..++.++|+|||
T Consensus 157 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~sl 193 (283)
T cd06617 157 SVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSL 193 (283)
T ss_pred ccc---cccccCCccccChhhcCCcccccccCccccchhh
Confidence 321 22357899999999753 557899999996
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=253.06 Aligned_cols=184 Identities=26% Similarity=0.458 Sum_probs=152.9
Q ss_pred CCCccceeecccCceEEEEEEec-CCC--EEEEEEecCC--hhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGK--ELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~--~vAVK~lk~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV 495 (611)
++|.+.+.||+|+||.||+|.+. ++. .+++|.++.. ....+.|.+|++++..+ +||||+++++++.+.+.+|+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 57888999999999999999865 343 4788888742 34557789999999999 799999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcE
Q 007254 496 YDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 563 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~v 563 (611)
|||+++|+|.+++..... ....+++..+..++.|++.||.|||+ .+|+||||||+||||+.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeE
Confidence 999999999999975431 12358899999999999999999999 899999999999999999999
Q ss_pred EEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 564 QLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 564 KL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
||+|||++........ ......+..|+|||+.. ..++.++|||||
T Consensus 159 kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSl 204 (297)
T cd05089 159 KIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSF 204 (297)
T ss_pred EECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHH
Confidence 9999999875332111 11123356799999876 778999999997
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=247.91 Aligned_cols=172 Identities=26% Similarity=0.433 Sum_probs=145.9
Q ss_pred eeecccCceEEEEEEecC-------------CCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEE
Q 007254 428 NLIGKGGSSQVYKGCLPD-------------GKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (611)
Q Consensus 428 ~~IG~G~fG~Vyk~~~~~-------------g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 493 (611)
+.||+|+||.||+|.+.+ ...|++|.+.... .....|.+|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998532 2358999887654 44567889999999999999999999999988999
Q ss_pred EEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCc-------EEEE
Q 007254 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE-------PQLS 566 (611)
Q Consensus 494 lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~-------vKL~ 566 (611)
+||||+++|+|..++.... ..+++..+..++.||+.||.|||+ ++|+||||||+||||+.++. +|++
T Consensus 81 lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS---DVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 9999999999998886532 358999999999999999999999 89999999999999987654 8999
Q ss_pred eeccccccCCCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 567 DFGLAKWASTSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 567 DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
|||++...... ....||+.|+|||+.. ..++.++|||||
T Consensus 155 d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl 195 (262)
T cd05077 155 DPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSF 195 (262)
T ss_pred CCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHH
Confidence 99998765432 2346889999999764 678999999996
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=246.00 Aligned_cols=183 Identities=23% Similarity=0.447 Sum_probs=158.3
Q ss_pred CCCccceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 501 (611)
.+|.+.+.||+|+||.||++.+.++..+|+|+++........|..|+++++.++||||+++++++......++||||+++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 46778899999999999999887788999999987655556789999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCce
Q 007254 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (611)
Q Consensus 502 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~ 581 (611)
++|.+++.... ..+++..+..++.+++.||.|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 84 ~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~- 156 (256)
T cd05112 84 GCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT- 156 (256)
T ss_pred CcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCccc-
Confidence 99999987543 347899999999999999999999 89999999999999999999999999999866443211
Q ss_pred eecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 582 TCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 582 ~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......++..|+|||+.. ..++.++|||||
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~sl 187 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSF 187 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHH
Confidence 112334567899999876 888999999996
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-28 Score=245.88 Aligned_cols=176 Identities=26% Similarity=0.409 Sum_probs=147.5
Q ss_pred eecccCceEEEEEEec---CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCC
Q 007254 429 LIGKGGSSQVYKGCLP---DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGS 503 (611)
Q Consensus 429 ~IG~G~fG~Vyk~~~~---~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 503 (611)
.||+|+||.||+|.+. ++..||+|+++... ...+.|.+|+.+++.++||||++++++|. ....++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999754 45579999997643 34567999999999999999999999885 457899999999999
Q ss_pred HHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCcee-
Q 007254 504 LEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT- 582 (611)
Q Consensus 504 L~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~- 582 (611)
|.+++.... ..+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++..........
T Consensus 81 L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSGKK---DEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 999987542 358999999999999999999999 8999999999999999999999999999987654433221
Q ss_pred ecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 583 CTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 583 ~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.....+++.|+|||+.. ..++.++|||||
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 184 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSY 184 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHH
Confidence 12233467899999765 778999999997
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-28 Score=254.03 Aligned_cols=180 Identities=24% Similarity=0.384 Sum_probs=146.0
Q ss_pred ceeecccCceEEEEEEec---CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CCeEEEEEEcCCC
Q 007254 427 ENLIGKGGSSQVYKGCLP---DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLLVYDFLSR 501 (611)
Q Consensus 427 ~~~IG~G~fG~Vyk~~~~---~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lV~Ey~~~ 501 (611)
...||+|+||.||+|... ++..||+|.++... ....+.+|+++++.++||||+++++++.. ...+|+||||+.+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 467999999999999864 45789999987643 23457789999999999999999999854 5678999999964
Q ss_pred CCHHHHHhcCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE----cCCCcEEEEeecccc
Q 007254 502 GSLEENLHGNK-----KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL----SDDFEPQLSDFGLAK 572 (611)
Q Consensus 502 gsL~~~L~~~~-----~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl----~~~~~vKL~DFGlA~ 572 (611)
+|.+.+.... .....+++..+..++.|++.||.|||+ .+|+||||||+|||+ +.++.+||+|||+|+
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 7877764321 122358899999999999999999999 899999999999999 566789999999998
Q ss_pred ccCCCCCc-eeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 573 WASTSSSH-ITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 573 ~~~~~~~~-~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
........ .......||+.|+|||+.. ..++.++|||||
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSl 202 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAI 202 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhH
Confidence 76543221 1223467899999999775 568999999996
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-28 Score=245.95 Aligned_cols=183 Identities=25% Similarity=0.371 Sum_probs=154.5
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCC------hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CeE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS------EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNL 492 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~ 492 (611)
.+|.+.+.||+|+||.||+|... +|+.||||.++.. ......+.+|+.++..++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57888999999999999999864 6899999988642 13456788999999999999999999998763 568
Q ss_pred EEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccc
Q 007254 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~ 572 (611)
++||||+++++|.+++.... .+++.....++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG----ALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 89999999999999987543 37888899999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCCc-eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 573 WASTSSSH-ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 573 ~~~~~~~~-~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
........ .......||..|+|||+.. ..++.++|+|||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 195 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSV 195 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHH
Confidence 65432111 1123456999999999765 778999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-28 Score=249.47 Aligned_cols=182 Identities=25% Similarity=0.367 Sum_probs=154.9
Q ss_pred CCccceeecccCceEEEEEEec-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
+|.+.+.||+|+||.||+|... +++.||||.++... ...+.+.+|+.+++.++||||+++++++.+.+.+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999865 78999999987532 3356788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
+. ++|.+++..... ...+++..+..++.|++.||.|||. .+|+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 589888865432 2458999999999999999999999 899999999999999999999999999998654332
Q ss_pred CceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 579 SHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
. ......|++.|+|||+.. ..++.++|||||
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 188 (285)
T cd07861 156 R--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSI 188 (285)
T ss_pred c--cccCCcccccccChHHhcCCCCcCcHHHHHHH
Confidence 1 223356799999999764 557899999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=246.46 Aligned_cols=178 Identities=29% Similarity=0.493 Sum_probs=153.5
Q ss_pred eeecccCceEEEEEEecC--C--CEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 007254 428 NLIGKGGSSQVYKGCLPD--G--KELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (611)
Q Consensus 428 ~~IG~G~fG~Vyk~~~~~--g--~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 501 (611)
+.||+|+||.||+|.+.+ + ..||||.++... ...+.+.+|+.+++.++||||+++++++.. +.+++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999998643 3 369999998754 457789999999999999999999999988 889999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCce
Q 007254 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (611)
Q Consensus 502 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~ 581 (611)
|+|.+.+..... ..++|..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++.+.......
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999976532 458999999999999999999999 899999999999999999999999999999876543332
Q ss_pred ee-cCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 582 TC-TDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 582 ~~-~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.. ....+++.|+|||+.. ..++.++|||||
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~sl 186 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMF 186 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHH
Confidence 22 2356889999999876 788999999996
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-28 Score=245.39 Aligned_cols=178 Identities=30% Similarity=0.483 Sum_probs=153.4
Q ss_pred CCCccceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEE-eCCeEEEEEEcCC
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCF-EDNNLLLVYDFLS 500 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~~~~~lV~Ey~~ 500 (611)
.+|.+.+.||+|+||.||++.. .|..+|+|.++... ..+.|.+|+.+++.++|+||+++++++. ..+..|+||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 4688899999999999999977 57889999987554 3567899999999999999999999865 4567899999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCc
Q 007254 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (611)
Q Consensus 501 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~ 580 (611)
+|+|.+++..... ..+++..+..++.|++.||.|||+ .+|+||||||+||++++++.+||+|||+++......
T Consensus 84 ~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 84 KGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 9999999875432 358899999999999999999999 899999999999999999999999999998654432
Q ss_pred eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 581 ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 581 ~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
....++..|+|||+.. ..++.++|||||
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 185 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSF 185 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHH
Confidence 2345567899999875 778999999996
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=253.34 Aligned_cols=182 Identities=23% Similarity=0.388 Sum_probs=155.3
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 497 (611)
.++|.+.+.||+|+||.||+|... +++.||+|.++... .....+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 457888999999999999999865 68899999987532 334567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCC
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~ 577 (611)
|+. ++|.+.+.... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 85 ~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 85 YLD-KDLKQYLDDCG---NSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred ccc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 997 58988886542 357899999999999999999999 89999999999999999999999999999865432
Q ss_pred CCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 578 SSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 578 ~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
.. ......+|+.|+|||+.. ..++.++|||||
T Consensus 158 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~sl 191 (301)
T cd07873 158 TK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGV 191 (301)
T ss_pred CC--cccccceeecccCcHHHhCCCCCccHHHHHHH
Confidence 22 122356799999999764 568899999996
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-28 Score=251.26 Aligned_cols=183 Identities=23% Similarity=0.311 Sum_probs=156.0
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
++|...+.||+|+||.||++... +++.||+|.++... .....+.+|+++++.++||||+++++.+...+++|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888999999999999999865 67899999987643 34567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
||+++++|.+++.... .+++..+..++.+++.||.|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKNIG----ALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 9999999999996543 48899999999999999999999 8999999999999999999999999999874321
Q ss_pred CC-------------CceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 577 SS-------------SHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~-------------~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.. .........|+..|+|||+.. ..++.++|||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 202 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAM 202 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHH
Confidence 10 001112356899999999875 778999999996
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-28 Score=248.41 Aligned_cols=186 Identities=23% Similarity=0.370 Sum_probs=158.0
Q ss_pred CCCccceeecccCceEEEEEEec------CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 493 (611)
++|.+...||.|+||.||+|..+ +.+.+++|.+.... .....+.+|++++..++|+||+++++++.+.+..|
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56888899999999999999853 34679999987643 25678999999999999999999999999988999
Q ss_pred EEEEcCCCCCHHHHHhcCCCC-----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEee
Q 007254 494 LVYDFLSRGSLEENLHGNKKD-----PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568 (611)
Q Consensus 494 lV~Ey~~~gsL~~~L~~~~~~-----~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DF 568 (611)
+||||+++|+|.+++...... ...+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999755421 1258999999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 569 GLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 569 GlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
|+++...... ........+++.|++||+.. ..++.++|||||
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl 204 (275)
T cd05046 162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSF 204 (275)
T ss_pred ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHH
Confidence 9998654322 22233456788899999765 678899999996
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-28 Score=242.84 Aligned_cols=182 Identities=25% Similarity=0.385 Sum_probs=159.0
Q ss_pred CCccceeecccCceEEEEEEe-cCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 423 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
+|...+.||.|+||.||.+.. .+++.+++|.+... .....++.+|+++++.++|+||+++++++.+.+.+++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 478889999999999998874 46889999987643 35567889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
+++|+|.+.+.... ...+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999997543 2458999999999999999999999 899999999999999999999999999998775543
Q ss_pred CceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 579 SHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
. ......||+.|+|||+.. ..++.++|+|||
T Consensus 156 ~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~sl 187 (256)
T cd08221 156 S--MAETVVGTPYYMSPELCQGVKYNFKSDIWAL 187 (256)
T ss_pred c--cccccCCCccccCHhhcCCCCCCCcchhHHH
Confidence 2 223467999999999875 668999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=244.13 Aligned_cols=183 Identities=25% Similarity=0.392 Sum_probs=155.1
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCC------hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CCeE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS------EDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNL 492 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~ 492 (611)
.+|...+.||+|+||.||++... +++.||+|.++.. ......+.+|+.+++.++||||+++++++.+ .+.+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47888999999999999999864 6899999998643 1345678899999999999999999999875 3678
Q ss_pred EEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccc
Q 007254 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~ 572 (611)
+++|||+++++|.+.+.... .+++.....++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG----ALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 99999999999999997543 37899999999999999999998 899999999999999999999999999998
Q ss_pred ccCCCCCc-eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 573 WASTSSSH-ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 573 ~~~~~~~~-~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.+...... .......|+..|+|||+.. ..++.++|+|||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 195 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSL 195 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHH
Confidence 76432111 1122356899999999875 778999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=275.20 Aligned_cols=186 Identities=18% Similarity=0.174 Sum_probs=147.5
Q ss_pred cCCCccceeecccCceEEEEEEecC--CCEEEEE------------------EecCChhHHHHHHHHHHHHHhcCCCCee
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLPD--GKELAVK------------------ILKPSEDVIKEFVLEIEIITTLHHKNII 480 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~~--g~~vAVK------------------~lk~~~~~~~~~~~Ei~il~~l~HpnIv 480 (611)
.++|.+.+.||+|+||+||+|.++. +...++| .++........+.+|+++|..++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 4689999999999999999987532 2222222 2222334456788999999999999999
Q ss_pred eEEEEEEeCCeEEEEEEcCCCCCHHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcC
Q 007254 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK-DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD 559 (611)
Q Consensus 481 ~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~-~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~ 559 (611)
++++++...+..|+|+|++. ++|.+++..... ........++..|+.||+.||.|||+ ++||||||||+||||+.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECC
Confidence 99999999999999999995 577777654321 11223456677899999999999999 89999999999999999
Q ss_pred CCcEEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 560 DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 560 ~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
++.+||+|||+++.+...... ......||+.|+|||+.. ..|+.++|||||
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 354 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSC 354 (501)
T ss_pred CCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHH
Confidence 999999999999877643322 223468999999999876 789999999996
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-29 Score=269.31 Aligned_cols=176 Identities=23% Similarity=0.408 Sum_probs=152.8
Q ss_pred ceeecccCceEEEEEEec-CCCEEEEEEe-----cCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCe--EEEEEEc
Q 007254 427 ENLIGKGGSSQVYKGCLP-DGKELAVKIL-----KPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN--LLLVYDF 498 (611)
Q Consensus 427 ~~~IG~G~fG~Vyk~~~~-~g~~vAVK~l-----k~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~--~~lV~Ey 498 (611)
..+||+|+|-+||+|.+. +|.+||=-.+ -+....+.+|..|+.+|+.|+||||+++|.+|.+..+ +.+|.|+
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 456999999999999975 5777763222 2345667899999999999999999999999987665 8899999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcC-CCcEEEEeeccccccCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~-~~~vKL~DFGlA~~~~~~ 577 (611)
|..|+|..++.+.+. +..+....++.||++||.|||++. .||||||||-+||+|+. .|.|||+|+|||.....+
T Consensus 125 ~TSGtLr~Y~kk~~~----vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRR----VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ccCCcHHHHHHHhcc----CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 999999999988764 667788999999999999999966 69999999999999975 589999999999988765
Q ss_pred CCceeecCCccCCCcccceeccCCCcCcceEEeC
Q 007254 578 SSHITCTDVAGTFGYVVLILNPIAFLFMFNCWFF 611 (611)
Q Consensus 578 ~~~~~~~~~~GT~~Y~aPE~~~~~~~~~sDiWSL 611 (611)
.. ..+.|||.|||||+..+.|++.+|||||
T Consensus 200 ~a----ksvIGTPEFMAPEmYEE~YnE~VDVYaF 229 (632)
T KOG0584|consen 200 HA----KSVIGTPEFMAPEMYEENYNELVDVYAF 229 (632)
T ss_pred cc----ceeccCccccChHHHhhhcchhhhhhhh
Confidence 42 3479999999999999999999999997
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-28 Score=246.83 Aligned_cols=187 Identities=27% Similarity=0.391 Sum_probs=160.6
Q ss_pred hcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCC------e
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDN------N 491 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~------~ 491 (611)
.+++|.+.+.||+|+||.||+|... +++.+++|++.........+.+|+++++.+ +|+||++++++|.+.. .
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence 4688999999999999999999975 678999999987766667899999999999 7999999999997644 4
Q ss_pred EEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccc
Q 007254 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (611)
Q Consensus 492 ~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA 571 (611)
+|+||||+++++|.+++.........+++..+..++.|++.||.|||+ .+|+|+||+|+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 899999999999999987544333568999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCceeecCCccCCCcccceecc------CCCcCcceEEeC
Q 007254 572 KWASTSSSHITCTDVAGTFGYVVLILNP------IAFLFMFNCWFF 611 (611)
Q Consensus 572 ~~~~~~~~~~~~~~~~GT~~Y~aPE~~~------~~~~~~sDiWSL 611 (611)
........ ......||+.|+|||+.. ..+++++|||||
T Consensus 161 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~sl 204 (275)
T cd06608 161 AQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSL 204 (275)
T ss_pred eecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHh
Confidence 87654332 223467999999999753 457889999997
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-28 Score=249.26 Aligned_cols=183 Identities=21% Similarity=0.381 Sum_probs=156.5
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
++|.+.+.||+|+||.||++... +++.||+|.++.. ......+.+|++++..++||||+++++.+...+.+|+||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 35778899999999999999875 7899999988753 34457899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
+++++|..++.... ....+++..+..++.+++.||.|||. ..+|+||||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 99999999887542 22358999999999999999999995 1589999999999999999999999999998764432
Q ss_pred CceeecCCccCCCcccceecc-------CCCcCcceEEeC
Q 007254 579 SHITCTDVAGTFGYVVLILNP-------IAFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~~~~~~~GT~~Y~aPE~~~-------~~~~~~sDiWSL 611 (611)
. ....|++.|+|||+.. ..++.++|||||
T Consensus 158 ~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Diwsl 193 (286)
T cd06622 158 A----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSL 193 (286)
T ss_pred c----ccCCCccCccCcchhcCCCCCccCCCCcccchHhH
Confidence 2 2357899999999763 346889999996
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-28 Score=244.76 Aligned_cols=175 Identities=25% Similarity=0.382 Sum_probs=148.5
Q ss_pred eecccCceEEEEEEe---cCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCC
Q 007254 429 LIGKGGSSQVYKGCL---PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 502 (611)
Q Consensus 429 ~IG~G~fG~Vyk~~~---~~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 502 (611)
.||+|+||.||+|.+ .+++.+|+|+++... ...+.+..|+.++..++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999975 367899999997542 35678899999999999999999999885 45779999999999
Q ss_pred CHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCcee
Q 007254 503 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 582 (611)
Q Consensus 503 sL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~ 582 (611)
+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||+++++.+||+|||+++..........
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQKNK----HVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 9999996543 48899999999999999999999 8999999999999999999999999999987765433222
Q ss_pred -ecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 583 -CTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 583 -~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.....+++.|+|||+.. ..++.++|||||
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 184 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSF 184 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHH
Confidence 12234568899999775 778999999996
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-28 Score=249.06 Aligned_cols=183 Identities=26% Similarity=0.415 Sum_probs=158.4
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
.++|.+.+.||.|+||.||++... +++.+|+|.++... ...+.|..|+++++.++||||+++++++...+.+|+||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356888899999999999999864 68999999997654 4567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
+++++|.+++.... ..+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 84 CDGGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred cCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 99999999987543 358999999999999999999999 899999999999999999999999999987664432
Q ss_pred CceeecCCccCCCcccceecc------CCCcCcceEEeC
Q 007254 579 SHITCTDVAGTFGYVVLILNP------IAFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~~~~~~~GT~~Y~aPE~~~------~~~~~~sDiWSL 611 (611)
. ......||+.|++||+.. ..++.++|||||
T Consensus 158 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~sl 194 (280)
T cd06611 158 Q--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSL 194 (280)
T ss_pred c--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHH
Confidence 2 223457899999999753 457889999996
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-28 Score=247.62 Aligned_cols=181 Identities=25% Similarity=0.333 Sum_probs=155.8
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 497 (611)
++|.....||+|+||.||+|... +|+.||+|.+.... ...+.+.+|+++++.++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999876 68999999986532 234668899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCC
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~ 577 (611)
|++++.|...+... ..++|..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKNP----RGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 99998887776533 248999999999999999999999 99999999999999999999999999999887654
Q ss_pred CCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 578 SSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 578 ~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
... .....|+..|+|||+.. ..++.++|||||
T Consensus 154 ~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~sl 187 (286)
T cd07847 154 GDD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAI 187 (286)
T ss_pred ccc--ccCcccccccCCHHHHhCCCCcCchhhhHHH
Confidence 321 22356889999999764 568999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=249.45 Aligned_cols=171 Identities=24% Similarity=0.386 Sum_probs=143.7
Q ss_pred eecccCceEEEEEEecC-------------------------CCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCCCeeeE
Q 007254 429 LIGKGGSSQVYKGCLPD-------------------------GKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISL 482 (611)
Q Consensus 429 ~IG~G~fG~Vyk~~~~~-------------------------g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~HpnIv~l 482 (611)
.||+|+||.||+|.+.. ...||+|++.... .....|.+|+++++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999997421 1358999987654 345678899999999999999999
Q ss_pred EEEEEeCCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCC-
Q 007254 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF- 561 (611)
Q Consensus 483 ~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~- 561 (611)
+++|.+.+..++||||+++|+|..++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK---GRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCc
Confidence 999999999999999999999999886532 358899999999999999999999 8999999999999997643
Q ss_pred ------cEEEEeeccccccCCCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 562 ------EPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 562 ------~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
.+||+|||++...... ....|++.|+|||+.. ..++.++|||||
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~sl 207 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSF 207 (274)
T ss_pred ccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHH
Confidence 4899999998654322 1246788999999764 568999999996
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-28 Score=247.37 Aligned_cols=192 Identities=27% Similarity=0.437 Sum_probs=161.3
Q ss_pred ChHHHHHhcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEe--
Q 007254 413 NYQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFE-- 488 (611)
Q Consensus 413 ~~~~l~~~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~-- 488 (611)
++.++....+.|.+.+.||.|+||.||+|... +++.+|+|++........++..|+.++..+ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 34445556678899999999999999999864 688999999977665567788999999998 79999999999853
Q ss_pred ----CCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEE
Q 007254 489 ----DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 564 (611)
Q Consensus 489 ----~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vK 564 (611)
.+.+|++|||+.+|+|.+++..... ..+++..+..++.|++.||.|||+ .+|+||||||+||++++++.++
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEE
Confidence 4678999999999999999875432 347888899999999999999999 8999999999999999999999
Q ss_pred EEeeccccccCCCCCceeecCCccCCCcccceecc------CCCcCcceEEeC
Q 007254 565 LSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP------IAFLFMFNCWFF 611 (611)
Q Consensus 565 L~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~------~~~~~~sDiWSL 611 (611)
|+|||++........ ......|++.|+|||.+. ..++.++|+|||
T Consensus 162 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~Dvwsl 212 (282)
T cd06636 162 LVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSL 212 (282)
T ss_pred EeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHH
Confidence 999999987653222 223467999999999753 468889999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-28 Score=250.68 Aligned_cols=181 Identities=27% Similarity=0.398 Sum_probs=157.4
Q ss_pred cCCCccceeecccCceEEEEEEe-cCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
..+|...+.||+|+||.||+|.. .+++.||+|.+.... .....+.+|+.+++.++|+||+++++.|...++.|+||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 35788899999999999999985 478999999987643 3456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
+++++|.+++... .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred cCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 9999999998642 37899999999999999999999 899999999999999999999999999988654332
Q ss_pred CceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 579 SHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
. ......|++.|+|||+.. ..++.++|||||
T Consensus 171 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~ 202 (296)
T cd06654 171 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 202 (296)
T ss_pred c--ccCcccCCccccCHHHHcCCCCCccchHHHH
Confidence 1 123457899999999875 678899999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-28 Score=245.77 Aligned_cols=182 Identities=27% Similarity=0.415 Sum_probs=155.9
Q ss_pred CCccceeecccCceEEEEEEec-CCCEEEEEEecCCh-----------hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-----------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN 490 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~-----------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 490 (611)
+|...+.||.|+||.||+|... +|+.+|+|.++... ...+.+..|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677899999999999999854 78999999886421 12356788999999999999999999999999
Q ss_pred eEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecc
Q 007254 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (611)
Q Consensus 491 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGl 570 (611)
..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeeccc
Confidence 999999999999999999765 258899999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCceeecCCccCCCcccceecc-C--CCcCcceEEeC
Q 007254 571 AKWASTSSSHITCTDVAGTFGYVVLILNP-I--AFLFMFNCWFF 611 (611)
Q Consensus 571 A~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~--~~~~~sDiWSL 611 (611)
++...............|+..|+|||+.. . .++.++|+|||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~sl 198 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSL 198 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHH
Confidence 98765433333334567899999999865 2 47999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=242.27 Aligned_cols=182 Identities=24% Similarity=0.382 Sum_probs=159.2
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 499 (611)
++|.+.+.||.|+||.||+|... +++.+|+|++.... ...+.+.+|+++++.++||||+++++++...+.+|++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57888999999999999999864 67899999997643 35678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~ 579 (611)
.+++|.+++.... ..+++.++..++.|++.||.|||+ .+|+|+||||+||+++.++.+||+|||++........
T Consensus 83 ~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 83 GGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred CCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 9999999887542 358899999999999999999999 8999999999999999999999999999987654321
Q ss_pred ceeecCCccCCCcccceecc-C---CCcCcceEEeC
Q 007254 580 HITCTDVAGTFGYVVLILNP-I---AFLFMFNCWFF 611 (611)
Q Consensus 580 ~~~~~~~~GT~~Y~aPE~~~-~---~~~~~sDiWSL 611 (611)
......|+..|+|||+.. . .++.++|+|||
T Consensus 157 --~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~sl 190 (262)
T cd06613 157 --KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWAL 190 (262)
T ss_pred --ccccccCCccccCchhhcccccCCcCchhhhHHH
Confidence 223467899999999865 4 78999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-28 Score=242.80 Aligned_cols=181 Identities=26% Similarity=0.435 Sum_probs=160.4
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 500 (611)
++|.+.+.||+|+||.||+|... +++.+++|.++.... ..++.+|+++++.++||||+++++++.+...+|++|||+.
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 57888899999999999999976 488999999987654 6789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCc
Q 007254 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (611)
Q Consensus 501 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~ 580 (611)
+++|.+++.... ..++|..+..++.|++.||.|||. .+|+||||+|+||+++.++.+||+|||++........
T Consensus 82 ~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 82 AGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 999999986543 358999999999999999999999 8999999999999999999999999999987765432
Q ss_pred eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 581 ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 581 ~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......|+..|++||+.. ..++.++|||||
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~ 185 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSL 185 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHH
Confidence 223456899999999875 778999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=244.14 Aligned_cols=189 Identities=22% Similarity=0.293 Sum_probs=157.7
Q ss_pred HHHhcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 007254 417 LLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (611)
Q Consensus 417 l~~~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 494 (611)
++.+++++.....||+|+||.||+|... ++..||+|.+.... ...+.+.+|+.+++.++|+||+++++++...+..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3455677777789999999999999854 67889999987654 456788999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcC-CCcEEEEeeccccc
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKW 573 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~-~~~vKL~DFGlA~~ 573 (611)
||||+++++|.+.+..... ....++..+..++.|++.||.|||+ .+|+||||||+||+++. ++.++|+|||++..
T Consensus 83 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEecCCCCCHHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 9999999999999975421 1112788888999999999999999 89999999999999976 67999999999987
Q ss_pred cCCCCCceeecCCccCCCcccceecc---CCCcCcceEEeC
Q 007254 574 ASTSSSHITCTDVAGTFGYVVLILNP---IAFLFMFNCWFF 611 (611)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~Y~aPE~~~---~~~~~~sDiWSL 611 (611)
...... ......|++.|+|||+.. ..++.++|+|||
T Consensus 159 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~sl 197 (268)
T cd06624 159 LAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSL 197 (268)
T ss_pred cccCCC--ccccCCCCccccChhhhccccccCCchhhhHHH
Confidence 653222 122356899999999864 458899999996
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-29 Score=258.74 Aligned_cols=183 Identities=22% Similarity=0.303 Sum_probs=155.9
Q ss_pred hcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEE
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLL 493 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 493 (611)
...+|..+.+||+|+||+|.++..+ +.+.+|||+|+++- +..+--+.|-++|... +-|++++|..+|++-+.+|
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 3457888999999999999999865 56789999999852 2223334566777665 5789999999999999999
Q ss_pred EEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccc
Q 007254 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (611)
Q Consensus 494 lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~ 573 (611)
+||||+.||+|...+++-.+ |.+..+..+|.+|+-||-|||+ ++||+||||.+||||+.+|++||+|||+++.
T Consensus 427 FVMEyvnGGDLMyhiQQ~Gk----FKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQVGK----FKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred eEEEEecCchhhhHHHHhcc----cCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeecccccc
Confidence 99999999999999987654 6677888999999999999999 9999999999999999999999999999986
Q ss_pred cCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 574 ASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.--... +..+++||+.|||||++. ..|..++|+|||
T Consensus 500 ni~~~~--TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~ 536 (683)
T KOG0696|consen 500 NIFDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAF 536 (683)
T ss_pred cccCCc--ceeeecCCCcccccceEEecccccchhHHHH
Confidence 443222 345789999999999887 899999999986
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-28 Score=242.75 Aligned_cols=179 Identities=27% Similarity=0.429 Sum_probs=156.7
Q ss_pred CCccceeecccCceEEEEEEec-CCCEEEEEEecCCh------hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 495 (611)
+|...+.||+|+||.||+|... +++.|++|.+.... +..+.+.+|+++++.++|+||+++++++...+.+|+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667789999999999999976 78999999986532 3567899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
|||+++++|.+++.... .+++..+..++.|++.||.|||+ .+|+|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKKYG----SFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 99999999999997542 47899999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCceeecCCccCCCcccceecc-CC-CcCcceEEeC
Q 007254 576 TSSSHITCTDVAGTFGYVVLILNP-IA-FLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~~-~~-~~~~sDiWSL 611 (611)
... ......|++.|++||+.. .. ++.++|+|||
T Consensus 154 ~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~sl 188 (258)
T cd06632 154 EFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSL 188 (258)
T ss_pred ccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHH
Confidence 433 223467999999999775 44 8999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-28 Score=245.15 Aligned_cols=185 Identities=25% Similarity=0.456 Sum_probs=156.3
Q ss_pred cCCCccceeecccCceEEEEEEec-CCC---EEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGK---ELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~---~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 494 (611)
.++|...+.||+|+||.||+|... +++ .+|+|.++.. ......+..|+++++.++||||+++++++...+..|+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 457788899999999999999864 333 7999998764 3445778999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccccc
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~ 574 (611)
||||+++++|.+++.... ..++|.++..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 84 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 84 ITEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceec
Confidence 999999999999987542 358999999999999999999999 89999999999999999999999999999877
Q ss_pred CCCCCcee-ecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 575 STSSSHIT-CTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 575 ~~~~~~~~-~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
........ ......++.|+|||+.. ..++.++|||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~sl 196 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSF 196 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHH
Confidence 54332211 11223456799999876 778999999996
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-28 Score=253.55 Aligned_cols=181 Identities=19% Similarity=0.227 Sum_probs=150.2
Q ss_pred cceeeccc--CceEEEEEEe-cCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 007254 426 AENLIGKG--GSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (611)
Q Consensus 426 ~~~~IG~G--~fG~Vyk~~~-~~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 499 (611)
+.++||+| +|++||++.. .+|+.||+|.++.. ......+.+|+++++.++||||++++++|..++..|+||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35789999 7899999986 47899999999764 234566778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~ 579 (611)
++|+|.+++..... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++++|||.+........
T Consensus 82 ~~~~l~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHFM--DGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 99999999865432 348999999999999999999999 8999999999999999999999999987654322111
Q ss_pred c-----eeecCCccCCCcccceecc---CCCcCcceEEeC
Q 007254 580 H-----ITCTDVAGTFGYVVLILNP---IAFLFMFNCWFF 611 (611)
Q Consensus 580 ~-----~~~~~~~GT~~Y~aPE~~~---~~~~~~sDiWSL 611 (611)
. .......++..|+|||+.. ..|+.++|||||
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diwsl 196 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSV 196 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHH
Confidence 0 0112346788899999875 468999999996
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.6e-28 Score=245.00 Aligned_cols=182 Identities=26% Similarity=0.395 Sum_probs=154.4
Q ss_pred CCCccceeecccCceEEEEEEecC----CCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLPD----GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~~----g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 495 (611)
++|.+.+.||+|+||.||+|.+.+ ...||||..... ....+.+.+|+.+++.++||||++++++|.+ +..|+|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457888999999999999998643 246899988764 3456789999999999999999999999865 567899
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
|||+++|+|.+++.... ..+++..+..++.+++.||.|||+ .+++||||||+|||++.++.+||+|||+++...
T Consensus 85 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 85 MELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEcCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeecc
Confidence 99999999999997543 358999999999999999999999 899999999999999999999999999998776
Q ss_pred CCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 576 TSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
..... ......+++.|+|||+.. ..++.++|||||
T Consensus 159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 194 (270)
T cd05056 159 DESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMF 194 (270)
T ss_pred cccce-ecCCCCccccccChhhhccCCCCchhhhHHH
Confidence 54322 223345567899999775 778999999996
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-29 Score=236.17 Aligned_cols=182 Identities=25% Similarity=0.375 Sum_probs=153.1
Q ss_pred CccceeecccCceEEEEEEe-cCCCEEEEEEecCC--hhHHHHHHHHHHH-HHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 007254 424 FLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEI-ITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (611)
Q Consensus 424 f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~--~~~~~~~~~Ei~i-l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 499 (611)
......||+|+||.|-+-++ .+|+..|+|.++.. .+..+++++|+++ +++..+|++|++||.+...+..++.||.|
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M 127 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM 127 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence 34456799999999977664 48999999999764 4567888999987 55678999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~ 579 (611)
.. +|..+....-.....+++...-+|+..|..||.|||+ ...|||||+||+||||+.+|++||||||++.++.++-.
T Consensus 128 ~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA 204 (282)
T KOG0984|consen 128 DT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA 204 (282)
T ss_pred hh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhhH
Confidence 55 8877765443444568888889999999999999998 47899999999999999999999999999999887643
Q ss_pred ceeecCCccCCCcccceecc-----CCCcCcceEEeC
Q 007254 580 HITCTDVAGTFGYVVLILNP-----IAFLFMFNCWFF 611 (611)
Q Consensus 580 ~~~~~~~~GT~~Y~aPE~~~-----~~~~~~sDiWSL 611 (611)
. +-.+|.-.|||||.+. ..|+-++|||||
T Consensus 205 k---t~daGCkpYmaPEri~~e~n~~gY~vksDvWSL 238 (282)
T KOG0984|consen 205 K---TMDAGCKPYMAPERINPELNQKGYSVKSDVWSL 238 (282)
T ss_pred H---HHhcCCCccCChhhcCcccCcccceeehhhhhh
Confidence 2 2367889999999753 589999999997
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=245.07 Aligned_cols=184 Identities=27% Similarity=0.387 Sum_probs=157.3
Q ss_pred CCCccceeecccCceEEEEEEec-----CCCEEEEEEecCChh--HHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CCeE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-----DGKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNL 492 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-----~g~~vAVK~lk~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~ 492 (611)
.+|...+.||+|+||.||++.+. +++.+|||+++.... ....|.+|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35667789999999999999853 468999999987654 47789999999999999999999999887 5578
Q ss_pred EEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccc
Q 007254 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~ 572 (611)
++||||+++++|.+++.... ..++|..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 99999999999999997653 258999999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCcee-ecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 573 WASTSSSHIT-CTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 573 ~~~~~~~~~~-~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.......... .....++..|++||+.. ..+++++|||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~sl 198 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSF 198 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHH
Confidence 8774333222 12345667799999775 788999999996
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=241.12 Aligned_cols=178 Identities=26% Similarity=0.437 Sum_probs=152.0
Q ss_pred eeecccCceEEEEEEecCCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCCHH
Q 007254 428 NLIGKGGSSQVYKGCLPDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLE 505 (611)
Q Consensus 428 ~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~ 505 (611)
+.||+|+||.||++.+.+++.||+|.++... .....+.+|+++++.++|+||+++++++.+.++.++||||+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 3689999999999998779999999987643 35678999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCceeecC
Q 007254 506 ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD 585 (611)
Q Consensus 506 ~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 585 (611)
+++.... ..+++..+..++.+++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.............
T Consensus 81 ~~l~~~~---~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKKK---NRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 9986542 257899999999999999999999 8999999999999999999999999999987653221111112
Q ss_pred CccCCCcccceecc-CCCcCcceEEeC
Q 007254 586 VAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 586 ~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
..++..|+|||+.. ..++.++|||||
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~sl 181 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSY 181 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHH
Confidence 34467799999765 778999999996
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=240.67 Aligned_cols=182 Identities=24% Similarity=0.347 Sum_probs=155.6
Q ss_pred CCccceeecccCceEEEEEEec-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-CCeEEEEEE
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFE-DNNLLLVYD 497 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lV~E 497 (611)
+|.+.+.||+|+||.||++... +++.||+|.+.... ...+.+.+|+++++.++|+|++++++.+.. .+.+|+|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788999999999999999864 67899999986532 345678899999999999999999998764 446899999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCC
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~ 577 (611)
|+++++|.+.+..... ..+++.++..++.+++.||.|||+ .+|+||||||+||+++.++.++|+|||+++.....
T Consensus 81 ~~~~~~l~~~l~~~~~--~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQKG--KLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 9999999999875422 358999999999999999999999 89999999999999999999999999999877543
Q ss_pred CCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 578 SSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 578 ~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.. ......|++.|+|||+.. ..++.++|+|||
T Consensus 156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 188 (257)
T cd08223 156 CD--MASTLIGTPYYMSPELFSNKPYNYKSDVWAL 188 (257)
T ss_pred CC--ccccccCCcCccChhHhcCCCCCchhhhHHH
Confidence 32 223467899999999876 778999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=250.59 Aligned_cols=185 Identities=29% Similarity=0.359 Sum_probs=158.5
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
++|...+.||+|+||.||+|... +++.||+|.+.... ...+.+..|++++..++||||+++++.+...+..|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999865 58999999997643 35567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
||+.+++|.+++.... ...+++..+..++.|++.||.|||. .+++|+||||+||+|+.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 9999999999987542 2458999999999999999999999 8999999999999999999999999999886543
Q ss_pred CCCc---------------------------eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 577 SSSH---------------------------ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~~---------------------------~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.... .......||..|+|||+.. ..++.++|||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~sl 218 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTL 218 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHH
Confidence 2211 1112357899999999875 778999999996
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=252.34 Aligned_cols=184 Identities=24% Similarity=0.462 Sum_probs=154.9
Q ss_pred cCCCccceeecccCceEEEEEEec-CCC----EEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGK----ELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~----~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 493 (611)
.++|...+.||+|+||.||+|.+. +|. .+|+|.+.... .....+.+|+.+++.++||||++++++|... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 456778899999999999999853 454 57999887643 3345788999999999999999999999754 568
Q ss_pred EEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccc
Q 007254 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (611)
Q Consensus 494 lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~ 573 (611)
+++||+++|+|.+++.... ..+++..+..++.|++.||.|||+ .+|+||||||+|||+++++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHK---DNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeehhcCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEcccccccc
Confidence 9999999999999987543 358899999999999999999999 8999999999999999999999999999998
Q ss_pred cCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 574 ASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
..............+++.|++||+.. ..++.++|||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Diwsl 197 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSY 197 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHH
Confidence 76544333333456788999999876 778999999996
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.7e-28 Score=243.75 Aligned_cols=182 Identities=25% Similarity=0.438 Sum_probs=155.6
Q ss_pred CCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----------hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCe
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 491 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 491 (611)
+|.+...||+|+||.||+|... +++.+|+|.+.... ...+.+.+|+.+++.++||||+++++++.+.++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4777899999999999999864 68899999886431 234578899999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccc
Q 007254 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (611)
Q Consensus 492 ~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA 571 (611)
.++||||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++||||+|+||++++++.++|+|||++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG----AFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCC
Confidence 999999999999999997543 47889999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCc----eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 572 KWASTSSSH----ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 572 ~~~~~~~~~----~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+........ .......|+..|+|||+.. ..++.++|+|||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~sl 198 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSL 198 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHH
Confidence 877632211 1122356899999999875 778999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=244.86 Aligned_cols=178 Identities=27% Similarity=0.472 Sum_probs=147.6
Q ss_pred eeecccCceEEEEEEec-CCC--EEEEEEecCC--hhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 007254 428 NLIGKGGSSQVYKGCLP-DGK--ELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 501 (611)
Q Consensus 428 ~~IG~G~fG~Vyk~~~~-~g~--~vAVK~lk~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 501 (611)
+.||+|+||.||+|.+. ++. .+|+|.++.. ......+..|++++..+ +||||++++++|...+.+|+||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36899999999999875 444 4688888753 34556888999999999 799999999999999999999999999
Q ss_pred CCHHHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeec
Q 007254 502 GSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569 (611)
Q Consensus 502 gsL~~~L~~~~~------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFG 569 (611)
|+|.+++..... ....+++.++..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence 999999975431 11348899999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 570 LAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 570 lA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
++....... ......+++.|+|||+.. ..++.++|||||
T Consensus 158 l~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~sl 197 (270)
T cd05047 158 LSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSY 197 (270)
T ss_pred Cccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHH
Confidence 986433211 111223467899999875 778999999997
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=247.02 Aligned_cols=183 Identities=25% Similarity=0.369 Sum_probs=153.9
Q ss_pred hcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
++++|.+.+.||+|+||.||+|... +|+.||+|.++... .....+.+|+++++.++|+||+++++++...+..|+||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4578999999999999999999864 68899999987543 33456778999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
||+. ++|.+.+.... ..+.+..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 83 e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 83 EYMH-TDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred eccc-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 9995 67777765432 347788899999999999999999 8999999999999999999999999999986543
Q ss_pred CCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 577 SSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
... ......+++.|+|||+.. ..++.++|||||
T Consensus 156 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 190 (291)
T cd07870 156 PSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGA 190 (291)
T ss_pred CCC--CCCCccccccccCCceeecCCCCCcHHHHHHH
Confidence 221 123356899999999875 457899999996
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=250.02 Aligned_cols=181 Identities=27% Similarity=0.366 Sum_probs=156.5
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 497 (611)
++|...+.||+|+||.||+|... +++.||+|++.... ...+.+.+|+++++.++||||++++++|...+..|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888899999999999999975 68999999986532 245678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCC
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~ 577 (611)
|++++.|....... ..++|.++..++.|++.||.|||+ .+|+||||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKYP----NGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 99998888776543 248999999999999999999999 89999999999999999999999999999876554
Q ss_pred CCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 578 SSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 578 ~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
.. ......|+..|+|||+.. ..++.++|||||
T Consensus 154 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 187 (286)
T cd07846 154 GE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAV 187 (286)
T ss_pred cc--ccCcccceeeccCcHHhccccccCchHhHHHH
Confidence 32 223457899999999875 457899999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-28 Score=249.92 Aligned_cols=180 Identities=27% Similarity=0.399 Sum_probs=157.5
Q ss_pred CCCccceeecccCceEEEEEEe-cCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 007254 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 499 (611)
.+|.+.+.||+|+||.||++.. .+++.||+|.+.... .....+.+|+.+++.++|+||++++++|...++.|+||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 6788899999999999999985 479999999997643 34466788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~ 579 (611)
++++|.+++... .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 99 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred CCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 999999998643 37889999999999999999999 8999999999999999999999999999987654322
Q ss_pred ceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 580 HITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 580 ~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......|++.|+|||+.. ..++.++|+|||
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 201 (297)
T cd06656 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 201 (297)
T ss_pred --CcCcccCCccccCHHHHcCCCCCcHHHHHHH
Confidence 123457899999999876 778999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.7e-28 Score=247.65 Aligned_cols=182 Identities=25% Similarity=0.391 Sum_probs=154.7
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 497 (611)
.++|...+.||+|+||.||+|... +++.||||.+.... .....+.+|+++++.++|+||+++++++.+.+..|+|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 467889999999999999999865 68999999987542 233557789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCC
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~ 577 (611)
|+.+ +|.+.+.... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~~-~L~~~~~~~~---~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 84 YLDT-DLKQYMDDCG---GGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred cCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 9975 9999887543 258899999999999999999999 89999999999999999999999999999765432
Q ss_pred CCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 578 SSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 578 ~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
.. ......+++.|+|||+.. ..++.++|||||
T Consensus 157 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~sl 190 (291)
T cd07844 157 SK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGV 190 (291)
T ss_pred Cc--cccccccccccCCcHHhhcCcccCcHHHHHHH
Confidence 21 122346789999999764 568999999996
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=241.12 Aligned_cols=182 Identities=30% Similarity=0.495 Sum_probs=156.6
Q ss_pred CccceeecccCceEEEEEEecC-----CCEEEEEEecCChh--HHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 424 FLAENLIGKGGSSQVYKGCLPD-----GKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 424 f~~~~~IG~G~fG~Vyk~~~~~-----g~~vAVK~lk~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
|.+.+.||.|+||.||++.... +..||+|.++.... ..+.+..|++++..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3456889999999999998653 38899999987543 5788999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
||+++++|.+++..... ..+++.++..++.|++.||.|||+ .+++||||||+||++++++.++|+|||+++....
T Consensus 81 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 99999999999975432 128999999999999999999999 8999999999999999999999999999987765
Q ss_pred CCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 577 SSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
...... ....+++.|+|||+.. ..++.++|||||
T Consensus 156 ~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~sl 190 (258)
T smart00219 156 DDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSF 190 (258)
T ss_pred cccccc-ccCCCcccccChHHhccCCCCcchhHHHH
Confidence 432211 1234789999999875 778999999996
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=244.72 Aligned_cols=180 Identities=25% Similarity=0.357 Sum_probs=158.8
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
++|.+.+.||.|+||.||+|... +++.||+|++.... .....+.+|+++++.++|+||+++++++.+...+|+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36778899999999999999865 68899999987643 4456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
+++++|.+++... .+++..+..++.|++.||.|||+ .+|+||||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 9999999998753 58899999999999999999999 899999999999999999999999999998876543
Q ss_pred CceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 579 SHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
. ......|++.|++||+.. ..+++++|||||
T Consensus 153 ~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~sl 184 (274)
T cd06609 153 S--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSL 184 (274)
T ss_pred c--ccccccCCccccChhhhccCCCCchhhHHHH
Confidence 2 223467899999999875 668999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=245.10 Aligned_cols=181 Identities=21% Similarity=0.314 Sum_probs=157.4
Q ss_pred CCccceeecccCceEEEEEEec-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
+|.+.+.||+|+||.||+|... +|+.||+|++.... .....+.+|+.+++.++||||+++++++...+.+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778899999999999999864 78999999987543 3457789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
+ +++|.+.+.... ..+++.++..++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 999999987543 458999999999999999999999 899999999999999999999999999998776533
Q ss_pred CceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 579 SHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
. .......||..|+|||+.. ..++.++|||||
T Consensus 154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 187 (286)
T cd07832 154 P-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAV 187 (286)
T ss_pred C-CccccccCcccccCceeeeccccCCchhHHHHH
Confidence 2 1223457999999999864 557999999996
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-28 Score=248.45 Aligned_cols=180 Identities=25% Similarity=0.363 Sum_probs=157.0
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
++|.+.+.||+|+||+||++... +|+.||+|++... ....+.+.+|+++++.++||||+++++++...+.+|+||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 56778899999999999999864 6899999988654 34567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
+++|+|.+.+...+ .+++..+..++.+++.||.|||+ ..+|+||||||+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 85 MDCGSLDRIYKKGG----PIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred CCCCCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 99999999886542 48999999999999999999996 1479999999999999999999999999987654332
Q ss_pred CceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 579 SHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
. ....||..|+|||+.. ..++.++|||||
T Consensus 159 ~----~~~~~~~~~~aPE~~~~~~~~~~~Di~sl 188 (284)
T cd06620 159 A----DTFVGTSTYMSPERIQGGKYTVKSDVWSL 188 (284)
T ss_pred c----CccccCcccCCHHHHccCCCCccchHHHH
Confidence 2 2457999999999875 788999999996
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=240.01 Aligned_cols=186 Identities=24% Similarity=0.397 Sum_probs=160.7
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
++|.+.+.||.|+||.||+|... ++..+|+|++.... .....+.+|+++++.++|+||+++++.+...+..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47888999999999999999854 68899999997542 3567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
+++++|.+.+..... ...+++..+..++.|++.||.|||+ .+|+||||||+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999975422 2358999999999999999999999 999999999999999999999999999998776543
Q ss_pred Cce--eecCCccCCCcccceecc-C-CCcCcceEEeC
Q 007254 579 SHI--TCTDVAGTFGYVVLILNP-I-AFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~--~~~~~~GT~~Y~aPE~~~-~-~~~~~sDiWSL 611 (611)
... ......|+..|++||+.. . .++.++|+|||
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~sl 193 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSF 193 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhH
Confidence 221 223457999999999875 3 68999999996
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-28 Score=246.76 Aligned_cols=181 Identities=26% Similarity=0.416 Sum_probs=151.7
Q ss_pred eeecccCceEEEEEEecC-------CCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 428 NLIGKGGSSQVYKGCLPD-------GKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 428 ~~IG~G~fG~Vyk~~~~~-------g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
+.||+|+||.||+|...+ ++.+|||.+.... .....+.+|+++++.++||||++++++|...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998542 2579999887543 4567889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCC-----cEEEEeecc
Q 007254 499 LSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-----EPQLSDFGL 570 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~---~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~-----~vKL~DFGl 570 (611)
+++|+|.+++..... ....++|.++..++.|++.||.|||+ .+++|+||||+|||++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999975322 22458999999999999999999998 8899999999999999887 899999999
Q ss_pred ccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 571 AKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 571 A~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
++...............++..|+|||+.. ..++.++|||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 199 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSF 199 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHH
Confidence 98765433222222345678999999775 778999999996
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=241.49 Aligned_cols=187 Identities=27% Similarity=0.351 Sum_probs=158.2
Q ss_pred CCccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CCeEEEEE
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLLVY 496 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lV~ 496 (611)
+|.+.+.||.|+||.||++... +++.+|+|.++.. ....+++..|+++++.++||||+++++++.. ...+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4778899999999999999854 7889999998653 3456678899999999999999999998864 45689999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCeEecCCCCCCEEEcCCCcEEEEeecccccc
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS--AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~--~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~ 574 (611)
||+++++|.+++.........+++..+..++.|++.||.|||..+ ..+|+|+||||+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999765444456999999999999999999999321 289999999999999999999999999999887
Q ss_pred CCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 575 STSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 575 ~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
...... .....|++.|++||+.. ..++.++|+|||
T Consensus 161 ~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~sl 196 (265)
T cd08217 161 GHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSL 196 (265)
T ss_pred cCCccc--ccccccCCCccChhhhcCCCCCchhHHHHH
Confidence 654321 23457999999999876 778999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-28 Score=250.61 Aligned_cols=185 Identities=25% Similarity=0.381 Sum_probs=154.7
Q ss_pred CCccceeecccCceEEEEEEec---CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CeEE
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP---DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLL 493 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~---~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~ 493 (611)
.|.+.+.||+|+||.||+|... +++.||+|.+.... .....+.+|+.++..++||||+++++++.+. +.+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3777899999999999999964 47899999998632 3456778899999999999999999999988 8899
Q ss_pred EEEEcCCCCCHHHHHhcCCCCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcC----CCcEEEEee
Q 007254 494 LVYDFLSRGSLEENLHGNKKDP-AAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD----DFEPQLSDF 568 (611)
Q Consensus 494 lV~Ey~~~gsL~~~L~~~~~~~-~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~----~~~vKL~DF 568 (611)
+||||+++ +|.+.+....... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999965 7777765433222 368899999999999999999999 89999999999999999 899999999
Q ss_pred ccccccCCCCC-ceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 569 GLAKWASTSSS-HITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 569 GlA~~~~~~~~-~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
|+++....... ........||+.|+|||+.. ..++.++|||||
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 202 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAI 202 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHH
Confidence 99987754332 22334567899999999764 568999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=243.45 Aligned_cols=182 Identities=25% Similarity=0.393 Sum_probs=156.0
Q ss_pred CCccceeecccCceEEEEEEe-cCCCEEEEEEecCCh-------hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 007254 423 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~~-------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 494 (611)
+|...+.||+|+||.||++.. .+++.||+|+++... ...+.+.+|+.+++.++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999985 578999999986532 245788999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCC-cEEEEeeccccc
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKW 573 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~-~vKL~DFGlA~~ 573 (611)
||||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++||||||+||+++.++ .+||+|||++..
T Consensus 81 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 999999999999997543 48899999999999999999999 8999999999999998775 599999999987
Q ss_pred cCCCCCc--eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 574 ASTSSSH--ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 574 ~~~~~~~--~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
....... .......||+.|+|||+.. ..++.++|+|||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~sl 194 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSV 194 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHH
Confidence 7643211 1112357899999999875 778999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=248.10 Aligned_cols=180 Identities=26% Similarity=0.416 Sum_probs=157.4
Q ss_pred CCCccceeecccCceEEEEEEe-cCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 007254 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 499 (611)
.+|...+.||.|+||.||+|.. .+|+.||+|.+.... ...+.+.+|+.+++.++||||+++++++...+.+|+||||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688899999999999999985 478999999986543 34567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~ 579 (611)
++++|..++... .+++.++..++.+++.||.|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 99 AGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred CCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 999999988643 48899999999999999999999 8999999999999999999999999999986654322
Q ss_pred ceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 580 HITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 580 ~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......|++.|+|||+.. ..++.++|+|||
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 201 (296)
T cd06655 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 201 (296)
T ss_pred --cCCCcCCCccccCcchhcCCCCCchhhHHHH
Confidence 122457899999999876 778999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-28 Score=243.88 Aligned_cols=179 Identities=27% Similarity=0.390 Sum_probs=158.6
Q ss_pred CCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 497 (611)
+|.+.+.||.|+||.||++... +++.||+|++.... ...+.+.+|+++++.++||||+++++++.+.+++|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5788999999999999999875 68999999997532 456789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCC
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~ 577 (611)
|+.+++|.+.+... ..+++..+..++.|++.||.|||. .+|+|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 99999999999754 358899999999999999999999 89999999999999999999999999999876554
Q ss_pred CCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 578 SSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 578 ~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
. ......|+..|++||+.. ..++.++|+|||
T Consensus 154 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl 185 (258)
T cd05578 154 T---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSL 185 (258)
T ss_pred c---cccccCCChhhcCHHHHcccCCCCcccchhh
Confidence 3 223467899999999875 668999999996
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=241.08 Aligned_cols=176 Identities=27% Similarity=0.403 Sum_probs=148.8
Q ss_pred eeecccCceEEEEEEec--C--CCEEEEEEecCChh--HHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 007254 428 NLIGKGGSSQVYKGCLP--D--GKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (611)
Q Consensus 428 ~~IG~G~fG~Vyk~~~~--~--g~~vAVK~lk~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 501 (611)
+.||+|+||.||+|.+. + +..+|+|.++.... ..+++..|+.+++.+.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999753 2 26899999986653 5678999999999999999999999875 4568999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCce
Q 007254 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (611)
Q Consensus 502 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~ 581 (611)
|+|.+++.... .+++..+..++.|++.||.|||. .+|+||||||+|||++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 99999997653 58899999999999999999998 899999999999999999999999999999775543322
Q ss_pred e-ecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 582 T-CTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 582 ~-~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
. .....++..|+|||+.. ..++.++|||||
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 184 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSY 184 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHH
Confidence 1 11223457899999775 778999999996
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.7e-28 Score=243.06 Aligned_cols=178 Identities=27% Similarity=0.436 Sum_probs=147.1
Q ss_pred eeecccCceEEEEEEec----CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-CCeEEEEEEcCC
Q 007254 428 NLIGKGGSSQVYKGCLP----DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFE-DNNLLLVYDFLS 500 (611)
Q Consensus 428 ~~IG~G~fG~Vyk~~~~----~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lV~Ey~~ 500 (611)
+.||+|+||.||+|.+. ++..+|+|.+... ......+.+|+.+++.++||||+++++++.. ++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 36899999999999853 2457999998643 3456788999999999999999999998764 556899999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCc
Q 007254 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (611)
Q Consensus 501 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~ 580 (611)
+|+|.+++.... ..+.+..+..++.|++.||.|||+ .+|+||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSET---HNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 999999997543 246788888999999999999999 89999999999999999999999999999865432211
Q ss_pred --eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 581 --ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 581 --~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.......+++.|+|||+.. ..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 188 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSF 188 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHH
Confidence 1122456788899999765 788999999996
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.7e-28 Score=248.53 Aligned_cols=180 Identities=27% Similarity=0.381 Sum_probs=155.6
Q ss_pred CCccceeecccCceEEEEEEec-CCCEEEEEEecCCh------hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 495 (611)
+|...+.||+|+||.||+|... +|+.||||.++... .....+..|+++++.++|+||+++++++.+.+.+++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999865 68999999997643 2345677899999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
|||+ +|+|.+++.... ..+++..+..++.||+.||.|||. .+|+|+||||+|||++.++.++|+|||+++...
T Consensus 81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 899999997543 358999999999999999999999 899999999999999999999999999998776
Q ss_pred CCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 576 TSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
..... .....+++.|+|||+.. ..++.++|||||
T Consensus 154 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 189 (298)
T cd07841 154 SPNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSV 189 (298)
T ss_pred CCCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHH
Confidence 54321 23346788999999764 567999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=245.20 Aligned_cols=182 Identities=27% Similarity=0.355 Sum_probs=156.8
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 497 (611)
++|.+.+.||+|+||.||+|... +++.||||.++.. ....+.+.+|+++++.++|+||+++++++...+.+++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999865 6889999998753 2345788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCC
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~ 577 (611)
|++++.+..++... ..+++.++..++.+|+.||.|||. .+|+||||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEASP----GGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 99987776655432 348899999999999999999999 89999999999999999999999999999887654
Q ss_pred CCceeecCCccCCCcccceecc-C-CCcCcceEEeC
Q 007254 578 SSHITCTDVAGTFGYVVLILNP-I-AFLFMFNCWFF 611 (611)
Q Consensus 578 ~~~~~~~~~~GT~~Y~aPE~~~-~-~~~~~sDiWSL 611 (611)
... ......|+..|+|||+.. . .++.++|||||
T Consensus 154 ~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~sl 188 (288)
T cd07833 154 PAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAI 188 (288)
T ss_pred ccc-cccCcccccCCcCCchhcCCCCcCchhhHHHH
Confidence 421 223467899999999875 4 78999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=262.54 Aligned_cols=178 Identities=25% Similarity=0.358 Sum_probs=153.6
Q ss_pred eeecccCceEEEEEEec-CCCEEEEEEecCC-hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCCHH
Q 007254 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLE 505 (611)
Q Consensus 428 ~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~ 505 (611)
-+||+|.||+||-|++. +...+|||-+... ......+.+||.+-+.|+|.|||+++|.|.+++++-|.||-++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 47999999999999965 4556899988654 355677899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEc-CCCcEEEEeeccccccCCCCCceeec
Q 007254 506 ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKWASTSSSHITCT 584 (611)
Q Consensus 506 ~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~-~~~~vKL~DFGlA~~~~~~~~~~~~~ 584 (611)
.+|+.. ..+..=.+.+.-.+..||++||.|||. +.|||||||-+|+|++ -.|.+||+|||-++.+..-.. ...
T Consensus 661 sLLrsk-WGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP--~TE 734 (1226)
T KOG4279|consen 661 SLLRSK-WGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP--CTE 734 (1226)
T ss_pred HHHHhc-cCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccCCc--ccc
Confidence 999754 323223677888899999999999999 8899999999999996 468999999999998865443 234
Q ss_pred CCccCCCcccceecc---CCCcCcceEEeC
Q 007254 585 DVAGTFGYVVLILNP---IAFLFMFNCWFF 611 (611)
Q Consensus 585 ~~~GT~~Y~aPE~~~---~~~~~~sDiWSL 611 (611)
++.||+.|||||++. ..|..++|||||
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~ 764 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSF 764 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhc
Confidence 688999999999874 889999999998
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=241.03 Aligned_cols=183 Identities=24% Similarity=0.380 Sum_probs=154.8
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCC------hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CeE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS------EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNL 492 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~ 492 (611)
.+|.+.+.||+|+||.||+|... +++.||+|.+... ......+.+|+++++.++|+||+++++++.+. +.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47889999999999999999864 6899999987532 23456788999999999999999999998764 568
Q ss_pred EEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccc
Q 007254 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~ 572 (611)
++||||+++++|.+.+.... .+++.....++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG----ALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 99999999999999987543 37889999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCC-ceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 573 WASTSSS-HITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 573 ~~~~~~~-~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
....... ........||+.|+|||+.. ..++.++|+|||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 195 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSV 195 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHH
Confidence 6543211 11123457999999999876 678999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=241.12 Aligned_cols=177 Identities=30% Similarity=0.490 Sum_probs=152.1
Q ss_pred CCCccceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 501 (611)
++|.+.+.||+|+||.||++.. +++.||+|.++... ....+.+|+.+++.++||||+++++++.. +..++||||+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~~~ 82 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMSK 82 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECCCC
Confidence 4678899999999999999875 77889999997653 34678899999999999999999999865 457999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCce
Q 007254 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (611)
Q Consensus 502 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~ 581 (611)
|+|.+++..... ..+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 83 GNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 999999975432 358899999999999999999999 899999999999999999999999999998654321
Q ss_pred eecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 582 TCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 582 ~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.....+..|+|||+.. ..++.++|+|||
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~sl 183 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSY 183 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHH
Confidence 1234567899999876 788999999997
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=256.48 Aligned_cols=178 Identities=29% Similarity=0.429 Sum_probs=149.1
Q ss_pred cceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHH--hcCCCCeeeEEEEEEeCC----eEEEEEEcC
Q 007254 426 AENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIIT--TLHHKNIISLLGFCFEDN----NLLLVYDFL 499 (611)
Q Consensus 426 ~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~--~l~HpnIv~l~~~~~~~~----~~~lV~Ey~ 499 (611)
..++||+|.||.||||.+ +++.||||++...+ ...|+.|-+|.. .+.|+||++++++-.... .++||++|.
T Consensus 214 l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~~--kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh 290 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQE--KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH 290 (534)
T ss_pred hHHHhhcCccceeehhhc-cCceeEEEecCHHH--HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence 356799999999999999 56999999997543 456777877766 468999999999876554 789999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHc------CCCCCeEecCCCCCCEEEcCCCcEEEEeeccccc
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS------GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~------~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~ 573 (611)
+.|+|.++|..+ .++|....+|+..+++||+|||. +.+.+|+|||||.+|||+-+|+...|+|||||..
T Consensus 291 ~kGsL~dyL~~n-----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 291 PKGSLCDYLKAN-----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR 365 (534)
T ss_pred cCCcHHHHHHhc-----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence 999999999865 48999999999999999999997 3335899999999999999999999999999998
Q ss_pred cCCCCCceeecCCccCCCcccceeccCCCcC-------cceEEeC
Q 007254 574 ASTSSSHITCTDVAGTFGYVVLILNPIAFLF-------MFNCWFF 611 (611)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~~~-------~sDiWSL 611 (611)
+............+||.-|||||++....++ +.||||+
T Consensus 366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYam 410 (534)
T KOG3653|consen 366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAM 410 (534)
T ss_pred ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHH
Confidence 8765444444457999999999998644444 4777764
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-28 Score=247.52 Aligned_cols=180 Identities=23% Similarity=0.321 Sum_probs=153.2
Q ss_pred CCccceeecccCceEEEEEEec-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
+|.+.+.||+|+||.||+|... +|+.||+|.++... .....+.+|+++++.++||||+++++++.+.+.+|+|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778899999999999999865 78999999987532 2345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
+. ++|.+.+.... ..+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDSCN---GDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 96 58888776432 348999999999999999999999 899999999999999999999999999998664432
Q ss_pred CceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 579 SHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
. ......+|+.|+|||+.. ..++.++|||||
T Consensus 154 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl 186 (284)
T cd07839 154 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSA 186 (284)
T ss_pred C--CcCCCccccCCcChHHHhCCcccCcHHHHHHH
Confidence 2 123457899999999764 457999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=237.89 Aligned_cols=181 Identities=24% Similarity=0.339 Sum_probs=156.6
Q ss_pred CCccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
+|...+.||+|+||.||++... +++.+|||.+... ......+.+|+++++.++||||+++++.+...+.+++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778899999999999999864 7889999998653 34567889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCC-CcEEEEeeccccccCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDFGLAKWASTS 577 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~-~~vKL~DFGlA~~~~~~ 577 (611)
+++++|.+++.... ...+++..+..++.+++.||.|||+ ++|+|+||||+||+++++ +.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999999997643 2358999999999999999999999 899999999999999855 46899999999887654
Q ss_pred CCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 578 SSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 578 ~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
... ....|+..|+|||+.. ..++.++|+|||
T Consensus 156 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 187 (256)
T cd08220 156 SKA---YTVVGTPCYISPELCEGKPYNQKSDIWAL 187 (256)
T ss_pred ccc---cccccCCcccCchhccCCCCCcccchHHH
Confidence 321 2357899999999876 778999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=245.68 Aligned_cols=178 Identities=26% Similarity=0.406 Sum_probs=152.7
Q ss_pred ceeecccCceEEEEEE-ecCCCEEEEEEecCCh-hHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEEEEcCCCCC
Q 007254 427 ENLIGKGGSSQVYKGC-LPDGKELAVKILKPSE-DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSRGS 503 (611)
Q Consensus 427 ~~~IG~G~fG~Vyk~~-~~~g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 503 (611)
.+.||+|+|+.|--+. +.+|+++|||++.+.. ...++..+|++++..- .|+||++|+++|.++.++|||||-|.||+
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 3679999999999887 6799999999997754 5678999999998877 59999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCc---EEEEeeccccccCCC---
Q 007254 504 LEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE---PQLSDFGLAKWASTS--- 577 (611)
Q Consensus 504 L~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~---vKL~DFGlA~~~~~~--- 577 (611)
|..+|++++ .|++.++.++..+|+.||.|||. +||.||||||+|||..+-.. +|||||.|..-....
T Consensus 163 lLshI~~~~----~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 163 LLSHIQKRK----HFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred HHHHHHHhh----hccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 999998775 49999999999999999999999 99999999999999976543 799999987644321
Q ss_pred --CCceeecCCccCCCcccceecc------CCCcCcceEEeC
Q 007254 578 --SSHITCTDVAGTFGYVVLILNP------IAFLFMFNCWFF 611 (611)
Q Consensus 578 --~~~~~~~~~~GT~~Y~aPE~~~------~~~~~~sDiWSL 611 (611)
.+.....+.+|+-.|||||+.. ..|+...|.|||
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSL 277 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSL 277 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHH
Confidence 1112334688999999999642 778999999997
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=266.53 Aligned_cols=194 Identities=25% Similarity=0.430 Sum_probs=165.6
Q ss_pred ccChHHHHHhcC---------CCccceeecccCceEEEEEEec-C---CCEEEEEEecCC--hhHHHHHHHHHHHHHhcC
Q 007254 411 LFNYQDLLSATS---------NFLAENLIGKGGSSQVYKGCLP-D---GKELAVKILKPS--EDVIKEFVLEIEIITTLH 475 (611)
Q Consensus 411 ~~~~~~l~~~~~---------~f~~~~~IG~G~fG~Vyk~~~~-~---g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~ 475 (611)
.++|++...+.. ...++++||.|.||.||+|.++ . ...||||.||.. +....+|+.|..||.+++
T Consensus 609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd 688 (996)
T KOG0196|consen 609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD 688 (996)
T ss_pred CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC
Confidence 345655544433 3467899999999999999976 2 357999999974 577889999999999999
Q ss_pred CCCeeeEEEEEEeCCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCE
Q 007254 476 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNI 555 (611)
Q Consensus 476 HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NI 555 (611)
||||++|.|+......+.||.|||++|+|+.+|+.+. ..|.|.+..-++++|+.||.||-. .++|||||..+||
T Consensus 689 HPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNI 762 (996)
T KOG0196|consen 689 HPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNI 762 (996)
T ss_pred CCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhhe
Confidence 9999999999999999999999999999999998764 349999999999999999999998 9999999999999
Q ss_pred EEcCCCcEEEEeeccccccCCCCCceeecCCccC--CCcccceecc-CCCcCcceEEeC
Q 007254 556 LLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT--FGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 556 Ll~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT--~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
|++.+...|++||||++.+.++... ..++.-|- .-|-|||.+- .++|.+||+|||
T Consensus 763 LVNsnLvCKVsDFGLSRvledd~~~-~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSy 820 (996)
T KOG0196|consen 763 LVNSNLVCKVSDFGLSRVLEDDPEA-AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSY 820 (996)
T ss_pred eeccceEEEeccccceeecccCCCc-cccccCCccceeecChhHhhhcccCchhhcccc
Confidence 9999999999999999988765522 22333343 4599999775 999999999997
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-28 Score=244.85 Aligned_cols=172 Identities=23% Similarity=0.359 Sum_probs=146.3
Q ss_pred eeecccCceEEEEEEec-C-------CCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 428 NLIGKGGSSQVYKGCLP-D-------GKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 428 ~~IG~G~fG~Vyk~~~~-~-------g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
+.||+|+||.||+|... . ...+|+|.+.... ...+.+.+|+.+++.+.||||+++++++...+..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 36899999999999753 2 2358888886544 4456788999999999999999999999998999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCc--------EEEEeecc
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE--------PQLSDFGL 570 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~--------vKL~DFGl 570 (611)
+++|+|.+++.... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++. ++++|||+
T Consensus 81 ~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKNK---NLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 99999999997653 258899999999999999999999 99999999999999987765 69999999
Q ss_pred ccccCCCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 571 AKWASTSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 571 A~~~~~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
+...... ....|++.|+|||+.. ..++.++|||||
T Consensus 155 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl 191 (258)
T cd05078 155 SITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSF 191 (258)
T ss_pred ccccCCc------hhccccCCccCchhccCCCCCCchhhHHHH
Confidence 8765432 2357899999999875 468999999996
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=241.83 Aligned_cols=184 Identities=28% Similarity=0.447 Sum_probs=156.0
Q ss_pred CCccceeecccCceEEEEEEecC--CCEEEEEEecCC-----------hhHHHHHHHHHHHHHh-cCCCCeeeEEEEEEe
Q 007254 423 NFLAENLIGKGGSSQVYKGCLPD--GKELAVKILKPS-----------EDVIKEFVLEIEIITT-LHHKNIISLLGFCFE 488 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~~--g~~vAVK~lk~~-----------~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~ 488 (611)
+|.+.+.||+|+||.||+|.... ++.+|+|.+... .....++..|+.++.. ++||||++++++|.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778899999999999999754 688999988532 2345678889998875 799999999999999
Q ss_pred CCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEee
Q 007254 489 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568 (611)
Q Consensus 489 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DF 568 (611)
.++.++||||+++++|.+.+.........+++..++.++.|++.||.|||. ..+|+|+||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence 999999999999999999886533334568999999999999999999995 167999999999999999999999999
Q ss_pred ccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 569 GLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 569 GlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
|++....... ......|++.|++||+.. ..++.++|+|||
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~sl 199 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAF 199 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHH
Confidence 9998765543 233567999999999876 678999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.8e-28 Score=246.47 Aligned_cols=178 Identities=28% Similarity=0.425 Sum_probs=154.7
Q ss_pred CccceeecccCceEEEEEEec-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 007254 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (611)
Q Consensus 424 f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 500 (611)
|...+.||+|+||.||+|... +++.||+|.++.. ....+.+.+|+++++.++||||++++++|...+..|+||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 556678999999999999864 6889999998753 3455778999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCc
Q 007254 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (611)
Q Consensus 501 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~ 580 (611)
+++|.+.+... .+++..+..++.|++.||.|||+ .+|+|+||+|+||++++++.++|+|||++..+.....
T Consensus 86 ~~~L~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 86 GGSALDLLKPG-----PLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 99999988542 47899999999999999999999 8999999999999999999999999999987654321
Q ss_pred eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 581 ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 581 ~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......|+..|+|||+.. ..++.++|+|||
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 187 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSL 187 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHH
Confidence 222356899999999876 778999999996
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-28 Score=259.08 Aligned_cols=184 Identities=29% Similarity=0.467 Sum_probs=158.7
Q ss_pred hcCCCccceeecccCceEEEEEEecC---CC--EEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeE
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLPD---GK--ELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 492 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~~---g~--~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 492 (611)
........++||.|-||.||+|.+.+ |+ .||||..|.+. +..+.|+.|.-+|++++||||++|+|+|.+ ...
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~ 465 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPM 465 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cce
Confidence 34455667899999999999998643 33 58999998743 567889999999999999999999999976 568
Q ss_pred EEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccc
Q 007254 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~ 572 (611)
+||||+++-|.|..+|+.++ ..++......++.||+.||.|||+ ..+|||||..+|||+.+..-+||+||||++
T Consensus 466 WivmEL~~~GELr~yLq~nk---~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNK---DSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred eEEEecccchhHHHHHHhcc---ccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhh
Confidence 99999999999999998765 368888889999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 573 WASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 573 ~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
++.+.... ..+...-...|||||-++ .+++.+||+|-|
T Consensus 540 ~~ed~~yY-kaS~~kLPIKWmaPESINfRrFTtASDVWMF 578 (974)
T KOG4257|consen 540 YLEDDAYY-KASRGKLPIKWMAPESINFRRFTTASDVWMF 578 (974)
T ss_pred hccccchh-hccccccceeecCccccchhcccchhhHHHH
Confidence 99886644 333455567799999765 999999999975
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=243.70 Aligned_cols=181 Identities=25% Similarity=0.315 Sum_probs=154.4
Q ss_pred CCccceeecccCceEEEEEEe----cCCCEEEEEEecCCh-----hHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeE
Q 007254 423 NFLAENLIGKGGSSQVYKGCL----PDGKELAVKILKPSE-----DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 492 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~----~~g~~vAVK~lk~~~-----~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 492 (611)
+|.+.+.||+|+||.||++.. .+|+.||+|+++... ...+.+..|+.++..+ +|+||+.+++++..++.+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999985 378999999997532 2346678899999999 599999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccc
Q 007254 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~ 572 (611)
|+||||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE----RFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 99999999999999997543 47889999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCCceeecCCccCCCcccceecc---CCCcCcceEEeC
Q 007254 573 WASTSSSHITCTDVAGTFGYVVLILNP---IAFLFMFNCWFF 611 (611)
Q Consensus 573 ~~~~~~~~~~~~~~~GT~~Y~aPE~~~---~~~~~~sDiWSL 611 (611)
........ ......|++.|+|||+.. ..++.++|||||
T Consensus 154 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~sl 194 (290)
T cd05613 154 EFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSM 194 (290)
T ss_pred eccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHH
Confidence 76543211 122467999999999875 457889999996
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.8e-28 Score=254.87 Aligned_cols=182 Identities=24% Similarity=0.331 Sum_probs=158.8
Q ss_pred CCCccceeecccCceEEEEEEecCCCEEEEEEecC---ChhHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCeEEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~---~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E 497 (611)
..|.+++.||+||.+.||++...+.+.+|+|.+.. +.....-|.+||.+|.+|+ |.+||+||+|-..++++|+|||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 45778899999999999999987888899887653 4567888999999999995 8999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCC
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~ 577 (611)
|= .-+|...|.+.... ...| .+..|..||+.|+.++|. .||||.||||.|+||.++ .+||+|||+|..+..+
T Consensus 441 ~G-d~DL~kiL~k~~~~--~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlVkG-~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 441 CG-DIDLNKILKKKKSI--DPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLVKG-RLKLIDFGIANAIQPD 512 (677)
T ss_pred cc-cccHHHHHHhccCC--CchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEEee-eEEeeeechhcccCcc
Confidence 85 44999999876542 3345 677899999999999999 999999999999999765 8999999999999999
Q ss_pred CCceeecCCccCCCcccceecc------------CCCcCcceEEeC
Q 007254 578 SSHITCTDVAGTFGYVVLILNP------------IAFLFMFNCWFF 611 (611)
Q Consensus 578 ~~~~~~~~~~GT~~Y~aPE~~~------------~~~~~~sDiWSL 611 (611)
++.+.....+||+.||+||-+. .+.+.++|||||
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSL 558 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSL 558 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhh
Confidence 9999989999999999999542 236789999997
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=242.83 Aligned_cols=174 Identities=26% Similarity=0.320 Sum_probs=150.7
Q ss_pred ecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCCH
Q 007254 430 IGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504 (611)
Q Consensus 430 IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 504 (611)
||+|+||+||++... +|+.||+|++.... .....+..|+++++.++||||+++++.+...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999854 78999999986532 2345677899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCceeec
Q 007254 505 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 584 (611)
Q Consensus 505 ~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~ 584 (611)
.+++..... ..+++.++..++.|++.||.|||+ .+|+||||+|+||++++++.+||+|||++....... ...
T Consensus 81 ~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~ 152 (277)
T cd05577 81 KYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIK 152 (277)
T ss_pred HHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccc
Confidence 999976543 358999999999999999999999 899999999999999999999999999998765422 123
Q ss_pred CCccCCCcccceecc-CCCcCcceEEeC
Q 007254 585 DVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 585 ~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
...|++.|++||+.. ..++.++|||||
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~sl 180 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFAL 180 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHH
Confidence 357899999999875 668999999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-28 Score=249.33 Aligned_cols=175 Identities=27% Similarity=0.408 Sum_probs=152.1
Q ss_pred ceeecccCceEEEEEEec-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCCH
Q 007254 427 ENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504 (611)
Q Consensus 427 ~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 504 (611)
...||+|+||.||++... +++.||||.+.... ...+.+.+|+.+++.++|+||+++++.+...++.|+||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 466999999999999864 68899999987543 4456788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCceeec
Q 007254 505 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 584 (611)
Q Consensus 505 ~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~ 584 (611)
.+++... .+++.++..++.||+.||.|||+ .+|+||||||+||++++++.+||+|||++........ ...
T Consensus 107 ~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~ 176 (292)
T cd06658 107 TDIVTHT-----RMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRK 176 (292)
T ss_pred HHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCc
Confidence 9987532 37899999999999999999999 8999999999999999999999999999986654322 123
Q ss_pred CCccCCCcccceecc-CCCcCcceEEeC
Q 007254 585 DVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 585 ~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
...||+.|+|||+.. ..++.++|+|||
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 204 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSL 204 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHH
Confidence 457899999999875 778999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=261.98 Aligned_cols=191 Identities=26% Similarity=0.422 Sum_probs=167.0
Q ss_pred hHHHHHhcCCCccceeecccCceEEEEEE-ecCCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEe---
Q 007254 414 YQDLLSATSNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFE--- 488 (611)
Q Consensus 414 ~~~l~~~~~~f~~~~~IG~G~fG~Vyk~~-~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~--- 488 (611)
++.+...++-|.+.+.||.|.+|+||++. .++++..||||+..+.+...++..|.+||+.+ +|||++.+||+|..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 33444556778999999999999999998 55899999999999887778888899999988 59999999999974
Q ss_pred --CCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEE
Q 007254 489 --DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 566 (611)
Q Consensus 489 --~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~ 566 (611)
++.++||||||.+|+..+++.+.+ ...+.|..+..|+.+++.||.+||+ ..+||||||-.||||+.++.+||+
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEe
Confidence 468999999999999999998765 5679999999999999999999999 889999999999999999999999
Q ss_pred eeccccccCCCCCceeecCCccCCCcccceecc------CCCcCcceEEeC
Q 007254 567 DFGLAKWASTSSSHITCTDVAGTFGYVVLILNP------IAFLFMFNCWFF 611 (611)
Q Consensus 567 DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~------~~~~~~sDiWSL 611 (611)
|||.+..+... -....+..||++|||||++- ..|+..+|+|||
T Consensus 166 DFGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsL 214 (953)
T KOG0587|consen 166 DFGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSL 214 (953)
T ss_pred eeeeeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhc
Confidence 99999877653 23455789999999999863 567889999997
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=240.95 Aligned_cols=185 Identities=24% Similarity=0.405 Sum_probs=152.4
Q ss_pred CccceeecccCceEEEEEEec----CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC------
Q 007254 424 FLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN------ 490 (611)
Q Consensus 424 f~~~~~IG~G~fG~Vyk~~~~----~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------ 490 (611)
|.+.+.||+|+||.||+|.+. +++.||||+++.. ....+++.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566789999999999999853 4688999999764 345677899999999999999999999886532
Q ss_pred eEEEEEEcCCCCCHHHHHhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEee
Q 007254 491 NLLLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568 (611)
Q Consensus 491 ~~~lV~Ey~~~gsL~~~L~~~~--~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DF 568 (611)
..++++||+.+|+|.+++.... .....+++.....++.|++.||.|||+ .+|+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence 2478999999999998875322 223458899999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 569 GLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 569 GlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
|+++...............+++.|++||... ..++.++|||||
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~sl 201 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAF 201 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHH
Confidence 9998775443322333445678899999775 778999999996
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=242.95 Aligned_cols=172 Identities=26% Similarity=0.302 Sum_probs=143.0
Q ss_pred eecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHH---hcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 007254 429 LIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIIT---TLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (611)
Q Consensus 429 ~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~---~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 500 (611)
.||+|+||.||++... +++.+|+|.+.+.. .....+.+|..++. ..+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999864 68999999986532 22233445544443 4479999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCc
Q 007254 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (611)
Q Consensus 501 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~ 580 (611)
+|+|.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+|||+++++.++|+|||++........
T Consensus 81 ~~~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~- 152 (279)
T cd05633 81 GGDLHYHLSQHG----VFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (279)
T ss_pred CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc-
Confidence 999999886543 48999999999999999999999 8999999999999999999999999999976543221
Q ss_pred eeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 581 ITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 581 ~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
....||+.|+|||+.. ..++.++|||||
T Consensus 153 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 182 (279)
T cd05633 153 ---HASVGTHGYMAPEVLQKGTAYDSSADWFSL 182 (279)
T ss_pred ---cCcCCCcCccCHHHhcCCCCCCchhhhHHH
Confidence 2357999999999764 568999999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=244.66 Aligned_cols=181 Identities=24% Similarity=0.329 Sum_probs=154.9
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CeEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLLV 495 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lV 495 (611)
++|.+.+.||.|+||.||+|... +++.+|+|.++... .....+.+|++++..++||||+++++++... +.+|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 56888899999999999999975 68899999997543 2345677899999999999999999999877 889999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
|||+. ++|.+.+.... ..+++.++..++.||+.||.|||+ .+|+|+||||+|||++.++.+||+|||++....
T Consensus 85 ~e~~~-~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVE-HDLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcC-cCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 99997 49988887543 258999999999999999999999 899999999999999999999999999998776
Q ss_pred CCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 576 TSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
.... ......+++.|+|||+.. ..++.++|||||
T Consensus 158 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~sl 193 (293)
T cd07843 158 SPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSV 193 (293)
T ss_pred CCcc--ccccccccccccCchhhcCCccccchhhHHHH
Confidence 5422 223456899999999764 446899999996
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-28 Score=238.02 Aligned_cols=192 Identities=24% Similarity=0.298 Sum_probs=163.2
Q ss_pred HhcCCCccceeecccCceEEEEEE-ecCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-----e
Q 007254 419 SATSNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN-----N 491 (611)
Q Consensus 419 ~~~~~f~~~~~IG~G~fG~Vyk~~-~~~g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~ 491 (611)
..-++|.+.+.||+|||+.||.+. ..++..+|+|.+.... +..+..++|++..++++|||++++++++..+. .
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 445689999999999999999998 6688999999987755 67888999999999999999999998876433 4
Q ss_pred EEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccc
Q 007254 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (611)
Q Consensus 492 ~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA 571 (611)
.||+++|...|+|.+.+...+.....+++.+.+.|+.+|++||++||... .++.||||||.|||+++.+.++|.|||-+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 89999999999999999887776778999999999999999999999844 36999999999999999999999999998
Q ss_pred cccCCCC---C-c---eeecCCccCCCcccceecc----CCCcCcceEEeC
Q 007254 572 KWASTSS---S-H---ITCTDVAGTFGYVVLILNP----IAFLFMFNCWFF 611 (611)
Q Consensus 572 ~~~~~~~---~-~---~~~~~~~GT~~Y~aPE~~~----~~~~~~sDiWSL 611 (611)
...+-.- . . ........|..|.|||+.. ..+++++|||||
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSL 227 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSL 227 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhh
Confidence 8765211 0 0 0111245689999999875 778999999997
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=241.76 Aligned_cols=182 Identities=24% Similarity=0.399 Sum_probs=155.5
Q ss_pred CCccceeecccCceEEEEEEec-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 499 (611)
+|...+.||.|++|.||+|... +|+.||||.++... .....+.+|+++++.++|+||+++++++.+.+.+++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788899999999999999975 68999999997643 23466788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~ 579 (611)
.+ +|.+++..... ...+++..+..++.|++.||.|||+ .+|+||||||+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 75 88888865432 2458999999999999999999999 8999999999999999999999999999986654322
Q ss_pred ceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 580 HITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 580 ~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
......+|+.|++||+.. ..++.++|||||
T Consensus 156 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~sl 187 (284)
T cd07836 156 --TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSV 187 (284)
T ss_pred --ccccccccccccChHHhcCCCCCCcHHHHHHH
Confidence 123456899999999764 457899999996
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-27 Score=243.01 Aligned_cols=183 Identities=26% Similarity=0.386 Sum_probs=156.9
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CeEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLLVY 496 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lV~ 496 (611)
++|...+.||.|++|.||++... +++.+|+|.+.... ....++.+|+++++.++||||++++++|.+. +.+|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46788899999999999999974 68899999997643 3567899999999999999999999998653 4789999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
||+++++|.+++.........+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999999876543344568899999999999999999999 9999999999999999999999999999876543
Q ss_pred CCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 577 SSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
... ....++..|++||+.. ..++.++|||||
T Consensus 158 ~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~sl 189 (287)
T cd06621 158 SLA----GTFTGTSFYMAPERIQGKPYSITSDVWSL 189 (287)
T ss_pred ccc----ccccCCccccCHHHhcCCCCCchhhHHHH
Confidence 221 2356889999999775 778999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-27 Score=240.19 Aligned_cols=178 Identities=27% Similarity=0.420 Sum_probs=154.9
Q ss_pred CccceeecccCceEEEEEEec-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 007254 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (611)
Q Consensus 424 f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 500 (611)
|...+.||+|+||.||+|... +++.||||++.... .....+.+|+.++..++||||+++++++..+++.|+||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 566788999999999999864 78899999986543 345678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCc
Q 007254 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (611)
Q Consensus 501 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~ 580 (611)
+++|.+.+... .+++..+..++.+++.||.|||+ .+++|+||||+||+++.++.++|+|||++..+.....
T Consensus 86 ~~~l~~~i~~~-----~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 86 GGSALDLLEPG-----PLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 99999988642 47899999999999999999999 9999999999999999999999999999987654321
Q ss_pred eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 581 ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 581 ~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......|+..|++||+.. ..++.++|+|||
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~sl 187 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSL 187 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHH
Confidence 223457899999999875 678899999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-27 Score=236.18 Aligned_cols=182 Identities=23% Similarity=0.361 Sum_probs=157.2
Q ss_pred CCccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
+|.+.+.||+|+||.||++... +|+.||+|.+... ....+++.+|+.+++.++||||+++++++...++.|+||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788899999999999999854 7899999998643 34456889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
+.+++|.+.+..... ..+++.++..++.|++.||.|||+ .+++|+||+|+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQRG--VLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 999999998875422 357899999999999999999999 899999999999999999999999999998765432
Q ss_pred CceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 579 SHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
. ......|++.|+|||+.. ..++.++|+|||
T Consensus 156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~sl 187 (256)
T cd08218 156 E--LARTCIGTPYYLSPEICENRPYNNKSDIWAL 187 (256)
T ss_pred h--hhhhccCCccccCHHHhCCCCCCCccchhHH
Confidence 2 122356899999999875 778899999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-28 Score=248.93 Aligned_cols=185 Identities=28% Similarity=0.401 Sum_probs=155.9
Q ss_pred CCCccceeecccCceEEEEEEe-cCCCEEEEEEecCCh--------hHHHHHHHHHHHHHhcCCCCeeeEEEEEE-eCCe
Q 007254 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE--------DVIKEFVLEIEIITTLHHKNIISLLGFCF-EDNN 491 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~~--------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~~~ 491 (611)
++|..+.+||+|||+.||++.+ ...+.||||+-.... ...+...+|.+|-+.|+||.||++|++|. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 4588889999999999999984 457789999864322 33456788999999999999999999996 4567
Q ss_pred EEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCC---CcEEEEee
Q 007254 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD---FEPQLSDF 568 (611)
Q Consensus 492 ~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~---~~vKL~DF 568 (611)
+|-|+|||+|.+|.-+|..++ .++++++..|.+||+.||.||.... .+|||-||||.||||.+. |.+||+||
T Consensus 543 FCTVLEYceGNDLDFYLKQhk----lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHK----LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred ceeeeeecCCCchhHHHHhhh----hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeec
Confidence 899999999999999997765 4899999999999999999999754 799999999999999654 78999999
Q ss_pred ccccccCCCCCc-----eeecCCccCCCcccceec-----cCCCcCcceEEeC
Q 007254 569 GLAKWASTSSSH-----ITCTDVAGTFGYVVLILN-----PIAFLFMFNCWFF 611 (611)
Q Consensus 569 GlA~~~~~~~~~-----~~~~~~~GT~~Y~aPE~~-----~~~~~~~sDiWSL 611 (611)
||++.+.+.... -.....+||+.|++||.. +.+++.++||||.
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSv 670 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSV 670 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEee
Confidence 999998765433 123357899999999954 2678999999994
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=243.25 Aligned_cols=184 Identities=21% Similarity=0.277 Sum_probs=153.1
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCe-----
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNN----- 491 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~----- 491 (611)
++|.+.+.||+|+||.||+|... +|+.||||.++... .....+.+|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999865 78999999987542 23467888999999995 6999999999987665
Q ss_pred EEEEEEcCCCCCHHHHHhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcC-CCcEEEEeec
Q 007254 492 LLLVYDFLSRGSLEENLHGNKKD-PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFG 569 (611)
Q Consensus 492 ~~lV~Ey~~~gsL~~~L~~~~~~-~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~-~~~vKL~DFG 569 (611)
+|+||||+++ +|.+++...... ...+++..+..++.||+.||.|||. ++|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 888887654322 3468999999999999999999999 89999999999999998 8899999999
Q ss_pred cccccCCCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 570 LAKWASTSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 570 lA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
+++.+...... .....+++.|+|||+.. ..++.++|||||
T Consensus 157 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~sl 198 (295)
T cd07837 157 LGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSV 198 (295)
T ss_pred cceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHH
Confidence 99866443221 12346789999999764 567999999996
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=241.08 Aligned_cols=179 Identities=25% Similarity=0.416 Sum_probs=156.2
Q ss_pred CCccceeecccCceEEEEEEe-cCCCEEEEEEecCC--hhHHHHHHHHHHHHHhcC---CCCeeeEEEEEEeCCeEEEEE
Q 007254 423 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLH---HKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~lV~ 496 (611)
.|...+.||+|+||.||+|.. .+++.||+|.++.. .....++.+|+.+++.++ |||+++++++|......|+||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467778999999999999996 47899999998754 345677889999999997 999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
||+++++|.+++... .+++..+..++.+++.||.|||+ .+|+|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 999999999988643 48899999999999999999999 8999999999999999999999999999988765
Q ss_pred CCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 577 SSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
... ......|+..|+|||+.. ..++.++|+|||
T Consensus 154 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 188 (277)
T cd06917 154 NSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSL 188 (277)
T ss_pred Ccc--ccccccCCcceeCHHHhccCCccccchhHHHH
Confidence 432 223457999999999764 457899999996
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=248.43 Aligned_cols=175 Identities=26% Similarity=0.375 Sum_probs=152.0
Q ss_pred ceeecccCceEEEEEEec-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCCH
Q 007254 427 ENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504 (611)
Q Consensus 427 ~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 504 (611)
...||+|+||.||++... +++.||+|.+.... ...+.+.+|+.++..++||||++++++|...+..|+||||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 457999999999999864 78999999986543 3456788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCceeec
Q 007254 505 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 584 (611)
Q Consensus 505 ~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~ 584 (611)
...+... .+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++........ ...
T Consensus 106 ~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~ 175 (297)
T cd06659 106 TDIVSQT-----RLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRK 175 (297)
T ss_pred HHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--ccc
Confidence 9877542 48899999999999999999999 8999999999999999999999999999986654322 123
Q ss_pred CCccCCCcccceecc-CCCcCcceEEeC
Q 007254 585 DVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 585 ~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
...|++.|+|||+.. ..++.++|||||
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 203 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSL 203 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHH
Confidence 467999999999876 678999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-27 Score=237.22 Aligned_cols=182 Identities=26% Similarity=0.400 Sum_probs=158.2
Q ss_pred CCccceeecccCceEEEEEEec-CCCEEEEEEecCChh---HHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSED---VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
+|...+.||+|+||.||+|... +++.||+|.++.... ....+..|+++++.++|+||+++++++...+.+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999864 789999999976543 677899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
+++++|.+.+.... .+++..+..++.+++.||.|||+ .+|+|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEHGR----ILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhhcC----CCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 99999999987542 47889999999999999999999 899999999999999999999999999998876543
Q ss_pred Ccee--ecCCccCCCcccceecc-CC---CcCcceEEeC
Q 007254 579 SHIT--CTDVAGTFGYVVLILNP-IA---FLFMFNCWFF 611 (611)
Q Consensus 579 ~~~~--~~~~~GT~~Y~aPE~~~-~~---~~~~sDiWSL 611 (611)
.... .....|+..|++||+.. .. ++.++|||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~ 192 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSL 192 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHH
Confidence 3211 12367899999999875 33 7999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=242.88 Aligned_cols=181 Identities=27% Similarity=0.404 Sum_probs=154.2
Q ss_pred CCccceeecccCceEEEEEEec-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
+|...+.||.|+||.||+|... +|+.||||.++... .....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999865 78999999987542 2346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
+. ++|..++..... ..+++..+..++.|++.||.|||. .+++||||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDASPL--SGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 95 689888865432 458999999999999999999999 899999999999999999999999999998765432
Q ss_pred CceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 579 SHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
. ......+++.|+|||+.. ..++.++|||||
T Consensus 155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 187 (284)
T cd07860 155 R--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSL 187 (284)
T ss_pred c--ccccccccccccCCeEEecCCCCCcHHHHHHH
Confidence 2 122346789999999764 446899999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-27 Score=240.90 Aligned_cols=179 Identities=26% Similarity=0.403 Sum_probs=155.9
Q ss_pred CCccceeecccCceEEEEEEec-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 499 (611)
.|...+.||.|+||.||+|... +++.||+|+++.. ......+.+|+.+++.++||||+++++++.+.+..|+||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4666788999999999999865 6889999998754 345678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~ 579 (611)
++|+|.+++... .+++.++..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~i~~~-----~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 85 GGGSALDLLRAG-----PFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999999988642 37888999999999999999999 8999999999999999999999999999987654322
Q ss_pred ceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 580 HITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 580 ~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......||..|+|||+.. ..++.++|+|||
T Consensus 157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~sl 187 (277)
T cd06640 157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSL 187 (277)
T ss_pred --ccccccCcccccCHhHhccCCCccHHHHHHH
Confidence 123357899999999875 678999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-27 Score=237.03 Aligned_cols=172 Identities=24% Similarity=0.320 Sum_probs=151.9
Q ss_pred ecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCCH
Q 007254 430 IGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504 (611)
Q Consensus 430 IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 504 (611)
||.|+||.||++... +++.+|+|++.+.. ...+.+.+|+.+++.++||||+++++++.+.+.+|+||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999975 58999999987532 3457799999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCceeec
Q 007254 505 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 584 (611)
Q Consensus 505 ~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~ 584 (611)
.+++.+.. .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||+++...... ...
T Consensus 81 ~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~ 150 (262)
T cd05572 81 WTILRDRG----LFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTW 150 (262)
T ss_pred HHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccc
Confidence 99997643 38899999999999999999999 999999999999999999999999999998776543 122
Q ss_pred CCccCCCcccceecc-CCCcCcceEEeC
Q 007254 585 DVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 585 ~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
...|++.|++||+.. ..++.++|+|||
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~sl 178 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSL 178 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhh
Confidence 357899999999875 778999999996
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-27 Score=243.36 Aligned_cols=180 Identities=28% Similarity=0.406 Sum_probs=157.3
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 499 (611)
++|.+.+.||+|+||.||++... +++.||+|.+.... .....+.+|+.+++.++||||+++++.|...+..|+||||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 57888999999999999999854 78899999986543 34567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~ 579 (611)
++++|.+++.+. .+++.++..++.+++.||.|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 99 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999998643 37899999999999999999999 8999999999999999999999999999887654332
Q ss_pred ceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 580 HITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 580 ~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......|++.|++||+.. ..++.++|+|||
T Consensus 171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~sl 201 (293)
T cd06647 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 201 (293)
T ss_pred --ccccccCChhhcCchhhccCCCCchhhHHHH
Confidence 223357899999999775 778999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-29 Score=263.29 Aligned_cols=181 Identities=24% Similarity=0.262 Sum_probs=160.1
Q ss_pred cCCCccceeecccCceEEEEEEecCCC-EEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLPDGK-ELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~~g~-~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 495 (611)
..++.....||-||||.|-++...... .+|+|++++.. ...+....|-.||...+.|+||+||..|.+..++|++
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 445666778999999999998875433 48999998743 4567788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
||-|-||.|...|+.+. .|......+++.++++|++|||+ ++||+|||||+|++|+.+|.+||.|||+|+.+.
T Consensus 499 mEaClGGElWTiLrdRg----~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 499 MEACLGGELWTILRDRG----SFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred HHhhcCchhhhhhhhcC----CcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 99999999999998765 48888889999999999999999 999999999999999999999999999999988
Q ss_pred CCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 576 TSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.... ..+++||+.|.|||++. +..+.++|+|||
T Consensus 572 ~g~K---TwTFcGTpEYVAPEIILnKGHD~avDyWaL 605 (732)
T KOG0614|consen 572 SGRK---TWTFCGTPEYVAPEIILNKGHDRAVDYWAL 605 (732)
T ss_pred cCCc---eeeecCCcccccchhhhccCcchhhHHHHH
Confidence 7553 34589999999999775 899999999997
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-26 Score=241.50 Aligned_cols=177 Identities=26% Similarity=0.363 Sum_probs=152.7
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
..|...+.||+|+||.||+|... +|+.||+|.+... .....++.+|+++++.++||||++++++|...+..|+||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45778899999999999999865 6899999998642 234567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
||+. |+|.+.+.... ..+++..+..++.|++.||.|||+ .+|+||||+|+||++++++.+||+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~~---~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 95 EYCL-GSASDILEVHK---KPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HhhC-CCHHHHHHHcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 9996 57777765432 248999999999999999999999 8999999999999999999999999999986654
Q ss_pred CCCceeecCCccCCCcccceecc----CCCcCcceEEeC
Q 007254 577 SSSHITCTDVAGTFGYVVLILNP----IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~~~~~~~~~GT~~Y~aPE~~~----~~~~~~sDiWSL 611 (611)
.. ...|++.|+|||+.. ..++.++|||||
T Consensus 168 ~~------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~ 200 (307)
T cd06607 168 AN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 200 (307)
T ss_pred CC------CccCCccccCceeeeccCCCCCCcccchHHH
Confidence 32 357899999999762 668999999996
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=231.38 Aligned_cols=180 Identities=32% Similarity=0.489 Sum_probs=160.1
Q ss_pred CCccceeecccCceEEEEEEec-CCCEEEEEEecCChh-HHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSED-VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 500 (611)
+|...+.||+|+||.||++... +++.+++|+++.... ....+.+|+++++.++|+||+++++++...+..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4677899999999999999975 789999999987653 66789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCc
Q 007254 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (611)
Q Consensus 501 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~ 580 (611)
+++|.+.+.... ..+++..+..++.+++.||.|||. .+++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 999999987643 358999999999999999999999 9999999999999999999999999999987765432
Q ss_pred eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 581 ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 581 ~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.....|+..|++||+.. ..++.++|+|||
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~sl 183 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSL 183 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHH
Confidence 23467899999999876 668999999996
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-27 Score=240.05 Aligned_cols=181 Identities=25% Similarity=0.395 Sum_probs=158.1
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
++|...+.||.|+||.||++... +++.+|+|.+... .....++.+|+++++.++||||+++++++...+.+++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35777889999999999999875 6899999998764 34567889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
+.+++|.+++.... ..+++..+..++.|++.||.|||+ ..+++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999997653 358889999999999999999997 3689999999999999999999999999997664332
Q ss_pred CceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 579 SHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.. ...|+..|++||+.. ..++.++|||||
T Consensus 156 ~~----~~~~~~~y~~PE~~~~~~~~~~~Dv~sl 185 (265)
T cd06605 156 AK----TFVGTSSYMAPERIQGNDYSVKSDIWSL 185 (265)
T ss_pred hh----cccCChhccCHHHHcCCCCCchhhHHHH
Confidence 21 267899999999875 788999999996
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-27 Score=241.03 Aligned_cols=182 Identities=24% Similarity=0.347 Sum_probs=152.9
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 497 (611)
++|.+.+.||+|+||.||+|... +|+.||+|.++... .....+.+|+++++.++||||+++++++...++.|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57888999999999999999865 78999999986532 345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcC-CCcEEEEeeccccccCC
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWAST 576 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~-~~~vKL~DFGlA~~~~~ 576 (611)
|++ ++|.+.+..... ..+++..+..++.||+.||.|||+ .+|+||||||+||+++. ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhCCC--CCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 995 588887754432 346788888999999999999999 89999999999999985 56799999999987654
Q ss_pred CCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 577 SSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
... ......|++.|+|||+.. ..++.++|||||
T Consensus 156 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~sl 190 (294)
T PLN00009 156 PVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSV 190 (294)
T ss_pred Ccc--ccccCceeecccCHHHHhCCCCCCcHHHHHHH
Confidence 322 123457899999999764 467899999996
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.6e-28 Score=223.68 Aligned_cols=179 Identities=23% Similarity=0.329 Sum_probs=155.2
Q ss_pred CCccceeecccCceEEEEEEe-cCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 423 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
+|...+.||+|.||+||+|.. .+++.||+|.++.++ ......++||-+|+.+.|.|||+|+++...++.+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 355567899999999999984 478999999998754 3567789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
|.. +|..+..... ..++-..+..++.|+++||.|+|+ +++.||||||.|+||+.+|++||+|||+|+.+.-..
T Consensus 83 cdq-dlkkyfdsln---g~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLN---GDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hhH-HHHHHHHhcC---CcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 955 8888876543 347788889999999999999999 899999999999999999999999999999877654
Q ss_pred CceeecCCccCCCcccceecc--CCCcCcceEEe
Q 007254 579 SHITCTDVAGTFGYVVLILNP--IAFLFMFNCWF 610 (611)
Q Consensus 579 ~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWS 610 (611)
..+ ...+-|+-|.+|.++. +.|+++.|+||
T Consensus 156 rcy--saevvtlwyrppdvlfgakly~tsidmws 187 (292)
T KOG0662|consen 156 RCY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWS 187 (292)
T ss_pred Eee--eceeeeeeccCcceeeeeehhccchHhhh
Confidence 332 2356799999999876 89999999998
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=232.75 Aligned_cols=182 Identities=27% Similarity=0.379 Sum_probs=161.3
Q ss_pred CCccceeecccCceEEEEEEec-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CeEEEEE
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLLVY 496 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lV~ 496 (611)
+|...+.||+|++|.||+|... +++.|++|+++... ...+.+.+|+++++.++||||+++++.+... +..++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4777899999999999999976 78999999997654 4578899999999999999999999999988 8899999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
||+++++|.+++.... .+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 9999999999997653 58999999999999999999999 8999999999999999999999999999988776
Q ss_pred CCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 577 SSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
...........++..|++||+.. ..++.++|||||
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~sl 189 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSL 189 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHH
Confidence 54322234567999999999876 668999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=238.95 Aligned_cols=184 Identities=30% Similarity=0.414 Sum_probs=161.7
Q ss_pred hcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
.++.|...+.||+|+||.||++... +++.+++|+++........+..|+++++.++|+||+++++.+...+..|+|+||
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence 4567888899999999999999976 688999999987655567888999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
+++++|.+++.... ..+++..+..++.+++.||.|||+ .+|+|+||+|+||+++.++.++|+|||++.......
T Consensus 97 ~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 97 MDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred cCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 99999999998653 358999999999999999999999 999999999999999999999999999987665432
Q ss_pred CceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 579 SHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
. ......|+..|++||+.. ..++.++|+|||
T Consensus 171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~sl 202 (286)
T cd06614 171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSL 202 (286)
T ss_pred h--hhccccCCcccCCHhHhcCCCCCCccccHHH
Confidence 2 122356889999999765 678999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=238.85 Aligned_cols=172 Identities=26% Similarity=0.318 Sum_probs=142.9
Q ss_pred eecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHH---HHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 007254 429 LIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEI---EIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (611)
Q Consensus 429 ~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei---~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 500 (611)
+||+|+||.||++... +++.||+|++.+.. .....+..|. .++....||||+.+++++...+.+|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999854 68899999986532 1122234444 34455689999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCc
Q 007254 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (611)
Q Consensus 501 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~ 580 (611)
||+|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 81 g~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~- 152 (278)
T cd05606 81 GGDLHYHLSQH----GVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (278)
T ss_pred CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC-
Confidence 99999988644 358999999999999999999999 8999999999999999999999999999986643322
Q ss_pred eeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 581 ITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 581 ~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
....||..|+|||+.. ..++.++|||||
T Consensus 153 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~ 182 (278)
T cd05606 153 ---HASVGTHGYMAPEVLQKGVAYDSSADWFSL 182 (278)
T ss_pred ---cCcCCCcCCcCcHHhcCCCCCCcccchHhH
Confidence 2357999999999875 468999999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-27 Score=248.83 Aligned_cols=182 Identities=24% Similarity=0.383 Sum_probs=153.3
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----CeE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NNL 492 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~ 492 (611)
.++|.+.+.||+|+||.||+|... +|+.||||.++.. ......+.+|+.+++.++||||+++++++... ..+
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 578999999999999999999854 7899999999753 24456788999999999999999999987654 358
Q ss_pred EEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccc
Q 007254 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~ 572 (611)
|+||||+.+ +|...+... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 84 ~lv~e~~~~-~l~~~~~~~-----~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELMET-DLYKLIKTQ-----HLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhccc-CHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECccccee
Confidence 999999964 888777543 48999999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCCc-eeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 573 WASTSSSH-ITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 573 ~~~~~~~~-~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
........ .......||+.|+|||+.. ..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dvwsl 196 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSV 196 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHH
Confidence 76543221 1223467899999999753 578999999996
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.3e-28 Score=235.87 Aligned_cols=178 Identities=25% Similarity=0.380 Sum_probs=152.2
Q ss_pred ccceeecccCceEEEEEEec-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEEEEcCC
Q 007254 425 LAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLS 500 (611)
Q Consensus 425 ~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~ 500 (611)
.....||.|..|.|+++... +|..+|||.+.... +..++++..++++..- +.|+||+.+|+|..+..+++.||.|.
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs 174 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS 174 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence 34577999999999999865 68999999998753 5678899999886555 58999999999999999999999984
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCc
Q 007254 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (611)
Q Consensus 501 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~ 580 (611)
--++.+|.+.+ .++++...-++...++.||.||-. .++|||||+||+|||||+.|++||||||++.++-++..+
T Consensus 175 -~C~ekLlkrik---~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh 248 (391)
T KOG0983|consen 175 -TCAEKLLKRIK---GPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH 248 (391)
T ss_pred -HHHHHHHHHhc---CCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccccc
Confidence 36666666543 358888888999999999999986 489999999999999999999999999999998877654
Q ss_pred eeecCCccCCCcccceecc----CCCcCcceEEeC
Q 007254 581 ITCTDVAGTFGYVVLILNP----IAFLFMFNCWFF 611 (611)
Q Consensus 581 ~~~~~~~GT~~Y~aPE~~~----~~~~~~sDiWSL 611 (611)
+..+|.+.|||||-+. ..|+..+|+|||
T Consensus 249 ---trsAGC~~YMaPERidp~~~~kYDiRaDVWSl 280 (391)
T KOG0983|consen 249 ---TRSAGCAAYMAPERIDPPDKPKYDIRADVWSL 280 (391)
T ss_pred ---ccccCCccccCccccCCCCCCccchhhhhhhh
Confidence 4469999999999763 679999999997
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.1e-27 Score=248.32 Aligned_cols=179 Identities=25% Similarity=0.322 Sum_probs=152.9
Q ss_pred hcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC------
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED------ 489 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------ 489 (611)
..++|...+.||+|+||.||+|... +|+.||||.+... ......+.+|+.+++.++||||++++++|...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999864 7899999998642 34456788999999999999999999998643
Q ss_pred CeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeec
Q 007254 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569 (611)
Q Consensus 490 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFG 569 (611)
.+.|+||||+. ++|.+.+... +++..+..++.|++.||.|||. .+|+||||||+|||++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~------l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD------LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc------CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCc
Confidence 35799999995 5888877532 7888999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 570 LAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 570 lA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+++....... .....||..|+|||+.. ..++.++|||||
T Consensus 164 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 203 (353)
T cd07850 164 LARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSV 203 (353)
T ss_pred cceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhH
Confidence 9987654322 23457899999999875 788999999996
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=232.34 Aligned_cols=184 Identities=28% Similarity=0.417 Sum_probs=161.4
Q ss_pred CCccceeecccCceEEEEEEec-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
+|.+.+.||.|+||.||++... +++.+|+|++.... .....+.+|+++++.++|||++++++.+...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999865 68899999997642 4567788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
+++++|.+.+.........+++..+..++.+++.||.|||+ .+++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999997654334569999999999999999999999 899999999999999999999999999998776543
Q ss_pred CceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 579 SHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
. ......|++.|+|||+.. ..++.++|+|||
T Consensus 158 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~sl 189 (258)
T cd08215 158 D--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSL 189 (258)
T ss_pred c--eecceeeeecccChhHhccCCCCccccHHHH
Confidence 1 233467999999999765 778999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=233.83 Aligned_cols=182 Identities=23% Similarity=0.435 Sum_probs=160.3
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
++|.+.+.||+|+||.||++... +++.|+||++.... .....+..|+.++..++|+||+++++++...+.+++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46888899999999999999876 59999999998754 4567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
+++++|.+++... ..+++..+..++.|++.||.|||. ..+++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~--~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhc--cCCCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999999754 358899999999999999999996 2679999999999999999999999999998776543
Q ss_pred CceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 579 SHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.. .....|+..|+|||+.. ..++.++|+|||
T Consensus 155 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~sl 186 (264)
T cd06623 155 DQ--CNTFVGTVTYMSPERIQGESYSYAADIWSL 186 (264)
T ss_pred Cc--ccceeecccccCHhhhCCCCCCchhhHHHH
Confidence 32 12457899999999876 778999999996
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-27 Score=240.06 Aligned_cols=183 Identities=32% Similarity=0.404 Sum_probs=159.1
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCeEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~----~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV 495 (611)
++|.+.+.||+|+||.||++... +|+.||+|++.+. ......+.+|++++..++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47888999999999999999865 7899999999763 234567889999999998 99999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
|||+++++|.+.+.... .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRKYG----SLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 99999999999997653 59999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCC------------------ceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 576 TSSS------------------HITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~------------------~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.... ........|+..|++||... ..++.++|+|||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~sl 208 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWAL 208 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHH
Confidence 4322 12223457899999999765 668999999986
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=241.03 Aligned_cols=184 Identities=27% Similarity=0.360 Sum_probs=152.0
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC------
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN------ 490 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------ 490 (611)
.++|.+.+.||+|+||.||+|... +++.||||.+.... .....+.+|+.+++.++||||++++++|...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 467899999999999999999865 78999999886432 23445678999999999999999999987643
Q ss_pred --eEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEee
Q 007254 491 --NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568 (611)
Q Consensus 491 --~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DF 568 (611)
..++||||+. ++|.+.+.... ..+++.++..++.|++.||.|||+ .+|+|+||||+||+++.++.+||+||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcC
Confidence 4599999996 48888876432 358999999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCc--eeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 569 GLAKWASTSSSH--ITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 569 GlA~~~~~~~~~--~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
|++......... .......+++.|+|||+.. ..++.++|||||
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 210 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGA 210 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHH
Confidence 999876543221 1123356889999999764 447899999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.8e-27 Score=246.18 Aligned_cols=183 Identities=26% Similarity=0.366 Sum_probs=153.8
Q ss_pred hcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC--CeE
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED--NNL 492 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~--~~~ 492 (611)
..++|.+.+.||+|+||.||+|... +|+.+|||.+... ......+.+|+.++..+ +||||++++++|... ..+
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3567888999999999999999865 6889999988542 23455677899999999 999999999998653 368
Q ss_pred EEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccc
Q 007254 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~ 572 (611)
|+||||++ ++|...+... .+.|..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999997 5998888643 47899999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCCc---eeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 573 WASTSSSH---ITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 573 ~~~~~~~~---~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
........ .......||+.|+|||+.. ..++.++|||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~sl 199 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSV 199 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHH
Confidence 77543321 2233467999999999764 668899999996
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=230.36 Aligned_cols=180 Identities=29% Similarity=0.427 Sum_probs=159.0
Q ss_pred CCccceeecccCceEEEEEEec-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
+|.+.+.||+|++|.||++... +++.||+|.+.... .....+.+|++++..++|||++++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999865 67899999997754 4567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
+++++|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 9999999998754 358999999999999999999999 899999999999999999999999999998776543
Q ss_pred CceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 579 SHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.. .....|+..|++||+.. ..++.++|+|||
T Consensus 154 ~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~l 185 (254)
T cd06627 154 KD--DASVVGTPYWMAPEVIEMSGASTASDIWSL 185 (254)
T ss_pred cc--ccccccchhhcCHhhhcCCCCCcchhHHHH
Confidence 32 23467899999999875 568899999986
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-27 Score=235.27 Aligned_cols=182 Identities=26% Similarity=0.388 Sum_probs=158.9
Q ss_pred CCccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
+|.+.+.||.|+||.||++... +++.+|+|.++.. ......+.+|+++++.++|+||+++++++.+.+..|+||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999754 7889999998763 24456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
+++++|.+++.........+++..++.++.+++.||.|||+ .+++|+||+|+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 99999999987643334568999999999999999999999 899999999999999999999999999998876542
Q ss_pred CceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 579 SHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.....|++.|++||+.. ..++.++|+|||
T Consensus 158 ----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~sl 187 (256)
T cd08530 158 ----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSL 187 (256)
T ss_pred ----cccccCCccccCHHHHCCCCCCchhhHHHH
Confidence 12356899999999875 778899999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.2e-27 Score=235.49 Aligned_cols=182 Identities=20% Similarity=0.348 Sum_probs=156.4
Q ss_pred CCccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
+|.+.+.||+|+||.||++... +|..+|+|.+... ....+.+.+|+++++.++|+||+++++.+...+..|+||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5788899999999999999865 6889999998653 23456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCC-cEEEEeeccccccCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKWASTS 577 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~-~vKL~DFGlA~~~~~~ 577 (611)
+++++|.+.+..... ..+++..+..++.|++.||.|||+ .+|+|+||||+||++++++ .+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQRG--VLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 999999999875432 357999999999999999999999 8999999999999999885 4699999999877643
Q ss_pred CCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 578 SSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 578 ~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
... .....|++.|+|||+.. ..++.++|+|||
T Consensus 156 ~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~sl 188 (257)
T cd08225 156 MEL--AYTCVGTPYYLSPEICQNRPYNNKTDIWSL 188 (257)
T ss_pred ccc--ccccCCCccccCHHHHcCCCCCchhhHHHH
Confidence 321 12356899999999775 778999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-28 Score=241.69 Aligned_cols=186 Identities=25% Similarity=0.375 Sum_probs=155.6
Q ss_pred CCCccceeecccCceEEEEEEec---C--CCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-CCeE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP---D--GKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFE-DNNL 492 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~---~--g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~ 492 (611)
..|.....||+|.||.||+|.-. + .+++|||.++... .......+|+.+++.++|||++.|..+|.. +..+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 35677789999999999999632 2 3479999998653 234567899999999999999999999987 7789
Q ss_pred EEEEEcCCCCCHHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCC----CcEEEEe
Q 007254 493 LLVYDFLSRGSLEENLHGNK-KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD----FEPQLSD 567 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~-~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~----~~vKL~D 567 (611)
+|++||.+. +|...++-++ .....++-..+..|+.||+.|+.|||+ .-|+||||||.|||+..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeec
Confidence 999999977 8988886432 223568888999999999999999999 899999999999999887 8999999
Q ss_pred eccccccCCCC-CceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 568 FGLAKWASTSS-SHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 568 FGlA~~~~~~~-~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
||||+.+...- +......++-|+-|.|||++. ..||.++|+|+.
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAi 226 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAI 226 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHH
Confidence 99999887543 223455688899999999876 899999999983
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=236.51 Aligned_cols=177 Identities=25% Similarity=0.304 Sum_probs=148.7
Q ss_pred CccceeecccCceEEEEEEec-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeC--CeEEEEEE
Q 007254 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLH-HKNIISLLGFCFED--NNLLLVYD 497 (611)
Q Consensus 424 f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~--~~~~lV~E 497 (611)
|.+.+.||+|+||.||+|... +++.||+|.++... ........|+.++..+. |+||+++++++.+. +.+++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567789999999999999854 78999999987642 22334567899999885 99999999999987 89999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCC
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~ 577 (611)
|+. |+|.+.+.... ..++|.++..++.|++.||.|||+ .+|+||||||+||+++. +.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 996 58888876542 358999999999999999999999 89999999999999999 99999999999877543
Q ss_pred CCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 578 SSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 578 ~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
... ....+|..|+|||+.. ..++.++|||||
T Consensus 153 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 185 (282)
T cd07831 153 PPY---TEYISTRWYRAPECLLTDGYYGPKMDIWAV 185 (282)
T ss_pred CCc---CCCCCCcccCChhHhhcCCCCCcchhHHHH
Confidence 322 2356899999999653 567999999996
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.3e-27 Score=235.27 Aligned_cols=175 Identities=25% Similarity=0.375 Sum_probs=152.0
Q ss_pred ecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCCH
Q 007254 430 IGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504 (611)
Q Consensus 430 IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 504 (611)
||.|+||.||++... +|+.+++|++.... .....+.+|++++..++||||+++++.+...+..|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 59999999997643 3566788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCC-----
Q 007254 505 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS----- 579 (611)
Q Consensus 505 ~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~----- 579 (611)
.+++.+.. .+++..+..++.||+.||.|||. .+++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENVG----SLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 99997643 48999999999999999999999 8999999999999999999999999999986544321
Q ss_pred -ceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 580 -HITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 580 -~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
........++..|++||+.. ..++.++|+|||
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~sl 187 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSL 187 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHH
Confidence 11223467899999999875 668999999996
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=240.48 Aligned_cols=185 Identities=26% Similarity=0.377 Sum_probs=154.8
Q ss_pred HhcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC----
Q 007254 419 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN---- 490 (611)
Q Consensus 419 ~~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~---- 490 (611)
...++|.+.+.||+|+||.||+|... +|+.||+|.++... .....+.+|+++++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 35678999999999999999999975 68899999997532 33456778999999999999999999987654
Q ss_pred ------eEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEE
Q 007254 491 ------NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 564 (611)
Q Consensus 491 ------~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vK 564 (611)
.+|+||||+++ +|...+... ...+++..+..++.|++.||.|||+ .+|+||||||+||++++++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEE
Confidence 79999999976 777777643 2358999999999999999999999 8999999999999999999999
Q ss_pred EEeeccccccCCCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 565 LSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 565 L~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
|+|||++......... ......+++.|+|||+.. ..++.++|||||
T Consensus 157 l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~sl 204 (302)
T cd07864 157 LADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSC 204 (302)
T ss_pred eCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHH
Confidence 9999999877654321 112345788999999764 567899999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-27 Score=238.33 Aligned_cols=180 Identities=23% Similarity=0.317 Sum_probs=151.7
Q ss_pred hcCCCccc-eeecccCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHH-HHhcCCCCeeeEEEEEEe----CCeE
Q 007254 420 ATSNFLAE-NLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEI-ITTLHHKNIISLLGFCFE----DNNL 492 (611)
Q Consensus 420 ~~~~f~~~-~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~i-l~~l~HpnIv~l~~~~~~----~~~~ 492 (611)
.+++|.+. .+||-|-.|+|-.+..+ +|+.+|+|+|.-... ..+|+++ +..-.|||||.++++|.. ...+
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~K----ARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPK----ARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHH----HHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 45667654 68999999999998854 899999999975543 3457776 445579999999999864 3468
Q ss_pred EEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcC---CCcEEEEeec
Q 007254 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSDFG 569 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~---~~~vKL~DFG 569 (611)
.+|||+|+||.|+..++.++. ..|++.++-.|+.||+.|+.|||+ .+|.||||||+|+|... |..+||+|||
T Consensus 135 LiVmE~meGGeLfsriq~~g~--~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGD--QAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred EeeeecccchHHHHHHHHccc--ccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecccc
Confidence 899999999999999987654 569999999999999999999999 99999999999999964 5579999999
Q ss_pred cccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 570 LAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 570 lA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
||+.-.. +....+.+-|+.|.|||++. ++|+...|+|||
T Consensus 210 FAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSl 249 (400)
T KOG0604|consen 210 FAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSL 249 (400)
T ss_pred cccccCC---CccccCCcccccccCHHHhCchhcCCCCCccch
Confidence 9997554 33456789999999999886 999999999997
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=242.31 Aligned_cols=182 Identities=26% Similarity=0.377 Sum_probs=153.4
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CeEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLL 494 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~l 494 (611)
.++|.+.+.||+|+||.||+|... +|+.||+|.++... .....+.+|+.+++.++|+||+++++++... +.+++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 567899999999999999999864 68999999987532 2234567899999999999999999998754 56899
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccccc
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~ 574 (611)
||||+.+ +|.+++.... ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++...
T Consensus 86 v~e~~~~-~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 9999964 8888886543 358999999999999999999999 89999999999999999999999999999877
Q ss_pred CCCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 575 STSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 575 ~~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
..... ......+++.|+|||+.. ..++.++|||||
T Consensus 159 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dvwsl 195 (309)
T cd07845 159 GLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAV 195 (309)
T ss_pred CCccC--CCCcccccccccChhhhcCCCCcCchHHHHHH
Confidence 64322 223345688999999764 568999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=237.65 Aligned_cols=180 Identities=26% Similarity=0.379 Sum_probs=153.4
Q ss_pred CccceeecccCceEEEEEEec-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 007254 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (611)
Q Consensus 424 f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 499 (611)
|.+.+.||.|++|.||+|... +|+.||+|++.... .....+.+|+++++.++||||+++++++.+.+..|+||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566789999999999999864 79999999987543 23467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~ 579 (611)
+ ++|.+++..... ..+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||+++.......
T Consensus 81 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 689998875432 358999999999999999999999 8999999999999999999999999999986643322
Q ss_pred ceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 580 HITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 580 ~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
. .....+++.|+|||+.. ..++.++|||||
T Consensus 155 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~sl 186 (283)
T cd07835 155 T--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSI 186 (283)
T ss_pred c--cCccccccCCCCCceeecCcccCcHHHHHHH
Confidence 1 12346789999999765 457899999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=245.06 Aligned_cols=188 Identities=22% Similarity=0.317 Sum_probs=157.8
Q ss_pred cccChHHHHHhcCCCccceeecccCceEEEEEEe-cCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEE
Q 007254 410 RLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGF 485 (611)
Q Consensus 410 ~~~~~~~l~~~~~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~ 485 (611)
+.....++...+++|.+.+.||+|+||.||+|.. .+++.||+|+++... .....+.+|++++..++||||++++++
T Consensus 5 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~ 84 (345)
T cd07877 5 RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84 (345)
T ss_pred hhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeee
Confidence 3344556667889999999999999999999985 478999999997532 335678899999999999999999998
Q ss_pred EEeC------CeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcC
Q 007254 486 CFED------NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD 559 (611)
Q Consensus 486 ~~~~------~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~ 559 (611)
+... +..|++++++ +++|.+.+... .+++..+..++.|++.||.|||+ .+|+||||||+||+++.
T Consensus 85 ~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~ 155 (345)
T cd07877 85 FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNE 155 (345)
T ss_pred eeecccccccccEEEEehhc-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcC
Confidence 8643 3478888887 78998877542 38899999999999999999999 89999999999999999
Q ss_pred CCcEEEEeeccccccCCCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 560 DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 560 ~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
++.+||+|||+++..... .....||+.|+|||+.. ..++.++|||||
T Consensus 156 ~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dvwsl 204 (345)
T cd07877 156 DCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 204 (345)
T ss_pred CCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHH
Confidence 999999999999865432 23457899999999764 568899999996
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=236.25 Aligned_cols=180 Identities=28% Similarity=0.384 Sum_probs=154.1
Q ss_pred CccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CeEEEEEE
Q 007254 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLLVYD 497 (611)
Q Consensus 424 f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lV~E 497 (611)
|.+.+.||.|+||.||+|... +++.+|+|.++.. ......+..|+++++.++|+|++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567789999999999999865 5889999999875 23456788999999999999999999999988 89999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCC
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~ 577 (611)
|+++ +|.+++.... ..+++..+..++.||+.||.|||. .+++|+||||+||++++++.+||+|||++......
T Consensus 81 ~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9975 8888886542 358999999999999999999999 89999999999999999999999999999877654
Q ss_pred CCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 578 SSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 578 ~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
.. .......++..|+|||... ..++.++|||||
T Consensus 154 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~sl 188 (287)
T cd07840 154 NS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSV 188 (287)
T ss_pred Cc-ccccccccccccCCceeeEccccCChHHHHHHH
Confidence 32 1223456788999999654 568999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-27 Score=246.33 Aligned_cols=183 Identities=25% Similarity=0.374 Sum_probs=154.3
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEe----CCeE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFE----DNNL 492 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~ 492 (611)
.++|.+.+.||.|+||.||+|... +|+.||+|++.... ...+.+..|+.+|+.++||||+++++++.. ...+
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 367889999999999999999854 79999999987642 345677889999999999999999998753 3578
Q ss_pred EEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccc
Q 007254 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~ 572 (611)
|+||||+. |+|.+++.... .+++..+..++.||+.||.|||. .+|+||||||+|||+++++.+||+|||+++
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ----PLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccce
Confidence 99999995 68988886542 48999999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCCc--eeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 573 WASTSSSH--ITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 573 ~~~~~~~~--~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
........ .......||..|+|||+.. ..++.++|||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~sl 198 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSV 198 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHH
Confidence 76543221 1223468999999999764 568999999996
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=236.37 Aligned_cols=178 Identities=26% Similarity=0.385 Sum_probs=154.0
Q ss_pred CccceeecccCceEEEEEEe-cCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 007254 424 FLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (611)
Q Consensus 424 f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 501 (611)
|...+.||+|++|.||++.. .+++.+++|.++... ...+.+.+|+.+++.++||||+++++++...++.|+|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 34457899999999999985 478899999986543 3456688999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCce
Q 007254 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (611)
Q Consensus 502 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~ 581 (611)
++|.+.+... .+++.++..++.|++.||.|||+ .+|+||||+|+||+++.++.++|+|||++.........
T Consensus 101 ~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~- 171 (285)
T cd06648 101 GALTDIVTHT-----RMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR- 171 (285)
T ss_pred CCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc-
Confidence 9999998752 37899999999999999999999 89999999999999999999999999998866543321
Q ss_pred eecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 582 TCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 582 ~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.....|++.|+|||+.. ..++.++|+|||
T Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 201 (285)
T cd06648 172 -RKSLVGTPYWMAPEVISRLPYGTEVDIWSL 201 (285)
T ss_pred -cccccCCccccCHHHhcCCCCCCcccHHHH
Confidence 22357999999999875 678999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-27 Score=239.16 Aligned_cols=183 Identities=20% Similarity=0.330 Sum_probs=159.6
Q ss_pred hcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEE
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLL 493 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~----~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 493 (611)
..++|..+.+||+|+|.+|..+.+. +.+.+|+|++|+. ++...-.+.|-.+.... +||++|-|..+|.+...++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 4578899999999999999999854 7789999999863 34455566777777665 7999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccc
Q 007254 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (611)
Q Consensus 494 lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~ 573 (611)
+|.||++||+|.-++++.+ .+++..+..+..+|+.||.|||+ +|||+||||.+|+||+..|++||+|+|+++.
T Consensus 328 fvieyv~ggdlmfhmqrqr----klpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred EEEEEecCcceeeehhhhh----cCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhc
Confidence 9999999999998887664 48899999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 574 ASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.-.... ...+++||+.|+|||.+- +.|.+++|+|+|
T Consensus 401 ~l~~gd--~tstfcgtpnyiapeilrgeeygfsvdwwal 437 (593)
T KOG0695|consen 401 GLGPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWAL 437 (593)
T ss_pred CCCCCc--ccccccCCCcccchhhhcccccCceehHHHH
Confidence 544332 335689999999999875 999999999986
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-26 Score=260.94 Aligned_cols=182 Identities=26% Similarity=0.310 Sum_probs=155.8
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 495 (611)
.++|.+.+.||+|+||.||+|.+. +++.||||+++... .....+..|+.++..++||||+++++++...+++|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 467899999999999999999975 68999999997542 3456788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
|||+.+++|.+++.... .+++..++.|+.||+.||.|||. .+||||||||+||||+.++.+||+|||+++...
T Consensus 83 mEy~~g~~L~~li~~~~----~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~ 155 (669)
T cd05610 83 MEYLIGGDVKSLLHIYG----YFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTL 155 (669)
T ss_pred EeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCcccc
Confidence 99999999999997543 47889999999999999999999 899999999999999999999999999999765
Q ss_pred CCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 576 TSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
.... ......||+.|++||... ..-...+++|+|
T Consensus 156 ~~~~--~~~~~~~t~~~~~pe~~~~~~~~~~~s~~~s~ 191 (669)
T cd05610 156 NREL--NMMDILTTPSMAKPKNDYSRTPGQVLSLISSL 191 (669)
T ss_pred CCcc--cccccccCccccCccccccCCCCceeeeeeec
Confidence 4332 334678999999999432 333446677764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-26 Score=231.32 Aligned_cols=171 Identities=23% Similarity=0.289 Sum_probs=144.4
Q ss_pred eeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHH-HHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 007254 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEI-ITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (611)
Q Consensus 428 ~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~i-l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 501 (611)
+.||+|+||.||+|... +|+.||||.+++.. .....+..|..+ ....+|+||+++++++...+.+|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999864 68999999997643 222344555554 4456899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCce
Q 007254 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (611)
Q Consensus 502 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~ 581 (611)
++|.+++.... .+++..+..++.|++.||.|||+ .+|+||||+|+||++++++.+||+|||+++....
T Consensus 82 ~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKTLG----GLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 99999997543 47889999999999999999999 8999999999999999999999999999986543
Q ss_pred eecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 582 TCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 582 ~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.....|++.|++||+.. ..++.++|||||
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~sl 179 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSL 179 (260)
T ss_pred -cccCCCCcCccChhhhcCCCCcchhhhHHH
Confidence 12457899999999875 558999999996
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-26 Score=238.00 Aligned_cols=175 Identities=26% Similarity=0.380 Sum_probs=150.9
Q ss_pred CccceeecccCceEEEEEEec-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 424 f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
|...+.||+|+||.||++... ++..+|+|.+... ......+..|+++++.++|||+++++++|.+.+..|+||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 566788999999999999864 6889999998643 23456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
+. |+|.+.+.... ..++|.++..++.+++.||.|||+ .+|+||||+|+||+++.++.+||+|||++......
T Consensus 107 ~~-g~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 107 CL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 96 47877775432 358999999999999999999999 89999999999999999999999999998765432
Q ss_pred CceeecCCccCCCcccceecc----CCCcCcceEEeC
Q 007254 579 SHITCTDVAGTFGYVVLILNP----IAFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~~~~~~~GT~~Y~aPE~~~----~~~~~~sDiWSL 611 (611)
....|++.|+|||+.. ..++.++|||||
T Consensus 179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~sl 210 (317)
T cd06635 179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 210 (317)
T ss_pred -----ccccCCccccChhhhhcCCCCCCCccccHHHH
Confidence 2357899999999852 578999999996
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-27 Score=269.18 Aligned_cols=187 Identities=25% Similarity=0.385 Sum_probs=153.2
Q ss_pred HhcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-------
Q 007254 419 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFE------- 488 (611)
Q Consensus 419 ~~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------- 488 (611)
.-..+|....+||+||||.||+++.+ ||+.||||.+... ......+.+|+.+|.+|+|||||++|..|.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 34567888899999999999999965 9999999998765 5667789999999999999999999873311
Q ss_pred --------------------------------------------------------------------------------
Q 007254 489 -------------------------------------------------------------------------------- 488 (611)
Q Consensus 489 -------------------------------------------------------------------------------- 488 (611)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ------------------------C--------CeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 007254 489 ------------------------D--------NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536 (611)
Q Consensus 489 ------------------------~--------~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~y 536 (611)
. -.+||=||||+.-.|.++++.+.... .-...++++.+|++||.|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAY 712 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHH
Confidence 0 13689999999977777777654211 356778999999999999
Q ss_pred HHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC----------------CCCCceeecCCccCCCcccceecc-
Q 007254 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS----------------TSSSHITCTDVAGTFGYVVLILNP- 599 (611)
Q Consensus 537 LH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~----------------~~~~~~~~~~~~GT~~Y~aPE~~~- 599 (611)
+|+ +|||||||||.||+|++++.|||+|||+|.... ........+..+||.-|+|||++.
T Consensus 713 IH~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHD---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHh---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 999 999999999999999999999999999998721 011122456789999999999875
Q ss_pred -C--CCcCcceEEeC
Q 007254 600 -I--AFLFMFNCWFF 611 (611)
Q Consensus 600 -~--~~~~~sDiWSL 611 (611)
. .|+.++|||||
T Consensus 790 ~~~~~Yn~KiDmYSL 804 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSL 804 (1351)
T ss_pred cccccccchhhhHHH
Confidence 3 79999999997
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=236.40 Aligned_cols=181 Identities=25% Similarity=0.308 Sum_probs=153.6
Q ss_pred CCccceeecccCceEEEEEEe----cCCCEEEEEEecCCh-----hHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeE
Q 007254 423 NFLAENLIGKGGSSQVYKGCL----PDGKELAVKILKPSE-----DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 492 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~----~~g~~vAVK~lk~~~-----~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 492 (611)
+|.+.+.||+|+||.||++.. .+++.||||.++... ...+.+..|+.++..+ +||||+++++.+...+.+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477889999999999999874 357889999997532 2346788999999999 599999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccc
Q 007254 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~ 572 (611)
|+||||+.+|+|.+.+.... .+++..+..++.|++.||.|||. .+++||||||+||+++.++.++|+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE----HFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC----CcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 99999999999999986542 48899999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCCceeecCCccCCCcccceecc-C--CCcCcceEEeC
Q 007254 573 WASTSSSHITCTDVAGTFGYVVLILNP-I--AFLFMFNCWFF 611 (611)
Q Consensus 573 ~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~--~~~~~sDiWSL 611 (611)
........ ......|++.|++||+.. . ..+.++|+|||
T Consensus 154 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~sl 194 (288)
T cd05583 154 EFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSL 194 (288)
T ss_pred cccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHH
Confidence 76543221 112356899999999865 2 37899999996
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-26 Score=232.54 Aligned_cols=176 Identities=23% Similarity=0.247 Sum_probs=145.6
Q ss_pred HhcCCCccceee--cccCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEE
Q 007254 419 SATSNFLAENLI--GKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLL 494 (611)
Q Consensus 419 ~~~~~f~~~~~I--G~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l 494 (611)
...++|.+.+.+ |+|+||.||++..+ ++..+|+|++....... .|+.+...+ +||||+++++.|...+..|+
T Consensus 11 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 11 QFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----hhHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 334566666665 99999999999854 78899999987543111 122222222 79999999999999999999
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCC-cEEEEeeccccc
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKW 573 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~-~vKL~DFGlA~~ 573 (611)
||||+++|+|.+++.... .++|.++..++.|++.||.|||+ .+|+||||||+||+++.++ .++|+|||+++.
T Consensus 87 v~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~ 159 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI 159 (267)
T ss_pred EEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCcccee
Confidence 999999999999997553 58999999999999999999999 8999999999999999998 999999999987
Q ss_pred cCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 574 ASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
..... ...||..|+|||+.. ..++.++|+|||
T Consensus 160 ~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 192 (267)
T PHA03390 160 IGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAV 192 (267)
T ss_pred cCCCc------cCCCCCcccChhhhcCCCCCchhhHHHH
Confidence 65432 246899999999876 778999999996
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=236.67 Aligned_cols=183 Identities=23% Similarity=0.312 Sum_probs=149.4
Q ss_pred CCccceeecccCceEEEEEEec-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCeEEEEEEc
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
+|...+.||+|+||.||++... +++.+|+|.+.... .....+..|+.++.++. |+||+++++++...+..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556678999999999999864 68999999987543 44567889999999996 99999999999999999999999
Q ss_pred CCCCCHHHHHhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCC
Q 007254 499 LSRGSLEENLHGN-KKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 499 ~~~gsL~~~L~~~-~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~ 577 (611)
+.. +|.++.... ......+++..+..++.+++.||.|||+ ..+|+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 854 665543211 1112458999999999999999999996 148999999999999999999999999999876543
Q ss_pred CCceeecCCccCCCcccceecc-C---CCcCcceEEeC
Q 007254 578 SSHITCTDVAGTFGYVVLILNP-I---AFLFMFNCWFF 611 (611)
Q Consensus 578 ~~~~~~~~~~GT~~Y~aPE~~~-~---~~~~~sDiWSL 611 (611)
.. .....||+.|+|||+.. . .++.++|||||
T Consensus 162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~sl 196 (288)
T cd06616 162 IA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSL 196 (288)
T ss_pred Cc---cccccCccCccCHHHhccccccCCcchhhhhHH
Confidence 32 13357899999999875 3 68999999996
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=243.29 Aligned_cols=179 Identities=22% Similarity=0.346 Sum_probs=152.8
Q ss_pred HhcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC----
Q 007254 419 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN---- 490 (611)
Q Consensus 419 ~~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~---- 490 (611)
...++|.+.+.||+|+||.||++... +|+.||||+++.. ......+.+|+++|+.++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 34678999999999999999999854 7899999998653 234567889999999999999999999987543
Q ss_pred --eEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEee
Q 007254 491 --NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568 (611)
Q Consensus 491 --~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DF 568 (611)
..++||||+ +++|.+++... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+||
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKHE-----KLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeec
Confidence 469999999 77998887532 48899999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 569 GLAKWASTSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 569 GlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
|++....... ....||+.|++||+.. ..++.++|+|||
T Consensus 163 g~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 202 (343)
T cd07880 163 GLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSV 202 (343)
T ss_pred ccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHH
Confidence 9998765432 2356899999999765 468999999996
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-27 Score=274.17 Aligned_cols=184 Identities=24% Similarity=0.324 Sum_probs=157.2
Q ss_pred cCCCccceeecccCceEEEEEE-ecCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~-~~~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
+-+|.-...||.|.||.||.|. ..+|...|+|-++-.+ ...+...+|..+|..|+|||+|+.||+-.+.+.++|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 4457778899999999999998 5589999999886532 34567788999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
|||++|+|.+.+...+. .++.....+..|++.|+.|||+ .|||||||||.||||+.+|.+|++|||.|..+..
T Consensus 1314 EyC~~GsLa~ll~~gri----~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRI----EDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHhccCcHHHHHHhcch----hhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecC
Confidence 99999999999975432 4455556688999999999999 9999999999999999999999999999998876
Q ss_pred CCC--ceeecCCccCCCcccceecc----CCCcCcceEEeC
Q 007254 577 SSS--HITCTDVAGTFGYVVLILNP----IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~--~~~~~~~~GT~~Y~aPE~~~----~~~~~~sDiWSL 611 (611)
+.. .......+||+.|||||++. +...-+.|||||
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWsl 1427 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSL 1427 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcc
Confidence 531 12334689999999999875 667789999997
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=238.00 Aligned_cols=174 Identities=27% Similarity=0.397 Sum_probs=151.5
Q ss_pred eeecccCceEEEEEEec-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCCHH
Q 007254 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLE 505 (611)
Q Consensus 428 ~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~ 505 (611)
..||+|+||.||++... +++.||||.+.... .....+.+|+.+++.++|+||+++++.+...++.|+||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 56999999999999864 78999999986533 34567889999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCceeecC
Q 007254 506 ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD 585 (611)
Q Consensus 506 ~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 585 (611)
+.+... .+++.....++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++......... ...
T Consensus 106 ~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~--~~~ 175 (292)
T cd06657 106 DIVTHT-----RMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKS 175 (292)
T ss_pred HHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccccc--ccc
Confidence 887532 37899999999999999999999 89999999999999999999999999998876543321 234
Q ss_pred CccCCCcccceecc-CCCcCcceEEeC
Q 007254 586 VAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 586 ~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
..||+.|++||+.. ..++.++|+|||
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~sl 202 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSL 202 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHH
Confidence 57899999999875 678999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=242.99 Aligned_cols=181 Identities=23% Similarity=0.368 Sum_probs=153.5
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----Ce
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NN 491 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~ 491 (611)
.++|.+.+.||+|+||.||++... +++.||||.++.. ......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457889999999999999999854 7899999998753 23456778899999999999999999988644 35
Q ss_pred EEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccc
Q 007254 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (611)
Q Consensus 492 ~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA 571 (611)
+|+||||+. ++|.+.+... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS----QTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 899999995 6898888654 248999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 572 KWASTSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 572 ~~~~~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
+....... ......||..|+|||+.. ..++.++|||||
T Consensus 156 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl 195 (337)
T cd07858 156 RTTSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSV 195 (337)
T ss_pred cccCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHH
Confidence 87755322 223457899999999764 568999999996
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-26 Score=237.22 Aligned_cols=183 Identities=19% Similarity=0.192 Sum_probs=138.7
Q ss_pred cCCCccceeecccCceEEEEEEecC----CCEEEEEEecCChhH------------HHHHHHHHHHHHhcCCCCeeeEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLPD----GKELAVKILKPSEDV------------IKEFVLEIEIITTLHHKNIISLLG 484 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~~----g~~vAVK~lk~~~~~------------~~~~~~Ei~il~~l~HpnIv~l~~ 484 (611)
.++|.+.+.||+|+||.||+|...+ +..+|+|+....... ......+...+..+.|+||+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3578999999999999999998653 456777764332110 012233444566778999999999
Q ss_pred EEEeCC----eEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCC
Q 007254 485 FCFEDN----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD 560 (611)
Q Consensus 485 ~~~~~~----~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~ 560 (611)
++.... ..+++||++. .++.+.+.... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK----CKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGN 162 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHhhc----cCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCC
Confidence 876543 4578888874 46766665432 35688889999999999999999 899999999999999999
Q ss_pred CcEEEEeeccccccCCCCCce-----eecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 561 FEPQLSDFGLAKWASTSSSHI-----TCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 561 ~~vKL~DFGlA~~~~~~~~~~-----~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+.++|+|||+|+.+....... ......||+.|+|||+.. ..++.++|||||
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSl 219 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESL 219 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHH
Confidence 999999999998775332211 122357999999999775 778999999996
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-26 Score=234.04 Aligned_cols=179 Identities=23% Similarity=0.332 Sum_probs=153.1
Q ss_pred CccceeecccCceEEEEEEec-CCCEEEEEEecCChh--HHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCeEEEEEEcC
Q 007254 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSED--VIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDFL 499 (611)
Q Consensus 424 f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~--~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~ 499 (611)
|.+.+.||.|+||.||+|... +++.|+||.+..... ......+|+..+..++ |+||+++++++...+..|+||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567889999999999999975 578999999875432 2234567999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~ 579 (611)
+|+|.+.+.... ...++|.++..++.|++.+|.|||+ .+|+|+||+|+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 889999887653 2458999999999999999999999 8999999999999999999999999999987654332
Q ss_pred ceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 580 HITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 580 ~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
.....||..|+|||+.. ..++.++|+|||
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~ 185 (283)
T cd07830 155 ---YTDYVSTRWYRAPEILLRSTSYSSPVDIWAL 185 (283)
T ss_pred ---cCCCCCcccccCceeeecCcCcCCccchhhH
Confidence 23457899999999763 568999999996
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-26 Score=241.36 Aligned_cols=182 Identities=23% Similarity=0.316 Sum_probs=150.7
Q ss_pred CCCc-cceeecccCceEEEEEEec-CCCEEEEEEecCChhH---------------HHHHHHHHHHHHhcCCCCeeeEEE
Q 007254 422 SNFL-AENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDV---------------IKEFVLEIEIITTLHHKNIISLLG 484 (611)
Q Consensus 422 ~~f~-~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~---------------~~~~~~Ei~il~~l~HpnIv~l~~ 484 (611)
++|. +.+.||.|+||.||+|... +++.||||+++..... ...+.+|+++++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4554 4577999999999999865 7899999998754211 125778999999999999999999
Q ss_pred EEEeCCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEE
Q 007254 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 564 (611)
Q Consensus 485 ~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vK 564 (611)
++...+..|+||||+. |+|.+.+... ..+++.....++.|++.||.|||+ .+|+||||||+||+++.++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK----IRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEE
Confidence 9999999999999996 5899988643 248899999999999999999999 8999999999999999999999
Q ss_pred EEeeccccccCCCC------------CceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 565 LSDFGLAKWASTSS------------SHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 565 L~DFGlA~~~~~~~------------~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
|+|||++....... .........+++.|+|||+.. ..++.++|+|||
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 220 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSV 220 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHH
Confidence 99999998765211 011122346789999999875 457999999996
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.5e-28 Score=235.43 Aligned_cols=183 Identities=25% Similarity=0.351 Sum_probs=150.1
Q ss_pred CCccceeecccCceEEEEEEe-cCCCEEEEEEecCC--hhHHHHHHHHHHH-HHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 423 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEI-ITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~--~~~~~~~~~Ei~i-l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
+...+..||.|+||+|+|-.. +.|+..|||.++.. +...++|+.|.+. ++.-+.||||++||+++..+..++.||+
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 334567899999999999764 47999999999764 4567889999986 5566899999999999999999999999
Q ss_pred CCCCCHHHHHhc-CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCC
Q 007254 499 LSRGSLEENLHG-NKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 499 ~~~gsL~~~L~~-~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~ 577 (611)
|.- +|..+... .......+++...-.|+...+.||.||-. ...|||||+||+||||+..|.+||||||++..+.++
T Consensus 145 Md~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 145 MDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred Hhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence 954 77654421 11122457788888899999999999986 478999999999999999999999999999988765
Q ss_pred CCceeecCCccCCCcccceecc---CCCcCcceEEeC
Q 007254 578 SSHITCTDVAGTFGYVVLILNP---IAFLFMFNCWFF 611 (611)
Q Consensus 578 ~~~~~~~~~~GT~~Y~aPE~~~---~~~~~~sDiWSL 611 (611)
-. .+..+|...|||||-+. ..|+-.||+|||
T Consensus 222 iA---kT~daGCrpYmAPERi~p~~~gyDiRSDvWSL 255 (361)
T KOG1006|consen 222 IA---KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSL 255 (361)
T ss_pred HH---hhhccCCccccChhccCCccCCcchhhhhhhh
Confidence 43 34578999999999764 569999999997
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-26 Score=240.33 Aligned_cols=181 Identities=22% Similarity=0.306 Sum_probs=149.7
Q ss_pred CCccceeecccCceEEEEEEec-C--CCEEEEEEecCC---hhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC----Ce
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP-D--GKELAVKILKPS---EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED----NN 491 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~-~--g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~----~~ 491 (611)
+|.+.+.||+|+||.||++... + ++.||+|.+... ....+.+.+|++++..+ .||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778899999999999999864 4 789999998753 23456788999999999 599999999976432 45
Q ss_pred EEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccc
Q 007254 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (611)
Q Consensus 492 ~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA 571 (611)
+|+++||+. ++|.+.+... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG----QPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 789999985 6898888654 348899999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCc--eeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 572 KWASTSSSH--ITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 572 ~~~~~~~~~--~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
+........ .......||+.|+|||+.. ..++.++|||||
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~sl 196 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSV 196 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHH
Confidence 876543211 1123457999999999764 578999999996
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-26 Score=245.87 Aligned_cols=182 Identities=21% Similarity=0.309 Sum_probs=156.2
Q ss_pred HhcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCChhHHH---------HHHHHHHHHHhcC---CCCeeeEEEE
Q 007254 419 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIK---------EFVLEIEIITTLH---HKNIISLLGF 485 (611)
Q Consensus 419 ~~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~---------~~~~Ei~il~~l~---HpnIv~l~~~ 485 (611)
....+|.....+|+|+||.|+.|.++ +...|.||.+.+..-... ..-.||.||..|+ |+||++++++
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 44567899999999999999999975 567899999987543222 3446999999998 9999999999
Q ss_pred EEeCCeEEEEEEcCC-CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEE
Q 007254 486 CFEDNNLLLVYDFLS-RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 564 (611)
Q Consensus 486 ~~~~~~~~lV~Ey~~-~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vK 564 (611)
|++++++||+||-.. |-+|++++..+. .+++.++..|+.||+-|+++||. ++|||||||-+|++++.+|-+|
T Consensus 638 FEddd~yyl~te~hg~gIDLFd~IE~kp----~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~k 710 (772)
T KOG1152|consen 638 FEDDDYYYLETEVHGEGIDLFDFIEFKP----RMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVK 710 (772)
T ss_pred eecCCeeEEEecCCCCCcchhhhhhccC----ccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEE
Confidence 999999999999864 459999997653 58999999999999999999999 9999999999999999999999
Q ss_pred EEeeccccccCCCCCceeecCCccCCCcccceecc-CCC-cCcceEEeC
Q 007254 565 LSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAF-LFMFNCWFF 611 (611)
Q Consensus 565 L~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~-~~~sDiWSL 611 (611)
|+|||-|.+..... ...++||.+|-|||++. +.| ...-|||+|
T Consensus 711 lidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwal 755 (772)
T KOG1152|consen 711 LIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWAL 755 (772)
T ss_pred EeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhh
Confidence 99999998765433 24579999999999886 444 888999986
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.8e-27 Score=252.34 Aligned_cols=180 Identities=26% Similarity=0.454 Sum_probs=158.7
Q ss_pred cceeecccCceEEEEEEec--CCC--EEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 007254 426 AENLIGKGGSSQVYKGCLP--DGK--ELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (611)
Q Consensus 426 ~~~~IG~G~fG~Vyk~~~~--~g~--~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 499 (611)
..++||+|.||.|++|.|. .|+ .||||+++.+. ....+|++|+.+|.+|+|+|+++|||+..+ ..+.+|||++
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 3477999999999999975 354 68999999765 368899999999999999999999999987 6789999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~ 579 (611)
+.|+|.+.|++.. ...|.......|+.|||.||.||.. +++|||||..+|+||...-.+||+||||.+-+.....
T Consensus 193 plGSLldrLrka~--~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAK--KAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred ccchHHHHHhhcc--ccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 9999999998733 3568888999999999999999999 9999999999999999998999999999999998887
Q ss_pred ceeecCC-ccCCCcccceecc-CCCcCcceEEeC
Q 007254 580 HITCTDV-AGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 580 ~~~~~~~-~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
++.+... .-.|.|+|||-+. ..++.+||+|+|
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmy 301 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMY 301 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhh
Confidence 7766542 3367899999765 999999999986
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-26 Score=237.62 Aligned_cols=184 Identities=22% Similarity=0.337 Sum_probs=151.9
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-------
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFED------- 489 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------- 489 (611)
+++|.+.+.||.|+||.||+|... +++.+|||++.... .....+.+|+++++.++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999865 68999999886432 2234677899999999999999999987543
Q ss_pred -CeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEee
Q 007254 490 -NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568 (611)
Q Consensus 490 -~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DF 568 (611)
..+++||||+.+ +|...+.... ..+++..+..++.|++.||.|||+ .+|+||||||+|||+++++.+||+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS---VKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcC
Confidence 347999999965 7777776432 358999999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCc---------eeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 569 GLAKWASTSSSH---------ITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 569 GlA~~~~~~~~~---------~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
|+++........ ...+...||+.|+|||+.. ..++.++|||||
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 213 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGI 213 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHH
Confidence 999866532211 1223457899999999764 568999999996
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.2e-26 Score=239.43 Aligned_cols=181 Identities=23% Similarity=0.343 Sum_probs=154.0
Q ss_pred HHHhcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-CCe
Q 007254 417 LLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE-DNN 491 (611)
Q Consensus 417 l~~~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~ 491 (611)
+...+++|.+.+.||.|+||.||++... +++.||||.+.+. ....+.+..|++++..++||||++++++|.. .+.
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3456789999999999999999999854 7899999988642 2345778899999999999999999999875 567
Q ss_pred EEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccc
Q 007254 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (611)
Q Consensus 492 ~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA 571 (611)
.|+||||+ +++|...+... .+++.....++.|++.||.|||+ .+|+||||||+|||+++++.+||+|||++
T Consensus 85 ~~lv~e~~-~~~L~~~~~~~-----~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred EEEEeehh-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccc
Confidence 89999999 56898888632 37788888999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 572 KWASTSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 572 ~~~~~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
....... ....|+..|+|||+.. ..++.++|||||
T Consensus 156 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 192 (328)
T cd07856 156 RIQDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSA 192 (328)
T ss_pred cccCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHH
Confidence 8654321 2356789999999764 578999999996
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.3e-26 Score=237.15 Aligned_cols=180 Identities=21% Similarity=0.175 Sum_probs=148.5
Q ss_pred cceeecccCceEEEEEEecCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCC
Q 007254 426 AENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 502 (611)
Q Consensus 426 ~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 502 (611)
+.+.+|.|+++.||++.. +++.||||+++.. ......+.+|+++++.++|+||+++++++.+.+..|++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 344455666666666555 7899999999754 345678999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCC---
Q 007254 503 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS--- 579 (611)
Q Consensus 503 sL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~--- 579 (611)
+|.+++..... ..+++.....++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++..+.....
T Consensus 85 ~l~~~l~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 85 SCEDLLKTHFP--EGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 99999975432 348889999999999999999999 8999999999999999999999999999876543221
Q ss_pred --ceeecCCccCCCcccceecc---CCCcCcceEEeC
Q 007254 580 --HITCTDVAGTFGYVVLILNP---IAFLFMFNCWFF 611 (611)
Q Consensus 580 --~~~~~~~~GT~~Y~aPE~~~---~~~~~~sDiWSL 611 (611)
........++..|+|||+.. ..|+.++|||||
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~ 196 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSV 196 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHH
Confidence 11223456888999999864 458899999996
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.4e-26 Score=241.03 Aligned_cols=176 Identities=23% Similarity=0.366 Sum_probs=149.1
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC------C
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED------N 490 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~ 490 (611)
.++|.+.+.||+|+||.||+|... +|+.||||.++.. +.....+.+|+.+++.++||||++++++|... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 378999999999999999999864 7899999998753 23446788999999999999999999998754 3
Q ss_pred eEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecc
Q 007254 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (611)
Q Consensus 491 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGl 570 (611)
+.|+|+||+.. +|...+. ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 46999999964 7766552 248899999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 571 AKWASTSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 571 A~~~~~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
++...... ....||..|+|||+.. ..++.++|||||
T Consensus 164 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 201 (342)
T cd07879 164 ARHADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSV 201 (342)
T ss_pred CcCCCCCC-----CCceeeecccChhhhcCccccCchHHHHHH
Confidence 98754322 2457899999999865 468999999996
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=229.13 Aligned_cols=179 Identities=26% Similarity=0.396 Sum_probs=150.5
Q ss_pred CccceeecccCceEEEEEEec-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhc---CCCCeeeEEEEEEeCCe-----
Q 007254 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTL---HHKNIISLLGFCFEDNN----- 491 (611)
Q Consensus 424 f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~~~----- 491 (611)
|.+.+.||+|+||.||+|... +++.||+|.++... .....+.+|+.++..+ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567889999999999999976 58999999997532 2345566788877766 59999999999988776
Q ss_pred EEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccc
Q 007254 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (611)
Q Consensus 492 ~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA 571 (611)
++++|||+.+ +|.+++..... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCcc
Confidence 9999999964 89888865432 358999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 572 KWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 572 ~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
........ .....|++.|+|||+.. ..++.++|||||
T Consensus 155 ~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~ 192 (287)
T cd07838 155 RIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSV 192 (287)
T ss_pred eeccCCcc---cccccccccccChHHhccCCCCCcchhhhH
Confidence 87654322 22346899999999875 778999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-26 Score=238.40 Aligned_cols=183 Identities=28% Similarity=0.434 Sum_probs=150.4
Q ss_pred cCCCccceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHH--hcCCCCeeeEEEEEEeCC----eEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIIT--TLHHKNIISLLGFCFEDN----NLLL 494 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~--~l~HpnIv~l~~~~~~~~----~~~l 494 (611)
..+..+.+.||+|.||.||+|.+ .|+.||||++...++ ..+.+|.+|.. .|+|+||+.+++.=..++ .++|
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE--~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE--RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred hheeEEEEEecCccccceeeccc-cCCceEEEEecccch--hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 34567789999999999999999 688999999987654 33445666655 579999999988755432 5899
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-----CCCCCeEecCCCCCCEEEcCCCcEEEEeec
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS-----GSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~-----~~~~~IvHrDLKp~NILl~~~~~vKL~DFG 569 (611)
|.+|.+.|+|.++|.+. .++....++++..+|.||.|||- +++..|.|||||+.|||+.+++...|+|+|
T Consensus 287 vTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred eeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 99999999999999864 48889999999999999999995 455679999999999999999999999999
Q ss_pred cccccCCCCC--ceeecCCccCCCcccceeccCCCcC-------cceEEeC
Q 007254 570 LAKWASTSSS--HITCTDVAGTFGYVVLILNPIAFLF-------MFNCWFF 611 (611)
Q Consensus 570 lA~~~~~~~~--~~~~~~~~GT~~Y~aPE~~~~~~~~-------~sDiWSL 611 (611)
||-..+.... .......+||--|||||++.+.++. .+|||||
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYaf 412 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAF 412 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHH
Confidence 9987765432 2344567999999999987644332 6899987
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.5e-26 Score=234.87 Aligned_cols=183 Identities=25% Similarity=0.400 Sum_probs=151.9
Q ss_pred hcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCeEEEE
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV 495 (611)
..++|.+.+.||+|+||.||+|... +++.||||.++... .....+..|+.++.... ||||++++++|.+...+|+|
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 3467888999999999999999976 48999999997643 34566777888777665 99999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
|||+. +.|.+++.... ..+++..+..++.+++.||.|||+ ..+|+||||+|+||++++++.+||+|||++....
T Consensus 93 ~e~~~-~~l~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 93 MELMS-TCLDKLLKRIQ---GPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eeccC-cCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 99985 57777765432 368999999999999999999996 1489999999999999999999999999998765
Q ss_pred CCCCceeecCCccCCCcccceecc-C----CCcCcceEEeC
Q 007254 576 TSSSHITCTDVAGTFGYVVLILNP-I----AFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~~-~----~~~~~sDiWSL 611 (611)
..... ....|+..|+|||+.. . .++.++|||||
T Consensus 167 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~sl 204 (296)
T cd06618 167 DSKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSL 204 (296)
T ss_pred CCCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHH
Confidence 43322 2346889999999875 2 38899999996
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.5e-26 Score=237.92 Aligned_cols=179 Identities=20% Similarity=0.229 Sum_probs=147.0
Q ss_pred eeeccc--CceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 007254 428 NLIGKG--GSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (611)
Q Consensus 428 ~~IG~G--~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 501 (611)
..||+| +||+||++... +|+.||+|+++.. ....+.+.+|+.+++.++||||++++++|...+.+|+||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 99999999864 7999999998753 23457788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCce
Q 007254 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (611)
Q Consensus 502 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~ 581 (611)
|+|.+++..... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++++|||.+..........
T Consensus 84 ~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 999999876532 358899999999999999999999 899999999999999999999999998664432211110
Q ss_pred -----eecCCccCCCcccceecc---CCCcCcceEEeC
Q 007254 582 -----TCTDVAGTFGYVVLILNP---IAFLFMFNCWFF 611 (611)
Q Consensus 582 -----~~~~~~GT~~Y~aPE~~~---~~~~~~sDiWSL 611 (611)
......++..|++||+.. ..++.++|||||
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diwsl 196 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSV 196 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHH
Confidence 011234567899999875 457899999996
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=232.94 Aligned_cols=175 Identities=27% Similarity=0.399 Sum_probs=149.8
Q ss_pred CccceeecccCceEEEEEEec-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 424 f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
|...+.||+|+||.||+|... +|+.|++|++... ......+..|+++++.++|||++++++++.+.+..|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999864 6889999998642 23456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
+. |+|.+.+.... ..+++.++..++.|++.||.|||+ .+|+|+||||+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 103 CL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred CC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 95 57878776432 358999999999999999999999 8999999999999999999999999999865332
Q ss_pred CceeecCCccCCCcccceecc----CCCcCcceEEeC
Q 007254 579 SHITCTDVAGTFGYVVLILNP----IAFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~~~~~~~GT~~Y~aPE~~~----~~~~~~sDiWSL 611 (611)
.....|++.|+|||+.. ..++.++|||||
T Consensus 174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~sl 206 (313)
T cd06633 174 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 206 (313)
T ss_pred ----CCCccccccccChhhccccCCCCCCchhhHHHH
Confidence 22457899999999762 668899999996
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.1e-26 Score=231.96 Aligned_cols=183 Identities=20% Similarity=0.304 Sum_probs=152.0
Q ss_pred CCccceeecccCceEEEEEEec-CCCEEEEEEecCC------hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS------EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 495 (611)
+|.+.+.||+|+||.||++... .+..+++|+++.. .....++..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4778899999999999999864 3455677776541 22344677899999999999999999999998999999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
|||+++++|.+.+.........+++.++..++.|++.||.|||+ .+++|+||||+||++++ +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecC
Confidence 99999999999887543334569999999999999999999999 89999999999999976 469999999998765
Q ss_pred CCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 576 TSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.... ......|++.|+|||+.. ..++.++|+|||
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~sl 191 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSL 191 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHH
Confidence 4322 223467899999999765 678889999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.4e-26 Score=238.39 Aligned_cols=181 Identities=24% Similarity=0.335 Sum_probs=155.5
Q ss_pred CCccceeecccCceEEEEEEec-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-----eEE
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN-----NLL 493 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~~ 493 (611)
+|.+.+.||.|+||.||+|... +++.||||.+.... ...+.+..|+.+++.++|+||+++++++...+ .+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999965 58999999987642 34578899999999999999999999998765 789
Q ss_pred EEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccc
Q 007254 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (611)
Q Consensus 494 lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~ 573 (611)
+||||+. ++|.+.+.... .+++..+..++.+++.||.|||+ .+|+||||||+|||++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ----PLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999997 48888886542 58999999999999999999999 8999999999999999999999999999998
Q ss_pred cCCCCC-ceeecCCccCCCcccceecc-C-CCcCcceEEeC
Q 007254 574 ASTSSS-HITCTDVAGTFGYVVLILNP-I-AFLFMFNCWFF 611 (611)
Q Consensus 574 ~~~~~~-~~~~~~~~GT~~Y~aPE~~~-~-~~~~~sDiWSL 611 (611)
...... ........||+.|+|||+.. . .++.++|+|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~sl 193 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSV 193 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHH
Confidence 765431 11233457899999999875 4 78999999996
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-26 Score=247.31 Aligned_cols=191 Identities=21% Similarity=0.396 Sum_probs=163.5
Q ss_pred HHHHHhcCCCccceeecccCceEEEEEEecC-CCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEE
Q 007254 415 QDLLSATSNFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (611)
Q Consensus 415 ~~l~~~~~~f~~~~~IG~G~fG~Vyk~~~~~-g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 493 (611)
++++....+....+.||-|-||.||.|.|+. .-.||||.||.+.....+|+.|..+|+.++|||+|+|+|+|...-.+|
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 3444445566778899999999999999874 457999999998888899999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccc
Q 007254 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (611)
Q Consensus 494 lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~ 573 (611)
||.|||.+|+|.++|+.+.+ ..++--..++++.||..||+||.. +++|||||..+|+|+.++..+|++||||+++
T Consensus 340 IiTEfM~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred EEEecccCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhh
Confidence 99999999999999987754 335556678899999999999998 8999999999999999999999999999999
Q ss_pred cCCCCCceeecCCccCCCcccceec-cCCCcCcceEEeC
Q 007254 574 ASTSSSHITCTDVAGTFGYVVLILN-PIAFLFMFNCWFF 611 (611)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~Y~aPE~~-~~~~~~~sDiWSL 611 (611)
+..++.. ......-...|-|||-+ -+.++.++|+|+|
T Consensus 415 MtgDTYT-AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAF 452 (1157)
T KOG4278|consen 415 MTGDTYT-AHAGAKFPIKWTAPESLAYNTFSIKSDVWAF 452 (1157)
T ss_pred hcCCcee-cccCccCcccccCcccccccccccchhhHHH
Confidence 8765432 11223335679999965 4999999999987
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=233.64 Aligned_cols=175 Identities=27% Similarity=0.371 Sum_probs=150.1
Q ss_pred CccceeecccCceEEEEEEec-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 424 f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
|...+.||+|+||.||+|... +++.+|+|.+... .....++.+|+++++.++|+|++++++++...+..++||||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 556688999999999999864 6889999998642 23456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
+. |+|.+.+.... ..+++.++..++.|++.||.|||+ .+++||||||+|||++.++.++|+|||++......
T Consensus 97 ~~-~~l~~~~~~~~---~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 97 CL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred cC-CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 96 58877775432 348899999999999999999999 89999999999999999999999999999866542
Q ss_pred CceeecCCccCCCcccceecc----CCCcCcceEEeC
Q 007254 579 SHITCTDVAGTFGYVVLILNP----IAFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~~~~~~~GT~~Y~aPE~~~----~~~~~~sDiWSL 611 (611)
....||+.|+|||+.. ..++.++|||||
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~sl 200 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 200 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCCcccchHHH
Confidence 2356899999999752 568999999996
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.2e-26 Score=230.71 Aligned_cols=179 Identities=26% Similarity=0.350 Sum_probs=154.5
Q ss_pred CccceeecccCceEEEEEEec-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 007254 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (611)
Q Consensus 424 f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 499 (611)
|...+.||.|++|.||++... +++.+++|.++... .....+.+|+++++.++|+||+++++++...+..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456788999999999999864 78899999987643 34567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~ 579 (611)
++ +|.+.+.... ..+++..+..++.|++.||.|||. .+|+|+||||+||+++.++.+||+|||++........
T Consensus 81 ~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~ 153 (283)
T cd05118 81 DT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR 153 (283)
T ss_pred CC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence 75 8888886542 358999999999999999999999 8999999999999999999999999999987765431
Q ss_pred ceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 580 HITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 580 ~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
......++..|+|||+.. ..++.++|||||
T Consensus 154 --~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~sl 185 (283)
T cd05118 154 --PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSV 185 (283)
T ss_pred --cccCccCcccccCcHHHhcCCCCCchhHHHHH
Confidence 223356899999999875 378999999996
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=268.13 Aligned_cols=174 Identities=26% Similarity=0.440 Sum_probs=148.4
Q ss_pred cCCCccceeecccCceEEEEEEe-cCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 499 (611)
...|...+.||+|+||.||+|.. .++..||||.++...... ..|+++++.++|||||+++++|.+.+..|+||||+
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP---SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc---HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 34577788999999999999986 478999999987543221 24688999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~ 579 (611)
++|+|.++++ .++|..+.+++.|++.||.|||..+..+|+||||||+||+++.++.+++. ||.+......
T Consensus 766 ~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-- 835 (968)
T PLN00113 766 EGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-- 835 (968)
T ss_pred CCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC--
Confidence 9999999995 27899999999999999999996545899999999999999999988876 7766544322
Q ss_pred ceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 580 HITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 580 ~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
....||+.|+|||+.. ..|+.++|||||
T Consensus 836 ----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~ 864 (968)
T PLN00113 836 ----TKCFISSAYVAPETRETKDITEKSDIYGF 864 (968)
T ss_pred ----CCccccccccCcccccCCCCCcccchhhH
Confidence 2347899999999876 789999999997
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-25 Score=235.18 Aligned_cols=172 Identities=19% Similarity=0.145 Sum_probs=134.6
Q ss_pred hcCCCccceeecccCceEEEEEEec--CCCEEEEEEecCC------hhHHHHHHHHHHHHHhcCCCCeee-EEEEEEeCC
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLP--DGKELAVKILKPS------EDVIKEFVLEIEIITTLHHKNIIS-LLGFCFEDN 490 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~--~g~~vAVK~lk~~------~~~~~~~~~Ei~il~~l~HpnIv~-l~~~~~~~~ 490 (611)
..++|.+.+.||+|+||+||+|... +++.+|||++... ......|.+|+++|..++|+||+. ++++ +
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~ 91 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G 91 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence 3467889999999999999999864 5778899987532 234567899999999999999985 4432 4
Q ss_pred eEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCC-CCCCEEEcCCCcEEEEeec
Q 007254 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDV-KSSNILLSDDFEPQLSDFG 569 (611)
Q Consensus 491 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDL-Kp~NILl~~~~~vKL~DFG 569 (611)
..||||||++|++|.. +... . ...++.+++.||.|||+ .+|+|||| ||+|||++.++.+||+|||
T Consensus 92 ~~~LVmE~~~G~~L~~-~~~~-------~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 92 KDGLVRGWTEGVPLHL-ARPH-------G---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CcEEEEEccCCCCHHH-hCcc-------c---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 6799999999999963 2111 0 13578899999999999 99999999 9999999999999999999
Q ss_pred cccccCCCCCcee------ecCCccCCCcccceecc-------CCCcCcceEE
Q 007254 570 LAKWASTSSSHIT------CTDVAGTFGYVVLILNP-------IAFLFMFNCW 609 (611)
Q Consensus 570 lA~~~~~~~~~~~------~~~~~GT~~Y~aPE~~~-------~~~~~~sDiW 609 (611)
+|+.+........ .+.+.||+.|+|||+.. -..+...|-|
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 9998765443222 14678999999999874 1223456667
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=223.46 Aligned_cols=173 Identities=30% Similarity=0.381 Sum_probs=152.0
Q ss_pred ecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCCH
Q 007254 430 IGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504 (611)
Q Consensus 430 IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 504 (611)
||.|+||.||++... +++.+|+|+++... .....+..|+++++.++||||+++++.+...+..|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999865 58999999987643 2456888999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCceeec
Q 007254 505 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 584 (611)
Q Consensus 505 ~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~ 584 (611)
.+++.... .+++..+..++.|++.||.|||. .+++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 81 ~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~ 151 (250)
T cd05123 81 FSHLSKEG----RFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTN 151 (250)
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC--ccc
Confidence 99997553 48899999999999999999999 9999999999999999999999999999987655321 233
Q ss_pred CCccCCCcccceecc-CCCcCcceEEeC
Q 007254 585 DVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 585 ~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
...|+..|++||... ..++.++|+|||
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~sl 179 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSL 179 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHH
Confidence 467899999999876 667899999996
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=238.54 Aligned_cols=181 Identities=24% Similarity=0.357 Sum_probs=149.3
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC----------
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFED---------- 489 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~---------- 489 (611)
++|.+.+.||.|+||.||+|... +|+.||+|.+.... ...+.+.+|+++++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 67889999999999999999864 68999999986543 4557788999999999999999999776543
Q ss_pred ----CeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEc-CCCcEE
Q 007254 490 ----NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-DDFEPQ 564 (611)
Q Consensus 490 ----~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~-~~~~vK 564 (611)
..+|+||||+. ++|.+++... .+++..+..++.|++.||.|||+ .+|+||||||+||+++ .++.+|
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQG-----PLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEE
Confidence 46899999996 5898887532 38899999999999999999999 8999999999999997 456789
Q ss_pred EEeeccccccCCCCCc-eeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 565 LSDFGLAKWASTSSSH-ITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 565 L~DFGlA~~~~~~~~~-~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
|+|||+++.+...... .......||..|+|||+.. ..++.++|||||
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSl 205 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAA 205 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHH
Confidence 9999999876432211 1122346899999999654 568899999996
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-25 Score=228.13 Aligned_cols=179 Identities=26% Similarity=0.375 Sum_probs=154.1
Q ss_pred CccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 007254 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (611)
Q Consensus 424 f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 499 (611)
|...+.||+|+||.||+|... +++.+|+|+++.. ....+.+..|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456688999999999999865 5899999999864 344567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~ 579 (611)
+ ++|.+++.... ..+++..+..++.+++.||.|||. .+|+||||+|+||++++++.+||+|||+++.......
T Consensus 81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 7 58999997653 358999999999999999999999 8999999999999999999999999999987654332
Q ss_pred ceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 580 HITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 580 ~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
......++..|+|||+.. ..++.++|+|||
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~sl 185 (282)
T cd07829 154 --TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSV 185 (282)
T ss_pred --ccCccccCcCcCChHHhcCCcCCCccccHHHH
Confidence 122345688899999875 478999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-25 Score=237.53 Aligned_cols=178 Identities=23% Similarity=0.357 Sum_probs=153.1
Q ss_pred hcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCe----
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN---- 491 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~---- 491 (611)
..++|.+...||+|+||.||+|... +++.||||++... ......+.+|+.+++.++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4678999999999999999999875 6889999998753 2345677889999999999999999988866554
Q ss_pred --EEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeec
Q 007254 492 --LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569 (611)
Q Consensus 492 --~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFG 569 (611)
+|+|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999999 6799998864 248999999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 570 LAKWASTSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 570 lA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
++...... .....+|..|+|||+.. ..++.++|||||
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dvwsl 202 (343)
T cd07851 164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 202 (343)
T ss_pred cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHH
Confidence 99876543 23457899999999864 467899999996
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.1e-25 Score=221.77 Aligned_cols=163 Identities=20% Similarity=0.192 Sum_probs=139.4
Q ss_pred cCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCCHHHHHhcC
Q 007254 433 GGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGN 511 (611)
Q Consensus 433 G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~ 511 (611)
|.||.||++... +++.||+|.++.... +..|...+....||||+++++++.+.+..|+||||+++|+|.+.+...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 889999999864 789999999986532 334555566678999999999999999999999999999999998654
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCceeecCCccCCC
Q 007254 512 KKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG 591 (611)
Q Consensus 512 ~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~ 591 (611)
. .+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++...... .....++..
T Consensus 80 ~----~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~ 147 (237)
T cd05576 80 L----NIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENM 147 (237)
T ss_pred c----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcc
Confidence 3 38899999999999999999999 89999999999999999999999999988765442 123466788
Q ss_pred cccceecc-CCCcCcceEEeC
Q 007254 592 YVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 592 Y~aPE~~~-~~~~~~sDiWSL 611 (611)
|+|||+.. ..++.++|+|||
T Consensus 148 y~aPE~~~~~~~~~~~Dvwsl 168 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSL 168 (237)
T ss_pred ccCCcccCCCCCCchhhHHHH
Confidence 99999876 678999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd01989 STK_N The N-terminal domain of Eukaryotic Serine Threonine kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=200.77 Aligned_cols=138 Identities=25% Similarity=0.382 Sum_probs=119.7
Q ss_pred EEEEEeCCCHhHHHHHHHHHHHccCCCCEEEEEEEeeCCCcccC-CC-----chhHHHHHHHHHHHHHHHHhhhhhcCCc
Q 007254 18 TVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDR-DG-----KSSLLSLVKAFDSVLAVYEGFCNLKQVD 91 (611)
Q Consensus 18 ~IlVaVD~s~~S~~AL~WAl~~~~~~g~~vvlvHV~~~~~~~~~-~~-----~~~~~~~~~~~~~ll~~~~~~C~~k~V~ 91 (611)
+||||||+|+.|++||+||++++...|++|++|||.++...... .. ........+..++++..+...|...+++
T Consensus 1 ~ILVavD~S~~s~~al~~a~~~a~~~~~~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 80 (146)
T cd01989 1 SVAVAVDKDKKSKNALKWALDNLATKGQTIVLVHVHPPITSIPSSSGKLEVASAYKQEEDKEAKELLLPYRCFCSRKGVQ 80 (146)
T ss_pred CEEEEecCccccHHHHHHHHHhccCCCCcEEEEEeccCcccCCCCccchHHHHHHHHHHHHHHHHHHHHHHHHHhhcCCe
Confidence 59999999999999999999999999999999999876432111 11 1223344567788999999999999999
Q ss_pred EEEEEEECCchhHHHHHHHHhcCCCEEEEccCCCCceeec-cc-chhHHHHhcCCCCcEEEEEeCC
Q 007254 92 LKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRS-TT-SLAKYCAKKLSKDCSVLAVNNG 155 (611)
Q Consensus 92 ~~~~v~~g~~~~~~Iv~~a~~~~ad~LVlG~~g~~~~~R~-~g-sva~~v~k~ap~~C~VlvV~kg 155 (611)
++..+++|+++++.|+++|++.++|+||||++|++++.|+ +| ||+++|++++|++||||||++|
T Consensus 81 ~~~~~~~g~~~~~~I~~~a~~~~~dlIV~Gs~g~~~l~~~~~gssva~~Vi~~a~~~c~Vlvv~~~ 146 (146)
T cd01989 81 CEDVVLEDDDVAKAIVEYVADHGITKLVMGASSDNHFSMKFKKSDVASSVLKEAPDFCTVYVVSKG 146 (146)
T ss_pred EEEEEEeCCcHHHHHHHHHHHcCCCEEEEeccCCCceeecccCCchhHHHHhcCCCCceEEEEeCc
Confidence 9999999889999999999999999999999999999885 76 7999999999999999999997
|
The Serine Threonine kinases are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. The N-terminal domain is homologous to the USP family which has a ATP binding fold. The N-terminal domain is predicted to be involved in ATP binding. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=239.67 Aligned_cols=176 Identities=20% Similarity=0.241 Sum_probs=134.0
Q ss_pred hcCCCccceeecccCceEEEEEEe-----------------cCCCEEEEEEecCChh-HHHH--------------HHHH
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCL-----------------PDGKELAVKILKPSED-VIKE--------------FVLE 467 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~-----------------~~g~~vAVK~lk~~~~-~~~~--------------~~~E 467 (611)
..++|.+.++||+|+||.||+|.+ ..++.||||.++.... ...+ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 367899999999999999999964 2356899999875432 2223 3346
Q ss_pred HHHHHhcCCCCe-----eeEEEEEEe--------CCeEEEEEEcCCCCCHHHHHhcCCC--------------------C
Q 007254 468 IEIITTLHHKNI-----ISLLGFCFE--------DNNLLLVYDFLSRGSLEENLHGNKK--------------------D 514 (611)
Q Consensus 468 i~il~~l~HpnI-----v~l~~~~~~--------~~~~~lV~Ey~~~gsL~~~L~~~~~--------------------~ 514 (611)
+.++..++|.++ +.++++|.. .+..+|||||+++|+|.++|+.... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 677777776654 677777753 3568999999999999999875321 0
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCceeecCCccCCCccc
Q 007254 515 PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVV 594 (611)
Q Consensus 515 ~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~a 594 (611)
...++|..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++........ .......+|+.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 1235788899999999999999999 8999999999999999999999999999976543221 11112345889999
Q ss_pred ceecc
Q 007254 595 LILNP 599 (611)
Q Consensus 595 PE~~~ 599 (611)
||...
T Consensus 379 PE~l~ 383 (507)
T PLN03224 379 PEELV 383 (507)
T ss_pred hhhhc
Confidence 99653
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-26 Score=227.98 Aligned_cols=180 Identities=23% Similarity=0.355 Sum_probs=149.8
Q ss_pred CCccceeecccCceEEEEEEec-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----CeEE
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NNLL 493 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~~ 493 (611)
+....+.||-|+||.||.+.+. +|+.||.|++..-. ...+++.+|+.+|..++|.|++.++++..-. ..+|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 3445788999999999998865 89999999887543 3468899999999999999999999887543 2468
Q ss_pred EEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccc
Q 007254 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (611)
Q Consensus 494 lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~ 573 (611)
.+.|+|.. +|...+-. +..++-..+.-+.+||++||+|||+ .+|.||||||.|+|+++|..+||||||||+.
T Consensus 134 V~TELmQS-DLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHHHh-hhhheecc----CCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccc
Confidence 88898854 77776643 3457777888899999999999999 9999999999999999999999999999986
Q ss_pred cCCCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 574 ASTSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
-..... ..++..+-|-.|.|||+++ ..|+.++||||.
T Consensus 206 ee~d~~-~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSV 244 (449)
T KOG0664|consen 206 WDQRDR-LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSV 244 (449)
T ss_pred cchhhh-hhhHHHHHHHHhccHHHhhcchhhcCccceehh
Confidence 654332 2455667789999999886 899999999983
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.1e-25 Score=223.90 Aligned_cols=180 Identities=19% Similarity=0.316 Sum_probs=156.9
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCC--C----CeeeEEEEEEeCCeEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHH--K----NIISLLGFCFEDNNLL 493 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~H--p----nIv~l~~~~~~~~~~~ 493 (611)
+++|.+...+|+|.||.|-.+.+. .+..||||+++.-....+...-|+++|.++.+ | -+|++.++|...++.|
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC 167 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC 167 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence 778999999999999999998864 57899999999888777888899999999942 2 4788889999999999
Q ss_pred EEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcC--------------
Q 007254 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-------------- 559 (611)
Q Consensus 494 lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~-------------- 559 (611)
||+|.| |-++.++|..+.. .+|+...+..++.|+++++.|||. .+++|-||||+|||+.+
T Consensus 168 ivfell-G~S~~dFlk~N~y--~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 168 IVFELL-GLSTFDFLKENNY--IPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEecc-ChhHHHHhccCCc--cccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccCCccc
Confidence 999999 7799999987654 568889999999999999999999 99999999999999942
Q ss_pred ------CCcEEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 560 ------DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 560 ------~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+..+||+|||-|.+-.... .+++.|..|.|||++. -.|++.+||||+
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSi 295 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSI 295 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceee
Confidence 3458999999998765533 4578999999999887 899999999996
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=247.39 Aligned_cols=187 Identities=27% Similarity=0.413 Sum_probs=157.1
Q ss_pred cCCCccceeecccCceEEEEEEec----C----CCEEEEEEecCCh--hHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP----D----GKELAVKILKPSE--DVIKEFVLEIEIITTL-HHKNIISLLGFCFED 489 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~----~----g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 489 (611)
.++..+.+.||+|.||.|++|... . ...||||.++... ...+.+..|+++|+.+ .|+||+.|+|+|...
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 344455669999999999999743 1 3479999998643 5678899999999998 599999999999999
Q ss_pred CeEEEEEEcCCCCCHHHHHhcCC---CC-------C--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE
Q 007254 490 NNLLLVYDFLSRGSLEENLHGNK---KD-------P--AAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557 (611)
Q Consensus 490 ~~~~lV~Ey~~~gsL~~~L~~~~---~~-------~--~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl 557 (611)
+.+++|+||+..|+|.++|+.++ .. . ..++..+.+.++.|||.||+||++ .++|||||..+||||
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEe
Confidence 99999999999999999998776 00 0 238899999999999999999999 899999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCceeecCCccCCC--cccceecc-CCCcCcceEEeC
Q 007254 558 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG--YVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 558 ~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~--Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.++..+||+|||||+........ ....-.||+. |||||-+. ..|+.++|||||
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y-~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSf 507 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYY-RTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSF 507 (609)
T ss_pred cCCCEEEEccccceeccCCCCce-EecCCCCccceeecCHHHhccCcccccchhhHH
Confidence 99999999999999977665433 3233444444 99999776 899999999997
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.7e-25 Score=244.00 Aligned_cols=180 Identities=25% Similarity=0.467 Sum_probs=157.3
Q ss_pred ccceeecccCceEEEEEEe-cCCC----EEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 007254 425 LAENLIGKGGSSQVYKGCL-PDGK----ELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 425 ~~~~~IG~G~fG~Vyk~~~-~~g~----~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 497 (611)
...++||+|+||+||+|.+ +.|+ +||||++.... ....+|+.|.-+|.+|+|||+++|+|+|.... +.||.+
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3468899999999999985 3443 78999987643 55789999999999999999999999998765 889999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCC
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~ 577 (611)
||+.|.|.++++.++. .+.-+..+.+.+||+.||.|||. +++|||||..+|||+.+-..+||.|||+|+.+..+
T Consensus 778 ~mP~G~LlDyvr~hr~---~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRD---NIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred hcccchHHHHHHHhhc---cccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 9999999999987653 57778889999999999999998 99999999999999999999999999999999888
Q ss_pred CCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 578 SSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 578 ~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
...+......--+.|||-|-+. ..|+.++|||||
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsf 886 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSF 886 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhh
Confidence 7776655555567788888765 899999999997
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.9e-25 Score=238.21 Aligned_cols=175 Identities=29% Similarity=0.376 Sum_probs=149.2
Q ss_pred cCCCccceeecccCceEEEEEEe-cCCCEEEEEEecCChhHHHHHHHHHHHHH-hcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIIT-TLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~~~~~~~~~~Ei~il~-~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
++.|.+...+|.|+|+.|..+.. .+++..+||++.... .+-.+|+.++. ..+||||+++.+.|.+..+.|+|||+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~ 397 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL 397 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence 55677777899999999988874 478899999997663 22334776644 45799999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE-cCCCcEEEEeeccccccCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl-~~~~~vKL~DFGlA~~~~~~ 577 (611)
+.||-|.+.+...+. +. .++..++.+|+.|+.|||. +|||||||||+|||+ ++.++++|+|||+++.....
T Consensus 398 l~g~ell~ri~~~~~----~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 398 LDGGELLRRIRSKPE----FC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred ccccHHHHHHHhcch----hH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 999999888865532 33 7778899999999999999 999999999999999 68899999999999988775
Q ss_pred CCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 578 SSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 578 ~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+.+.+-|..|.|||+.. ..|++++|||||
T Consensus 470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSL 499 (612)
T KOG0603|consen 470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSL 499 (612)
T ss_pred -----hcccchhhcccChhhhccCCCCcchhhHHH
Confidence 44567899999999876 999999999997
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-26 Score=224.01 Aligned_cols=181 Identities=30% Similarity=0.427 Sum_probs=149.0
Q ss_pred CCccceeecccCceEEEEEEe-cCCCEEEEEEecC---ChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--------CC
Q 007254 423 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFE--------DN 490 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--------~~ 490 (611)
.|.-...||+|.||.||+|.. .+|+.||+|++-- .+......++|+++|..|.|+|++.|+.+|.. ..
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 344567899999999999984 4788899886532 22334567899999999999999999998853 23
Q ss_pred eEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecc
Q 007254 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (611)
Q Consensus 491 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGl 570 (611)
.+|+||++|+. +|.-+|...+ ..|+..++.+++.++..||.|+|+ ..|+|||+||.|+||+.++.+||+|||+
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~~---vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNRK---VRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCcc---ccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeecccc
Confidence 48999999976 8988886543 458899999999999999999999 8899999999999999999999999999
Q ss_pred ccccCCC--CCceeecCCccCCCcccceecc--CCCcCcceEEe
Q 007254 571 AKWASTS--SSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWF 610 (611)
Q Consensus 571 A~~~~~~--~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWS 610 (611)
|+.+..+ ......+..+-|+.|..||.+. ..|+.+.|||.
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWg 214 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWG 214 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHh
Confidence 9876543 2223344566799999999876 88999999995
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=6e-24 Score=239.62 Aligned_cols=171 Identities=18% Similarity=0.189 Sum_probs=121.4
Q ss_pred hcCCCccceeecccCceEEEEEEec-C----CCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEE------EEe
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLP-D----GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGF------CFE 488 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~-~----g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~------~~~ 488 (611)
..++|.+.+.||+|+||.||+|.+. + +..||||.++..... ..+..| .+....+.++..++.. +..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-EIWMNE--RVRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-HHHHHH--HHHhhchhhHHHHHHhhhccccccc
Confidence 4578999999999999999999865 4 689999988753321 111111 1122222222222111 245
Q ss_pred CCeEEEEEEcCCCCCHHHHHhcCCCC----------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCC
Q 007254 489 DNNLLLVYDFLSRGSLEENLHGNKKD----------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKS 552 (611)
Q Consensus 489 ~~~~~lV~Ey~~~gsL~~~L~~~~~~----------------~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp 552 (611)
...++|||||+.+++|.+++...... .....+..+..++.||+.||.|||+ ++||||||||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLKP 283 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKP 283 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCCH
Confidence 56799999999999999998754210 0011233456799999999999999 8999999999
Q ss_pred CCEEEcC-CCcEEEEeeccccccCCCCCceeecCCccCCCccccee
Q 007254 553 SNILLSD-DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLIL 597 (611)
Q Consensus 553 ~NILl~~-~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~ 597 (611)
+||||+. ++.+||+|||+|+.+..... .......||+.|+|||.
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~ 328 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQ 328 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHH
Confidence 9999986 57899999999987654322 23345789999999994
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-23 Score=203.69 Aligned_cols=181 Identities=31% Similarity=0.424 Sum_probs=157.0
Q ss_pred CccceeecccCceEEEEEEecC-CCEEEEEEecCChh--HHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 007254 424 FLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (611)
Q Consensus 424 f~~~~~IG~G~fG~Vyk~~~~~-g~~vAVK~lk~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 500 (611)
|.+.+.||.|++|.||++.... ++.+|+|.+..... ..+.+.+|++.+..++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567899999999999999764 88999999987543 57788999999999999999999999999899999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCc
Q 007254 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (611)
Q Consensus 501 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~ 580 (611)
+++|.+++..... .+++.....++.+++.+|.|||. .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 9999999976432 17899999999999999999999 89999999999999999999999999999887654311
Q ss_pred eeecCCccCCCcccceec-c-CCCcCcceEEeC
Q 007254 581 ITCTDVAGTFGYVVLILN-P-IAFLFMFNCWFF 611 (611)
Q Consensus 581 ~~~~~~~GT~~Y~aPE~~-~-~~~~~~sDiWSL 611 (611)
......++..|++||+. . ..++.++|+|+|
T Consensus 155 -~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~l 186 (225)
T smart00221 155 -LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSL 186 (225)
T ss_pred -cccceeccCCcCCHhHhcCCCCCCchhhHHHH
Confidence 22345788899999986 3 778889999986
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-24 Score=208.46 Aligned_cols=177 Identities=22% Similarity=0.382 Sum_probs=149.4
Q ss_pred hcCCCccceeecccCceEEEEEE-ecCCCEEEEEEecCChhHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeC--CeEEEE
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFED--NNLLLV 495 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~-~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~--~~~~lV 495 (611)
..++|.+.+.+|+|.|+.||.|. ..+++.+.||+|++-. .+.+.+|+.||..|+ ||||++|+++..+. ....||
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 35678899999999999999998 4578899999999764 367888999999998 99999999998764 457899
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCC-CcEEEEeecccccc
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDFGLAKWA 574 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~-~~vKL~DFGlA~~~ 574 (611)
+||+++.+...+.. .|+..++..++.+++.||.|+|+ .||+|||+||.|++||.. -.++|+|+|||.++
T Consensus 114 FE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred hhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhc
Confidence 99999877766653 36667888899999999999999 999999999999999965 46999999999988
Q ss_pred CCCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 575 STSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 575 ~~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
....... -.+.+..|--||++. ..|+++-|+|||
T Consensus 184 Hp~~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~ 219 (338)
T KOG0668|consen 184 HPGKEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSL 219 (338)
T ss_pred CCCceee---eeeehhhcCCchheeechhccccHHHHHH
Confidence 7644321 235567788999875 889999999997
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.4e-25 Score=236.30 Aligned_cols=182 Identities=25% Similarity=0.399 Sum_probs=161.3
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
.++|.....+|.|.||.|||+++. +++..|+|+++... +..+-+.+||-+++.-+|||||-++|.|...+.++++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 356778899999999999999854 79999999999754 4567778899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
|.+|+|.+..+.. .++++.++..++++.+.||+|||+ ++-+|||||-.|||+++.|.+|+.|||.+-.+...-
T Consensus 94 cgggslQdiy~~T----gplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 94 CGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred cCCCcccceeeec----ccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhhh
Confidence 9999999988654 458889999999999999999999 899999999999999999999999999987766533
Q ss_pred CceeecCCccCCCcccceecc----CCCcCcceEEeC
Q 007254 579 SHITCTDVAGTFGYVVLILNP----IAFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~~~~~~~GT~~Y~aPE~~~----~~~~~~sDiWSL 611 (611)
. ...++.||+.|||||+.- ..|...+|||++
T Consensus 167 ~--KrksfiGtpywmapEvaaverkggynqlcdiwa~ 201 (829)
T KOG0576|consen 167 A--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAL 201 (829)
T ss_pred h--hhhcccCCccccchhHHHHHhccccccccccccc
Confidence 2 445789999999999752 889999999985
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=194.79 Aligned_cols=174 Identities=34% Similarity=0.566 Sum_probs=152.7
Q ss_pred ecccCceEEEEEEec-CCCEEEEEEecCChh--HHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCCHHH
Q 007254 430 IGKGGSSQVYKGCLP-DGKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEE 506 (611)
Q Consensus 430 IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 506 (611)
||+|++|.||++... +++.+++|++..... ....+.+|+++++.+.|++|+++++++......+++|||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999975 489999999987654 46789999999999999999999999999899999999999999999
Q ss_pred HHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcC-CCcEEEEeeccccccCCCCCceeecC
Q 007254 507 NLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWASTSSSHITCTD 585 (611)
Q Consensus 507 ~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~-~~~vKL~DFGlA~~~~~~~~~~~~~~ 585 (611)
++.... ..+++..+..++.+++.+|.|||+ .+++|+||+|.||+++. ++.++|+|||++........ ....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT 152 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence 987542 358899999999999999999999 89999999999999999 89999999999987765432 2234
Q ss_pred CccCCCcccceecc-C-CCcCcceEEeC
Q 007254 586 VAGTFGYVVLILNP-I-AFLFMFNCWFF 611 (611)
Q Consensus 586 ~~GT~~Y~aPE~~~-~-~~~~~sDiWSL 611 (611)
..++..|++||+.. . .++.++|+|+|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~l 180 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSL 180 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHH
Confidence 67889999999876 4 88999999985
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.1e-23 Score=204.27 Aligned_cols=168 Identities=30% Similarity=0.431 Sum_probs=148.8
Q ss_pred CceEEEEEEec-CCCEEEEEEecCChh-H-HHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCCHHHHHhc
Q 007254 434 GSSQVYKGCLP-DGKELAVKILKPSED-V-IKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHG 510 (611)
Q Consensus 434 ~fG~Vyk~~~~-~g~~vAVK~lk~~~~-~-~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~ 510 (611)
+||.||+|... +|+.+|+|++..... . .+.+.+|+++++.++|+||+++++++......+++|||+.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 589999999976542 2 68899999999999999999999999999999999999999999999875
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCceeecCCccCC
Q 007254 511 NKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 590 (611)
Q Consensus 511 ~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~ 590 (611)
... +++..+..++.+++.+|.|||+ .+|+|+||+|+||++++++.++|+|||++....... ......|+.
T Consensus 81 ~~~----~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~ 150 (244)
T smart00220 81 RGR----LSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTP 150 (244)
T ss_pred ccC----CCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCc
Confidence 432 8899999999999999999999 899999999999999999999999999998876643 234567899
Q ss_pred Ccccceecc-CCCcCcceEEeC
Q 007254 591 GYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 591 ~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.|++||... ..++.++|||||
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~sl 172 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSL 172 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHH
Confidence 999999876 778999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-23 Score=228.73 Aligned_cols=181 Identities=25% Similarity=0.335 Sum_probs=143.7
Q ss_pred CccceeecccCceE-EEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 007254 424 FLAENLIGKGGSSQ-VYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 501 (611)
Q Consensus 424 f~~~~~IG~G~fG~-Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 501 (611)
|...+++|.|+.|+ ||+|.. .|++||||.+-... .....+||..|+.- +|||||++|+.-.+...+||..|.|..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~--~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~ 587 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF--FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC 587 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh--HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh
Confidence 44456789998876 599999 78999999775432 23456899998876 699999999999999999999999955
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcC---C--CcEEEEeeccccccCC
Q 007254 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---D--FEPQLSDFGLAKWAST 576 (611)
Q Consensus 502 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~---~--~~vKL~DFGlA~~~~~ 576 (611)
+|.+++.....+.....-.....+..|++.||++||+ .+||||||||.||||+. + ..++|+|||+++.++.
T Consensus 588 -sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 588 -SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred -hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 9999997642111112214456788999999999999 99999999999999976 3 4689999999998875
Q ss_pred CCCc-eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 577 SSSH-ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~~-~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.... .......||-||+|||.+. ..-+.++|||||
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFsl 700 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSL 700 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccccCcccchhhc
Confidence 4433 3355789999999999875 556779999997
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.4e-23 Score=216.22 Aligned_cols=193 Identities=25% Similarity=0.292 Sum_probs=162.4
Q ss_pred cccChHHHHHhcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCC------CCeeeE
Q 007254 410 RLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHH------KNIISL 482 (611)
Q Consensus 410 ~~~~~~~l~~~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~H------pnIv~l 482 (611)
-.|.+...+..-++|.+....|+|-|++|.+|.+. -|+.||||||+..+...+.-+.|++||++|+. -|+++|
T Consensus 420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl 499 (752)
T KOG0670|consen 420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRL 499 (752)
T ss_pred ceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence 34455444555678999999999999999999865 57899999999999888889999999999963 489999
Q ss_pred EEEEEeCCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCC-C
Q 007254 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-F 561 (611)
Q Consensus 483 ~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~-~ 561 (611)
+..|...+++|||+|-+.. +|.+.|.+.+. ...|....+..|+.|++.||..|-+ .+|+|.||||+|||+++. .
T Consensus 500 ~r~F~hknHLClVFE~Lsl-NLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~k~ 574 (752)
T KOG0670|consen 500 FRHFKHKNHLCLVFEPLSL-NLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNESKN 574 (752)
T ss_pred HHHhhhcceeEEEehhhhc-hHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccCcc
Confidence 9999999999999999854 89999987644 3457888999999999999999998 889999999999999876 4
Q ss_pred cEEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 562 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 562 ~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.+||||||-|..+.++.. +...-+..|.|||++. ..|++..|+||.
T Consensus 575 iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSv 621 (752)
T KOG0670|consen 575 ILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSV 621 (752)
T ss_pred eeeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceee
Confidence 589999999988876542 2233355699999876 999999999983
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.8e-23 Score=207.03 Aligned_cols=176 Identities=24% Similarity=0.331 Sum_probs=148.4
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC------Ce
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED------NN 491 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~~ 491 (611)
.+|..+..+|.|.- .|..+.+. .++.||+|.+... ....++..+|..++.+++|+||++++.+|.-. ..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666778899887 66666543 6889999987543 23457788999999999999999999999643 35
Q ss_pred EEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccc
Q 007254 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (611)
Q Consensus 492 ~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA 571 (611)
+|+|||||.. +|...++- .++......|..|+++|+.|||+ .+|+||||||+||++..++.+||.|||+|
T Consensus 96 ~y~v~e~m~~-nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVILM------ELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHHHHHhhhh-HHHHHHHH------hcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhh
Confidence 7999999954 88888862 36778889999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 572 KWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 572 ~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+....+ ..+++.+.|..|.|||++. ..|.+.+||||+
T Consensus 166 r~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSv 203 (369)
T KOG0665|consen 166 RTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 203 (369)
T ss_pred cccCcc---cccCchhheeeccCchheeccCCcccchhhhh
Confidence 876554 5678899999999999775 669999999995
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.7e-22 Score=209.73 Aligned_cols=132 Identities=21% Similarity=0.347 Sum_probs=116.5
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHHHhcC-----C---CCeeeEEEEEEe---
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLH-----H---KNIISLLGFCFE--- 488 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~-----H---pnIv~l~~~~~~--- 488 (611)
..+|.+.+.||.|.|++||+|.+. +.+.||+|+.|......+..+.||.+|++++ | .+||+|++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 468999999999999999999864 5678999999988888888999999999984 2 479999999975
Q ss_pred -CCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE
Q 007254 489 -DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557 (611)
Q Consensus 489 -~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl 557 (611)
+.++|+|+|++ |.+|...|..... ..++...+..|++||+.||.|||.. .+|||-||||+||||
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~Y--rGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNY--RGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCC--CCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeee
Confidence 45899999999 7799999876654 4588899999999999999999984 589999999999999
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.5e-23 Score=200.90 Aligned_cols=178 Identities=23% Similarity=0.369 Sum_probs=147.2
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCCCeeeEEEE-EEeCCeEEEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGF-CFEDNNLLLVYD 497 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~-~~~~~~~~lV~E 497 (611)
.+.|.+.+.||+|-||.+-++..+ +.+.+++|.+........+|++|...--.| .|.||+.-|++ |++.+..++++|
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 356788899999999999999875 577899999988777889999999876555 58999988764 667788899999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEc--CCCcEEEEeeccccccC
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS--DDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~--~~~~vKL~DFGlA~~~~ 575 (611)
|++.|+|.+.+... .+.+....+|+.|++.||.|+|+ .++||||||.+||||- +...+||||||+.+...
T Consensus 103 ~aP~gdL~snv~~~-----GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 103 FAPRGDLRSNVEAA-----GIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred cCccchhhhhcCcc-----cccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccC
Confidence 99999999988653 37778888999999999999999 8999999999999983 34579999999998765
Q ss_pred CCCCceeecCCccCCCcccceecc------CCCcCcceEEeC
Q 007254 576 TSSSHITCTDVAGTFGYVVLILNP------IAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~~------~~~~~~sDiWSL 611 (611)
... ....-+..|.+||++. -.....+|||.|
T Consensus 175 ~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~Wqf 211 (378)
T KOG1345|consen 175 TTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQF 211 (378)
T ss_pred cee-----hhhhhhcccCCcHHHhhccccceEecccccchhe
Confidence 532 2344577899999763 334779999986
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.3e-22 Score=193.63 Aligned_cols=140 Identities=20% Similarity=0.219 Sum_probs=109.1
Q ss_pred ceeecccCceEEEEEEecCCCEEEEEEecCChh---H-------H-----------------HHHHHHHHHHHhcCCCCe
Q 007254 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSED---V-------I-----------------KEFVLEIEIITTLHHKNI 479 (611)
Q Consensus 427 ~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~---~-------~-----------------~~~~~Ei~il~~l~HpnI 479 (611)
...||+|+||.||+|...+|+.||||++++... . . .....|+++|..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 467999999999999987899999999976421 1 1 122349999999987776
Q ss_pred eeEEEEEEeCCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCCeEecCCCCCCEEEc
Q 007254 480 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL-HSGSAQRVIHRDVKSSNILLS 558 (611)
Q Consensus 480 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yL-H~~~~~~IvHrDLKp~NILl~ 558 (611)
.....+... ..+|||||++++++...+... ..+++.+...++.|++.+|.|| |. .+|+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE
Confidence 433333222 238999999988776543222 2488899999999999999999 67 8999999999999998
Q ss_pred CCCcEEEEeeccccccCC
Q 007254 559 DDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 559 ~~~~vKL~DFGlA~~~~~ 576 (611)
++.++|+|||+|.....
T Consensus 153 -~~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 153 -DGKLYIIDVSQSVEHDH 169 (190)
T ss_pred -CCcEEEEEccccccCCC
Confidence 47899999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.6e-21 Score=185.36 Aligned_cols=140 Identities=24% Similarity=0.259 Sum_probs=111.2
Q ss_pred ceeecccCceEEEEEEecCCCEEEEEEecCChh---------------------------HHHHHHHHHHHHHhcCCCCe
Q 007254 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSED---------------------------VIKEFVLEIEIITTLHHKNI 479 (611)
Q Consensus 427 ~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~---------------------------~~~~~~~Ei~il~~l~HpnI 479 (611)
...||+|+||.||+|...+|+.||||++++... ....+..|.+.+..+.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 568999999999999977899999999986421 01223578999999999987
Q ss_pred eeEEEEEEeCCeEEEEEEcCCCCCHHHH-HhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEc
Q 007254 480 ISLLGFCFEDNNLLLVYDFLSRGSLEEN-LHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 558 (611)
Q Consensus 480 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~-L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~ 558 (611)
.....+.... .||||||++|+++... +.. ..++..+...++.+++.+|.|||. ..+|+||||||+|||++
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE
Confidence 5444443333 3899999998865443 322 236678889999999999999996 26899999999999998
Q ss_pred CCCcEEEEeeccccccCC
Q 007254 559 DDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 559 ~~~~vKL~DFGlA~~~~~ 576 (611)
++.++|+|||+|...+.
T Consensus 153 -~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 -DGKPYIIDVSQAVELDH 169 (190)
T ss_pred -CCCEEEEEcccceecCC
Confidence 78999999999987765
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.8e-21 Score=202.20 Aligned_cols=181 Identities=23% Similarity=0.304 Sum_probs=148.3
Q ss_pred HhcCCCccceeecccCceEEEEEEec----CCCEEEEEEecCChhHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCeEE
Q 007254 419 SATSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLL 493 (611)
Q Consensus 419 ~~~~~f~~~~~IG~G~fG~Vyk~~~~----~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~ 493 (611)
...+.|...+.||+|.|++||++.+. ..+.||+|.+.... ...++..|+++|..+. +.||+.+.+++..++...
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 34566888999999999999999853 36789999887543 2356889999999985 899999999999999999
Q ss_pred EEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCC-CcEEEEeecccc
Q 007254 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDFGLAK 572 (611)
Q Consensus 494 lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~-~~vKL~DFGlA~ 572 (611)
+||||++.-.-.+++.. ++..++..++..++.||.|+|. .|||||||||+|+|.+.. +.-.|+|||||.
T Consensus 112 ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred EEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHH
Confidence 99999999888888753 5678889999999999999999 999999999999999854 567899999998
Q ss_pred ccCCCC--------------------------------Cce----------eecCCccCCCcccceecc--CCCcCcceE
Q 007254 573 WASTSS--------------------------------SHI----------TCTDVAGTFGYVVLILNP--IAFLFMFNC 608 (611)
Q Consensus 573 ~~~~~~--------------------------------~~~----------~~~~~~GT~~Y~aPE~~~--~~~~~~sDi 608 (611)
+..... ..+ ..-..+||+||.|||++. ..-+.++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 322100 000 111378999999999886 666999999
Q ss_pred Ee
Q 007254 609 WF 610 (611)
Q Consensus 609 WS 610 (611)
||
T Consensus 262 ws 263 (418)
T KOG1167|consen 262 WS 263 (418)
T ss_pred ee
Confidence 98
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.8e-20 Score=196.20 Aligned_cols=183 Identities=26% Similarity=0.294 Sum_probs=148.2
Q ss_pred CCccceeecccCceEEEEEEecCC--CEEEEEEecCCh-hHHHHHHHHHHHHHhcCC----CCeeeEEEEE-EeCCeEEE
Q 007254 423 NFLAENLIGKGGSSQVYKGCLPDG--KELAVKILKPSE-DVIKEFVLEIEIITTLHH----KNIISLLGFC-FEDNNLLL 494 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~~g--~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~H----pnIv~l~~~~-~~~~~~~l 494 (611)
+|.+.+.||+|+||.||++..... +.+|+|+-.... .....+..|+.++..+.. +++..+++.. ....+-|+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999996543 478999876543 222267789999998873 6899999998 47778899
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCC-----CcEEEEeec
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-----FEPQLSDFG 569 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~-----~~vKL~DFG 569 (611)
||+.+ |.+|.++..... ...|+..+..+|+.|++.+|.+||+ .|+|||||||+|+++... ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99988 889999886554 4579999999999999999999999 999999999999999865 468999999
Q ss_pred cccccC---CCCC---cee--ecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 570 LAKWAS---TSSS---HIT--CTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 570 lA~~~~---~~~~---~~~--~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+|+... .... ... .....||.-|.++..-. ...+...|+|||
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~ 223 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESL 223 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhH
Confidence 998332 2211 111 12356999999999765 888999999996
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-19 Score=184.23 Aligned_cols=182 Identities=32% Similarity=0.460 Sum_probs=154.1
Q ss_pred CccceeecccCceEEEEEEecCCCEEEEEEecCChh----HHHHHHHHHHHHHhcCCC-CeeeEEEEEEeCCeEEEEEEc
Q 007254 424 FLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSED----VIKEFVLEIEIITTLHHK-NIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 424 f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~----~~~~~~~Ei~il~~l~Hp-nIv~l~~~~~~~~~~~lV~Ey 498 (611)
|.....||.|+||.||++... ..+++|.+..... ....|.+|+.++..+.|+ +|+.+++++...+..+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 567788999999999999876 7899999976432 477899999999999988 799999999877778999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCC-cEEEEeeccccccCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKWASTS 577 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~-~vKL~DFGlA~~~~~~ 577 (611)
+.+++|.+++...... ..+.......++.|++.++.|+|. .+++|||+||+||+++..+ .++++|||+++.....
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999766543211 258888999999999999999999 8899999999999999988 7999999999866654
Q ss_pred CCce----eecCCccCCCcccceecc----CCCcCcceEEeC
Q 007254 578 SSHI----TCTDVAGTFGYVVLILNP----IAFLFMFNCWFF 611 (611)
Q Consensus 578 ~~~~----~~~~~~GT~~Y~aPE~~~----~~~~~~sDiWSL 611 (611)
.... ......||..|++||... ..+....|+||+
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~ 197 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSL 197 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHH
Confidence 3221 345789999999999875 378999999974
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.6e-20 Score=184.42 Aligned_cols=161 Identities=12% Similarity=0.149 Sum_probs=126.7
Q ss_pred hcCCCccceeecccCceEEEEEEecCCCEEEEEEecCCh----hHHHH------HHHHHHHHHhcCCCCeeeEEEEEEeC
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE----DVIKE------FVLEIEIITTLHHKNIISLLGFCFED 489 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~----~~~~~------~~~Ei~il~~l~HpnIv~l~~~~~~~ 489 (611)
..++|...++||.|+||.||.... ++..+|||++++.. ..... +.+|+..+..+.|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 357899999999999999999655 67789999997542 22223 57899999999999999999886643
Q ss_pred --------CeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCC
Q 007254 490 --------NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 561 (611)
Q Consensus 490 --------~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~ 561 (611)
+..+|||||++|.+|.+... ++. ....+++.+|..||. .+++|||+||+||+++.++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC
Confidence 35899999999999977632 222 245689999999999 9999999999999999988
Q ss_pred cEEEEeeccccccCCCCCceeecCCccCCCcccceec-cCCCcCcceEEeC
Q 007254 562 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILN-PIAFLFMFNCWFF 611 (611)
Q Consensus 562 ~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~-~~~~~~~sDiWSL 611 (611)
++|+|||............ .+. ...|+.++|||||
T Consensus 173 -i~liDfg~~~~~~e~~a~d--------------~~vler~y~~~~di~~l 208 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAKD--------------RIDLERHYGIKNEIKDL 208 (232)
T ss_pred -EEEEECCCcccccchhhHH--------------HHHHHhHhcccccccce
Confidence 9999999887553322110 033 3667789999997
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.2e-20 Score=184.86 Aligned_cols=178 Identities=21% Similarity=0.247 Sum_probs=143.5
Q ss_pred CCccceeecccCceEEEEEE-ecCCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEEEEcCC
Q 007254 423 NFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLS 500 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~-~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~ 500 (611)
+|.+.+.||+|+||.++.|. +-+++.||||.=.. ....-++..|....+.| ..+.|...|-|..++-+-.||||++
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL- 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL- 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccc-cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence 68889999999999999997 45899999995432 22234455677777766 4689999999988888889999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCC-----CcEEEEeeccccccC
Q 007254 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-----FEPQLSDFGLAKWAS 575 (611)
Q Consensus 501 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~-----~~vKL~DFGlA~~~~ 575 (611)
|.+|++++.-+. ..|+.+++..||.|++.-++|+|. +.+|+|||||+|+||..- ..+.|+|||+|+.+.
T Consensus 107 GPSLEDLFD~Cg---R~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 107 GPSLEDLFDLCG---RRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred CcCHHHHHHHhc---CcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 899999997554 469999999999999999999999 899999999999999743 458999999999987
Q ss_pred CCCCce-----eecCCccCCCcccceecc-CCCcCcceE
Q 007254 576 TSSSHI-----TCTDVAGTFGYVVLILNP-IAFLFMFNC 608 (611)
Q Consensus 576 ~~~~~~-----~~~~~~GT~~Y~aPE~~~-~~~~~~sDi 608 (611)
+..+.. ......||--||+--.-. .+.+...|+
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDL 219 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDL 219 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhH
Confidence 655442 244678999999987644 444555554
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.9e-19 Score=176.68 Aligned_cols=138 Identities=20% Similarity=0.293 Sum_probs=107.0
Q ss_pred cceeecccCceEEEEEEecCCCEEEEEEecCC-hhHHHHHHHHHHHHHhc-----CCCCeeeEEEEEEeCC---eEE-EE
Q 007254 426 AENLIGKGGSSQVYKGCLPDGKELAVKILKPS-EDVIKEFVLEIEIITTL-----HHKNIISLLGFCFEDN---NLL-LV 495 (611)
Q Consensus 426 ~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~-~~~~~~~~~Ei~il~~l-----~HpnIv~l~~~~~~~~---~~~-lV 495 (611)
....||+|+||.||. ...++.. +||++... ....+.+.+|+.+++.+ .||||++++|++.++. .++ +|
T Consensus 6 ~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 6 EQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 457899999999996 3334444 69988764 23457789999999999 5799999999998863 444 78
Q ss_pred EEc--CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHH-HHHHcCCCCCeEecCCCCCCEEEcC----CCcEEEEe-
Q 007254 496 YDF--LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL-EYLHSGSAQRVIHRDVKSSNILLSD----DFEPQLSD- 567 (611)
Q Consensus 496 ~Ey--~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL-~yLH~~~~~~IvHrDLKp~NILl~~----~~~vKL~D- 567 (611)
+|| +.+|+|.+++.+. .+++. ..++.+++.++ +|||+ ++||||||||+|||++. ++.++|+|
T Consensus 84 ~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred ecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 999 5579999999653 14444 35577888788 99999 99999999999999974 34799999
Q ss_pred eccccccC
Q 007254 568 FGLAKWAS 575 (611)
Q Consensus 568 FGlA~~~~ 575 (611)
||...+++
T Consensus 154 ~G~~~~ip 161 (210)
T PRK10345 154 IGESTFIP 161 (210)
T ss_pred CCCcceee
Confidence 55544433
|
|
| >PRK15456 universal stress protein UspG; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.1e-19 Score=164.05 Aligned_cols=132 Identities=18% Similarity=0.179 Sum_probs=104.6
Q ss_pred CEEEEEeCCC--HhHHHHHHHHHHHccCCCCEEEEEEEeeCCCcccC-----CCchhHHHHHHHHHHHHHHHHhhhhhcC
Q 007254 17 RTVVVGVKLD--THSRELLTWALVKVAQPGDTVIALHVLANNAIVDR-----DGKSSLLSLVKAFDSVLAVYEGFCNLKQ 89 (611)
Q Consensus 17 ~~IlVaVD~s--~~S~~AL~WAl~~~~~~g~~vvlvHV~~~~~~~~~-----~~~~~~~~~~~~~~~ll~~~~~~C~~k~ 89 (611)
++||||||+| +.|.+|+.||+..+.. ++.|++|||+++...... ..........+..++.|..+.......+
T Consensus 3 ~~ILv~vD~S~~~~s~~al~~A~~la~~-~~~l~llhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 81 (142)
T PRK15456 3 KTIIMPVDVFEMELSDKAVRHAEFLAQD-DGVIHLLHVLPGSASLSLHRFAADVRRFEEHLQHEAEERLQTMVSHFTIDP 81 (142)
T ss_pred ccEEEeccCCchhHHHHHHHHHHHHHhc-CCeEEEEEEecCcccccccccccchhhHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 6899999998 4899999999988765 569999999976432111 1112333445566677777776655567
Q ss_pred CcEEEEEEECCchhHHHHHHHHhcCCCEEEEccCCCCceee-cccchhHHHHhcCCCCcEEEEEe
Q 007254 90 VDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIR-STTSLAKYCAKKLSKDCSVLAVN 153 (611)
Q Consensus 90 V~~~~~v~~g~~~~~~Iv~~a~~~~ad~LVlG~~g~~~~~R-~~gsva~~v~k~ap~~C~VlvV~ 153 (611)
++++.++..| ++.+.|+++|+++++|+||||+||++ +.+ ++||++++|+++++ |||+||+
T Consensus 82 ~~v~~~v~~G-~~~~~I~~~a~~~~~DLIVmG~~g~~-~~~~llGS~a~~v~~~a~--~pVLvV~ 142 (142)
T PRK15456 82 SRIKQHVRFG-SVRDEVNELAEELGADVVVIGSRNPS-ISTHLLGSNASSVIRHAN--LPVLVVR 142 (142)
T ss_pred cceEEEEcCC-ChHHHHHHHHhhcCCCEEEEcCCCCC-ccceecCccHHHHHHcCC--CCEEEeC
Confidence 8888888776 78999999999999999999999986 666 49999999999998 9999985
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=4e-20 Score=189.80 Aligned_cols=195 Identities=22% Similarity=0.314 Sum_probs=162.5
Q ss_pred hHHHHHhcCCCccceeecccCceEEEEEEecC------CCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEE
Q 007254 414 YQDLLSATSNFLAENLIGKGGSSQVYKGCLPD------GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGF 485 (611)
Q Consensus 414 ~~~l~~~~~~f~~~~~IG~G~fG~Vyk~~~~~------g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 485 (611)
.+++.....++....++-+|.||.||+|.|.+ .+.|-+|.++.. .-+...|++|--.+..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 34555666678888889999999999997653 345677877654 3456788999999999999999999999
Q ss_pred EEeC-CeEEEEEEcCCCCCHHHHHhcCCCC----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCC
Q 007254 486 CFED-NNLLLVYDFLSRGSLEENLHGNKKD----PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD 560 (611)
Q Consensus 486 ~~~~-~~~~lV~Ey~~~gsL~~~L~~~~~~----~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~ 560 (611)
+.+. ...+.+|.++.-|+|..+|..++.+ ...++..+...++.|++.|++|||+ ++|||.||..+|.+|++.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhh
Confidence 9764 5678899999999999999855433 2457788888999999999999999 999999999999999999
Q ss_pred CcEEEEeeccccccCCCCCceeecCCccCCCcccceec-cCCCcCcceEEeC
Q 007254 561 FEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILN-PIAFLFMFNCWFF 611 (611)
Q Consensus 561 ~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~-~~~~~~~sDiWSL 611 (611)
.++||+|=.|++-+-+...+..-...-....||+||-+ +..|+.++|+|||
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsf 484 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSF 484 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHH
Confidence 99999999999987766666554455567789999965 5999999999997
|
|
| >PRK15005 universal stress protein F; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.4e-18 Score=161.02 Aligned_cols=133 Identities=17% Similarity=0.182 Sum_probs=104.3
Q ss_pred CEEEEEeCCCHh--HHHHHHHHHHHccCCCCEEEEEEEeeCCCccc-C-----CCchhHHHHHHHHHHHHHHHHhhhhhc
Q 007254 17 RTVVVGVKLDTH--SRELLTWALVKVAQPGDTVIALHVLANNAIVD-R-----DGKSSLLSLVKAFDSVLAVYEGFCNLK 88 (611)
Q Consensus 17 ~~IlVaVD~s~~--S~~AL~WAl~~~~~~g~~vvlvHV~~~~~~~~-~-----~~~~~~~~~~~~~~~ll~~~~~~C~~k 88 (611)
++||||||+|+. +++|+.||++.+...|.+|++|||+++..... . ..........+..++.|..+...+...
T Consensus 3 ~~ILv~~D~s~~~~~~~a~~~a~~la~~~~~~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 82 (144)
T PRK15005 3 RTILVPIDISDSELTQRVISHVEAEAKIDDAEVHFLTVIPSLPYYASLGLAYSAELPAMDDLKAEAKSQLEEIIKKFKLP 82 (144)
T ss_pred ccEEEecCCCchhHHHHHHHHHHHHHhccCCeEEEEEEEccCcccccccccccccchHHHHHHHHHHHHHHHHHHHhCCC
Confidence 679999999998 58999999999999999999999997543211 0 001112233445556666666555566
Q ss_pred CCcEEEEEEECCchhHHHHHHHHhcCCCEEEEccCCCCceeec-ccchhHHHHhcCCCCcEEEEEe
Q 007254 89 QVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRS-TTSLAKYCAKKLSKDCSVLAVN 153 (611)
Q Consensus 89 ~V~~~~~v~~g~~~~~~Iv~~a~~~~ad~LVlG~~g~~~~~R~-~gsva~~v~k~ap~~C~VlvV~ 153 (611)
+++++.++..| ++.+.|+++|++.++|+||||+++ +++.++ +||++.+|++++| |||+||+
T Consensus 83 ~~~~~~~v~~G-~p~~~I~~~a~~~~~DLIV~Gs~~-~~~~~~llGS~a~~vl~~a~--cpVlvVr 144 (144)
T PRK15005 83 TDRVHVHVEEG-SPKDRILELAKKIPADMIIIASHR-PDITTYLLGSNAAAVVRHAE--CSVLVVR 144 (144)
T ss_pred CCceEEEEeCC-CHHHHHHHHHHHcCCCEEEEeCCC-CCchheeecchHHHHHHhCC--CCEEEeC
Confidence 77888888776 689999999999999999999995 567774 9999999999999 9999984
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.9e-19 Score=172.69 Aligned_cols=170 Identities=25% Similarity=0.340 Sum_probs=138.6
Q ss_pred HhcCCCccceeecccCceEEEEEE-ecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCC-CCeeeEEEEEEeCCeEEEEE
Q 007254 419 SATSNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH-KNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 419 ~~~~~f~~~~~IG~G~fG~Vyk~~-~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~lV~ 496 (611)
...+.|...+.||+|+||.+|.|. ..+|..||||+=..... -.++.-|..+.+.|++ ..|..+..+..+..+-.+||
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 345789999999999999999998 56899999998765432 2356678889998875 67888888888888889999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcC---CCcEEEEeeccccc
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSDFGLAKW 573 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~---~~~vKL~DFGlA~~ 573 (611)
|++ |.+|++++.-+. ..|+-.+++.++.|++.-++|+|. +++|||||||+|+|+.- ...+.|+|||||+.
T Consensus 91 dLL-GPsLEdLfnfC~---R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCS---RRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred ecc-CccHHHHHHHHh---hhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhh
Confidence 999 899999987543 468899999999999999999999 99999999999999963 34689999999998
Q ss_pred cCCCCCc-----eeecCCccCCCcccce
Q 007254 574 ASTSSSH-----ITCTDVAGTFGYVVLI 596 (611)
Q Consensus 574 ~~~~~~~-----~~~~~~~GT~~Y~aPE 596 (611)
+-+..+. ..-....||.-|-+--
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASin 191 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASIN 191 (341)
T ss_pred hccccccccCccccCCccceeeeehhhh
Confidence 7654332 1223467888887654
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.7e-19 Score=177.24 Aligned_cols=143 Identities=20% Similarity=0.192 Sum_probs=112.3
Q ss_pred CCccceeecccCceEEEEEE--ecCCCEEEEEEecCChh-------------------------HHHHHHHHHHHHHhcC
Q 007254 423 NFLAENLIGKGGSSQVYKGC--LPDGKELAVKILKPSED-------------------------VIKEFVLEIEIITTLH 475 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~--~~~g~~vAVK~lk~~~~-------------------------~~~~~~~Ei~il~~l~ 475 (611)
.|.+.+.||+|+||.||+|. ..+|+.||||+++.... ....+..|++++..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788999999999999998 56899999999875320 1123568999999997
Q ss_pred CC--CeeeEEEEEEeCCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC-eEecCCCC
Q 007254 476 HK--NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR-VIHRDVKS 552 (611)
Q Consensus 476 Hp--nIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~-IvHrDLKp 552 (611)
+. .+..++++ +..+|||||+.|++|...+... ..+...+...++.|++.+|.|||. .+ |+||||||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp 177 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD----VEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSE 177 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc----CCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCCh
Confidence 53 34444443 2348999999998886654322 234556678899999999999999 88 99999999
Q ss_pred CCEEEcCCCcEEEEeeccccccCCC
Q 007254 553 SNILLSDDFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 553 ~NILl~~~~~vKL~DFGlA~~~~~~ 577 (611)
+||+++ ++.++|+|||+|......
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~~~~ 201 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVELDHP 201 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhccCCc
Confidence 999999 889999999999876553
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.8e-18 Score=168.14 Aligned_cols=135 Identities=23% Similarity=0.389 Sum_probs=115.2
Q ss_pred eeecccCceEEEEEEecCCCEEEEEEecCCh---------hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 428 NLIGKGGSSQVYKGCLPDGKELAVKILKPSE---------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 428 ~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~---------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
+.||+|++|.||+|.. +|..+++|+..... .....+.+|++++..+.|++|+....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5789999999999987 77889999876421 1134678899999999999988777777777788999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
++|++|.+.+.... + .+..++.+++.+|.+||. .+++|||++|+|||++ ++.++|+|||++++..
T Consensus 81 ~~G~~L~~~~~~~~-------~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~~ 145 (211)
T PRK14879 81 IEGEPLKDLINSNG-------M-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEFSK 145 (211)
T ss_pred eCCcCHHHHHHhcc-------H-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccCCC
Confidence 99999999986431 2 778899999999999999 8999999999999999 7899999999998754
|
|
| >PRK15118 universal stress global response regulator UspA; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.4e-18 Score=158.00 Aligned_cols=132 Identities=13% Similarity=0.121 Sum_probs=96.7
Q ss_pred CCEEEEEeCCCHhHHHHHHHHHHHccCCCCEEEEEEEeeCCCccc-C-C-C--chhHHHHHHHHHHHHHHHHhhhhhcCC
Q 007254 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVD-R-D-G--KSSLLSLVKAFDSVLAVYEGFCNLKQV 90 (611)
Q Consensus 16 ~~~IlVaVD~s~~S~~AL~WAl~~~~~~g~~vvlvHV~~~~~~~~-~-~-~--~~~~~~~~~~~~~ll~~~~~~C~~k~V 90 (611)
-++||||+|+|+.|+.||.||+..+...|+.|++|||..+..... . . . ............+. +..++...++
T Consensus 3 ~~~ILvavD~S~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---l~~~~~~~~~ 79 (144)
T PRK15118 3 YKHILIAVDLSPESKVLVEKAVSMARPYNAKVSLIHVDVNYSDLYTGLIDVNLGDMQKRISEETHHA---LTELSTNAGY 79 (144)
T ss_pred ceEEEEEccCChhHHHHHHHHHHHHHhhCCEEEEEEEccChhhhhhhhhhcchHHHHHHHHHHHHHH---HHHHHHhCCC
Confidence 378999999999999999999999988899999999953221110 0 0 0 01111122222233 3344556678
Q ss_pred cEEEEEEECCchhHHHHHHHHhcCCCEEEEccCCCCceeecccchhHHHHhcCCCCcEEEEEeC
Q 007254 91 DLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTSLAKYCAKKLSKDCSVLAVNN 154 (611)
Q Consensus 91 ~~~~~v~~g~~~~~~Iv~~a~~~~ad~LVlG~~g~~~~~R~~gsva~~v~k~ap~~C~VlvV~k 154 (611)
.....++..+++.++|+++|++.++|+||||+||+ .+.+ +||||++|+++++ ||||||+.
T Consensus 80 ~~~~~~~~~G~p~~~I~~~a~~~~~DLIV~Gs~~~-~~~~-lgSva~~v~~~a~--~pVLvv~~ 139 (144)
T PRK15118 80 PITETLSGSGDLGQVLVDAIKKYDMDLVVCGHHQD-FWSK-LMSSARQLINTVH--VDMLIVPL 139 (144)
T ss_pred CceEEEEEecCHHHHHHHHHHHhCCCEEEEeCccc-HHHH-HHHHHHHHHhhCC--CCEEEecC
Confidence 77655665568899999999999999999999963 3433 5899999999999 99999974
|
|
| >PRK09982 universal stress protein UspD; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=4e-18 Score=158.41 Aligned_cols=131 Identities=17% Similarity=0.123 Sum_probs=102.1
Q ss_pred CEEEEEeCCCHhHHHHHHHHHHHccCCCCEEEEEEEeeCCCcccC-----CCchhHHHHHHHHHHHHHHHHhhhhhcCCc
Q 007254 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDR-----DGKSSLLSLVKAFDSVLAVYEGFCNLKQVD 91 (611)
Q Consensus 17 ~~IlVaVD~s~~S~~AL~WAl~~~~~~g~~vvlvHV~~~~~~~~~-----~~~~~~~~~~~~~~~ll~~~~~~C~~k~V~ 91 (611)
++||||||+|+.|+.||.||+..+...|.+|+++||.++...... ..........+..++.+..+...+. ...
T Consensus 4 k~ILvavD~S~~s~~al~~A~~lA~~~~a~l~llhV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~--~~~ 81 (142)
T PRK09982 4 KHIGVAISGNEEDALLVNKALELARHNDAHLTLIHIDDGLSELYPGIYFPATEDILQLLKNKSDNKLYKLTKNIQ--WPK 81 (142)
T ss_pred eEEEEEecCCcchHHHHHHHHHHHHHhCCeEEEEEEccCcchhchhhhccchHHHHHHHHHHHHHHHHHHHHhcC--CCc
Confidence 689999999999999999999999999999999999875421110 1112233444555566766665443 234
Q ss_pred EEEEEEECCchhHHHHHHHHhcCCCEEEEccCCCCceeecccchhHHHHhcCCCCcEEEEEeC
Q 007254 92 LKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTSLAKYCAKKLSKDCSVLAVNN 154 (611)
Q Consensus 92 ~~~~v~~g~~~~~~Iv~~a~~~~ad~LVlG~~g~~~~~R~~gsva~~v~k~ap~~C~VlvV~k 154 (611)
++..+..| ++++.|+++|++.+||+||||++ ++++.|+++ |+++|++|++ ||||||+.
T Consensus 82 ~~~~v~~G-~p~~~I~~~A~~~~aDLIVmG~~-~~~~~~~~~-va~~V~~~s~--~pVLvv~~ 139 (142)
T PRK09982 82 TKLRIERG-EMPETLLEIMQKEQCDLLVCGHH-HSFINRLMP-AYRGMINKMS--ADLLIVPF 139 (142)
T ss_pred ceEEEEec-CHHHHHHHHHHHcCCCEEEEeCC-hhHHHHHHH-HHHHHHhcCC--CCEEEecC
Confidence 56666665 78999999999999999999986 788888764 9999999998 99999974
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.9e-18 Score=165.17 Aligned_cols=154 Identities=14% Similarity=0.091 Sum_probs=118.7
Q ss_pred ccceeecccCceEEEEEEecCCCEEEEEEecCChhHHH-----HHHHHHHHHHhcC-CCCeeeEEEEEEeCCeEEEEEEc
Q 007254 425 LAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIK-----EFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 425 ~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~-----~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
.....|++|+||+||.+.. .+..++.+.+........ .|.+|+++|+.|. |++|++++++ +..|++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3467899999999997665 677888887776554333 5789999999995 5889999886 346999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCC-CCCCEEEcCCCcEEEEeeccccccCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDV-KSSNILLSDDFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDL-Kp~NILl~~~~~vKL~DFGlA~~~~~~ 577 (611)
+.|.+|...+.. ....++.|++.+|.++|. +||+|||| ||+|||++.++.++|+|||+|......
T Consensus 80 I~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 80 LAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred ecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 999998654321 013467899999999999 99999999 799999999999999999999866543
Q ss_pred CCc----e-------eecCCccCCCccccee
Q 007254 578 SSH----I-------TCTDVAGTFGYVVLIL 597 (611)
Q Consensus 578 ~~~----~-------~~~~~~GT~~Y~aPE~ 597 (611)
... . .......++.|++|+-
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~ 176 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVE 176 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHH
Confidence 321 0 0111346888888873
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.3e-18 Score=166.15 Aligned_cols=137 Identities=20% Similarity=0.205 Sum_probs=109.6
Q ss_pred CCccceeecccCceEEEEEEecCCCEEEEEEecCChh-----------------------HHHHHHHHHHHHHhcCCC--
Q 007254 423 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSED-----------------------VIKEFVLEIEIITTLHHK-- 477 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~-----------------------~~~~~~~Ei~il~~l~Hp-- 477 (611)
.|.+.+.||+|+||.||++...+|+.||||+++.... ....+..|+.++..+.|+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 4777899999999999999988899999998764320 112356789999999887
Q ss_pred CeeeEEEEEEeCCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE
Q 007254 478 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557 (611)
Q Consensus 478 nIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl 557 (611)
.++..++. ...++||||++|++|...... .....++.+++.++.++|. .+|+||||||+||+|
T Consensus 96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nill 158 (198)
T cd05144 96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNILV 158 (198)
T ss_pred CCCceeec----CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEEE
Confidence 44444442 345999999999998765421 2345688999999999999 999999999999999
Q ss_pred cCCCcEEEEeeccccccCC
Q 007254 558 SDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 558 ~~~~~vKL~DFGlA~~~~~ 576 (611)
+.++.++|+|||+|.....
T Consensus 159 ~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 159 DDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred cCCCcEEEEECCccccCCC
Confidence 9999999999999966554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.1e-18 Score=165.26 Aligned_cols=132 Identities=20% Similarity=0.345 Sum_probs=108.7
Q ss_pred eecccCceEEEEEEecCCCEEEEEEecCCh---------hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 007254 429 LIGKGGSSQVYKGCLPDGKELAVKILKPSE---------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (611)
Q Consensus 429 ~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~---------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 499 (611)
.||+|+||.||+|.+ +|..+++|...... ....++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999986 67889999865321 12366788999999999887655555555666779999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
+|++|.+.+.... . .++.+++.+|.+||+ .+++|+|++|+||+++ ++.++|+|||+++....
T Consensus 80 ~g~~l~~~~~~~~-----~------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~~ 141 (199)
T TIGR03724 80 EGKPLKDVIEEGN-----D------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYSDE 141 (199)
T ss_pred CCccHHHHHhhcH-----H------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcCCCc
Confidence 9999998875421 0 689999999999999 9999999999999999 78999999999987543
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PF00582 Usp: Universal stress protein family; InterPro: IPR006016 The universal stress protein UspA P28242 from SWISSPROT [] is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.2e-17 Score=151.26 Aligned_cols=136 Identities=15% Similarity=0.143 Sum_probs=103.4
Q ss_pred CCEEEEEeCCCHhHHHHHHHHHHHccCCCCEEEEEEEeeCCCcccCCCch--hHHHHHHHHHHHHHHHHhhhhhcCCcEE
Q 007254 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKS--SLLSLVKAFDSVLAVYEGFCNLKQVDLK 93 (611)
Q Consensus 16 ~~~IlVaVD~s~~S~~AL~WAl~~~~~~g~~vvlvHV~~~~~~~~~~~~~--~~~~~~~~~~~ll~~~~~~C~~k~V~~~ 93 (611)
-++|+|++|+++.+.+|++||+..+...|+.|++|||.+........... ...................+...+....
T Consensus 2 ~~~Ilv~~d~~~~~~~al~~a~~la~~~~~~i~~l~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (140)
T PF00582_consen 2 YKRILVAIDGSEESRRALRFALELAKRSGAEITLLHVIPPPPQYSFSAAEDEESEEEAEEEEQARQAEAEEAEAEGGIVI 81 (140)
T ss_dssp TSEEEEEESSSHHHHHHHHHHHHHHHHHTCEEEEEEEEESCHCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTSEE
T ss_pred CCEEEEEECCCHHHHHHHHHHHHHHHhhCCeEEEEEeeccccccccccccccccccccchhhhhhhHHHHHHhhhcccee
Confidence 37899999999999999999999999999999999999865321100000 0000001111111111145566677777
Q ss_pred EEEEECCchhHHHHHHHHhcCCCEEEEccCCCCceeec-ccchhHHHHhcCCCCcEEEEEe
Q 007254 94 LKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRS-TTSLAKYCAKKLSKDCSVLAVN 153 (611)
Q Consensus 94 ~~v~~g~~~~~~Iv~~a~~~~ad~LVlG~~g~~~~~R~-~gsva~~v~k~ap~~C~VlvV~ 153 (611)
...+..+++.++|++++++.++|+||||+++++++.++ +||++++|++++| |||+||+
T Consensus 82 ~~~~~~~~~~~~i~~~~~~~~~dliv~G~~~~~~~~~~~~gs~~~~l~~~~~--~pVlvv~ 140 (140)
T PF00582_consen 82 EVVIESGDVADAIIEFAEEHNADLIVMGSRGRSGLERLLFGSVAEKLLRHAP--CPVLVVP 140 (140)
T ss_dssp EEEEEESSHHHHHHHHHHHTTCSEEEEESSSTTSTTTSSSHHHHHHHHHHTS--SEEEEEE
T ss_pred EEEEEeeccchhhhhccccccceeEEEeccCCCCccCCCcCCHHHHHHHcCC--CCEEEeC
Confidence 77777789999999999999999999999999988885 9999999999999 9999985
|
UspA enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae UspA [] reveals an alpha/beta fold similar to that of the Methanocaldococcus jannaschii (Methanococcus jannaschii) MJ0577 protein, which binds ATP [], though UspA lacks ATP-binding activity.; GO: 0006950 response to stress; PDB: 3DLO_C 3QTB_A 2PFS_A 3TNJ_A 1JMV_D 3FH0_B 3FDX_B 3AB7_A 3AB8_A 2GM3_F .... |
| >cd01988 Na_H_Antiporter_C The C-terminal domain of a subfamily of Na+ /H+ antiporter existed in bacteria and archea | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.7e-17 Score=148.47 Aligned_cols=131 Identities=19% Similarity=0.162 Sum_probs=112.6
Q ss_pred EEEEEeCCCHhHHHHHHHHHHHccCCCCEEEEEEEeeCCCcccCCCchhHHHHHHHHHHHHHHHHhhhhhcCCcEEEEEE
Q 007254 18 TVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKIC 97 (611)
Q Consensus 18 ~IlVaVD~s~~S~~AL~WAl~~~~~~g~~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~C~~k~V~~~~~v~ 97 (611)
+|+|+||+++.++.||.||...+...+..|+++||.+....... .......+..++.+..+..++...+++++..+.
T Consensus 1 ~ILv~vd~s~~~~~~l~~a~~la~~~~~~v~ll~v~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~ 77 (132)
T cd01988 1 RILVPVANPNTARDLLELAAALARAQNGEIIPLNVIEVPNHSSP---SQLEVNVQRARKLLRQAERIAASLGVPVHTIIR 77 (132)
T ss_pred CEEEecCCchhHHHHHHHHHHHhhcCCCeEEEEEEEecCCCCCc---chhHHHHHHHHHHHHHHHHHhhhcCCceEEEEE
Confidence 59999999999999999999999999999999999986432111 112233456778899999999999999998888
Q ss_pred ECCchhHHHHHHHHhcCCCEEEEccCCCCceee-cccchhHHHHhcCCCCcEEEEEe
Q 007254 98 RGTSIRKILVREAQSYSATKFIVGTAKNHHTIR-STTSLAKYCAKKLSKDCSVLAVN 153 (611)
Q Consensus 98 ~g~~~~~~Iv~~a~~~~ad~LVlG~~g~~~~~R-~~gsva~~v~k~ap~~C~VlvV~ 153 (611)
.++++.+.|++++++.++|+||||+++++.+.+ ++||++++|+++++ |||++|+
T Consensus 78 ~~~~~~~~I~~~a~~~~~dlIV~G~~~~~~~~~~~lGs~~~~v~~~~~--~pvlvv~ 132 (132)
T cd01988 78 IDHDIASGILRTAKERQADLIIMGWHGSTSLRDRLFGGVIDQVLESAP--CDVAVVK 132 (132)
T ss_pred ecCCHHHHHHHHHHhcCCCEEEEecCCCCCccceecCchHHHHHhcCC--CCEEEeC
Confidence 777899999999999999999999999998866 49999999999998 9999985
|
Na+/H+ exchange proteins eject protons from cells, effectively eliminating excess acid from actively metabolising cells. Na+ /H+ exchange activity is also crucial for the regulation of cell volume, and for the reabsorption of NaCl across renal, intestinal, and other epithelia. These antiports exchange Na+ for H+ in an electroneutral manner, and this activity is carried out by a family of Na+ /H+ exchangers, or NHEs, which are known to be present in both prokaryotic and eukaryotic cells. These exchangers are highly-regulated (glyco)phosphoproteins, which, based on their primary structure, appear to contain 10-12 membrane-spanning regions (M) at the N-terminus and a large cytoplasmic region at the C-terminus. The transmembrane regions M3-M12 share identity wit h other members of the family. The M6 and M7 regions are highly conserved. Thus, this is thought to be the regio |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-17 Score=188.34 Aligned_cols=139 Identities=19% Similarity=0.322 Sum_probs=113.5
Q ss_pred cCCCccceeecccCceEEEEEEecCCCEEEEEEe-cCC---h-----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCe
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKIL-KPS---E-----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 491 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~l-k~~---~-----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 491 (611)
...|...+.||+|+||.||+|.+... .+++|+. .+. . ....++.+|++++..++|++|+....++...+.
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 34456788999999999999987543 3444432 211 1 123568899999999999999988888877777
Q ss_pred EEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccc
Q 007254 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (611)
Q Consensus 492 ~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA 571 (611)
.++||||++|++|.+.+. ....++.+++.+|.|||+ .+|+||||||+|||+ +++.++|+|||+|
T Consensus 411 ~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred CEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCccc
Confidence 899999999999999885 346789999999999999 999999999999999 6779999999999
Q ss_pred cccCC
Q 007254 572 KWAST 576 (611)
Q Consensus 572 ~~~~~ 576 (611)
+....
T Consensus 475 ~~~~~ 479 (535)
T PRK09605 475 KYSDL 479 (535)
T ss_pred ccCCc
Confidence 87653
|
|
| >cd01987 USP_OKCHK USP domain is located between the N-terminal sensor domain and C-terminal catalytic domain of this Osmosensitive K+ channel histidine kinase family | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.6e-17 Score=150.04 Aligned_cols=122 Identities=15% Similarity=0.104 Sum_probs=102.5
Q ss_pred EEEEEeCCCHhHHHHHHHHHHHccCCCCEEEEEEEeeCCCcccCCCchhHHHHHHHHHHHHHHHHhhhhhcCCcEEEEEE
Q 007254 18 TVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKIC 97 (611)
Q Consensus 18 ~IlVaVD~s~~S~~AL~WAl~~~~~~g~~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~C~~k~V~~~~~v~ 97 (611)
+|+||||+++.|++||+||+..+...+..|++|||.++... ....+.++.++.+..+++..+++ ..++
T Consensus 1 ~Ilv~vd~s~~s~~al~~a~~la~~~~~~l~ll~v~~~~~~----------~~~~~~~~~l~~~~~~~~~~~~~--~~~~ 68 (124)
T cd01987 1 RILVCISGGPNAERLIRRAARLADRLKAPWYVVYVETPRLN----------RLSEAERRRLAEALRLAEELGAE--VVTL 68 (124)
T ss_pred CEEEEECCCcchHHHHHHHHHHHHHhCCCEEEEEEecCccc----------cCCHHHHHHHHHHHHHHHHcCCE--EEEE
Confidence 59999999999999999999999999999999999875421 01133456677777777766665 3466
Q ss_pred ECCchhHHHHHHHHhcCCCEEEEccCCCCceeec-ccchhHHHHhcCCCCcEEEEE
Q 007254 98 RGTSIRKILVREAQSYSATKFIVGTAKNHHTIRS-TTSLAKYCAKKLSKDCSVLAV 152 (611)
Q Consensus 98 ~g~~~~~~Iv~~a~~~~ad~LVlG~~g~~~~~R~-~gsva~~v~k~ap~~C~VlvV 152 (611)
.+++++++|+++++++++|+||||+++++.+.|+ +||+++++++++ ..|||+||
T Consensus 69 ~~~~~~~~I~~~~~~~~~dllviG~~~~~~~~~~~~Gs~~~~v~~~a-~~~~v~v~ 123 (124)
T cd01987 69 PGDDVAEAIVEFAREHNVTQIVVGKSRRSRWRELFRGSLVDRLLRRA-GNIDVHIV 123 (124)
T ss_pred eCCcHHHHHHHHHHHcCCCEEEeCCCCCchHHHHhcccHHHHHHHhC-CCCeEEEe
Confidence 7788999999999999999999999999999995 999999999999 24999997
|
The family of KdpD sensor kinase proteins regulates the kdpFABC operon responsible for potassium transport. The USP domain is homologous to the universal stress protein Usp Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=7.1e-19 Score=206.89 Aligned_cols=132 Identities=17% Similarity=0.186 Sum_probs=98.9
Q ss_pred hcCC-CCeeeEEEEE-------EeCCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC
Q 007254 473 TLHH-KNIISLLGFC-------FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 544 (611)
Q Consensus 473 ~l~H-pnIv~l~~~~-------~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~ 544 (611)
.++| +||.+++++| .....++++|||+ +++|.+.|.... ..+++.+++.|+.||+.||.|||+ ++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~g 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD---RSVDAFECFHVFRQIVEIVNAAHS---QG 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc---ccccHHHHHHHHHHHHHHHHHHHh---CC
Confidence 3445 5777788877 2335678889988 669999996432 358999999999999999999999 99
Q ss_pred eEecCCCCCCEEEcC-------------------CCcEEEEeeccccccCCCCC--------------ceeecCCccCCC
Q 007254 545 VIHRDVKSSNILLSD-------------------DFEPQLSDFGLAKWASTSSS--------------HITCTDVAGTFG 591 (611)
Q Consensus 545 IvHrDLKp~NILl~~-------------------~~~vKL~DFGlA~~~~~~~~--------------~~~~~~~~GT~~ 591 (611)
||||||||+||||+. ++.+||+|||+++....... ........||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999965 44566666666654321000 001112468999
Q ss_pred cccceecc-CCCcCcceEEeC
Q 007254 592 YVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 592 Y~aPE~~~-~~~~~~sDiWSL 611 (611)
|||||++. ..|+.++|||||
T Consensus 181 Y~APE~~~~~~~~~~sDVwSl 201 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRL 201 (793)
T ss_pred eEChhhhccCCCCchhhhhhH
Confidence 99999876 789999999997
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.8e-18 Score=196.11 Aligned_cols=184 Identities=21% Similarity=0.271 Sum_probs=144.6
Q ss_pred HhcCCCccceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcC---CCCeeeEEEEEEeCCeEEEE
Q 007254 419 SATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLH---HKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 419 ~~~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~lV 495 (611)
..-..|.+.+.||+|+||+||+|...+|+.||+|+-++...+ +|+-=.+++.+|+ -+-|..+..++...+.-+||
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W--EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW--EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce--eeeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence 334568889999999999999999888999999998875422 2222223444444 23444555555566777999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEc-------CCCcEEEEee
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-------DDFEPQLSDF 568 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~-------~~~~vKL~DF 568 (611)
+||.+.|+|.+++... ..++|..++.+++|+++-++.||. .+|||+||||+|+||. +...++|+||
T Consensus 773 ~ey~~~Gtlld~~N~~----~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 773 SEYSPYGTLLDLINTN----KVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred eeccccccHHHhhccC----CCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEEec
Confidence 9999999999999744 458999999999999999999999 9999999999999994 2346899999
Q ss_pred ccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 569 GLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 569 GlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
|.+--+..-.........++|-++-.+|+.. ..|++.+|.|-|
T Consensus 846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGl 889 (974)
T KOG1166|consen 846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGL 889 (974)
T ss_pred ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHH
Confidence 9987554333334566789999999999886 999999998753
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.6e-17 Score=148.74 Aligned_cols=138 Identities=22% Similarity=0.253 Sum_probs=116.7
Q ss_pred cceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCC--CCeeeEEEEEEeCCeEEEEEEcCCCCC
Q 007254 426 AENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH--KNIISLLGFCFEDNNLLLVYDFLSRGS 503 (611)
Q Consensus 426 ~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~lV~Ey~~~gs 503 (611)
+.+.||.|+++.||++...+ ..+++|..+.... ...+..|+.++..++| .+++++++++...+..+++|||++++.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 35779999999999999744 7899999876544 5678899999999977 599999999888788999999998877
Q ss_pred HHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 504 LEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 504 L~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
+... ++.....++.+++.+|.+||.....+++|+||+|+||++++++.++++|||++.+.+.
T Consensus 80 ~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~~ 141 (155)
T cd05120 80 LDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGPP 141 (155)
T ss_pred cccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCCh
Confidence 7543 4456677899999999999984445899999999999999989999999999986553
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK10116 universal stress protein UspC; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.4e-16 Score=145.73 Aligned_cols=132 Identities=12% Similarity=0.112 Sum_probs=101.0
Q ss_pred CCEEEEEeCCCHhHHHHHHHHHHHccCCCCEEEEEEEeeCCCcccCCC----chhHHHHHHHHHHHHHHHHhhhhhcCCc
Q 007254 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDG----KSSLLSLVKAFDSVLAVYEGFCNLKQVD 91 (611)
Q Consensus 16 ~~~IlVaVD~s~~S~~AL~WAl~~~~~~g~~vvlvHV~~~~~~~~~~~----~~~~~~~~~~~~~ll~~~~~~C~~k~V~ 91 (611)
-++|+|++|+|..++.||.+|+..+.+.|..|+++||.+......... ....+...++.++.|. .++.+.++.
T Consensus 3 ~~~ILv~~D~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~---~~~~~~~~~ 79 (142)
T PRK10116 3 YSNILVAVAVTPESQQLLAKAVSIARPVNGKISLITLASDPEMYNQFAAPMLEDLRSVMQEETQSFLD---KLIQDADYP 79 (142)
T ss_pred CceEEEEccCCcchHHHHHHHHHHHHHhCCEEEEEEEccCcccchhhhHHHHHHHHHHHHHHHHHHHH---HHHHhcCCC
Confidence 378999999999999999999999988899999999986542211111 1112222223334443 344566776
Q ss_pred EEEEEEECCchhHHHHHHHHhcCCCEEEEccCCCCceeecccchhHHHHhcCCCCcEEEEEe
Q 007254 92 LKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTSLAKYCAKKLSKDCSVLAVN 153 (611)
Q Consensus 92 ~~~~v~~g~~~~~~Iv~~a~~~~ad~LVlG~~g~~~~~R~~gsva~~v~k~ap~~C~VlvV~ 153 (611)
.+..++..+++.+.|+++|++.++|+||||+++++++.++ +|++++|+++++ ||||||+
T Consensus 80 ~~~~~~~~G~~~~~I~~~a~~~~~DLiV~g~~~~~~~~~~-~s~a~~v~~~~~--~pVLvv~ 138 (142)
T PRK10116 80 IEKTFIAYGELSEHILEVCRKHHFDLVICGNHNHSFFSRA-SCSAKRVIASSE--VDVLLVP 138 (142)
T ss_pred eEEEEEecCCHHHHHHHHHHHhCCCEEEEcCCcchHHHHH-HHHHHHHHhcCC--CCEEEEe
Confidence 6545555568899999999999999999999999988886 489999999999 9999997
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=5.3e-18 Score=184.42 Aligned_cols=169 Identities=27% Similarity=0.312 Sum_probs=143.8
Q ss_pred eecccCceEEEEEE----ecCCCEEEEEEecCChh---HHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCeEEEEEEcCC
Q 007254 429 LIGKGGSSQVYKGC----LPDGKELAVKILKPSED---VIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDFLS 500 (611)
Q Consensus 429 ~IG~G~fG~Vyk~~----~~~g~~vAVK~lk~~~~---~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~ 500 (611)
.+|+|.||.|+.+. .+.|..+|+|++++... .......|..++...+ ||++|++.-.++....++++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999765 23577899999876421 1114456888899887 9999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCc
Q 007254 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (611)
Q Consensus 501 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~ 580 (611)
||+|...+... ..+.......+..+++.+++++|+ .+|+|||+|++||+++.+|++++.|||+++..-+...
T Consensus 81 gg~lft~l~~~----~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKE----VMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI- 152 (612)
T ss_pred cchhhhccccC----CchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhh-
Confidence 99999988654 347778888899999999999999 9999999999999999999999999999997665432
Q ss_pred eeecCCccCCCcccceeccCCCcCcceEEeC
Q 007254 581 ITCTDVAGTFGYVVLILNPIAFLFMFNCWFF 611 (611)
Q Consensus 581 ~~~~~~~GT~~Y~aPE~~~~~~~~~sDiWSL 611 (611)
.+||.-|||||+.. ....++|+|||
T Consensus 153 -----~cgt~eymApEI~~-gh~~a~D~ws~ 177 (612)
T KOG0603|consen 153 -----ACGTYEYRAPEIIN-GHLSAADWWSF 177 (612)
T ss_pred -----cccchhhhhhHhhh-ccCCcccchhh
Confidence 28999999999888 77899999996
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.8e-17 Score=184.64 Aligned_cols=177 Identities=21% Similarity=0.256 Sum_probs=139.2
Q ss_pred cceeecccCceEEEEEEec-CCCEEEEEEec----CCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 007254 426 AENLIGKGGSSQVYKGCLP-DGKELAVKILK----PSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 426 ~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk----~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 497 (611)
...++|.|++|.|+..... ..+.++.|..+ +.+ .....+..|+-+-..|.|||++..+..+.+....+-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4678999999977776532 33334444332 322 222336678888889999999888777776666666699
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCC
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~ 577 (611)
||++ +|..++.... .+.-.++.+++.|++.|+.|||. .||.||||||+|+|++.+|.+||+|||.+......
T Consensus 402 ~~~~-Dlf~~~~~~~----~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNG----KLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred cccH-HHHHHHhccc----ccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 9999 9999997652 37778899999999999999999 99999999999999999999999999999876554
Q ss_pred CCc--eeecCCccCCCcccceecc-CCC-cCcceEEe
Q 007254 578 SSH--ITCTDVAGTFGYVVLILNP-IAF-LFMFNCWF 610 (611)
Q Consensus 578 ~~~--~~~~~~~GT~~Y~aPE~~~-~~~-~~~sDiWS 610 (611)
... .....++|+-+|+|||+.- ..| ....||||
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS 510 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWS 510 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhh
Confidence 433 4556789999999999775 555 67999998
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.1e-16 Score=152.67 Aligned_cols=137 Identities=21% Similarity=0.281 Sum_probs=99.6
Q ss_pred ceeecccCceEEEEEEecCCCEEEEEEecCChh---HHHHH----------------------HHHHHHHHhcCCCC--e
Q 007254 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSED---VIKEF----------------------VLEIEIITTLHHKN--I 479 (611)
Q Consensus 427 ~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~---~~~~~----------------------~~Ei~il~~l~Hpn--I 479 (611)
.+.||+|+||.||+|...+|+.||||++++... ....+ ..|.+.+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999987899999999876421 11111 34666666665443 4
Q ss_pred eeEEEEEEeCCeEEEEEEcCCCCCHHH-HHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEc
Q 007254 480 ISLLGFCFEDNNLLLVYDFLSRGSLEE-NLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 558 (611)
Q Consensus 480 v~l~~~~~~~~~~~lV~Ey~~~gsL~~-~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~ 558 (611)
...+++ ...++||||++++.+.. .+.... .. .+...++.+++.++.+||. ..+|+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE
Confidence 444443 24599999999855432 121110 11 4567899999999999996 26899999999999999
Q ss_pred CCCcEEEEeeccccccCC
Q 007254 559 DDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 559 ~~~~vKL~DFGlA~~~~~ 576 (611)
++.++|+|||.|.....
T Consensus 150 -~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 -DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred -CCcEEEEECcccccccC
Confidence 88999999999976554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.62 E-value=5.4e-15 Score=149.47 Aligned_cols=136 Identities=14% Similarity=0.162 Sum_probs=106.2
Q ss_pred ceeec-ccCceEEEEEEecCCCEEEEEEecCCh--------------hHHHHHHHHHHHHHhcCCCCe--eeEEEEEEeC
Q 007254 427 ENLIG-KGGSSQVYKGCLPDGKELAVKILKPSE--------------DVIKEFVLEIEIITTLHHKNI--ISLLGFCFED 489 (611)
Q Consensus 427 ~~~IG-~G~fG~Vyk~~~~~g~~vAVK~lk~~~--------------~~~~~~~~Ei~il~~l~HpnI--v~l~~~~~~~ 489 (611)
...|| .||.|+||.+.. .+..++||.++... .....+.+|++++..|+|++| +..++++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35687 899999999877 46789999875311 123567889999999998875 6777765432
Q ss_pred C----eEEEEEEcCCC-CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEE
Q 007254 490 N----NLLLVYDFLSR-GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 564 (611)
Q Consensus 490 ~----~~~lV~Ey~~~-gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vK 564 (611)
. ..++||||++| .+|.+++... .++.. .+.+++.+|.+||. .||+||||||.|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEE
Confidence 2 23599999997 6998888542 24433 35789999999999 9999999999999999999999
Q ss_pred EEeeccccccC
Q 007254 565 LSDFGLAKWAS 575 (611)
Q Consensus 565 L~DFGlA~~~~ 575 (611)
|+|||.+....
T Consensus 183 LIDfg~~~~~~ 193 (239)
T PRK01723 183 LIDFDRGELRT 193 (239)
T ss_pred EEECCCcccCC
Confidence 99999998754
|
|
| >cd00293 USP_Like Usp: Universal stress protein family | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.4e-14 Score=129.64 Aligned_cols=129 Identities=19% Similarity=0.247 Sum_probs=110.0
Q ss_pred EEEEEeCCCHhHHHHHHHHHHHccCCCCEEEEEEEeeCCCcccCCCchhHHHHHHHHHHHHHHHHhhhhhcCCcEEEEEE
Q 007254 18 TVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKIC 97 (611)
Q Consensus 18 ~IlVaVD~s~~S~~AL~WAl~~~~~~g~~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~C~~k~V~~~~~v~ 97 (611)
+|+|++|++..++.++.||.+.+...+..|+++||.+....... ........+.++.|..+...|...++.++..+.
T Consensus 1 ~ilv~i~~~~~~~~~l~~a~~~a~~~~~~i~~l~v~~~~~~~~~---~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 77 (130)
T cd00293 1 RILVAVDGSEESERALRWAARLARRLGAELVLLHVVDPPPSSAA---ELAELLEEEARALLEALREALAEAGVKVETVVL 77 (130)
T ss_pred CEEEEeCCCHHHHHHHHHHHHHHHhcCCEEEEEEEecCCCCcch---hHHHHHHHHHHHHHHHHHHHHhcCCCceEEEEe
Confidence 58999999999999999999999999999999999875432111 223345566778999999989888999988888
Q ss_pred ECCchhHHHHHHHHhcCCCEEEEccCCCCceeec-ccchhHHHHhcCCCCcEEEEE
Q 007254 98 RGTSIRKILVREAQSYSATKFIVGTAKNHHTIRS-TTSLAKYCAKKLSKDCSVLAV 152 (611)
Q Consensus 98 ~g~~~~~~Iv~~a~~~~ad~LVlG~~g~~~~~R~-~gsva~~v~k~ap~~C~VlvV 152 (611)
.|.. .++|++++++.++|+||||+++++.+.++ .|+++++++++++ |||++|
T Consensus 78 ~~~~-~~~i~~~~~~~~~dlvvig~~~~~~~~~~~~~~~~~~ll~~~~--~pvliv 130 (130)
T cd00293 78 EGDP-AEAILEAAEELGADLIVMGSRGRSGLRRLLLGSVAERVLRHAP--CPVLVV 130 (130)
T ss_pred cCCC-HHHHHHHHHHcCCCEEEEcCCCCCccceeeeccHHHHHHhCCC--CCEEeC
Confidence 7654 89999999999999999999999887664 8999999999998 999985
|
The universal stress protein Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae Usp reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, athough Usp lacks ATP-binding activity. |
| >PRK11175 universal stress protein UspE; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.7e-15 Score=155.69 Aligned_cols=138 Identities=10% Similarity=0.056 Sum_probs=110.8
Q ss_pred CCEEEEEeCCCHhHHHHHHHHHHHccCCCCEEEEEEEeeCCCcc--cCCCch----hHHHHHHHHHHHHHHHHhhhhhcC
Q 007254 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIV--DRDGKS----SLLSLVKAFDSVLAVYEGFCNLKQ 89 (611)
Q Consensus 16 ~~~IlVaVD~s~~S~~AL~WAl~~~~~~g~~vvlvHV~~~~~~~--~~~~~~----~~~~~~~~~~~ll~~~~~~C~~k~ 89 (611)
-++|||++|+|+.|..||.||+..+...+.+|+++||+...... ...... ......++.++.++.+...+...+
T Consensus 3 ~~~ILv~~D~s~~~~~al~~a~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 82 (305)
T PRK11175 3 YQNILVVIDPNQDDQPALRRAVYLAQRNGGKITAFLPIYDFSYEMTTLLSPDEREAMRQGVISQRTAWIREQAKPYLDAG 82 (305)
T ss_pred cceEEEEcCCCccccHHHHHHHHHHHhcCCCEEEEEeccCchhhhhcccchhHHHHHHHHHHHHHHHHHHHHHHHHhhcC
Confidence 35799999999999999999999999999999999998643211 100101 112223344566777777777789
Q ss_pred CcEEEEEEECCchhHHHHHHHHhcCCCEEEEccCCCCceeec-ccchhHHHHhcCCCCcEEEEEeCC
Q 007254 90 VDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRS-TTSLAKYCAKKLSKDCSVLAVNNG 155 (611)
Q Consensus 90 V~~~~~v~~g~~~~~~Iv~~a~~~~ad~LVlG~~g~~~~~R~-~gsva~~v~k~ap~~C~VlvV~kg 155 (611)
++++..+..++++.++|+++|+++++|+||||++|.+++.++ +||++..+++++| |||++|+.+
T Consensus 83 ~~~~~~v~~~g~~~~~i~~~a~~~~~DLiV~G~~~~~~~~~~~~gs~~~~l~~~~~--~pvlvv~~~ 147 (305)
T PRK11175 83 IPIEIKVVWHNRPFEAIIQEVIAGGHDLVVKMTHQHDKLESVIFTPTDWHLLRKCP--CPVLMVKDQ 147 (305)
T ss_pred CceEEEEecCCCcHHHHHHHHHhcCCCEEEEeCCCCcHHHhhccChhHHHHHhcCC--CCEEEeccc
Confidence 999988887678999999999999999999999999888885 8999999999999 999999863
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.7e-14 Score=156.54 Aligned_cols=141 Identities=22% Similarity=0.315 Sum_probs=100.0
Q ss_pred ceeecccCceEEEEEEecCCCEEEEEEecCChh-H-------H-----------------------H----------HHH
Q 007254 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSED-V-------I-----------------------K----------EFV 465 (611)
Q Consensus 427 ~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~-~-------~-----------------------~----------~~~ 465 (611)
.+.||.|++|+||+|.+++|+.||||+.++.-. . . + +|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 467999999999999999999999999987410 0 0 0 133
Q ss_pred HHHHHHHhc----CCCCeeeEEEEEE-eCCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHH-HHHHHHc
Q 007254 466 LEIEIITTL----HHKNIISLLGFCF-EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE-ALEYLHS 539 (611)
Q Consensus 466 ~Ei~il~~l----~HpnIv~l~~~~~-~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~-aL~yLH~ 539 (611)
+|...+..+ +|.+-+.+-.+|. ..+..+|||||++|++|.+.+..... .+ .+..++..++. .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~---~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA---GL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc---CC---CHHHHHHHHHHHHHHHHHh
Confidence 444444443 2333333333332 23446999999999999887643211 12 23456666665 4678888
Q ss_pred CCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 540 ~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
.|++|+|+||+||+++.++.++|+|||++..++.
T Consensus 276 ---~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 ---DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 8999999999999999999999999999987764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK11175 universal stress protein UspE; Provisional | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.1e-14 Score=147.80 Aligned_cols=135 Identities=15% Similarity=0.129 Sum_probs=99.1
Q ss_pred CCCEEEEEeCCCHh-------HHHHHHHHHHHccCC-CCEEEEEEEeeCCCcccC------CCchhHHHHHHHHHHHHHH
Q 007254 15 AGRTVVVGVKLDTH-------SRELLTWALVKVAQP-GDTVIALHVLANNAIVDR------DGKSSLLSLVKAFDSVLAV 80 (611)
Q Consensus 15 ~~~~IlVaVD~s~~-------S~~AL~WAl~~~~~~-g~~vvlvHV~~~~~~~~~------~~~~~~~~~~~~~~~ll~~ 80 (611)
..++|+||+|+|.. +..||++|+..+... +..|++|||.+....... ..........+...+.+
T Consensus 151 ~~~~Ilva~D~s~~~~~~~~~~~~al~~a~~la~~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l-- 228 (305)
T PRK11175 151 EGGKILVAVNVASEEPYHDALNEKLVEEAIDLAEQLNHAEVHLVNAYPVTPINIAIELPEFDPSVYNDAIRGQHLLAM-- 228 (305)
T ss_pred CCCeEEEEeCCCCCccchhHHHHHHHHHHHHHHhhCcCCceEEEEEecCcchhccccccccchhhHHHHHHHHHHHHH--
Confidence 35799999999865 368999999998876 999999999875421110 01111122222223333
Q ss_pred HHhhhhhcCCcEEEEEEECCchhHHHHHHHHhcCCCEEEEccCCCCceeec-ccchhHHHHhcCCCCcEEEEEeC
Q 007254 81 YEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRS-TTSLAKYCAKKLSKDCSVLAVNN 154 (611)
Q Consensus 81 ~~~~C~~k~V~~~~~v~~g~~~~~~Iv~~a~~~~ad~LVlG~~g~~~~~R~-~gsva~~v~k~ap~~C~VlvV~k 154 (611)
+.+.+..++..+...+..+++.+.|+++|++.+||+||||++|++++.++ +||++++|++++| ||||+|+.
T Consensus 229 -~~~~~~~~~~~~~~~v~~G~~~~~I~~~a~~~~~DLIVmG~~~~~~~~~~llGS~a~~v~~~~~--~pVLvv~~ 300 (305)
T PRK11175 229 -KALRQKFGIDEEQTHVEEGLPEEVIPDLAEHLDAELVILGTVGRTGLSAAFLGNTAEHVIDHLN--CDLLAIKP 300 (305)
T ss_pred -HHHHHHhCCChhheeeccCCHHHHHHHHHHHhCCCEEEECCCccCCCcceeecchHHHHHhcCC--CCEEEEcC
Confidence 33444556765433444457899999999999999999999999999885 9999999999999 99999964
|
|
| >COG0589 UspA Universal stress protein UspA and related nucleotide-binding proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.4e-13 Score=127.50 Aligned_cols=138 Identities=18% Similarity=0.193 Sum_probs=114.8
Q ss_pred CCCEEEEEeC-CCHhHHHHHHHHHHHccCCCCEEEEEEEeeCCCcccCCC--------chhHHHHHHHHHHHHHHHHhhh
Q 007254 15 AGRTVVVGVK-LDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDG--------KSSLLSLVKAFDSVLAVYEGFC 85 (611)
Q Consensus 15 ~~~~IlVaVD-~s~~S~~AL~WAl~~~~~~g~~vvlvHV~~~~~~~~~~~--------~~~~~~~~~~~~~ll~~~~~~C 85 (611)
..++|++++| +++.+..|+.+|+..+...+..+.++||.+......... ...........++.+.......
T Consensus 4 ~~~~il~~~d~~s~~~~~a~~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (154)
T COG0589 4 MYKKILVAVDVGSEAAEKALEEAVALAKRLGAPLILLVVIDPLEPTALVSVALADAPIPLSEEELEEEAEELLAEAKALA 83 (154)
T ss_pred ccceEEEEeCCCCHHHHHHHHHHHHHHHhcCCeEEEEEEecccccccccccccccchhhhhHHHHHHHHHHHHHHHHHHH
Confidence 4578999999 999999999999999999999999999987653211110 0112334566678888888888
Q ss_pred hhcCCcE-EEEEEECCchhHHHHHHHHhcCCCEEEEccCCCCceeec-ccchhHHHHhcCCCCcEEEEEeC
Q 007254 86 NLKQVDL-KLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRS-TTSLAKYCAKKLSKDCSVLAVNN 154 (611)
Q Consensus 86 ~~k~V~~-~~~v~~g~~~~~~Iv~~a~~~~ad~LVlG~~g~~~~~R~-~gsva~~v~k~ap~~C~VlvV~k 154 (611)
.+.++.. +..+.+|......|+++|.+.++|+||||++|++++.++ +||++++|+++++ |||++|+.
T Consensus 84 ~~~~~~~~~~~~~~g~~~~~~i~~~a~~~~adliV~G~~g~~~l~~~llGsvs~~v~~~~~--~pVlvv~~ 152 (154)
T COG0589 84 EAAGVPVVETEVVEGSPSAEEILELAEEEDADLIVVGSRGRSGLSRLLLGSVAEKVLRHAP--CPVLVVRS 152 (154)
T ss_pred HHcCCCeeEEEEecCCCcHHHHHHHHHHhCCCEEEECCCCCccccceeeehhHHHHHhcCC--CCEEEEcc
Confidence 8888884 788888877689999999999999999999999999985 9999999999999 99999974
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.7e-14 Score=137.67 Aligned_cols=89 Identities=21% Similarity=0.142 Sum_probs=77.1
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCce
Q 007254 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (611)
Q Consensus 502 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~ 581 (611)
|+|.+++...+ ..++|.++..++.|++.||.|||+ .+ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVRG---RPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc---
Confidence 68999997542 359999999999999999999998 44 999999999999999 99998765432
Q ss_pred eecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 582 TCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 582 ~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
..||+.|||||++. ..|+.++|||||
T Consensus 64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSl 90 (176)
T smart00750 64 ----SRVDPYFMAPEVIQGQSYTEKADIYSL 90 (176)
T ss_pred ----CCCcccccChHHhcCCCCcchhhHHHH
Confidence 26899999999876 788999999996
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.7e-14 Score=158.86 Aligned_cols=145 Identities=19% Similarity=0.239 Sum_probs=95.1
Q ss_pred CCCccceeecccCceEEEEEEecC-CCEEEEEEecCCh-----------------------------------hHHHH--
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSE-----------------------------------DVIKE-- 463 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~~-g~~vAVK~lk~~~-----------------------------------~~~~~-- 463 (611)
..|.. +.||+|++|+||+|.+++ |+.||||++++.- +..+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 44665 789999999999999887 9999999998641 01112
Q ss_pred ----HHHHHHHHHhc----CCCCeeeEEEEEEe-CCeEEEEEEcCCCCCHHHH--HhcCCCCCCCCCHHHHHHHHHHHHH
Q 007254 464 ----FVLEIEIITTL----HHKNIISLLGFCFE-DNNLLLVYDFLSRGSLEEN--LHGNKKDPAAFGWSERYKVAMGVAE 532 (611)
Q Consensus 464 ----~~~Ei~il~~l----~HpnIv~l~~~~~~-~~~~~lV~Ey~~~gsL~~~--L~~~~~~~~~l~~~~~~~ia~qia~ 532 (611)
|.+|..-+..+ .+.+.+.+-.++.+ ....+|||||+.|+.|.+. +...+.+...+....+..++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 22333333333 24444444344432 3456899999999999764 33222111123222233333333
Q ss_pred HHHHHHcCCCCCeEecCCCCCCEEEcCCC----cEEEEeeccccccCCC
Q 007254 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDF----EPQLSDFGLAKWASTS 577 (611)
Q Consensus 533 aL~yLH~~~~~~IvHrDLKp~NILl~~~~----~vKL~DFGlA~~~~~~ 577 (611)
+. .|++|+|+||+||+++.++ .++++|||++..++..
T Consensus 277 -----f~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 277 -----FR---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred -----Hh---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 33 7899999999999999988 9999999999887643
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=4e-15 Score=146.94 Aligned_cols=171 Identities=22% Similarity=0.395 Sum_probs=136.2
Q ss_pred ceeecccCceEEEEEEecCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCC
Q 007254 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGS 503 (611)
Q Consensus 427 ~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 503 (611)
...|.+...|..|+|.+ .|..+.+|+++..+ ....+|..|.--|+-+.||||..++|.|....++.++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 34577888899999999 55667788887543 455789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEec-CCCCCCEEEcCCCcEEEE--eeccccccCCCCCc
Q 007254 504 LEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHR-DVKSSNILLSDDFEPQLS--DFGLAKWASTSSSH 580 (611)
Q Consensus 504 L~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHr-DLKp~NILl~~~~~vKL~--DFGlA~~~~~~~~~ 580 (611)
|...|+.... ...+..++.+++.++++|+.|||+. .++|-| -|....++||++..++|+ |--++
T Consensus 274 lynvlhe~t~--vvvd~sqav~faldiargmaflhsl--ep~ipr~~lns~hvmidedltarismad~kfs--------- 340 (448)
T KOG0195|consen 274 LYNVLHEQTS--VVVDHSQAVRFALDIARGMAFLHSL--EPMIPRFYLNSKHVMIDEDLTARISMADTKFS--------- 340 (448)
T ss_pred HHHHHhcCcc--EEEecchHHHHHHHHHhhHHHHhhc--chhhhhhhcccceEEecchhhhheecccceee---------
Confidence 9999987543 4577789999999999999999984 344444 688999999999988874 22222
Q ss_pred eeecCCccCCCcccceecc----CCCcCcceEEeC
Q 007254 581 ITCTDVAGTFGYVVLILNP----IAFLFMFNCWFF 611 (611)
Q Consensus 581 ~~~~~~~GT~~Y~aPE~~~----~~~~~~sDiWSL 611 (611)
.++....-.+.||+||.+. ...-.++|+|||
T Consensus 341 fqe~gr~y~pawmspealqrkped~n~raadmwsf 375 (448)
T KOG0195|consen 341 FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSF 375 (448)
T ss_pred eeccccccCcccCCHHHHhcCchhcchhhhhHHHH
Confidence 1223345578899999765 444669999997
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.1e-14 Score=163.51 Aligned_cols=147 Identities=27% Similarity=0.366 Sum_probs=107.6
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 500 (611)
++|..+++|..|+||.||...++ +.+.+|+|+-+... ..+. |+....+|++|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l-ilRn------ilt~a~npfvv-------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL-ILRN------ILTFAGNPFVV-------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcccccch-hhhc------cccccCCccee--------------------
Confidence 56778899999999999999865 56788985444322 2111 44444455544
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC--
Q 007254 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS-- 578 (611)
Q Consensus 501 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~-- 578 (611)
|+-...+...+. ++ .+++.+++|||+ .+|+|||+||+|.||+.-|++|++||||++..-...
T Consensus 136 -gDc~tllk~~g~----lP--------vdmvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 -GDCATLLKNIGP----LP--------VDMVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred -chhhhhcccCCC----Cc--------chhhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 454555543322 22 233789999999 999999999999999999999999999998653211
Q ss_pred -----------CceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 579 -----------SHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 579 -----------~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.+..-..++||+.|+|||++. +.|...+|+|++
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwam 244 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAM 244 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHH
Confidence 112233589999999999997 889999999985
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.39 E-value=3.3e-13 Score=138.64 Aligned_cols=179 Identities=23% Similarity=0.338 Sum_probs=114.1
Q ss_pred CccceeecccCceEEEEEEec-CCCEEEEEEecC----ChhHHHHHHHHHHHHHhcCC----------CCeeeEEEEEE-
Q 007254 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP----SEDVIKEFVLEIEIITTLHH----------KNIISLLGFCF- 487 (611)
Q Consensus 424 f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~----~~~~~~~~~~Ei~il~~l~H----------pnIv~l~~~~~- 487 (611)
+.....||.|+++.||.+.+. +|+++|||+... .....+++.+|.-....+.+ -.++.-++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 445788999999999999975 689999998743 22456666666544433222 11111111111
Q ss_pred --------eC-----C---eEEEEEEcCCCCCHHHHHh---cCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEec
Q 007254 488 --------ED-----N---NLLLVYDFLSRGSLEENLH---GNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHR 548 (611)
Q Consensus 488 --------~~-----~---~~~lV~Ey~~~gsL~~~L~---~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHr 548 (611)
.. . +.+++|+-+ .++|.+++. ........+....+..+..|+++.+++||. .||||+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEec
Confidence 11 1 347888888 458887753 222222334556667778999999999999 999999
Q ss_pred CCCCCCEEEcCCCcEEEEeeccccccCCCCCceeecCCccCCCcccceecc---------CCCcCcceEEeC
Q 007254 549 DVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP---------IAFLFMFNCWFF 611 (611)
Q Consensus 549 DLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~---------~~~~~~sDiWSL 611 (611)
||||+|++++.+|.+.|+||+......... .+ ...+..|.+||... -.++++.|.|+|
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~---~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~L 236 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRY---RC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQL 236 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEE---EG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCcee---ec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHH
Confidence 999999999999999999998776655422 11 23457799999764 247889999975
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.8e-12 Score=122.89 Aligned_cols=133 Identities=21% Similarity=0.187 Sum_probs=98.5
Q ss_pred ceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCe-eeEEEEEEeCCeEEEEEEcCCCCCHH
Q 007254 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI-ISLLGFCFEDNNLLLVYDFLSRGSLE 505 (611)
Q Consensus 427 ~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV~Ey~~~gsL~ 505 (611)
.+.|+.|.++.||++.. .++.+++|+..........+..|+.++..+.+.++ .+++.+.. ...++||||++|.++.
T Consensus 3 ~~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELL 79 (170)
T ss_pred eeecCCcccCceEEEEE-CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccc
Confidence 35688999999999887 47789999987654323456789999998866554 45555443 2348999999998775
Q ss_pred HHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 506 ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS--AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 506 ~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~--~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
... . ....++.+++.+|..||... +.+++|+|++|.||+++ ++.++|+|||.|.+..
T Consensus 80 ~~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~~ 138 (170)
T cd05151 80 TED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMND 138 (170)
T ss_pred ccc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCCC
Confidence 430 0 01235678999999999832 23469999999999999 6689999999998654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.37 E-value=6.3e-13 Score=137.60 Aligned_cols=181 Identities=24% Similarity=0.341 Sum_probs=123.5
Q ss_pred cCCCccceeecccCceEEEEEEecC-C-----------------------------------CEEEEEEecC------Ch
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLPD-G-----------------------------------KELAVKILKP------SE 458 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~~-g-----------------------------------~~vAVK~lk~------~~ 458 (611)
.++|.+...||+|....||.+.+.+ | -+.|||.+-. +.
T Consensus 156 iddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~~ 235 (598)
T KOG4158|consen 156 IDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGDA 235 (598)
T ss_pred hhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCchH
Confidence 3567889999999999999887432 1 1346665532 12
Q ss_pred hHHHHHHHHHH------H--------HHh--------cCCCCeeeEEEEEEeC---------------------------
Q 007254 459 DVIKEFVLEIE------I--------ITT--------LHHKNIISLLGFCFED--------------------------- 489 (611)
Q Consensus 459 ~~~~~~~~Ei~------i--------l~~--------l~HpnIv~l~~~~~~~--------------------------- 489 (611)
..++.+.+|.- . .+. -+|||||.+.++|.+.
T Consensus 236 ~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~ 315 (598)
T KOG4158|consen 236 HILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEP 315 (598)
T ss_pred HHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCC
Confidence 33455555531 1 111 2599999999988642
Q ss_pred CeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE--cCCC--cEEE
Q 007254 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL--SDDF--EPQL 565 (611)
Q Consensus 490 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl--~~~~--~vKL 565 (611)
..+|+||.-++. +|.++|-.+. .+...+.-++.|+++|+.|||+ ++|.|||+|.+|||| ++|+ .+.|
T Consensus 316 ~tlylvMkrY~~-tLr~yl~~~~-----~s~r~~~~~laQlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVv 386 (598)
T KOG4158|consen 316 KTLYLVMKRYRQ-TLREYLWTRH-----RSYRTGRVILAQLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVV 386 (598)
T ss_pred ceEEEehhcchh-hHHHHHhcCC-----CchHHHHHHHHHHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEE
Confidence 358999998855 8888886542 4455667789999999999999 999999999999998 4444 4678
Q ss_pred EeeccccccCCCCCc--e--eecCCccCCCcccceecc---C---CCc-CcceEEe
Q 007254 566 SDFGLAKWASTSSSH--I--TCTDVAGTFGYVVLILNP---I---AFL-FMFNCWF 610 (611)
Q Consensus 566 ~DFGlA~~~~~~~~~--~--~~~~~~GT~~Y~aPE~~~---~---~~~-~~sDiWS 610 (611)
+|||.|-.-.....+ + ...+.-|.-+-||||+.. . ..+ .++|.|+
T Consensus 387 aDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA 442 (598)
T KOG4158|consen 387 ADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWA 442 (598)
T ss_pred cccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhh
Confidence 999987533321111 1 112456888999999864 1 122 3788886
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.30 E-value=3.4e-13 Score=152.72 Aligned_cols=182 Identities=24% Similarity=0.270 Sum_probs=147.5
Q ss_pred CccceeecccCceEEEEEEec--CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCeEEEEEE
Q 007254 424 FLAENLIGKGGSSQVYKGCLP--DGKELAVKILKPS---EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 424 f~~~~~IG~G~fG~Vyk~~~~--~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E 497 (611)
|.+.+.||+|+|+.|-..... ....+|+|.+... .........|..+-..+. |+|++.+++.....+..+++++
T Consensus 22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~ 101 (601)
T KOG0590|consen 22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLS 101 (601)
T ss_pred ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccC
Confidence 444566999999999887653 3445677766443 344455556777777776 9999999999999999999999
Q ss_pred cCCCCCHHHHH-hcCCCCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCCeEecCCCCCCEEEcCCC-cEEEEeecccccc
Q 007254 498 FLSRGSLEENL-HGNKKDPAAFGWSERYKVAMGVAEALEYLH-SGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKWA 574 (611)
Q Consensus 498 y~~~gsL~~~L-~~~~~~~~~l~~~~~~~ia~qia~aL~yLH-~~~~~~IvHrDLKp~NILl~~~~-~vKL~DFGlA~~~ 574 (611)
|..+|++.+.+ .... ...+-.....++.|+..++.|+| . .++.||||||+|.+++..+ .+++.|||+|..+
T Consensus 102 ~s~g~~~f~~i~~~~~---~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 102 YSDGGSLFSKISHPDS---TGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cccccccccccccCCc---cCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 99999999888 3321 23445566778999999999999 7 8999999999999999999 9999999999988
Q ss_pred CC-CCCceeecCCcc-CCCcccceecc--CCCcCcceEEeC
Q 007254 575 ST-SSSHITCTDVAG-TFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 575 ~~-~~~~~~~~~~~G-T~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
.. ..........+| ++.|+|||... .......|+||.
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~ 216 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSL 216 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccc
Confidence 87 667777778899 99999999876 356889999985
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=4.3e-13 Score=153.11 Aligned_cols=179 Identities=18% Similarity=0.170 Sum_probs=136.3
Q ss_pred CCccceeecccCceEEEEEEecCCCEEEEEEecCCh-----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 007254 423 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 497 (611)
+|...+.||.+.|=+|.+|..+.|. |.||++-+.. .-.++.+.|++ ...++|||.+.+..+-......|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5666788999999999999998887 8999985432 22344455666 667799999998888777778899999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccc--ccC
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK--WAS 575 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~--~~~ 575 (611)
|... +|.+.|..+ +.+...+.+.|+.|++.||.-+|+ .+|+|+|||.+||||+.=.=+.|+||.--| +++
T Consensus 102 yvkh-nLyDRlSTR----PFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTR----PFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred HHhh-hhhhhhccc----hHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCC
Confidence 9855 899988654 347778888999999999999999 999999999999999998889999997554 233
Q ss_pred CCC---CceeecCCccCCCcccceecc-----------CC-CcCcceEEeC
Q 007254 576 TSS---SHITCTDVAGTFGYVVLILNP-----------IA-FLFMFNCWFF 611 (611)
Q Consensus 576 ~~~---~~~~~~~~~GT~~Y~aPE~~~-----------~~-~~~~sDiWSL 611 (611)
.+. -.+...+-..-.||+|||-.. .. .+.+=||||+
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~ 224 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSA 224 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhh
Confidence 221 112333444556999999432 11 4567788874
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.25 E-value=9.2e-11 Score=114.61 Aligned_cols=136 Identities=18% Similarity=0.206 Sum_probs=98.5
Q ss_pred ceeecccCceEEEEEEecC-------CCEEEEEEecCC-------------h----------hHHHHHH----HHHHHHH
Q 007254 427 ENLIGKGGSSQVYKGCLPD-------GKELAVKILKPS-------------E----------DVIKEFV----LEIEIIT 472 (611)
Q Consensus 427 ~~~IG~G~fG~Vyk~~~~~-------g~~vAVK~lk~~-------------~----------~~~~~~~----~Ei~il~ 472 (611)
...||.|--+.||.|...+ +..+|||+.+.. + ...+.+. .|+..|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998543 479999997531 0 0122223 7889998
Q ss_pred hcCC--CCeeeEEEEEEeCCeEEEEEEcCCCCCHHH-HHhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCCeEec
Q 007254 473 TLHH--KNIISLLGFCFEDNNLLLVYDFLSRGSLEE-NLHGNKKDPAAFGWSERYKVAMGVAEALEYL-HSGSAQRVIHR 548 (611)
Q Consensus 473 ~l~H--pnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~-~L~~~~~~~~~l~~~~~~~ia~qia~aL~yL-H~~~~~~IvHr 548 (611)
++.. -++..++++ +.-+|||||+.++.+.. .|.. ..++..+...+..+++.+|..| |. .+|||+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHG 149 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHA 149 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHh---CCeecC
Confidence 8853 566777765 33499999997654422 2221 1244455667889999999999 88 899999
Q ss_pred CCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 549 DVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 549 DLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
||++.|||+. ++.+.|+|||.|-...
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 9999999997 4689999999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.24 E-value=6.6e-11 Score=116.70 Aligned_cols=143 Identities=20% Similarity=0.279 Sum_probs=112.2
Q ss_pred eeecccCceEEEEEEecCCCEEEEEEecCChh--HHHHHHHHHHHHHhcCC--CCeeeEEEEEEeC---CeEEEEEEcCC
Q 007254 428 NLIGKGGSSQVYKGCLPDGKELAVKILKPSED--VIKEFVLEIEIITTLHH--KNIISLLGFCFED---NNLLLVYDFLS 500 (611)
Q Consensus 428 ~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~--~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~---~~~~lV~Ey~~ 500 (611)
+.||.|.++.||++...+|+.+++|+...... ....+..|.+++..+.+ .++.+++.++... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999886678999999876543 45678899999999976 4467788777653 35689999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC----------------------------------------
Q 007254 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG---------------------------------------- 540 (611)
Q Consensus 501 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~---------------------------------------- 540 (611)
|.++.+.+.. ..++..+...++.+++.+|.+||+.
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9888665431 2366777778888888888888852
Q ss_pred -------------CCCCeEecCCCCCCEEEcC--CCcEEEEeeccccccC
Q 007254 541 -------------SAQRVIHRDVKSSNILLSD--DFEPQLSDFGLAKWAS 575 (611)
Q Consensus 541 -------------~~~~IvHrDLKp~NILl~~--~~~vKL~DFGlA~~~~ 575 (611)
.+..++|+|++|.|||++. ++.+.|+||+.+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g~ 208 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLGD 208 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccCC
Confidence 1356799999999999998 6678999999887644
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.4e-12 Score=140.04 Aligned_cols=115 Identities=24% Similarity=0.329 Sum_probs=98.1
Q ss_pred CeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeec
Q 007254 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569 (611)
Q Consensus 490 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFG 569 (611)
.++||.|++|..++|++.|.+... ....+|.....++.|++.|++| ++.+|||+||.||++..+..+||.|||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhh
Confidence 368999999999999999975432 3457788899999999999999 678999999999999999999999999
Q ss_pred cccccCCCC----CceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 570 LAKWASTSS----SHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 570 lA~~~~~~~----~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
|........ .....+.-+||.-||+||-+. ..|+.++|||||
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaL 448 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYAL 448 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhH
Confidence 988776544 233456689999999999665 999999999997
|
|
| >PRK12652 putative monovalent cation/H+ antiporter subunit E; Reviewed | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.8e-10 Score=122.20 Aligned_cols=106 Identities=14% Similarity=0.162 Sum_probs=84.7
Q ss_pred CCCEEEEEeCCCHhHHHHHHHHHHHccCC--CCEEEEEEEeeCCCcccCCCchhHHHHHHHHHHHHHHHHhhhhh-----
Q 007254 15 AGRTVVVGVKLDTHSRELLTWALVKVAQP--GDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNL----- 87 (611)
Q Consensus 15 ~~~~IlVaVD~s~~S~~AL~WAl~~~~~~--g~~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~C~~----- 87 (611)
.-++||||||+|+.|++|+++|++.+... +++|++|||.+....... .....+..+++++.++..+..
T Consensus 4 ~ykkILVavDGSe~S~~Al~~AielA~~~g~~AeL~lL~Vv~~~~~~~~-----~~~~~~~~eelle~~~~~~~~~l~~~ 78 (357)
T PRK12652 4 AANRLLVPVADSVTVRQTVAYAVESAEEAAETPTVHLVAAASGRAVDPE-----GQDELAAAEELLERVEVWATEDLGDD 78 (357)
T ss_pred ccCeEEEEeCCCHHHHHHHHHHHHHHHhcCCCCEEEEEEEecCcccccc-----hhHHHHHHHHHHHHHHHHHHHhhhcc
Confidence 34789999999999999999999999874 699999999985432111 123335566777777777765
Q ss_pred -cCCcEEEEEEEC-------CchhHHHHHHHHhcCCCEEEEccCCC
Q 007254 88 -KQVDLKLKICRG-------TSIRKILVREAQSYSATKFIVGTAKN 125 (611)
Q Consensus 88 -k~V~~~~~v~~g-------~~~~~~Iv~~a~~~~ad~LVlG~~g~ 125 (611)
.+|+++..++.+ +++++.|+++|++++||+||||-.=.
T Consensus 79 ~~gV~ve~~vv~~~~~~~~~G~pae~Iv~~Aee~~aDLIVm~~~~~ 124 (357)
T PRK12652 79 ASSVTIETALLGTDEYLFGPGDYAEVLIAYAEEHGIDRVVLDPEYN 124 (357)
T ss_pred cCCCceEEEEEeccccccCCCCHHHHHHHHHHHcCCCEEEECCCCC
Confidence 599999998874 68999999999999999999997643
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=4.7e-11 Score=130.32 Aligned_cols=135 Identities=21% Similarity=0.348 Sum_probs=109.7
Q ss_pred HHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCe-EecC
Q 007254 471 ITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV-IHRD 549 (611)
Q Consensus 471 l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~I-vHrD 549 (611)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+... ...++|.-...+..+++.||.|||. -+| .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~---~~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE---DIKLDYFFILSFIRDISKGLAYLHN---SPIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc---ccCccHHHHHHHHHHHHHHHHHHhc---Ccceeeee
Confidence 45789999999999999999999999999999999999763 3468999999999999999999998 334 9999
Q ss_pred CCCCCEEEcCCCcEEEEeeccccccCCCCCceeecCCccCCCcccceeccC--------CCcCcceEEeC
Q 007254 550 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNPI--------AFLFMFNCWFF 611 (611)
Q Consensus 550 LKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~~--------~~~~~sDiWSL 611 (611)
|++.|.+++....+||+|||+.................-..-|.|||++-. ..+.+.|||||
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~ 144 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSF 144 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehH
Confidence 999999999999999999999987754111111112234456899997641 15778999986
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.5e-09 Score=103.55 Aligned_cols=130 Identities=23% Similarity=0.333 Sum_probs=97.3
Q ss_pred eeecccCceEEEEEEecCCCEEEEEEecCC----h-----hHHHHHHHHHHHHHhcCC--CCeeeEEEEEEeCCeEEEEE
Q 007254 428 NLIGKGGSSQVYKGCLPDGKELAVKILKPS----E-----DVIKEFVLEIEIITTLHH--KNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 428 ~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~----~-----~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~lV~ 496 (611)
..|++|+-+.+|.+.+. |..+.+|.-.+. + -...+-.+|..+|..++- -+...++.+ +.+...|+|
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv--D~~~~~I~m 78 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV--DPDNGLIVM 78 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE--cCCCCEEEE
Confidence 35789999999998763 444666654321 1 123456789999998864 344445554 556669999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
||++|..|.+.+... +..++..|-.-+.-||. .+|||+||.++||++..+. +.++||||+..-.
T Consensus 79 e~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~ 142 (204)
T COG3642 79 EYIEGELLKDALEEA-----------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEFSD 142 (204)
T ss_pred EEeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccccc
Confidence 999998888888654 13467778888889999 9999999999999998774 9999999998544
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.97 E-value=9.7e-09 Score=97.64 Aligned_cols=143 Identities=22% Similarity=0.291 Sum_probs=102.7
Q ss_pred cceeecccCceEEEEEEecCCCEEEEEEecCC---------hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 426 AENLIGKGGSSQVYKGCLPDGKELAVKILKPS---------EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 426 ~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~---------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
...+|-+|+-+.|+++.+ .|+.+.||.-... .-..++..+|+.+|.+++--.|.--.-++.+.+.-+|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 567899999999999988 7787777754221 123467788999998876433332222444555568999
Q ss_pred EcCCC-CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCc---EEEEeecccc
Q 007254 497 DFLSR-GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE---PQLSDFGLAK 572 (611)
Q Consensus 497 Ey~~~-gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~---vKL~DFGlA~ 572 (611)
||++| .++.+++...-.+ ...+. ....++..|-+.+.-||. ..|||+||..+||+|..++. +-|+||||+.
T Consensus 90 E~~~g~~~vk~~i~~~~~~-~~~d~-~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMED-ESEDE-GLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHccC-cccch-hHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchh
Confidence 99987 4777887654322 22222 225678889999999999 89999999999999976654 4799999986
Q ss_pred cc
Q 007254 573 WA 574 (611)
Q Consensus 573 ~~ 574 (611)
.-
T Consensus 165 ~s 166 (229)
T KOG3087|consen 165 VS 166 (229)
T ss_pred cc
Confidence 43
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.92 E-value=6.2e-09 Score=101.27 Aligned_cols=125 Identities=24% Similarity=0.315 Sum_probs=82.7
Q ss_pred EEEEEEecCCCEEEEEEecCC--------------h-------------hHHHHHHHHHHHHHhcCCC--CeeeEEEEEE
Q 007254 437 QVYKGCLPDGKELAVKILKPS--------------E-------------DVIKEFVLEIEIITTLHHK--NIISLLGFCF 487 (611)
Q Consensus 437 ~Vyk~~~~~g~~vAVK~lk~~--------------~-------------~~~~~~~~Ei~il~~l~Hp--nIv~l~~~~~ 487 (611)
.||.|...+|..+|||+.+.. . .......+|.+.|..+..- ++.+++.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 389999889999999997541 0 0123456799999999765 567776553
Q ss_pred eCCeEEEEEEcCC--CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHH-HHcCCCCCeEecCCCCCCEEEcCCCcEE
Q 007254 488 EDNNLLLVYDFLS--RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY-LHSGSAQRVIHRDVKSSNILLSDDFEPQ 564 (611)
Q Consensus 488 ~~~~~~lV~Ey~~--~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~y-LH~~~~~~IvHrDLKp~NILl~~~~~vK 564 (611)
.+ +|||||+. |..+..+.... +...+...++.+++..+.. +|. .||||+||.+.|||++++ .+.
T Consensus 80 -~~--~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 80 -RN--VIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp -TT--EEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEE
T ss_pred -CC--EEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEE
Confidence 33 89999998 54454333211 1123345577778775555 567 899999999999999988 999
Q ss_pred EEeeccccccC
Q 007254 565 LSDFGLAKWAS 575 (611)
Q Consensus 565 L~DFGlA~~~~ 575 (611)
|+|||.|....
T Consensus 147 iIDf~qav~~~ 157 (188)
T PF01163_consen 147 IIDFGQAVDSS 157 (188)
T ss_dssp E--GTTEEETT
T ss_pred EEecCcceecC
Confidence 99999886554
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.89 E-value=6.8e-10 Score=121.51 Aligned_cols=181 Identities=22% Similarity=0.178 Sum_probs=138.4
Q ss_pred Cccceeecc--cCceEEEEEEe---cCCCEEEEEEecC--C-hhHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCeEEE
Q 007254 424 FLAENLIGK--GGSSQVYKGCL---PDGKELAVKILKP--S-EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLL 494 (611)
Q Consensus 424 f~~~~~IG~--G~fG~Vyk~~~---~~g~~vAVK~lk~--~-~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~l 494 (611)
|-+...+|. |.+|.||.+.. .++..+|+|.-+. . ....+.=++|+....+++ |+|.++.+..+...+.+|+
T Consensus 116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfi 195 (524)
T KOG0601|consen 116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFI 195 (524)
T ss_pred cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCccee
Confidence 455677899 99999999865 3678899997432 2 122333346676666774 9999999999999999999
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHH----HHHHHHcCCCCCeEecCCCCCCEEEcCC-CcEEEEeec
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE----ALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDFG 569 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~----aL~yLH~~~~~~IvHrDLKp~NILl~~~-~~vKL~DFG 569 (611)
-.|++ +.+|..+.+.... .++....+.+..+... ||.++|. .+++|-|+||.||++..+ ...+++|||
T Consensus 196 qtE~~-~~sl~~~~~~~~~---~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 196 QTELC-GESLQSYCHTPCN---FLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeccc-cchhHHhhhcccc---cCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCcc
Confidence 99999 4688777764432 2344444555566666 9999999 899999999999999999 889999999
Q ss_pred cccccCCCCCc---eeecCCccCCCcccceeccCCCcCcceEEeC
Q 007254 570 LAKWASTSSSH---ITCTDVAGTFGYVVLILNPIAFLFMFNCWFF 611 (611)
Q Consensus 570 lA~~~~~~~~~---~~~~~~~GT~~Y~aPE~~~~~~~~~sDiWSL 611 (611)
+...+.+..-. .......|..-|++||.....++++.||+||
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl 313 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSL 313 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcch
Confidence 99887654311 1123346777899999999999999999986
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.85 E-value=7.8e-08 Score=98.82 Aligned_cols=139 Identities=18% Similarity=0.166 Sum_probs=99.0
Q ss_pred eecccCceEEEEEEecCCCEEEEEEecCCh--hHHH----------HHHHHHHHHHhcCCC--CeeeEEEEEEe-----C
Q 007254 429 LIGKGGSSQVYKGCLPDGKELAVKILKPSE--DVIK----------EFVLEIEIITTLHHK--NIISLLGFCFE-----D 489 (611)
Q Consensus 429 ~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~--~~~~----------~~~~Ei~il~~l~Hp--nIv~l~~~~~~-----~ 489 (611)
.+-......|++..+ +|+.|.||...... ...+ .+.+|...+..+..- ..+.+.++... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 333334445667666 77889999775432 1222 377899888887433 33444455432 2
Q ss_pred CeEEEEEEcCCCC-CHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcC-------CC
Q 007254 490 NNLLLVYDFLSRG-SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-------DF 561 (611)
Q Consensus 490 ~~~~lV~Ey~~~g-sL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~-------~~ 561 (611)
..-+||+|++++. +|.+++..... ...+...+..++.+++..+.-||. .||+|+|++++|||++. ++
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCc
Confidence 3568999999886 79888853211 224456677899999999999999 99999999999999975 46
Q ss_pred cEEEEeeccccc
Q 007254 562 EPQLSDFGLAKW 573 (611)
Q Consensus 562 ~vKL~DFGlA~~ 573 (611)
.+.|+||+.++.
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 899999998864
|
|
| >PRK10490 sensor protein KdpD; Provisional | Back alignment and domain information |
|---|
Probab=98.82 E-value=3.2e-08 Score=117.94 Aligned_cols=127 Identities=16% Similarity=0.082 Sum_probs=102.5
Q ss_pred CCCCEEEEEeCCCHhHHHHHHHHHHHccCCCCEEEEEEEeeCCCcccCCCchhHHHHHHHHHHHHHHHHhhhhhcCCcEE
Q 007254 14 GAGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLK 93 (611)
Q Consensus 14 ~~~~~IlVaVD~s~~S~~AL~WAl~~~~~~g~~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~C~~k~V~~~ 93 (611)
..+.+|||+|++++++..++++|...+.+.+..+++|||..+... . .....+.-+..+..+|++-|.+
T Consensus 248 ~~~eriLV~v~~~~~~~~lIr~~~rlA~~~~a~~~~l~V~~~~~~----~------~~~~~~~~l~~~~~lA~~lGa~-- 315 (895)
T PRK10490 248 HTRDAILLCIGHNTGSEKLVRTAARLAARLGSVWHAVYVETPRLH----R------LPEKKRRAILSALRLAQELGAE-- 315 (895)
T ss_pred CcCCeEEEEECCCcchHHHHHHHHHHHHhcCCCEEEEEEecCCcC----c------CCHHHHHHHHHHHHHHHHcCCE--
Confidence 467889999999999999999999999999999999999865310 0 0011122233333588777766
Q ss_pred EEEEECCchhHHHHHHHHhcCCCEEEEccCCCCceeec-ccchhHHHHhcCCCCcEEEEEeCC
Q 007254 94 LKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRS-TTSLAKYCAKKLSKDCSVLAVNNG 155 (611)
Q Consensus 94 ~~v~~g~~~~~~Iv~~a~~~~ad~LVlG~~g~~~~~R~-~gsva~~v~k~ap~~C~VlvV~kg 155 (611)
..++.|+|++++|++||+.++|+.||||.++++++ | .||+++.+++.++ ...|+||...
T Consensus 316 ~~~~~~~dva~~i~~~A~~~~vt~IViG~s~~~~~--~~~~s~~~~l~r~~~-~idi~iv~~~ 375 (895)
T PRK10490 316 TATLSDPAEEKAVLRYAREHNLGKIIIGRRASRRW--WRRESFADRLARLGP-DLDLVIVALD 375 (895)
T ss_pred EEEEeCCCHHHHHHHHHHHhCCCEEEECCCCCCCC--ccCCCHHHHHHHhCC-CCCEEEEeCC
Confidence 55788999999999999999999999999999876 4 6899999999998 7899999643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.82 E-value=2.5e-09 Score=117.11 Aligned_cols=182 Identities=22% Similarity=0.166 Sum_probs=131.8
Q ss_pred HhcCCCccceeecccCceEEEEEEec--CCCEEEEEEecCChh--HHH-HHHHHHHHHHhc-CCCCeeeEEEEEEeCCeE
Q 007254 419 SATSNFLAENLIGKGGSSQVYKGCLP--DGKELAVKILKPSED--VIK-EFVLEIEIITTL-HHKNIISLLGFCFEDNNL 492 (611)
Q Consensus 419 ~~~~~f~~~~~IG~G~fG~Vyk~~~~--~g~~vAVK~lk~~~~--~~~-~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 492 (611)
..+.+|.....||.|.|+.|++...+ ++..|++|-+.+.-. ..+ .-..|+-+...+ .|.+++..+..|....+.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 34567888999999999999998744 677899998765321 111 113455554444 588889888888887888
Q ss_pred EEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCC-CcEEEEeeccc
Q 007254 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDFGLA 571 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~-~~vKL~DFGlA 571 (611)
|+-.||+.++++...+... ..+....++.+..|++.++.++|+ ..++|+|+||+||++..+ +..++.|||++
T Consensus 342 ~ip~e~~~~~s~~l~~~~~----~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTS----QMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred cCchhhhcCcchhhhhHHH----HhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhccccccc
Confidence 9999999999988776221 346667788899999999999999 899999999999999886 78899999988
Q ss_pred cccCCCCCceeecCCccCCCc-ccceecc-CCCcCcceEEeC
Q 007254 572 KWASTSSSHITCTDVAGTFGY-VVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 572 ~~~~~~~~~~~~~~~~GT~~Y-~aPE~~~-~~~~~~sDiWSL 611 (611)
..+.-. ......++.-| .+++... ..+..+.|++||
T Consensus 415 t~~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl 452 (524)
T KOG0601|consen 415 TRLAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSL 452 (524)
T ss_pred ccccee----cccccccccccccchhhccccccccccccccc
Confidence 653221 11112223333 2444443 666778888876
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.78 E-value=3e-09 Score=108.46 Aligned_cols=142 Identities=17% Similarity=0.232 Sum_probs=107.1
Q ss_pred HHHHhcCCCCeeeEEEEEEeCC-----eEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC
Q 007254 469 EIITTLHHKNIISLLGFCFEDN-----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543 (611)
Q Consensus 469 ~il~~l~HpnIv~l~~~~~~~~-----~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~ 543 (611)
+-|..+.|.|||+++.++.+.. ...++.|||..|+|..+|++.+++...+....-.+++.||+.||.|||+. ..
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence 4456677999999999987543 47899999999999999998777767777777788999999999999984 48
Q ss_pred CeEecCCCCCCEEEcCCCcEEEEeeccccccC--CCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS--TSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 544 ~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~--~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+|+|+++.-+-|++..+|-+||.---.....+ ............|-++|.+||+-. ...+-++|||+|
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~f 268 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKF 268 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhh
Confidence 99999999999999999988874221111000 000000111234678999999986 667889999976
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.78 E-value=2.4e-08 Score=110.84 Aligned_cols=138 Identities=20% Similarity=0.256 Sum_probs=89.5
Q ss_pred eeecccCceEEEEEEecCCCEEEEEEecCChh-----------------------------------HHHH------HHH
Q 007254 428 NLIGKGGSSQVYKGCLPDGKELAVKILKPSED-----------------------------------VIKE------FVL 466 (611)
Q Consensus 428 ~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~-----------------------------------~~~~------~~~ 466 (611)
.-|+.++-|+||+|.+++|+.||||+.+++-. ..+. +.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 67999999999999999999999999987310 0111 122
Q ss_pred HHHHHHhc----CCCCeeeEEEEEEe-CCeEEEEEEcCCCCCHHHHH--hcCCCCCCCCCHHHHHHHHHHHHHHH-HHHH
Q 007254 467 EIEIITTL----HHKNIISLLGFCFE-DNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEAL-EYLH 538 (611)
Q Consensus 467 Ei~il~~l----~HpnIv~l~~~~~~-~~~~~lV~Ey~~~gsL~~~L--~~~~~~~~~l~~~~~~~ia~qia~aL-~yLH 538 (611)
|..-+..+ ++..-+.+=.+|.+ .+.-.|+|||++|-.+.+.. ...+ ++- ..++..++++. ..+-
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g-----~d~---k~ia~~~~~~f~~q~~ 282 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG-----IDR---KELAELLVRAFLRQLL 282 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcC-----CCH---HHHHHHHHHHHHHHHH
Confidence 32222222 22222333333322 34559999999998888774 3332 332 22333332221 1111
Q ss_pred cCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 539 ~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
. .|++|.|.+|.||+++.+|.+-+.|||+...+++
T Consensus 283 ~---dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 283 R---DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred h---cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 2 6799999999999999999999999999887764
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.71 E-value=9.2e-08 Score=106.03 Aligned_cols=139 Identities=21% Similarity=0.267 Sum_probs=90.6
Q ss_pred ceeecccCceEEEEEEecCCCEEEEEEecCCh--------------------------------hHHHHHHHHHH-----
Q 007254 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSE--------------------------------DVIKEFVLEIE----- 469 (611)
Q Consensus 427 ~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~--------------------------------~~~~~~~~Ei~----- 469 (611)
.+.||..+.|+||+|.+++|+.||||+.++.- +..+.+..|++
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 46799999999999999999999999987631 11122223332
Q ss_pred -----HHHhcCCCC------eeeEEEEEEeCCeEEEEEEcCCCCCHHHH--HhcCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 007254 470 -----IITTLHHKN------IISLLGFCFEDNNLLLVYDFLSRGSLEEN--LHGNKKDPAAFGWSERYKVAMGVAEALEY 536 (611)
Q Consensus 470 -----il~~l~Hpn------Iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~--L~~~~~~~~~l~~~~~~~ia~qia~aL~y 536 (611)
+...+.|-+ |.++|-.+. ..-.|+||||+|..+.+. |.+.+ ++-.. |+..+.++ |
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~~~g-----i~~~~---i~~~l~~~--~ 313 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDAIDKRG-----ISPHD---ILNKLVEA--Y 313 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHHHHHcC-----CCHHH---HHHHHHHH--H
Confidence 333345555 444444333 345999999999877654 44433 33333 33333332 2
Q ss_pred HHcCCCCCeEecCCCCCCEEEcC----CCcEEEEeeccccccCCC
Q 007254 537 LHSGSAQRVIHRDVKSSNILLSD----DFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 537 LH~~~~~~IvHrDLKp~NILl~~----~~~vKL~DFGlA~~~~~~ 577 (611)
++.--..|++|+|-.|.||++.. ++.+.+-|||+...++..
T Consensus 314 ~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 314 LEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred HHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 22211267999999999999984 678999999998876643
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.6e-07 Score=104.25 Aligned_cols=123 Identities=25% Similarity=0.290 Sum_probs=101.0
Q ss_pred ecCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHH
Q 007254 443 LPDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWS 521 (611)
Q Consensus 443 ~~~g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~ 521 (611)
..++.+|.|...+... .......+-++-|+.++||||++++..+...+.+|||.|-+. .|...+.... ..
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~-------~~ 104 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG-------KE 104 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH-------HH
Confidence 4478899998887644 334456677889999999999999999999999999999874 5777775432 34
Q ss_pred HHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 522 ERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 522 ~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
.....+.||+.||.|||. ..+++|++|.-+.|+++..|+.||.+|-++...+.
T Consensus 105 ~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~ 157 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASG 157 (690)
T ss_pred HHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEecccc
Confidence 556678999999999986 26799999999999999999999999988865554
|
|
| >COG2205 KdpD Osmosensitive K+ channel histidine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.60 E-value=4.1e-07 Score=102.79 Aligned_cols=137 Identities=18% Similarity=0.097 Sum_probs=111.3
Q ss_pred CCCCCEEEEEeCCCHhHHHHHHHHHHHccCCCCEEEEEEEeeCCCcccCCCchhHHHHHHHHHHHHHHHHhhhhhcCCcE
Q 007254 13 SGAGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDL 92 (611)
Q Consensus 13 ~~~~~~IlVaVD~s~~S~~AL~WAl~~~~~~g~~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~C~~k~V~~ 92 (611)
...+.+|+|+|+++..|...++||...+.+.+...++|||-.+... ...+..+..+.....+|++-| .
T Consensus 245 ~~~~e~ilvcI~~~~~~e~liR~a~RlA~~~~a~~~av~v~~~~~~----------~~~~~~~~~l~~~~~Lae~lG--a 312 (890)
T COG2205 245 WAARERILVCISGSPGSEKLIRRAARLASRLHAKWTAVYVETPELH----------RLSEKEARRLHENLRLAEELG--A 312 (890)
T ss_pred ccccceEEEEECCCCchHHHHHHHHHHHHHhCCCeEEEEEeccccc----------cccHHHHHHHHHHHHHHHHhC--C
Confidence 3566899999999999999999999999999999999999876421 111233345566666666544 4
Q ss_pred EEEEEECCchhHHHHHHHHhcCCCEEEEccCCCCceee-cccchhHHHHhcCCCCcEEEEEeCCceeeccc
Q 007254 93 KLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIR-STTSLAKYCAKKLSKDCSVLAVNNGKVVFQKE 162 (611)
Q Consensus 93 ~~~v~~g~~~~~~Iv~~a~~~~ad~LVlG~~g~~~~~R-~~gsva~~v~k~ap~~C~VlvV~kgki~~~r~ 162 (611)
+.+.+.|+|++++|++||+.++++.||||.+.++.+.+ |.+|++++++++++ ...|.+|..+...-.|.
T Consensus 313 e~~~l~~~dv~~~i~~ya~~~~~TkiViG~~~~~rw~~~~~~~l~~~L~~~~~-~idv~ii~~~~~~~~~~ 382 (890)
T COG2205 313 EIVTLYGGDVAKAIARYAREHNATKIVIGRSRRSRWRRLFKGSLADRLAREAP-GIDVHIVALDAPPDKRP 382 (890)
T ss_pred eEEEEeCCcHHHHHHHHHHHcCCeeEEeCCCcchHHHHHhcccHHHHHHhcCC-CceEEEeeCCCCccccc
Confidence 56788999999999999999999999999999998877 48999999999998 78999998766554443
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.50 E-value=6.7e-07 Score=90.26 Aligned_cols=132 Identities=20% Similarity=0.228 Sum_probs=92.6
Q ss_pred CccceeecccCceEEEEEEecCCCEEEEEEecCC----------h-------------hHHHHHHHHHHHHHhcCCC--C
Q 007254 424 FLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS----------E-------------DVIKEFVLEIEIITTLHHK--N 478 (611)
Q Consensus 424 f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~----------~-------------~~~~~~~~Ei~il~~l~Hp--n 478 (611)
..+...||-|--+.||.|..+.|.++|||.=+.. . .......+|.++|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 3456889999999999999999999999974321 0 0123456799999998754 6
Q ss_pred eeeEEEEEEeCCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEc
Q 007254 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 558 (611)
Q Consensus 479 Iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~ 558 (611)
+..-+++ +.-.+||||++|-.|...-- .....-.++..|++-+.-+-. .||||+|+.+=|||++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~---------~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~ 236 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRL---------DVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVT 236 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccC---------cccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEe
Confidence 6666554 45599999998865543321 111122233334443333334 8999999999999999
Q ss_pred CCCcEEEEeeccc
Q 007254 559 DDFEPQLSDFGLA 571 (611)
Q Consensus 559 ~~~~vKL~DFGlA 571 (611)
+||.+.++||=-+
T Consensus 237 ~dg~~~vIDwPQ~ 249 (304)
T COG0478 237 EDGDIVVIDWPQA 249 (304)
T ss_pred cCCCEEEEeCccc
Confidence 9999999999544
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.3e-06 Score=94.38 Aligned_cols=140 Identities=19% Similarity=0.247 Sum_probs=110.3
Q ss_pred eEEEEEEe-cCCCEEEEEEecCChh-HHHHHHHHHHHHHhcCCCCeeeEEEEEEe----CCeEEEEEEcCCC-CCHHHHH
Q 007254 436 SQVYKGCL-PDGKELAVKILKPSED-VIKEFVLEIEIITTLHHKNIISLLGFCFE----DNNLLLVYDFLSR-GSLEENL 508 (611)
Q Consensus 436 G~Vyk~~~-~~g~~vAVK~lk~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~lV~Ey~~~-gsL~~~L 508 (611)
.+.||+.. .||..|.+|.++-... .......-++.++++.|+|+|++..+|.. +..++|||+|+++ ++|.++.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 56789874 4899999999944321 12223345789999999999999998873 4579999999986 5888776
Q ss_pred hcCCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCC
Q 007254 509 HGNKKD-----------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 509 ~~~~~~-----------~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~ 577 (611)
...... +...++...|.++.|+..||.++|+ .|+.-+-|.|.+||++.+.+++|+.-|+...+..+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 543322 2457788999999999999999999 88888999999999999989999988887766554
Q ss_pred C
Q 007254 578 S 578 (611)
Q Consensus 578 ~ 578 (611)
.
T Consensus 447 ~ 447 (655)
T KOG3741|consen 447 P 447 (655)
T ss_pred C
Confidence 3
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.41 E-value=3.9e-06 Score=82.71 Aligned_cols=144 Identities=19% Similarity=0.154 Sum_probs=104.4
Q ss_pred CCccceeecccCceEEEEEEecCCCEEEEEEecCC-------hhHHHHHHHHHHHHHhcCC--CCeeeEEEEEE-e----
Q 007254 423 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS-------EDVIKEFVLEIEIITTLHH--KNIISLLGFCF-E---- 488 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~-------~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~-~---- 488 (611)
++...---|.||-+.|++-.+ +|+.+-+|.-... ......|.+|+..|..|.. -.+.... ++. .
T Consensus 19 ~wve~pN~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~ 96 (216)
T PRK09902 19 DWVEEPNYRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEG 96 (216)
T ss_pred ceecCCCcCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCC
Confidence 333333457799999999776 5557888876421 2245789999999998853 2344444 332 1
Q ss_pred CCeEEEEEEcCCC-CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCc--EEE
Q 007254 489 DNNLLLVYDFLSR-GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE--PQL 565 (611)
Q Consensus 489 ~~~~~lV~Ey~~~-gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~--vKL 565 (611)
...-+||+|-+.| -+|.+.+..... ...+...+..+..+++..|.-||. .|+.|+|+-+.|||++.++. +++
T Consensus 97 ~~rA~LVTe~L~g~~~L~~~l~~~~~--~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~l 171 (216)
T PRK09902 97 EWRALLVTEDMAGFISIADWYAQHAV--SPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGF 171 (216)
T ss_pred ceEEEEEEEeCCCCccHHHHHhcCCc--CCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEE
Confidence 1246899998864 589888865422 234566778899999999999999 99999999999999986666 999
Q ss_pred Eeeccccc
Q 007254 566 SDFGLAKW 573 (611)
Q Consensus 566 ~DFGlA~~ 573 (611)
+||--++.
T Consensus 172 IDlEk~r~ 179 (216)
T PRK09902 172 LDLEKSRR 179 (216)
T ss_pred EEhhccch
Confidence 99976553
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.40 E-value=2.1e-06 Score=84.88 Aligned_cols=108 Identities=19% Similarity=0.194 Sum_probs=83.9
Q ss_pred HHHHHHHHHHHHhcCC--CCeeeEEEEEEeC----CeEEEEEEcCCCC-CHHHHHhcCCCCCCCCCHHHHHHHHHHHHHH
Q 007254 461 IKEFVLEIEIITTLHH--KNIISLLGFCFED----NNLLLVYDFLSRG-SLEENLHGNKKDPAAFGWSERYKVAMGVAEA 533 (611)
Q Consensus 461 ~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~----~~~~lV~Ey~~~g-sL~~~L~~~~~~~~~l~~~~~~~ia~qia~a 533 (611)
..+..+|...+..|.. -.++..+++.... ...+||+|++++. +|.+++..... ++......++.+++..
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~----~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ----LDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc----cchhhHHHHHHHHHHH
Confidence 3467788888777753 3445666665542 2458999999884 89999875322 4445677899999999
Q ss_pred HHHHHcCCCCCeEecCCCCCCEEEcCCC---cEEEEeeccccccC
Q 007254 534 LEYLHSGSAQRVIHRDVKSSNILLSDDF---EPQLSDFGLAKWAS 575 (611)
Q Consensus 534 L~yLH~~~~~~IvHrDLKp~NILl~~~~---~vKL~DFGlA~~~~ 575 (611)
+.-||. .||+|+|+++.|||++.+. .+.|+||+-++...
T Consensus 131 i~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 131 IAKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 999999 9999999999999999887 89999999887654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.39 E-value=6.1e-06 Score=82.82 Aligned_cols=141 Identities=16% Similarity=0.249 Sum_probs=88.4
Q ss_pred eeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCC--CeeeEEEEEEeCCeEEEEEEcCCCCC-H
Q 007254 428 NLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK--NIISLLGFCFEDNNLLLVYDFLSRGS-L 504 (611)
Q Consensus 428 ~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~~~~~~~~~lV~Ey~~~gs-L 504 (611)
..||+|..+.||+. .|..+++|...... ......+|.+++..+..- .+.+.++++...+...+|||+++|.. +
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 56899999999984 24567788877533 234467899999888643 34677888877778899999998863 1
Q ss_pred HHH---------------------HhcCCCCCCCCCHHHHH-HHHH----------HHHH-HHHHHHc-CCCCCeEecCC
Q 007254 505 EEN---------------------LHGNKKDPAAFGWSERY-KVAM----------GVAE-ALEYLHS-GSAQRVIHRDV 550 (611)
Q Consensus 505 ~~~---------------------L~~~~~~~~~l~~~~~~-~ia~----------qia~-aL~yLH~-~~~~~IvHrDL 550 (611)
... ||..... ........ .+.. .+.. ...+|.. .....++|+|+
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~--~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCD--TSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCC--CCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 111 2211111 11111100 0000 0111 1222321 12346789999
Q ss_pred CCCCEEEcCCCcEEEEeeccccccC
Q 007254 551 KSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 551 Kp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
.|.||++++++ +.|+||+.+.+.+
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~~Gd 184 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFGYGN 184 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcCcCC
Confidence 99999999888 9999999987665
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.35 E-value=4.8e-06 Score=82.26 Aligned_cols=148 Identities=21% Similarity=0.296 Sum_probs=90.1
Q ss_pred ceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCC--CeeeEEEEEEe---CCeEEEEEEcCCC
Q 007254 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK--NIISLLGFCFE---DNNLLLVYDFLSR 501 (611)
Q Consensus 427 ~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~~~~---~~~~~lV~Ey~~~ 501 (611)
.+.|+.|..+.||+....+ ..+++|..... .....+..|..++..+... .+..++.++.. ....+++|++++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 3578999999999998866 68999998766 5566777888888888533 35677765432 3457999999999
Q ss_pred CCHHH----------------HH---hcCCCCCCCCCHHHH---------HHH------------HHHHHH-HHHHHHc-
Q 007254 502 GSLEE----------------NL---HGNKKDPAAFGWSER---------YKV------------AMGVAE-ALEYLHS- 539 (611)
Q Consensus 502 gsL~~----------------~L---~~~~~~~~~l~~~~~---------~~i------------a~qia~-aL~yLH~- 539 (611)
..+.. .+ +........+.+... ... ...+.. .+..++.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 87776 11 121111111111110 000 011222 3334432
Q ss_pred ---CCCCCeEecCCCCCCEEEc-CCCcEEEEeeccccccCC
Q 007254 540 ---GSAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 540 ---~~~~~IvHrDLKp~NILl~-~~~~vKL~DFGlA~~~~~ 576 (611)
..+..++|+|+.|.|||++ +++.+.|+||+.+.+.+.
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~~~ 200 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWGDP 200 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEEET
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccceECCH
Confidence 2457899999999999999 667778999999876643
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.33 E-value=7.3e-06 Score=81.16 Aligned_cols=137 Identities=15% Similarity=0.151 Sum_probs=89.5
Q ss_pred hcCCCccceeecccCceEEEEEEecCCCEEEEEEecCChhHHHH----------HHHHHHHHHhcC---CCCeeeEEEEE
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKE----------FVLEIEIITTLH---HKNIISLLGFC 486 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~----------~~~Ei~il~~l~---HpnIv~l~~~~ 486 (611)
..++|...+++-......|.+-.. +|+.+.+|.-+......++ ..+.+..+..++ --.+..++-+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 346777778887777777777666 6788999988764321111 122333333332 22222222222
Q ss_pred E-----eCCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCC
Q 007254 487 F-----EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 561 (611)
Q Consensus 487 ~-----~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~ 561 (611)
. .....+|||||++|-.|.+... ++. .++..++.+|.-||. .|++|+|..|+|++++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~- 171 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN- 171 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC-
Confidence 1 2234578999999988866542 111 245667788999999 999999999999999866
Q ss_pred cEEEEeeccccc
Q 007254 562 EPQLSDFGLAKW 573 (611)
Q Consensus 562 ~vKL~DFGlA~~ 573 (611)
.++++||+..+.
T Consensus 172 ~i~iID~~~k~~ 183 (229)
T PF06176_consen 172 GIRIIDTQGKRM 183 (229)
T ss_pred cEEEEECccccc
Confidence 599999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.27 E-value=1.1e-07 Score=109.66 Aligned_cols=185 Identities=19% Similarity=0.200 Sum_probs=127.0
Q ss_pred hcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCChhHH----HHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVI----KEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~----~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 494 (611)
..+.|.+.+-+-.|.++.++.+.-. .|...++|+.+...... .....+-.++-.-++|.++...--+.-...++|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 3455666677788999998876533 34455666655443222 222333344444556777655554555677899
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccccc
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~ 574 (611)
|++|+.+++|...|+... ..+..-..-+...+..+++|||. ..++|||++|.|+|+..+++.++.|||+....
T Consensus 882 ~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCcccccccc
Confidence 999999999999998654 22222333455668889999998 77999999999999999999999999954432
Q ss_pred CCC---C-C-------------------c------eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 575 STS---S-S-------------------H------ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 575 ~~~---~-~-------------------~------~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
... . . . .....+.||+.|++||... .....++|+|++
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~ 1021 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSS 1021 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhh
Confidence 210 0 0 0 1122477999999999776 888999999974
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.20 E-value=2.2e-05 Score=79.22 Aligned_cols=143 Identities=19% Similarity=0.157 Sum_probs=87.8
Q ss_pred ecccCc-eEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCeEEEEEEcCCCCCHHHH
Q 007254 430 IGKGGS-SQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDFLSRGSLEEN 507 (611)
Q Consensus 430 IG~G~f-G~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~ 507 (611)
|-.|.+ ..||+.... +..+.||+..... ...+..|++++..+. +--+.+++++....+..++|||+++|.+|...
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 344555 789998764 4678888886543 345667888888874 34566788887766677999999998777543
Q ss_pred H-------------------hcCCCCCCCCC--HHHHHHHHH--------------------HHHHHHHHHHc----CCC
Q 007254 508 L-------------------HGNKKDPAAFG--WSERYKVAM--------------------GVAEALEYLHS----GSA 542 (611)
Q Consensus 508 L-------------------~~~~~~~~~l~--~~~~~~ia~--------------------qia~aL~yLH~----~~~ 542 (611)
. +........+. +........ .+...+..|-. ...
T Consensus 83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 162 (244)
T cd05150 83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED 162 (244)
T ss_pred hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence 1 21111011111 000000000 01111222211 122
Q ss_pred CCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 543 ~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
..++|+|+.|.|||++++..+.|+||+.|.+.+
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~gd 195 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLGVAD 195 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEcccccccc
Confidence 468999999999999998778899999987655
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.17 E-value=7.7e-06 Score=79.74 Aligned_cols=104 Identities=25% Similarity=0.263 Sum_probs=81.9
Q ss_pred HHHHHHHhcCC-CCeeeEEEEEEeCCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC
Q 007254 466 LEIEIITTLHH-KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 544 (611)
Q Consensus 466 ~Ei~il~~l~H-pnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~ 544 (611)
.|.-+|..+.+ +++++++|+|-. ++|.||...+++......- ..-...+|..|.+||.++++.+++|+......
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l-~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPL-SQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccccc-ccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 47788888876 699999999943 7789999877664321000 01123689999999999999999999865556
Q ss_pred eEecCCCCCCEEEcCCCcEEEEeecccccc
Q 007254 545 VIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (611)
Q Consensus 545 IvHrDLKp~NILl~~~~~vKL~DFGlA~~~ 574 (611)
+.-.|++|+|+-++++|.+|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 777999999999999999999999876544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd01984 AANH_like Adenine nucleotide alpha hydrolases superfamily including N type ATP PPases, ATP sulphurylases Universal Stress Response protein and electron transfer flavoprotein (ETF) | Back alignment and domain information |
|---|
Probab=98.07 E-value=1.2e-05 Score=67.73 Aligned_cols=83 Identities=25% Similarity=0.224 Sum_probs=71.4
Q ss_pred EEEEeCCCHhHHHHHHHHHHHccCCCCEEEEEEEeeCCCcccCCCchhHHHHHHHHHHHHHHHHhhhhhcCCcEEEEEEE
Q 007254 19 VVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKICR 98 (611)
Q Consensus 19 IlVaVD~s~~S~~AL~WAl~~~~~~g~~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~C~~k~V~~~~~v~~ 98 (611)
|+|++++...|..++.||.... +.+..++++|+.
T Consensus 1 ilv~~sgg~dS~~~l~~~~~~~-~~~~~~~~~~~~--------------------------------------------- 34 (86)
T cd01984 1 ILVALSGGLDSSVLLHLAKRLK-SGGPEVVALVVV--------------------------------------------- 34 (86)
T ss_pred CEEEeeCCHHHHHHHHHHHHHH-hcCCCEEEEEeH---------------------------------------------
Confidence 6899999999999999999977 557778888885
Q ss_pred CCchhHHHHHHHHhcCCCEEEEccCCCCceeec-cc-chhHHHHhcCCCCcEEEE
Q 007254 99 GTSIRKILVREAQSYSATKFIVGTAKNHHTIRS-TT-SLAKYCAKKLSKDCSVLA 151 (611)
Q Consensus 99 g~~~~~~Iv~~a~~~~ad~LVlG~~g~~~~~R~-~g-sva~~v~k~ap~~C~Vlv 151 (611)
-..+.+.+.|++.++++|++|+++.....+. .+ +++.++.+.++ |||+.
T Consensus 35 --~~~~~~~~~a~~~~~~~Iv~G~~~~d~~~~~~~~~~~~~~~~~~~~--~~vl~ 85 (86)
T cd01984 35 --AFVRILKRLAAEEGADVIILGHNADDVAGRRLGASANVLVVIKGAG--IPVLT 85 (86)
T ss_pred --HHHHHHHHHHHHcCCCEEEEcCCchhhhhhccCchhhhhhcccccC--CceeC
Confidence 4567888999999999999999998776664 56 89999999998 99874
|
The domain forms a apha/beta/apha fold which binds to Adenosine nucleotide. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.05 E-value=7e-05 Score=75.16 Aligned_cols=151 Identities=23% Similarity=0.238 Sum_probs=94.6
Q ss_pred ChHHHHHhcCCCccce---eecccCceEEEEEEecCCCEEEEEEecCChhH--------------------HH-----HH
Q 007254 413 NYQDLLSATSNFLAEN---LIGKGGSSQVYKGCLPDGKELAVKILKPSEDV--------------------IK-----EF 464 (611)
Q Consensus 413 ~~~~l~~~~~~f~~~~---~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~--------------------~~-----~~ 464 (611)
+...+....+...+.. .|.+|--+.||+|...++..+|||+.+..... .. ..
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 3444444455555544 45567778899999878999999998753211 01 11
Q ss_pred HHHHHHHHhcC--CCCeeeEEEEEEeCCeEEEEEEcCCCCCH-HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC
Q 007254 465 VLEIEIITTLH--HKNIISLLGFCFEDNNLLLVYDFLSRGSL-EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541 (611)
Q Consensus 465 ~~Ei~il~~l~--HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL-~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~ 541 (611)
..|+.-|.++. +-.+.+-+.+.. -.|||||+....+ .-.|.. ..+...+...+..+++..+.-|-.
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkD-----v~~e~~e~~~~~~~~v~~~~~l~~-- 184 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLKD-----VPLELEEAEGLYEDVVEYMRRLYK-- 184 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCccc-----CCcCchhHHHHHHHHHHHHHHHHH--
Confidence 23555555553 344445555542 2899999954311 111111 112222456666777777776654
Q ss_pred CCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 542 ~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
..++||+||..=|||+. ++.+.|+|||-|-...
T Consensus 185 ~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 185 EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred hcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence 26899999999999999 7899999999876544
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.98 E-value=0.00011 Score=87.46 Aligned_cols=150 Identities=15% Similarity=0.330 Sum_probs=94.0
Q ss_pred ceeecccCceEEEEEEecCC---CEEEEEEecCCh--hHHHHHHHHHHHHHhcC-CCCe--eeEEEEEEeC---CeEEEE
Q 007254 427 ENLIGKGGSSQVYKGCLPDG---KELAVKILKPSE--DVIKEFVLEIEIITTLH-HKNI--ISLLGFCFED---NNLLLV 495 (611)
Q Consensus 427 ~~~IG~G~fG~Vyk~~~~~g---~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~-HpnI--v~l~~~~~~~---~~~~lV 495 (611)
...|+.|.+..+|+....++ ..+++|+..... .....+.+|+++|+.+. |.++ .+++.+|.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46789999999999876543 367777665432 22356789999999995 6655 7888888664 467999
Q ss_pred EEcCCCCCHHH-----------------------HHhcCCCCC-------CCCCH--------HHHHHH---------HH
Q 007254 496 YDFLSRGSLEE-----------------------NLHGNKKDP-------AAFGW--------SERYKV---------AM 528 (611)
Q Consensus 496 ~Ey~~~gsL~~-----------------------~L~~~~~~~-------~~l~~--------~~~~~i---------a~ 528 (611)
|||++|..+.+ .||...... ....+ ...+.- .-
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99998754211 122211100 01111 111110 01
Q ss_pred HHHHHHHHHHcCCC--------CCeEecCCCCCCEEEcC-CCc-EEEEeeccccccCC
Q 007254 529 GVAEALEYLHSGSA--------QRVIHRDVKSSNILLSD-DFE-PQLSDFGLAKWAST 576 (611)
Q Consensus 529 qia~aL~yLH~~~~--------~~IvHrDLKp~NILl~~-~~~-vKL~DFGlA~~~~~ 576 (611)
.+...+.+|..+.+ ..+||+|+++.|||++. +.. +-|.||.++.+.+.
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~GdP 260 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGNQ 260 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCCh
Confidence 23344667754222 35999999999999985 333 57999999886653
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.98 E-value=1.1e-06 Score=97.15 Aligned_cols=167 Identities=19% Similarity=0.095 Sum_probs=118.9
Q ss_pred ceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCC-eeeEEEEEEeCCeEEEEEEcCCCC-CH
Q 007254 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKN-IISLLGFCFEDNNLLLVYDFLSRG-SL 504 (611)
Q Consensus 427 ~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~lV~Ey~~~g-sL 504 (611)
.+.+++|+++++||.+....+....+.+... ....-++++|.+++||| .+..++-+....+.+++++|+.+| +.
T Consensus 247 fh~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~ 322 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS 322 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence 4557899999999987533344445554433 33445889999999999 777777777778899999999877 21
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCceeec
Q 007254 505 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 584 (611)
Q Consensus 505 ~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~ 584 (611)
..... .....|...+...+...-.++|+|||+ ..-+||| |||..+ +..|..||+....+.... ...
T Consensus 323 ~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~ 388 (829)
T KOG0576|consen 323 ALEMT---VSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPR 388 (829)
T ss_pred cccCC---hhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc---ccc
Confidence 11110 001123333444566677889999998 4458998 888766 588999999887776543 345
Q ss_pred CCccCCCcccceecc-CCCcCcceEEeC
Q 007254 585 DVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 585 ~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+..+|+.+++||+.. ..+....|.|++
T Consensus 389 t~~~~~~~~~pev~~~~~~~~~p~~~~~ 416 (829)
T KOG0576|consen 389 TAIGTPEPLAPEVIQENTIDGCPDSGSL 416 (829)
T ss_pred cCCCCCCCCCchhhcccccccCCCccCC
Confidence 688999999999765 889999999985
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00016 Score=70.92 Aligned_cols=124 Identities=22% Similarity=0.344 Sum_probs=91.1
Q ss_pred CCCccceeecccCc-eEEEEEEecCCCEEEEEEecC---C------------h-------hHHHHHHHHHHHHHhcC---
Q 007254 422 SNFLAENLIGKGGS-SQVYKGCLPDGKELAVKILKP---S------------E-------DVIKEFVLEIEIITTLH--- 475 (611)
Q Consensus 422 ~~f~~~~~IG~G~f-G~Vyk~~~~~g~~vAVK~lk~---~------------~-------~~~~~~~~Ei~il~~l~--- 475 (611)
.++...+.||.|.- |.||++.+ +|+.+|+|+++. . + .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67888999999999 99999998 788999999432 0 0 12345788888777664
Q ss_pred CCCe--eeEEEEEEeC------------------CeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHH
Q 007254 476 HKNI--ISLLGFCFED------------------NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 535 (611)
Q Consensus 476 HpnI--v~l~~~~~~~------------------~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~ 535 (611)
+.++ |+.+|+..-. -..-||.||.+... .+. ..-+.+|.+-|.
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~----~~~~~~~~~dl~ 178 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQ----IRDIPQMLRDLK 178 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccc----hhHHHHHHHHHH
Confidence 5566 8999987422 12467888776533 111 223567788888
Q ss_pred HHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccc
Q 007254 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (611)
Q Consensus 536 yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA 571 (611)
.+|. .+|+-+|+|+.|.. .-||+|||.+
T Consensus 179 ~~~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHK---LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHH---CCeeeccCcccccc-----CCEEEecccC
Confidence 9999 99999999999987 4589999865
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00012 Score=73.39 Aligned_cols=145 Identities=19% Similarity=0.263 Sum_probs=85.1
Q ss_pred eeecccCceEEEEEEecC--CCEEEEEEecCChhHHHHHHHHHHHHHhcCC-CCeeeEEEEEEeCCeEEEEEEcCCCCCH
Q 007254 428 NLIGKGGSSQVYKGCLPD--GKELAVKILKPSEDVIKEFVLEIEIITTLHH-KNIISLLGFCFEDNNLLLVYDFLSRGSL 504 (611)
Q Consensus 428 ~~IG~G~fG~Vyk~~~~~--g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~lV~Ey~~~gsL 504 (611)
+.|..|-...+|+....+ ++.|.+|+........-...+|+.++..+.. ...+++++.+. + .+||||++|..+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~~l 79 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGRTL 79 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCCcC
Confidence 557778888999987654 6789999876543222233468888888853 33445555432 2 479999988665
Q ss_pred HHH-----------------HhcCCCCC--------CCCCHHHHHHHHH----------------------HHHHHHHHH
Q 007254 505 EEN-----------------LHGNKKDP--------AAFGWSERYKVAM----------------------GVAEALEYL 537 (611)
Q Consensus 505 ~~~-----------------L~~~~~~~--------~~l~~~~~~~ia~----------------------qia~aL~yL 537 (611)
... +|...... ....|.....+.. .+...+..|
T Consensus 80 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l 159 (235)
T cd05157 80 EPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISWL 159 (235)
T ss_pred CHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHHH
Confidence 211 12111111 1111222111111 111111111
Q ss_pred ----Hc-CCCCCeEecCCCCCCEEEcC-CCcEEEEeeccccccCC
Q 007254 538 ----HS-GSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWAST 576 (611)
Q Consensus 538 ----H~-~~~~~IvHrDLKp~NILl~~-~~~vKL~DFGlA~~~~~ 576 (611)
-. ..+..++|+|+.+.|||++. ++.+.|+||-.|.+...
T Consensus 160 ~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~~~~ 204 (235)
T cd05157 160 KELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGYNYR 204 (235)
T ss_pred HHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCcCch
Confidence 11 13357999999999999998 57899999998876543
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.91 E-value=8.5e-05 Score=74.73 Aligned_cols=143 Identities=17% Similarity=0.199 Sum_probs=80.4
Q ss_pred eeecccCce-EEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCC---CeeeEEEEEEeC---CeEEEEEEcCC
Q 007254 428 NLIGKGGSS-QVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK---NIISLLGFCFED---NNLLLVYDFLS 500 (611)
Q Consensus 428 ~~IG~G~fG-~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~~~~~~~---~~~~lV~Ey~~ 500 (611)
+.|+.||.. .||+. +..+.+|+.+.. .....+..|.++|..+... .+..+++..... +..+++|++++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~-~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA-GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc-chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 457777776 48874 235677875542 2345788899999887532 345555544332 24588999998
Q ss_pred CCCHHHH------------------HhcCCCCCCCC-------------CHHHHH--HHH-------HHHHHH-HH-HHH
Q 007254 501 RGSLEEN------------------LHGNKKDPAAF-------------GWSERY--KVA-------MGVAEA-LE-YLH 538 (611)
Q Consensus 501 ~gsL~~~------------------L~~~~~~~~~l-------------~~~~~~--~ia-------~qia~a-L~-yLH 538 (611)
|.++.+. |+......... .|.... .+. .+.+.. +. +++
T Consensus 78 G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 157 (235)
T cd05155 78 GETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAALR 157 (235)
T ss_pred CCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHHhc
Confidence 8666321 22211100000 121110 000 011111 11 112
Q ss_pred c--CCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 539 S--GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 539 ~--~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
. ..+..++|+|+.|.|||++++...-|+||+.|....
T Consensus 158 ~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~gD 196 (235)
T cd05155 158 APWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGVGD 196 (235)
T ss_pred ccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCcCC
Confidence 1 133559999999999999877556799999987654
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00043 Score=68.05 Aligned_cols=127 Identities=24% Similarity=0.405 Sum_probs=91.4
Q ss_pred ceeecccCceEEEEEEecCCCEEEEEEecCCh-----------------hHHHHHHHHHHHHHhcC------CCCeeeEE
Q 007254 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-----------------DVIKEFVLEIEIITTLH------HKNIISLL 483 (611)
Q Consensus 427 ~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~-----------------~~~~~~~~Ei~il~~l~------HpnIv~l~ 483 (611)
...||+|+.=.||. .++.....||++++.. ...++..+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 46799999998885 4455667899987654 23466777777666665 88999999
Q ss_pred EEEEeCCeEEEEEEcCCC------CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE
Q 007254 484 GFCFEDNNLLLVYDFLSR------GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557 (611)
Q Consensus 484 ~~~~~~~~~~lV~Ey~~~------gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl 557 (611)
|+..++-.+-+|+|.+.. -+|.+++.... ++. ..... +-+-..||-. ..|+.+||+|.||++
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~-----~~~-~~~~~---L~~f~~~l~~---~~Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG-----LTE-ELRQA---LDEFKRYLLD---HHIVIRDLNPHNIVV 151 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC-----ccH-HHHHH---HHHHHHHHHH---cCCeecCCCcccEEE
Confidence 999999889999998642 36778885432 444 33333 3344456666 789999999999999
Q ss_pred cCCC----cEEEEe
Q 007254 558 SDDF----EPQLSD 567 (611)
Q Consensus 558 ~~~~----~vKL~D 567 (611)
..+. .+.|+|
T Consensus 152 ~~~~~~~~~lvlID 165 (199)
T PF10707_consen 152 QRRDSGEFRLVLID 165 (199)
T ss_pred EecCCCceEEEEEe
Confidence 6432 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00021 Score=68.21 Aligned_cols=129 Identities=19% Similarity=0.267 Sum_probs=89.7
Q ss_pred ceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCee-eEEEEEEeCCeEEEEEEcCCCCCHH
Q 007254 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNII-SLLGFCFEDNNLLLVYDFLSRGSLE 505 (611)
Q Consensus 427 ~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv-~l~~~~~~~~~~~lV~Ey~~~gsL~ 505 (611)
.+.|++|.+|.||+|.+ .|..+|+|+-+.+. -...+..|.++|..+.-.++. ++|.+- .-++.|||+.|-.|.
T Consensus 27 ~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~ds-~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~L~ 100 (201)
T COG2112 27 EKELAKGTTSVVYLGEW-RGGEVALKVRRRDS-PRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRPLG 100 (201)
T ss_pred hhhhhcccccEEEEeec-cCceEEEEEecCCc-chhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcchh
Confidence 46799999999999999 55689999877554 356788899999999877665 444443 236779999998887
Q ss_pred HHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCC-CCCEEEcCCCcEEEEeeccccccC
Q 007254 506 ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVK-SSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 506 ~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLK-p~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
+.-.... -. -...+++.---|-. .||-|..|. |..++|..+..+.|+||--|....
T Consensus 101 ~~~~~~~-------rk----~l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~ 157 (201)
T COG2112 101 KLEIGGD-------RK----HLLRVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATFKK 157 (201)
T ss_pred hhhhccc-------HH----HHHHHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhhcc
Confidence 7654211 11 22334444333333 678888774 556666666699999999887443
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.0008 Score=70.38 Aligned_cols=76 Identities=11% Similarity=0.016 Sum_probs=56.5
Q ss_pred ceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCC---CCeeeEEEEEEe---CCeEEEEEEcCC
Q 007254 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH---KNIISLLGFCFE---DNNLLLVYDFLS 500 (611)
Q Consensus 427 ~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~H---pnIv~l~~~~~~---~~~~~lV~Ey~~ 500 (611)
.+.||.|..+.||+....+++ +.+|..+. ......|..|.+.|+.|.. ..+.+++++|.. .+..+||||+++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~ 96 (297)
T PRK10593 19 VECISEQPYAALWALYDSQGN-PMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLR 96 (297)
T ss_pred eeecCCccceeEEEEEcCCCC-EEEEEecc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccC
Confidence 467999999999998765554 66677543 1123577889999998853 468888988754 366899999999
Q ss_pred CCCH
Q 007254 501 RGSL 504 (611)
Q Consensus 501 ~gsL 504 (611)
|+++
T Consensus 97 G~~~ 100 (297)
T PRK10593 97 GVSV 100 (297)
T ss_pred CEec
Confidence 8754
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00035 Score=72.91 Aligned_cols=145 Identities=25% Similarity=0.341 Sum_probs=88.1
Q ss_pred eeecccCceEEEEEEecC-------CCEEEEEEecCChhHHHHHHHHHHHHHhcCCCC-eeeEEEEEEeCCeEEEEEEcC
Q 007254 428 NLIGKGGSSQVYKGCLPD-------GKELAVKILKPSEDVIKEFVLEIEIITTLHHKN-IISLLGFCFEDNNLLLVYDFL 499 (611)
Q Consensus 428 ~~IG~G~fG~Vyk~~~~~-------g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~lV~Ey~ 499 (611)
+.|..|-...+|+....+ ++.+.+|+.........+..+|.+++..+.... ..++++++. + .+||||+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~--~--~~v~e~i 79 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFP--N--GRIEEFI 79 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeC--C--Cchhhee
Confidence 445566667899887654 578999998765444445677888888885333 345566553 2 4689999
Q ss_pred CCCCHHHH-----------------HhcCCCC--C-----CCCCHHHHHH--------------------------HHHH
Q 007254 500 SRGSLEEN-----------------LHGNKKD--P-----AAFGWSERYK--------------------------VAMG 529 (611)
Q Consensus 500 ~~gsL~~~-----------------L~~~~~~--~-----~~l~~~~~~~--------------------------ia~q 529 (611)
+|..+... ||..... . ...-|..... +...
T Consensus 80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (302)
T cd05156 80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED 159 (302)
T ss_pred CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence 88765321 2221111 0 0111111111 1122
Q ss_pred HHHHHHHHHc------CCCCCeEecCCCCCCEEEcCC----CcEEEEeeccccccCC
Q 007254 530 VAEALEYLHS------GSAQRVIHRDVKSSNILLSDD----FEPQLSDFGLAKWAST 576 (611)
Q Consensus 530 ia~aL~yLH~------~~~~~IvHrDLKp~NILl~~~----~~vKL~DFGlA~~~~~ 576 (611)
+...+.+|-. ..+..++|+|+.|.|||++++ +.+.|+||..|.....
T Consensus 160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~~p 216 (302)
T cd05156 160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYNYR 216 (302)
T ss_pred HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCCCc
Confidence 2233444432 245789999999999999985 7899999999976543
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.0017 Score=70.53 Aligned_cols=75 Identities=20% Similarity=0.196 Sum_probs=55.0
Q ss_pred ceeecccCceEEEEEEecCC-CEEEEEEecCC-----h---hHHHHHHHHHHHHHhcC---CCCeeeEEEEEEeCCeEEE
Q 007254 427 ENLIGKGGSSQVYKGCLPDG-KELAVKILKPS-----E---DVIKEFVLEIEIITTLH---HKNIISLLGFCFEDNNLLL 494 (611)
Q Consensus 427 ~~~IG~G~fG~Vyk~~~~~g-~~vAVK~lk~~-----~---~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~l 494 (611)
.+.||.|.+..||++...+| +.+.||.-.+. + -...++..|.+.|..+. -.++++++.+.. +..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEE
Confidence 35789999999999998777 48999985421 1 13466777888888763 356788887743 45699
Q ss_pred EEEcCCCCC
Q 007254 495 VYDFLSRGS 503 (611)
Q Consensus 495 V~Ey~~~gs 503 (611)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00094 Score=68.01 Aligned_cols=140 Identities=14% Similarity=0.146 Sum_probs=81.6
Q ss_pred ecccCceEEEEEEecCCCEEEEEEecCChhHH-HHHHHHHHHHHhcCCCCe-eeEEEEEEeCCeEEEEEEcCCCCCHHH-
Q 007254 430 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVI-KEFVLEIEIITTLHHKNI-ISLLGFCFEDNNLLLVYDFLSRGSLEE- 506 (611)
Q Consensus 430 IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~-~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV~Ey~~~gsL~~- 506 (611)
+..|-...+|+... +++.+.+|+........ -+...|.++++.+....+ .+++..+ .+ ++||||++|..+..
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~~--~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--EH--WLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--CC--EEEEEeccCcccccc
Confidence 45577788998764 66778888765543221 235678889988864333 3445443 22 78999998866431
Q ss_pred ----------------HHhcCCCCCCCCCHHHH-HHHHHH---------HHHHHHHHHc-----CCCCCeEecCCCCCCE
Q 007254 507 ----------------NLHGNKKDPAAFGWSER-YKVAMG---------VAEALEYLHS-----GSAQRVIHRDVKSSNI 555 (611)
Q Consensus 507 ----------------~L~~~~~~~~~l~~~~~-~~ia~q---------ia~aL~yLH~-----~~~~~IvHrDLKp~NI 555 (611)
.||........++.... ..+..+ +...+..+-. ..+..++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 12222111122222211 111111 1111222211 1134689999999999
Q ss_pred EEcCCCcEEEEeeccccccC
Q 007254 556 LLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 556 Ll~~~~~vKL~DFGlA~~~~ 575 (611)
|+++++ +.|+||..|....
T Consensus 159 l~~~~~-~~lIDwE~a~~gd 177 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASDGD 177 (256)
T ss_pred EEeCCC-CEEEeccccCcCC
Confidence 999876 7899999987654
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.0018 Score=68.17 Aligned_cols=144 Identities=18% Similarity=0.212 Sum_probs=78.8
Q ss_pred eeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCC--CCeeeEEE------EEEeCCeEEEEEEcC
Q 007254 428 NLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH--KNIISLLG------FCFEDNNLLLVYDFL 499 (611)
Q Consensus 428 ~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~------~~~~~~~~~lV~Ey~ 499 (611)
+.|+.|....+|+....+| .+.+|+.... ....+..|+.++..|.. -.+...+. +....+..+++|+|+
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~--~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l 104 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFERL--TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL 104 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEeccC--ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence 4466777788999876555 6888987621 12333345555555531 12333332 122356679999999
Q ss_pred CCCCHH-----------HH---HhcCCCC-------CCCCCH-HHHHHHH-------------HHHHHHHHHHHc----C
Q 007254 500 SRGSLE-----------EN---LHGNKKD-------PAAFGW-SERYKVA-------------MGVAEALEYLHS----G 540 (611)
Q Consensus 500 ~~gsL~-----------~~---L~~~~~~-------~~~l~~-~~~~~ia-------------~qia~aL~yLH~----~ 540 (611)
+|..+. .. +|..... ...+.| .....-. ..+...+..+-. .
T Consensus 105 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 184 (319)
T PRK05231 105 EGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPA 184 (319)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccccc
Confidence 886431 11 1211110 011222 2211111 111122233321 1
Q ss_pred CCCCeEecCCCCCCEEEcCCCcEEEEeecccccc
Q 007254 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (611)
Q Consensus 541 ~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~ 574 (611)
-+.++||+|+.|.|||++.+...-|+||+.+...
T Consensus 185 lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~~ 218 (319)
T PRK05231 185 LPRGVIHADLFRDNVLFEGDRLSGFIDFYFACND 218 (319)
T ss_pred CCcccCCCCCCCCcEEEECCceEEEEecccccCC
Confidence 3568999999999999987755689999998654
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.0012 Score=68.66 Aligned_cols=146 Identities=16% Similarity=0.175 Sum_probs=88.7
Q ss_pred ceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCC--CeeeEEEE------EEeCCeEEEEEEc
Q 007254 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK--NIISLLGF------CFEDNNLLLVYDF 498 (611)
Q Consensus 427 ~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~------~~~~~~~~lV~Ey 498 (611)
.+.|..|....+|+....+ ..+++|+.... ....+..|++++..+.+. .+..++.. ....+..++||+|
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~--~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEKV--SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCCC--ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 4567777778999987644 46888988752 234566688888777432 24444432 1234567899999
Q ss_pred CCCCCHHH--------------HHhcCCC-------CCCCCCHHHHHH----------HHHHHHHHHHHHHc----CCCC
Q 007254 499 LSRGSLEE--------------NLHGNKK-------DPAAFGWSERYK----------VAMGVAEALEYLHS----GSAQ 543 (611)
Q Consensus 499 ~~~gsL~~--------------~L~~~~~-------~~~~l~~~~~~~----------ia~qia~aL~yLH~----~~~~ 543 (611)
++|..+.. .||.... ......|..... ....+..++.++-. ..+.
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 98866421 1121100 001123332211 11123344555543 2346
Q ss_pred CeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 544 ~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
+++|+|+.|.|||+++++.+.|+||+.+...+
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~g~ 207 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFACTDA 207 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhcCch
Confidence 79999999999999998778999999887644
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0019 Score=67.75 Aligned_cols=146 Identities=18% Similarity=0.177 Sum_probs=84.8
Q ss_pred ceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCC--CeeeEEEEE------EeCCeEEEEEEc
Q 007254 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK--NIISLLGFC------FEDNNLLLVYDF 498 (611)
Q Consensus 427 ~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~~------~~~~~~~lV~Ey 498 (611)
...++.|....+|+....+| .+.+|+.+... ....+..|++++..|... .+.+++... ...+..++||+|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~ 104 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF 104 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence 45567777788998876555 57788876532 123445567777776422 244444321 124567899999
Q ss_pred CCCCCHH-----------H---HHhcCCCC---C-----CCCCHHHHHH------------HHHHHHHHHHHHHc----C
Q 007254 499 LSRGSLE-----------E---NLHGNKKD---P-----AAFGWSERYK------------VAMGVAEALEYLHS----G 540 (611)
Q Consensus 499 ~~~gsL~-----------~---~L~~~~~~---~-----~~l~~~~~~~------------ia~qia~aL~yLH~----~ 540 (611)
++|..+. . .+|..... . ..-.|..... ....+...+++|.. .
T Consensus 105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~ 184 (307)
T TIGR00938 105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD 184 (307)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 9885431 1 12211110 0 0112322111 01123345555542 3
Q ss_pred CCCCeEecCCCCCCEEEcCCCcEEEEeecccccc
Q 007254 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (611)
Q Consensus 541 ~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~ 574 (611)
.+.+++|+|+.+.||+++.++...|+||+.+...
T Consensus 185 ~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~~ 218 (307)
T TIGR00938 185 LPRGVIHADLFPDNVLFDGDSVKGVIDFYFACTD 218 (307)
T ss_pred CCCccCCCCCCcCcEEEECCceEEEeecccccCc
Confidence 4578999999999999999877789999998643
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.00024 Score=79.79 Aligned_cols=83 Identities=13% Similarity=0.178 Sum_probs=63.5
Q ss_pred HHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCc--ee-----ecCCccCCCcccceecc
Q 007254 527 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH--IT-----CTDVAGTFGYVVLILNP 599 (611)
Q Consensus 527 a~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~--~~-----~~~~~GT~~Y~aPE~~~ 599 (611)
+.+++.||.|+|+ ..++||+.|.|++|.++.++..||+.|+++--....... .. ..-..-...|.||||..
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 4456699999997 378999999999999999999999999988655442211 00 01123456799999987
Q ss_pred -CCCcCcceEEeC
Q 007254 600 -IAFLFMFNCWFF 611 (611)
Q Consensus 600 -~~~~~~sDiWSL 611 (611)
..-+.++|++||
T Consensus 183 ~~~~~~~sd~fSl 195 (700)
T KOG2137|consen 183 GTTNTPASDVFSL 195 (700)
T ss_pred cccccccccceee
Confidence 777899999996
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=97.18 E-value=9.8e-05 Score=85.84 Aligned_cols=66 Identities=11% Similarity=0.082 Sum_probs=50.9
Q ss_pred EecCCCCC-CEEEcCCCcEEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 546 IHRDVKSS-NILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 546 vHrDLKp~-NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.|++..|. |++++.++.+++.|||.++.+...........+.||+.|+|||++. ..|++++|||||
T Consensus 499 ~~~~~~p~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~~~~~~~~~DiwSl 566 (669)
T cd05610 499 PTQKPRPHGNLYQTPKQVKIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLGKPHGPAVDWWAL 566 (669)
T ss_pred CCCCCCCCCceeECCccccccccCCCchhhhcccccccCCceeeCccccCHHHcCCCCCCcHHHHHHH
Confidence 34556666 6777777788999999998876544433445578999999999776 779999999996
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0059 Score=65.25 Aligned_cols=144 Identities=15% Similarity=0.240 Sum_probs=85.1
Q ss_pred eeecccCceEEEEEEecC-----CCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCee-eEEEEEEeCCeEEEEEEcCCC
Q 007254 428 NLIGKGGSSQVYKGCLPD-----GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNII-SLLGFCFEDNNLLLVYDFLSR 501 (611)
Q Consensus 428 ~~IG~G~fG~Vyk~~~~~-----g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv-~l~~~~~~~~~~~lV~Ey~~~ 501 (611)
..|-.|-.-.+|+....+ ++.|.+|+........-+..+|+.++..+..-++. ++++.+.. + .|++|+++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~g 117 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIHA 117 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeCC
Confidence 445557788899987532 36789998876433222336788888888644443 55665532 2 58999987
Q ss_pred CCHHHH-----------------HhcCCCC--CCCCCHHHHHHHHHH-----------------HHHHHHHH----Hc-C
Q 007254 502 GSLEEN-----------------LHGNKKD--PAAFGWSERYKVAMG-----------------VAEALEYL----HS-G 540 (611)
Q Consensus 502 gsL~~~-----------------L~~~~~~--~~~l~~~~~~~ia~q-----------------ia~aL~yL----H~-~ 540 (611)
.+|... +|..... .....|.+..++..+ +...+..| .. .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 665321 2221110 011223333333211 11112222 21 2
Q ss_pred CCCCeEecCCCCCCEEEcC-CCcEEEEeeccccccC
Q 007254 541 SAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWAS 575 (611)
Q Consensus 541 ~~~~IvHrDLKp~NILl~~-~~~vKL~DFGlA~~~~ 575 (611)
.+..++|+|+++.|||+++ ++.+.|+||.+|.+..
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~~ 233 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYNP 233 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccccc
Confidence 3357899999999999986 4689999999998655
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.0011 Score=68.82 Aligned_cols=150 Identities=19% Similarity=0.222 Sum_probs=98.6
Q ss_pred hcccccccChHHHHHhcC---CCccceeecccCceEEEEEEecCCCEEEEEEecCC----------h---------h--H
Q 007254 405 YSATCRLFNYQDLLSATS---NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS----------E---------D--V 460 (611)
Q Consensus 405 ~~~~~~~~~~~~l~~~~~---~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~----------~---------~--~ 460 (611)
|.-++.-|+|--|..-.+ -+..++.||-|--+-||.+-...|++.++|+-+.. . . .
T Consensus 72 YRLTy~GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWly 151 (465)
T KOG2268|consen 72 YRLTYAGYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLY 151 (465)
T ss_pred eEeeeccchHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhh
Confidence 344444555544433333 36778999999999999999989999999864321 0 0 1
Q ss_pred HH--HHHHHHHHHHhcCC--CCeeeEEEEEEeCCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 007254 461 IK--EFVLEIEIITTLHH--KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536 (611)
Q Consensus 461 ~~--~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~y 536 (611)
+. ...+|+..|+.|.. --+...+++ +..++|||++.|-.|...-+- ..... +...+..-+--
T Consensus 152 LSRlaa~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v-------~d~~~---ly~~lm~~Iv~ 217 (465)
T KOG2268|consen 152 LSRLAATKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHV-------EDPPT---LYDDLMGLIVR 217 (465)
T ss_pred hHHHHHHHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeec-------CChHH---HHHHHHHHHHH
Confidence 11 23468888888753 223344443 455999999998777554321 11222 23333333445
Q ss_pred HHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccc
Q 007254 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (611)
Q Consensus 537 LH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA 571 (611)
|-. .|+||+|..-=||++.+++.++++||=-.
T Consensus 218 la~---~GlIHgDFNEFNimv~dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 218 LAN---HGLIHGDFNEFNIMVKDDDKIVVIDFPQM 249 (465)
T ss_pred HHH---cCceecccchheeEEecCCCEEEeechHh
Confidence 555 89999999999999999999999999644
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.01 Score=61.40 Aligned_cols=34 Identities=26% Similarity=0.429 Sum_probs=28.1
Q ss_pred CCeEecCCCCCCEEEcCCCc-EEEEeeccccccCC
Q 007254 543 QRVIHRDVKSSNILLSDDFE-PQLSDFGLAKWAST 576 (611)
Q Consensus 543 ~~IvHrDLKp~NILl~~~~~-vKL~DFGlA~~~~~ 576 (611)
..++|+|+.|.|||+++++. .-|+||+.+...+.
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iGDP 219 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVGDP 219 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccCCH
Confidence 35899999999999997555 46999999987653
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.029 Score=58.50 Aligned_cols=32 Identities=31% Similarity=0.368 Sum_probs=27.5
Q ss_pred CCCeEecCCCCCCEEEcCCCcEEEEeecccccc
Q 007254 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (611)
Q Consensus 542 ~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~ 574 (611)
..+++|+|+.+.|||++. +.+.|+||+.+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~~ 217 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCTID 217 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccccC
Confidence 468999999999999987 57899999977653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.0076 Score=63.82 Aligned_cols=137 Identities=23% Similarity=0.294 Sum_probs=91.1
Q ss_pred ceeecccCceEEEEEEecCCCEEEEEEecCCh--------------------------hHH-HHHHHHHHHHHhcCCCCe
Q 007254 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSE--------------------------DVI-KEFVLEIEIITTLHHKNI 479 (611)
Q Consensus 427 ~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~--------------------------~~~-~~~~~Ei~il~~l~HpnI 479 (611)
..+|..|--+.||.+.-.+|..+|||+++.+- ... -....|++=|.+|+...|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 46788899999999998899999999986420 001 112246666777765444
Q ss_pred eeEEEEEEeCCeEEEEEEcCCCCCHHH-HHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEc
Q 007254 480 ISLLGFCFEDNNLLLVYDFLSRGSLEE-NLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 558 (611)
Q Consensus 480 v~l~~~~~~~~~~~lV~Ey~~~gsL~~-~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~ 558 (611)
.----+... .-.|||+|+.+..... .|. ...++...+..+-.+++.-|.-|.+. -++||.||.-=|+|.
T Consensus 229 P~PePIlLk--~hVLVM~FlGrdgw~aPkLK-----d~~ls~~ka~~~Y~~~v~~MR~lY~~--c~LVHADLSEfN~Ly- 298 (520)
T KOG2270|consen 229 PCPEPILLK--NHVLVMEFLGRDGWAAPKLK-----DASLSTSKARELYQQCVRIMRRLYQK--CRLVHADLSEFNLLY- 298 (520)
T ss_pred CCCCceeee--cceEeeeeccCCCCcCcccc-----cccCChHHHHHHHHHHHHHHHHHHHH--hceeccchhhhhheE-
Confidence 322222222 2389999995322211 121 12366667777777888878777763 579999999999998
Q ss_pred CCCcEEEEeeccccc
Q 007254 559 DDFEPQLSDFGLAKW 573 (611)
Q Consensus 559 ~~~~vKL~DFGlA~~ 573 (611)
.+|.+.|+|.+-+-.
T Consensus 299 hdG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 299 HDGKLYIIDVSQSVE 313 (520)
T ss_pred ECCEEEEEEcccccc
Confidence 566999999987643
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.014 Score=62.45 Aligned_cols=72 Identities=17% Similarity=0.199 Sum_probs=48.9
Q ss_pred eecccCceEEEEEEecCC-CEEEEEEecC-----C---hhHHHHHHHHHHHHHhcC--CC-CeeeEEEEEEeCCeEEEEE
Q 007254 429 LIGKGGSSQVYKGCLPDG-KELAVKILKP-----S---EDVIKEFVLEIEIITTLH--HK-NIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 429 ~IG~G~fG~Vyk~~~~~g-~~vAVK~lk~-----~---~~~~~~~~~Ei~il~~l~--Hp-nIv~l~~~~~~~~~~~lV~ 496 (611)
.||-|....||++...+| +.|.||.-.+ . .-...+...|.+.|+... -| .++++|.+ +.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 479999999999997654 5899997532 1 122455567778887653 23 45666655 445558999
Q ss_pred EcCCCC
Q 007254 497 DFLSRG 502 (611)
Q Consensus 497 Ey~~~g 502 (611)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 999653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02432 lysidine_TilS_N tRNA(Ile)-lysidine synthetase, N-terminal domain | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.019 Score=55.62 Aligned_cols=94 Identities=18% Similarity=0.176 Sum_probs=69.2
Q ss_pred EEEEEeCCCHhHHHHHHHHHHHccCCCCEEEEEEEeeCCCcccCCCchhHHHHHHHHHHHHHHHHhhhhhcCCcEEEEEE
Q 007254 18 TVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKIC 97 (611)
Q Consensus 18 ~IlVaVD~s~~S~~AL~WAl~~~~~~g~~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~C~~k~V~~~~~v~ 97 (611)
+|+||+.|...|.-++.++.+.....|..|++|||-.... ...++-.+..+.+|+..||++...-+
T Consensus 1 ~v~va~SGG~DS~~ll~ll~~~~~~~~~~v~~v~vd~g~~--------------~~~~~~~~~~~~~~~~~gi~~~~~~~ 66 (189)
T TIGR02432 1 RILVAVSGGVDSMALLHLLLKLQPKLKIRLIAAHVDHGLR--------------PESDEEAEFVQQFCKKLNIPLEIKKV 66 (189)
T ss_pred CEEEEeCCCHHHHHHHHHHHHHHHHcCCCEEEEEeCCCCC--------------hhHHHHHHHHHHHHHHcCCCEEEEEe
Confidence 5899999999999999888776655577799999964321 01123455667788888998876544
Q ss_pred ECCc--------hh--------HHHHHHHHhcCCCEEEEccCCC
Q 007254 98 RGTS--------IR--------KILVREAQSYSATKFIVGTAKN 125 (611)
Q Consensus 98 ~g~~--------~~--------~~Iv~~a~~~~ad~LVlG~~g~ 125 (611)
.... .. +.|.+.|++++++.|+.|.+..
T Consensus 67 ~~~~~~~~~~~~~~~~~r~~R~~~l~~~a~~~g~~~i~~Gh~~~ 110 (189)
T TIGR02432 67 DVKALAKGKKKNLEEAAREARYDFFEEIAKKHGADYILTAHHAD 110 (189)
T ss_pred cchhhccccCCCHHHHHHHHHHHHHHHHHHHcCCCEEEEcCccH
Confidence 3211 22 6888999999999999999864
|
The only examples in which the wobble position of a tRNA must discriminate between G and A of mRNA are AUA (Ile) vs. AUG (Met) and UGA (stop) vs. UGG (Trp). In all bacteria, the wobble position of the tRNA(Ile) recognizing AUA is lysidine, a lysine derivative of cytidine. This family describes a protein domain found, apparently, in all bacteria in a single copy. Eukaryotic sequences appear to be organellar. The domain archictecture of this protein family is variable; some, including characterized proteins of E. coli and B. subtilis known to be tRNA(Ile)-lysidine synthetase, include a conserved 50-residue domain that many other members lack. This protein belongs to the ATP-binding PP-loop family ( pfam01171). It appears in the literature and protein databases as TilS, YacA, and putative cell cycle protein MesJ (a misnomer). |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 611 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 8e-32 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-31 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-28 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-28 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-23 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-23 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-23 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-22 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-16 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-15 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 7e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-11 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-11 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-11 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-11 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-11 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-11 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-11 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-11 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-11 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-11 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-11 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-11 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-11 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-10 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-10 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-10 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-10 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-10 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-10 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-10 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-10 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-10 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-10 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-10 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-10 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-10 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-10 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-10 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-10 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-10 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-10 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-10 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-10 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-10 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-10 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-10 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-10 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-10 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-10 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-10 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-10 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-10 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-10 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 8e-10 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-10 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-10 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 9e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 9e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-09 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-09 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-09 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-09 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-09 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-09 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-09 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-09 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-09 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-09 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-09 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-09 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-09 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-09 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-09 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-09 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-09 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-09 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-09 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-09 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-09 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-09 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 9e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 9e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-08 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-08 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-08 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-08 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-08 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-08 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-08 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-08 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-08 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-08 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-08 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-08 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-08 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-08 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-08 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-08 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-08 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-08 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-08 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-08 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-08 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-08 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 7e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-08 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-07 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-07 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-07 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-07 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-07 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-07 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-07 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-07 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-07 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-07 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-07 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-07 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-07 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-07 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-07 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-07 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-07 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-07 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-07 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-07 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-07 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-07 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-07 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-07 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-07 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-07 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-07 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-07 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-07 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-07 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-07 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-07 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 7e-07 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-07 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 7e-07 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 8e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 8e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-06 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-06 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-06 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-06 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-06 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-06 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-06 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-06 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-06 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-06 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-06 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-06 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-06 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-06 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-06 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-06 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-06 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-06 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-06 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-06 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-06 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-06 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-06 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-06 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-06 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-06 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-06 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-06 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-06 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-06 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-06 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-06 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-06 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-06 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-06 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-06 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-06 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-06 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-06 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-06 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-06 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-06 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-06 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-06 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-06 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-06 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-06 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-06 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-06 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-06 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-06 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-06 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-06 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-06 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-06 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-06 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-06 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-06 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-06 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 7e-06 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 7e-06 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-06 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 8e-06 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 9e-06 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 9e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 9e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 9e-06 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 9e-06 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-05 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-05 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-05 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-05 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-05 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-05 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-05 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-05 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-05 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-05 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-05 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-05 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-05 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-05 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-05 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-05 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-05 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-05 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-05 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-05 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-05 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-05 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-05 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-05 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-05 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-05 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 7e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-05 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 9e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-05 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-04 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-04 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-04 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-04 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-04 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-04 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-04 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-04 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-04 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-04 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-04 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-04 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-04 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-04 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-04 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-04 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-04 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-04 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-04 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-04 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-04 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-04 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-04 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-04 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-04 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-04 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-04 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-04 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-04 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-04 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-04 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-04 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-04 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-04 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-04 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-04 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-04 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-04 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-04 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-04 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-04 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-04 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-04 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-04 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-04 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-04 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-04 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-04 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-04 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-04 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-04 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-04 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-04 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-04 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-04 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-04 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-04 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-04 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-04 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-04 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-04 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-04 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-04 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-04 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-04 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-04 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-04 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-04 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-04 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-04 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-04 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-04 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-04 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-04 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-04 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-04 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-04 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-04 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-04 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-04 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-04 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-04 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-04 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-04 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-04 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-04 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-04 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-04 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-04 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-04 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-04 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-04 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-04 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-04 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-04 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-04 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-04 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-04 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-04 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-04 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-04 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-04 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-04 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-04 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-04 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-04 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-04 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-04 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 5e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 5e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-04 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 5e-04 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-04 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-04 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-04 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 6e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-04 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-04 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-04 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 6e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 6e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-04 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-04 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-04 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 6e-04 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-04 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 7e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 7e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-04 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-04 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 7e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 7e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-04 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-04 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-04 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-04 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-04 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 8e-04 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 8e-04 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-04 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 8e-04 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-04 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 8e-04 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 262 bits (671), Expect = 6e-83
Identities = 74/197 (37%), Positives = 113/197 (57%), Gaps = 3/197 (1%)
Query: 399 EGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE 458
E E + + F+ ++L A+ NF +N++G+GG +VYKG L DG +AVK LK
Sbjct: 7 EEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEER 66
Query: 459 D--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPA 516
+F E+E+I+ H+N++ L GFC LLVY +++ GS+ L +
Sbjct: 67 TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP 126
Query: 517 AFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576
W +R ++A+G A L YLH ++IHRDVK++NILL ++FE + DFGLAK
Sbjct: 127 PLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 186
Query: 577 SSSHITCTDVAGTFGYV 593
+H+T T V GT G++
Sbjct: 187 KDTHVT-TAVRGTIGHI 202
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 251 bits (643), Expect = 9e-79
Identities = 75/210 (35%), Positives = 119/210 (56%), Gaps = 6/210 (2%)
Query: 386 STDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPD 445
S +T + DL AT+NF + LIG G +VYKG L D
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 446 GKELAVKILKP-SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504
G ++A+K P S I+EF EIE ++ H +++SL+GFC E N ++L+Y ++ G+L
Sbjct: 63 GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122
Query: 505 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 564
+ +L+G+ + W +R ++ +G A L YLH+ + +IHRDVKS NILL ++F P+
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPK 179
Query: 565 LSDFGLAKWA-STSSSHITCTDVAGTFGYV 593
++DFG++K +H++ T V GT GY+
Sbjct: 180 ITDFGISKKGTELDQTHLS-TVVKGTLGYI 208
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 232 bits (595), Expect = 6e-72
Identities = 66/203 (32%), Positives = 108/203 (53%), Gaps = 18/203 (8%)
Query: 403 EKYSATCRLFNYQDLLSATSNF------LAENLIGKGGSSQVYKGCLPDGKELAVKILKP 456
E F++ +L + T+NF + N +G+GG VYKG + + +AVK L
Sbjct: 6 EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAA 64
Query: 457 SEDV-----IKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGN 511
D+ ++F EI+++ H+N++ LLGF + ++L LVY ++ GSL + L
Sbjct: 65 MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 512 KKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571
P W R K+A G A + +LH IHRD+KS+NILL + F ++SDFGLA
Sbjct: 125 DGTPP-LSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLA 180
Query: 572 KWAST-SSSHITCTDVAGTFGYV 593
+ + + + +T + + GT Y+
Sbjct: 181 RASEKFAQTVMT-SRIVGTTAYM 202
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 2e-52
Identities = 49/204 (24%), Positives = 82/204 (40%), Gaps = 17/204 (8%)
Query: 400 GLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSED 459
G H + ++ ++L + + +G V+K + +AVKI +
Sbjct: 2 GHHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDK 60
Query: 460 VIKEFVLEIEIITTLHHKNIISLLGFCFEDNN----LLLVYDFLSRGSLEENLHGNKKDP 515
+ E+ + + H+NI+ +G + L L+ F +GSL + L N
Sbjct: 61 QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVS- 119
Query: 516 AAFGWSERYKVAMGVAEALEYLHS-------GSAQRVIHRDVKSSNILLSDDFEPQLSDF 568
W+E +A +A L YLH G + HRD+KS N+LL ++ ++DF
Sbjct: 120 ----WNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175
Query: 569 GLAKWASTSSSHITCTDVAGTFGY 592
GLA S GT Y
Sbjct: 176 GLALKFEAGKSAGDTHGQVGTRRY 199
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 6e-43
Identities = 50/200 (25%), Positives = 75/200 (37%), Gaps = 27/200 (13%)
Query: 412 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEII 471
+ N LIG+G VYKG L D + +AVK+ + + F+ E I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR--QNFINEKNIY 59
Query: 472 TT--LHHKNIISLLGFCFEDN-----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY 524
+ H NI + LLV ++ GSL + L + D W
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD-----WVSSC 114
Query: 525 KVAMGVAEALEYLHSGSAQR------VIHRDVKSSNILLSDDFEPQLSDFGLAK------ 572
++A V L YLH+ + + HRD+ S N+L+ +D +SDFGL+
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 573 WASTSSSHITCTDVAGTFGY 592
GT Y
Sbjct: 175 LVRPGEEDNAAISEVGTIRY 194
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-42
Identities = 48/167 (28%), Positives = 83/167 (49%), Gaps = 11/167 (6%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
E ++G+G V K K++A+K ++ SE K F++E+ ++ ++H NI+ L G C
Sbjct: 13 EEVVGRGAFGVVCKAKW-RAKDVAIKQIE-SESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
N + LV ++ GSL LHG + P + + + ++ + YLHS + +I
Sbjct: 71 L--NPVCLVMEYAEGGSLYNVLHGAEPLPY-YTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 547 HRDVKSSNILLSDDFE-PQLSDFGLAKWASTSSSHITCTDVAGTFGY 592
HRD+K N+LL ++ DFG A T T+ G+ +
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTACDIQT-----HMTNNKGSAAW 169
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 3e-41
Identities = 54/170 (31%), Positives = 86/170 (50%), Gaps = 10/170 (5%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILK---PSEDVIKEFVLEIEIITTLHHKNIISLL 483
+ IG G V++ G ++AVKIL + + EF+ E+ I+ L H NI+ +
Sbjct: 42 KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 484 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
G + NL +V ++LSRGSL LH R +A VA+ + YLH+
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLH-KSGAREQLDERRRLSMAYDVAKGMNYLHN-RNP 158
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAK-WASTSSSHITCTDVAGTFGY 592
++HR++KS N+L+ + ++ DFGL++ AST S AGT +
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS---KSAAGTPEW 205
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-39
Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 25/180 (13%)
Query: 427 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPSED--------VIKEFVLEIEIITTLHHK 477
E IGKGG V+KG + D +A+K L + +EF E+ I++ L+H
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 478 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
NI+ L G N +V +F+ G L L WS + ++ + +A +EY+
Sbjct: 84 NIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHP---IKWSVKLRLMLDIALGIEYM 138
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQ-----LSDFGLAKWASTSSSHITCTDVAGTFGY 592
+ ++HRD++S NI L E ++DFGL++ + S + + G F +
Sbjct: 139 QN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV-----SGLLGNFQW 192
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 7e-39
Identities = 55/179 (30%), Positives = 82/179 (45%), Gaps = 23/179 (12%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSED-----VIKEFVLEIEIITTLHHKNIIS 481
E +IG GG +VY+ G E+AVK + D I+ E ++ L H NII+
Sbjct: 12 EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
L G C ++ NL LV +F G L L G + A+ +A + YLH +
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIP-----PDILVNWAVQIARGMNYLHDEA 125
Query: 542 AQRVIHRDVKSSNILLSDDFEPQ--------LSDFGLAKWASTSSSHITCTDVAGTFGY 592
+IHRD+KSSNIL+ E ++DFGLA+ ++ AG + +
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK----MSAAGAYAW 180
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-37
Identities = 31/171 (18%), Positives = 66/171 (38%), Gaps = 16/171 (9%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLL 483
+ + S +++KG G ++ VK+LK S ++F E + H N++ +L
Sbjct: 15 LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 484 GFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
G C + L+ ++ GSL LH S+ K A+ +A + +LH+
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV--VDQSQAVKFALDMARGMAFLHT-L 130
Query: 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 592
+ + S ++++ +D ++S + +
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAW 174
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 6e-36
Identities = 46/179 (25%), Positives = 76/179 (42%), Gaps = 21/179 (11%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITT--LHHKNIISLLG 484
+GKG +V++G G+ +AVKI ++ K + E E+ T L H+NI+ +
Sbjct: 13 LECVGKGRYGEVWRGSW-QGENVAVKIFSSRDE--KSWFRETELYNTVMLRHENILGFIA 69
Query: 485 FC----FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
L L+ + GSL + L D ++ + +A L +LH
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLD-----TVSCLRIVLSIASGLAHLHIE 124
Query: 541 SAQR-----VIHRDVKSSNILLSDDFEPQLSDFGLA--KWASTSSSHITCTDVAGTFGY 592
+ HRD+KS NIL+ + + ++D GLA ST+ + GT Y
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 48/179 (26%), Positives = 76/179 (42%), Gaps = 21/179 (11%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITT--LHHKNIISLLG 484
IGKG +V+ G G+++AVK+ +E+ + E EI T + H+NI+ +
Sbjct: 42 VKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEE--ASWFRETEIYQTVLMRHENILGFIA 98
Query: 485 FCFEDN----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
+ L L+ D+ GSL + L D K+A L +LH+
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLD-----AKSMLKLAYSSVSGLCHLHTE 153
Query: 541 SAQR-----VIHRDVKSSNILLSDDFEPQLSDFGLA--KWASTSSSHITCTDVAGTFGY 592
+ HRD+KS NIL+ + ++D GLA + T+ I GT Y
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-35
Identities = 40/148 (27%), Positives = 76/148 (51%), Gaps = 8/148 (5%)
Query: 427 ENLIGKGGSSQVYKG-CLPDGKELAVKIL-KPSEDVIKEFVLEIEIITTLHHKNIISLLG 484
++GKG Q K G+ + +K L + E+ + F+ E++++ L H N++ +G
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 544
++D L + +++ G+L + + WS+R A +A + YLHS
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIKSMDSQ---YPWSQRVSFAKDIASGMAYLHS---MN 128
Query: 545 VIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+IHRD+ S N L+ ++ ++DFGLA+
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLAR 156
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 38/172 (22%), Positives = 74/172 (43%), Gaps = 15/172 (8%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLL 483
LIGKG QVY G E+A++++ +ED +K F E+ H+N++ +
Sbjct: 38 GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 484 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
G C +L ++ +L + K ++ ++A + + + YLH+ +
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVRDAKI---VLDVNKTRQIAQEIVKGMGYLHA---K 149
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAK---WASTSSSHITCTDVAGTFGY 592
++H+D+KS N+ D+ + ++DFGL G +
Sbjct: 150 GILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCH 200
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 6e-35
Identities = 53/179 (29%), Positives = 81/179 (45%), Gaps = 21/179 (11%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITT--LHHKNIISLLG 484
+ IGKG +V++G G+E+AVKI E+ + + E EI T L H+NI+ +
Sbjct: 47 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIA 103
Query: 485 FCFEDNN----LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
+DN L LV D+ GSL + L+ K+A+ A L +LH
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT-----VEGMIKLALSTASGLAHLHME 158
Query: 541 SAQR-----VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH--ITCTDVAGTFGY 592
+ HRD+KS NIL+ + ++D GLA +++ I GT Y
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 47/166 (28%), Positives = 80/166 (48%), Gaps = 12/166 (7%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
IG G VYKG ++AVK+L + ++ F E+ ++ H NI+ +G+
Sbjct: 32 IGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
L +V + SL +LH ++ F + +A A ++YLH+ + +I
Sbjct: 90 TAPQ-LAIVTQWCEGSSLYHHLHASET---KFEMKKLIDIARQTARGMDYLHA---KSII 142
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 592
HRD+KS+NI L +D ++ DFGLA S S ++G+ +
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILW 188
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 52/175 (29%), Positives = 88/175 (50%), Gaps = 14/175 (8%)
Query: 422 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILK----PSEDVIKEFVLEIEIITTLHH 476
+NF E IG+G S+VY+ CL DG +A+K ++ + + EI+++ L+H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 477 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEAL 534
N+I EDN L +V + G L + KK ER K + + AL
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLI--PERTVWKYFVQLCSAL 149
Query: 535 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 589
E++HS +RV+HRD+K +N+ ++ +L D GL ++ S+ ++ + GT
Sbjct: 150 EHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGT 199
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 44/159 (27%), Positives = 72/159 (45%), Gaps = 9/159 (5%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKEFVLEIEIITTLHHKNII 480
++L +G+GG S V L DG A+K IL + +E E ++ +H NI+
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 481 SLLGFCFEDNN----LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
L+ +C + L+ F RG+L + K + + +G+ LE
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575
+H+ + HRD+K +NILL D+ +P L D G A
Sbjct: 150 IHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 45/147 (30%), Positives = 77/147 (52%), Gaps = 15/147 (10%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
IGKG +V+KG K +A+KI L+ +ED I++ EI +++ + G
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQR 544
+D L ++ ++L GS + L E + + + L+YLHS ++
Sbjct: 90 LKDTKLWIIMEYLGGGSALDLLEPGP-------LDETQIATILREILKGLDYLHS---EK 139
Query: 545 VIHRDVKSSNILLSDDFEPQLSDFGLA 571
IHRD+K++N+LLS+ E +L+DFG+A
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVA 166
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 52/168 (30%), Positives = 79/168 (47%), Gaps = 11/168 (6%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
IG G ++ V C P +++A+K L+ + + E + EI+ ++ HH NI+S
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGW--SERY--KVAMGVAEALEYLHSGSA 542
+ L LV LS GS+ + + E + V E LEYLH
Sbjct: 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK--- 139
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 590
IHRDVK+ NILL +D Q++DFG++ + + IT V TF
Sbjct: 140 NGQIHRDVKAGNILLGEDGSVQIADFGVSAFL-ATGGDITRNKVRKTF 186
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-27
Identities = 41/184 (22%), Positives = 75/184 (40%), Gaps = 18/184 (9%)
Query: 396 KELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSS--QVYKG-CLPDGKELAVK 452
H + + ++ + +IGKG V P G+ + V+
Sbjct: 2 AHHHHHHMENLYFQGMSSFLP---EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVR 58
Query: 453 IL---KPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLH 509
+ S +++ E+ + +H NI+ DN L +V F++ GS ++ +
Sbjct: 59 RINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLIC 118
Query: 510 GNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSD 567
+ D G +E + GV +AL+Y+H +HR VK+S+IL+S D + LS
Sbjct: 119 THFMD----GMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSG 171
Query: 568 FGLA 571
Sbjct: 172 LRSN 175
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-27
Identities = 43/194 (22%), Positives = 85/194 (43%), Gaps = 15/194 (7%)
Query: 402 HEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL---KPS 457
H +S+ L + ++ IG+G + DG++ +K + + S
Sbjct: 4 HHHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS 63
Query: 458 EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAA 517
+E E+ ++ + H NI+ E+ +L +V D+ G L + ++ K
Sbjct: 64 SKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVL-- 121
Query: 518 FGWSERY--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575
+ E + + AL+++H ++++HRD+KS NI L+ D QL DFG+A+ +
Sbjct: 122 --FQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176
Query: 576 TSSSHITCTDVAGT 589
++ GT
Sbjct: 177 STVEL-ARA-CIGT 188
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-27
Identities = 38/147 (25%), Positives = 68/147 (46%), Gaps = 9/147 (6%)
Query: 430 IGKGGSSQVYKGCL-PDGKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
IG+G +V+ G L D +AVK + D+ +F+ E I+ H NI+ L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
+ + +V + + G L ++ A +EYL S + I
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGAR---LRVKTLLQMVGDAAAGMEYLES---KCCI 235
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLAKW 573
HRD+ + N L+++ ++SDFG+++
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSRE 262
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 37/180 (20%), Positives = 69/180 (38%), Gaps = 32/180 (17%)
Query: 428 NLIGKGGSSQVYKGCLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKN--IISL 482
IG GGSS+V++ + A+K + + + + EI + L + II L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 483 LGFCFEDNNLLLV--------YDFL-SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 533
+ D + +V +L + S++ W + EA
Sbjct: 94 YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWE-------RKSYWKN-------MLEA 139
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYV 593
+ +H ++H D+K +N L+ D +L DFG+A ++ + GT Y+
Sbjct: 140 VHTIHQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 195
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 45/191 (23%), Positives = 82/191 (42%), Gaps = 34/191 (17%)
Query: 422 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNII 480
+F LIG GG QV+K DGK +K +K + + + E++ + L H NI+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER---EVKALAKLDHVNIV 67
Query: 481 SLLGFCFED-----------------NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER 523
G C++ L + +F +G+LE+ + + + +
Sbjct: 68 HYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK----LDKV 122
Query: 524 Y--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581
++ + + ++Y+HS +++I+RD+K SNI L D + ++ DFGL
Sbjct: 123 LALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT 179
Query: 582 TCTDVAGTFGY 592
GT Y
Sbjct: 180 R---SKGTLRY 187
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 17/161 (10%)
Query: 421 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKN 478
F L+G G QVYKG + G+ A+K++ + D +E EI ++ HH+N
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 82
Query: 479 IISLLG------FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGV 530
I + G D+ L LV +F GS+ + + K + E + + +
Sbjct: 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL----KEEWIAYICREI 138
Query: 531 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571
L +LH +VIHRD+K N+LL+++ E +L DFG++
Sbjct: 139 LRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVS 176
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 42/154 (27%), Positives = 74/154 (48%), Gaps = 12/154 (7%)
Query: 421 TSNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI 479
F +G+G VYK G+ +A+K + D ++E + EI I+ ++
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-LQEIIKEISIMQQCDSPHV 86
Query: 480 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYL 537
+ G F++ +L +V ++ GS+ + + K +E + + LEYL
Sbjct: 87 VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK-----TLTEDEIATILQSTLKGLEYL 141
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571
H R IHRD+K+ NILL+ + +L+DFG+A
Sbjct: 142 HF---MRKIHRDIKAGNILLNTEGHAKLADFGVA 172
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 37/180 (20%), Positives = 69/180 (38%), Gaps = 32/180 (17%)
Query: 428 NLIGKGGSSQVYKGCLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKN--IISL 482
IG GGSS+V++ + A+K + + + + EI + L + II L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 483 LGFCFEDNNLLLV--------YDFL-SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 533
+ D + +V +L + S++ W + EA
Sbjct: 75 YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWE-------RKSYWKN-------MLEA 120
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYV 593
+ +H ++H D+K +N L+ D +L DFG+A ++ + GT Y+
Sbjct: 121 VHTIHQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 45/146 (30%), Positives = 84/146 (57%), Gaps = 12/146 (8%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKP-SEDVIKEFVLEIEIITTLHHKNIISLLGFCF 487
+G G +VYK G A K+++ SE+ ++++++EIEI+ T H I+ LLG +
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRV 545
D L ++ +F G+++ + + G +E V + EAL +LHS +R+
Sbjct: 87 HDGKLWIMIEFCPGGAVDAIMLELDR-----GLTEPQIQVVCRQMLEALNFLHS---KRI 138
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLA 571
IHRD+K+ N+L++ + + +L+DFG++
Sbjct: 139 IHRDLKAGNVLMTLEGDIRLADFGVS 164
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 39/166 (23%), Positives = 72/166 (43%), Gaps = 19/166 (11%)
Query: 422 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKN 478
++F +G+GG V++ D A+K L E ++ + E++ + L H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 479 IISLLGFCFEDNN------------LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKV 526
I+ E N L + + +L++ ++G S +
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE-RERSVCLHI 123
Query: 527 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+ +AEA+E+LHS + ++HRD+K SNI + D ++ DFGL
Sbjct: 124 FLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVT 166
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 46/174 (26%), Positives = 85/174 (48%), Gaps = 22/174 (12%)
Query: 416 DLLSATSNFLAE---------NLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDV 460
+L+ A + + +IG+G VY G L DGK++ AVK L
Sbjct: 10 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 69
Query: 461 IKEFVLEIEIITTLHHKNIISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFG 519
+ +F+ E I+ H N++SLLG C + + L+V ++ G L + +P
Sbjct: 70 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-- 127
Query: 520 WSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573
+ + VA+ ++YL ++++ +HRD+ + N +L + F +++DFGLA+
Sbjct: 128 -KDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARD 177
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 8e-25
Identities = 50/154 (32%), Positives = 81/154 (52%), Gaps = 8/154 (5%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
IGKG V G G ++AVK +K + F+ E ++T L H N++ LLG
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA-QAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 487 FEDN-NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
E+ L +V +++++GSL + L + G K ++ V EA+EYL
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG---NNF 310
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579
+HRD+ + N+L+S+D ++SDFGL K AS++
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 344
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 50/154 (32%), Positives = 81/154 (52%), Gaps = 8/154 (5%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
IGKG V G G ++AVK +K + F+ E ++T L H N++ LLG
Sbjct: 26 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA-QAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 487 FEDN-NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
E+ L +V +++++GSL + L + G K ++ V EA+EYL
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYL---EGNNF 138
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579
+HRD+ + N+L+S+D ++SDFGL K AS++
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 172
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 46/155 (29%), Positives = 77/155 (49%), Gaps = 14/155 (9%)
Query: 427 ENLIGKGGSSQVYKGC---LPDGKEL--AVKILKP-SEDVIKEFVLEIEIITTLHHKNII 480
+GKG V L D AVK L+ +E+ +++F EIEI+ +L H NI+
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 481 SLLGFCFEDNN--LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
G C+ L L+ ++L GSL + L +K+ + + + + +EYL
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLG 131
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573
+ +R IHRD+ + NIL+ ++ ++ DFGL K
Sbjct: 132 T---KRYIHRDLATRNILVENENRVKIGDFGLTKV 163
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 49/153 (32%), Positives = 76/153 (49%), Gaps = 17/153 (11%)
Query: 430 IGKGGSSQVYKGCL---PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIISL 482
+G+G +V C DG AVK LK + EI+I+ TL+H++II
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 483 LGFCFED--NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
G C + +L LV +++ GSL + L + G ++ A + E + YLH+
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-----IGLAQLLLFAQQICEGMAYLHA- 152
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573
Q IHRD+ + N+LL +D ++ DFGLAK
Sbjct: 153 --QHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 36/180 (20%), Positives = 68/180 (37%), Gaps = 32/180 (17%)
Query: 428 NLIGKGGSSQVYKGCLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKN--IISL 482
IG GGSS+V++ + A+K + + + + EI + L + II L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 483 LGFCFEDNNLLLV--------YDFL-SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 533
+ D + +V +L + S++ W + EA
Sbjct: 122 YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWE-------RKSYWKN-------MLEA 167
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYV 593
+ +H ++H D+K +N L+ D +L DFG+A ++ + G Y+
Sbjct: 168 VHTIHQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYM 223
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-24
Identities = 37/148 (25%), Positives = 77/148 (52%), Gaps = 6/148 (4%)
Query: 427 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
++ +G G +VY+G +AVK LK ++EF+ E ++ + H N++ LLG
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
C + ++ +F++ G+L + L + + +A ++ A+EYL +
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLEK---KNF 339
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAKW 573
IHR++ + N L+ ++ +++DFGL++
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRL 367
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 46/155 (29%), Positives = 77/155 (49%), Gaps = 14/155 (9%)
Query: 427 ENLIGKGGSSQVYKGC---LPDGKEL--AVKILKP-SEDVIKEFVLEIEIITTLHHKNII 480
+GKG V L D AVK L+ +E+ +++F EIEI+ +L H NI+
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 481 SLLGFCFEDNN--LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
G C+ L L+ ++L GSL + L +K+ + + + + +EYL
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLG 162
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573
+ +R IHRD+ + NIL+ ++ ++ DFGL K
Sbjct: 163 T---KRYIHRDLATRNILVENENRVKIGDFGLTKV 194
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 47/158 (29%), Positives = 70/158 (44%), Gaps = 16/158 (10%)
Query: 421 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL----KPSEDVIKEFVLEIEIITTLH 475
F IG G VY + + + +A+K + K S + ++ + E+ + L
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 476 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEA 533
H N I G ++ LV ++ GS + L +KK E V G +
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK-----PLQEVEIAAVTHGALQG 166
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571
L YLHS +IHRDVK+ NILLS+ +L DFG A
Sbjct: 167 LAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSA 201
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 36/147 (24%), Positives = 68/147 (46%), Gaps = 6/147 (4%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
+G G V G ++AVK++K EF E + + L H ++ G C
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
++ + +V +++S G L L + K S+ ++ V E + +L + + I
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGKG---LEPSQLLEMCYDVCEGMAFL---ESHQFI 126
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLAKW 573
HRD+ + N L+ D ++SDFG+ ++
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRY 153
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 48/155 (30%), Positives = 82/155 (52%), Gaps = 15/155 (9%)
Query: 427 ENLIGKGGSSQVYKGCLP-----DGKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNI 479
+G+G +V G+++AVK LKP + I + EIEI+ L+H+NI
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 480 ISLLGFCFEDNN--LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
+ G C ED + L+ +FL GSL+E L NK ++ K A+ + + ++YL
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYL 142
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
S ++ +HRD+ + N+L+ + + ++ DFGL K
Sbjct: 143 GS---RQYVHRDLAARNVLVESEHQVKIGDFGLTK 174
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 42/167 (25%), Positives = 78/167 (46%), Gaps = 22/167 (13%)
Query: 421 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI 479
S+F ++G+G QV K D + A+K ++ +E+ + + E+ ++ +L+H+ +
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 480 ISLLGFCFEDNN-------------LLLVYDFLSRGSLEENLH-GNKKDPAAFGWSERYK 525
+ E N L + ++ G+L + +H N W +
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW----R 120
Query: 526 VAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+ + EAL Y+HS Q +IHRD+K NI + + ++ DFGLAK
Sbjct: 121 LFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAK 164
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 45/154 (29%), Positives = 73/154 (47%), Gaps = 14/154 (9%)
Query: 427 ENLIGKGGSSQVYKGC---LPDGKEL--AVKILKP-SEDVIKEFVLEIEIITTLHHKNII 480
+ +GKG V L D AVK L+ D ++F EI+I+ LH I+
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 481 SLLGFCFED--NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
G + +L LV ++L G L + L ++ A S + + + +EYL
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLG 144
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
S +R +HRD+ + NIL+ + +++DFGLAK
Sbjct: 145 S---RRCVHRDLAARNILVESEAHVKIADFGLAK 175
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 43/154 (27%), Positives = 79/154 (51%), Gaps = 13/154 (8%)
Query: 427 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 480
+IG+G VY G L DGK++ AVK L + +F+ E I+ H N++
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 481 SLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 539
SLLG C + + L+V ++ G L + +P + + VA+ +++L
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV---KDLIGFGLQVAKGMKFL-- 208
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573
++++ +HRD+ + N +L + F +++DFGLA+
Sbjct: 209 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARD 241
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 6e-24
Identities = 38/147 (25%), Positives = 70/147 (47%), Gaps = 6/147 (4%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
IG G V+ G + ++A+K ++ ++F+ E E++ L H ++ L G C
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
E + LV +F+ G L + L + F + + V E + YL VI
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGMAYL---EEACVI 126
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLAKW 573
HRD+ + N L+ ++ ++SDFG+ ++
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRF 153
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 44/153 (28%), Positives = 75/153 (49%), Gaps = 12/153 (7%)
Query: 427 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 480
E +IG G S +V G L P +++ A+K LK +E ++F+ E I+ H NII
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
L G ++V +++ GSL+ L + F + + GV + YL
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ---FTIMQLVGMLRGVGAGMRYL--- 167
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573
S +HRD+ + N+L+ + ++SDFGL++
Sbjct: 168 SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 39/154 (25%), Positives = 76/154 (49%), Gaps = 14/154 (9%)
Query: 427 ENLIGKGGSSQVYKGCL-PDGKEL----AVKILKP--SEDVIKEFVLEIEIITTLHHKNI 479
++G G VYKG P+G+++ A+K L+ S KE + E ++ ++ + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 480 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 539
LLG C + L+ + G L + + +K + G + +A+ + YL
Sbjct: 80 CRLLGICLTST-VQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED 135
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573
+R++HRD+ + N+L+ +++DFGLAK
Sbjct: 136 ---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 7e-24
Identities = 35/146 (23%), Positives = 76/146 (52%), Gaps = 6/146 (4%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
E +G G +V+ ++AVK +KP ++ F+ E ++ TL H ++ L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
++ + ++ +F+++GSL + L ++ + + +AE + ++ + I
Sbjct: 253 TKE-PIYIITEFMAKGSLLDFLKSDEGSK--QPLPKLIDFSAQIAEGMAFI---EQRNYI 306
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLAK 572
HRD++++NIL+S +++DFGLA+
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLAR 332
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 46/146 (31%), Positives = 74/146 (50%), Gaps = 14/146 (9%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFCF 487
IG+G S VY + G+E+A++ + + KE ++ EI ++ + NI++ L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRV 545
+ L +V ++L+ GSL + + E V +ALE+LHS +V
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETC-------MDEGQIAAVCRECLQALEFLHS---NQV 137
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLA 571
IHRD+KS NILL D +L+DFG
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFC 163
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 36/147 (24%), Positives = 75/147 (51%), Gaps = 6/147 (4%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
+G G V G ++A+K++K EF+ E +++ L H+ ++ L G C
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
+ + ++ ++++ G L L + F + ++ V EA+EYL +++ +
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYL---ESKQFL 142
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLAKW 573
HRD+ + N L++D ++SDFGL+++
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRY 169
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 36/157 (22%), Positives = 75/157 (47%), Gaps = 17/157 (10%)
Query: 430 IGKGGSSQVYKG----CLPDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIIS 481
+G+G VY+G + D E A+K + S EF+ E ++ + +++
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER------YKVAMGVAEALE 535
LLG + L++ + ++RG L+ L + A ++A +A+ +
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
YL +A + +HRD+ + N ++++DF ++ DFG+ +
Sbjct: 153 YL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 51/212 (24%), Positives = 82/212 (38%), Gaps = 28/212 (13%)
Query: 383 SPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGC 442
P + D++ L ++L+ + +Y +Q +G+G +V++
Sbjct: 31 GPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPR------------VGRGSFGEVHRMK 78
Query: 443 -LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501
G + AVK + E E E+ L I+ L G E + + + L
Sbjct: 79 DKQTGFQCAVKKV-RLEVFRVE---ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG 134
Query: 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD- 560
GSL + + K E LEYLH+ +R++H DVK+ N+LLS D
Sbjct: 135 GSLGQLI----KQMGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDG 187
Query: 561 FEPQLSDFGLAK---WASTSSSHITCTDVAGT 589
L DFG A S +T + GT
Sbjct: 188 SRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 41/154 (26%), Positives = 78/154 (50%), Gaps = 12/154 (7%)
Query: 425 LAENLIGKGGSSQVYKGCL-PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNI 479
+A+ +G G V +G K++ A+K+LK + +E + E +I+ L + I
Sbjct: 13 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72
Query: 480 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 539
+ L+G C + L+LV + G L + L G +++ S ++ V+ ++YL
Sbjct: 73 VRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYL-- 126
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573
+ +HRD+ + N+LL + ++SDFGL+K
Sbjct: 127 -EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA 159
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 1e-23
Identities = 51/174 (29%), Positives = 79/174 (45%), Gaps = 22/174 (12%)
Query: 428 NLIGKGGSSQVYKG-CLPDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISL 482
+GKG VY LA+K+L ++ V + E+EI + L H NI+ L
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHS 539
G+ + + L+ ++ G++ L K A +E +A AL Y HS
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE-------LANALSYCHS 127
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYV 593
+RVIHRD+K N+LL E +++DFG + A +S C GT Y+
Sbjct: 128 ---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYL 174
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 46/161 (28%), Positives = 76/161 (47%), Gaps = 17/161 (10%)
Query: 427 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP---SEDVIKEFVLEIEIITTLHHKNI 479
++G+G V +G L DG L AVK +K S+ I+EF+ E + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 480 ISLLGFCFEDN-----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG--VAE 532
I LLG C E + +++ F+ G L L ++ + + + +A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573
+EYL S + +HRD+ + N +L DD ++DFGL+K
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKK 196
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-23
Identities = 38/148 (25%), Positives = 77/148 (52%), Gaps = 6/148 (4%)
Query: 427 ENLIGKGGSSQVYKGCLPDGK-ELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
++ +G G +VY+G +AVK LK ++EF+ E ++ + H N++ LLG
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
C + ++ +F++ G+L + L + + +A ++ A+EYL +
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYL---EKKNF 132
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAKW 573
IHRD+ + N L+ ++ +++DFGL++
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRL 160
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 38/154 (24%), Positives = 76/154 (49%), Gaps = 13/154 (8%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKEL----AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 480
+ +IGKG VY G D + A+K L ++ F+ E ++ L+H N++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 481 SLLGFCF-EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 539
+L+G + ++ ++ G L + + +++P + + VA +EYL
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV---KDLISFGLQVARGMEYL-- 140
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573
+ Q+ +HRD+ + N +L + F +++DFGLA+
Sbjct: 141 -AEQKFVHRDLAARNCMLDESFTVKVADFGLARD 173
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 42/177 (23%), Positives = 75/177 (42%), Gaps = 22/177 (12%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGF 485
++G+G ++ V++G G A+K+ + + E E++ L+HKNI+ L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 486 CFED---NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSG 540
E+ + +L+ +F GSL L A+G E V V + +L
Sbjct: 76 -EEETTTRHKVLIMEFCPCGSLYTVLEEPSN---AYGLPESEFLIVLRDVVGGMNHLRE- 130
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFGYV 593
++HR++K NI+ + Q L+DFG A+ + GT Y+
Sbjct: 131 --NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYL 182
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 40/159 (25%), Positives = 72/159 (45%), Gaps = 18/159 (11%)
Query: 430 IGKGGSSQVYKGCL--PDGKEL--AVKILKP---SEDVIKEFVLEIEIITTLHHKNIISL 482
+GKG V + L DG + AVK+LK + I+EF+ E + H ++ L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 483 LGFCFED------NNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEAL 534
+G +++ F+ G L L ++P + + +A +
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 535 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573
EYL S++ IHRD+ + N +L++D ++DFGL++
Sbjct: 151 EYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRK 186
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 99.1 bits (248), Expect = 3e-23
Identities = 47/176 (26%), Positives = 81/176 (46%), Gaps = 25/176 (14%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLL 483
L+GKG + VY+ + G E+A+K++ +++ E++I L H +I+ L
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 484 GFCFED-NNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHS 539
FED N + LV + G + L K + A R+ + + + YLHS
Sbjct: 78 N-YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEA-----RHFMHQ-IITGMLYLHS 130
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS--HITCTDVAGTFGYV 593
++HRD+ SN+LL+ + +++DFGLA + C GT Y+
Sbjct: 131 ---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC----GTPNYI 179
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 3e-23
Identities = 43/146 (29%), Positives = 72/146 (49%), Gaps = 14/146 (9%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFCF 487
IG+G + V G+++AVK++ + +E + E+ I+ H N++ +
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRV 545
L ++ +FL G+L + + + +E V V +AL YLH+ Q V
Sbjct: 113 VGEELWVLMEFLQGGALTDIVSQVR-------LNEEQIATVCEAVLQALAYLHA---QGV 162
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLA 571
IHRD+KS +ILL+ D +LSDFG
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFC 188
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-23
Identities = 44/160 (27%), Positives = 75/160 (46%), Gaps = 21/160 (13%)
Query: 430 IGKGGSSQVYKG----CLPDGKEL--AVKILKP-SEDVIKEFVLEIEIITTLHHKNIISL 482
+G+G +V+ LP+ ++ AVK LK SE ++F E E++T L H++I+
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 483 LGFCFEDNNLLLVYDFLSRGSL-----------EENLHGNKKDPAAFGWSERYKVAMGVA 531
G C E LL+V++++ G L + G P G + VA VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 532 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571
+ YL + +HRD+ + N L+ ++ DFG++
Sbjct: 169 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 4e-23
Identities = 45/155 (29%), Positives = 75/155 (48%), Gaps = 15/155 (9%)
Query: 427 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP----SEDVIKEFVLEIEIITTLHHKN 478
+G G V +G P GK + AVK LKP + + +F+ E+ + +L H+N
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
+I L G + +V + GSL + L ++ F + A+ VAE + YL
Sbjct: 83 LIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGYL- 137
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573
++R IHRD+ + N+LL+ ++ DFGL +
Sbjct: 138 --ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA 170
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 47/252 (18%), Positives = 83/252 (32%), Gaps = 32/252 (12%)
Query: 369 DSGAIVPVGNEIVSSPLSTDHDST---ELPKELEGLHEKYSATCRLFNYQ---DLLSATS 422
S V N IV +P L K + + C+L + + +
Sbjct: 6 SSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSK 65
Query: 423 NFLAENLIGKGGSSQVYKGC------LPDGKELAVKILKPSEDVIKEFVL---EIEIITT 473
+L+G+G +QVY+ + ++ +K+ KP+ EF + +E +
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKP 123
Query: 474 LHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDP-AAFGWSERYKVAMGVAE 532
+ N +LV + S G+L ++ K P AM +
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEP-----------QLSDFGLAKWASTSSSHI 581
+E +H +IH D+K N +L + F L D G +
Sbjct: 184 MIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 582 TCTDVAGTFGYV 593
T T G+
Sbjct: 241 IFTAKCETSGFQ 252
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 4e-23
Identities = 35/147 (23%), Positives = 72/147 (48%), Gaps = 6/147 (4%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
+G G +V+ G ++AVK LK F+ E ++ L H+ ++ L
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
++ + ++ +++ GSL + L ++ +A +AE + ++ + I
Sbjct: 78 TQE-PIYIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFI---EERNYI 131
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLAKW 573
HRD++++NIL+SD +++DFGLA+
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARL 158
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-23
Identities = 48/164 (29%), Positives = 86/164 (52%), Gaps = 21/164 (12%)
Query: 427 ENLIGKGGSSQVYKGCL-PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTL-HHKNII 480
+++IG+G QV K + DG + A+K +K S+D ++F E+E++ L HH NII
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY------------KVAM 528
+LLG C L L ++ G+L + L ++ ++ A
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
VA ++YL S ++ IHRD+ + NIL+ +++ +++DFGL++
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 190
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 5e-23
Identities = 46/184 (25%), Positives = 72/184 (39%), Gaps = 14/184 (7%)
Query: 419 SATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTL 474
S ++ IG G + K DGK L K L +E + V E+ ++ L
Sbjct: 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 475 HHKNIISLLG-FCFEDNNLL-LVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGV 530
H NI+ N L +V ++ G L + K+ E + +V +
Sbjct: 63 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL--DEEFVLRVMTQL 120
Query: 531 AEALEYLHS--GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 588
AL+ H V+HRD+K +N+ L +L DFGLA+ + +S G
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKTFVG 178
Query: 589 TFGY 592
T Y
Sbjct: 179 TPYY 182
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 5e-23
Identities = 41/178 (23%), Positives = 76/178 (42%), Gaps = 16/178 (8%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIIS 481
+F ++++G G + + D +++AVK + P + E++++ H N+I
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP--ECFSFADREVQLLRESDEHPNVIR 82
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
+ + + L +L+E + ++ A E + L +LHS
Sbjct: 83 YFCTEKDRQFQYIAIE-LCAATLQEYV---EQKDFAHLGLEPITLLQQTTSGLAHLHS-- 136
Query: 542 AQRVIHRDVKSSNILLSDDFEPQ-----LSDFGLAKW-ASTSSSHITCTDVAGTFGYV 593
++HRD+K NIL+S +SDFGL K A S + V GT G++
Sbjct: 137 -LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-23
Identities = 37/147 (25%), Positives = 76/147 (51%), Gaps = 6/147 (4%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
E +G+G +V+ G +A+K LKP + F+ E +++ L H+ ++ L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
E+ + +V +++S+GSL + L G + +A +A + Y+ +
Sbjct: 249 SEE-PIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER---MNYV 302
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLAKW 573
HRD++++NIL+ ++ +++DFGLA+
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARL 329
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 7e-23
Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 23/165 (13%)
Query: 427 ENLIGKGGSSQVYKG----CLPDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKN 478
+G+ +VYKG P + A+K LK + +EF E + L H N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENL------------HGNKKDPAAFGWSERYKV 526
++ LLG +D L +++ + S G L E L ++ +A + +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 527 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571
+A +EYL S+ V+H+D+ + N+L+ D ++SD GL
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLF 175
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 9e-23
Identities = 38/161 (23%), Positives = 76/161 (47%), Gaps = 22/161 (13%)
Query: 430 IGKGGSSQVYKG----CLPDGKEL--AVKILKP-SEDVIKEFVLEIEIITTLHHKNIISL 482
+G+G +V+ P ++ AVK LK + K+F E E++T L H++I+
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY------------KVAMGV 530
G C + + L++V++++ G L + L + D + +A +
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 531 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571
A + YL ++Q +HRD+ + N L+ + ++ DFG++
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 41/155 (26%), Positives = 69/155 (44%), Gaps = 14/155 (9%)
Query: 425 LAENLIGKGGSSQVYKGCLPDGKEL---AVKILKP---SEDVIKEFVLEIEIITTLHHKN 478
L + +G G V KG K + AVKILK + E + E ++ L +
Sbjct: 20 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 79
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
I+ ++G C E + +LV + G L + L N+ ++ V+ ++YL
Sbjct: 80 IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYL- 133
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573
+HRD+ + N+LL ++SDFGL+K
Sbjct: 134 --EESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-22
Identities = 40/153 (26%), Positives = 74/153 (48%), Gaps = 13/153 (8%)
Query: 427 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 480
IG+G V++G P+ L A+K K S+ V ++F+ E + H +I+
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
L+G +N + ++ + + G L L K + A ++ AL YL
Sbjct: 80 KLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYL--- 132
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573
++R +HRD+ + N+L+S + +L DFGL+++
Sbjct: 133 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 43/154 (27%), Positives = 80/154 (51%), Gaps = 13/154 (8%)
Query: 427 ENLIGKGGSSQVYKGCL--PDGKEL---AVKILKP--SEDVIKEFVLEIEIITTLHHKNI 479
+ +IG G +VYKG L GK+ A+K LK +E +F+ E I+ H NI
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 480 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 539
I L G + ++++ +++ G+L++ L + F + + G+A ++YL
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGE---FSVLQLVGMLRGIAAGMKYL-- 163
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573
+ +HRD+ + NIL++ + ++SDFGL++
Sbjct: 164 -ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-22
Identities = 44/153 (28%), Positives = 78/153 (50%), Gaps = 12/153 (7%)
Query: 427 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 480
+ ++G G +V G L P KE+ A+K LK +E ++F+ E I+ H NII
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
L G + +++V +++ GSL+ L + F + + G+A ++YL
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYL--- 163
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573
S +HRD+ + NIL++ + ++SDFGL +
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLGRV 196
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-22
Identities = 39/151 (25%), Positives = 75/151 (49%), Gaps = 14/151 (9%)
Query: 430 IGKGGSSQVYKGCL-PDGKEL----AVKILKP--SEDVIKEFVLEIEIITTLHHKNIISL 482
+G G VYKG P+G+++ A+K L+ S KE + E ++ ++ + ++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
LG C + L+ + G L + + +K + G + +A+ + YL
Sbjct: 83 LGICLTST-VQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED--- 135
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573
+R++HRD+ + N+L+ +++DFGLAK
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 1e-22
Identities = 43/166 (25%), Positives = 74/166 (44%), Gaps = 13/166 (7%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
++GKG VY G L + +A+K I + + EI + L HKNI+ LG
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQR 544
E+ + + + + GSL L + +E+ + E L+YLH +
Sbjct: 89 SENGFIKIFMEQVPGGSLSALL---RSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQ 142
Query: 545 VIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 589
++HRD+K N+L+ + ++SDFG +K + + GT
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC--TETFTGT 186
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-22
Identities = 46/199 (23%), Positives = 91/199 (45%), Gaps = 12/199 (6%)
Query: 389 HDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCL-PDGK 447
+P + +S L + + L + +A+ +G G V +G K
Sbjct: 303 DKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKK 362
Query: 448 EL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGS 503
++ A+K+LK + +E + E +I+ L + I+ L+G C + L+LV + G
Sbjct: 363 QIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGP 421
Query: 504 LEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 563
L + L G +++ S ++ V+ ++YL + +HR++ + N+LL +
Sbjct: 422 LHKFLVGKREE---IPVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYA 475
Query: 564 QLSDFGLAKWASTSSSHIT 582
++SDFGL+K S+ T
Sbjct: 476 KISDFGLSKALGADDSYYT 494
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 41/169 (24%), Positives = 78/169 (46%), Gaps = 14/169 (8%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKI--LKPSEDVIKEFVLEIEII-TTLHHKNIISLLGF 485
+G+G V K +P G+ +AVK + K +++++I T+ ++ G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 543
F + ++ + + + SL++ E K+A+ + +ALE+LHS
Sbjct: 75 LFREGDVWICMELMD-TSLDKFYKQVIDKGQTI--PEDILGKIAVSIVKALEHLHS--KL 129
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 592
VIHRDVK SN+L++ + ++ DFG++ + + AG Y
Sbjct: 130 SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD---VAKDIDAGCKPY 175
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 37/147 (25%), Positives = 76/147 (51%), Gaps = 6/147 (4%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
E +G+G +V+ G +A+K LKP + F+ E +++ L H+ ++ L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
E+ + +V +++S+GSL + L G + +A +A + Y+ +
Sbjct: 332 SEE-PIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER---MNYV 385
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLAKW 573
HRD++++NIL+ ++ +++DFGLA+
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARL 412
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 37/164 (22%), Positives = 73/164 (44%), Gaps = 23/164 (14%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKEL--------AVKILKP-SEDVIKEFVLEIEIITTLHHK 477
+G+G ++++KG + + +K+L + + F +++ L HK
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 478 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
+++ G C + +LV +F+ GSL+ L NK + +VA +A A+ +L
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC---INILWKLEVAKQLAAAMHFL 129
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQ--------LSDFGLAKW 573
+IH +V + NILL + + + LSD G++
Sbjct: 130 ---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT 170
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 39/167 (23%), Positives = 66/167 (39%), Gaps = 12/167 (7%)
Query: 422 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKE---FVLEIEIITTL-HH 476
+F + +G G +V+K DG+ AVK K+ + E+ + H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 477 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
+ L E L L + SL+++ + A+ ++ + AL +
Sbjct: 117 PCCVRLEQAWEEGGILYLQTEL-CGPSLQQHC---EAWGASLPEAQVWGYLRDTLLALAH 172
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 583
LHS Q ++H DVK +NI L +L DFGL T+ +
Sbjct: 173 LHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ 216
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 42/170 (24%), Positives = 69/170 (40%), Gaps = 18/170 (10%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISLLG 484
IG+G VYKG E+A L K ++ + F E E++ L H NI+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 485 FCF----EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
++LV + ++ G+L+ L K + + L++LH+
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHTR 148
Query: 541 SAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKWASTSSSHITCTDVAGT 589
+ +IHRD+K NI ++ ++ D GLA S V GT
Sbjct: 149 TPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGT 193
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 3e-22
Identities = 42/177 (23%), Positives = 75/177 (42%), Gaps = 22/177 (12%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKIL--KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
++G+G ++ V++G G A+K+ + + E E++ L+HKNI+ L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 486 CFED---NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSG 540
E+ + +L+ +F GSL L A+G E V V + +L
Sbjct: 76 -EEETTTRHKVLIMEFCPCGSLYTVLEEPSN---AYGLPESEFLIVLRDVVGGMNHLRE- 130
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFGYV 593
++HR++K NI+ + Q L+DFG A+ + GT Y+
Sbjct: 131 --NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYL 182
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 4e-22
Identities = 40/153 (26%), Positives = 75/153 (49%), Gaps = 13/153 (8%)
Query: 424 FLAENLIGKGGSSQVYKGCL-PDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNII 480
F + +G G V+K P G +A K+ L+ + + + E++++ + I+
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLH 538
G + D + + + + GSL++ L + P E+ KV++ V + L YL
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP------EQILGKVSIAVIKGLTYLR 148
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571
+++HRDVK SNIL++ E +L DFG++
Sbjct: 149 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 179
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 4e-22
Identities = 40/183 (21%), Positives = 70/183 (38%), Gaps = 27/183 (14%)
Query: 421 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILK---PSEDVIKEFVLEIEIITTL-H 475
T+ F IG G V+K DG A+K K + + E+ L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 476 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 535
H +++ ED+++L+ ++ + GSL + + N + + F +E + + V L
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQ-------------------LSDFGLAKWAST 576
Y+HS ++H D+K SNI +S P + D G S+
Sbjct: 130 YIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 577 SSS 579
Sbjct: 187 PQV 189
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 5e-22
Identities = 37/154 (24%), Positives = 73/154 (47%), Gaps = 14/154 (9%)
Query: 427 ENLIGKGGSSQVYKGCL-PDGKEL----AVKILK--PSEDVIKEFVLEIEIITTLHHKNI 479
++G G V+KG P+G+ + +K+++ + + I +L H +I
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 480 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 539
+ LLG C + L LV +L GSL +++ ++ G + +A+ + YL
Sbjct: 78 VRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGA---LGPQLLLNWGVQIAKGMYYL-- 131
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573
++HR++ + N+LL + Q++DFG+A
Sbjct: 132 -EEHGMVHRNLAARNVLLKSPSQVQVADFGVADL 164
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 6e-22
Identities = 41/157 (26%), Positives = 72/157 (45%), Gaps = 17/157 (10%)
Query: 430 IGKGGSSQVYKG----CLPDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIIS 481
+G G +VY+G D L AVK L SE +F++E II+ +H+NI+
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNK---KDPAAFGWSERYKVAMGVAEALEYLH 538
+G + ++ + ++ G L+ L + P++ + VA +A +YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 156
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQL---SDFGLAK 572
IHRD+ + N LL+ ++ DFG+A+
Sbjct: 157 --EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 6e-22
Identities = 49/175 (28%), Positives = 80/175 (45%), Gaps = 24/175 (13%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNIISLL 483
+GKGG ++ ++ + A KI+ ++ +EI I +L H++++
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 484 GFCFED-NNLLLVYDFLSRGSLEENLHGNKK--DPAAFGWSERYKVAMGVAEALEYLHSG 540
G FED + + +V + R SL E K +P A RY + + +YLH
Sbjct: 82 G-FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA-----RYYL-RQIVLGCQYLHR- 133
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS--HITCTDVAGTFGYV 593
RVIHRD+K N+ L++D E ++ DFGLA + C GT Y+
Sbjct: 134 --NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC----GTPNYI 182
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 7e-22
Identities = 42/169 (24%), Positives = 72/169 (42%), Gaps = 13/169 (7%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKI--LKPSEDVIKEFVLEIEII-TTLHHKNIISLLGF 485
IG+G V K P G+ +AVK E K+ +++++++ + I+ G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 543
F + + + + +S S ++ E K+ + +AL +L
Sbjct: 90 LFREGDCWICMELMS-TSFDKFYKYVYSVLDD-VIPEEILGKITLATVKALNHLKE--NL 145
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 592
++IHRD+K SNILL +L DFG++ S I T AG Y
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS---IAKTRDAGCRPY 191
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 7e-22
Identities = 48/175 (27%), Positives = 79/175 (45%), Gaps = 24/175 (13%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNIISLL 483
+GKGG ++ ++ + A KI+ ++ +EI I +L H++++
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 484 GFCFED-NNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
G FED + + +V + R SL E +P A RY + + +YLH
Sbjct: 108 G-FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA-----RYYL-RQIVLGCQYLHR- 159
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS--HITCTDVAGTFGYV 593
RVIHRD+K N+ L++D E ++ DFGLA + C GT Y+
Sbjct: 160 --NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC----GTPNYI 208
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 1e-21
Identities = 39/153 (25%), Positives = 73/153 (47%), Gaps = 13/153 (8%)
Query: 427 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 480
++G+G +VY+G G+++ AVK K + D ++F+ E I+ L H +I+
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
L+G E+ ++ + G L L NK ++ + +A+ YL
Sbjct: 77 KLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKV---LTLVLYSLQICKAMAYL--- 129
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573
+ +HRD+ NIL++ +L DFGL+++
Sbjct: 130 ESINCVHRDIAVRNILVASPECVKLGDFGLSRY 162
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 41/157 (26%), Positives = 72/157 (45%), Gaps = 17/157 (10%)
Query: 430 IGKGGSSQVYKG----CLPDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIIS 481
+G G +VY+G D L AVK L SE +F++E II+ +H+NI+
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLH 538
+G + ++ + ++ G L+ L + P++ + VA +A +YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 197
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQL---SDFGLAK 572
IHRD+ + N LL+ ++ DFG+A+
Sbjct: 198 --EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 48/173 (27%), Positives = 80/173 (46%), Gaps = 22/173 (12%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLL 483
+GKG VY + +A+K+L S+ V + EIEI + L H NI+ +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 484 GFCFEDNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHSG 540
+ + + L+ +F RG L + L + + +A E +A+AL Y H
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE-------LADALHYCHE- 132
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYV 593
++VIHRD+K N+L+ E +++DFG + A + C GT Y+
Sbjct: 133 --RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC----GTLDYL 179
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 2e-21
Identities = 39/153 (25%), Positives = 74/153 (48%), Gaps = 13/153 (8%)
Query: 427 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 480
IG+G V++G P+ + A+K K S+ V ++F+ E + H +I+
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
L+G +N + ++ + + G L L K + A ++ AL YL
Sbjct: 455 KLIGVI-TENPVWIIMELCTLGELRSFLQVRKFS---LDLASLILYAYQLSTALAYL--- 507
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573
++R +HRD+ + N+L+S + +L DFGL+++
Sbjct: 508 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 50/176 (28%), Positives = 71/176 (40%), Gaps = 19/176 (10%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKI-----LKPSEDVIKEFVL-EIEIITTLHHKNIISL 482
IGKG S V + G++ AVKI S + E + E I L H +I+ L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSG 540
L D L +V++F+ L + K+ A F +SE + EAL Y H
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEI--VKRADAGFVYSEAVASHYMRQILEALRYCHD- 148
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQ---LSDFGLAKWASTSSSHITCTDVAGTFGYV 593
+IHRDVK +LL+ L FG+A S GT ++
Sbjct: 149 --NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA--GGRVGTPHFM 200
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 3e-21
Identities = 44/191 (23%), Positives = 80/191 (41%), Gaps = 25/191 (13%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEI-ITTLHHKNII 480
+ ++E ++G G S V G+ +AVK + D ++EI++ + H N+I
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI--DFCDIALMEIKLLTESDDHPNVI 72
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLE---ENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
D L + + L +L+ E+ + + ++ + +A + +L
Sbjct: 73 RYYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQ-------------LSDFGLAK--WASTSSSHIT 582
HS ++IHRD+K NIL+S +SDFGL K + SS
Sbjct: 132 HS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 583 CTDVAGTFGYV 593
+ +GT G+
Sbjct: 189 LNNPSGTSGWR 199
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 41/171 (23%), Positives = 74/171 (43%), Gaps = 31/171 (18%)
Query: 430 IGKGGSSQVYKG----CLPDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIIS 481
IG+G +V++ LP AVK+LK S D+ +F E ++ + NI+
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY----------------- 524
LLG C + L++++++ G L E L
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 525 ---KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+A VA + YL S ++ +HRD+ + N L+ ++ +++DFGL++
Sbjct: 175 EQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 222
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 3e-21
Identities = 40/171 (23%), Positives = 82/171 (47%), Gaps = 31/171 (18%)
Query: 430 IGKGGSSQVYKGCLPDGKEL------AVKILKP--SEDVIKEFVLEIEIITTLHHKNIIS 481
+G+G +V K K AVK+LK S +++ + E ++ ++H ++I
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG------------ 529
L G C +D LLL+ ++ GSL L ++K + S + +
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 530 --------VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+++ ++YL + +++HRD+ + NIL+++ + ++SDFGL++
Sbjct: 151 DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 39/164 (23%), Positives = 72/164 (43%), Gaps = 22/164 (13%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKEL------AVKILKP--SEDVIKEFVLEIEIITTL-HHK 477
+G G +V + + AVK+LK D + + E++I++ L H+
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 478 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY----------KVA 527
NI++LLG C +L++ ++ G L L + +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 528 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571
VA+ + +L +++ IHRDV + N+LL++ ++ DFGLA
Sbjct: 171 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 6e-21
Identities = 44/174 (25%), Positives = 77/174 (44%), Gaps = 22/174 (12%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNIISLLG 484
+GKG +V G+E AVK++ + + + E++++ L H NI+ L
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSA 542
F + LV + + G L + + K+ +SE ++ V + Y+H
Sbjct: 94 FFEDKGYFYLVGEVYTGGELFDEIISRKR------FSEVDAARIIRQVLSGITYMHK--- 144
Query: 543 QRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYV 593
+++HRD+K N+LL S D ++ DFGL+ S D GT Y+
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYYI 195
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 7e-21
Identities = 50/172 (29%), Positives = 73/172 (42%), Gaps = 22/172 (12%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCF 487
IG G S + E AVKI+ S+ E EIEI+ H NII+L
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE---EIEILLRYGQHPNIITLKDVYD 86
Query: 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRV 545
+ + +V + + G L + + K +SER V + + +EYLH+ Q V
Sbjct: 87 DGKYVYVVTELMKGGELLDKILRQKF------FSEREASAVLFTITKTVEYLHA---QGV 137
Query: 546 IHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFGYV 593
+HRD+K SNIL D+ + DFG AK + T +V
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG--LLMTPCYTANFV 187
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 7e-21
Identities = 49/194 (25%), Positives = 90/194 (46%), Gaps = 29/194 (14%)
Query: 419 SATSNF-----LAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEII 471
S + F L E+++G+G ++V L +E AVKI++ I+ V E+E++
Sbjct: 5 SFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEML 64
Query: 472 TTL-HHKNIISLLGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVA 527
H+N++ L+ F FE+ + LV++ + GS+ ++H + ++E V
Sbjct: 65 YQCQGHRNVLELIEF-FEEEDRFYLVFEKMRGGSILSHIHKRRH------FNELEASVVV 117
Query: 528 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP---QLSDFGLAK-----WASTSSS 579
VA AL++LH+ + + HRD+K NIL + ++ DF L + S
Sbjct: 118 QDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174
Query: 580 HITCTDVAGTFGYV 593
G+ Y+
Sbjct: 175 TPELLTPCGSAEYM 188
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-20
Identities = 50/210 (23%), Positives = 86/210 (40%), Gaps = 37/210 (17%)
Query: 408 TCRLFNYQDLLSATSNFLAENL---------IGKGGSSQVYKGC-LPDGKELAVKILKPS 457
++F + DL + + L +G G +V K++A++I+
Sbjct: 112 RNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKR 171
Query: 458 EDVIKEFVL---------EIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENL 508
+ I EIEI+ L+H II + F F+ + +V + + G L + +
Sbjct: 172 KFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKV 230
Query: 509 HGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ-- 564
GNK+ E + A++YLH +IHRD+K N+LLS E
Sbjct: 231 VGNKR------LKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLI 281
Query: 565 -LSDFGLAKWASTSSSHITCTDVAGTFGYV 593
++DFG +K +S + GT Y+
Sbjct: 282 KITDFGHSKILGETS---LMRTLCGTPTYL 308
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 39/169 (23%), Positives = 71/169 (42%), Gaps = 17/169 (10%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKI--LKPSEDVIKEFVLEIEII-TTLHHKNIISLLGF 485
+G G QV+K G +AVK +++ K +++++++ + I+ G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 543
+ ++ + + + + + P ER K+ + + +AL YL
Sbjct: 93 FITNTDVFIAMELMGTCAEKLKKRMQGPIP------ERILGKMTVAIVKALYYLKE--KH 144
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 592
VIHRDVK SNILL + + +L DFG++ AG Y
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD---KAKDRSAGCAAY 190
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 1e-20
Identities = 35/187 (18%), Positives = 77/187 (41%), Gaps = 31/187 (16%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILK------------------PSEDVIKEFVLEIEII 471
+ +G +++ C D K A+K + + +F E++II
Sbjct: 39 LNQGKFNKIIL-CEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 472 TTLHHKNIISLLGFCFED-NNLLLVYDFLSRGSL----EENLHGNKKDPAAFGWSERYKV 526
T + ++ ++ G + + + ++Y+++ S+ E +K +
Sbjct: 98 TDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 527 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV 586
V + Y+H+ + + HRDVK SNIL+ + +LSDFG +++ +
Sbjct: 157 IKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSR--- 211
Query: 587 AGTFGYV 593
GT+ ++
Sbjct: 212 -GTYEFM 217
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 1e-20
Identities = 44/171 (25%), Positives = 81/171 (47%), Gaps = 15/171 (8%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLL 483
+G GG S VY ++A+K + E+ +K F E+ + L H+NI+S++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 484 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
ED+ LV +++ +L E + + + + +++ H
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAH---DM 130
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD-VAGTFGYV 593
R++HRD+K NIL+ + ++ DFG+AK + S + +T T+ V GT Y
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAK--ALSETSLTQTNHVLGTVQYF 179
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 93.2 bits (231), Expect = 1e-20
Identities = 22/198 (11%), Positives = 45/198 (22%), Gaps = 41/198 (20%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKIL----KPSEDVIKEFVLEIEIITTLHHKNIISLL 483
+ G S V+ + ++ A+K+ + S ++ L ++
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 484 GFC--------------------------FEDNNLLLVYDFL--SRGSLEENLHGNKKDP 515
+ N LL+ L L
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 516 AAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575
G + + + L S + ++H N+ + D L D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
Query: 576 TSSSHITCTDVAGTFGYV 593
T + Y
Sbjct: 246 T-----RGPASSVPVTYA 258
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 45/166 (27%), Positives = 83/166 (50%), Gaps = 26/166 (15%)
Query: 430 IGKGGSSQVYKGCLPDGKEL--------AVKILKP--SEDVIKEFVLEIEIITTL-HHKN 478
+G+G QV + AVK+LK +E + + V E+E++ + HKN
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY------------KV 526
II+LLG C +D L ++ ++ S+G+L E L + + +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 527 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+A +EYL ++Q+ IHRD+ + N+L++++ +++DFGLA+
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-20
Identities = 41/176 (23%), Positives = 68/176 (38%), Gaps = 21/176 (11%)
Query: 427 ENLIGKGGSSQVYKG-CLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISL 482
+G G +V E A+KI+ S + + E+ ++ L H NI+ L
Sbjct: 42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSG 540
F + N LV + G L + + K ++E + V + YLH
Sbjct: 102 YDFFEDKRNYYLVMECYKGGELFDEIIHRMK------FNEVDAAVIIKQVLSGVTYLHK- 154
Query: 541 SAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYV 593
++HRD+K N+LL D ++ DFGL+ + GT Y+
Sbjct: 155 --HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYYI 205
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-20
Identities = 42/176 (23%), Positives = 77/176 (43%), Gaps = 21/176 (11%)
Query: 427 ENLIGKGGSSQVYKG-CLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISL 482
++GKG +V K +E AVK++ + E+E++ L H NI+ L
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSG 540
+ ++ +V + + G L + + K+ +SE ++ V + Y+H
Sbjct: 87 FEILEDSSSFYIVGELYTGGELFDEIIKRKR------FSEHDAARIIKQVFSGITYMHK- 139
Query: 541 SAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYV 593
++HRD+K NILL D + ++ DFGL+ ++ D GT Y+
Sbjct: 140 --HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYI 190
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 43/181 (23%), Positives = 83/181 (45%), Gaps = 28/181 (15%)
Query: 425 LAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISL 482
L++ ++G G + +V + G++ A+K+L S +E ++ +I+ +
Sbjct: 32 LSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQE----VDHHWQASGGPHIVCI 87
Query: 483 LGFCFED-----NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALE 535
L +E+ LL++ + + G L + ++ AF +ER ++ + A++
Sbjct: 88 LDV-YENMHHGKRCLLIIMECMEGGELFSRIQ--ERGDQAF--TEREAAEIMRDIGTAIQ 142
Query: 536 YLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 592
+LHS + HRDVK N+L D +L+DFG AK + ++ C T Y
Sbjct: 143 FLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPC----YTPYY 195
Query: 593 V 593
V
Sbjct: 196 V 196
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 45/166 (27%), Positives = 83/166 (50%), Gaps = 26/166 (15%)
Query: 430 IGKGGSSQVYKGCLPDGKEL--------AVKILKP--SEDVIKEFVLEIEIITTL-HHKN 478
+G+G QV + AVK+LK +E + + V E+E++ + HKN
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY------------KV 526
II+LLG C +D L ++ ++ S+G+L E L + + +
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 527 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+A +EYL ++Q+ IHRD+ + N+L++++ +++DFGLA+
Sbjct: 209 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 4e-20
Identities = 38/155 (24%), Positives = 66/155 (42%), Gaps = 12/155 (7%)
Query: 427 ENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKEFVLEIEIITTL-HHKNIISLL 483
++ +GG + VY+ + G+E A+K +L E+ + + E+ + L H NI+
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 484 GFCF-------EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
L+ L +G L E L + K+ A+++
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLK-KMESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571
+H +IHRD+K N+LLS+ +L DFG A
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 5e-20
Identities = 39/172 (22%), Positives = 64/172 (37%), Gaps = 15/172 (8%)
Query: 427 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIIS 481
L+G+GG VY+ + +A+K++ + E L +++
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
+ F D L + ++ L L + + + AL+ H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAML----RRQGPLAPPRAVAIVRQIGSALDAAH--- 151
Query: 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA-GTFGY 592
A HRDVK NIL+S D L DFG+A +T+ +T GT Y
Sbjct: 152 AAGATHRDVKPENILVSADDFAYLVDFGIAS--ATTDEKLTQLGNTVGTLYY 201
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 5e-20
Identities = 41/165 (24%), Positives = 80/165 (48%), Gaps = 25/165 (15%)
Query: 430 IGKGGSSQVYKGCLPDGKEL------AVKILKP--SEDVIKEFVLEIEIITTL-HHKNII 480
+G+G QV + + AVK+LK + + + E++I+ + HH N++
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 481 SLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY------------KVA 527
+LLG C + L+++ +F G+L L + + + + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 528 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
VA+ +E+L ++++ IHRD+ + NILLS+ ++ DFGLA+
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 6e-20
Identities = 46/166 (27%), Positives = 87/166 (52%), Gaps = 26/166 (15%)
Query: 430 IGKGGSSQVYKGCLPDGKEL--------AVKILKP--SEDVIKEFVLEIEIITTL-HHKN 478
+G+G QV + AVK+LK +E + + + E+E++ + HKN
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK----------VAM 528
II+LLG C +D L ++ ++ S+G+L E L + + ++ + V+
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 529 G--VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
VA +EYL ++++ IHRD+ + N+L+++D +++DFGLA+
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 6e-20
Identities = 45/187 (24%), Positives = 70/187 (37%), Gaps = 32/187 (17%)
Query: 427 ENLIGKGGSSQVYKG-CLPDGKELAVKILK--------------PSEDVIKEFVLEIEII 471
+G G +V E A+K++K E +E EI ++
Sbjct: 41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100
Query: 472 TTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMG 529
+L H NII L + LV +F G L E + K + E +
Sbjct: 101 KSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK------FDECDAANIMKQ 154
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDV 586
+ + YLH ++HRD+K NILL + ++ DFGL+ + S D
Sbjct: 155 ILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDR 208
Query: 587 AGTFGYV 593
GT Y+
Sbjct: 209 LGTAYYI 215
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 7e-20
Identities = 49/178 (27%), Positives = 80/178 (44%), Gaps = 26/178 (14%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPS----------EDVIKEFVLEIEIITTL-HHK 477
+G+G SS V + P KE AVKI+ + +++ + + E++I+ + H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 478 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALE 535
NII L + LV+D + +G L + L SE+ K+ + E +
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT------LSEKETRKIMRALLEVIC 138
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYV 593
LH ++HRD+K NILL DD +L+DFG + +V GT Y+
Sbjct: 139 ALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYL 190
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 8e-20
Identities = 48/172 (27%), Positives = 79/172 (45%), Gaps = 16/172 (9%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKIL--KPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
+G G V+ G E +K + S+ +++ EIE++ +L H NII +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQR 544
+ +N+ +V + G L E + + A SE Y ++ + AL Y HS Q
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKAL--SEGYVAELMKQMMNALAYFHS---QH 144
Query: 545 VIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYV 593
V+H+D+K NIL S ++ DFGLA+ + T+ AGT Y+
Sbjct: 145 VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE---HSTNAAGTALYM 193
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 47/183 (25%), Positives = 77/183 (42%), Gaps = 38/183 (20%)
Query: 427 ENLIGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLG 484
++G G S+V+ GK A+K +K S + EI ++ + H+NI++L
Sbjct: 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 485 FCFED-NNLLLVYDFLS----------RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 533
+E + LV +S RG E KD + V V A
Sbjct: 74 I-YESTTHYYLVMQLVSGGELFDRILERGVYTE------KDAS--------LVIQQVLSA 118
Query: 534 LEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 590
++YLH ++HRD+K N+L ++ + ++DFGL+K + GT
Sbjct: 119 VKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTP 171
Query: 591 GYV 593
GYV
Sbjct: 172 GYV 174
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 43/177 (24%), Positives = 72/177 (40%), Gaps = 22/177 (12%)
Query: 425 LAENLIGKGGSSQVYKGC-LPDGKELAVK-ILKPSEDVIKEFVLEIEIITTL-HHKNIIS 481
L + +G+G S K + AVK I K E ++ EI + H NI+
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVK 70
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHS 539
L + + LV + L+ G L E + K +SE + + A+ ++H
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGELFERIKKKKH------FSETEASYIMRKLVSAVSHMHD 124
Query: 540 GSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYV 593
V+HRD+K N+L +D+ E ++ DFG A+ + + T Y
Sbjct: 125 ---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL--KTPCFTLHYA 176
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 42/173 (24%), Positives = 76/173 (43%), Gaps = 21/173 (12%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
+GKG +V K +E AVK++ + E+E++ L H NI+ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 543
+ ++ +V + + G L + + K+ +SE ++ V + Y+H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKR------FSEHDAARIIKQVFSGITYMHK---H 140
Query: 544 RVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYV 593
++HRD+K NILL D + ++ DFGL+ ++ D GT Y+
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYI 190
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 1e-19
Identities = 43/182 (23%), Positives = 82/182 (45%), Gaps = 27/182 (14%)
Query: 424 FLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIIS 481
+ ++G G + +V + ++ A+K+L+ +E +E+ +I+
Sbjct: 64 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE----VELHWRASQCPHIVR 119
Query: 482 LLGFCFED-----NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEAL 534
++ +E+ LL+V + L G L + + AF +ER ++ + EA+
Sbjct: 120 IVDV-YENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAF--TEREASEIMKSIGEAI 174
Query: 535 EYLHSGSAQRVIHRDVKSSNILLSDDFEP---QLSDFGLAKWASTSSSHITCTDVAGTFG 591
+YLHS + HRDVK N+L + +L+DFG AK ++ + + T T
Sbjct: 175 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPY 228
Query: 592 YV 593
YV
Sbjct: 229 YV 230
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 2e-19
Identities = 42/172 (24%), Positives = 70/172 (40%), Gaps = 21/172 (12%)
Query: 430 IGKGGSSQVYKGCL--PDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFC 486
+G G V++ C+ G+ K + + K V EI I+ LHH +I+L
Sbjct: 59 LGSGAFGVVHR-CVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA- 116
Query: 487 FED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 543
FED ++L+ +FLS G L + + +D + SE E L+++H
Sbjct: 117 FEDKYEMVLILEFLSGGELFDRI--AAED---YKMSEAEVINYMRQACEGLKHMHE---H 168
Query: 544 RVIHRDVKSSNILLSDDFEPQL--SDFGLAKWASTSSSHITCTDVAGTFGYV 593
++H D+K NI+ + DFGLA + T +
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV---KVTTATAEFA 217
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 46/211 (21%), Positives = 72/211 (34%), Gaps = 50/211 (23%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILK------PSEDVIKEFVLEIEIITTLHHKNIISL 482
IG+G V A+KI+ + ++ E+ ++ LHH NI L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 483 LGFCFEDNNLLLVYDFLSRGSL----------------------------------EENL 508
++ + LV + G L
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 509 HGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS--DDFEPQ 564
++ F E+ + + AL YLH+ Q + HRD+K N L S FE +
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIK 210
Query: 565 LSDFGLAKW--ASTSSSHITCTDVAGTFGYV 593
L DFGL+K + + T AGT +V
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFV 241
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 39/165 (23%), Positives = 71/165 (43%), Gaps = 26/165 (15%)
Query: 430 IGKGGSSQVYKG----CLPDGKEL--AVKILKP--SEDVIKEFVLEIEIITTL-HHKNII 480
+G G +V + + + AVK+LKP + + E+++++ L +H NI+
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG----------- 529
+LLG C L++ ++ G L L + S
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 530 ---VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571
VA+ + +L +++ IHRD+ + NILL+ ++ DFGLA
Sbjct: 151 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLA 192
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 43/175 (24%), Positives = 80/175 (45%), Gaps = 17/175 (9%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLL 483
++G GG S+V+ L D +++AVK+L+ F E + L+H I+++
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 484 GFCFEDNNLL----LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 539
+ +V +++ +L + +H +V +AL + H
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSH- 133
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD-VAGTFGYV 593
+IHRDVK +NI++S ++ DFG+A+ + S + +T T V GT Y+
Sbjct: 134 --QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 36/170 (21%), Positives = 71/170 (41%), Gaps = 31/170 (18%)
Query: 430 IGKGGSSQVYKGCLPDGKEL------AVKILKP--SEDVIKEFVLEIEIITTL-HHKNII 480
+G G +V + AVK+LK + + E++++T L H+NI+
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG----------- 529
+LLG C + L++++ G L L ++ + + +
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 530 --------VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571
VA+ +E+L + +HRD+ + N+L++ ++ DFGLA
Sbjct: 173 DLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLA 219
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 50/177 (28%), Positives = 83/177 (46%), Gaps = 25/177 (14%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILK---------PSEDVIKEFVLEIEIITTLH-HKN 478
IG+G SS V + G E AVKI++ E+V + E I+ + H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEY 536
II+L+ + + LV+D + +G L + L SE+ + + EA+ +
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA------LSEKETRSIMRSLLEAVSF 215
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYV 593
LH+ ++HRD+K NILL D+ + +LSDFG + ++ GT GY+
Sbjct: 216 LHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYL 266
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 4e-19
Identities = 51/172 (29%), Positives = 69/172 (40%), Gaps = 21/172 (12%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCF 487
IG+G +V A K I K + + F EIEI+ +L H NII L F
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET-F 75
Query: 488 ED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQR 544
ED ++ LV + + G L E + + + E ++ V A+ Y H
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRV------FRESDAARIMKDVLSAVAYCHK---LN 126
Query: 545 VIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYV 593
V HRD+K N L S D +L DFGLA GT YV
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTKVGTPYYV 175
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-19
Identities = 47/179 (26%), Positives = 77/179 (43%), Gaps = 28/179 (15%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL---------EIEIITTLHHKNI 479
+G G +V K++A+KI+ + I EIEI+ L+H I
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 480 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYL 537
I + F F+ + +V + + G L + + GNK+ E + A++YL
Sbjct: 78 IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR------LKEATCKLYFYQMLLAVQYL 130
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQ---LSDFGLAKWASTSSSHITCTDVAGTFGYV 593
H +IHRD+K N+LLS E ++DFG +K +S + GT Y+
Sbjct: 131 HE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYL 183
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 6e-19
Identities = 34/185 (18%), Positives = 69/185 (37%), Gaps = 27/185 (14%)
Query: 430 IGKGGSSQVYKGCL--PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCF 487
+G+G V++ C+ K K +K EI I+ H+NI+ L
Sbjct: 13 LGRGEFGIVHR-CVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 488 EDNNLLLVYDFLSRGSL-----EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
L+++++F+S + N+++ ++ V EAL++LHS
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFELNEREIVSY--------VHQVCEALQFLHS--- 120
Query: 543 QRVIHRDVKSSNILLSDDFEPQL--SDFGLAKWASTSSSHITCTDVAGTFGYV---VLIL 597
+ H D++ NI+ + +FG A+ + + Y V
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAPEVHQH 177
Query: 598 NPIAF 602
+ ++
Sbjct: 178 DVVST 182
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 6e-19
Identities = 50/173 (28%), Positives = 78/173 (45%), Gaps = 21/173 (12%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
+GKG S V + G E A KI+ K S ++ E I L H NI+ L
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 543
E++ LV+D ++ G L E++ + +SE + E++ Y HS
Sbjct: 74 IQEESFHYLVFDLVTGGELFEDIVAREF------YSEADASHCIQQILESIAYCHS---N 124
Query: 544 RVIHRDVKSSNILLSDDFEPQ---LSDFGLAKWASTSSSHITCTDVAGTFGYV 593
++HR++K N+LL+ + L+DFGLA + S AGT GY+
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYL 174
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 9e-19
Identities = 48/191 (25%), Positives = 83/191 (43%), Gaps = 24/191 (12%)
Query: 423 NFLAENLIGKGGSSQVYKGCL--PDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNI 479
++G G QV+K C G +LA KI+K KE V EI ++ L H N+
Sbjct: 90 TVSKTEILGGGRFGQVHK-CEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANL 148
Query: 480 ISLLGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEY 536
I L FE N+++LV +++ G L + + + + +E + E + +
Sbjct: 149 IQLYDA-FESKNDIVLVMEYVDGGELFDRI--IDES---YNLTELDTILFMKQICEGIRH 202
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQL--SDFGLAKWASTSSSHITCTDVAGTFGYV- 593
+H ++H D+K NIL + Q+ DFGLA+ GT ++
Sbjct: 203 MHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLA 256
Query: 594 --VLILNPIAF 602
V+ + ++F
Sbjct: 257 PEVVNYDFVSF 267
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 1e-18
Identities = 38/174 (21%), Positives = 71/174 (40%), Gaps = 25/174 (14%)
Query: 430 IGKGGSSQVYKGCL--PDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFC 486
+G G V++ G A K + + KE V EI+ ++ L H +++L
Sbjct: 165 LGTGAFGVVHR-VTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 487 FEDNNLLLVYDFLSRGSL-----EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
+DN ++++Y+F+S G L +E+ ++ + + V + L ++H
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY--------MRQVCKGLCHMHE-- 273
Query: 542 AQRVIHRDVKSSNILLSDDFEPQL--SDFGLAKWASTSSSHITCTDVAGTFGYV 593
+H D+K NI+ + +L DFGL S GT +
Sbjct: 274 -NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV---KVTTGTAEFA 323
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-18
Identities = 47/173 (27%), Positives = 75/173 (43%), Gaps = 20/173 (11%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
+GKG S V + + G+E A I+ K S ++ E I L H NI+ L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 543
E+ + L++D ++ G L E++ + +SE + EA+ + H
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDIVAREY------YSEADASHCIQQILEAVLHCHQ---M 129
Query: 544 RVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYV 593
V+HR++K N+LL +L+DFGLA AGT GY+
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW--FGFAGTPGYL 180
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 46/218 (21%), Positives = 90/218 (41%), Gaps = 30/218 (13%)
Query: 402 HEKYSATCRLFNYQDLLSATSNF-----LAENLIGKGGSSQVYKG-CLPDGKELAVKIL- 454
H +S+ L + NF L +G+G + V + G+E A K L
Sbjct: 4 HHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLK 63
Query: 455 --KPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFED-NNLLLVYDFLSRGSLEENLHG 510
+ +D E + EI ++ +I+L +E+ + ++L+ ++ + G +
Sbjct: 64 KRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV-YENTSEIILILEYAAGGEIFSLCL- 121
Query: 511 NKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ---L 565
+ SE ++ + E + YLH ++H D+K NILLS + +
Sbjct: 122 -PELAEMV--SENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKI 175
Query: 566 SDFGLAKWASTSSSHITCTDVAGTFGYV---VLILNPI 600
DFG+++ + ++ GT Y+ +L +PI
Sbjct: 176 VDFGMSRKIGHACEL---REIMGTPEYLAPEILNYDPI 210
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 50/173 (28%), Positives = 78/173 (45%), Gaps = 21/173 (12%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
+GKG S V + G E A KI+ K S ++ E I L H NI+ L
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 543
E++ LV+D ++ G L E++ + +SE + E++ Y HS
Sbjct: 97 IQEESFHYLVFDLVTGGELFEDIVAREF------YSEADASHCIQQILESIAYCHS---N 147
Query: 544 RVIHRDVKSSNILLSDDFEPQ---LSDFGLAKWASTSSSHITCTDVAGTFGYV 593
++HR++K N+LL+ + L+DFGLA + S AGT GY+
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYL 197
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 85.5 bits (211), Expect = 6e-18
Identities = 26/199 (13%), Positives = 57/199 (28%), Gaps = 38/199 (19%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKIL----KPSEDVIKEFVLEIEIITTL----HHKNI 479
++G+ + G+ V + +P + IK+ E+ + L + K
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 480 ISLLGFCFEDN-----------------------NLLLVYDFL--SRGSLEENLHGNKKD 514
L F F + + +Y + + + E L +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 515 PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574
+ R ++ + V L LH ++H ++ +I+L L+ F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 575 STSSSHITCTDVAGTFGYV 593
S+
Sbjct: 262 GASAV-SPIGRGFAPPETT 279
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 8e-18
Identities = 51/172 (29%), Positives = 78/172 (45%), Gaps = 21/172 (12%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCF 487
+G+G +S VY+ K A+K+LK + D K EI ++ L H NII L F
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-KKIVRTEIGVLLRLSHPNIIKLKEI-F 117
Query: 488 ED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQR 544
E + LV + ++ G L + + +SER + EA+ YLH
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGY------YSERDAADAVKQILEAVAYLHE---NG 168
Query: 545 VIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYV 593
++HRD+K N+L + D +++DFGL+K V GT GY
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV---LMKTVCGTPGYC 217
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 84.7 bits (209), Expect = 8e-18
Identities = 23/199 (11%), Positives = 58/199 (29%), Gaps = 43/199 (21%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKIL----KPSEDVIKE-------------------- 463
++G+ + G+ V + +P + IK+
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 464 -----FVLEIEIITTLHHKNIISLLGFC--FEDNNLLLVYDFL--SRGSLEENLHGNKKD 514
F+ +++ K +I + + +Y + + + E L +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 515 PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574
+ R ++ + V L LH ++H ++ +I+L L+ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 575 STSSSHITCTDVAGTFGYV 593
+ + G+
Sbjct: 257 GAR------VVSSVSRGFE 269
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 9e-18
Identities = 39/161 (24%), Positives = 74/161 (45%), Gaps = 24/161 (14%)
Query: 424 FLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIIS 481
+ ++G G + +V + ++ A+K+L+ +E +E+ +I+
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE----VELHWRASQCPHIVR 75
Query: 482 LLGFCFED-----NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEAL 534
++ +E+ LL+V + L G L + + AF +ER ++ + EA+
Sbjct: 76 IVDV-YENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAF--TEREASEIMKSIGEAI 130
Query: 535 EYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAK 572
+YLHS + HRDVK N+L + +L+DFG AK
Sbjct: 131 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 2e-17
Identities = 46/188 (24%), Positives = 79/188 (42%), Gaps = 29/188 (15%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILK-------PSEDVIKEFVLEIEIITTLHHKNIIS 481
+G G + V K GKE A K +K +E E+ I+ + H NII+
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHS 539
L +++L+ + +S G L + L + +E + + + + YLHS
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKES------LTEDEATQFLKQILDGVHYLHS 126
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFGYV-- 593
+R+ H D+K NI+L D P L DFG+A + ++ GT +V
Sbjct: 127 ---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEFVAP 180
Query: 594 -VLILNPI 600
++ P+
Sbjct: 181 EIVNYEPL 188
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 85.1 bits (210), Expect = 2e-17
Identities = 41/164 (25%), Positives = 72/164 (43%), Gaps = 20/164 (12%)
Query: 423 NFLAENLIGKGGSSQVYKGC-LPDGKELAVKIL--KPSEDVIKEFVLEIEIITTLHHKNI 479
+ + +G GG V + G+++A+K + S + + LEI+I+ L+H N+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 480 ISLL------GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVA 531
+S ++ LL ++ G L + L+ + G E + ++
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN---CCGLKEGPIRTLLSDIS 131
Query: 532 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ---LSDFGLAK 572
AL YLH R+IHRD+K NI+L + + D G AK
Sbjct: 132 SALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 2e-17
Identities = 35/174 (20%), Positives = 71/174 (40%), Gaps = 27/174 (15%)
Query: 429 LIGKGGSSQVYKG--CLPDGKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLG 484
I GG +Y +G+ + +K L S D + E + + + H +I+ +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 485 FCFEDNNLL------LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
F E + +V +++ SL+ + +E + + AL YLH
Sbjct: 147 F-VEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLH 199
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 592
+ +++ D+K NI+L+++ + +L D G S + + GT G+
Sbjct: 200 ---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS-RINSFGY-----LYGTPGF 243
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 46/191 (24%), Positives = 78/191 (40%), Gaps = 31/191 (16%)
Query: 430 IGKGGSSQVYKGCL--PDGKELAVKILK------PSEDVIKEFVL-EIEIITTLHHKNII 480
+G G + V K C G E A K +K V +E + E+ I+ + H N+I
Sbjct: 20 LGSGQFAIVKK-CREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLH 538
+L +++L+ + +S G L + L SE + + + YLH
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFL------AQKESLSEEEATSFIKQILDGVNYLH 132
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFGYV- 593
+ +++ H D+K NI+L D P L DFGLA ++ GT +V
Sbjct: 133 T---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVA 186
Query: 594 --VLILNPIAF 602
++ P+
Sbjct: 187 PEIVNYEPLGL 197
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 47/191 (24%), Positives = 78/191 (40%), Gaps = 31/191 (16%)
Query: 430 IGKGGSSQVYKGCL--PDGKELAVKILK------PSEDVIKEFVL-EIEIITTLHHKNII 480
+G G + V K C G E A K +K V +E + E+ I+ + H NII
Sbjct: 20 LGSGQFAIVKK-CREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLH 538
+L +++L+ + +S G L + L SE + + + YLH
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFL------AQKESLSEEEATSFIKQILDGVNYLH 132
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFGYV- 593
+ +++ H D+K NI+L D P L DFGLA ++ GT +V
Sbjct: 133 T---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVA 186
Query: 594 --VLILNPIAF 602
++ P+
Sbjct: 187 PEIVNYEPLGL 197
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 6e-17
Identities = 42/160 (26%), Positives = 76/160 (47%), Gaps = 11/160 (6%)
Query: 418 LSATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILK-PSEDVIKEFVL-EIEIITTL 474
+S++S F +G G + VYKG G +A+K +K SE+ + EI ++ L
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 475 HHKNIISLLGFCFEDNNLLLVYDFLS---RGSLEENLHGNKKDPAAFGWSERYKVAMGVA 531
H+NI+ L +N L LV++F+ + ++ P + +
Sbjct: 61 KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDS--RTVGNTPRGLELNLVKYFQWQLL 118
Query: 532 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571
+ L + H +++HRD+K N+L++ + +L DFGLA
Sbjct: 119 QGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 44/198 (22%), Positives = 82/198 (41%), Gaps = 49/198 (24%)
Query: 430 IGKGGSSQVYKGCL--PDGKELAVKILK------PSEDVIKEFVL-EIEIITTLHHKNII 480
+G G + V K C G + A K +K V +E + E+ I+ + H N+I
Sbjct: 19 LGSGQFAVVKK-CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 481 SLLGFCFED-NNLLLVYDFLS----------RGSLEENLHGNKKDPAAFGWSERYKVAMG 529
+L +E+ +++L+ + ++ + SL E ++ F
Sbjct: 78 TLHEV-YENKTDVILILELVAGGELFDFLAEKESLTE------EEATEF--------LKQ 122
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTD 585
+ + YLHS ++ H D+K NI+L D P+ + DFGLA + +
Sbjct: 123 ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KN 176
Query: 586 VAGTFGYV---VLILNPI 600
+ GT +V ++ P+
Sbjct: 177 IFGTPEFVAPEIVNYEPL 194
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 51/165 (30%), Positives = 81/165 (49%), Gaps = 16/165 (9%)
Query: 416 DLLSATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKEFV----L-EI 468
D+ S + + +G+G + VYK + +A+K I K+ + L EI
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 469 EIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM 528
+++ L H NII LL +N+ LV+DF+ LE + K + S K M
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVII---KDNSLVLTPSH-IKAYM 118
Query: 529 G-VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+ LEYLH ++HRD+K +N+LL ++ +L+DFGLAK
Sbjct: 119 LMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 4e-16
Identities = 52/178 (29%), Positives = 79/178 (44%), Gaps = 28/178 (15%)
Query: 429 LIGKGGSSQVY----KGCLPDGKELAVKILKPSEDVIK----EFVL-EIEIITTLHHKNI 479
++G+G S V +E A+KIL+ +IK +V E ++++ L H
Sbjct: 37 ILGEGSFSTVVLARELA---TSREYAIKILE-KRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 480 ISLLGFCFEDN-NLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALE 535
+ L F F+D+ L + G L + + F +E + ALE
Sbjct: 93 VKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE-------IVSALE 144
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYV 593
YLH + +IHRD+K NILL++D Q++DFG AK S S GT YV
Sbjct: 145 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 199
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 8e-16
Identities = 34/155 (21%), Positives = 64/155 (41%), Gaps = 17/155 (10%)
Query: 430 IGKGGSSQVYKGC---LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
+G+G VYK D K+ A+K ++ + EI ++ L H N+ISL
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIE-GTGISMSACREIALLRELKHPNVISLQKVF 87
Query: 487 FE--DNNLLLVYDFLS---RGSLEENLHGNKKDPAA-FGWSERYKVAMGVAEALEYLHSG 540
D + L++D+ ++ + + + + + YLH+
Sbjct: 88 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA- 146
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLA 571
V+HRD+K +NIL+ + + ++D G A
Sbjct: 147 --NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 179
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 40/149 (26%), Positives = 73/149 (48%), Gaps = 13/149 (8%)
Query: 428 NLIGKGGSSQVYKG-CLPDGKELAVKILKPSED--VIKEFVL-EIEIITTLHHKNIISLL 483
L+G+G V K G+ +A+K S+D ++K+ + EI+++ L H+N+++LL
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90
Query: 484 GFCFEDNNLLLVYDFLSRGSLEENLHGN-KKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
C + LV++F+ + + + + P + K + + + HS
Sbjct: 91 EVCKKKKRWYLVFEFV-----DHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS--- 142
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLA 571
+IHRD+K NIL+S +L DFG A
Sbjct: 143 HNIIHRDIKPENILVSQSGVVKLCDFGFA 171
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 2e-15
Identities = 42/146 (28%), Positives = 66/146 (45%), Gaps = 11/146 (7%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKPSED--VIKEFVL-EIEIITTLHHKNIISLLGF 485
IG+G V+K G+ +A+K SED VIK+ L EI ++ L H N+++LL
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
L LV+++ ++ L + + +A+ + H
Sbjct: 71 FRRKRRLHLVFEYCDH-TVLHEL---DRYQRGVPEHLVKSITWQTLQAVNFCHK---HNC 123
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLA 571
IHRDVK NIL++ +L DFG A
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFA 149
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-15
Identities = 40/159 (25%), Positives = 76/159 (47%), Gaps = 14/159 (8%)
Query: 419 SATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFV-----LEIEIITT 473
+ +G+G VYK G+ +A+K ++ + E + EI ++
Sbjct: 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE--DEGIPSTAIREISLLKE 75
Query: 474 LHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 533
LHH NI+SL+ + L LV++F+ + L++ L ++ S+ +
Sbjct: 76 LHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVL---DENKTGLQDSQIKIYLYQLLRG 131
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+ + H R++HRD+K N+L++ D +L+DFGLA+
Sbjct: 132 VAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 75.6 bits (187), Expect = 3e-15
Identities = 48/158 (30%), Positives = 77/158 (48%), Gaps = 18/158 (11%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-----EIEIITTLHH 476
NF IG+G VYK G+ +A+K ++ + E V EI ++ L+H
Sbjct: 4 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TEGVPSTAIREISLLKELNH 61
Query: 477 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY-KVAMG-VAEAL 534
NI+ LL +N L LV++FL ++L A G K + + + L
Sbjct: 62 PNIVKLLDVIHTENKLYLVFEFL-----HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 535 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+ HS RV+HRD+K N+L++ + +L+DFGLA+
Sbjct: 117 AFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 5e-15
Identities = 42/154 (27%), Positives = 77/154 (50%), Gaps = 12/154 (7%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVK--ILKPSEDVIKEFVLEIEIITTLHHKNI 479
++ + +G+G + VYKG L A+K L+ E + E+ ++ L H NI
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62
Query: 480 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG-VAEALEYLH 538
++L + +L LV+++L +++L D K+ + + L Y H
Sbjct: 63 VTLHDIIHTEKSLTLVFEYL-----DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH 117
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
Q+V+HRD+K N+L+++ E +L+DFGLA+
Sbjct: 118 R---QKVLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 8e-15
Identities = 40/156 (25%), Positives = 71/156 (45%), Gaps = 15/156 (9%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFV-----LEIEIITTLHH 476
+ IG+G V+K + +A+K ++ +D E V EI ++ L H
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKH 60
Query: 477 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
KNI+ L D L LV++F + L++ + + L +
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYF---DSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
HS + V+HRD+K N+L++ + E +L++FGLA+
Sbjct: 117 CHS---RNVLHRDLKPQNLLINRNGELKLANFGLAR 149
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 8e-15
Identities = 24/150 (16%), Positives = 53/150 (35%), Gaps = 18/150 (12%)
Query: 429 LIGKGGSSQVYKGCLPD---GKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIIS 481
G Q ++ D +++A+ + P +DV++E + ++ + +
Sbjct: 38 FHGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
+L L+V +++ GSL+E + A + +A A + H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGA------IRAMQSLAAAADAAH--- 146
Query: 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571
V S + +S D + L+
Sbjct: 147 RAGVALSIDHPSRVRVSIDGDVVLAYPATM 176
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 42/169 (24%), Positives = 68/169 (40%), Gaps = 36/169 (21%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILK---------PSEDVIKEFVLEIEIIT 472
+ + +G G V+ KE+ VK +K + + + LEI I++
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 473 TLHHKNIISLLGFCFEDNNLLLV----------YDFLSRGSLEENLHGNKKDPAAFGWSE 522
+ H NII +L LV + F+ R H +P A
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR-------HPRLDEPLA----- 132
Query: 523 RYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571
Y + A+ YL + +IHRD+K NI++++DF +L DFG A
Sbjct: 133 SYIFRQ-LVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSA 177
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 36/162 (22%), Positives = 68/162 (41%), Gaps = 21/162 (12%)
Query: 422 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-----EIEIITTLH 475
+ +G+G +VYK + +A+K ++ + +E V E+ ++ L
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE--EEGVPGTAIREVSLLKELQ 91
Query: 476 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 535
H+NII L ++ L L++++ E +L + +
Sbjct: 92 HRNIIELKSVIHHNHRLHLIFEY-----AENDLKKYMDKNPDVSMRVIKSFLYQLINGVN 146
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQ-----LSDFGLAK 572
+ HS +R +HRD+K N+LLS + + DFGLA+
Sbjct: 147 FCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 1e-14
Identities = 40/155 (25%), Positives = 71/155 (45%), Gaps = 14/155 (9%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFV-----LEIEIITTLHHK 477
+ IG+G VYK G+ A+K ++ ++ E + EI I+ L H
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE--DEGIPSTTIREISILKELKHS 60
Query: 478 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
NI+ L L+LV++ L + L++ L + + + Y
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLL---DVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
H +RV+HRD+K N+L++ + E +++DFGLA+
Sbjct: 117 HD---RRVLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 7e-14
Identities = 45/169 (26%), Positives = 73/169 (43%), Gaps = 33/169 (19%)
Query: 421 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKN 478
++ +IG G VY+ G+ +A+K K +D K F E++I+ L H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQD--KRFKNRELQIMRKLDHCN 108
Query: 479 IISLLGF------CFEDNNLLLVYDFLSRGSLEENLH--------GNKKDPAAFGWSERY 524
I+ L F ++ L LV D+ + E ++ + P + Y
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDY-----VPETVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 525 KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAK 572
++ +A Y+HS + HRD+K N+LL D +L DFG AK
Sbjct: 164 QLFRSLA----YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 7e-14
Identities = 48/234 (20%), Positives = 84/234 (35%), Gaps = 43/234 (18%)
Query: 382 SSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKG 441
SS H S +P+ +L ++ S + L+G GG VY G
Sbjct: 3 SSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG 62
Query: 442 C-LPDGKELAVKILK-------PSEDVIKEFVLEIEIITTLHHK--NIISLLGFCFEDNN 491
+ D +A+K ++ +E+ ++ + +I LL + ++
Sbjct: 63 IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122
Query: 492 LLLV----------YDFL-SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
+L+ +DF+ RG+L+E V EA+ + H+
Sbjct: 123 FVLILERPEPVQDLFDFITERGALQEE--------------LARSFFWQVLEAVRHCHN- 167
Query: 541 SAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYV 593
V+HRD+K NIL+ + E +L DFG + GT Y
Sbjct: 168 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYS 215
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 8e-14
Identities = 31/147 (21%), Positives = 55/147 (37%), Gaps = 14/147 (9%)
Query: 457 SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPA 516
S + ++I + KN + L L + + +L++ +
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKD-WMNRRCSLE 159
Query: 517 AFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576
+ + +AEA+E+LHS + ++HRD+K SNI + D ++ DFGL
Sbjct: 160 DREHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ 216
Query: 577 SSSHITC----------TDVAGTFGYV 593
T T GT Y+
Sbjct: 217 DEEEQTVLTPMPAYATHTGQVGTKLYM 243
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 45/158 (28%), Positives = 80/158 (50%), Gaps = 27/158 (17%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKE-F----VLEIEIITTLHHKNIISLL 483
IG+G +V+K G+++A+K + + KE F + EI+I+ L H+N+++L+
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLI 82
Query: 484 GFCFED--------NNLLLVYDFLSR--GSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 533
C ++ LV+DF L N+ F SE +V +
Sbjct: 83 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK------FTLSEIKRVMQMLLNG 136
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571
L Y+H +++HRD+K++N+L++ D +L+DFGLA
Sbjct: 137 LYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLA 171
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 49/176 (27%), Positives = 81/176 (46%), Gaps = 29/176 (16%)
Query: 429 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFV----LEIEIITTLHHKNIISLL 483
IGKG +V D K++ A+K + + V + V E++I+ L H +++L
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 484 GFCFEDN-NLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAE---ALEY 536
+ F+D ++ +V D L G L +L N + + + E AL+Y
Sbjct: 82 -YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKL-----F-----ICELVMALDY 130
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 592
L + QR+IHRD+K NILL + ++DF +A + T +AGT Y
Sbjct: 131 LQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT---MAGTKPY 180
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 38/168 (22%), Positives = 71/168 (42%), Gaps = 32/168 (19%)
Query: 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVK-ILKPSEDVIKEFVLEIEIITTLHHKNI 479
+ +IG G V++ L + E+A+K +L+ +E ++I+ + H N+
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRE----LQIMRIVKHPNV 94
Query: 480 ISLLGFCF------EDNNLLLVYDFLSRGSLEENLH--------GNKKDPAAFGWSERYK 525
+ L F + ++ L LV ++ + E ++ + P Y+
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEY-----VPETVYRASRHYAKLKQTMPMLLIKLYMYQ 149
Query: 526 VAMGVAEALEYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAK 572
+ +A Y+HS + HRD+K N+LL +L DFG AK
Sbjct: 150 LLRSLA----YIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 39/170 (22%), Positives = 66/170 (38%), Gaps = 29/170 (17%)
Query: 421 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKEFVLEIEIITTLHHKN 478
F E + G+G V G G +A+K +++ +E + ++ + LHH N
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPN 80
Query: 479 IISLLGF-------CFEDNNLLLVYDFLSRGSLEENLH--------GNKKDPAAFGWSER 523
I+ L + D L +V ++ + + LH P
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEY-----VPDTLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 524 YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAK 572
+++ + LH S V HRD+K N+L+ D +L DFG AK
Sbjct: 136 FQLIRSIG----CLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAK 180
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 43/189 (22%), Positives = 69/189 (36%), Gaps = 45/189 (23%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKIL------KPSEDVIKEFV-LEIEIITTLH----H 476
L+GKGG V+ G L D ++A+K++ S LE+ ++ + H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 477 KNIISLLGFCFEDNNLLLV----------YDFL-SRGSLEENLHGNKKDPAAFGWSERYK 525
+I LL + +LV +D++ +G L E
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEG--------------PSRC 143
Query: 526 VAMGVAEALEYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCT 584
V A+++ HS + V+HRD+K NIL+ +L DFG
Sbjct: 144 FFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD- 199
Query: 585 DVAGTFGYV 593
GT Y
Sbjct: 200 ---GTRVYS 205
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 3e-13
Identities = 46/188 (24%), Positives = 82/188 (43%), Gaps = 35/188 (18%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEIEIITTLHHKNII 480
++F +IG+GG +VY D ++ A+K L + IK + L+ + ++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLD--KKRIKM---KQGETLALNERIML 243
Query: 481 SL-----------LGFCFEDN-NLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYK 525
SL + + F L + D ++ G L +L + F +E
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE--- 300
Query: 526 VAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD 585
+ LE++H+ + V++RD+K +NILL + ++SD GLA S H +
Sbjct: 301 ----IILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-- 351
Query: 586 VAGTFGYV 593
GT GY+
Sbjct: 352 --GTHGYM 357
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 6e-13
Identities = 42/185 (22%), Positives = 83/185 (44%), Gaps = 33/185 (17%)
Query: 421 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTLHH 476
+++ +G G V G+++A+K + +P + I K E+ ++ + H
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 477 KNIISLL------GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-G 529
+N+I LL + LV F+ + +L + E+ + +
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGLKFS---EEKIQYLVYQ 134
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 589
+ + L+Y+HS V+HRD+K N+ +++D E ++ DFGLA+ + + +T
Sbjct: 135 MLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMT------- 181
Query: 590 FGYVV 594
GYVV
Sbjct: 182 -GYVV 185
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 71.0 bits (173), Expect = 6e-13
Identities = 92/611 (15%), Positives = 163/611 (26%), Gaps = 185/611 (30%)
Query: 125 NHHTIRSTTSLAKYCAKKL--------SKDCSVLAVNNG-KVVFQKEGCPSTAGESKGTE 175
+HH + T +Y K + + V + K + KE
Sbjct: 3 HHHHMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVS 62
Query: 176 DHRRNSLLDVIHRSIS------------------MSKITGQKNSK------------VVT 205
R L + MS I ++ +
Sbjct: 63 GTLR--LFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLY 120
Query: 206 DDGSSITSKPVDDLGGSVMNLEQALVKARSDCSGSAAKRNCSICGPVRNLPDGSCSQSEE 265
+D V L + L QAL++ R +N I G
Sbjct: 121 NDNQVFAKYNVSRL-QPYLKLRQALLELRPA-------KNVLIDG--------------- 157
Query: 266 ESPSDGGAGDESLAIVPVQNVEAASTS------ITMLVRQLPES--RPGWPLLRRAIFPD 317
G+G +A+ + + + + PE+ LL +
Sbjct: 158 ----VLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNW 213
Query: 318 RRAPDRSS---LRKISVVQWALRLPTRQP---SYLANSDVKQITYDPGDNESINLN---- 367
D SS LR S+ RL +P L +V + + NL+
Sbjct: 214 TSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNV----QNAKAWNAFNLSCKIL 269
Query: 368 ---GDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDL--LSATS 422
+ + H T P E++ L KY CR QDL T+
Sbjct: 270 LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKY-LDCRP---QDLPREVLTT 325
Query: 423 NFLAENLIG---KGGSS--QVYKGCLPDGK----ELAVKILKPSE-------------DV 460
N ++I + G + +K D E ++ +L+P+E
Sbjct: 326 NPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSA 385
Query: 461 -IKEFVLEI-----------EIITTLHHKNIISLLGFCFEDNNLLLVY------DFLSRG 502
I +L + ++ LH SL+ + + + +
Sbjct: 386 HIPTILLSLIWFDVIKSDVMVVVNKLHKY---SLV---EKQPKESTISIPSIYLELKVKL 439
Query: 503 SLEENLH---------GNKKDPAAFG--WSERYKVAMGVAEALEYLHSGSAQRVIHRDVK 551
E LH D + ++Y + + H + + R
Sbjct: 440 ENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQY-----FYSHIGH-HLKNIEH-PERMTL 492
Query: 552 SSNILLSDDF-EPQLSDFGLAKWASTSS------------SHITCTDVAGTF-GYVVLIL 597
+ L F E ++ A W ++ S +I D + V IL
Sbjct: 493 FRMVFLDFRFLEQKIRHDSTA-WNASGSILNTLQQLKFYKPYI--CDNDPKYERLVNAIL 549
Query: 598 NPIAFLFMFNC 608
+ F+
Sbjct: 550 D-----FLPKI 555
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.0 bits (108), Expect = 3e-05
Identities = 83/516 (16%), Positives = 153/516 (29%), Gaps = 158/516 (30%)
Query: 44 GDTVIALHVLANNAIVDR-DGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKL--KICRGT 100
G T +AL V + + + D K L+L CN + L++ K+
Sbjct: 162 GKTWVALDVCLSYKVQCKMDFKIFWLNL------------KNCNSPETVLEMLQKLLY-- 207
Query: 101 SIRKILVREAQSYSATKFIVGTAKNHHTIRSTTSLAKYCAKKLSKDC-SVLA-VNNGKVV 158
I + S K + + + L + K ++C VL V N K
Sbjct: 208 QIDPNWTSRSDHSSNIKLRIHSIQAE--------LRRLLKSKPYENCLLVLLNVQNAKAW 259
Query: 159 --FQKEGCP---STAGESKGTEDHRRNSLLDVIHRSISMSKITGQKNSKVVTDDGS---- 209
F C +T R + D + + + + I+ +S +T D
Sbjct: 260 NAF-NLSCKILLTT----------RFKQVTDFL-SAATTTHISLDHHSMTLTPDEVKSLL 307
Query: 210 -SITSKPVDDLGGSVMNLEQALVKARSDCSGSAAKRNCSICGPVRNLPDGSCSQSEEESP 268
DL R + + R SI ++ DG +
Sbjct: 308 LKYLDCRPQDL-------------PREVLTTNP--RRLSIIA--ESIRDGLATW------ 344
Query: 269 SDGGAGDESLAIVPVQNVEAASTSITMLVRQL--PESRPGWPLLRRAIFPDRRAPDRSSL 326
D + N + +T I + L E R + L ++FP
Sbjct: 345 ------DNWKHV----NCDKLTTIIESSLNVLEPAEYRKMFDRL--SVFPP----S---- 384
Query: 327 RKIS----VVQWALRLPTRQPSYLANSDVKQ--ITYDPGDNESINLNG---DSGAIVPVG 377
I + W + + N K + P +I++ + V +
Sbjct: 385 AHIPTILLSLIWF-DVIKSDVMVVVNKLHKYSLVEKQP-KESTISIPSIYLEL--KVKLE 440
Query: 378 NE------IVSS---PLSTDHDSTELPKELE------GLH-------EKYSATCRLFN-- 413
NE IV P + D D P + G H E+ + LF
Sbjct: 441 NEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMT----LFRMV 496
Query: 414 YQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAV--KILKPSEDV-------IKEF 464
+ D FL + + + L ++L + ++ I +F
Sbjct: 497 FLDF-----RFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDF 551
Query: 465 VLEIEIITTLH---HKNIISLLGFCFEDNNLLLVYD 497
+ +IE L + +++ + ED +++
Sbjct: 552 LPKIE--ENLICSKYTDLLR-IALMAEDEA---IFE 581
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 7e-13
Identities = 42/148 (28%), Positives = 78/148 (52%), Gaps = 15/148 (10%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
IGKG ++V + G+E+A+KI+ + + +++ E+ I+ L+H NI+ L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 486 CFEDNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
+ L L+ ++ S G + + L HG K+ A R + A++Y H +
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEA-----R-SKFRQIVSAVQYCHQ---K 133
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLA 571
R++HRD+K+ N+LL D +++DFG +
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFS 161
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 43/155 (27%), Positives = 79/155 (50%), Gaps = 20/155 (12%)
Query: 429 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKE------FVLEIEIITTLHHKNIIS 481
++G+GG +V+ + +L A K L + +K+ ++E +I+ +H + I+S
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLN--KKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 482 LLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSE---RYKVAMGVAEALEYL 537
L + FE +L LV ++ G + +++ +D F E + A + LE+L
Sbjct: 250 LA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGF--QEPRAIFYTAQ-IVSGLEHL 305
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
H + +I+RD+K N+LL DD ++SD GLA
Sbjct: 306 HQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAV 337
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 56/226 (24%), Positives = 88/226 (38%), Gaps = 46/226 (20%)
Query: 385 LSTDHDSTELPKE--LEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVY--- 439
L D D L K ++ +Y T +DL ++ +IG+G +V
Sbjct: 32 LVYDLDFPALRKNKNIDNFLSRYKDTIN--KIRDLRMKAEDYEVVKVIGRGAFGEVQLVR 89
Query: 440 -KGCLPDGKELAVKILKPSEDVIK----EFVL-EIEIITTLHHKNIISLLGFCFEDN-NL 492
K K A+K+L E +IK F E +I+ + ++ L + F+D+ L
Sbjct: 90 HKS---TRKVYAMKLLSKFE-MIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYL 144
Query: 493 LLVYDF---------LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
+V ++ +S + E A F +E V AL+ +HS
Sbjct: 145 YMVMEYMPGGDLVNLMSNYDVPE-------KWARFYTAE-------VVLALDAIHS---M 187
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 589
IHRDVK N+LL +L+DFG + T V GT
Sbjct: 188 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GT 232
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 44/159 (27%), Positives = 74/159 (46%), Gaps = 22/159 (13%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTLHHKNIISLL-- 483
IG G V + +A+K + +P ++ K E+ ++ ++HKNIISLL
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 129
Query: 484 ----GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-GVAEALEYLH 538
E ++ LV + + + NL + ER + + +++LH
Sbjct: 130 FTPQKTLEEFQDVYLVMELM-----DANLCQVIQMEL---DHERMSYLLYQMLCGIKHLH 181
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577
S +IHRD+K SNI++ D ++ DFGLA+ A TS
Sbjct: 182 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 217
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 42/181 (23%), Positives = 74/181 (40%), Gaps = 30/181 (16%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKILK-----PSEDVIKEFVLEIEIITTLHHKNIISL 482
L+G+G +V + AVKILK + EI+++ L HKN+I L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 483 LGFCF--EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVA--------E 532
+ + E + +V ++ G E + + A +
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQE-----------MLDSVPEKRFPVCQAHGYFCQLID 120
Query: 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 592
LEYLHS Q ++H+D+K N+LL+ ++S G+A+ ++ TC G+ +
Sbjct: 121 GLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177
Query: 593 V 593
Sbjct: 178 Q 178
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 50/187 (26%), Positives = 82/187 (43%), Gaps = 46/187 (24%)
Query: 423 NFLAENLIGKGGSSQVY---KGCLPDGKEL-AVKILKPSEDVIKEFVLEIEIITTLHHKN 478
L ++G+G +V+ K D ++L A+K+LK K + + + T ++
Sbjct: 27 ELLK--VLGQGSFGKVFLVKKISGSDARQLYAMKVLK------KATLKVRDRVRTKMERD 78
Query: 479 IISL--------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKV 526
I+ L + F+ + L L+ DFL G L L + F Y
Sbjct: 79 ILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-----Y-- 131
Query: 527 AMGVAE---ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 583
+AE AL++LHS +I+RD+K NILL ++ +L+DFGL+K I
Sbjct: 132 ---LAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK------ESIDH 179
Query: 584 TDVAGTF 590
A +F
Sbjct: 180 EKKAYSF 186
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 37/180 (20%), Positives = 79/180 (43%), Gaps = 29/180 (16%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVI--KEFVLEIEIITTLHHKNIISLL--- 483
+G+G V P G+ +A+K ++P + + + EI+I+ H+NII++
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQ 78
Query: 484 --GFCFEDNNLLLVYDFLSRGSLEENLH----GNKKDPAAFGWSERYKVAM-GVAEALEY 536
N + ++ + + + +LH + + + A++
Sbjct: 79 RPDSFENFNEVYIIQELM-----QTDLHRVISTQMLSD------DHIQYFIYQTLRAVKV 127
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF--GYVV 594
LH + VIHRD+K SN+L++ + + ++ DFGLA+ S++ + + +V
Sbjct: 128 LHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 45/161 (27%), Positives = 73/161 (45%), Gaps = 22/161 (13%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIK----EFVL-EIEIITTLH 475
F +G G +V + A+KIL + V+K E L E I+ ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVN 99
Query: 476 HKNIISLLGFCFEDN-NLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVA 531
++ L F F+DN NL +V ++++ G + +L + A F Y A +
Sbjct: 100 FPFLVKLE-FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-----Y--AAQIV 151
Query: 532 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
EYLHS +I+RD+K N+L+ Q++DFG AK
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 5e-12
Identities = 43/161 (26%), Positives = 74/161 (45%), Gaps = 26/161 (16%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTLHHKNIISLL-- 483
IG G V + +A+K + +P ++ K E+ ++ ++HKNII LL
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 92
Query: 484 ------GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-GVAEALEY 536
F+D + +V + + + NL + ER + + +++
Sbjct: 93 FTPQKSLEEFQD--VYIVMELM-----DANLCQVIQME---LDHERMSYLLYQMLCGIKH 142
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577
LHS +IHRD+K SNI++ D ++ DFGLA+ A TS
Sbjct: 143 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 46/223 (20%), Positives = 88/223 (39%), Gaps = 32/223 (14%)
Query: 359 GDNESINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLL 418
+ +SG V H S++ + H + R Y+
Sbjct: 3 SHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDR---YEIR- 58
Query: 419 SATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTL 474
+LIG G V + + + +A+K IL+ ED+I K + EI I+ L
Sbjct: 59 ---------HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL 109
Query: 475 HHKNIISLL-----GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM- 528
+H +++ +L + + L +V + + + + P K +
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIA-----DSDFKKLFRTPVYLT-ELHIKTLLY 163
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571
+ ++Y+HS ++HRD+K +N L++ D ++ DFGLA
Sbjct: 164 NLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 44/180 (24%), Positives = 79/180 (43%), Gaps = 40/180 (22%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTLHHKNIISLL-- 483
+G G V G +AVK + +P + +I K E+ ++ + H+N+I LL
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 484 ----GFCFEDNNLLLVYDFLSRGSLEENLH----GNKKDPAAFGWSERYKVAM-GVAEAL 534
E N++ LV + +L+ K + + + + L
Sbjct: 97 FTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTD------DHVQFLIYQILRGL 145
Query: 535 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVV 594
+Y+HS +IHRD+K SN+ +++D E ++ DFGLA+ ++ +T GYV
Sbjct: 146 KYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMT--------GYVA 191
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 41/157 (26%), Positives = 77/157 (49%), Gaps = 26/157 (16%)
Query: 429 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKE------FVLEIEIITTLHHKNIIS 481
++GKGG +V + ++ A K L+ + IK+ + E +I+ ++ + ++S
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLE--KKRIKKRKGEAMALNEKQILEKVNSRFVVS 248
Query: 482 LLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDP-----AAFGWSERYKVAMGVAEALE 535
L + +E + L LV ++ G L+ +++ + A F +E + LE
Sbjct: 249 L-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-------ICCGLE 300
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
LH +R+++RD+K NILL D ++SD GLA
Sbjct: 301 DLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAV 334
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 44/179 (24%), Positives = 79/179 (44%), Gaps = 38/179 (21%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTLHHKNIISLL-- 483
+G G V G ++A+K + +P + + K E+ ++ + H+N+I LL
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 484 ------GFCFEDNNLLLVYDFLSRGSLEENLHGN-KKDPAAFGWSERYKVAM-GVAEALE 535
F D LV F+ +L K + +R + + + + L
Sbjct: 93 FTPDETLDDFTD--FYLVMPFM-----GTDLGKLMKHEKLG---EDRIQFLVYQMLKGLR 142
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVV 594
Y+H+ +IHRD+K N+ +++D E ++ DFGLA+ + S +T GYVV
Sbjct: 143 YIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEMT--------GYVV 187
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 1e-11
Identities = 39/172 (22%), Positives = 70/172 (40%), Gaps = 27/172 (15%)
Query: 419 SATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKEFVL-----EIEII 471
ATS + IG G VYK G +A+K + P+ + E+ ++
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 472 TTLH---HKNIISLL-----GFCFEDNNLLLVYDFLSR--GSLEENLHGNKKDPAAFGWS 521
L H N++ L+ + + LV++ + + + +
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPA------ 119
Query: 522 ERYKVAMG-VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
E K M L++LH+ ++HRD+K NIL++ +L+DFGLA+
Sbjct: 120 ETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 1e-11
Identities = 42/154 (27%), Positives = 74/154 (48%), Gaps = 24/154 (15%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNIISLL 483
+G G +V G G ++AVKIL S DV+ + EI+ + H +II L
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL- 76
Query: 484 GFCFE----DNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYL 537
++ + +V +++S G L + + HG ++ A R ++ + A++Y
Sbjct: 77 ---YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEA-----R-RLFQQILSAVDYC 127
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571
H V+HRD+K N+LL +++DFGL+
Sbjct: 128 HR---HMVVHRDLKPENVLLDAHMNAKIADFGLS 158
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 41/148 (27%), Positives = 73/148 (49%), Gaps = 19/148 (12%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCF 487
+G+G S+V++ + + +++ VKILKP + K+ EI+I+ L NII+L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPNIITLAD-IV 100
Query: 488 ED---NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 544
+D LV++ ++ ++ F E K AL+Y HS
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK-------ALDYCHS---MG 150
Query: 545 VIHRDVKSSNILL-SDDFEPQLSDFGLA 571
++HRDVK N+++ + + +L D+GLA
Sbjct: 151 IMHRDVKPHNVMIDHEHRKLRLIDWGLA 178
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 48/182 (26%), Positives = 77/182 (42%), Gaps = 37/182 (20%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 480
+L L+GKG +V A+KILK KE ++ E+ TL ++
Sbjct: 151 EYLK--LLGKGTFGKVILVKEKATGRYYAMKILK------KEVIVAKDEVAHTLTENRVL 202
Query: 481 SL--------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAM 528
L + F+ + L V ++ + G L +L + D A F +E
Sbjct: 203 QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE------ 256
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 588
+ AL+YLHS + V++RD+K N++L D +++DFGL K I
Sbjct: 257 -IVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK------EGIKDGATMK 307
Query: 589 TF 590
TF
Sbjct: 308 TF 309
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 46/193 (23%), Positives = 78/193 (40%), Gaps = 19/193 (9%)
Query: 421 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTLHH 476
N++ ++LIG+G VY K +A+K + + ED+I K + EI I+ L
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS 84
Query: 477 KNIISLL-----GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG-V 530
II L + + L +V + + +L K P E K + +
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIA-----DSDLKKLFKTPIFLT-EEHIKTILYNL 138
Query: 531 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 590
++H +IHRD+K +N LL+ D ++ DFGLA+ ++ D+
Sbjct: 139 LLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195
Query: 591 GYVVLILNPIAFL 603
N L
Sbjct: 196 EPGPHNKNLKKQL 208
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 44/174 (25%), Positives = 73/174 (41%), Gaps = 28/174 (16%)
Query: 429 LIGKGGSSQVY----KGCLPDGKELAVKILKPSEDVIKE----FVLEIEIITTLHHKNII 480
+IG+G S+V K G+ A+KI+ + + + F E +++ + I
Sbjct: 68 VIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWIT 124
Query: 481 SLLGFCFEDN-NLLLVYDFLSRGSLEENL--HGNK--KDPAAFGWSERYKVAMGVAEALE 535
L F F+D L LV ++ G L L G + + A F +E + A++
Sbjct: 125 QLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAE-------IVMAID 176
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 589
+H +HRD+K NILL +L+DFG + + V GT
Sbjct: 177 SVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GT 226
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 39/173 (22%), Positives = 73/173 (42%), Gaps = 27/173 (15%)
Query: 421 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVI--KEFVLEIEIITTLHHK 477
+ + IG+G V + +A+K + P E + + EI+I+ H+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85
Query: 478 NIISLL-----GFCFEDNNLLLVYDFLSRGSLEENLH----GNKKDPAAFGWSERYKVAM 528
NII + + ++ +V D + E +L+ + +
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSN------DHICYFL 134
Query: 529 -GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580
+ L+Y+HS + V+HRD+K SN+LL+ + ++ DFGLA+ A H
Sbjct: 135 YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 40/178 (22%), Positives = 72/178 (40%), Gaps = 48/178 (26%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKIL---------------------------KPSEDV 460
IGKG V D A+K+L
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 461 IKEFVLEIEIITTLHHKNIISLLGFCFE------DNNLLLVYDFLSRGSL-EENLHGNKK 513
I++ EI I+ L H N++ L E +++L +V++ +++G + E
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKL----VEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLS 135
Query: 514 DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571
+ A + + +EYLH Q++IHRD+K SN+L+ +D +++DFG++
Sbjct: 136 EDQAR------FYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVS 184
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 2e-11
Identities = 46/164 (28%), Positives = 80/164 (48%), Gaps = 28/164 (17%)
Query: 422 SNFLAENLIGKGGSSQVY----KGCLPDGKELAVKILKPSEDVIK----EFVL-EIEIIT 472
+F +G G +V+ + +G+ A+K+LK E V++ E E +++
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLK-KEIVVRLKQVEHTNDERLMLS 61
Query: 473 TLHHKNIISLLGFCFEDN-NLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAM 528
+ H II + F+D + ++ D++ G L L +++ A F +E
Sbjct: 62 IVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAE------ 114
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
V ALEYLHS + +I+RD+K NILL + +++DFG AK
Sbjct: 115 -VCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK 154
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 47/181 (25%), Positives = 76/181 (41%), Gaps = 28/181 (15%)
Query: 422 SNFLAENLIGKGGSSQVY----KGCLPDGKELAVKILKPSEDVIKE----FVLEIEIITT 473
+F +IG+G +V K K A+KIL E + + F E +++
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREERDVLVN 130
Query: 474 LHHKNIISLLGFCFED-NNLLLVYDFLSRGSLEENLHGNKK----DPAAFGWSERYKVAM 528
K I +L + F+D NNL LV D+ G L L + + A F +E
Sbjct: 131 GDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAE------ 183
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 588
+ A++ +H +HRD+K NIL+ + +L+DFG + + V G
Sbjct: 184 -MVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-G 238
Query: 589 T 589
T
Sbjct: 239 T 239
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 2e-11
Identities = 46/182 (25%), Positives = 79/182 (43%), Gaps = 38/182 (20%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 480
++L L+GKG +V A+KIL+ KE ++ E+ T+ ++
Sbjct: 8 DYLK--LLGKGTFGKVILVREKATGRYYAMKILR------KEVIIAKDEVAHTVTESRVL 59
Query: 481 SL--------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAM 528
L + F+ + L V ++ + G L +L + + A F +E
Sbjct: 60 QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE------ 113
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 588
+ ALEYLHS + V++RD+K N++L D +++DFGL K I+
Sbjct: 114 -IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK------EGISDGATMK 163
Query: 589 TF 590
TF
Sbjct: 164 TF 165
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 3e-11
Identities = 40/172 (23%), Positives = 76/172 (44%), Gaps = 29/172 (16%)
Query: 419 SATSNFLAENLIGKGGSSQVYKG--CLPDGKELAVKILKPSEDVIKEFV----L-EIEII 471
A + IG+G +V+K G+ +A+K ++ +E + + E+ ++
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG--EEGMPLSTIREVAVL 65
Query: 472 TTLH---HKNIISLL-----GFCFEDNNLLLVYDFLSR--GSLEENLHGNKKDPAAFGWS 521
L H N++ L + L LV++ + + + + +
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT------ 119
Query: 522 ERYKVAMG-VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
E K M + L++LHS RV+HRD+K NIL++ + +L+DFGLA+
Sbjct: 120 ETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.3 bits (155), Expect = 4e-11
Identities = 51/186 (27%), Positives = 82/186 (44%), Gaps = 42/186 (22%)
Query: 423 NFLAENLIGKGGSSQVY---KGCLPDGKEL-AVKILKPSEDVIKEFVLEIE-------II 471
L ++GKGG +V+ K + ++ A+K+LK + +I + I+
Sbjct: 20 ELLR--VLGKGGYGKVFQVRKVTGANTGKIFAMKVLK--KAMIVRNAKDTAHTKAERNIL 75
Query: 472 TTLHHKNIISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVA 527
+ H I+ L+ + F+ L L+ ++LS G L L D A F Y
Sbjct: 76 EEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-----Y--- 126
Query: 528 MGVAE---ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 584
+AE AL +LH + +I+RD+K NI+L+ +L+DFGL K I
Sbjct: 127 --LAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCK------ESIHDG 175
Query: 585 DVAGTF 590
V TF
Sbjct: 176 TVTHTF 181
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 4e-11
Identities = 50/183 (27%), Positives = 78/183 (42%), Gaps = 39/183 (21%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 480
+FL +IGKG +V + AVK+L+ K+ +L+ E + +N++
Sbjct: 41 HFLK--VIGKGSFGKVLLARHKAEEVFYAVKVLQ------KKAILKKKEEKHIMSERNVL 92
Query: 481 SL---------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVA 527
L F F+ + L V D+++ G L +L + A F +E
Sbjct: 93 LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAE----- 147
Query: 528 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 587
+A AL YLHS +++RD+K NILL L+DFGL K +I
Sbjct: 148 --IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK------ENIEHNSTT 196
Query: 588 GTF 590
TF
Sbjct: 197 STF 199
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 5e-11
Identities = 42/183 (22%), Positives = 67/183 (36%), Gaps = 35/183 (19%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVK-ILKPSEDVIKEFVL-----------EIEIITTLHHK 477
I G V G +G +A+K + D +L EI ++ HH
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 478 NIISLL-----GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-GVA 531
NI+ L + L LV + + +L D + + M +
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTELM-----RTDLAQVIHDQRIVISPQHIQYFMYHIL 144
Query: 532 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG 591
L LH V+HRD+ NILL+D+ + + DF LA+ T+ ++ T
Sbjct: 145 LGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR-EDTADANKT--------H 192
Query: 592 YVV 594
YV
Sbjct: 193 YVT 195
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 5e-11
Identities = 44/172 (25%), Positives = 67/172 (38%), Gaps = 21/172 (12%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFC 486
IG G + +AVK + I E V EI +L H NI+
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYI-ERGAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 487 FEDNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 544
+L ++ ++ S G L E + G + A R+ ++ + Y HS +
Sbjct: 86 LTPTHLAIIMEYASGGELYERICNAGRFSEDEA-----RFFFQQLLS-GVSYCHS---MQ 136
Query: 545 VIHRDVKSSNILLSDDFEPQL--SDFGLAKWASTSSS-HITCTDVAGTFGYV 593
+ HRD+K N LL P+L DFG +K + S T GT Y+
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV----GTPAYI 184
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 7e-11
Identities = 48/183 (26%), Positives = 85/183 (46%), Gaps = 39/183 (21%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 480
F+ ++GKG +V + + +L AVK+LK K+ +L+ ++ T+ K I+
Sbjct: 26 EFIR--VLGKGSFGKVMLARVKETGDLYAVKVLK------KDVILQDDDVECTMTEKRIL 77
Query: 481 SL---------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVA 527
SL L CF+ + L V +F++ G L ++ +++ A F +E
Sbjct: 78 SLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE----- 132
Query: 528 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 587
+ AL +LH + +I+RD+K N+LL + +L+DFG+ K I
Sbjct: 133 --IISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK------EGICNGVTT 181
Query: 588 GTF 590
TF
Sbjct: 182 ATF 184
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 64.3 bits (156), Expect = 7e-11
Identities = 67/389 (17%), Positives = 128/389 (32%), Gaps = 46/389 (11%)
Query: 224 MNLEQALVKARSDCSGSAAKRNCSICGPVRNLPDGSCSQSEEESPSDGGAGDESLAIVPV 283
MN+ + V G+ ++ ++ + L+ V
Sbjct: 138 MNVHKRCVMNVPSLCGTDHTERRGRIYIQAHIDREVLIVVVRDAKNLVPMDPNGLSDPYV 197
Query: 284 QNVEAASTSITMLVRQLPESRPGWPLLRRAIFPDRRAPDRSSLRKISVVQWALRLPTR-- 341
+ + P + D+ + + W L
Sbjct: 198 KLKLIPDPKSESKQKTKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSRNDFM 257
Query: 342 -QPSYLANSDVKQITYDPGDNESINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEG 400
S+ + K S VP + L + ++ + +
Sbjct: 258 GSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKA 317
Query: 401 LHEKYSATCRLFNYQDLLSATS----NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILK 455
EK + T F+ NFL ++GKG +V EL AVKILK
Sbjct: 318 PEEKTANTISKFDNNGNRDRMKLTDFNFLM--VLGKGSFGKVMLSERKGTDELYAVKILK 375
Query: 456 PSEDVIKEFVLEI-EIITTLHHKNIISL---------LGFCFE-DNNLLLVYDFLSRGSL 504
K+ V++ ++ T+ K +++L L CF+ + L V ++++ G L
Sbjct: 376 ------KDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL 429
Query: 505 EENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 561
++ + A F +E +A L +L S + +I+RD+K N++L +
Sbjct: 430 MYHIQQVGRFKEPHAVFYAAE-------IAIGLFFLQS---KGIIYRDLKLDNVMLDSEG 479
Query: 562 EPQLSDFGLAKWASTSSSHITCTDVAGTF 590
+++DFG+ K +I TF
Sbjct: 480 HIKIADFGMCK------ENIWDGVTTKTF 502
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 7e-11
Identities = 44/183 (24%), Positives = 78/183 (42%), Gaps = 39/183 (21%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 480
++GKG +V+ + A+K LK K+ VL ++ T+ K ++
Sbjct: 20 ILHK--MLGKGSFGKVFLAEFKKTNQFFAIKALK------KDVVLMDDDVECTMVEKRVL 71
Query: 481 SL---------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVA 527
SL + F+ NL V ++L+ G L ++ K A F +E
Sbjct: 72 SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAE----- 126
Query: 528 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 587
+ L++LHS + +++RD+K NILL D +++DFG+ K ++
Sbjct: 127 --IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK------ENMLGDAKT 175
Query: 588 GTF 590
TF
Sbjct: 176 NTF 178
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 7e-11
Identities = 45/174 (25%), Positives = 73/174 (41%), Gaps = 22/174 (12%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGF 485
+G+G +V + +AVKI+ D + EI I L+H+N++ G
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 486 CFEDNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
E N L ++ S G L + + +P A + +A + YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA-----QRFFHQLMA-GVVYLHG---I 124
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS----HITCTDVAGTFGYV 593
+ HRD+K N+LL + ++SDFGLA ++ + C GT YV
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC----GTLPYV 174
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 7e-11
Identities = 44/183 (24%), Positives = 82/183 (44%), Gaps = 39/183 (21%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 480
+ L +IG+G ++V L + A+K++K KE V + +I K++
Sbjct: 12 DLLR--VIGRGSYAKVLLVRLKKTDRIYAMKVVK------KELVNDDEDIDWVQTEKHVF 63
Query: 481 SL---------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVA 527
L CF+ ++ L V ++++ G L ++ +K + A F +E
Sbjct: 64 EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE----- 118
Query: 528 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 587
++ AL YLH + +I+RD+K N+LL + +L+D+G+ K + D
Sbjct: 119 --ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK------EGLRPGDTT 167
Query: 588 GTF 590
TF
Sbjct: 168 STF 170
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 8e-11
Identities = 37/192 (19%), Positives = 63/192 (32%), Gaps = 47/192 (24%)
Query: 421 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKN 478
+ + +G G V + + GK A+K K +D + E++I+ L H N
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALK--KVLQD--PRYKNRELDIMKVLDHVN 61
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER--------------- 523
II L+ + + + + N +
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 524 ---YKVAMGVAE-------------------ALEYLHSGSAQRVIHRDVKSSNILL-SDD 560
+KV A+ ++HS + HRD+K N+L+ S D
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKD 178
Query: 561 FEPQLSDFGLAK 572
+L DFG AK
Sbjct: 179 NTLKLCDFGSAK 190
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 43/183 (23%), Positives = 82/183 (44%), Gaps = 39/183 (21%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 480
+ L +IG+G ++V L + A++++K KE V + +I K++
Sbjct: 55 DLLR--VIGRGSYAKVLLVRLKKTDRIYAMRVVK------KELVNDDEDIDWVQTEKHVF 106
Query: 481 SL---------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVA 527
L CF+ ++ L V ++++ G L ++ +K + A F +E
Sbjct: 107 EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE----- 161
Query: 528 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 587
++ AL YLH + +I+RD+K N+LL + +L+D+G+ K + D
Sbjct: 162 --ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK------EGLRPGDTT 210
Query: 588 GTF 590
TF
Sbjct: 211 STF 213
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 47/183 (25%), Positives = 83/183 (45%), Gaps = 39/183 (21%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 480
NFL ++GKG +V EL AVKILK K+ V++ ++ T+ K ++
Sbjct: 23 NFLM--VLGKGSFGKVMLSERKGTDELYAVKILK------KDVVIQDDDVECTMVEKRVL 74
Query: 481 SL---------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVA 527
+L L CF+ + L V ++++ G L ++ + A F +E
Sbjct: 75 ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE----- 129
Query: 528 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 587
+A L +L S + +I+RD+K N++L + +++DFG+ K +I
Sbjct: 130 --IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK------ENIWDGVTT 178
Query: 588 GTF 590
TF
Sbjct: 179 KTF 181
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 41/180 (22%), Positives = 65/180 (36%), Gaps = 21/180 (11%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH-KNII 480
NF IG G ++ G L + +A+K+ + LE L I
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-PQLHLEYRFYKQLGSGDGIP 68
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEE--NLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
+ F +V + L SLE+ +L F +A+ + +EY+H
Sbjct: 69 QVYYFGPCGKYNAMVLELLGP-SLEDLFDLCDRT-----FSLKTVLMIAIQLISRMEYVH 122
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQ-----LSDFGLAK--WASTSSSHITCTDVAGTFG 591
S + +I+RDVK N L+ + DF LAK + HI + G
Sbjct: 123 S---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTG 179
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 33/159 (20%), Positives = 67/159 (42%), Gaps = 31/159 (19%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNIISLL 483
+G+G +V +++A+K + D+ EI + L H +II L
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 484 GFCFEDNNLLLV--------YDFL-SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL 534
++++V +D++ + + E+ E + + A+
Sbjct: 76 DVITTPTDIVMVIEYAGGELFDYIVEKKRMTED--------------EGRRFFQQIICAI 121
Query: 535 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573
EY H +++HRD+K N+LL D+ +++DFGL+
Sbjct: 122 EYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNI 157
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 39/154 (25%), Positives = 73/154 (47%), Gaps = 24/154 (15%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNIISLL 483
+G G +V G G ++AVKIL S DV+ + EI+ + H +II L
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL- 81
Query: 484 GFCFE----DNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYL 537
++ +++ +V +++S G L + + +G + + R ++ ++Y
Sbjct: 82 ---YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKES-----RRLFQQILS-GVDYC 132
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571
H V+HRD+K N+LL +++DFGL+
Sbjct: 133 HR---HMVVHRDLKPENVLLDAHMNAKIADFGLS 163
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 43/184 (23%), Positives = 73/184 (39%), Gaps = 43/184 (23%)
Query: 423 NFLAENLIGKGGSSQVY---KGCLPDGKEL-AVKILKPSEDVIKEFVLEI--EIITTLHH 476
L ++G G +V+ K D +L A+K+LK K +++ T
Sbjct: 57 ELLK--VLGTGAYGKVFLVRKISGHDTGKLYAMKVLK------KATIVQKAKTTEHTRTE 108
Query: 477 KNIISL---------LGFCFEDN-NLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSER 523
+ ++ L + F+ L L+ D+++ G L +L ++
Sbjct: 109 RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQI----- 163
Query: 524 YKVAMGVAE---ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580
Y V E ALE+LH +I+RD+K NILL + L+DFGL+K +
Sbjct: 164 Y-----VGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 215
Query: 581 ITCT 584
Sbjct: 216 RAYD 219
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 45/174 (25%), Positives = 73/174 (41%), Gaps = 22/174 (12%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGF 485
+G+G +V + +AVKI+ D + EI I L+H+N++ G
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 486 CFEDNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
E N L ++ S G L + + +P A + +A + YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA-----QRFFHQLMA-GVVYLHG---I 124
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS----HITCTDVAGTFGYV 593
+ HRD+K N+LL + ++SDFGLA ++ + C GT YV
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC----GTLPYV 174
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 8e-10
Identities = 43/154 (27%), Positives = 71/154 (46%), Gaps = 19/154 (12%)
Query: 429 LIGKGGSSQVYKGC--LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK------NII 480
+IGKG QV K + +A+K+++ + ++ EI I+ L + N+I
Sbjct: 104 VIGKGSFGQVVK-AYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 481 SLLG-FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 539
+L F F N++ + ++ LS +L E + NK F K A + + L+ LH
Sbjct: 163 HMLENFTFR-NHICMTFELLSM-NLYELIKKNKFQG--FSLPLVRKFAHSILQCLDALHK 218
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQ--LSDFGLA 571
R+IH D+K NILL + DFG +
Sbjct: 219 ---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 31/170 (18%), Positives = 70/170 (41%), Gaps = 29/170 (17%)
Query: 429 LIGKGGSSQVYKGC--LPDGKELAVKILKPSEDVIKEFVLEIEIITTLH----------- 475
+G G S V+ + + +A+KI++ + + EI+++ ++
Sbjct: 26 KLGWGHFSTVWL-AKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 476 HKNIISLLG-FCFEDNN---LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVA 531
+I+ LL F + N +++V++ L +L + + +++ +
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRG--IPLIYVKQISKQLL 141
Query: 532 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ------LSDFGLAKWAS 575
L+Y+H +IH D+K N+L+ P+ ++D G A W
Sbjct: 142 LGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 189
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 38/173 (21%), Positives = 69/173 (39%), Gaps = 21/173 (12%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH-KNIISLLGFCF 487
IG+G +++G L + +++A+K +P + E L I ++ F
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ 76
Query: 488 EDNNLLLVYDFLSRGSLEE--NLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
E + +LV D L SLE+ +L G K F A + ++ +H + +
Sbjct: 77 EGLHNVLVIDLLGP-SLEDLLDLCGRK-----FSVKTVAMAAKQMLARVQSIHE---KSL 127
Query: 546 IHRDVKSSNILLSDDFEPQ-----LSDFGLAK--WASTSSSHITCTDVAGTFG 591
++RD+K N L+ + DFG+ K + HI + G
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 180
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 41/155 (26%), Positives = 70/155 (45%), Gaps = 17/155 (10%)
Query: 428 NLIGKGGSSQVYKGC--LPDGKELAVKILKPSEDVIKEFVLEIEIITTL------HHKNI 479
+LIGKG QV K + + +A+KI+K + + + +E+ ++ + I
Sbjct: 60 SLIGKGSFGQVVK-AYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYI 118
Query: 480 ISLLG-FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
+ L F F N+L LV++ LS +L + L + K A + AL +L
Sbjct: 119 VHLKRHFMFR-NHLCLVFEMLSY-NLYDLLRNTNFRG--VSLNLTRKFAQQMCTALLFLA 174
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQ--LSDFGLA 571
+ +IH D+K NILL + + DFG +
Sbjct: 175 TPEL-SIIHCDLKPENILLCNPKRSAIKIVDFGSS 208
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 57.6 bits (138), Expect = 4e-09
Identities = 36/229 (15%), Positives = 65/229 (28%), Gaps = 67/229 (29%)
Query: 418 LSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDV---------IKEFVLEI 468
T IG+G +V++ D +A+KI+ +E + EI
Sbjct: 16 CLPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74
Query: 469 EIITTLH---------HKNIISLLGFC------------------------------FED 489
I L + I L F+D
Sbjct: 75 IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134
Query: 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 549
+ L +V +F G E + + + + +L ++ R HRD
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTKLSS-----LATAKSILHQLTASLAVAE--ASLRFEHRD 187
Query: 550 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILN 598
+ N+LL +L K ++ + G V I++
Sbjct: 188 LHWGNVLLKKTSLKKLHYTLNGKSSTI-----------PSCGLQVSIID 225
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 48/154 (31%), Positives = 81/154 (52%), Gaps = 26/154 (16%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTLH-HKNIISLLG 484
+GKG V+K G+ +AVK I ++ + EI I+T L H+NI++LL
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 485 FCFEDNN--LLLVYDFLSRGSLEENLH----GNKKDPAAFGWSERYKVAM-GVAEALEYL 537
DN+ + LV+D++ E +LH N +P + + + + ++YL
Sbjct: 77 VLRADNDRDVYLVFDYM-----ETDLHAVIRANILEP------VHKQYVVYQLIKVIKYL 125
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571
HSG ++HRD+K SNILL+ + +++DFGL+
Sbjct: 126 HSGG---LLHRDMKPSNILLNAECHVKVADFGLS 156
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 33/184 (17%), Positives = 67/184 (36%), Gaps = 33/184 (17%)
Query: 423 NFLAENLIGKGGSSQVYKGC---------LPDGKELAVKILKPSEDVIKEF--------V 465
+ ++ + +Y+ P ++ ++K+ + E
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKP 102
Query: 466 LEIEIITTLH---HKNIISLLGF-CFEDNNLLLVYDFLSRGSLEE--NLHGNKKDPAAFG 519
L++ L+ I + +GF +D LV L R SL+ ++
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHV----LS 157
Query: 520 WSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ--LSDFGLAKWASTS 577
+VA + +ALE+LH +H +V + NI + + + Q L+ +G A S
Sbjct: 158 ERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPS 214
Query: 578 SSHI 581
H+
Sbjct: 215 GKHV 218
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 42/173 (24%), Positives = 77/173 (44%), Gaps = 36/173 (20%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLL---- 483
+G GG+ V+ K +A+K + ++ + L EI+II L H NI+ +
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 484 ----------GFCFEDNNLLLVYDFLSRGSLEENLH----GNKKDPAAFGWSERYKVAM- 528
G E N++ +V +++ E +L E ++ M
Sbjct: 79 PSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLLE------EHARLFMY 127
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSH 580
+ L+Y+HS + V+HRD+K +N+ + ++D ++ DFGLA+ SH
Sbjct: 128 QLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH 177
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 34/177 (19%), Positives = 65/177 (36%), Gaps = 34/177 (19%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEI-----------ITTLHH 476
IG GG +Y ++ A ++K + + L E+ I
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVK--VEYQENGPLFSELKFYQRVAKKDCIKKWIE 101
Query: 477 KNIISLLGF----------CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKV 526
+ + LG + +V + L L++ N F S ++
Sbjct: 102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKISGQNGT----FKKSTVLQL 156
Query: 527 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ--LSDFGLAKWASTSSSHI 581
+ + + LEY+H +H D+K++N+LL Q L+D+GL+ + +H
Sbjct: 157 GIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 43/171 (25%), Positives = 72/171 (42%), Gaps = 19/171 (11%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH-KNIISLLGFCF 487
IG G +Y G + G+E+A+K+ + + + +E +I + I ++
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA 75
Query: 488 EDNNLLLVYDFLSRGSLEE--NLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
E + ++V + L SLE+ N K F +A + +EY+HS +
Sbjct: 76 EGDYNVMVMELLGP-SLEDLFNFCSRK-----FSLKTVLLLADQMISRIEYIHS---KNF 126
Query: 546 IHRDVKSSNILL---SDDFEPQLSDFGLAK--WASTSSSHITCTDVAGTFG 591
IHRDVK N L+ + DFGLAK + + HI + G
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 177
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 5e-08
Identities = 33/140 (23%), Positives = 63/140 (45%), Gaps = 16/140 (11%)
Query: 429 LIGKGGSSQVYKGC--LPDGKELAVKILKPSEDVIKEFVLEIEIITTL-----HHKNIIS 481
+G G +V C + + K AVK+++ + + +E +I+ + ++ NI+
Sbjct: 42 KMGDGTFGRVLL-CQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVK 100
Query: 482 LLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
G F +++ L+++ L SL E + N + F + + + +AL YL
Sbjct: 101 YHG-KFMYYDHMCLIFEPLGP-SLYEIITRNNYNG--FHIEDIKLYCIEILKALNYLRK- 155
Query: 541 SAQRVIHRDVKSSNILLSDD 560
+ H D+K NILL D
Sbjct: 156 --MSLTHTDLKPENILLDDP 173
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 33/142 (23%), Positives = 65/142 (45%), Gaps = 18/142 (12%)
Query: 429 LIGKGGSSQVYKGCL---PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK------NI 479
+G+G +V + C+ G+ +AVKI+K + + EI+++ L+
Sbjct: 21 TLGEGAFGKVVE-CIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRC 79
Query: 480 ISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
+ +L FE ++ +V++ L S + + N P F K+A + +++ +LH
Sbjct: 80 VQMLE-WFEHHGHICIVFELLGL-STYDFIKENGFLP--FRLDHIRKMAYQICKSVNFLH 135
Query: 539 SGSAQRVIHRDVKSSNILLSDD 560
S ++ H D+K NIL
Sbjct: 136 S---NKLTHTDLKPENILFVQS 154
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 32/170 (18%), Positives = 64/170 (37%), Gaps = 35/170 (20%)
Query: 429 LIGKGGSSQVYKGCLPDGKELAVKI-----LKPSED-------------VIKEFVLEIEI 470
IG+GG +Y + + + ++PS++ E + +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 471 ITTLHHKNIISLLGFCFEDNNLL----LVYDFLSRGSLEE--NLHGNKKDPAAFGWSERY 524
L + + G D N ++ D L++ + + F
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKR-----FSRKTVL 155
Query: 525 KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ--LSDFGLAK 572
++++ + + LEY+H +H D+K+SN+LL+ Q L D+GLA
Sbjct: 156 QLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 23/99 (23%), Positives = 48/99 (48%), Gaps = 10/99 (10%)
Query: 430 IGKGGSSQVYKGCL------PDGKELAVKILKP--SEDVIKEFVLEIEIITTL-HHKNII 480
+G+G QV + + +AVK+LK + + + E++I+ + HH N++
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 481 SLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAF 518
+LLG C + L+++ +F G+L L + + +
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 128
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 18/46 (39%), Positives = 32/46 (69%), Gaps = 3/46 (6%)
Query: 527 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+ VA+ +E+L ++++ IHRD+ + NILLS+ ++ DFGLA+
Sbjct: 199 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 34/164 (20%), Positives = 68/164 (41%), Gaps = 19/164 (11%)
Query: 429 LIGKGGSSQVYKGC--LPDGKEL-AVKILKPSEDVIKEFVLEIEIITTLHHK------NI 479
+G+G +V + C GK A+KI++ + LEI ++ + K
Sbjct: 26 NLGEGTFGKVVE-CLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC 84
Query: 480 ISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
+ + F ++ + ++ L + + E L N P + +A + AL +LH
Sbjct: 85 VLMSD-WFNFHGHMCIAFELLGK-NTFEFLKENNFQP--YPLPHVRHMAYQLCHALRFLH 140
Query: 539 SGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWASTSSSHI 581
++ H D+K NIL + +FE ++ + S ++ I
Sbjct: 141 E---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSI 181
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 50.8 bits (121), Expect = 9e-07
Identities = 42/171 (24%), Positives = 71/171 (41%), Gaps = 19/171 (11%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCF 487
IG G ++Y G + +E+A+K+ + + E +I L I ++ F
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-PQLLYESKIYRILQGGTGIPNVRWFGV 73
Query: 488 EDNNLLLVYDFLSRGSLEE--NLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
E + +LV D L SLE+ N K +A + +E++HS +
Sbjct: 74 EGDYNVLVMDLLGP-SLEDLFNFCSRK-----LSLKTVLMLADQMINRVEFVHS---KSF 124
Query: 546 IHRDVKSSNILLSDDFEPQ---LSDFGLAK--WASTSSSHITCTDVAGTFG 591
+HRD+K N L+ + DFGLAK +++ HI + G
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 8e-06
Identities = 33/145 (22%), Positives = 66/145 (45%), Gaps = 20/145 (13%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLH--------HKNII 480
+G G S V+ + K +A+K++K +E + + EI ++ ++ + ++
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVV 104
Query: 481 SLLGFCFE-----DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 535
LL F+ ++ +V++ L L + + + K+ V + L+
Sbjct: 105 QLLD-DFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQG--LPLPCVKKIIQQVLQGLD 160
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDD 560
YLH+ R+IH D+K NILLS +
Sbjct: 161 YLHT--KCRIIHTDIKPENILLSVN 183
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 611 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.98 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.98 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.98 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.98 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.98 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.98 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.98 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.98 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.98 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.98 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.98 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.98 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.98 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.98 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.98 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.98 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.98 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.98 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.98 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.98 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.98 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.98 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.98 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.98 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.98 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.98 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.98 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.98 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.97 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.97 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.97 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.97 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.97 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.97 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.97 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.97 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.97 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.97 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.97 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.97 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.97 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.97 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.97 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.97 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.97 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.97 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.97 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.97 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.97 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.97 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.97 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.97 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.97 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.97 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.97 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.97 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.97 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.97 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.97 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.97 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.97 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.97 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.97 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.97 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.97 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.97 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.97 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.97 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.97 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.97 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.97 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.97 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.97 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.97 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.97 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.97 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.97 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.97 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.97 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.97 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.97 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.97 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.97 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.97 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.97 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.97 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.97 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.97 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.97 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.97 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.97 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.97 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.97 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.97 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.97 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.97 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.97 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.97 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.97 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.97 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.97 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.97 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.97 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.97 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.97 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.97 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.97 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.97 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.97 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.97 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.97 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.97 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.97 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.97 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.97 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.97 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.97 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.97 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.97 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.97 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.97 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.97 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.97 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.97 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.97 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.97 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.97 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.97 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.97 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.97 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.97 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.97 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.97 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.97 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.97 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.97 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.97 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.97 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.97 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.97 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.97 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.97 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.97 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.97 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.97 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.97 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.97 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.97 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.97 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.97 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.97 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.96 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.96 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.96 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.96 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.96 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.96 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.96 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.96 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.96 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.96 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.96 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.96 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.96 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.96 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.96 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.96 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.96 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.96 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.96 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.96 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.95 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.95 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.94 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1mjh_A | 162 | Protein (ATP-binding domain of protein MJ0577); hy | 99.84 | |
| 3s3t_A | 146 | Nucleotide-binding protein, universal stress PROT | 99.84 | |
| 3fg9_A | 156 | Protein of universal stress protein USPA family; A | 99.83 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.83 | |
| 3hgm_A | 147 | Universal stress protein TEAD; rossman fold, signa | 99.82 | |
| 3idf_A | 138 | USP-like protein; universal, stress, PSI, MCSG, st | 99.82 | |
| 2dum_A | 170 | Hypothetical protein PH0823; conserved hypothetica | 99.81 | |
| 1tq8_A | 163 | Hypothetical protein RV1636; MTCY01B2.28, structur | 99.81 | |
| 3dlo_A | 155 | Universal stress protein; unknown function, struct | 99.8 | |
| 2z08_A | 137 | Universal stress protein family; uncharacterized c | 99.79 | |
| 2gm3_A | 175 | Unknown protein; AT3G01520, putative ethylene-resp | 99.79 | |
| 3fdx_A | 143 | Putative filament protein / universal stress PROT; | 99.78 | |
| 3tnj_A | 150 | Universal stress protein (USP); structural genomic | 99.77 | |
| 1jmv_A | 141 | USPA, universal stress protein A; chaperone; 1.85A | 99.72 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.68 | |
| 1q77_A | 138 | Hypothetical protein AQ_178; structural genomics, | 99.67 | |
| 3ab8_A | 268 | Putative uncharacterized protein TTHA0350; tandem- | 99.66 | |
| 3mt0_A | 290 | Uncharacterized protein PA1789; structural genomic | 99.65 | |
| 3cis_A | 309 | Uncharacterized protein; alpha/beta hydrolase, ATP | 99.64 | |
| 3olq_A | 319 | Universal stress protein E; structural genomics, P | 99.64 | |
| 3loq_A | 294 | Universal stress protein; structural genomics, PSI | 99.64 | |
| 3loq_A | 294 | Universal stress protein; structural genomics, PSI | 99.61 | |
| 3cis_A | 309 | Uncharacterized protein; alpha/beta hydrolase, ATP | 99.61 | |
| 3mt0_A | 290 | Uncharacterized protein PA1789; structural genomic | 99.6 | |
| 3olq_A | 319 | Universal stress protein E; structural genomics, P | 99.57 | |
| 3ab8_A | 268 | Putative uncharacterized protein TTHA0350; tandem- | 99.44 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.36 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.31 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.11 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.74 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.61 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.56 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.43 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.42 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.42 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.25 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.22 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.19 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.75 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.62 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.54 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.53 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.51 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.42 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.36 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.21 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.14 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.11 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.94 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.67 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.87 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.68 | |
| 3a2k_A | 464 | TRNA(Ile)-lysidine synthase; ligase, pseudo-knot, | 93.2 | |
| 1wy5_A | 317 | TILS, hypothetical UPF0072 protein AQ_1887; N-type | 92.73 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.77 | |
| 1ni5_A | 433 | Putative cell cycle protein MESJ; structural genom | 87.37 | |
| 1k92_A | 455 | Argininosuccinate synthase, argininosuccinate SY; | 86.85 | |
| 2nz2_A | 413 | Argininosuccinate synthase; amino-acid biosynthesi | 83.67 | |
| 3bl5_A | 219 | Queuosine biosynthesis protein QUEC; PREQ1 biosynt | 81.94 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 81.64 | |
| 1kor_A | 400 | Argininosuccinate synthetase; ligase, riken struct | 80.26 | |
| 2pg3_A | 232 | Queuosine biosynthesis protein QUEC; YP_049261.1, | 80.17 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=369.49 Aligned_cols=183 Identities=27% Similarity=0.379 Sum_probs=166.5
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
++|.+.+.||+|+||+||+|... +|+.||||++++. ....+.+.+|+++|+.++|||||+++++|.+.+++||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46899999999999999999864 7999999999753 244678999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
|||+||+|.++|.+.+ .+++.++..|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+.+..
T Consensus 112 Ey~~gG~L~~~i~~~~----~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 9999999999997653 48999999999999999999999 9999999999999999999999999999998876
Q ss_pred CCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 577 SSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
........+.+||+.|||||++. ..|++++|||||
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSl 220 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWAL 220 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHH
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHH
Confidence 55555566789999999999876 889999999996
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=367.50 Aligned_cols=188 Identities=23% Similarity=0.421 Sum_probs=164.5
Q ss_pred cCCCccceeecccCceEEEEEEec------CCCEEEEEEecCC-hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAVK~lk~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 493 (611)
.++|.+.+.||+|+||+||+|.+. +++.||||+++.. ....++|.+|+++|+.++|||||+++|+|.+.+.+|
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 357888999999999999999863 4778999999864 456788999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhcCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEE
Q 007254 494 LVYDFLSRGSLEENLHGNK---------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 564 (611)
Q Consensus 494 lV~Ey~~~gsL~~~L~~~~---------~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vK 564 (611)
||||||++|+|.++|+... .....++|.++..|+.||+.||.|||+ ++||||||||+||||++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEE
Confidence 9999999999999997643 233569999999999999999999999 8999999999999999999999
Q ss_pred EEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 565 LSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 565 L~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
|+|||+|+...............||+.|||||++. ..|+.++|||||
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~ 216 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSL 216 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHH
Confidence 99999999876655444445578999999999876 889999999996
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=367.46 Aligned_cols=188 Identities=24% Similarity=0.416 Sum_probs=156.0
Q ss_pred cCCCccceeecccCceEEEEEEec------CCCEEEEEEecCC-hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAVK~lk~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 493 (611)
.++|.+.+.||+|+||+||+|.+. +++.||||+++.. ....++|.+|+++|+.++|||||+++|+|.+.+.+|
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 356778899999999999999864 4788999999864 356788999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhcCCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCc
Q 007254 494 LVYDFLSRGSLEENLHGNKKD-----------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE 562 (611)
Q Consensus 494 lV~Ey~~~gsL~~~L~~~~~~-----------~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~ 562 (611)
||||||++|+|.++|+..... ...++|.++..|+.||+.||.|||+ ++||||||||+||||++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCc
Confidence 999999999999999865321 2469999999999999999999999 89999999999999999999
Q ss_pred EEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 563 PQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 563 vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+||+|||+|+.+............+||+.|||||++. ..|+.++|||||
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~ 246 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSF 246 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHH
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccch
Confidence 9999999999876655444455688999999999876 889999999997
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=370.59 Aligned_cols=184 Identities=23% Similarity=0.345 Sum_probs=158.0
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
.++|.+.+.||+|+||+||+|... +|+.||||++++. ....+.|.+|+++|+.|+|||||+++++|.+.+.+||||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 368999999999999999999864 7999999999754 345678999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
|||+||+|.++|...+. ..+++.++..|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+.+..
T Consensus 103 Ey~~gg~L~~~i~~~~~--~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKG--VLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp ECCTTCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred eCCCCCcHHHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 99999999999976432 457899999999999999999999 9999999999999999999999999999997754
Q ss_pred CCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 577 SSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.. ...++.+||+.|||||++. ..|+.++|||||
T Consensus 178 ~~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSl 211 (350)
T 4b9d_A 178 TV--ELARACIGTPYYLSPEICENKPYNNKSDIWAL 211 (350)
T ss_dssp HH--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHH
T ss_pred Cc--ccccccCCCccccCHHHHCCCCCCcHHHHHHH
Confidence 22 1234578999999999876 789999999996
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=367.99 Aligned_cols=180 Identities=27% Similarity=0.373 Sum_probs=162.1
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 499 (611)
+.|...+.||+|+||+||+|... +|+.||||+++... ...+.+.+|+++|+.++|||||+++++|.+.+++|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46888999999999999999865 79999999997543 34456889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~ 579 (611)
+||+|.+++... .+++.++..|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+.+.....
T Consensus 154 ~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 154 EGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp TTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred CCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 999999999753 38999999999999999999999 9999999999999999999999999999998765433
Q ss_pred ceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 580 HITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 580 ~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
...+.+||+.|||||++. ..|++++|||||
T Consensus 226 --~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSl 256 (346)
T 4fih_A 226 --RRKSLVGTPYWMAPELISRLPYGPEVDIWSL 256 (346)
T ss_dssp --CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred --cccccccCcCcCCHHHHCCCCCCcHHHHHHH
Confidence 335689999999999876 889999999996
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=362.97 Aligned_cols=187 Identities=24% Similarity=0.351 Sum_probs=162.9
Q ss_pred CCCccceeecccCceEEEEEEec------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 493 (611)
+++.+.+.||+|+||+||+|.+. +++.||||+++.. ....++|.+|+.+|+.++|||||+++|+|.+.+.+|
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34566789999999999999863 5678999999754 345688999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhcCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCC
Q 007254 494 LVYDFLSRGSLEENLHGNKKD------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 561 (611)
Q Consensus 494 lV~Ey~~~gsL~~~L~~~~~~------------~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~ 561 (611)
||||||++|+|.++|...... ...++|.++..|+.||+.||.|||+ ++||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCC
Confidence 999999999999999754321 2459999999999999999999999 8999999999999999999
Q ss_pred cEEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 562 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 562 ~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.+||+|||+|+.+............+||+.|||||++. ..|+.++|||||
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSf 233 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSY 233 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhH
Confidence 99999999999876554444456688999999999876 899999999997
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=360.22 Aligned_cols=183 Identities=28% Similarity=0.468 Sum_probs=153.8
Q ss_pred hcCCCccceeecccCceEEEEEEecCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
..++|.+.+.||+|+||+||+|.+.+ .||||+++.. ....+.|.+|+++|+.++|||||+++|+|.+ +.+||||
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 34677889999999999999998743 5999999753 4567889999999999999999999998854 6789999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
|||+||+|.++|+... ..++|.++..|+.||+.||.|||+ ++||||||||+||||++++.+||+|||+|+....
T Consensus 111 Ey~~gGsL~~~l~~~~---~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQE---TKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp ECCSSCBHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EcCCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 9999999999997543 359999999999999999999999 8999999999999999999999999999998765
Q ss_pred CCCceeecCCccCCCcccceecc----CCCcCcceEEeC
Q 007254 577 SSSHITCTDVAGTFGYVVLILNP----IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~~~~~~~~~GT~~Y~aPE~~~----~~~~~~sDiWSL 611 (611)
..........+||+.|||||++. ..|++++|||||
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~ 223 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSY 223 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHH
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhH
Confidence 44444456689999999999863 468999999997
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=369.86 Aligned_cols=181 Identities=27% Similarity=0.370 Sum_probs=162.9
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
.+.|.+.+.||+|+||.||+|... +|+.||||+++... ...+.+.+|+.+|+.++|||||+++++|.+.+++||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 356899999999999999999965 79999999997643 3456688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
|+||+|.+++... .+++.++..|+.||+.||.|||+ ++||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 230 ~~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 230 LEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp CTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred CCCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 9999999999753 38999999999999999999999 999999999999999999999999999999876543
Q ss_pred CceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 579 SHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
. ...+.+||+.|||||++. ..|+.++|||||
T Consensus 302 ~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSl 333 (423)
T 4fie_A 302 P--RRKSLVGTPYWMAPELISRLPYGPEVDIWSL 333 (423)
T ss_dssp C--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHH
T ss_pred c--cccccccCcCcCCHHHHCCCCCCcHHHHHHH
Confidence 3 335689999999999876 889999999996
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=351.36 Aligned_cols=176 Identities=24% Similarity=0.338 Sum_probs=154.5
Q ss_pred ccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe----CCeEEEEE
Q 007254 425 LAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE----DNNLLLVY 496 (611)
Q Consensus 425 ~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~lV~ 496 (611)
.+.+.||+|+||.||+|.+. ++..||||++... ....+.|.+|+++|+.++|||||+++++|.+ .+.+||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45678999999999999865 6899999999653 3456789999999999999999999999875 35689999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEecCCCCCCEEEcC-CCcEEEEeeccccc
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR--VIHRDVKSSNILLSD-DFEPQLSDFGLAKW 573 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~--IvHrDLKp~NILl~~-~~~vKL~DFGlA~~ 573 (611)
|||+||+|.++|.+.. .+++..+..++.||+.||.|||+ ++ ||||||||+||||+. ++.+||+|||+|+.
T Consensus 109 Ey~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 9999999999997653 48999999999999999999998 55 999999999999984 78999999999986
Q ss_pred cCCCCCceeecCCccCCCcccceeccCCCcCcceEEeC
Q 007254 574 ASTSSSHITCTDVAGTFGYVVLILNPIAFLFMFNCWFF 611 (611)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~~~~sDiWSL 611 (611)
..... ..+.+||+.|||||++...|+.++|||||
T Consensus 182 ~~~~~----~~~~~GTp~YmAPE~~~~~y~~~~DiwSl 215 (290)
T 3fpq_A 182 KRASF----AKAVIGTPEFMAPEMYEEKYDESVDVYAF 215 (290)
T ss_dssp CCTTS----BEESCSSCCCCCGGGGGTCCCTHHHHHHH
T ss_pred CCCCc----cCCcccCccccCHHHcCCCCCcHHHHHHH
Confidence 54432 34579999999999888889999999996
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=352.83 Aligned_cols=186 Identities=23% Similarity=0.335 Sum_probs=150.1
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC--------
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN-------- 490 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-------- 490 (611)
++|.+.+.||+|+||+||+|... +|+.||||+++.. ....+.+.+|+++|+.++|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46889999999999999999864 7999999998653 345678999999999999999999999997644
Q ss_pred ----eEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEE
Q 007254 491 ----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 566 (611)
Q Consensus 491 ----~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~ 566 (611)
++|||||||++|+|.+++..... .....+..+..|+.||+.||.|||+ ++||||||||+||||+.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEc
Confidence 47999999999999999986532 2346778889999999999999999 899999999999999999999999
Q ss_pred eeccccccCCCCCc----------eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 567 DFGLAKWASTSSSH----------ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 567 DFGlA~~~~~~~~~----------~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
|||+|+.+...... ...++.+||+.|||||++. ..|++++|||||
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSl 216 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSL 216 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHH
Confidence 99999987643221 2334578999999999876 889999999996
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=358.69 Aligned_cols=179 Identities=24% Similarity=0.238 Sum_probs=154.8
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 500 (611)
+.|.+.+.||+|+||.||+|... +|+.||||+++.... +.+|+.+|+.++|||||+++++|.+.+++|||||||+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~ 133 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 133 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 45778899999999999999964 799999999986532 2469999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCC-cEEEEeeccccccCCCCC
Q 007254 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKWASTSSS 579 (611)
Q Consensus 501 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~-~vKL~DFGlA~~~~~~~~ 579 (611)
||+|.++|.... .+++.++..|+.||+.||.|||+ ++||||||||+||||+.++ .+||+|||+|+.+.....
T Consensus 134 gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 134 GGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp TCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 999999997653 49999999999999999999999 9999999999999999987 699999999998765322
Q ss_pred ---ceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 580 ---HITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 580 ---~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......++||+.|||||++. ..|+.++|||||
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSl 242 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSS 242 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHH
Confidence 12334578999999999876 889999999996
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=345.96 Aligned_cols=180 Identities=21% Similarity=0.376 Sum_probs=145.9
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 495 (611)
.++|.+.+.||+|+||+||+|... +|+.||||++++. ......+.+|+++|+.++|||||++++++.+.+++|||
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 468999999999999999999864 7999999999753 23467899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
|||+ +|+|.+.+.... .+++.++..++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+...
T Consensus 92 mEy~-~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRD----KMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp EECC-CEEHHHHHHHSC----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred EeCC-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecC
Confidence 9999 679999997653 49999999999999999999999 999999999999999999999999999998766
Q ss_pred CCCCceeecCCccCCCcccceecc-CCC-cCcceEEeC
Q 007254 576 TSSSHITCTDVAGTFGYVVLILNP-IAF-LFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~~-~~~-~~~sDiWSL 611 (611)
... ...+.+||+.|||||++. ..| ++++|||||
T Consensus 164 ~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSl 198 (275)
T 3hyh_A 164 DGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC 198 (275)
T ss_dssp --------------CTTSCHHHHSSSSCCCTHHHHHHH
T ss_pred CCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHH
Confidence 533 234579999999999876 554 689999996
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=357.34 Aligned_cols=181 Identities=27% Similarity=0.323 Sum_probs=153.3
Q ss_pred CCCccceeecccCceEEEEEEec----CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~----~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 494 (611)
++|.+.+.||+|+||+||+|... +++.||||++++.. ....++.+|+++|+.++|||||+++++|.+.+++||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57899999999999999999752 57899999997642 233468889999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccccc
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~ 574 (611)
|||||+||+|.++|.+.. .+++.++..++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 999999999999997653 48999999999999999999999 99999999999999999999999999999976
Q ss_pred CCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 575 STSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 575 ~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
..... ...+.+||+.|||||++. ..|+.++|||||
T Consensus 177 ~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSl 212 (304)
T 3ubd_A 177 IDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSF 212 (304)
T ss_dssp ----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHH
T ss_pred cCCCc--cccccccCcccCCHHHhccCCCCCCCcccch
Confidence 54332 334679999999999875 889999999996
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=350.63 Aligned_cols=184 Identities=28% Similarity=0.337 Sum_probs=151.6
Q ss_pred CCCccceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC----eEEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN----NLLLVYD 497 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~~lV~E 497 (611)
++|.+.+.||+|+||+||+|.+ +|+.||||+++........+..|+.++..++|||||+++++|.+.+ .+|||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 4577889999999999999998 7899999999876543333445666667899999999999998754 5899999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-----CCCCeEecCCCCCCEEEcCCCcEEEEeecccc
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG-----SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~-----~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~ 572 (611)
||++|+|.++|+.. .++|..+.+++.|++.||.|||+. ...+||||||||+||||+.++.+||+|||+|+
T Consensus 82 y~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 82 YHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp CCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999764 389999999999999999999973 12489999999999999999999999999999
Q ss_pred ccCCCCCce--eecCCccCCCcccceeccC-------CCcCcceEEeC
Q 007254 573 WASTSSSHI--TCTDVAGTFGYVVLILNPI-------AFLFMFNCWFF 611 (611)
Q Consensus 573 ~~~~~~~~~--~~~~~~GT~~Y~aPE~~~~-------~~~~~sDiWSL 611 (611)
......... .....+||+.|||||++.. .|+.++|||||
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~ 204 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM 204 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHH
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhH
Confidence 876544322 2335689999999998752 47889999997
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=356.67 Aligned_cols=196 Identities=22% Similarity=0.350 Sum_probs=169.3
Q ss_pred ChHHHHHhcCCCccceeecccCceEEEEEEec------CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCC-CCeeeEE
Q 007254 413 NYQDLLSATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHH-KNIISLL 483 (611)
Q Consensus 413 ~~~~l~~~~~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~H-pnIv~l~ 483 (611)
+..+++...++|.+.+.||+|+||+||+|.+. +++.||||.++... ...+.|.+|+++|..++| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 33444556678999999999999999999854 24689999997643 456789999999999976 8999999
Q ss_pred EEEEeC-CeEEEEEEcCCCCCHHHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCC
Q 007254 484 GFCFED-NNLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDV 550 (611)
Q Consensus 484 ~~~~~~-~~~~lV~Ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDL 550 (611)
|+|.+. +.+|||||||++|+|.++|+.... ....++|.++..|+.||+.||.|||+ ++||||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCcc
Confidence 999764 568999999999999999976432 12458999999999999999999999 89999999
Q ss_pred CCCCEEEcCCCcEEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 551 KSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 551 Kp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
||+||||++++.+||+|||+|+.+............+||+.|||||++. ..|+.++|||||
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~ 273 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 273 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeeh
Confidence 9999999999999999999999887766666667789999999999876 889999999997
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=344.01 Aligned_cols=182 Identities=24% Similarity=0.364 Sum_probs=157.0
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEe------CCe
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFE------DNN 491 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------~~~ 491 (611)
++|.+.+.||+|+||+||+|... +|+.||||+++... ...+.+.+|+++|+.++|||||++++++.. .++
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999864 79999999997642 456788999999999999999999999864 367
Q ss_pred EEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccc
Q 007254 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (611)
Q Consensus 492 ~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA 571 (611)
+|||||||. |+|.+++.... .+++.++..|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~----~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQ----PLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSS----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeCCC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeeccee
Confidence 999999995 68999997543 59999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCC--CceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 572 KWASTSS--SHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 572 ~~~~~~~--~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
+.+.... ......+.+||+.|||||++. ..|+.++|||||
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSl 249 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSV 249 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHH
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehh
Confidence 9775432 223445789999999999765 567999999996
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=355.94 Aligned_cols=180 Identities=24% Similarity=0.324 Sum_probs=157.2
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHH---HHHHHHHhcCCCCeeeEEEEEEeCCeE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFV---LEIEIITTLHHKNIISLLGFCFEDNNL 492 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~---~Ei~il~~l~HpnIv~l~~~~~~~~~~ 492 (611)
.++|.+.++||+|+||.||+|... +|+.||||++++.. .....+. .++.+++.++|||||+++++|.+.+++
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 578999999999999999999865 79999999997532 1222333 345667788999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccc
Q 007254 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~ 572 (611)
|||||||+||+|.++|.+.. .|++..+..|+.||+.||.|||+ ++||||||||+||||+.+|++||+|||+|+
T Consensus 268 ylVmEy~~GGdL~~~l~~~~----~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceee
Confidence 99999999999999997653 49999999999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 573 WASTSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 573 ~~~~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
.+..... .+.+||+.|||||++. ..|+.++|||||
T Consensus 341 ~~~~~~~----~t~~GTp~YmAPEvl~~~~~y~~~vDiWSL 377 (689)
T 3v5w_A 341 DFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSL 377 (689)
T ss_dssp ECSSCCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHH
T ss_pred ecCCCCC----CCccCCcCccCHHHHhCCCCCCcHHHHHHH
Confidence 8765432 3579999999999875 579999999996
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=333.33 Aligned_cols=181 Identities=23% Similarity=0.331 Sum_probs=154.6
Q ss_pred hcCCCccceeecccCceEEEEEEec----CCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEE
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLL 494 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~----~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l 494 (611)
..++|.+.+.||+|+||+||+|..+ +++.||||++.+... ..++.+|+++|+.+ +||||++++++|.+.+++||
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l 97 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI 97 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence 3578999999999999999999753 467899999876543 35678999999998 69999999999999999999
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCC-CcEEEEeeccccc
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDFGLAKW 573 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~-~~vKL~DFGlA~~ 573 (611)
|||||++|+|.+++. .+++.++..++.||+.||.|||+ ++||||||||+||||+.+ +.+||+|||+|+.
T Consensus 98 vmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 98 AMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 999999999999983 38899999999999999999999 999999999999999877 7999999999986
Q ss_pred cCCCCC--------------------------ceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 574 ASTSSS--------------------------HITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 574 ~~~~~~--------------------------~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
...... ....++.+||+.|+|||++. ..|++++|||||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSl 233 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSA 233 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHH
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhh
Confidence 653221 11234568999999999775 468999999996
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=345.55 Aligned_cols=182 Identities=20% Similarity=0.336 Sum_probs=162.4
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
.++|.+.+.||+|+||.||+|..+ +|+.||||+++... ...+.+.+|+++|+.++|||||+|+++|.+.+++||||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 468999999999999999999865 79999999997643 4567788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCC--CcEEEEeeccccccCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD--FEPQLSDFGLAKWAST 576 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~--~~vKL~DFGlA~~~~~ 576 (611)
|+||+|.++|.... ..|++.++..|+.||+.||.|||+ ++||||||||+||||+.+ +.+||+|||+|+.+..
T Consensus 236 ~~gg~L~~~i~~~~---~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 236 MSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp CCCCBHHHHHTCTT---SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred cCCCcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 99999999996432 358999999999999999999999 999999999999999854 8999999999998865
Q ss_pred CCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 577 SSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.. .....+||+.|||||++. ..|++++|||||
T Consensus 310 ~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSl 342 (573)
T 3uto_A 310 KQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSV 342 (573)
T ss_dssp TS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHH
T ss_pred CC---ceeeeEECccccCHHHhCCCCCCcHHHHHHH
Confidence 43 234568999999999876 889999999996
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=306.42 Aligned_cols=196 Identities=37% Similarity=0.632 Sum_probs=172.6
Q ss_pred ChHHHHHhcCCCccceeecccCceEEEEEEecCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCe
Q 007254 413 NYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 491 (611)
Q Consensus 413 ~~~~l~~~~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 491 (611)
.+.++...+++|.+.+.||+|+||.||+|.+.+|+.||||++.... ...+.+.+|+.+++.++||||++++++|.+.+.
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 3444556788999999999999999999998889999999987643 556789999999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccc
Q 007254 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (611)
Q Consensus 492 ~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA 571 (611)
+|+||||+++|+|.+++.........++|.++..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGIS 186 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeecccc
Confidence 999999999999999997665444569999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 572 KWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 572 ~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+...............||+.|+|||+.. ..++.++|||||
T Consensus 187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 227 (321)
T 2qkw_B 187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSF 227 (321)
T ss_dssp EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHH
T ss_pred cccccccccccccccCCCccccCHHHhcCCCCCcccchHhH
Confidence 8765443333344567999999999875 889999999996
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=305.71 Aligned_cols=202 Identities=35% Similarity=0.610 Sum_probs=177.0
Q ss_pred ccccChHHHHHhcCCCccceeecccCceEEEEEEecCCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEE
Q 007254 409 CRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFC 486 (611)
Q Consensus 409 ~~~~~~~~l~~~~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 486 (611)
...|++.++....++|.+.+.||+|+||.||+|...+|+.||||+++... .....+.+|+++++.++||||++++++|
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 45788899999999999999999999999999998889999999998643 2234688999999999999999999999
Q ss_pred EeCCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEE
Q 007254 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 566 (611)
Q Consensus 487 ~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~ 566 (611)
.+.+..++||||+.+|+|.+++.........++|..+..++.|++.||.|||+.+..+|+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999998776556679999999999999999999999222299999999999999999999999
Q ss_pred eeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 567 DFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 567 DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
|||+++........ ......||+.|+|||+.. ..++.++|||||
T Consensus 177 Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 221 (326)
T 3uim_A 177 DFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGY 221 (326)
T ss_dssp CCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHH
T ss_pred cCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhH
Confidence 99999987654433 334567999999999875 778999999996
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=304.38 Aligned_cols=182 Identities=25% Similarity=0.331 Sum_probs=161.8
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 495 (611)
.++|.+.+.||+|+||.||+|... +|+.||||++++.. .....+.+|+.+|..++||||++++++|.+.+++|+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 467999999999999999999865 79999999997642 3456788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
|||+++|+|..++.... .+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+...
T Consensus 84 ~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 99999999999997643 48999999999999999999999 899999999999999999999999999998754
Q ss_pred CCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 576 TSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.... .....+||+.|+|||+.. ..|+.++|||||
T Consensus 157 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 191 (337)
T 1o6l_A 157 SDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 191 (337)
T ss_dssp CTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHH
T ss_pred cCCC--cccccccChhhCChhhhcCCCCCchhhcccc
Confidence 3322 234578999999999876 789999999996
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-35 Score=318.06 Aligned_cols=192 Identities=23% Similarity=0.244 Sum_probs=166.9
Q ss_pred ChHHHHHhcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q 007254 413 NYQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCF 487 (611)
Q Consensus 413 ~~~~l~~~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 487 (611)
.+.++...+++|.+.+.||+|+||+||+|... +++.||||++++.. .....+.+|+.++..++||||++++++|.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34556667889999999999999999999976 58899999997632 12234888999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEe
Q 007254 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSD 567 (611)
Q Consensus 488 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~D 567 (611)
+.+.+|||||||++|+|.++|.... ..+++..+..++.||+.||.|||+ ++||||||||+||||+.++.+||+|
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~---~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~D 218 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFE---DRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLAD 218 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcc
Confidence 9999999999999999999997632 358999999999999999999999 9999999999999999999999999
Q ss_pred eccccccCCCCCceeecCCccCCCcccceecc------CCCcCcceEEeC
Q 007254 568 FGLAKWASTSSSHITCTDVAGTFGYVVLILNP------IAFLFMFNCWFF 611 (611)
Q Consensus 568 FGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~------~~~~~~sDiWSL 611 (611)
||+|+....... ......+||+.|+|||++. ..|+.++|||||
T Consensus 219 FGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSl 267 (437)
T 4aw2_A 219 FGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSL 267 (437)
T ss_dssp CTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHH
T ss_pred hhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHH
Confidence 999987765433 2334578999999999864 568999999996
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=306.86 Aligned_cols=187 Identities=19% Similarity=0.273 Sum_probs=161.9
Q ss_pred hcCCCccceeecccCceEEEEEE------ecCCCEEEEEEecCChhHHHHHHHHHHHHHhcC---CCCeeeEEEEEEeCC
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGC------LPDGKELAVKILKPSEDVIKEFVLEIEIITTLH---HKNIISLLGFCFEDN 490 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~------~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~ 490 (611)
..++|.+.+.||+|+||.||+|. ..+++.||||+++... ..++..|++++..++ |+||+.+++++...+
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC--HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC--hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 35678899999999999999994 4478999999998654 356788888888887 999999999999999
Q ss_pred eEEEEEEcCCCCCHHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcC----------
Q 007254 491 NLLLVYDFLSRGSLEENLHGNKK-DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---------- 559 (611)
Q Consensus 491 ~~~lV~Ey~~~gsL~~~L~~~~~-~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~---------- 559 (611)
..||||||+++|+|.+++..... ....++|.++..|+.||+.||.|||+ ++||||||||+||||+.
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC-----
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCcccccc
Confidence 99999999999999999975322 23469999999999999999999999 89999999999999998
Q ss_pred -CCcEEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 560 -DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 560 -~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
++.+||+|||+|+.+............+||+.|+|||+.. ..|++++|||||
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 271 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGV 271 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHH
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHH
Confidence 8999999999998766444444556789999999999876 779999999996
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-34 Score=294.72 Aligned_cols=185 Identities=24% Similarity=0.448 Sum_probs=161.3
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC-hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
.++|.+.+.||+|+||.||+|... +++.||+|++... ....+.|.+|+++++.++||||++++++|.+.+..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 467889999999999999999975 6899999988654 46678899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
+++|+|.+++.... ..++|.++..++.|++.||.|||+ .+|+||||||+||||+.++.+||+|||+++......
T Consensus 89 ~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 89 IKGGTLRGIIKSMD---SQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp CTTCBHHHHHHHCC---TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 99999999998643 358999999999999999999999 899999999999999999999999999998775433
Q ss_pred Cce------------eecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 579 SHI------------TCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~------------~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
... ......||+.|+|||+.. ..++.++|||||
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 208 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSF 208 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHH
Confidence 211 112568999999999876 888999999996
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=306.80 Aligned_cols=183 Identities=25% Similarity=0.364 Sum_probs=156.7
Q ss_pred hcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEE
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLL 493 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 493 (611)
..++|.+.+.||+|+||.||+|... +|+.||||++++.. .....+..|+.++..+ +||||+++++++.+.+.+|
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 4578999999999999999999865 68999999998642 3456788999999988 7999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccc
Q 007254 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (611)
Q Consensus 494 lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~ 573 (611)
|||||+++|+|.+++.... .+++.++..++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+.
T Consensus 101 lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSR----RFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceee
Confidence 9999999999999997653 48999999999999999999999 8999999999999999999999999999986
Q ss_pred cCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 574 ASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
...... .....+||+.|+|||+.. ..|+.++|||||
T Consensus 174 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 210 (353)
T 3txo_A 174 GICNGV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAM 210 (353)
T ss_dssp SCC-----------CCGGGCCHHHHHHHHCTTHHHHHHH
T ss_pred cccCCc--cccccCCCcCeEChhhcCCCCcCCccCCCcc
Confidence 443222 234578999999999876 779999999996
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-34 Score=294.14 Aligned_cols=181 Identities=27% Similarity=0.398 Sum_probs=161.9
Q ss_pred cCCCccceeecccCceEEEEEEe-cCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... .....+.+|+.+++.++||||++++++|...+.+|+||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46799999999999999999985 478999999987543 3456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
+++|+|.+++... .+++.++..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+|.......
T Consensus 99 ~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 9999999999754 38899999999999999999999 899999999999999999999999999998876543
Q ss_pred CceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 579 SHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
. ......||+.|+|||+.. ..|+.++|||||
T Consensus 171 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 202 (297)
T 3fxz_A 171 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 202 (297)
T ss_dssp C--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHH
T ss_pred c--ccCCccCCcCccChhhhcCCCCCcHHHHHHH
Confidence 3 234578999999999875 889999999996
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=313.37 Aligned_cols=189 Identities=23% Similarity=0.275 Sum_probs=164.6
Q ss_pred hHHHHHhcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Q 007254 414 YQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFE 488 (611)
Q Consensus 414 ~~~l~~~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 488 (611)
+.++....++|.+.+.||+|+||.||+|... +++.||+|++++.. .....+.+|+.++..++||||++++++|.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3455567789999999999999999999975 68999999997632 123457889999999999999999999999
Q ss_pred CCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEee
Q 007254 489 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568 (611)
Q Consensus 489 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DF 568 (611)
.+++||||||++||+|.+++... .+++..+..++.||+.||.|||+ ++||||||||+||||+.++.+||+||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEecc
Confidence 99999999999999999999754 38899999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCceeecCCccCCCcccceecc-CC----CcCcceEEeC
Q 007254 569 GLAKWASTSSSHITCTDVAGTFGYVVLILNP-IA----FLFMFNCWFF 611 (611)
Q Consensus 569 GlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~----~~~~sDiWSL 611 (611)
|+|+...... .......+||+.|+|||++. .. |+.++|||||
T Consensus 213 G~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSl 259 (410)
T 3v8s_A 213 GTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV 259 (410)
T ss_dssp TTCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHH
T ss_pred ceeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecc
Confidence 9998776543 22345679999999999875 33 8899999996
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-35 Score=314.73 Aligned_cols=192 Identities=20% Similarity=0.233 Sum_probs=167.3
Q ss_pred ChHHHHHhcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q 007254 413 NYQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCF 487 (611)
Q Consensus 413 ~~~~l~~~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 487 (611)
.+.+.....++|.+.+.||+|+||.||++... +|+.||||++++.. .....+.+|+.++..++||||++++++|.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 44555667889999999999999999999975 79999999997643 23345788999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEe
Q 007254 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSD 567 (611)
Q Consensus 488 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~D 567 (611)
+.+++||||||++||+|.+++.+.. ..+++..+..++.||+.||.|||+ ++||||||||+||||+.++++||+|
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFG---ERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEee
Confidence 9999999999999999999997542 258999999999999999999999 9999999999999999999999999
Q ss_pred eccccccCCCCCceeecCCccCCCcccceecc--------CCCcCcceEEeC
Q 007254 568 FGLAKWASTSSSHITCTDVAGTFGYVVLILNP--------IAFLFMFNCWFF 611 (611)
Q Consensus 568 FGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~--------~~~~~~sDiWSL 611 (611)
||+|+....... ......+||+.|+|||++. ..|+.++|||||
T Consensus 206 FGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSl 256 (412)
T 2vd5_A 206 FGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWAL 256 (412)
T ss_dssp CTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHH
T ss_pred chhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHH
Confidence 999988765433 2234578999999999864 468999999996
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=300.39 Aligned_cols=182 Identities=24% Similarity=0.401 Sum_probs=161.9
Q ss_pred hcCCCccceeecccCceEEEEEEe-cCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 495 (611)
..++|.+.+.||+|+||.||+|.. .+|+.||||++... ....+.+.+|+++|+.++||||+++++++.+.+.+|+|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 357899999999999999999986 58999999999753 34567889999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
|||+++|+|.+++.... .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+|+...
T Consensus 93 ~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHG----RMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp ECCCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred EECCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 99999999999997653 48899999999999999999999 899999999999999999999999999998776
Q ss_pred CCCCceeecCCccCCCcccceecc-CCC-cCcceEEeC
Q 007254 576 TSSSHITCTDVAGTFGYVVLILNP-IAF-LFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~~-~~~-~~~sDiWSL 611 (611)
... .....+||+.|+|||+.. ..+ +.++|||||
T Consensus 166 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl 200 (328)
T 3fe3_A 166 VGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSL 200 (328)
T ss_dssp SSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHH
T ss_pred CCC---ccccccCCcceeCcccccCCCcCCchhhhhhh
Confidence 543 234678999999999875 454 589999996
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=305.17 Aligned_cols=188 Identities=26% Similarity=0.428 Sum_probs=163.2
Q ss_pred cCCCccceeecccCceEEEEEEec--------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP--------DGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED 489 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~--------~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 489 (611)
.++|.+.+.||+|+||.||+|.+. ++..||||+++.. ......+.+|+.+|+.+ +||||++++++|.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 357888999999999999999852 3557999999864 34567899999999999 899999999999999
Q ss_pred CeEEEEEEcCCCCCHHHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE
Q 007254 490 NNLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557 (611)
Q Consensus 490 ~~~~lV~Ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl 557 (611)
+.+|+||||+++|+|.+++..... ....+++.++..++.||+.||.|||+ ++||||||||+||||
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEE
Confidence 999999999999999999986532 12458999999999999999999999 899999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 558 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 558 ~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+.++.+||+|||+|+...............||+.|+|||+.. ..|+.++|||||
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvwsl 291 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 291 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHH
Confidence 999999999999999776544333344567889999999775 789999999996
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=302.96 Aligned_cols=184 Identities=23% Similarity=0.382 Sum_probs=161.3
Q ss_pred HhcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeE
Q 007254 419 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 492 (611)
Q Consensus 419 ~~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 492 (611)
...++|.+.+.||+|+||.||+|... +|+.||||++++.. .....+..|..++..+ +||||+++++++.+.+++
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 45688999999999999999999975 68999999998642 3456778899999877 999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccc
Q 007254 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~ 572 (611)
|+||||+++|+|.+++.... .+++.++..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 99999999999999997643 48999999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 573 WASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 573 ~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
....... .....+||+.|+|||+.. ..|+.++|||||
T Consensus 167 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 204 (345)
T 1xjd_A 167 ENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSF 204 (345)
T ss_dssp CCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred hcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHH
Confidence 6543222 234678999999999876 789999999996
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=309.30 Aligned_cols=182 Identities=21% Similarity=0.339 Sum_probs=159.4
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLL 494 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l 494 (611)
.++|.+.+.||+|+||.||+|... +++.||||++++.. .....+..|..+|..+ +||||++++++|.+.+.+||
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 467899999999999999999865 68899999997642 3345678899999887 89999999999999999999
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccccc
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~ 574 (611)
||||+++|+|..++.... .+++..+..++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+..
T Consensus 131 V~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEcCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 999999999999997653 48999999999999999999999 89999999999999999999999999999864
Q ss_pred CCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 575 STSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 575 ~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
..... .....+||+.|+|||++. ..|+.++|||||
T Consensus 204 ~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~Diwsl 239 (396)
T 4dc2_A 204 LRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWAL 239 (396)
T ss_dssp CCTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred ccCCC--ccccccCCcccCCchhhcCCCCChHHHHHHH
Confidence 33222 234678999999999876 889999999996
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=296.11 Aligned_cols=187 Identities=21% Similarity=0.308 Sum_probs=158.6
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-------
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN------- 490 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------- 490 (611)
.++|.+.+.||+|+||.||+|... +|+.||||+++.. ....+.+.+|+.+|+.++||||++++++|.+.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 457889999999999999999976 7999999999753 345678999999999999999999999986643
Q ss_pred --------------------------------------------------eEEEEEEcCCCCCHHHHHhcCCCCCCCCCH
Q 007254 491 --------------------------------------------------NLLLVYDFLSRGSLEENLHGNKKDPAAFGW 520 (611)
Q Consensus 491 --------------------------------------------------~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~ 520 (611)
++|+||||+++|+|.+++..... .....+
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhh
Confidence 38999999999999999986543 344678
Q ss_pred HHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCc----------eeecCCccCC
Q 007254 521 SERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH----------ITCTDVAGTF 590 (611)
Q Consensus 521 ~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~----------~~~~~~~GT~ 590 (611)
..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++........ .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 8899999999999999999 89999999999999999999999999999987654221 1234568999
Q ss_pred Ccccceecc-CCCcCcceEEeC
Q 007254 591 GYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 591 ~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.|+|||+.. ..++.++|||||
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~sl 262 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSL 262 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHH
T ss_pred CccChHHhcCCCCcchhhHHHH
Confidence 999999875 789999999996
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-34 Score=297.82 Aligned_cols=179 Identities=26% Similarity=0.379 Sum_probs=161.0
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 495 (611)
.++|.+.+.||+|+||.||++... +|+.||+|++++.. .....+.+|+.++..++||||+++++++.+.+.+|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 467899999999999999999865 79999999997642 3456788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+...
T Consensus 85 ~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp ECCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 99999999999997653 48999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 576 TSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
... ...+||+.|+|||+.. ..|+.++|||||
T Consensus 158 ~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 189 (318)
T 1fot_A 158 DVT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSF 189 (318)
T ss_dssp SCB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHH
T ss_pred Ccc-----ccccCCccccCHhHhcCCCCCcccchhhh
Confidence 432 3468999999999876 789999999996
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=291.39 Aligned_cols=199 Identities=32% Similarity=0.567 Sum_probs=176.1
Q ss_pred cccccChHHHHHhcCCCccc------eeecccCceEEEEEEecCCCEEEEEEecCC-----hhHHHHHHHHHHHHHhcCC
Q 007254 408 TCRLFNYQDLLSATSNFLAE------NLIGKGGSSQVYKGCLPDGKELAVKILKPS-----EDVIKEFVLEIEIITTLHH 476 (611)
Q Consensus 408 ~~~~~~~~~l~~~~~~f~~~------~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~-----~~~~~~~~~Ei~il~~l~H 476 (611)
....|++.++..++++|... +.||+|+||.||+|.. +++.||||++... ....+.+.+|+.+++.++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 45678999999999998877 8999999999999987 6889999998653 3456789999999999999
Q ss_pred CCeeeEEEEEEeCCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEE
Q 007254 477 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 556 (611)
Q Consensus 477 pnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NIL 556 (611)
|||+++++++.+.+..++||||+++|+|.+++.... ....++|..+..++.|++.||.|||+ .+|+||||||+|||
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil 165 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANIL 165 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEE
Confidence 999999999999999999999999999999997532 23468999999999999999999999 89999999999999
Q ss_pred EcCCCcEEEEeeccccccCCCCCceeecCCccCCCcccceeccCCCcCcceEEeC
Q 007254 557 LSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNPIAFLFMFNCWFF 611 (611)
Q Consensus 557 l~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~~~~sDiWSL 611 (611)
++.++.+||+|||+++...............||+.|+|||.....++.++|||||
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~sl 220 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSF 220 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHH
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcCCCCccchhHHH
Confidence 9999999999999998876654444445678999999999888779999999996
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=295.55 Aligned_cols=191 Identities=24% Similarity=0.340 Sum_probs=166.4
Q ss_pred ccChHHHHHhcCC----------CccceeecccCceEEEEEEec-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCCC
Q 007254 411 LFNYQDLLSATSN----------FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKN 478 (611)
Q Consensus 411 ~~~~~~l~~~~~~----------f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~Hpn 478 (611)
.++++++..+++. |...+.||+|+||.||+|... +|+.||||+++... ...+.+.+|+.+++.++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 4566666666553 667789999999999999976 79999999997643 44677889999999999999
Q ss_pred eeeEEEEEEeCCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEc
Q 007254 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 558 (611)
Q Consensus 479 Iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~ 558 (611)
|++++++|...+..|+||||+++|+|.+++... .+++..+..++.|++.||.|||+ .+|+||||||+|||++
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-----RLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLT 175 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEC
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEC
Confidence 999999999999999999999999999998643 48999999999999999999999 8999999999999999
Q ss_pred CCCcEEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 559 DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 559 ~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.++.+||+|||+++........ .....||+.|+|||+.. ..++.++|||||
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~sl 227 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRSLYATEVDIWSL 227 (321)
T ss_dssp TTCCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred CCCcEEEeeeeeeeecccCccc--cccccCCccccCHhhhcCCCCCchhhHHHH
Confidence 9999999999999887654322 24578999999999876 778999999996
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-34 Score=305.67 Aligned_cols=181 Identities=26% Similarity=0.394 Sum_probs=161.5
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 495 (611)
.++|.+.+.||+|+||.||++... +++.||+|++++.. .....+.+|+++|..++||||++++++|.+.+.+|+|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467889999999999999999865 68899999997542 3457888999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
|||+.||+|.+++.... .+++..+..++.||+.||.|||+ .+||||||||+||||+.++.+||+|||+|+.+.
T Consensus 94 ~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNV----HFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp ECCCTTEEHHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 99999999999997643 48999999999999999999999 899999999999999999999999999999876
Q ss_pred CCCCceeecCCccCCCcccceecc----CCCcCcceEEeC
Q 007254 576 TSSSHITCTDVAGTFGYVVLILNP----IAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~~----~~~~~~sDiWSL 611 (611)
... .....+||+.|+|||++. ..|+.++|||||
T Consensus 167 ~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSl 203 (384)
T 4fr4_A 167 RET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSL 203 (384)
T ss_dssp TTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHH
T ss_pred CCC---ceeccCCCccccCCeeeccCCCCCCCccceeech
Confidence 543 234578999999999874 458999999996
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-34 Score=300.10 Aligned_cols=182 Identities=21% Similarity=0.350 Sum_probs=160.9
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLL 494 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~----~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l 494 (611)
.++|.+.+.||+|+||.||+|... +++.||||++++. ......+.+|+.++..+ +||||++++++|.+.+.+|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 457889999999999999999975 6899999999753 34566788999999988 89999999999999999999
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccccc
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~ 574 (611)
||||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+..
T Consensus 88 v~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp EECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 999999999999997643 48999999999999999999999 89999999999999999999999999999865
Q ss_pred CCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 575 STSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 575 ~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
..... .....+||+.|+|||+.. ..|+.++|||||
T Consensus 161 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 196 (345)
T 3a8x_A 161 LRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWAL 196 (345)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred cCCCC--cccccCCCccccCccccCCCCCChHHhHHHH
Confidence 43222 234578999999999876 789999999996
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=299.42 Aligned_cols=183 Identities=25% Similarity=0.370 Sum_probs=160.7
Q ss_pred hcCCCccceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC----eEEEE
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN----NLLLV 495 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~~lV 495 (611)
..++|.+.+.||+|+||.||+|.+ .++.||||+++........+..|+.++..++||||+++++++.... .+|+|
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred chhhchhhheecccCceEEEEEEE-CCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 346789999999999999999987 4789999999877666667777999999999999999999998744 47999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC----------CeEecCCCCCCEEEcCCCcEEE
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ----------RVIHRDVKSSNILLSDDFEPQL 565 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~----------~IvHrDLKp~NILl~~~~~vKL 565 (611)
|||+++|+|.+++... .++|..+..++.|++.||.|||+ . +|+||||||+||||+.++.+||
T Consensus 101 ~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 101 TAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred EecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence 9999999999999764 38999999999999999999998 7 9999999999999999999999
Q ss_pred EeeccccccCCCCCceeecCCccCCCcccceecc------CCCcCcceEEeC
Q 007254 566 SDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP------IAFLFMFNCWFF 611 (611)
Q Consensus 566 ~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~------~~~~~~sDiWSL 611 (611)
+|||+|+...............||+.|+|||+.. ..++.++|||||
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diwsl 224 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAM 224 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHH
Confidence 9999998877655444445578999999999865 356779999996
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=295.21 Aligned_cols=182 Identities=19% Similarity=0.246 Sum_probs=163.1
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 499 (611)
.++|.+.+.||+|+||.||+|... +++.||+|+++........+.+|+.+++.++||||++++++|.+.+.+|+||||+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 468999999999999999999865 6889999999877666678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcC--CCcEEEEeeccccccCCC
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD--DFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~--~~~vKL~DFGlA~~~~~~ 577 (611)
++|+|.+.+.... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++. ++.+||+|||+++.....
T Consensus 84 ~g~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 84 SGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 9999999996542 358999999999999999999999 89999999999999987 789999999999987654
Q ss_pred CCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 578 SSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 578 ~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
. ......||+.|+|||+.. ..++.++|||||
T Consensus 158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 189 (321)
T 1tki_A 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSL 189 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHH
T ss_pred C---ccccccCChhhcCcHHhcCCCCCchhhHHHH
Confidence 3 233468999999999876 668999999996
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=300.43 Aligned_cols=181 Identities=24% Similarity=0.332 Sum_probs=161.1
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh-------hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 492 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~-------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 492 (611)
.++|.+.+.||+|+||.||+|... +|+.||||++++.. .....+.+|+.+|..++||||++++++|.+.+.+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467899999999999999999865 79999999997642 1357889999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCC----cEEEEee
Q 007254 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF----EPQLSDF 568 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~----~vKL~DF 568 (611)
|+||||+++|+|.+++... ..+++.++..++.||+.||.|||+ .+|+||||||+|||++.++ .+||+||
T Consensus 91 ~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC----SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 9999999999999999654 358999999999999999999999 8999999999999998877 7999999
Q ss_pred ccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 569 GLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 569 GlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
|+++....... .....||+.|+|||+.. ..|+.++|||||
T Consensus 164 G~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 204 (361)
T 2yab_A 164 GLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSI 204 (361)
T ss_dssp SSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred CCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHH
Confidence 99998765432 34578999999999876 789999999996
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=291.20 Aligned_cols=183 Identities=24% Similarity=0.343 Sum_probs=155.9
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecC----ChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~----~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 495 (611)
.++|.+.+.||+|+||.||+|... +++.||+|++.. .....+.|.+|+.++..++||||+++++++.+.+.+|+|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 467999999999999999999864 789999999854 235567899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
|||+++|+|.+++.... .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 90 ~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG----PLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 99999999999997653 48999999999999999999999 899999999999999999999999999998775
Q ss_pred CCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 576 TSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.... .......||+.|+|||... ..++.++|||||
T Consensus 163 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 198 (294)
T 4eqm_A 163 ETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSI 198 (294)
T ss_dssp -------------CCSSCCHHHHHTCCCCTTHHHHHH
T ss_pred cccc-cccCccccCccccCHhHhcCCCCCchHhHHHH
Confidence 4332 1234568999999999775 778999999996
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-34 Score=300.07 Aligned_cols=185 Identities=24% Similarity=0.304 Sum_probs=160.3
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh------hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 494 (611)
++|.+.+.||+|+||.||+|... +|+.||||+++... ...+.+.+|+.+++.++||||++++++|.+.+.+|+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 46888999999999999999864 78999999986432 135788999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCc---EEEEeeccc
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE---PQLSDFGLA 571 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~---vKL~DFGlA 571 (611)
||||+++|+|.+.+.........+++..+..++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 999999999998886543333458999999999999999999999 89999999999999987654 999999999
Q ss_pred cccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 572 KWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 572 ~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+....... ......||+.|+|||+.. ..|+.++|||||
T Consensus 181 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 219 (351)
T 3c0i_A 181 IQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGC 219 (351)
T ss_dssp EECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred eEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHH
Confidence 88765432 234568999999999876 778999999996
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-34 Score=298.29 Aligned_cols=184 Identities=23% Similarity=0.324 Sum_probs=159.4
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 497 (611)
.++|.+.+.||+|+||.||+|... +++.||||++.... ...+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999865 78999999996543 345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCC
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~ 577 (611)
|+++|+|.+++.... .+++.++..++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+++.+...
T Consensus 86 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 999999999986543 48999999999999999999999 99999999999999999999999999999876544
Q ss_pred CCceeecCCccCCCcccceecc-CC-CcCcceEEeC
Q 007254 578 SSHITCTDVAGTFGYVVLILNP-IA-FLFMFNCWFF 611 (611)
Q Consensus 578 ~~~~~~~~~~GT~~Y~aPE~~~-~~-~~~~sDiWSL 611 (611)
..........||+.|+|||+.. .. ++.++|||||
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl 194 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC 194 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHH
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHH
Confidence 3333345678999999999875 44 4889999996
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=299.57 Aligned_cols=179 Identities=22% Similarity=0.293 Sum_probs=161.3
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 495 (611)
.++|.+.+.||+|+||.||++... +|+.||||++++.. .....+.+|+.+|..++||||+++++++.+.+.+|+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 467999999999999999999965 79999999997643 3457788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+...
T Consensus 120 ~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceecc
Confidence 99999999999997653 48999999999999999999999 999999999999999999999999999999775
Q ss_pred CCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 576 TSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
... ...+||+.|+|||+.. ..|+.++|||||
T Consensus 193 ~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 224 (350)
T 1rdq_E 193 GRT-----WTLCGTPEALAPEIILSKGYNKAVDWWAL 224 (350)
T ss_dssp SCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred CCc-----ccccCCccccCHHHhcCCCCCCcCCEecc
Confidence 432 3468999999999875 789999999996
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=301.10 Aligned_cols=197 Identities=23% Similarity=0.386 Sum_probs=167.3
Q ss_pred cChHHHHHhcCCCccceeecccCceEEEEEEe------cCCCEEEEEEecCCh--hHHHHHHHHHHHHHhc-CCCCeeeE
Q 007254 412 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPSE--DVIKEFVLEIEIITTL-HHKNIISL 482 (611)
Q Consensus 412 ~~~~~l~~~~~~f~~~~~IG~G~fG~Vyk~~~------~~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l-~HpnIv~l 482 (611)
+....+....++|.+.+.||+|+||.||+|.+ .+++.||||+++... ...+.+.+|++++..+ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 33445556678899999999999999999973 256799999998643 4567899999999999 78999999
Q ss_pred EEEEEeCC-eEEEEEEcCCCCCHHHHHhcCCCC-----------------------------------------------
Q 007254 483 LGFCFEDN-NLLLVYDFLSRGSLEENLHGNKKD----------------------------------------------- 514 (611)
Q Consensus 483 ~~~~~~~~-~~~lV~Ey~~~gsL~~~L~~~~~~----------------------------------------------- 514 (611)
+++|.+.+ .+++||||+++|+|.+++......
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99998755 489999999999999999765321
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 007254 515 ---------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (611)
Q Consensus 515 ---------------~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~ 579 (611)
...+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 1228999999999999999999999 8999999999999999999999999999998766555
Q ss_pred ceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 580 HITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 580 ~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
........||+.|+|||+.. ..++.++|||||
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 281 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 281 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhH
Confidence 55556788999999999775 889999999996
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=295.22 Aligned_cols=182 Identities=25% Similarity=0.334 Sum_probs=150.7
Q ss_pred cCCCccceeecccCceEEEEEEe----cCCCEEEEEEecCCh-----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCe
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCL----PDGKELAVKILKPSE-----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 491 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~----~~g~~vAVK~lk~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 491 (611)
.++|.+.+.||+|+||.||++.. .+|+.||||++++.. .....+.+|+.+|+.++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 45788999999999999999986 478999999998642 334567889999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccc
Q 007254 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (611)
Q Consensus 492 ~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA 571 (611)
+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG----IFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 999999999999999997643 48899999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 572 KWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 572 ~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+....... ......||+.|+|||+.. ..++.++|||||
T Consensus 169 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 207 (327)
T 3a62_A 169 KESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSL 207 (327)
T ss_dssp ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHH
T ss_pred cccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhH
Confidence 86543322 234578999999999875 778999999996
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=300.44 Aligned_cols=183 Identities=22% Similarity=0.279 Sum_probs=161.1
Q ss_pred hcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEE
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLL 493 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 493 (611)
..++|.+.+.||+|+||.||+|... +|+.||||++++.. .....+..|..+|..+ +||||+++++++.+.+.+|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 4678999999999999999999975 58899999998642 3456788999999988 8999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccc
Q 007254 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (611)
Q Consensus 494 lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~ 573 (611)
|||||++||+|.+++.... .+++..+..++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+.
T Consensus 98 lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 9999999999999997643 48999999999999999999999 8999999999999999999999999999986
Q ss_pred cCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 574 ASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
...... .....+||+.|+|||+.. ..|+.++|||||
T Consensus 171 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 207 (353)
T 2i0e_A 171 NIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAF 207 (353)
T ss_dssp CCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHH
T ss_pred cccCCc--ccccccCCccccChhhhcCCCcCCcccccch
Confidence 543222 234578999999999876 889999999996
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=293.31 Aligned_cols=180 Identities=23% Similarity=0.202 Sum_probs=153.4
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
++|.+.+.||+|+||+||+|.+. +|+.||||++... ......+..|+..+..+ +||||++++++|.+.+.+|+||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57899999999999999999976 7999999998653 23344556666665555 9999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
||+ +|+|.+.+.... ..++|..+..++.|++.||.|||+ .+|+||||||+||||+.++.+||+|||+++....
T Consensus 137 e~~-~~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG---ASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp ECC-CCBHHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred ecc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 999 779999887543 359999999999999999999999 8999999999999999999999999999987765
Q ss_pred CCCceeecCCccCCCcccceeccCCCcCcceEEeC
Q 007254 577 SSSHITCTDVAGTFGYVVLILNPIAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~~~~~~~~~GT~~Y~aPE~~~~~~~~~sDiWSL 611 (611)
... .....||+.|+|||+....++.++|||||
T Consensus 210 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~Diwsl 241 (311)
T 3p1a_A 210 AGA---GEVQEGDPRYMAPELLQGSYGTAADVFSL 241 (311)
T ss_dssp --------CCCCCGGGCCGGGGGTCCSTHHHHHHH
T ss_pred CCC---CcccCCCccccCHhHhcCCCCchhhHHHH
Confidence 432 23467999999999888889999999996
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-34 Score=287.52 Aligned_cols=184 Identities=23% Similarity=0.422 Sum_probs=163.8
Q ss_pred cCCCccceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 500 (611)
.++|.+.+.||+|+||.||+|...+++.||+|+++......+++.+|+++++.++||||+++++++.+.+..|+||||++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 45788899999999999999998888999999998876566789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCc
Q 007254 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (611)
Q Consensus 501 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~ 580 (611)
+|+|.+++.... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 89 ~~~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 161 (269)
T 4hcu_A 89 HGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-Y 161 (269)
T ss_dssp TCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-H
T ss_pred CCcHHHHHHhcC---cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEeccccccccccccc-c
Confidence 999999997543 358999999999999999999999 899999999999999999999999999998765432 1
Q ss_pred eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 581 ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 581 ~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.......||+.|+|||+.. ..++.++|||||
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 193 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSF 193 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHH
Confidence 1223467788999999876 889999999996
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=290.36 Aligned_cols=182 Identities=25% Similarity=0.382 Sum_probs=158.0
Q ss_pred cCCCccceeecccCceEEEEEEecCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 497 (611)
.++|.+.+.||+|+||.||+|...+|+.||||+++... .....+.+|+++++.++||||+++++++.+.+.+|+|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 46788999999999999999999889999999997543 345788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCC
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~ 577 (611)
|+++ +|.+.+.... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+|+.....
T Consensus 100 ~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 100 FMEK-DLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp CCSE-EHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred CCCC-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9975 8888886543 358999999999999999999999 89999999999999999999999999999887643
Q ss_pred CCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 578 SSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 578 ~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
.. ......||+.|+|||+.. ..++.++|||||
T Consensus 173 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 206 (311)
T 3niz_A 173 VR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSI 206 (311)
T ss_dssp CC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHH
T ss_pred cc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHH
Confidence 32 233468999999999764 678999999996
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-33 Score=296.98 Aligned_cols=181 Identities=27% Similarity=0.401 Sum_probs=160.1
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
.++|.+.+.||+|+||.||+|... +|+.||||+++.. ......+.+|+.+++.++||||++++++|.+.+..|+||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457889999999999999999865 6899999999754 345677899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCC---cEEEEeeccccc
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF---EPQLSDFGLAKW 573 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~---~vKL~DFGlA~~ 573 (611)
||+.+|+|.+.+.... .+++.++..++.||+.||.|||+ ++|+||||||+||||+.++ .+||+|||+++.
T Consensus 108 e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 108 DLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp CCCCSCBHHHHHTTCS----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 9999999999997543 48999999999999999999999 8999999999999998654 599999999987
Q ss_pred cCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 574 ASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
...... .....||+.|+|||+.. ..|+.++|||||
T Consensus 181 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 216 (362)
T 2bdw_A 181 VNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWAC 216 (362)
T ss_dssp CTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHH
T ss_pred ecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHH
Confidence 765432 23578999999999876 689999999996
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=294.63 Aligned_cols=185 Identities=26% Similarity=0.404 Sum_probs=158.3
Q ss_pred cCCCccceeecccCceEEEEEEec----CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~----~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 494 (611)
.++|.+.+.||+|+||.||+|.+. .+..||||+++.. ....+.|.+|+.+++.++||||++++++|.+.+.+|+
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 457888999999999999999874 3446999999864 4556789999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccccc
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~ 574 (611)
||||+++|+|.+++.... ..+++.++..++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+++..
T Consensus 128 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHD---GQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EeeCCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 999999999999997543 358999999999999999999999 89999999999999999999999999999987
Q ss_pred CCCCC-ceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 575 STSSS-HITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 575 ~~~~~-~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
..... ........||+.|+|||+.. ..++.++|||||
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 240 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSF 240 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHH
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHH
Confidence 65432 22333456788999999876 889999999996
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=293.27 Aligned_cols=186 Identities=27% Similarity=0.443 Sum_probs=152.3
Q ss_pred HhcCCCccceeecccCceEEEEEEecCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 007254 419 SATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 419 ~~~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 495 (611)
...++|.+.+.||+|+||.||+|.. +|+.||||++... ....+.|.+|+++++.++||||+++++++.+.+.+++|
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 3456788999999999999999987 7889999999764 34567899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEecCCCCCCEEEcCCCcEEEEeeccccc
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR--VIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~--IvHrDLKp~NILl~~~~~vKL~DFGlA~~ 573 (611)
|||+++|+|.+++..... ...+++..+..++.|++.||.|||+ .+ |+||||||+|||++.++.+||+|||+++.
T Consensus 113 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp EECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred EecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 999999999999975421 1238999999999999999999999 77 99999999999999999999999999986
Q ss_pred cCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 574 ASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
...... ......||+.|+|||+.. ..++.++|||||
T Consensus 189 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 225 (309)
T 3p86_A 189 KASTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSF 225 (309)
T ss_dssp ---------------CCTTSCHHHHTTCCCCTTHHHHHH
T ss_pred cccccc--ccccCCCCccccChhhhcCCCCCchhhHHHH
Confidence 554322 234568999999999876 778999999996
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=312.42 Aligned_cols=186 Identities=25% Similarity=0.357 Sum_probs=165.4
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 495 (611)
.++|.+.+.||+|+||.||+|... +|+.||||++++.. .....+..|+++|..++||||++++++|.+.+.+|||
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999975 79999999997643 3356788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
|||++||+|.+++.........+++..+..++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999998665445579999999999999999999999 899999999999999999999999999999876
Q ss_pred CCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 576 TSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.... .....+||+.|+|||++. ..|+.++|||||
T Consensus 341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSl 375 (543)
T 3c4z_A 341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFAL 375 (543)
T ss_dssp TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHH
T ss_pred CCCc--ccccccCCccccChhhhcCCCCChHHhcCcc
Confidence 5432 223468999999999876 789999999996
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=284.57 Aligned_cols=185 Identities=21% Similarity=0.369 Sum_probs=164.9
Q ss_pred hcCCCccceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 499 (611)
..++|.+.+.||+|+||.||+|...++..||||+++......+++.+|++++..++||||+++++++.+.+..|+||||+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 34678899999999999999999888889999999887656678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~ 579 (611)
++|+|.+++.... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 86 SNGCLLNYLRSHG---KGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp TTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred CCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 9999999997542 358999999999999999999999 8999999999999999999999999999987765432
Q ss_pred ceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 580 HITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 580 ~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.......||+.|+|||+.. ..++.++|||||
T Consensus 160 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 191 (268)
T 3sxs_A 160 -VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAF 191 (268)
T ss_dssp -EECCSCCCCGGGCCHHHHHHSEEETTHHHHHH
T ss_pred -hcccCCCcCcccCCHHHHhccCCchhhhhHHH
Confidence 2334566788899999876 789999999996
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=295.55 Aligned_cols=190 Identities=23% Similarity=0.392 Sum_probs=163.2
Q ss_pred HhcCCCccceeecccCceEEEEEEec------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 007254 419 SATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN 490 (611)
Q Consensus 419 ~~~~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 490 (611)
...++|.+.+.||+|+||.||+|... +++.||||+++.. ......|.+|+.+++.++||||++++++|.+.+
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 34678999999999999999999864 3478999999864 345678999999999999999999999999999
Q ss_pred eEEEEEEcCCCCCHHHHHhcCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCC
Q 007254 491 NLLLVYDFLSRGSLEENLHGNKKD--------------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDV 550 (611)
Q Consensus 491 ~~~lV~Ey~~~gsL~~~L~~~~~~--------------------~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDL 550 (611)
.+|+||||+++|+|.+++...... ...+++.++..++.||+.||.|||+ ++|+||||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCC
Confidence 999999999999999999764321 1469999999999999999999999 89999999
Q ss_pred CCCCEEEcCCCcEEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 551 KSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 551 Kp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
||+||||+.++.+||+|||+++...............||+.|+|||+.. ..++.++|||||
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 262 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAY 262 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHH
Confidence 9999999999999999999998775443333344567899999999775 789999999996
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-33 Score=285.63 Aligned_cols=181 Identities=23% Similarity=0.320 Sum_probs=157.4
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 497 (611)
++|.+.+.||+|+||+||+|... +|+.||||+++.. ......+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57899999999999999999875 6899999999753 3456788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCC
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~ 577 (611)
|+.+ +|.+.+.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~-~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9976 6666665432 358999999999999999999999 89999999999999999999999999999877543
Q ss_pred CCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 578 SSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 578 ~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
.. ......||+.|+|||+.. ..++.++|||||
T Consensus 155 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 188 (292)
T 3o0g_A 155 VR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSA 188 (292)
T ss_dssp CS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHH
T ss_pred cc--cccCCccccCCcChHHHcCCCCcCchHHHHHH
Confidence 32 234568999999999875 448999999996
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-33 Score=291.27 Aligned_cols=180 Identities=22% Similarity=0.317 Sum_probs=160.0
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh-------hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~-------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 493 (611)
++|.+.+.||+|+||.||+|... +|+.||||+++... .....+.+|+.+|+.++||||++++++|.+.+.+|
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 46888999999999999999865 68999999997532 13678999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCC----cEEEEeec
Q 007254 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF----EPQLSDFG 569 (611)
Q Consensus 494 lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~----~vKL~DFG 569 (611)
+||||+++|+|.+++... ..+++.++..++.||+.||.|||+ .+|+||||||+|||++.++ .+||+|||
T Consensus 91 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEECCCSCBHHHHHTTS----SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEcCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 999999999999999654 358999999999999999999999 8999999999999999887 79999999
Q ss_pred cccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 570 LAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 570 lA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+++....... .....||+.|+|||+.. ..++.++|||||
T Consensus 164 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 203 (326)
T 2y0a_A 164 LAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSI 203 (326)
T ss_dssp TCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHH
T ss_pred CCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHH
Confidence 9988764332 23568999999999876 789999999996
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=307.48 Aligned_cols=183 Identities=20% Similarity=0.297 Sum_probs=145.2
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----Ce
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NN 491 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~ 491 (611)
.++|.+.+.||+|+||.||+|... +|+.||||++... ....+++.+|+.+|+.++||||++++++|... +.
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 367899999999999999999865 7899999999753 34567899999999999999999999999543 57
Q ss_pred EEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccc
Q 007254 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (611)
Q Consensus 492 ~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA 571 (611)
+|+||||+ +|+|.+++... ..+++..+..++.||+.||.|||+ .+||||||||+||||+.++.+||+|||+|
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTP----VYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecc-ccchhhhcccC----CCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccc
Confidence 99999998 56999999754 348999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCc-------------------------eeecCCccCCCcccceec-c-CCCcCcceEEeC
Q 007254 572 KWASTSSSH-------------------------ITCTDVAGTFGYVVLILN-P-IAFLFMFNCWFF 611 (611)
Q Consensus 572 ~~~~~~~~~-------------------------~~~~~~~GT~~Y~aPE~~-~-~~~~~~sDiWSL 611 (611)
+........ ...+..+||+.|+|||++ . ..|+.++|||||
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSl 270 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSI 270 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHH
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHH
Confidence 976532211 134567899999999965 3 779999999996
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=301.25 Aligned_cols=182 Identities=27% Similarity=0.346 Sum_probs=151.6
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHH-HHhcCCCCeeeEEEEEEeCCeEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEI-ITTLHHKNIISLLGFCFEDNNLLL 494 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~i-l~~l~HpnIv~l~~~~~~~~~~~l 494 (611)
.++|.+.+.||+|+||.||+|... +++.||||++++.. .....+..|..+ ++.++||||++++++|.+.+++||
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 457889999999999999999975 68899999997643 334566777776 577899999999999999999999
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccccc
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~ 574 (611)
||||++||+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+..
T Consensus 117 v~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 999999999999997643 48899999999999999999999 99999999999999999999999999999875
Q ss_pred CCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 575 STSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 575 ~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
..... .....+||+.|+|||++. ..|+.++|||||
T Consensus 190 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 225 (373)
T 2r5t_A 190 IEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCL 225 (373)
T ss_dssp BCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHH
T ss_pred ccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHH
Confidence 43322 234578999999999876 789999999996
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-33 Score=293.05 Aligned_cols=190 Identities=23% Similarity=0.334 Sum_probs=167.1
Q ss_pred ccChHHHHHhcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHHHhcC-----CCCeeeEEE
Q 007254 411 LFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLH-----HKNIISLLG 484 (611)
Q Consensus 411 ~~~~~~l~~~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~-----HpnIv~l~~ 484 (611)
.|++.+.....++|.+.+.||+|+||.||+|... +++.||||+++........+..|+++++.+. ||||+++++
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 3444555556789999999999999999999864 7899999999987777788889999999997 999999999
Q ss_pred EEEeCCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcC-----
Q 007254 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD----- 559 (611)
Q Consensus 485 ~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~----- 559 (611)
++...+.+|+||||+ +++|.+++..... ..+++.++..++.||+.||.|||+ .+||||||||+||||+.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRNNY--NGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccccc
Confidence 999999999999999 9999999986543 358999999999999999999999 99999999999999975
Q ss_pred --------------------CCcEEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 560 --------------------DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 560 --------------------~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
++.+||+|||+|+...... ....||+.|+|||+.. ..|+.++|||||
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 245 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSF 245 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHH
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHH
Confidence 7899999999998765432 3468999999999875 789999999996
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=291.50 Aligned_cols=189 Identities=23% Similarity=0.423 Sum_probs=164.5
Q ss_pred hcCCCccceeecccCceEEEEEEe------cCCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCe
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 491 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~------~~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 491 (611)
..++|.+.+.||+|+||.||+|.. .+++.||||+++.. ....+.+.+|+++++.++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 356788999999999999999985 24578999999764 3556789999999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhcCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCC
Q 007254 492 LLLVYDFLSRGSLEENLHGNKK--------------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVK 551 (611)
Q Consensus 492 ~~lV~Ey~~~gsL~~~L~~~~~--------------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLK 551 (611)
.|+||||+++|+|.+++..... ....+++.++..++.||+.||.|||+ ++|+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccc
Confidence 9999999999999999986543 12348999999999999999999999 899999999
Q ss_pred CCCEEEcCCCcEEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 552 SSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 552 p~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
|+|||++.++.+||+|||+++...............||+.|+|||... ..++.++|||||
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 238 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSF 238 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHH
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHH
Confidence 999999999999999999999876655444445567889999999775 778999999996
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-33 Score=288.59 Aligned_cols=183 Identities=23% Similarity=0.367 Sum_probs=159.5
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC--eEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN--NLLLVY 496 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~~lV~ 496 (611)
++|.+.+.||+|+||.||+|... +|+.||||+++... .....+.+|+++++.++||||+++++++...+ .+|+||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 56889999999999999999975 58999999998643 34677889999999999999999999998755 789999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE----cCCCcEEEEeecccc
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL----SDDFEPQLSDFGLAK 572 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl----~~~~~vKL~DFGlA~ 572 (611)
||+++|+|.+++..... ...+++.++..++.||+.||.|||+ .+|+||||||+|||| +.++.+||+|||+|+
T Consensus 89 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp ECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred eCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999976432 2348999999999999999999999 899999999999999 788889999999999
Q ss_pred ccCCCCCceeecCCccCCCcccceec---------cCCCcCcceEEeC
Q 007254 573 WASTSSSHITCTDVAGTFGYVVLILN---------PIAFLFMFNCWFF 611 (611)
Q Consensus 573 ~~~~~~~~~~~~~~~GT~~Y~aPE~~---------~~~~~~~sDiWSL 611 (611)
....... .....||+.|+|||+. ...++.++|||||
T Consensus 165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Diwsl 209 (319)
T 4euu_A 165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSI 209 (319)
T ss_dssp ECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHH
T ss_pred ecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHH
Confidence 8765442 2346799999999975 3778999999996
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-33 Score=303.48 Aligned_cols=182 Identities=25% Similarity=0.332 Sum_probs=159.4
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
.++|.+.+.||+|+||.||+|... +|+.+|+|+++... ...+.+.+|+.+++.++||||++++++|.+.+..|+||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 467899999999999999999864 78999999997643 44567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEc---CCCcEEEEeeccccc
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS---DDFEPQLSDFGLAKW 573 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~---~~~~vKL~DFGlA~~ 573 (611)
||+.+|+|.+.+.... .+++.++..++.||+.||.|||+ ++|+||||||+|||++ .++.+||+|||+|+.
T Consensus 90 E~~~gg~L~~~i~~~~----~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 90 DLVTGGELFEDIVARE----YYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp CCCBCCBHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 9999999999997653 48999999999999999999999 8999999999999998 567899999999987
Q ss_pred cCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 574 ASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
...... ......||+.|+|||+.. ..|+.++|||||
T Consensus 163 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSl 199 (444)
T 3soa_A 163 VEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWAC 199 (444)
T ss_dssp CCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred ecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHH
Confidence 765432 234578999999999876 689999999996
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.8e-33 Score=311.62 Aligned_cols=184 Identities=26% Similarity=0.341 Sum_probs=163.4
Q ss_pred hcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 494 (611)
..++|.+.+.||+|+||.||+|... +|+.||||++++.. .....+.+|+++|..++||||++++++|.+.+.+||
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 4567999999999999999999875 79999999997542 335678899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccccc
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~ 574 (611)
||||++||+|.+++..... ..+++..+..++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+..
T Consensus 262 VmEy~~gg~L~~~l~~~~~--~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQ--AGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EECCCCSCBHHHHHHSSSS--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceec
Confidence 9999999999999976432 358999999999999999999999 89999999999999999999999999999987
Q ss_pred CCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 575 STSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 575 ~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
..... ....+||+.|+|||++. ..|+.++|||||
T Consensus 337 ~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSL 371 (576)
T 2acx_A 337 PEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWAL 371 (576)
T ss_dssp CTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHH
T ss_pred ccCcc---ccccCCCccccCHHHHcCCCCCccchHHHH
Confidence 65432 23468999999999876 789999999996
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.98 E-value=4.6e-33 Score=285.36 Aligned_cols=181 Identities=24% Similarity=0.373 Sum_probs=155.4
Q ss_pred CCCccceeecccCceEEEEEEecCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
++|.+.+.||+|+||.||+|...+|+.||||+++... .....+.+|+++++.++||||+++++++.+.+.+|+||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5788999999999999999998889999999997543 2346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
+.+ +|.+.+.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CSE-EHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 975 9999887543 358999999999999999999999 899999999999999999999999999998775432
Q ss_pred CceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 579 SHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
. ......||+.|+|||+.. ..++.++|||||
T Consensus 155 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 187 (288)
T 1ob3_A 155 R--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSV 187 (288)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHH
T ss_pred c--ccccccccccccCchheeCCCCCCcHHHHHHH
Confidence 2 223468999999999874 568999999996
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=6e-33 Score=296.88 Aligned_cols=188 Identities=27% Similarity=0.425 Sum_probs=163.8
Q ss_pred cCCCccceeecccCceEEEEEEec--------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP--------DGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED 489 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~--------~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 489 (611)
.++|.+.+.||+|+||.||+|... ++..||||+++.. ......+.+|+++++.+ +||||++++++|.+.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 467888999999999999999852 2357999999864 34567899999999999 999999999999999
Q ss_pred CeEEEEEEcCCCCCHHHHHhcCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE
Q 007254 490 NNLLLVYDFLSRGSLEENLHGNKKD------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557 (611)
Q Consensus 490 ~~~~lV~Ey~~~gsL~~~L~~~~~~------------~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl 557 (611)
+.+|+||||+++|+|.+++...... ...+++.++..++.||+.||.|||+ .+|+||||||+||||
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEEE
Confidence 9999999999999999999865421 2459999999999999999999999 899999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 558 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 558 ~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+.++.+||+|||+|+...............||+.|+|||+.. ..++.++|||||
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Diwsl 279 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 279 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHH
Confidence 999999999999999876554434445567899999999775 788999999996
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-33 Score=300.64 Aligned_cols=188 Identities=22% Similarity=0.335 Sum_probs=160.2
Q ss_pred cCCCccceeecccCceEEEEEEec------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 492 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 492 (611)
.++|.+.+.||+|+||.||+|.+. +++.||||+++.. ......+.+|+.++..++||||+++++++.+.+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 356888999999999999999843 4678999999763 35566889999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCC---cEEEE
Q 007254 493 LLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF---EPQLS 566 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~~---~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~---~vKL~ 566 (611)
|+||||+++|+|.+++..... ....+++.++..++.||+.||.|||+ ++|+||||||+||||+.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999976432 22459999999999999999999999 8999999999999999554 59999
Q ss_pred eeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 567 DFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 567 DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
|||+|+...............||+.|+|||+.. ..++.++|||||
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvwsl 272 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF 272 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHH
Confidence 999998764433222334467899999999775 889999999996
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=6.2e-33 Score=285.54 Aligned_cols=181 Identities=23% Similarity=0.367 Sum_probs=152.8
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCChh---------------------------HHHHHHHHHHHHH
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSED---------------------------VIKEFVLEIEIIT 472 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~---------------------------~~~~~~~Ei~il~ 472 (611)
.++|.+.+.||+|+||.||+|... +++.||||+++.... ..+.+.+|+++|+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 468999999999999999999864 788999999975421 2356889999999
Q ss_pred hcCCCCeeeEEEEEEe--CCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCC
Q 007254 473 TLHHKNIISLLGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDV 550 (611)
Q Consensus 473 ~l~HpnIv~l~~~~~~--~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDL 550 (611)
.++||||+++++++.+ .+.+|+||||+++|+|.+++.. ..+++.++..++.||+.||.|||+ .+|+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCC
Confidence 9999999999999986 5689999999999999775432 358999999999999999999999 89999999
Q ss_pred CCCCEEEcCCCcEEEEeeccccccCCCCCceeecCCccCCCcccceecc-CC---CcCcceEEeC
Q 007254 551 KSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IA---FLFMFNCWFF 611 (611)
Q Consensus 551 Kp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~---~~~~sDiWSL 611 (611)
||+|||++.++.+||+|||+++....... ......||+.|+|||... .. ++.++|||||
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~sl 226 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAM 226 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHH
T ss_pred CHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhH
Confidence 99999999999999999999988765432 234578999999999875 22 4789999996
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=5.6e-33 Score=291.43 Aligned_cols=189 Identities=21% Similarity=0.374 Sum_probs=162.6
Q ss_pred hcCCCccceeecccCceEEEEEEe------cCCCEEEEEEecCCh--hHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCC
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPSE--DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDN 490 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~------~~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 490 (611)
..++|.+.+.||+|+||.||+|.. .++..||||+++... .....+.+|+.++..+ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 456889999999999999999985 245689999997643 3457889999999999 8999999999999999
Q ss_pred eEEEEEEcCCCCCHHHHHhcCCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCC
Q 007254 491 NLLLVYDFLSRGSLEENLHGNKKD-------------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVK 551 (611)
Q Consensus 491 ~~~lV~Ey~~~gsL~~~L~~~~~~-------------------~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLK 551 (611)
.+|+||||+++|+|.+++...... ...+++..+..++.||+.||.|||+ .+|+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCC
Confidence 999999999999999999765321 1348999999999999999999999 899999999
Q ss_pred CCCEEEcCCCcEEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 552 SSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 552 p~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
|+||||+.++.+||+|||+++...............||+.|+|||... ..++.++|||||
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 260 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSY 260 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHH
Confidence 999999999999999999999877655555555678899999999775 889999999996
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.98 E-value=3e-33 Score=285.24 Aligned_cols=185 Identities=22% Similarity=0.381 Sum_probs=160.6
Q ss_pred hcCCCccceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 499 (611)
..++|.+.+.||+|+||.||++.+.++..||||+++......+++.+|++++..++||||++++++|.+.+.+|+||||+
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 34678889999999999999999988889999999887656678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~ 579 (611)
++|+|.+++.... ..+++.++..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 102 ~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 174 (283)
T 3gen_A 102 ANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE- 174 (283)
T ss_dssp TTCBHHHHHHCGG---GCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-
T ss_pred CCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEccccccccccccc-
Confidence 9999999997532 348999999999999999999999 899999999999999999999999999998765432
Q ss_pred ceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 580 HITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 580 ~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
........||+.|+|||+.. ..++.++|||||
T Consensus 175 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 207 (283)
T 3gen_A 175 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAF 207 (283)
T ss_dssp HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHH
T ss_pred cccccCCccCcccCCHHHhccCCCCchhhHHHH
Confidence 11223456788999999876 889999999996
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1e-32 Score=300.31 Aligned_cols=183 Identities=23% Similarity=0.318 Sum_probs=155.3
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----Ce
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NN 491 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~ 491 (611)
.++|.+.+.||+|+||.||+|... +|+.||||+++.. ....+++.+|+.+|+.++||||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999865 6889999999763 34567899999999999999999999999766 57
Q ss_pred EEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccc
Q 007254 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (611)
Q Consensus 492 ~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA 571 (611)
+|+||||+. |+|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+|
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP----IFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 999999996 5999999754 348999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCc--------------------eeecCCccCCCcccceec-c-CCCcCcceEEeC
Q 007254 572 KWASTSSSH--------------------ITCTDVAGTFGYVVLILN-P-IAFLFMFNCWFF 611 (611)
Q Consensus 572 ~~~~~~~~~--------------------~~~~~~~GT~~Y~aPE~~-~-~~~~~~sDiWSL 611 (611)
+........ ...+..+||+.|+|||++ . ..|+.++|||||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSl 238 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWST 238 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHH
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchH
Confidence 987543221 124568999999999975 3 779999999996
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-33 Score=301.28 Aligned_cols=185 Identities=22% Similarity=0.365 Sum_probs=159.8
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 497 (611)
.++|.+.+.||+|+||.||+|.+. +++.||||+++.. ......|.+|+++|+.++||||++++++|...+.+|+|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 457888999999999999999976 7899999999864 3445678999999999999999999999999899999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCC
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~ 577 (611)
|+++|+|.+++.... ..+++.++..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 193 ~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred cCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 999999999997542 348899999999999999999999 89999999999999999999999999999875543
Q ss_pred CCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 578 SSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 578 ~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
..........+|+.|+|||... ..++.++|||||
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 301 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSF 301 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHH
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHH
Confidence 2111112234678899999876 889999999996
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.98 E-value=5e-33 Score=293.27 Aligned_cols=180 Identities=21% Similarity=0.360 Sum_probs=158.1
Q ss_pred cCCCccceeecccCceEEEEEEe-cCCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 495 (611)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... .....+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 57899999999999999999996 578999999997532 2345788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
|||+ +|+|.+++.... .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++....
T Consensus 88 ~E~~-~g~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK----RMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp ECCC-CEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EECC-CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 9999 789999886543 48999999999999999999999 899999999999999999999999999998766
Q ss_pred CCCCceeecCCccCCCcccceecc-CCC-cCcceEEeC
Q 007254 576 TSSSHITCTDVAGTFGYVVLILNP-IAF-LFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~~-~~~-~~~sDiWSL 611 (611)
.... ....+||+.|+|||+.. ..+ +.++|||||
T Consensus 160 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl 194 (336)
T 3h4j_B 160 DGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSC 194 (336)
T ss_dssp TSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHH
T ss_pred CCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHH
Confidence 5432 23568999999999876 444 789999996
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=4.3e-33 Score=297.54 Aligned_cols=185 Identities=24% Similarity=0.403 Sum_probs=149.1
Q ss_pred cCCCccceeecccCceEEEEEEec----CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~----~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 494 (611)
.++|.+.+.||+|+||.||+|.+. ++..||||+++.. ......|.+|+.++..++||||++++++|.+.+.+|+
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357889999999999999999864 5778999999864 3556789999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccccc
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~ 574 (611)
||||+++|+|.+++.... ..+++.++..++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+++..
T Consensus 124 v~e~~~~~sL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 999999999999997543 358999999999999999999999 89999999999999999999999999999987
Q ss_pred CCCCCc-eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 575 STSSSH-ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 575 ~~~~~~-~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
...... .......||+.|+|||+.. ..++.++|||||
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~Sl 236 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSY 236 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHH
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHH
Confidence 654321 1222345688999999876 889999999996
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=8e-33 Score=285.59 Aligned_cols=188 Identities=23% Similarity=0.387 Sum_probs=165.2
Q ss_pred cCCCccceeecccCceEEEEEEe------cCCCEEEEEEecCCh--hHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCe
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPSE--DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNN 491 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~------~~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 491 (611)
.++|.+.+.||+|+||.||+|.+ .+++.||||+++... .....+.+|+.++..+ +||||++++++|.+.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 46788999999999999999984 256789999998653 4567899999999999 99999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhcCCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE
Q 007254 492 LLLVYDFLSRGSLEENLHGNKKD--------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557 (611)
Q Consensus 492 ~~lV~Ey~~~gsL~~~L~~~~~~--------------~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl 557 (611)
.++||||+++|+|.+++...... ...+++.++..++.|++.||.|||+ .+|+||||||+|||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEE
Confidence 99999999999999999765321 2358999999999999999999999 899999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 558 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 558 ~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+.++.+||+|||+++...............||+.|+|||+.. ..++.++|||||
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 233 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSY 233 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHH
Confidence 999999999999999887665554555677899999999775 889999999996
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=8.2e-33 Score=288.02 Aligned_cols=185 Identities=24% Similarity=0.389 Sum_probs=146.2
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 497 (611)
.++|.+.+.||+|+||.||+|... +|+.||||+++... .....+.+|+++++.++||||+++++++.+.+.+|+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467889999999999999999864 68999999997543 344678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 498 FLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 498 y~~~gsL~~~L~~~~--~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
|++ |+|.+++.... .....+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 59999886432 223458999999999999999999999 899999999999999999999999999998775
Q ss_pred CCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 576 TSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
.... ......||+.|+|||+.. ..++.++|||||
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 195 (317)
T 2pmi_A 160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSC 195 (317)
T ss_dssp SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHH
T ss_pred CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHH
Confidence 4322 223568999999999875 568999999996
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.1e-33 Score=305.28 Aligned_cols=183 Identities=25% Similarity=0.325 Sum_probs=150.7
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 495 (611)
.++|.+.+.||+|+||.||+|... +|+.||||+++.. ......+.+|+.++..++||||++++++|.+.+.+|||
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467889999999999999999864 7899999999753 23456788899999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+ ..+||||||||+||||+.++.+||+|||+|+...
T Consensus 227 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 99999999999997643 48999999999999999999995 1689999999999999999999999999998654
Q ss_pred CCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 576 TSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.... .....+||+.|+|||+.. ..|+.++|||||
T Consensus 301 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 335 (446)
T 4ejn_A 301 KDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 335 (446)
T ss_dssp C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHH
T ss_pred CCCc--ccccccCCccccCHhhcCCCCCCCccchhhh
Confidence 4332 234578999999999875 889999999996
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=9.1e-33 Score=283.57 Aligned_cols=180 Identities=26% Similarity=0.418 Sum_probs=153.6
Q ss_pred cCCCccceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHh--cCCCCeeeEEEEEEeC----CeEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITT--LHHKNIISLLGFCFED----NNLLL 494 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~~----~~~~l 494 (611)
.++|.+.+.||+|+||.||+|.. +|+.||||++.... ...+..|.+++.. ++||||+++++++... +.+|+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD--EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc--chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 46799999999999999999988 78999999997653 3556677777777 7999999999997653 46899
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCCeEecCCCCCCEEEcCCCcEEEE
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH--------SGSAQRVIHRDVKSSNILLSDDFEPQLS 566 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH--------~~~~~~IvHrDLKp~NILl~~~~~vKL~ 566 (611)
||||+++|+|.+++... .+++..+..++.|++.||.||| + .+|+||||||+||||+.++.+||+
T Consensus 84 v~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EECCCTTCBHHHHHTTC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCEEEC
T ss_pred ehhhccCCCHHHHHhhc-----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCEEEe
Confidence 99999999999999543 4899999999999999999999 6 899999999999999999999999
Q ss_pred eeccccccCCCCCcee--ecCCccCCCcccceecc-C------CCcCcceEEeC
Q 007254 567 DFGLAKWASTSSSHIT--CTDVAGTFGYVVLILNP-I------AFLFMFNCWFF 611 (611)
Q Consensus 567 DFGlA~~~~~~~~~~~--~~~~~GT~~Y~aPE~~~-~------~~~~~sDiWSL 611 (611)
|||+|+.......... .....||+.|+|||+.. . .++.++|||||
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Dvwsl 209 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAF 209 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHH
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHH
Confidence 9999987765543321 23458999999999875 2 45679999996
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=8e-33 Score=291.29 Aligned_cols=182 Identities=22% Similarity=0.313 Sum_probs=152.3
Q ss_pred cCCCccceeecccCceEEEEEEecCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCC--CCeeeEEEEEEeCCeEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHH--KNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~lV 495 (611)
.++|.+.+.||+|+||.||++...+++.||||+++.. ....+.+.+|+.+|..++| |||+++++++.+.+.+|+|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4568899999999999999999888999999999753 3456789999999999987 9999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
||| .+|+|.+++.... .+++.++..++.||+.||.|||+ .+|+||||||+||||+ ++.+||+|||+|+...
T Consensus 88 ~e~-~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 88 MEC-GNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp ECC-CSEEHHHHHHHSC----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EeC-CCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 995 5889999998653 48999999999999999999999 8999999999999997 5789999999999876
Q ss_pred CCCCceeecCCccCCCcccceecc------------CCCcCcceEEeC
Q 007254 576 TSSSHITCTDVAGTFGYVVLILNP------------IAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~~------------~~~~~~sDiWSL 611 (611)
............||+.|+|||+.. ..++.++|||||
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Diwsl 206 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 206 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHH
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHH
Confidence 655444445678999999999863 578999999996
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.98 E-value=7.9e-33 Score=294.13 Aligned_cols=181 Identities=21% Similarity=0.254 Sum_probs=150.2
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 499 (611)
.++|.+.+.||+|+||.||++... +++.||||++.........+.+|+.+++.++||||+++++++.+.+.+|+||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 457889999999999999999975 7899999999876655677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCc--EEEEeeccccccCCC
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE--PQLSDFGLAKWASTS 577 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~--vKL~DFGlA~~~~~~ 577 (611)
++|+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+||||+.++. +||+|||+|+.....
T Consensus 99 ~~~~L~~~l~~~~----~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 99 SGGELYERICNAG----RFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 9999999997543 48999999999999999999999 99999999999999987765 999999999854432
Q ss_pred CCceeecCCccCCCcccceecc-CCCc-CcceEEeC
Q 007254 578 SSHITCTDVAGTFGYVVLILNP-IAFL-FMFNCWFF 611 (611)
Q Consensus 578 ~~~~~~~~~~GT~~Y~aPE~~~-~~~~-~~sDiWSL 611 (611)
. ......||+.|+|||+.. ..++ .++|||||
T Consensus 172 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl 204 (361)
T 3uc3_A 172 S---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSC 204 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHH
T ss_pred C---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehh
Confidence 2 223468999999999875 5554 45999996
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.7e-33 Score=290.51 Aligned_cols=184 Identities=22% Similarity=0.317 Sum_probs=151.1
Q ss_pred cCCCccceeecccCceEEEEEEe-cCCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC----e
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN----N 491 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~ 491 (611)
.++|.+.+.||+|+||.||+|.. .+++.||||+++.. ......+.+|+.++..++||||+++++++...+ .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46789999999999999999996 57899999999764 245678899999999999999999999987654 3
Q ss_pred EEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccc
Q 007254 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (611)
Q Consensus 492 ~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA 571 (611)
.|+||||+++|+|.+++.... .+++.++..++.|++.||.|||+ ++|+||||||+||||+.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 599999999999999997543 48999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCc-eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 572 KWASTSSSH-ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 572 ~~~~~~~~~-~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+........ .......||+.|+|||+.. ..++.++|||||
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 205 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 205 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHH
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHH
Confidence 877654322 2233467999999999875 788999999996
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=3.3e-33 Score=285.37 Aligned_cols=187 Identities=22% Similarity=0.410 Sum_probs=167.3
Q ss_pred HhcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 007254 419 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 419 ~~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 497 (611)
...++|.+.+.||+|+||.||+|.+. +++.||||+++......+.+.+|+++++.++||||+++++++.+.+.+|+|||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 35678999999999999999999976 58899999999877778899999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCC
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~ 577 (611)
|+++|+|.+++..... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 90 ~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp CCTTEEHHHHHHHCCT--TTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred cCCCCcHHHHHHhccc--CCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 9999999999976433 458999999999999999999999 89999999999999999999999999999877654
Q ss_pred CCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 578 SSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 578 ~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.. .......||+.|+|||+.. ..++.++|||||
T Consensus 165 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 198 (288)
T 3kfa_A 165 TY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF 198 (288)
T ss_dssp SS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred cc-ccccCCccccCcCChhhhccCCCCchhhHHHH
Confidence 32 3344567899999999876 889999999996
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.8e-32 Score=291.91 Aligned_cols=186 Identities=19% Similarity=0.216 Sum_probs=161.3
Q ss_pred cCCCccceeeccc--CceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 007254 421 TSNFLAENLIGKG--GSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (611)
Q Consensus 421 ~~~f~~~~~IG~G--~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 494 (611)
.++|.+.+.||+| +||.||+|... +|+.||||+++.. ......+.+|+.+++.++||||++++++|.+.+.+|+
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4678999999999 99999999975 7999999999754 3456778899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccccc
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~ 574 (611)
||||+++|+|.+++..... ..+++..+..++.||+.||.|||+ .+||||||||+||||+.++.+||+|||++...
T Consensus 104 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFM--DGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEECCTTCBHHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEccCCCCHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 9999999999999976532 348999999999999999999999 89999999999999999999999999998755
Q ss_pred CCCC-----CceeecCCccCCCcccceecc---CCCcCcceEEeC
Q 007254 575 STSS-----SHITCTDVAGTFGYVVLILNP---IAFLFMFNCWFF 611 (611)
Q Consensus 575 ~~~~-----~~~~~~~~~GT~~Y~aPE~~~---~~~~~~sDiWSL 611 (611)
.... .........||+.|+|||+.. ..|+.++|||||
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 223 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSV 223 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHH
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHH
Confidence 3221 111223458999999999875 478999999996
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-32 Score=294.04 Aligned_cols=182 Identities=20% Similarity=0.277 Sum_probs=160.3
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
.++|.+.+.||+|+||.||+|... +|+.||+|+++... .....+.+|+++|+.++||||++++++|.+.+.+|+||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 457899999999999999999865 78999999997653 3456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcC--CCcEEEEeeccccccCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD--DFEPQLSDFGLAKWAST 576 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~--~~~vKL~DFGlA~~~~~ 576 (611)
+.+|+|.+++.... ..+++.++..++.||+.||.|||+ .+|+||||||+|||++. ++.+||+|||+|+....
T Consensus 130 ~~gg~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 130 LSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 99999999997542 358999999999999999999999 89999999999999974 47799999999998765
Q ss_pred CCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 577 SSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
... .....||+.|+|||+.. ..++.++|||||
T Consensus 204 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 236 (387)
T 1kob_A 204 DEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAI 236 (387)
T ss_dssp TSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHH
T ss_pred Ccc---eeeeccCCCccCchhccCCCCCCcccEeeH
Confidence 432 23357999999999876 779999999996
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=8.6e-33 Score=289.08 Aligned_cols=183 Identities=21% Similarity=0.212 Sum_probs=158.8
Q ss_pred cCCCccceeecccCceEEEEEEe-cCCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
.++|.+.+.||+|+||.||+|.. .+|+.||||++..... ...+.+|+++++.+ +||||+++++++...+..|+||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 36799999999999999999985 4789999999875432 24678899999999 999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCc-----EEEEeeccccc
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE-----PQLSDFGLAKW 573 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~-----vKL~DFGlA~~ 573 (611)
+ +|+|.+++.... ..+++.++..++.|++.||.|||+ .+|+||||||+||||+.++. +||+|||+|+.
T Consensus 87 ~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 87 L-GPSLEDLFDLCD---RTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp C-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred C-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 9 999999998642 359999999999999999999999 89999999999999999887 99999999997
Q ss_pred cCCCCCce-----eecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 574 ASTSSSHI-----TCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 574 ~~~~~~~~-----~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+....... ......||+.|+|||+.. ..++.++|||||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 203 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEAL 203 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHH
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHH
Confidence 65433221 124678999999999876 778999999996
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=5.4e-33 Score=285.30 Aligned_cols=185 Identities=26% Similarity=0.430 Sum_probs=155.0
Q ss_pred cCCCccceeecccCceEEEEEEe-----cCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CCeE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNL 492 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~-----~~g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~ 492 (611)
.++|.+.+.||+|+||.||+|.+ .+++.||||+++... ...+.|.+|+++++.++||||++++++|.. ...+
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 35788999999999999999984 368899999998654 556789999999999999999999999965 3568
Q ss_pred EEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccc
Q 007254 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~ 572 (611)
++||||+++|+|.+++.... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCG---GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred EEEEEeCCCCCHHHHHHhcc---cccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 99999999999999997653 348999999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCc-eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 573 WASTSSSH-ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 573 ~~~~~~~~-~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
........ .......||..|+|||... ..++.++|||||
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 203 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSF 203 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHH
Confidence 87654322 2233456888899999876 889999999996
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=6.1e-33 Score=290.25 Aligned_cols=184 Identities=22% Similarity=0.426 Sum_probs=151.8
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCE----EEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKE----LAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~----vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 493 (611)
.++|.+.+.||+|+||.||+|.+. +++. ||+|.++... ...+.|.+|+.+++.++||||++++++|.+. ..+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeE
Confidence 356888999999999999999854 4443 5888886532 4567899999999999999999999999875 478
Q ss_pred EEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccc
Q 007254 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (611)
Q Consensus 494 lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~ 573 (611)
+||||+.+|+|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+.
T Consensus 93 ~v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCTTCBHHHHHHHST---TSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 9999999999999998653 358999999999999999999999 8999999999999999999999999999998
Q ss_pred cCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 574 ASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
..............||+.|+|||+.. ..++.++|||||
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 205 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSY 205 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhh
Confidence 87655544555567899999999876 889999999996
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.3e-32 Score=277.74 Aligned_cols=181 Identities=28% Similarity=0.335 Sum_probs=161.1
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
.++|.+.+.||+|+||.||+|... ++..||+|++.... ...+.+.+|+++++.++||||++++++|.+.+..|+||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 456889999999999999999865 57799999997643 4467889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE---cCCCcEEEEeeccccccC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl---~~~~~vKL~DFGlA~~~~ 575 (611)
+++++|.+.+.... .+++.++..++.|++.||.|||+ .+|+||||||+|||+ +.++.+||+|||++....
T Consensus 88 ~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 88 CTGGELFERVVHKR----VFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred cCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 99999999887643 48999999999999999999999 899999999999999 788999999999998776
Q ss_pred CCCCceeecCCccCCCcccceeccCCCcCcceEEeC
Q 007254 576 TSSSHITCTDVAGTFGYVVLILNPIAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~~~~~~~~sDiWSL 611 (611)
.... .....||+.|+|||+....++.++|||||
T Consensus 161 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~Di~sl 193 (277)
T 3f3z_A 161 PGKM---MRTKVGTPYYVSPQVLEGLYGPECDEWSA 193 (277)
T ss_dssp TTSC---BCCCCSCTTTCCHHHHTTCBCTTHHHHHH
T ss_pred Cccc---hhccCCCCCccChHHhcccCCchhhehhH
Confidence 5432 23468999999999988779999999996
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.98 E-value=2e-32 Score=293.06 Aligned_cols=183 Identities=27% Similarity=0.387 Sum_probs=147.9
Q ss_pred hcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCC--eE
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDN--NL 492 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~--~~ 492 (611)
..++|.+.+.||+|+||.||+|... +|+.||||++... ......+.+|+.+|..+. ||||+++++++...+ .+
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4578999999999999999999864 7899999998653 345677889999999997 999999999997544 79
Q ss_pred EEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccc
Q 007254 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~ 572 (611)
|+|||||. |+|...+... .+++..+..++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+|+
T Consensus 87 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 99999997 5999998753 48899999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCC-------------------CceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 573 WASTSS-------------------SHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 573 ~~~~~~-------------------~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
.+.... .....+..+||+.|+|||++. ..|+.++|||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl 217 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSL 217 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHH
Confidence 764311 112234578999999999774 679999999996
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-32 Score=291.15 Aligned_cols=180 Identities=27% Similarity=0.400 Sum_probs=143.4
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 499 (611)
.++|.+.+.||+|+||.||+|... +++.||||+++... ..+.+.+|+++|+.++||||++++++|.+.+.+++||||+
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 130 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV 130 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence 567899999999999999999976 68899999998654 3466888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcC---CCcEEEEeeccccccCC
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSDFGLAKWAST 576 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~---~~~vKL~DFGlA~~~~~ 576 (611)
++|+|.+.+.... .+++.++..++.|++.||.|||+ .+|+||||||+||||+. ++.+||+|||+++....
T Consensus 131 ~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 131 TGGELFDRIVEKG----YYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CSCBHHHHHTTCS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred CCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 9999999997543 48999999999999999999999 89999999999999975 88999999999987654
Q ss_pred CCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 577 SSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.. ......||+.|+|||+.. ..++.++|||||
T Consensus 204 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 236 (349)
T 2w4o_A 204 QV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSV 236 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHH
T ss_pred cc---ccccccCCCCccCHHHhcCCCCCcccchHHH
Confidence 32 223568999999999876 779999999996
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.98 E-value=6.3e-33 Score=284.13 Aligned_cols=184 Identities=26% Similarity=0.357 Sum_probs=156.3
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
++|.+.+.||+|+||.||++... +++.+|+|++.... ...+.+.+|+++++.++||||++++++|.+.+.+|+||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 46888999999999999999864 68999999997643 3467889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE---cCCCcEEEEeeccccccC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl---~~~~~vKL~DFGlA~~~~ 575 (611)
+++|+|.+.+.........+++..+..++.|++.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 99999999886542223468999999999999999999999 899999999999999 456789999999998765
Q ss_pred CCCCceeecCCccCCCcccceeccCCCcCcceEEeC
Q 007254 576 TSSSHITCTDVAGTFGYVVLILNPIAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~~~~~~~~sDiWSL 611 (611)
.... .....||+.|+|||+....+++++|||||
T Consensus 179 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~Di~sl 211 (285)
T 3is5_A 179 SDEH---STNAAGTALYMAPEVFKRDVTFKCDIWSA 211 (285)
T ss_dssp -----------CTTGGGCCHHHHTTCCCHHHHHHHH
T ss_pred Cccc---CcCcccccCcCChHHhccCCCcccCeehH
Confidence 5332 23568999999999988889999999996
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.4e-33 Score=307.22 Aligned_cols=186 Identities=22% Similarity=0.410 Sum_probs=164.6
Q ss_pred hcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
..++|.+.+.||+|+||.||+|.+. ++..||||+++......++|.+|+.+|+.++||||++++++|.+.+.+||||||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 3567888999999999999999976 488999999988766678899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
+++|+|.++|..... ..+++..+..++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+++......
T Consensus 298 ~~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 298 MTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp CTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred cCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 999999999976432 358999999999999999999999 899999999999999999999999999999875432
Q ss_pred CceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 579 SHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
........+|+.|+|||++. ..++.++|||||
T Consensus 373 -~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSl 405 (495)
T 1opk_A 373 -YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF 405 (495)
T ss_dssp -EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHH
T ss_pred -eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhH
Confidence 22233456788999999876 789999999996
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-33 Score=289.01 Aligned_cols=190 Identities=22% Similarity=0.391 Sum_probs=145.2
Q ss_pred HhcCCCccceeecccCceEEEEEEecC-C---CEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCe
Q 007254 419 SATSNFLAENLIGKGGSSQVYKGCLPD-G---KELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 491 (611)
Q Consensus 419 ~~~~~f~~~~~IG~G~fG~Vyk~~~~~-g---~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 491 (611)
...++|.+.+.||+|+||.||+|.+.. + ..||||+++.. ....+.+.+|+++++.++||||+++++++...+.
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 445789999999999999999998653 3 27999999764 3456889999999999999999999999987665
Q ss_pred E------EEEEEcCCCCCHHHHHhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcE
Q 007254 492 L------LLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 563 (611)
Q Consensus 492 ~------~lV~Ey~~~gsL~~~L~~~~--~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~v 563 (611)
. ++||||+.+|+|.+++.... .....+++.++..++.|++.||.|||+ ++|+||||||+||||+.++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCE
Confidence 4 99999999999999986432 223368999999999999999999999 899999999999999999999
Q ss_pred EEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 564 QLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 564 KL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
||+|||+|+...............||+.|+|||... ..++.++|||||
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 225 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAF 225 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhH
Confidence 999999998876544333444567889999999876 779999999996
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-32 Score=286.58 Aligned_cols=188 Identities=26% Similarity=0.433 Sum_probs=162.1
Q ss_pred cCCCccceeecccCceEEEEEEec--------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP--------DGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED 489 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~--------~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 489 (611)
.++|.+.+.||+|+||.||+|... ++..||||+++.. ......+.+|+++++.+ +||||++++++|.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 467889999999999999999863 4678999999864 34567899999999999 899999999999999
Q ss_pred CeEEEEEEcCCCCCHHHHHhcCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE
Q 007254 490 NNLLLVYDFLSRGSLEENLHGNKKD------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557 (611)
Q Consensus 490 ~~~~lV~Ey~~~gsL~~~L~~~~~~------------~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl 557 (611)
+.+|+||||+++|+|.+++...... ...+++.++..++.||+.||.|||+ .+|+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEE
Confidence 9999999999999999999865421 2348999999999999999999999 899999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 558 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 558 ~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+.++.+||+|||+++...............||+.|+|||+.. ..++.++|||||
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 245 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 245 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHH
Confidence 999999999999999876654433444567889999999775 778999999996
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-32 Score=294.92 Aligned_cols=181 Identities=22% Similarity=0.310 Sum_probs=153.1
Q ss_pred CCCccceeecccCceEEEEEEecCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcC--CCCeeeEEEEEEeCCeEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLH--HKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~~~lV~ 496 (611)
.+|.+.+.||+|+||.||++...+++.||||+++.. ......+.+|+.+|..++ ||||+++++++...+.+||||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 358889999999999999999888999999999653 345678999999999997 599999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
| +.+++|.+++.... .+++.++..++.||+.||.|||+ .+||||||||+||||+ ++.+||+|||+|+.+..
T Consensus 136 E-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp E-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred e-cCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 9 56889999998653 48899999999999999999999 8999999999999995 57999999999998765
Q ss_pred CCCceeecCCccCCCcccceecc------------CCCcCcceEEeC
Q 007254 577 SSSHITCTDVAGTFGYVVLILNP------------IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~~~~~~~~~GT~~Y~aPE~~~------------~~~~~~sDiWSL 611 (611)
..........+||+.|+|||++. ..|+.++|||||
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSl 253 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 253 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHH
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHH
Confidence 54443445678999999999864 368999999996
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-33 Score=307.99 Aligned_cols=185 Identities=21% Similarity=0.390 Sum_probs=161.6
Q ss_pred hcCCCccceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 499 (611)
..++|.+.+.||+|+||.||+|.+.++..||||+++......+.|.+|+.+|+.++||||+++++++. .+.+|+||||+
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~ 264 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM 264 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence 45678889999999999999999988889999999987666789999999999999999999999986 66789999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~ 579 (611)
++|+|.++|..... ..+++..+..++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+.......
T Consensus 265 ~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 265 AKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp TTCBHHHHHHSHHH--HTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred CCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 99999999975321 247899999999999999999999 8999999999999999999999999999987654221
Q ss_pred ceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 580 HITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 580 ~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.......+|+.|+|||+.. ..++.++|||||
T Consensus 340 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 371 (454)
T 1qcf_A 340 -TAREGAKFPIKWTAPEAINFGSFTIKSDVWSF 371 (454)
T ss_dssp -HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred -eccCCCcccccccCHHHhccCCCCcHHHHHhH
Confidence 1123356788999999876 889999999996
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-32 Score=293.86 Aligned_cols=179 Identities=23% Similarity=0.342 Sum_probs=146.0
Q ss_pred cCCCccc-eeecccCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHH-HhcCCCCeeeEEEEEEe----CCeEE
Q 007254 421 TSNFLAE-NLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEII-TTLHHKNIISLLGFCFE----DNNLL 493 (611)
Q Consensus 421 ~~~f~~~-~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~----~~~~~ 493 (611)
.++|.+. +.||+|+||+||+|... +|+.||||+++.. ..+.+|++++ +..+||||++++++|.. .+++|
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 3466665 78999999999999865 7899999999754 3456788886 45689999999999875 56799
Q ss_pred EEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcC---CCcEEEEeecc
Q 007254 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSDFGL 570 (611)
Q Consensus 494 lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~---~~~vKL~DFGl 570 (611)
|||||+++|+|.+++..... ..+++.++..|+.||+.||.|||+ .+||||||||+||||+. ++.+||+|||+
T Consensus 136 lv~E~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeCCCCcHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEeccc
Confidence 99999999999999976432 458999999999999999999999 89999999999999997 78999999999
Q ss_pred ccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 571 AKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 571 A~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
|+...... .....+||+.|+|||++. ..|+.++|||||
T Consensus 211 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 249 (400)
T 1nxk_A 211 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 249 (400)
T ss_dssp CEECC--------------CTTCCGGGSCCCCSSSHHHHHHH
T ss_pred ccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHH
Confidence 98765432 234578999999999886 889999999996
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-32 Score=315.15 Aligned_cols=184 Identities=22% Similarity=0.275 Sum_probs=161.5
Q ss_pred HhcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeE
Q 007254 419 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 492 (611)
Q Consensus 419 ~~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 492 (611)
...++|.+.+.||+|+||.||+|... +++.||||++++.. .....+..|..+|..+ +||||+.+++++.+.+.+
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 34678999999999999999999965 68899999998632 3456788899999987 799999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccc
Q 007254 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~ 572 (611)
||||||+++|+|.+++.... .+++..+..|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK 490 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred EEEEeCcCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceee
Confidence 99999999999999998653 48999999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 573 WASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 573 ~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
....... .....+||+.|+|||++. ..|+.++|||||
T Consensus 491 ~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSl 528 (674)
T 3pfq_A 491 ENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAF 528 (674)
T ss_dssp ECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHH
T ss_pred ccccCCc--ccccccCCCcccCHhhhcCCCCCccceEech
Confidence 6543322 234678999999999876 889999999996
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-32 Score=278.37 Aligned_cols=182 Identities=23% Similarity=0.308 Sum_probs=157.8
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV 495 (611)
.++|.+.+.||+|+||.||+|... +++.||||+++.. .....++.+|+.++..+ +||||+++++++.+.+.+++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467889999999999999999975 7999999999753 34567888999999999 999999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCC---------------
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD--------------- 560 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~--------------- 560 (611)
|||+++|+|.+++.........+++.++..++.||+.||.|||+ ++|+||||||+|||++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999997643323458999999999999999999999 899999999999999844
Q ss_pred ----CcEEEEeeccccccCCCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 561 ----FEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 561 ----~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
..+||+|||++....... ...||+.|+|||+.. ..++.++|||||
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~sl 217 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFAL 217 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHH
T ss_pred cCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHH
Confidence 479999999998776533 246999999999876 366789999996
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-32 Score=292.64 Aligned_cols=177 Identities=24% Similarity=0.320 Sum_probs=151.1
Q ss_pred cceeecccCceEEEEEEec-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCC
Q 007254 426 AENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGS 503 (611)
Q Consensus 426 ~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 503 (611)
..+.||+|+||.||+|... +|+.||+|+++... .....+.+|+++|..++||||++++++|.+.+.+||||||+++|+
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 3578999999999999864 78999999998754 456789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE--cCCCcEEEEeeccccccCCCCCce
Q 007254 504 LEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL--SDDFEPQLSDFGLAKWASTSSSHI 581 (611)
Q Consensus 504 L~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl--~~~~~vKL~DFGlA~~~~~~~~~~ 581 (611)
|.+.+.... ..+++.++..++.||+.||.|||+ .+|+||||||+|||| +.++.+||+|||+++.......
T Consensus 173 L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-- 244 (373)
T 2x4f_A 173 LFDRIIDES---YNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-- 244 (373)
T ss_dssp EHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred HHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence 999887543 358999999999999999999999 899999999999999 5678999999999998765432
Q ss_pred eecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 582 TCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 582 ~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.....||+.|+|||+.. ..+++++|||||
T Consensus 245 -~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 274 (373)
T 2x4f_A 245 -LKVNFGTPEFLAPEVVNYDFVSFPTDMWSV 274 (373)
T ss_dssp -CCCCCSSCTTCCHHHHTTCBCCHHHHHHHH
T ss_pred -cccccCCCcEeChhhccCCCCCcHHhHHHH
Confidence 23457999999999876 778999999996
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-32 Score=281.28 Aligned_cols=183 Identities=25% Similarity=0.363 Sum_probs=153.7
Q ss_pred hcCCCccceeecccCceEEEEEEe-cCCCEEEEEEecCCh------hHHHHHHHHHHHHHhc---CCCCeeeEEEEEEeC
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE------DVIKEFVLEIEIITTL---HHKNIISLLGFCFED 489 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~~------~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~ 489 (611)
..++|.+.+.||+|+||.||+|.. .+|+.||||+++... .....+.+|+.+++.+ +||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467899999999999999999996 478999999986421 2234566777777666 499999999999876
Q ss_pred C-----eEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEE
Q 007254 490 N-----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 564 (611)
Q Consensus 490 ~-----~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vK 564 (611)
. .+++||||+. |+|.+++..... ..+++.++..++.||+.||.|||+ .+|+||||||+||||+.++.+|
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP--PGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT--TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEE
Confidence 5 5899999996 599999976543 348999999999999999999999 8999999999999999999999
Q ss_pred EEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 565 LSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 565 L~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
|+|||+|+....... .....||+.|+|||+.. ..++.++|||||
T Consensus 161 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 205 (308)
T 3g33_A 161 LADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSV 205 (308)
T ss_dssp ECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHH
T ss_pred EeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHH
Confidence 999999987754332 34578999999999875 889999999996
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-32 Score=284.99 Aligned_cols=174 Identities=24% Similarity=0.347 Sum_probs=137.5
Q ss_pred ceeecccCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCeEEEEEEcCCCCCH
Q 007254 427 ENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDFLSRGSL 504 (611)
Q Consensus 427 ~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 504 (611)
.+.||+|+||.||+|... +|+.||||++... ....+.+|+.++..+. ||||++++++|.+.+..|+||||+++|+|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 478999999999999975 6899999999754 3466778999999997 99999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCC---cEEEEeeccccccCCCCCce
Q 007254 505 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF---EPQLSDFGLAKWASTSSSHI 581 (611)
Q Consensus 505 ~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~---~vKL~DFGlA~~~~~~~~~~ 581 (611)
.+++.... .+++.++..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||+++.......
T Consensus 94 ~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-- 164 (325)
T 3kn6_A 94 FERIKKKK----HFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-- 164 (325)
T ss_dssp HHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--
Confidence 99997653 48999999999999999999999 8999999999999998765 899999999987665432
Q ss_pred eecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 582 TCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 582 ~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......||+.|+|||+.. ..|+.++|||||
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~Diwsl 195 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSL 195 (325)
T ss_dssp -------------------CCCCHHHHHHHH
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHH
Confidence 234568999999999876 789999999996
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-32 Score=284.86 Aligned_cols=195 Identities=23% Similarity=0.377 Sum_probs=167.1
Q ss_pred hHHHHHhcCCCccceeecccCceEEEEEEe------cCCCEEEEEEecCCh--hHHHHHHHHHHHHHhc-CCCCeeeEEE
Q 007254 414 YQDLLSATSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPSE--DVIKEFVLEIEIITTL-HHKNIISLLG 484 (611)
Q Consensus 414 ~~~l~~~~~~f~~~~~IG~G~fG~Vyk~~~------~~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l-~HpnIv~l~~ 484 (611)
...+....++|.+.+.||+|+||.||+|.+ .+++.||||+++... .....+.+|+.++..+ +||||+++++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 344445567899999999999999999974 256899999998643 4557899999999999 7999999999
Q ss_pred EEEeCC-eEEEEEEcCCCCCHHHHHhcCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCC
Q 007254 485 FCFEDN-NLLLVYDFLSRGSLEENLHGNKKD------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVK 551 (611)
Q Consensus 485 ~~~~~~-~~~lV~Ey~~~gsL~~~L~~~~~~------------~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLK 551 (611)
+|...+ .+|+||||+++|+|.+++...... ...+++..+..++.|++.||.|||+ .+|+|||||
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dik 175 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLA 175 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCCS
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccCc
Confidence 998754 589999999999999999865431 1238899999999999999999999 899999999
Q ss_pred CCCEEEcCCCcEEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 552 SSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 552 p~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
|+|||++.++.+||+|||+++...............||+.|+|||+.. ..++.++|||||
T Consensus 176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 236 (316)
T 2xir_A 176 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 236 (316)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred cceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHH
Confidence 999999999999999999999877655555556678999999999875 889999999996
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-32 Score=280.65 Aligned_cols=182 Identities=25% Similarity=0.315 Sum_probs=153.9
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
.++|.+.+.||+|+||.||+|... +|+.||||++.... ...+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 367999999999999999999975 68999999986543 34677889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
||+++++|.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 82 e~~~~~~l~~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 82 EYCDHTVLHELDRYQR----GVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp ECCSEEHHHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EeCCCchHHHHHhhhc----CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 9999999998886543 48999999999999999999999 8999999999999999999999999999987764
Q ss_pred CCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 577 SSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
... ......||+.|+|||+.. ..++.++|||||
T Consensus 155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 189 (311)
T 4agu_A 155 PSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAI 189 (311)
T ss_dssp -------------GGGCCHHHHHTCSCCCTHHHHHHH
T ss_pred ccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHH
Confidence 332 223568999999999764 678999999996
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-32 Score=275.56 Aligned_cols=181 Identities=27% Similarity=0.404 Sum_probs=160.0
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
.++|.+.+.||+|+||.||+|... +|+.||+|+++.. ......+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 568999999999999999999865 6899999999653 345677889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCc---EEEEeeccccc
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE---PQLSDFGLAKW 573 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~---vKL~DFGlA~~ 573 (611)
||+++|+|.+.+.... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++. +||+|||++..
T Consensus 85 e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 9999999999887543 48999999999999999999999 89999999999999987655 99999999987
Q ss_pred cCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 574 ASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
...... .....||+.|+|||+.. ..++.++|||||
T Consensus 158 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 193 (284)
T 3kk8_A 158 VNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWAC 193 (284)
T ss_dssp CCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred cccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHH
Confidence 765432 23468999999999876 778999999996
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.5e-33 Score=289.58 Aligned_cols=184 Identities=21% Similarity=0.415 Sum_probs=155.1
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCE----EEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKE----LAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~----vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 493 (611)
.++|.+.+.||+|+||.||+|.+. +++. ||+|.+.... .....+.+|+.++..++||||++++++|. .+..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 357889999999999999999864 4554 7888875432 33456788999999999999999999986 56789
Q ss_pred EEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccc
Q 007254 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (611)
Q Consensus 494 lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~ 573 (611)
+||||+.+|+|.+++.... ..+++..+..++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+|+.
T Consensus 91 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHR---GALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEECCTTCBSHHHHHSSG---GGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEEeCCCCCHHHHHHHcc---ccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccc
Confidence 9999999999999997542 358889999999999999999999 8999999999999999999999999999998
Q ss_pred cCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 574 ASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
..............||+.|+|||+.. ..++.++|||||
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 203 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSY 203 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHH
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHh
Confidence 87665554556678999999999876 889999999996
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.2e-33 Score=290.88 Aligned_cols=175 Identities=21% Similarity=0.219 Sum_probs=150.1
Q ss_pred cCCCccceeecccCceEEEEEEecCCCEEEEEEecCCh---------hHHHHHHHHHHHHHhcC---------CCCeeeE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE---------DVIKEFVLEIEIITTLH---------HKNIISL 482 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~---------~~~~~~~~Ei~il~~l~---------HpnIv~l 482 (611)
.++|.+.+.||+|+||.||+|.. +|+.||||+++... ...+.+.+|+.+|+.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35688899999999999999988 78999999997542 23478899999999886 8888888
Q ss_pred EEEEE------------------------------eCCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHH
Q 007254 483 LGFCF------------------------------EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE 532 (611)
Q Consensus 483 ~~~~~------------------------------~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~ 532 (611)
++++. ..+.+||||||+++|++.+.+.+ ..+++.++..++.||+.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHH
Confidence 88753 26789999999999977776643 24899999999999999
Q ss_pred HHHHHH-cCCCCCeEecCCCCCCEEEcCCC--------------------cEEEEeeccccccCCCCCceeecCCccCCC
Q 007254 533 ALEYLH-SGSAQRVIHRDVKSSNILLSDDF--------------------EPQLSDFGLAKWASTSSSHITCTDVAGTFG 591 (611)
Q Consensus 533 aL~yLH-~~~~~~IvHrDLKp~NILl~~~~--------------------~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~ 591 (611)
||.||| + .+||||||||+||||+.++ .+||+|||+|+..... ..+||+.
T Consensus 173 aL~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~ 242 (336)
T 2vuw_A 173 SLAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDV 242 (336)
T ss_dssp HHHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCC
T ss_pred HHHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeec
Confidence 999999 8 8999999999999999887 8999999999977643 2489999
Q ss_pred cccceeccCCCcCcceEEeC
Q 007254 592 YVVLILNPIAFLFMFNCWFF 611 (611)
Q Consensus 592 Y~aPE~~~~~~~~~sDiWSL 611 (611)
|+|||+.....++++|||||
T Consensus 243 y~aPE~~~g~~~~~~Diwsl 262 (336)
T 2vuw_A 243 SMDEDLFTGDGDYQFDIYRL 262 (336)
T ss_dssp TTCSGGGCCCSSHHHHHHHH
T ss_pred ccChhhhcCCCccceehhhh
Confidence 99999987555999999995
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-32 Score=300.40 Aligned_cols=181 Identities=25% Similarity=0.396 Sum_probs=158.6
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh--------------hHHHHHHHHHHHHHhcCCCCeeeEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--------------DVIKEFVLEIEIITTLHHKNIISLLGF 485 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~--------------~~~~~~~~Ei~il~~l~HpnIv~l~~~ 485 (611)
.++|.+.+.||+|+||.||+|... +++.||||+++... .....+.+|+.+|+.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 567999999999999999999965 68899999997532 235678999999999999999999999
Q ss_pred EEeCCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCC---c
Q 007254 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF---E 562 (611)
Q Consensus 486 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~---~ 562 (611)
|.+.+.+|+||||+++|+|.+.+.... .+++..+..++.||+.||.|||+ .+|+||||||+||||+.++ .
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRH----KFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSS
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCcc
Confidence 999999999999999999999987643 48999999999999999999999 8999999999999998776 6
Q ss_pred EEEEeeccccccCCCCCceeecCCccCCCcccceeccCCCcCcceEEeC
Q 007254 563 PQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNPIAFLFMFNCWFF 611 (611)
Q Consensus 563 vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~~~~sDiWSL 611 (611)
+||+|||+|+...... ......||+.|+|||++...|+.++|||||
T Consensus 188 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~Diwsl 233 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLKKKYNEKCDVWSC 233 (504)
T ss_dssp EEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTTCBCTHHHHHHH
T ss_pred EEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhccCCCchHHHHHH
Confidence 9999999998876543 234568999999999988889999999996
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=8.5e-33 Score=287.13 Aligned_cols=194 Identities=19% Similarity=0.337 Sum_probs=165.4
Q ss_pred HHHHHhcCCCccceeecccCceEEEEEEec------CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEE
Q 007254 415 QDLLSATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFC 486 (611)
Q Consensus 415 ~~l~~~~~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 486 (611)
+++....++|.+.+.||+|+||.||+|... +++.||||+++... .....+.+|+.+++.++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 344455678999999999999999999754 46789999997643 4556789999999999999999999999
Q ss_pred EeCCeEEEEEEcCCCCCHHHHHhcCC------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCC
Q 007254 487 FEDNNLLLVYDFLSRGSLEENLHGNK------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD 560 (611)
Q Consensus 487 ~~~~~~~lV~Ey~~~gsL~~~L~~~~------~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~ 560 (611)
.+.+..|+||||+++|+|.+++.... .....+++..+..++.|++.||.|||+ ++|+||||||+||||+.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAED 174 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTT
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCC
Confidence 99999999999999999999987532 112357899999999999999999999 899999999999999999
Q ss_pred CcEEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 561 FEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 561 ~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+.+||+|||+++...............||+.|+|||+.. ..++.++|||||
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 226 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 226 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHH
Confidence 999999999998776544333344567899999999875 789999999996
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-32 Score=300.36 Aligned_cols=181 Identities=23% Similarity=0.398 Sum_probs=160.7
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 495 (611)
.++|.+.+.||+|+||.||+|... +|+.||||+++... .....+.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 467999999999999999999975 79999999997542 3456789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
|||+++|+|.+++.... .+++.++..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 95 ~E~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 95 MEYVSGGELFDYICKNG----RLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EECCSSEEHHHHTTSSS----SCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 99999999999997543 48999999999999999999999 899999999999999999999999999999876
Q ss_pred CCCCceeecCCccCCCcccceecc-CCC-cCcceEEeC
Q 007254 576 TSSSHITCTDVAGTFGYVVLILNP-IAF-LFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~~-~~~-~~~sDiWSL 611 (611)
... .....+||+.|+|||+.. ..+ +.++|||||
T Consensus 168 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl 202 (476)
T 2y94_A 168 DGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSS 202 (476)
T ss_dssp TTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHH
T ss_pred ccc---cccccCCCcCeEChhhccCCCCCCCcceehhh
Confidence 543 234568999999999876 444 789999996
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-32 Score=277.71 Aligned_cols=184 Identities=23% Similarity=0.409 Sum_probs=163.1
Q ss_pred cCCCccceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 500 (611)
.++|.+.+.||+|+||.||+|...+++.||+|+++......+.+.+|+++++.++||||+++++++.+.+..|+||||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 45788899999999999999998888899999998876556789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCc
Q 007254 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (611)
Q Consensus 501 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~ 580 (611)
+|+|.+++.... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 87 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~ 159 (267)
T 3t9t_A 87 HGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-Y 159 (267)
T ss_dssp TCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-H
T ss_pred CCcHHHHHhhCc---ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEccccccccccccc-c
Confidence 999999997653 358999999999999999999999 899999999999999999999999999998765421 1
Q ss_pred eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 581 ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 581 ~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.......||+.|+|||... ..++.++|||||
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 191 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSF 191 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred cccccccccccccChhhhcCCCccchhchhhh
Confidence 1223456788999999876 888999999996
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-32 Score=282.69 Aligned_cols=181 Identities=23% Similarity=0.331 Sum_probs=160.6
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh-------hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 492 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~-------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 492 (611)
.++|.+.+.||+|+||.||+|... +|+.||||+++... .....+.+|+.+++.++||||+++++++.+.+.+
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 356889999999999999999965 68999999997532 1367899999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCC----cEEEEee
Q 007254 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF----EPQLSDF 568 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~----~vKL~DF 568 (611)
|+||||+++++|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++ .+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC----SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 9999999999999999754 348999999999999999999999 8999999999999999888 7999999
Q ss_pred ccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 569 GLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 569 GlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
|+++....... .....||+.|+|||+.. ..++.++|||||
T Consensus 164 g~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 204 (321)
T 2a2a_A 164 GLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSI 204 (321)
T ss_dssp TTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred ccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHH
Confidence 99988765432 23567999999999876 788999999996
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-32 Score=275.18 Aligned_cols=183 Identities=25% Similarity=0.442 Sum_probs=142.1
Q ss_pred cCCCccceeecccCceEEEEEEe-cCCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 495 (611)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... .....+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46789999999999999999986 479999999997542 2357789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
|||+++++|.+++.... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV---KPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EECCTTEEHHHHHHTCS---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 99999999999997542 358999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 576 TSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.... ......||+.|+|||+.. ..++.++|||||
T Consensus 164 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 198 (278)
T 3cok_A 164 MPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSL 198 (278)
T ss_dssp ------------------------------CTHHHHH
T ss_pred CCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHH
Confidence 4322 123467999999999876 778999999996
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-32 Score=288.46 Aligned_cols=192 Identities=25% Similarity=0.296 Sum_probs=157.2
Q ss_pred HHHhcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC------hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q 007254 417 LLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS------EDVIKEFVLEIEIITTLHHKNIISLLGFCFED 489 (611)
Q Consensus 417 l~~~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 489 (611)
+....++|.+.+.||+|+||.||+|... +++.||+|+++.. ....+.+.+|+.+++.++||||++++++|.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 3445678999999999999999999864 7889999998653 24567899999999999999999999999999
Q ss_pred CeEEEEEEcCCCCCHHHHHhcCCCC------------------------------------CCCCCHHHHHHHHHHHHHH
Q 007254 490 NNLLLVYDFLSRGSLEENLHGNKKD------------------------------------PAAFGWSERYKVAMGVAEA 533 (611)
Q Consensus 490 ~~~~lV~Ey~~~gsL~~~L~~~~~~------------------------------------~~~l~~~~~~~ia~qia~a 533 (611)
+..|+||||+++|+|.+++...... ...+++..+..++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999998521110 1224677888999999999
Q ss_pred HHHHHcCCCCCeEecCCCCCCEEEcCCC--cEEEEeeccccccCCCC--CceeecCCccCCCcccceecc---CCCcCcc
Q 007254 534 LEYLHSGSAQRVIHRDVKSSNILLSDDF--EPQLSDFGLAKWASTSS--SHITCTDVAGTFGYVVLILNP---IAFLFMF 606 (611)
Q Consensus 534 L~yLH~~~~~~IvHrDLKp~NILl~~~~--~vKL~DFGlA~~~~~~~--~~~~~~~~~GT~~Y~aPE~~~---~~~~~~s 606 (611)
|.|||+ .+|+||||||+||||+.++ .+||+|||+|+.+.... .........||+.|+|||+.. ..++.++
T Consensus 181 l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 999999 8999999999999998776 89999999998764422 222344678999999999764 6789999
Q ss_pred eEEeC
Q 007254 607 NCWFF 611 (611)
Q Consensus 607 DiWSL 611 (611)
|||||
T Consensus 258 Diwsl 262 (345)
T 3hko_A 258 DAWSA 262 (345)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99996
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-32 Score=280.33 Aligned_cols=184 Identities=29% Similarity=0.463 Sum_probs=158.1
Q ss_pred CCCccceeecccCceEEEEEEe-----cCCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CeE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNL 492 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~-----~~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~ 492 (611)
++|.+.+.||+|+||.||+|.+ .+++.||||+++... .....+.+|+++++.++||||+++++++.+. +.+
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 3477889999999999999983 368899999998643 3457889999999999999999999999876 678
Q ss_pred EEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccc
Q 007254 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~ 572 (611)
++||||+++|+|.+++.... ..+++.++..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK---NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcccccc
Confidence 99999999999999996543 358999999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCc-eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 573 WASTSSSH-ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 573 ~~~~~~~~-~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
........ .......||..|+|||+.. ..++.++|||||
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 215 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSF 215 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHH
Confidence 87665432 2334567899999999775 788999999996
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-32 Score=299.77 Aligned_cols=178 Identities=25% Similarity=0.314 Sum_probs=149.5
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC------C
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED------N 490 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~ 490 (611)
.++|.+.+.||+|+||.||+|... +|+.||||++... ....+++.+|+.+|+.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 578999999999999999999864 7899999999763 34567889999999999999999999999654 4
Q ss_pred eEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecc
Q 007254 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (611)
Q Consensus 491 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGl 570 (611)
.+||||||+.+ +|.+.+.. .+++..+..++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 67999999976 57677642 28899999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 571 AKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 571 A~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
|+...... ..+..+||+.|+|||++. ..|+.++|||||
T Consensus 211 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 249 (464)
T 3ttj_A 211 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSV 249 (464)
T ss_dssp C-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHH
T ss_pred eeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHH
Confidence 98776532 234578999999999876 789999999996
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-32 Score=280.23 Aligned_cols=185 Identities=21% Similarity=0.371 Sum_probs=161.6
Q ss_pred hcCCCccceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 499 (611)
..++|.+.+.||+|+||.||+|...+++.||||+++......+.+.+|+++++.++||||+++++++. .+..++||||+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 45678899999999999999999888889999999877666788999999999999999999999986 45689999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~ 579 (611)
++++|.+++..... ..+++.++..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 90 ~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 90 ENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp TTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 99999999964321 248999999999999999999999 8999999999999999999999999999988765332
Q ss_pred ceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 580 HITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 580 ~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.......||+.|+|||+.. ..++.++|||||
T Consensus 165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 196 (279)
T 1qpc_A 165 -TAREGAKFPIKWTAPEAINYGTFTIKSDVWSF 196 (279)
T ss_dssp -ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHH
T ss_pred -ccccCCCCccCccChhhhccCCCCchhhhHHH
Confidence 2233456788999999876 788999999996
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-32 Score=297.02 Aligned_cols=180 Identities=29% Similarity=0.479 Sum_probs=156.6
Q ss_pred hcCCCccceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-eEEEEEEc
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN-NLLLVYDF 498 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~lV~Ey 498 (611)
..++|.+.+.||+|+||.||+|.+ .|+.||||+++... ..+.|.+|+.+|+.++||||+++++++.+.+ .+|+||||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred ChHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 456788899999999999999988 57899999998765 4578999999999999999999999988765 79999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
+++|+|.+++..... ..+++..+..++.||+.||.|||+ ++||||||||+|||++.++.+||+|||+++......
T Consensus 269 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 343 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 343 (450)
T ss_dssp CTTCBHHHHHHHHCT--TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc
Confidence 999999999986532 347899999999999999999999 899999999999999999999999999998654322
Q ss_pred CceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 579 SHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
....+|+.|+|||... ..++.++|||||
T Consensus 344 -----~~~~~~~~y~aPE~~~~~~~~~~sDvwsl 372 (450)
T 1k9a_A 344 -----DTGKLPVKWTAPEALREKKFSTKSDVWSF 372 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHH
T ss_pred -----cCCCCCcceeCHHHhcCCCCCcHHHHHHH
Confidence 2346789999999875 889999999996
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-32 Score=288.87 Aligned_cols=181 Identities=23% Similarity=0.358 Sum_probs=158.5
Q ss_pred cCCCccceeecccCceEEEEEEe-cCCCEEEEEEecCCh---------hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN 490 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~~---------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 490 (611)
.++|.+.+.||+|+||.||+|.. .+++.||||+++... .....+.+|+.+|+.++||||++++++|.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 46789999999999999999985 478999999997642 13446778999999999999999999999999
Q ss_pred eEEEEEEcCCCC-CHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeec
Q 007254 491 NLLLVYDFLSRG-SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569 (611)
Q Consensus 491 ~~~lV~Ey~~~g-sL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFG 569 (611)
.+++||||+.+| +|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHP----RLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEEEeCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeecc
Confidence 999999999777 9999997653 48999999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCCceeecCCccCCCcccceecc-CCC-cCcceEEeC
Q 007254 570 LAKWASTSSSHITCTDVAGTFGYVVLILNP-IAF-LFMFNCWFF 611 (611)
Q Consensus 570 lA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~-~~~sDiWSL 611 (611)
+++........ ....||+.|+|||+.. ..+ +.++|||||
T Consensus 176 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl 216 (335)
T 3dls_A 176 SAAYLERGKLF---YTFCGTIEYCAPEVLMGNPYRGPELEMWSL 216 (335)
T ss_dssp TCEECCTTCCB---CEECSCGGGCCHHHHTTCCBCSHHHHHHHH
T ss_pred cceECCCCCce---eccCCCccccChhhhcCCCCCCCcccchhH
Confidence 99987654432 3467999999999875 444 889999996
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-32 Score=286.85 Aligned_cols=188 Identities=24% Similarity=0.394 Sum_probs=163.1
Q ss_pred cCCCccceeecccCceEEEEEEec-CC-----CEEEEEEecCCh--hHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCe
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DG-----KELAVKILKPSE--DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNN 491 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g-----~~vAVK~lk~~~--~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 491 (611)
.++|.+.+.||+|+||.||+|... ++ +.||+|+++... .....+.+|+.++..+ +||||++++++|.+.+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 568889999999999999999864 22 479999998643 4567899999999999 89999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhcCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCC
Q 007254 492 LLLVYDFLSRGSLEENLHGNKK----------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 561 (611)
Q Consensus 492 ~~lV~Ey~~~gsL~~~L~~~~~----------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~ 561 (611)
+|+||||+++|+|.+++..... ....+++..+..++.|++.||.|||+ .+|+||||||+|||++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECCCC
Confidence 9999999999999999875321 12358999999999999999999999 8999999999999999999
Q ss_pred cEEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 562 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 562 ~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.+||+|||+++...............||+.|+|||... ..++.++|||||
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 252 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSY 252 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHH
Confidence 99999999999876655544555677899999999775 789999999996
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-32 Score=275.24 Aligned_cols=184 Identities=23% Similarity=0.327 Sum_probs=161.1
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 497 (611)
.++|.+.+.||+|+||.||+|... +++.||||+++... ...+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 457889999999999999999975 78999999996533 456788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCC
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~ 577 (611)
|+++++|.+++... ..+++.++..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 86 YCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp CCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ecCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 99999999988643 348999999999999999999999 89999999999999999999999999999876544
Q ss_pred CCceeecCCccCCCcccceecc-CC-CcCcceEEeC
Q 007254 578 SSHITCTDVAGTFGYVVLILNP-IA-FLFMFNCWFF 611 (611)
Q Consensus 578 ~~~~~~~~~~GT~~Y~aPE~~~-~~-~~~~sDiWSL 611 (611)
..........||+.|+|||+.. .. ++.++|||||
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 194 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC 194 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHH
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHH
Confidence 3333344578999999999876 44 4889999996
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-32 Score=292.20 Aligned_cols=183 Identities=25% Similarity=0.321 Sum_probs=157.1
Q ss_pred cCCCccceeecccCceEEEEEEe----cCCCEEEEEEecCCh-----hHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCC
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCL----PDGKELAVKILKPSE-----DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDN 490 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~----~~g~~vAVK~lk~~~-----~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 490 (611)
.++|.+.+.||+|+||.||++.. .+|+.||||+++... .....+.+|+++|..+ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 46789999999999999999986 378999999997532 2345677899999999 6999999999999999
Q ss_pred eEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecc
Q 007254 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (611)
Q Consensus 491 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGl 570 (611)
.+||||||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eEEEEeecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 9999999999999999997643 48999999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCceeecCCccCCCcccceecc---CCCcCcceEEeC
Q 007254 571 AKWASTSSSHITCTDVAGTFGYVVLILNP---IAFLFMFNCWFF 611 (611)
Q Consensus 571 A~~~~~~~~~~~~~~~~GT~~Y~aPE~~~---~~~~~~sDiWSL 611 (611)
++........ ......||+.|+|||+.. ..++.++|||||
T Consensus 206 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dvwsl 248 (355)
T 1vzo_A 206 SKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSL 248 (355)
T ss_dssp EEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHH
T ss_pred CeecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHH
Confidence 9876543222 233568999999999875 457899999996
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=275.19 Aligned_cols=182 Identities=26% Similarity=0.410 Sum_probs=160.9
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 495 (611)
.++|.+.+.||+|+||.||++... +++.||+|++... ......+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 357888999999999999999975 6889999998653 34567889999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
|||+++++|.+++.... .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 99999999999887543 48999999999999999999999 899999999999999999999999999998775
Q ss_pred CCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 576 TSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.... ......||+.|+|||+.. ..++.++|||||
T Consensus 167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 201 (294)
T 2rku_A 167 YDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSI 201 (294)
T ss_dssp STTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHH
T ss_pred cCcc--ccccccCCCCcCCcchhccCCCCchhhHHHH
Confidence 4332 223468999999999876 778999999996
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-32 Score=276.41 Aligned_cols=181 Identities=29% Similarity=0.430 Sum_probs=156.4
Q ss_pred hcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 494 (611)
+.++|.+.+.||+|+||.||+|... +++.||||++.... .....+.+|+.+++.++||||++++++|.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3568999999999999999999865 67899999996532 235678899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccccc
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~ 574 (611)
||||+++|+|.+.+.... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++...
T Consensus 87 v~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp EECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 999999999999997653 48999999999999999999999 89999999999999999999999999999765
Q ss_pred CCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 575 STSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 575 ~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.... .....||+.|+|||+.. ..++.++|||||
T Consensus 160 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 193 (279)
T 3fdn_A 160 PSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSL 193 (279)
T ss_dssp ------------CCCCTTCCHHHHTTCCCCTTHHHHHH
T ss_pred Cccc----ccccCCCCCccCHhHhccCCCCccchhHhH
Confidence 5432 23468999999999876 778999999996
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.9e-32 Score=282.34 Aligned_cols=182 Identities=26% Similarity=0.410 Sum_probs=161.1
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 495 (611)
.++|.+.+.||+|+||.||++... +++.||+|++... ......+.+|+.+++.++||||++++++|.+.+.+|+|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 457888999999999999999975 6889999998753 34567889999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
|||+.+++|.+++.... .+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 120 ~e~~~~~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 99999999999987543 48999999999999999999999 899999999999999999999999999998775
Q ss_pred CCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 576 TSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.... ......||+.|+|||+.. ..++.++|||||
T Consensus 193 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 227 (335)
T 2owb_A 193 YDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSI 227 (335)
T ss_dssp STTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHH
T ss_pred cCcc--cccccCCCccccCHHHhccCCCCchhhHHHH
Confidence 4332 223568999999999875 778999999996
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-32 Score=277.84 Aligned_cols=183 Identities=23% Similarity=0.368 Sum_probs=146.7
Q ss_pred cCCCccceeecccCceEEEEEEec----CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~----~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 494 (611)
.++|.+.+.||+|+||.||+|... .+..||+|+++.. ......+.+|+.+++.++||||+++++++ ..+..|+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEE
Confidence 467889999999999999999864 2457999998763 34567899999999999999999999998 4567899
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccccc
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~ 574 (611)
||||+++|+|.+++.... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 93 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECcccccccc
Confidence 999999999999997553 358999999999999999999999 89999999999999999999999999999887
Q ss_pred CCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 575 STSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 575 ~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
...... ......||+.|+|||+.. ..++.++|||||
T Consensus 167 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 203 (281)
T 1mp8_A 167 EDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMF 203 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHH
T ss_pred Cccccc-ccccCCCcccccChhhcccCCCCCccCchHH
Confidence 654322 223456788999999876 889999999996
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-32 Score=277.69 Aligned_cols=185 Identities=25% Similarity=0.405 Sum_probs=155.2
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-----------
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE----------- 488 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----------- 488 (611)
.++|.+.+.||+|+||.||+|... +|+.||||+++........+.+|+.+++.++||||++++++|.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 457889999999999999999964 78999999998777777889999999999999999999999865
Q ss_pred --CCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEE
Q 007254 489 --DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 566 (611)
Q Consensus 489 --~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~ 566 (611)
.+.+|+||||+++|+|.+++.... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHSC---GGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEEC
T ss_pred ccCCceEEEEecCCCCCHHHhhhccc---cccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEe
Confidence 357899999999999999997543 357889999999999999999999 899999999999999999999999
Q ss_pred eeccccccCCCCC------------ceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 567 DFGLAKWASTSSS------------HITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 567 DFGlA~~~~~~~~------------~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
|||+++....... ........||+.|+|||+.. ..++.++|||||
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 217 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSL 217 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHH
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHH
Confidence 9999987653211 11234567999999999875 468999999996
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-32 Score=301.12 Aligned_cols=184 Identities=22% Similarity=0.402 Sum_probs=154.5
Q ss_pred cCCCccceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 500 (611)
.++|.+.+.||+|+||.||+|.+.++..||||+++......+.|.+|+++|+.++||||+++++++.+ +.+|+||||++
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~ 261 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 261 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence 45678889999999999999999877889999998766556789999999999999999999999866 77899999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCc
Q 007254 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (611)
Q Consensus 501 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~ 580 (611)
+|+|.+++..... ..+++.++..++.||+.||.|||+ ++||||||||+|||++.++.+||+|||+++.......
T Consensus 262 ~gsL~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~- 335 (452)
T 1fmk_A 262 KGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY- 335 (452)
T ss_dssp TCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCce-
Confidence 9999999974321 348899999999999999999999 8999999999999999999999999999987764322
Q ss_pred eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 581 ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 581 ~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.......||+.|+|||... ..++.++|||||
T Consensus 336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwsl 367 (452)
T 1fmk_A 336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 367 (452)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred ecccCCcccccccCHhHHhcCCCCccccHHhH
Confidence 1223456788999999876 889999999996
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=285.51 Aligned_cols=184 Identities=27% Similarity=0.441 Sum_probs=161.5
Q ss_pred HHhcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh---------hHHHHHHHHHHHHHhc-CCCCeeeEEEEE
Q 007254 418 LSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---------DVIKEFVLEIEIITTL-HHKNIISLLGFC 486 (611)
Q Consensus 418 ~~~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~---------~~~~~~~~Ei~il~~l-~HpnIv~l~~~~ 486 (611)
....++|.+.+.||+|+||.||+|.+. +|+.||||+++... .....+.+|+.++..+ +||||++++++|
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 344567999999999999999999975 79999999997532 2356788999999999 799999999999
Q ss_pred EeCCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEE
Q 007254 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 566 (611)
Q Consensus 487 ~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~ 566 (611)
...+..|+||||+++|+|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEKV----ALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEEC
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEE
Confidence 99999999999999999999997542 48999999999999999999999 899999999999999999999999
Q ss_pred eeccccccCCCCCceeecCCccCCCcccceecc-------CCCcCcceEEeC
Q 007254 567 DFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-------IAFLFMFNCWFF 611 (611)
Q Consensus 567 DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-------~~~~~~sDiWSL 611 (611)
|||++..+..... .....||+.|+|||+.. ..++.++|||||
T Consensus 243 DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~sl 291 (365)
T 2y7j_A 243 DFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWAC 291 (365)
T ss_dssp CCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHH
T ss_pred ecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhH
Confidence 9999988765432 24578999999999763 358999999996
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-32 Score=288.13 Aligned_cols=179 Identities=28% Similarity=0.383 Sum_probs=154.7
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
.++|.+.+.||+|+||.||+|... +|+.||||++++... .+.+|++++..+ +||||++++++|.+.+.+|+||||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 456889999999999999999865 689999999976542 234688888888 799999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCC----CcEEEEeecccccc
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD----FEPQLSDFGLAKWA 574 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~----~~vKL~DFGlA~~~ 574 (611)
+++|+|.+.+.... .+++.++..++.||+.||.|||+ .+|+||||||+|||+.++ +.+||+|||+++..
T Consensus 98 ~~gg~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 98 MKGGELLDKILRQK----FFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCSCBHHHHHHTCT----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 99999999997653 48999999999999999999999 899999999999998543 35999999999977
Q ss_pred CCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 575 STSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 575 ~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
..... .....+||+.|+|||+.. ..|+.++|||||
T Consensus 171 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 206 (342)
T 2qr7_A 171 RAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSL 206 (342)
T ss_dssp BCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHH
T ss_pred cCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeH
Confidence 65432 234578999999999876 668999999996
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.8e-32 Score=285.16 Aligned_cols=177 Identities=27% Similarity=0.366 Sum_probs=155.8
Q ss_pred CCCccceeecccCceEEEEEEe-cCCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
+.|...+.||+|+||.||+|.. .+|+.||||+++.. ......+.+|+++++.++||||++++++|.+.+..||||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588889999999999999986 47899999999653 234578899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
||+. |+|.+.+.... ..+++.++..++.|++.||.|||+ .+|+||||||+||||+.++.+||+|||+++....
T Consensus 134 e~~~-g~l~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9997 58888876432 358999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCceeecCCccCCCcccceec----cCCCcCcceEEeC
Q 007254 577 SSSHITCTDVAGTFGYVVLILN----PIAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~~~~~~~~~GT~~Y~aPE~~----~~~~~~~sDiWSL 611 (611)
. ....||+.|+|||+. ...++.++|||||
T Consensus 207 ~------~~~~gt~~y~aPE~~~~~~~~~~~~~~Diwsl 239 (348)
T 1u5q_A 207 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 239 (348)
T ss_dssp B------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHH
T ss_pred C------CcccCCcceeCHhhhccccCCCCCcHHHHHHH
Confidence 3 246799999999976 3678999999996
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-32 Score=289.54 Aligned_cols=185 Identities=19% Similarity=0.251 Sum_probs=152.4
Q ss_pred hcCCCccceeecccCceEEEEEEecC------CCEEEEEEecCChhH------------HHHHHHHHHHHHhcCCCCeee
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLPD------GKELAVKILKPSEDV------------IKEFVLEIEIITTLHHKNIIS 481 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~~------g~~vAVK~lk~~~~~------------~~~~~~Ei~il~~l~HpnIv~ 481 (611)
..++|.+.+.||+|+||.||+|.+.. ++.||||++...... ...++.|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 35689999999999999999998754 478999998764311 113445666778889999999
Q ss_pred EEEEEEeC----CeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE
Q 007254 482 LLGFCFED----NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557 (611)
Q Consensus 482 l~~~~~~~----~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl 557 (611)
+++++... .++||||||+ +|+|.+++.... ..+++.++..++.||+.||.|||+ ++||||||||+||||
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill 185 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA---KRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEE
Confidence 99999864 4589999999 999999997642 359999999999999999999999 899999999999999
Q ss_pred c--CCCcEEEEeeccccccCCCCCce-----eecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 558 S--DDFEPQLSDFGLAKWASTSSSHI-----TCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 558 ~--~~~~vKL~DFGlA~~~~~~~~~~-----~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+ .++.+||+|||+|+.+....... ......||+.|+|||+.. ..++.++|||||
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 247 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEIL 247 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHH
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHH
Confidence 9 88999999999998775432211 113456999999999876 679999999996
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-32 Score=299.06 Aligned_cols=181 Identities=23% Similarity=0.391 Sum_probs=158.7
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
.++|.+.+.||+|+||.||+|... +++.||||++++. ......+.+|+++|+.++||||+++++++.+.+.+|+||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 356888999999999999999875 7899999999653 234678899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEc---CCCcEEEEeeccccc
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS---DDFEPQLSDFGLAKW 573 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~---~~~~vKL~DFGlA~~ 573 (611)
||+.+|+|.+.+.... .+++.++..++.||+.||.|||+ .+|+||||||+||||+ .++.+||+|||+|+.
T Consensus 101 e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp CCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999999999887643 48999999999999999999999 8999999999999995 556799999999987
Q ss_pred cCCCCCceeecCCccCCCcccceeccCCCcCcceEEeC
Q 007254 574 ASTSSSHITCTDVAGTFGYVVLILNPIAFLFMFNCWFF 611 (611)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~~~~sDiWSL 611 (611)
..... ......||+.|+|||+....|+.++|||||
T Consensus 174 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~Diwsl 208 (486)
T 3mwu_A 174 FQQNT---KMKDRIGTAYYIAPEVLRGTYDEKCDVWSA 208 (486)
T ss_dssp BCCC-------CCTTGGGGCCGGGGGSCCCHHHHHHHH
T ss_pred CCCCC---ccCCCcCCCCCCCHHHhCCCCCchhhHHHH
Confidence 76543 234568999999999988889999999996
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-32 Score=299.19 Aligned_cols=180 Identities=22% Similarity=0.334 Sum_probs=155.6
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 497 (611)
++|.+.+.||+|+||.||+|... ++..||||+++... .....+.+|+.+++.++||||++++++|.+.+.+|+|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 46888999999999999999975 78999999997642 335678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCC---CcEEEEeecccccc
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD---FEPQLSDFGLAKWA 574 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~---~~vKL~DFGlA~~~ 574 (611)
|+.+|+|.+.+.... .+++..+..++.||+.||.|||+ .+|+||||||+||||+.+ +.+||+|||+|+..
T Consensus 117 ~~~~g~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 117 CYKGGELFDEIIHRM----KFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp CCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 999999999887543 48999999999999999999999 899999999999999764 45999999999887
Q ss_pred CCCCCceeecCCccCCCcccceeccCCCcCcceEEeC
Q 007254 575 STSSSHITCTDVAGTFGYVVLILNPIAFLFMFNCWFF 611 (611)
Q Consensus 575 ~~~~~~~~~~~~~GT~~Y~aPE~~~~~~~~~sDiWSL 611 (611)
.... ......||+.|+|||++...|+.++|||||
T Consensus 190 ~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~Diwsl 223 (494)
T 3lij_A 190 ENQK---KMKERLGTAYYIAPEVLRKKYDEKCDVWSI 223 (494)
T ss_dssp BTTB---CBCCCCSCTTTCCHHHHTTCBCTHHHHHHH
T ss_pred CCCc---cccccCCCcCeeCHHHHcccCCCchhHHHH
Confidence 6543 234568999999999988889999999996
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-32 Score=284.63 Aligned_cols=182 Identities=21% Similarity=0.346 Sum_probs=149.1
Q ss_pred hcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 495 (611)
..++|.+.+.||+|+||.||+|... +++.||||+++... .....+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 3567899999999999999999854 78999999997543 3456788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEc-----CCCcEEEEeecc
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-----DDFEPQLSDFGL 570 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~-----~~~~vKL~DFGl 570 (611)
|||+.+ +|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+||||+ .++.+||+|||+
T Consensus 112 ~e~~~~-~L~~~~~~~~----~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 112 FEYAEN-DLKKYMDKNP----DVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EECCSE-EHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EecCCC-CHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 999974 9999997653 48999999999999999999999 8999999999999994 555699999999
Q ss_pred ccccCCCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 571 AKWASTSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 571 A~~~~~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
|+....... ......||+.|+|||+.. ..++.++|||||
T Consensus 184 a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 224 (329)
T 3gbz_A 184 ARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSI 224 (329)
T ss_dssp HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHH
T ss_pred ccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHH
Confidence 988764332 234568899999999875 458999999996
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-32 Score=279.84 Aligned_cols=183 Identities=23% Similarity=0.392 Sum_probs=151.1
Q ss_pred CCCcc-ceeecccCceEEEEEEec-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEEEE
Q 007254 422 SNFLA-ENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 422 ~~f~~-~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E 497 (611)
+.|.+ .+.||+|+||.||+|... +++.||||+++... .....+.+|++++..+ +||||+++++++.+.+.+|+|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 45666 478999999999999854 78999999997643 4567889999999884 79999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCc---EEEEeecccccc
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE---PQLSDFGLAKWA 574 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~---vKL~DFGlA~~~ 574 (611)
|+++|+|.+++.... .+++.++..++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||+++..
T Consensus 92 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 92 KMRGGSILSHIHKRR----HFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp CCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred cCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 999999999997653 48999999999999999999999 89999999999999998776 999999999876
Q ss_pred CCCCC-----ceeecCCccCCCcccceecc------CCCcCcceEEeC
Q 007254 575 STSSS-----HITCTDVAGTFGYVVLILNP------IAFLFMFNCWFF 611 (611)
Q Consensus 575 ~~~~~-----~~~~~~~~GT~~Y~aPE~~~------~~~~~~sDiWSL 611 (611)
..... ........||+.|+|||+.. ..++.++|||||
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diwsl 212 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSL 212 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhH
Confidence 43211 11223467999999999864 458999999996
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-32 Score=294.45 Aligned_cols=181 Identities=25% Similarity=0.404 Sum_probs=147.9
Q ss_pred hcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh---------hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---------DVIKEFVLEIEIITTLHHKNIISLLGFCFED 489 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~---------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 489 (611)
..++|.+.+.||+|+||.||+|... +++.||||++.+.. .....+.+|+.+|+.++||||+++++++. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 3578999999999999999999865 68999999987532 12335789999999999999999999974 5
Q ss_pred CeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCC---cEEEE
Q 007254 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF---EPQLS 566 (611)
Q Consensus 490 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~---~vKL~ 566 (611)
+.+|+||||+++|+|.+++.... .+++.++..++.|++.||.|||+ ++|+||||||+||||+.++ .+||+
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSC----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred CceEEEEEcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEe
Confidence 66899999999999999886543 58999999999999999999999 8999999999999997544 59999
Q ss_pred eeccccccCCCCCceeecCCccCCCcccceecc----CCCcCcceEEeC
Q 007254 567 DFGLAKWASTSSSHITCTDVAGTFGYVVLILNP----IAFLFMFNCWFF 611 (611)
Q Consensus 567 DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~----~~~~~~sDiWSL 611 (611)
|||+|+...... .....+||+.|+|||+.. ..|+.++|||||
T Consensus 285 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Diwsl 330 (419)
T 3i6u_A 285 DFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSL 330 (419)
T ss_dssp CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHH
T ss_pred ecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhH
Confidence 999999876533 234578999999999863 678999999996
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-32 Score=273.79 Aligned_cols=181 Identities=30% Similarity=0.492 Sum_probs=145.6
Q ss_pred cCCCccceeecccCceEEEEEEecCCCEEEEEEecCCh-----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 495 (611)
.++|.+.+.||+|+||.||+|.+ .|+.||||+++... ...+.+.+|+++++.++||||++++++|.+.+..|+|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 46889999999999999999997 58899999997642 2357789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcC--------CCcEEEEe
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD--------DFEPQLSD 567 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~--------~~~vKL~D 567 (611)
|||+++++|.+++... .+++..+..++.|++.||.|||+.+..+|+||||||+|||++. ++.+||+|
T Consensus 85 ~e~~~~~~L~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGK-----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EECCTTEEHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEcCCCCCHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 9999999999998532 4899999999999999999999922222999999999999986 67899999
Q ss_pred eccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 568 FGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 568 FGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
||+++....... ....||+.|+|||+.. ..++.++|||||
T Consensus 160 fg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 200 (271)
T 3dtc_A 160 FGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSY 200 (271)
T ss_dssp CCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHH
T ss_pred CCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHH
Confidence 999987655332 2457999999999876 778999999996
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-32 Score=275.39 Aligned_cols=180 Identities=25% Similarity=0.390 Sum_probs=157.2
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-----------
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE----------- 488 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----------- 488 (611)
.++|.+.+.||+|+||.||+|... +|+.||||+++... ..+.+|+++++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 356888999999999999999976 79999999998654 346689999999999999999999864
Q ss_pred -----CCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcE
Q 007254 489 -----DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 563 (611)
Q Consensus 489 -----~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~v 563 (611)
...+|+||||+++|+|.+++..... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEE
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCCE
Confidence 3458999999999999999975422 358999999999999999999999 899999999999999999999
Q ss_pred EEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 564 QLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 564 KL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
||+|||+++....... .....||+.|+|||+.. ..++.++|||||
T Consensus 162 kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 207 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYAL 207 (284)
T ss_dssp EECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHH
T ss_pred EECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHH
Confidence 9999999988765432 23467999999999875 778999999996
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=272.96 Aligned_cols=180 Identities=25% Similarity=0.373 Sum_probs=156.4
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh-------hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~-------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 493 (611)
++|.+.+.||+|+||.||+|... +|+.||+|+++... ...+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46889999999999999999976 78999999987532 13678999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCC----cEEEEeec
Q 007254 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF----EPQLSDFG 569 (611)
Q Consensus 494 lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~----~vKL~DFG 569 (611)
+||||+++++|.+++.... .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++ .+||+|||
T Consensus 85 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE----SLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEeecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 9999999999999997543 48999999999999999999999 8999999999999999877 89999999
Q ss_pred cccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 570 LAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 570 lA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
++........ .....||+.|+|||+.. ..++.++|||||
T Consensus 158 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 197 (283)
T 3bhy_A 158 IAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSI 197 (283)
T ss_dssp TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred cceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhH
Confidence 9987755332 23467999999999876 788999999996
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-32 Score=279.35 Aligned_cols=179 Identities=23% Similarity=0.386 Sum_probs=157.0
Q ss_pred cCCCccceeecccCceEEEEEEec-CC-------CEEEEEEecCCh-hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCe
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DG-------KELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 491 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g-------~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 491 (611)
.++|.+.+.||+|+||.||+|... ++ ..||+|+++... ...+.+.+|+.+++.++||||++++++|.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 457889999999999999999854 33 479999997644 556789999999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCc--------E
Q 007254 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE--------P 563 (611)
Q Consensus 492 ~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~--------v 563 (611)
.|+||||+++|+|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+||||+.++. +
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNK---NCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CEEEEECCCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCccccccccee
Confidence 999999999999999997653 348999999999999999999999 89999999999999998887 9
Q ss_pred EEEeeccccccCCCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 564 QLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 564 KL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
||+|||++...... ....||+.|+|||+.. ..++.++|||||
T Consensus 161 kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl 204 (289)
T 4fvq_A 161 KLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSF 204 (289)
T ss_dssp EECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHH
T ss_pred eeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHH
Confidence 99999999765432 2356899999999765 678999999996
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.9e-32 Score=277.85 Aligned_cols=186 Identities=27% Similarity=0.430 Sum_probs=150.0
Q ss_pred cCCCccceeecccCceEEEEEEe-cCCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 495 (611)
.++|.+.+.||+|+||.||+|.. .+|+.||||+++.. ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 45789999999999999999986 47899999999752 34567899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
|||+++|+|.+++.........+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 99999999999987533233468999999999999999999999 899999999999999999999999999998766
Q ss_pred CCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 576 TSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.... ......||+.|+|||+.. ..++.++|||||
T Consensus 188 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 222 (310)
T 2wqm_A 188 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSL 222 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHH
T ss_pred CCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHH
Confidence 5332 223467999999999775 788999999996
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=9.6e-32 Score=280.42 Aligned_cols=185 Identities=26% Similarity=0.354 Sum_probs=149.7
Q ss_pred HhcCCCccceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHh--cCCCCeeeEEEEEEeC----CeE
Q 007254 419 SATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITT--LHHKNIISLLGFCFED----NNL 492 (611)
Q Consensus 419 ~~~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~~----~~~ 492 (611)
...++|.+.+.||+|+||.||+|.. +|+.||||++..... ..+..|.+++.. ++||||+++++++... +.+
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 110 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEE--ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred ccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEecccc--chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence 3456899999999999999999988 489999999976543 344555666555 4999999999999887 789
Q ss_pred EEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCCeEecCCCCCCEEEcCCCcEEEEe
Q 007254 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS-----AQRVIHRDVKSSNILLSDDFEPQLSD 567 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~-----~~~IvHrDLKp~NILl~~~~~vKL~D 567 (611)
|+||||+++|+|.+++... .+++..+..++.|++.||.|||+.. ..+|+||||||+||||+.++.+||+|
T Consensus 111 ~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D 185 (337)
T 3mdy_A 111 YLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185 (337)
T ss_dssp EEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred EEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence 9999999999999999754 3899999999999999999999820 12999999999999999999999999
Q ss_pred eccccccCCCCCc--eeecCCccCCCcccceecc-CCCcC------cceEEeC
Q 007254 568 FGLAKWASTSSSH--ITCTDVAGTFGYVVLILNP-IAFLF------MFNCWFF 611 (611)
Q Consensus 568 FGlA~~~~~~~~~--~~~~~~~GT~~Y~aPE~~~-~~~~~------~sDiWSL 611 (611)
||+|+........ .......||+.|+|||+.. ..++. ++|||||
T Consensus 186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Diwsl 238 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSF 238 (337)
T ss_dssp CTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHH
T ss_pred CCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHH
Confidence 9999876544322 1223568999999999875 33444 3999996
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=6.1e-32 Score=277.13 Aligned_cols=182 Identities=27% Similarity=0.459 Sum_probs=145.2
Q ss_pred cCCCccceeecccCceEEEEEEecCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 497 (611)
.++|.+.+.||+|+||.||+|.+. ..||||+++.. ....+.|.+|+.+++.++||||+++++++ ..+.+++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 467889999999999999999864 35999999753 34567899999999999999999999965 5567899999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCC
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~ 577 (611)
|+++++|.+++.... ..+++.++..++.|++.||.|||+ .+|+||||||+||||+.++.+||+|||+++.....
T Consensus 100 ~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 100 WCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp CCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred ecCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccccccc
Confidence 999999999996543 458999999999999999999999 89999999999999999999999999999876643
Q ss_pred CCceeecCCccCCCcccceecc----CCCcCcceEEeC
Q 007254 578 SSHITCTDVAGTFGYVVLILNP----IAFLFMFNCWFF 611 (611)
Q Consensus 578 ~~~~~~~~~~GT~~Y~aPE~~~----~~~~~~sDiWSL 611 (611)
..........||+.|+|||+.. ..++.++|||||
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~sl 211 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAF 211 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHH
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHH
Confidence 3333445578999999999763 678899999996
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.4e-32 Score=282.19 Aligned_cols=181 Identities=28% Similarity=0.426 Sum_probs=148.2
Q ss_pred hcCCCccceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHH--HHhcCCCCeeeEEEEEEe-----CCeE
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEI--ITTLHHKNIISLLGFCFE-----DNNL 492 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~i--l~~l~HpnIv~l~~~~~~-----~~~~ 492 (611)
..++|.+.+.||+|+||.||+|.. +++.||||+++.... ..+..|.++ +..++||||+++++.+.. ...+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR--QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch--hhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 357899999999999999999977 789999999976543 344444444 456899999999987643 2367
Q ss_pred EEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC---------CeEecCCCCCCEEEcCCCcE
Q 007254 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ---------RVIHRDVKSSNILLSDDFEP 563 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~---------~IvHrDLKp~NILl~~~~~v 563 (611)
|+||||+++|+|.+++.... ++|..+..++.||+.||.|||+ . +||||||||+||||+.++.+
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHT-----SDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred EEEEecCCCCcHHHHHhhcc-----cchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCCcE
Confidence 99999999999999997653 5899999999999999999998 6 99999999999999999999
Q ss_pred EEEeeccccccCCCCC------ceeecCCccCCCcccceecc--------CCCcCcceEEeC
Q 007254 564 QLSDFGLAKWASTSSS------HITCTDVAGTFGYVVLILNP--------IAFLFMFNCWFF 611 (611)
Q Consensus 564 KL~DFGlA~~~~~~~~------~~~~~~~~GT~~Y~aPE~~~--------~~~~~~sDiWSL 611 (611)
||+|||+|+.+..... ........||+.|+|||+.. ..++.++|||||
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Diwsl 221 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYAL 221 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHH
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHH
Confidence 9999999987754321 12233567999999999875 356789999996
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-32 Score=299.34 Aligned_cols=181 Identities=24% Similarity=0.407 Sum_probs=161.3
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 495 (611)
.++|.+.+.||+|+||.||+|... +|+.||||++... ......+.+|+.+++.++||||++++++|.+.+.+|+|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 356888999999999999999975 7999999999653 24567899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE---cCCCcEEEEeecccc
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAK 572 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl---~~~~~vKL~DFGlA~ 572 (611)
|||+.+|+|.+.+.... .+++.++..++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||+|+
T Consensus 105 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRK----RFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp ECCCCSCBHHHHHHTCS----CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 99999999999997653 48999999999999999999999 899999999999999 567899999999998
Q ss_pred ccCCCCCceeecCCccCCCcccceeccCCCcCcceEEeC
Q 007254 573 WASTSSSHITCTDVAGTFGYVVLILNPIAFLFMFNCWFF 611 (611)
Q Consensus 573 ~~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~~~~sDiWSL 611 (611)
....... .....||+.|+|||+....|+.++|||||
T Consensus 178 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~Diwsl 213 (484)
T 3nyv_A 178 HFEASKK---MKDKIGTAYYIAPEVLHGTYDEKCDVWST 213 (484)
T ss_dssp HBCCCCS---HHHHTTGGGTCCHHHHHTCCCTHHHHHHH
T ss_pred Ecccccc---cccCCCCccccCceeecCCCCCcceeHHH
Confidence 8765432 23467999999999888889999999996
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-32 Score=292.54 Aligned_cols=183 Identities=23% Similarity=0.366 Sum_probs=158.5
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC--eEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN--NLLLVY 496 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~~lV~ 496 (611)
++|.+.+.||+|+||.||+|... +|+.||||+++... .....+.+|+++++.++||||+++++++...+ ..|+||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 56889999999999999999975 58999999998643 34577889999999999999999999998755 789999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE----cCCCcEEEEeecccc
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL----SDDFEPQLSDFGLAK 572 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl----~~~~~vKL~DFGlA~ 572 (611)
||+++|+|.+++..... ...+++.++..++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||+|+
T Consensus 89 e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp CCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred ecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999975432 2348999999999999999999999 899999999999999 777889999999998
Q ss_pred ccCCCCCceeecCCccCCCcccceecc---------CCCcCcceEEeC
Q 007254 573 WASTSSSHITCTDVAGTFGYVVLILNP---------IAFLFMFNCWFF 611 (611)
Q Consensus 573 ~~~~~~~~~~~~~~~GT~~Y~aPE~~~---------~~~~~~sDiWSL 611 (611)
...... ......||+.|+|||+.. ..++.++|||||
T Consensus 165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSl 209 (396)
T 4eut_A 165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSI 209 (396)
T ss_dssp ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHH
T ss_pred EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHH
Confidence 776533 223568999999999763 567899999996
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=273.80 Aligned_cols=183 Identities=19% Similarity=0.203 Sum_probs=158.9
Q ss_pred cCCCccceeecccCceEEEEEEe-cCCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
.++|.+.+.||+|+||.||+|.. .+|+.||||+++... ....+.+|+.++..+ +|+||+++++++.+.+..|+||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 45799999999999999999985 578999999987543 234577899999999 799999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCc-----EEEEeeccccc
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE-----PQLSDFGLAKW 573 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~-----vKL~DFGlA~~ 573 (611)
+ +++|.+++.... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++. +||+|||+|+.
T Consensus 88 ~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 88 L-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp C-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred c-CCCHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 9 999999998653 358999999999999999999999 89999999999999987776 99999999998
Q ss_pred cCCCCCc-----eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 574 ASTSSSH-----ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 574 ~~~~~~~-----~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
....... .......||+.|+|||+.. ..++.++|||||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 204 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEAL 204 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHH
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHH
Confidence 7654322 1234578999999999876 778999999996
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=272.72 Aligned_cols=178 Identities=24% Similarity=0.331 Sum_probs=155.6
Q ss_pred CCccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe----CCeEEE
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE----DNNLLL 494 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~l 494 (611)
.|.+.+.||+|+||.||+|... ++..||+|+++.. ....+.+.+|+.+++.++||||++++++|.. ...+|+
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 4677889999999999999864 6889999998753 3556789999999999999999999999875 356899
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEecCCCCCCEEEc-CCCcEEEEeeccc
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR--VIHRDVKSSNILLS-DDFEPQLSDFGLA 571 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~--IvHrDLKp~NILl~-~~~~vKL~DFGlA 571 (611)
||||+++|+|.+++.... .+++..+..++.|++.||.|||+ .+ |+||||||+|||++ .++.+||+|||++
T Consensus 107 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEecCCCCHHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 999999999999997643 48899999999999999999999 67 99999999999998 7899999999999
Q ss_pred cccCCCCCceeecCCccCCCcccceeccCCCcCcceEEeC
Q 007254 572 KWASTSSSHITCTDVAGTFGYVVLILNPIAFLFMFNCWFF 611 (611)
Q Consensus 572 ~~~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~~~~sDiWSL 611 (611)
....... .....||+.|+|||+....++.++|||||
T Consensus 180 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~Di~sl 215 (290)
T 1t4h_A 180 TLKRASF----AKAVIGTPEFMAPEMYEEKYDESVDVYAF 215 (290)
T ss_dssp GGCCTTS----BEESCSSCCCCCGGGGGTCCCTHHHHHHH
T ss_pred ccccccc----cccccCCcCcCCHHHHhccCCCcchHHHH
Confidence 7655432 23467999999999888889999999996
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-32 Score=280.94 Aligned_cols=190 Identities=24% Similarity=0.402 Sum_probs=149.1
Q ss_pred HhcCCCccceeecccCceEEEEEEec----CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-
Q 007254 419 SATSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN- 490 (611)
Q Consensus 419 ~~~~~f~~~~~IG~G~fG~Vyk~~~~----~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~- 490 (611)
...++|.+.+.||+|+||.||+|... +++.||||+++.. ......+.+|+.+++.++||||+++++++.+.+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 34577899999999999999999754 3458999999754 345678999999999999999999999998754
Q ss_pred ----eEEEEEEcCCCCCHHHHHhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEE
Q 007254 491 ----NLLLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 564 (611)
Q Consensus 491 ----~~~lV~Ey~~~gsL~~~L~~~~--~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vK 564 (611)
..++||||+++|+|.+++.... .....+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEE
Confidence 4599999999999999985432 233569999999999999999999999 8999999999999999999999
Q ss_pred EEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 565 LSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 565 L~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
|+|||+++...............||+.|+|||... ..++.++|||||
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 235 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAF 235 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHH
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHH
Confidence 99999998776544333334567889999999875 788999999996
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=277.48 Aligned_cols=180 Identities=29% Similarity=0.442 Sum_probs=156.7
Q ss_pred CccceeecccCceEEEEEEec-----CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CeEEE
Q 007254 424 FLAENLIGKGGSSQVYKGCLP-----DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLL 494 (611)
Q Consensus 424 f~~~~~IG~G~fG~Vyk~~~~-----~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~l 494 (611)
|.+.+.||+|+||.||++++. +++.||||+++... .....+.+|+++++.++||||+++++++.+. ..+++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 478899999999999998743 68899999998653 5567899999999999999999999999874 67899
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccccc
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~ 574 (611)
||||+++|+|.+++... .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 113 v~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCccccccc
Confidence 99999999999999754 28999999999999999999999 89999999999999999999999999999987
Q ss_pred CCCCCce-eecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 575 STSSSHI-TCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 575 ~~~~~~~-~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
....... ......||..|+|||+.. ..++.++|||||
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 223 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSF 223 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHH
Confidence 6644322 233567899999999876 788999999996
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=8.1e-32 Score=283.92 Aligned_cols=184 Identities=28% Similarity=0.375 Sum_probs=152.8
Q ss_pred HhcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh------hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCe
Q 007254 419 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 491 (611)
Q Consensus 419 ~~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 491 (611)
...++|.+.+.||+|+||.||+|... +|+.||||+++... .....+.+|+++++.++||||++++++|.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34678999999999999999999965 68999999997532 123468899999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccc
Q 007254 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (611)
Q Consensus 492 ~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA 571 (611)
+++||||+.+ +|.+.+.... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+|
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred eEEEEEcCCC-CHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccc
Confidence 9999999976 8988886543 358888999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 572 KWASTSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 572 ~~~~~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
+....... ......||+.|+|||+.. ..++.++|||||
T Consensus 160 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 199 (346)
T 1ua2_A 160 KSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAV 199 (346)
T ss_dssp STTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHH
T ss_pred eeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhH
Confidence 87754332 234578999999999874 568999999996
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-32 Score=283.45 Aligned_cols=181 Identities=24% Similarity=0.390 Sum_probs=149.9
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCChh--HHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
++|.+.+.||+|+||.||+|... +++.||||+++.... ....+.+|+++++.++||||+++++++.+.+.+|+||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57899999999999999999975 789999999976432 222456799999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
+. |+|.+++.... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG---NIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CS-EEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 97 59999887653 358999999999999999999999 899999999999999999999999999998765433
Q ss_pred CceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 579 SHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
. ......||+.|+|||+.. ..++.++|||||
T Consensus 155 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 187 (324)
T 3mtl_A 155 K--TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGV 187 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHH
T ss_pred c--ccccccCcccccChhhhcCCCCCCcHHHHHHH
Confidence 2 233468999999999764 678999999996
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=281.25 Aligned_cols=184 Identities=27% Similarity=0.372 Sum_probs=156.4
Q ss_pred cCCCccceeecccCceEEEEEEe-cCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--------
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFE-------- 488 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-------- 488 (611)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... .....+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 46789999999999999999997 478999999986532 335678899999999999999999999987
Q ss_pred CCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEee
Q 007254 489 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568 (611)
Q Consensus 489 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DF 568 (611)
.+.+|+||||+.+ +|.+.+.... ..+++.++..++.||+.||.|||+ .+|+||||||+||||+.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCC-CHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccc
Confidence 4568999999975 7878776543 358999999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCC--CceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 569 GLAKWASTSS--SHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 569 GlA~~~~~~~--~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
|+|+.+.... .........||+.|+|||+.. ..++.++|||||
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl 215 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGA 215 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHH
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHH
Confidence 9998765322 122334578999999999764 568999999996
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=277.04 Aligned_cols=183 Identities=20% Similarity=0.264 Sum_probs=150.0
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 495 (611)
.++|.+.+.||+|+||.||+|... +++.||||+++.. ....+.+.+|+.++..++||||+++++++...+.+|+|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 578999999999999999999965 7889999999764 23457889999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
|||+++++|.+++.... .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++....
T Consensus 113 ~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EECCCCEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 99999999999997643 48999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 576 TSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.... .......||+.|+|||+.. ..++.++|||||
T Consensus 186 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 221 (309)
T 2h34_A 186 DEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYAL 221 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHH
T ss_pred cccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHH
Confidence 5322 1223567999999999875 788999999996
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.1e-32 Score=280.70 Aligned_cols=185 Identities=26% Similarity=0.367 Sum_probs=160.6
Q ss_pred cCCCccceeecccCceEEEEEEe-----cCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCCCeeeEEEEEE--eCCeE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCF--EDNNL 492 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~-----~~g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~~ 492 (611)
.++|.+.+.||+|+||.||+|.+ .+++.||||+++... ...+.+.+|+++++.++||||+++++++. +.+.+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 35788999999999999999984 368899999998654 55677999999999999999999999987 45679
Q ss_pred EEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccc
Q 007254 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~ 572 (611)
|+||||+++|+|.+++.... ..+++.++..++.|++.||.|||+ .+|+||||||+||||+.++.+||+|||+++
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccce
Confidence 99999999999999997542 248999999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCce-eecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 573 WASTSSSHI-TCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 573 ~~~~~~~~~-~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......... ......||+.|+|||+.. ..++.++|||||
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 216 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSF 216 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHH
Confidence 876544322 233467899999999876 778999999996
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-31 Score=273.42 Aligned_cols=180 Identities=27% Similarity=0.410 Sum_probs=160.3
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
+.|.+.+.||+|+||.||+|... +++.||||+++.. ......+.+|+.+++.++||||+++++++.+.+.+|+||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 45888999999999999999864 7899999999764 34568899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
+++++|.+++... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 102 ~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 102 LGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CTTEEHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred CCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 9999999998642 48999999999999999999999 899999999999999999999999999998776533
Q ss_pred CceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 579 SHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
. ......||+.|+|||+.. ..++.++|||||
T Consensus 174 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 205 (303)
T 3a7i_A 174 I--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSL 205 (303)
T ss_dssp C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred c--ccCccCCCcCccCHHHHhcCCCCchhhhHHH
Confidence 2 234568999999999876 788999999996
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=273.06 Aligned_cols=184 Identities=24% Similarity=0.398 Sum_probs=157.9
Q ss_pred cCCCccce-eecccCceEEEEEEec---CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 007254 421 TSNFLAEN-LIGKGGSSQVYKGCLP---DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (611)
Q Consensus 421 ~~~f~~~~-~IG~G~fG~Vyk~~~~---~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 494 (611)
.++|.+.. .||+|+||.||+|.+. ++..||||+++.. ....+.+.+|+++++.++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 34566665 9999999999999853 6778999999874 35677899999999999999999999999 5667999
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccccc
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~ 574 (611)
||||+++|+|.+++.... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 87 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCCHHHHHHhCC---ccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 999999999999996432 358999999999999999999999 89999999999999999999999999999987
Q ss_pred CCCCCce-eecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 575 STSSSHI-TCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 575 ~~~~~~~-~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
....... ......||+.|+|||+.. ..++.++|||||
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 199 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSY 199 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHH
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHH
Confidence 6543322 223456789999999876 788999999996
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=279.17 Aligned_cols=182 Identities=25% Similarity=0.379 Sum_probs=153.8
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
.++|.+.+.||+|+||.||+|... +|+.||||++... ....+.+.+|+.+++.++||||++++++|.+.+.+|+||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 467889999999999999999975 5899999998653 244567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
||+++++|.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+||||+.++.+||+|||+++....
T Consensus 104 e~~~~~~l~~~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLELFPN----GLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHHSTT----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 9999999988775443 48999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 577 SSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
... ......||+.|+|||+.. ..++.++|||||
T Consensus 177 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~sl 211 (331)
T 4aaa_A 177 PGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAI 211 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHH
T ss_pred Ccc--ccCCCcCCccccCcccccCCCCcchHHHHHHH
Confidence 332 233568999999999875 478999999996
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-32 Score=281.34 Aligned_cols=190 Identities=27% Similarity=0.424 Sum_probs=156.8
Q ss_pred HHHHHhcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEe----
Q 007254 415 QDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFE---- 488 (611)
Q Consensus 415 ~~l~~~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~---- 488 (611)
.++....++|.+.+.||+|+||.||+|... +|+.||||++.........+.+|+.++..+ +||||+++++++..
T Consensus 17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 344445788999999999999999999964 789999999987665667889999999999 79999999999987
Q ss_pred --CCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEE
Q 007254 489 --DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 566 (611)
Q Consensus 489 --~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~ 566 (611)
.+.+|+||||+++|+|.+++..... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEEC
T ss_pred cccceEEEEEEcCCCCcHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEEe
Confidence 4689999999999999999976432 358899999999999999999999 899999999999999999999999
Q ss_pred eeccccccCCCCCceeecCCccCCCcccceecc------CCCcCcceEEeC
Q 007254 567 DFGLAKWASTSSSHITCTDVAGTFGYVVLILNP------IAFLFMFNCWFF 611 (611)
Q Consensus 567 DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~------~~~~~~sDiWSL 611 (611)
|||++........ ......||+.|+|||+.. ..++.++|||||
T Consensus 172 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~sl 220 (326)
T 2x7f_A 172 DFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSL 220 (326)
T ss_dssp CCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHH
T ss_pred eCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHH
Confidence 9999987654322 223467999999999763 568999999996
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=289.46 Aligned_cols=180 Identities=24% Similarity=0.314 Sum_probs=159.0
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHHHhc------CCCCeeeEEEEEEeCCeEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTL------HHKNIISLLGFCFEDNNLL 493 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l------~HpnIv~l~~~~~~~~~~~ 493 (611)
..+|.+.+.||+|+||.||+|... +++.||||+++........+.+|+.++..+ +|+||++++++|...+.+|
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 356889999999999999999865 689999999998877778888999998887 5779999999999999999
Q ss_pred EEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCc--EEEEeeccc
Q 007254 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE--PQLSDFGLA 571 (611)
Q Consensus 494 lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~--vKL~DFGlA 571 (611)
+||||+. ++|.+++..... ..+++..+..++.||+.||.|||+ .+||||||||+||||+.++. +||+|||+|
T Consensus 176 lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKNKF--QGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEECCCC-CBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEeccC-CCHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 9999995 699999876543 348999999999999999999999 89999999999999999987 999999999
Q ss_pred cccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 572 KWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 572 ~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+...... ....||+.|+|||++. ..|+.++|||||
T Consensus 250 ~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 285 (429)
T 3kvw_A 250 CYEHQRV-----YTYIQSRFYRAPEVILGARYGMPIDMWSL 285 (429)
T ss_dssp EETTCCC-----CSSCSCGGGCCHHHHHTBCCCTHHHHHHH
T ss_pred eecCCcc-----cccCCCCCccChHHHhCCCCCchHHHHhH
Confidence 8755432 3468999999999875 789999999996
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.3e-32 Score=278.79 Aligned_cols=181 Identities=24% Similarity=0.405 Sum_probs=149.5
Q ss_pred cCCCccceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 500 (611)
.++|.+.+.||+|+||.||+|.+ .++.||||+++... ..+.|.+|+++++.++||||+++++++.+ ..|+||||++
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESES-ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSSTT-HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecChh-HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 35688899999999999999988 57899999997543 45789999999999999999999998864 4799999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCc-EEEEeeccccccCCCCC
Q 007254 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE-PQLSDFGLAKWASTSSS 579 (611)
Q Consensus 501 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~-vKL~DFGlA~~~~~~~~ 579 (611)
+|+|.+++..... ...+++..+..++.|++.||.|||+.+.++|+||||||+||||+.++. +||+|||++.......
T Consensus 83 ~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~- 160 (307)
T 2eva_A 83 GGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM- 160 (307)
T ss_dssp TCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc-
Confidence 9999999976532 235789999999999999999999865578999999999999998886 7999999998665422
Q ss_pred ceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 580 HITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 580 ~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
....||+.|+|||+.. ..++.++|||||
T Consensus 161 ----~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 189 (307)
T 2eva_A 161 ----TNNKGSAAWMAPEVFEGSNYSEKCDVFSW 189 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHH
T ss_pred ----ccCCCCCceEChhhhCCCCCCcHHHHHHH
Confidence 2357999999999876 789999999996
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.7e-32 Score=288.21 Aligned_cols=184 Identities=21% Similarity=0.293 Sum_probs=151.6
Q ss_pred HHhcCCCccceeecccCceEEEEEEe-cCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--------
Q 007254 418 LSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE-------- 488 (611)
Q Consensus 418 ~~~~~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-------- 488 (611)
....++|.+.+.||+|+||.||+|.. .+|+.||||++..+... ..+|+++|+.++||||++++++|..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---HHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 34567899999999999999999986 47999999999765422 2369999999999999999999854
Q ss_pred ------------------------------CCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 007254 489 ------------------------------DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538 (611)
Q Consensus 489 ------------------------------~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH 538 (611)
..++++||||++ |+|.+.+.........+++..+..++.||+.||.|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 334899999997 5887777642222346999999999999999999999
Q ss_pred cCCCCCeEecCCCCCCEEEc-CCCcEEEEeeccccccCCCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 539 SGSAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 539 ~~~~~~IvHrDLKp~NILl~-~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
+ .+|+||||||+|||++ .++.+||+|||+|+.+..... .....||+.|+|||+.. ..|+.++|||||
T Consensus 159 ~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 228 (383)
T 3eb0_A 159 S---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSI 228 (383)
T ss_dssp T---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHH
T ss_pred H---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhH
Confidence 9 8999999999999997 688999999999997755432 23468899999999765 568999999996
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=272.67 Aligned_cols=180 Identities=27% Similarity=0.409 Sum_probs=159.6
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 495 (611)
.++|.+.+.||+|+||.||+|... +++.||||++.... .....+.+|+++++.++||||+++++++.+.+.+|+|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 467899999999999999999875 67899999997532 2356789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
|||+++|+|.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG----RFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp ECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 99999999999997653 48899999999999999999999 899999999999999999999999999997665
Q ss_pred CCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 576 TSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
... .....||+.|+|||+.. ..++.++|||||
T Consensus 166 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 198 (284)
T 2vgo_A 166 SLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCA 198 (284)
T ss_dssp SSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHH
T ss_pred ccc----cccccCCCCcCCHHHhccCCCCcccchhhH
Confidence 432 23468999999999876 778999999996
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-32 Score=285.85 Aligned_cols=180 Identities=23% Similarity=0.377 Sum_probs=159.2
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 497 (611)
.++|.+.+.||+|+||.||+|... +++.||+|+++.. ......+.+|+.+++.++||||++++++|.+.+.+|+|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467999999999999999999975 7899999999764 3556789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC-CeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ-RVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~-~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
|+++|+|.+++.... .+++..+..++.+++.||.|||+ . +|+||||||+||||+.++.+||+|||+++....
T Consensus 112 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp CCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred CCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 999999999997653 48899999999999999999998 6 899999999999999999999999999986643
Q ss_pred CCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 577 SSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.. .....||+.|+|||+.. ..++.++|||||
T Consensus 185 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 216 (360)
T 3eqc_A 185 SM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSM 216 (360)
T ss_dssp HC--------CCCCTTCCHHHHTTCCCSHHHHHHHH
T ss_pred cc----ccCCCCCCCeECHHHHcCCCCCchhhHHHH
Confidence 22 23468999999999876 779999999996
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=284.89 Aligned_cols=177 Identities=24% Similarity=0.367 Sum_probs=150.2
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC------
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN------ 490 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------ 490 (611)
.++|.+.+.||+|+||.||+|... +|+.||||++... ....+++.+|+++|+.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 467899999999999999999864 7999999999653 345678899999999999999999999997653
Q ss_pred eEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecc
Q 007254 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (611)
Q Consensus 491 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGl 570 (611)
.+|+||||+ +++|.+++... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeec
Confidence 469999999 88999998753 48899999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 571 AKWASTSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 571 A~~~~~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
|+..... .+...||+.|+|||+.. ..|+.++|||||
T Consensus 175 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 212 (367)
T 1cm8_A 175 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSV 212 (367)
T ss_dssp CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHH
T ss_pred ccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHH
Confidence 9876543 23568999999999764 679999999996
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-31 Score=271.58 Aligned_cols=178 Identities=29% Similarity=0.480 Sum_probs=153.5
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCChh--------HHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCe
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSED--------VIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 491 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~--------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 491 (611)
.++|.+.+.||+|+||.||+|.+. +++.||||++..... ..+.+.+|+++++.++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 467889999999999999999864 789999999965321 1267899999999999999999999997655
Q ss_pred EEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEecCCCCCCEEEcCCCc-----EE
Q 007254 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR--VIHRDVKSSNILLSDDFE-----PQ 564 (611)
Q Consensus 492 ~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~--IvHrDLKp~NILl~~~~~-----vK 564 (611)
++||||+++|+|.+.+.... ..+++..+..++.|++.||.|||+ .+ |+||||||+|||++.++. +|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred -eEEEEecCCCCHHHHHhccc---CCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEE
Confidence 79999999999999887543 368999999999999999999999 77 999999999999988776 99
Q ss_pred EEeeccccccCCCCCceeecCCccCCCcccceecc---CCCcCcceEEeC
Q 007254 565 LSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP---IAFLFMFNCWFF 611 (611)
Q Consensus 565 L~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~---~~~~~~sDiWSL 611 (611)
|+|||+++..... .....||+.|+|||+.. ..+++++|||||
T Consensus 170 l~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~sl 214 (287)
T 4f0f_A 170 VADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSF 214 (287)
T ss_dssp ECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHH
T ss_pred eCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHH
Confidence 9999999855442 34568999999999872 567899999996
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.7e-32 Score=280.52 Aligned_cols=188 Identities=23% Similarity=0.354 Sum_probs=156.3
Q ss_pred cCCCccceeecccCceEEEEEEe------cCCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 492 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~------~~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 492 (611)
.++|.+.+.||+|+||.||+|.+ .+++.||||++... .....++.+|+.+++.++||||+++++++.+.+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46788999999999999999983 25778999999753 35567899999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhcCCCC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcC---CCcEEEE
Q 007254 493 LLVYDFLSRGSLEENLHGNKKD---PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLS 566 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~~~---~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~---~~~vKL~ 566 (611)
|+||||+++|+|.+++...... ...+++.+++.++.|++.||.|||+ .+|+||||||+||||+. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEEC
Confidence 9999999999999999865422 2458999999999999999999999 89999999999999984 4569999
Q ss_pred eeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 567 DFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 567 DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
|||+++...............||+.|+|||+.. ..++.++|||||
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 231 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF 231 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHH
Confidence 999998765544333334567899999999875 889999999996
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-32 Score=304.96 Aligned_cols=186 Identities=22% Similarity=0.394 Sum_probs=161.2
Q ss_pred HhcCCCccceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 419 SATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 419 ~~~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
...++|.+.+.||+|+||.||+|.+.++..||||+++......+.|.+|+++|+.++||||++++++|.+ +.+||||||
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 3456788899999999999999999888889999998766556789999999999999999999999866 778999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
+.+|+|.++|..... ..+++.++..++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+++......
T Consensus 343 ~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 343 MSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp CTTEEHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred hcCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 999999999974321 348899999999999999999999 899999999999999999999999999998765421
Q ss_pred CceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 579 SHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
........||+.|+|||+.. ..++.++|||||
T Consensus 418 -~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSl 450 (535)
T 2h8h_A 418 -YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 450 (535)
T ss_dssp -HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred -eecccCCcCcccccCHHHhccCCCCchhhHHHH
Confidence 11122356788999999876 889999999996
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-31 Score=270.75 Aligned_cols=181 Identities=27% Similarity=0.417 Sum_probs=159.5
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----------hHHHHHHHHHHHHHhcC-CCCeeeEEEEEEe
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----------DVIKEFVLEIEIITTLH-HKNIISLLGFCFE 488 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----------~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~ 488 (611)
.++|.+.+.||+|+||.||+|... +|+.||||+++... .....+.+|+++++.+. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 568999999999999999999975 78999999996532 23567889999999996 9999999999999
Q ss_pred CCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEee
Q 007254 489 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568 (611)
Q Consensus 489 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DF 568 (611)
.+..|+||||+++|+|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCC
T ss_pred CCeEEEEEeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecc
Confidence 999999999999999999997642 48999999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCceeecCCccCCCcccceec-------cCCCcCcceEEeC
Q 007254 569 GLAKWASTSSSHITCTDVAGTFGYVVLILN-------PIAFLFMFNCWFF 611 (611)
Q Consensus 569 GlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~-------~~~~~~~sDiWSL 611 (611)
|++........ .....||+.|+|||+. ...++.++|||||
T Consensus 169 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~sl 215 (298)
T 1phk_A 169 GFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWST 215 (298)
T ss_dssp TTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHH
T ss_pred cchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhH
Confidence 99987765432 2346899999999975 2568999999996
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.1e-32 Score=275.21 Aligned_cols=186 Identities=24% Similarity=0.330 Sum_probs=158.0
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CCeEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLL 494 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~l 494 (611)
.++|.+.+.||+|+||.||++... +|+.||+|+++.. ....+.+.+|+.+++.++||||+++++++.. .+.+|+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467899999999999999999875 7899999999753 3456789999999999999999999998864 578999
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC-----eEecCCCCCCEEEcCCCcEEEEeec
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR-----VIHRDVKSSNILLSDDFEPQLSDFG 569 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~-----IvHrDLKp~NILl~~~~~vKL~DFG 569 (611)
||||+++|+|.+++.........+++..+..++.|++.||.|||+ .+ |+||||||+|||++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 999999999999997644334569999999999999999999999 66 9999999999999999999999999
Q ss_pred cccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 570 LAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 570 lA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+++....... ......||+.|+|||... ..++.++|||||
T Consensus 162 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 202 (279)
T 2w5a_A 162 LARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSL 202 (279)
T ss_dssp HHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHH
T ss_pred hheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHH
Confidence 9987654332 123457999999999875 778999999996
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-31 Score=274.78 Aligned_cols=176 Identities=22% Similarity=0.374 Sum_probs=155.6
Q ss_pred cCCCccceeecccCceEEEEEEe-cCCCEEEEEEecCChhHHHHHHHHHHHHHhcC-CCCeeeEEEEEEe--CCeEEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFE--DNNLLLVY 496 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~--~~~~~lV~ 496 (611)
.++|.+.+.||+|+||.||+|.. .+++.||||+++... .+.+.+|+.+++.++ ||||+++++++.+ ....++||
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC--HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc--hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 36789999999999999999985 478999999998644 467889999999997 9999999999987 67899999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCC-cEEEEeeccccccC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKWAS 575 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~-~vKL~DFGlA~~~~ 575 (611)
||+.+++|.+++.. +++.++..++.||+.||.|||+ ++|+||||||+||||+.++ .+||+|||+|+...
T Consensus 113 e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 113 EHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp ECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999998852 7889999999999999999999 8999999999999999776 89999999998776
Q ss_pred CCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 576 TSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
.... .....||..|+|||+.. ..+++++|||||
T Consensus 183 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl 217 (330)
T 3nsz_A 183 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSL 217 (330)
T ss_dssp TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHH
T ss_pred CCCc---cccccccccccChhhhcCCCcCCchhhHHHH
Confidence 5432 23468999999999765 678999999996
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=284.46 Aligned_cols=180 Identities=23% Similarity=0.312 Sum_probs=156.1
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHHHhcC--------CCCeeeEEEEEE----
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLH--------HKNIISLLGFCF---- 487 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~--------HpnIv~l~~~~~---- 487 (611)
.++|.+.+.||+|+||.||+|... +++.||||+++........+.+|+.+++.++ |+||++++++|.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 468999999999999999999854 6889999999988777788999999999986 788999999997
Q ss_pred eCCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC-CeEecCCCCCCEEEcCCC-----
Q 007254 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ-RVIHRDVKSSNILLSDDF----- 561 (611)
Q Consensus 488 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~-~IvHrDLKp~NILl~~~~----- 561 (611)
...++||||||+ +|+|.+.+..... ..+++..+..++.||+.||.|||+ + +||||||||+||||+.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKSNY--QGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHHHH
T ss_pred CCceEEEEEecc-CccHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhhhh
Confidence 456899999999 6677776654322 358999999999999999999999 7 999999999999999775
Q ss_pred --------------------------------------------cEEEEeeccccccCCCCCceeecCCccCCCccccee
Q 007254 562 --------------------------------------------EPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLIL 597 (611)
Q Consensus 562 --------------------------------------------~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~ 597 (611)
.+||+|||+|+...... ....||+.|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-----~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----TEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-----CSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-----ccCCCCCcccCChh
Confidence 79999999998876532 34689999999998
Q ss_pred cc-CCCcCcceEEeC
Q 007254 598 NP-IAFLFMFNCWFF 611 (611)
Q Consensus 598 ~~-~~~~~~sDiWSL 611 (611)
.. ..|+.++|||||
T Consensus 265 ~~~~~~~~~~Diwsl 279 (397)
T 1wak_A 265 LIGSGYNTPADIWST 279 (397)
T ss_dssp HHTSCCCTHHHHHHH
T ss_pred hcCCCCCcHHHHHHH
Confidence 75 779999999996
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=281.41 Aligned_cols=188 Identities=23% Similarity=0.336 Sum_probs=153.6
Q ss_pred hHHHHHhcCCCccceeecccCceEEEEEEecCCCEEEEEEecCC------------hhHHHHHHHHHHHHHhcCCCCeee
Q 007254 414 YQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS------------EDVIKEFVLEIEIITTLHHKNIIS 481 (611)
Q Consensus 414 ~~~l~~~~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~------------~~~~~~~~~Ei~il~~l~HpnIv~ 481 (611)
..++....++|.+.+.||+|+||.||+|...+|+.||||++... ....+.+.+|+++++.++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 45677788999999999999999999999888999999998642 123478999999999999999999
Q ss_pred EEEEEEe-----CCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEE
Q 007254 482 LLGFCFE-----DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 556 (611)
Q Consensus 482 l~~~~~~-----~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NIL 556 (611)
++++|.. ...+|+||||+. |+|.+.+.... ..+++..+..++.||+.||.|||+ .+|+||||||+|||
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR---IVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNIL 166 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEE
Confidence 9999954 346899999997 58888887442 358999999999999999999999 89999999999999
Q ss_pred EcCCCcEEEEeeccccccCCCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 557 LSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 557 l~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
|+.++.+||+|||+++....... .....||+.|+|||+.. ..++.++|||||
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 220 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSA 220 (362)
T ss_dssp ECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHH
T ss_pred EcCCCCEEEEecCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhH
Confidence 99999999999999986554332 23468999999999764 678999999996
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=282.04 Aligned_cols=188 Identities=22% Similarity=0.251 Sum_probs=147.3
Q ss_pred HHHhcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCe----
Q 007254 417 LLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN---- 491 (611)
Q Consensus 417 l~~~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~---- 491 (611)
.....++|.+.+.||+|+||.||+|... +|+.||||++.........+.++++.+..++||||++++++|...+.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence 4456789999999999999999999974 78999999997766555677888999999999999999999976443
Q ss_pred ---EEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH--cCCCCCeEecCCCCCCEEEcC-CCcEEE
Q 007254 492 ---LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH--SGSAQRVIHRDVKSSNILLSD-DFEPQL 565 (611)
Q Consensus 492 ---~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH--~~~~~~IvHrDLKp~NILl~~-~~~vKL 565 (611)
+++||||+.+ +|...+.........+++..+..++.|++.||.||| + .+|+||||||+||||+. ++.+||
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 98 DIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp CEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTEEEE
T ss_pred ceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCcEEE
Confidence 8999999976 555554432223346889999999999999999999 7 89999999999999997 899999
Q ss_pred EeeccccccCCCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 566 SDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 566 ~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
+|||+|+....... .....||+.|+|||+.. ..++.++|||||
T Consensus 174 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~sl 218 (360)
T 3e3p_A 174 CDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSV 218 (360)
T ss_dssp CCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHH
T ss_pred eeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHH
Confidence 99999998765442 23468999999999764 558999999996
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.8e-32 Score=281.81 Aligned_cols=184 Identities=22% Similarity=0.425 Sum_probs=148.9
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCE----EEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKE----LAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~----vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 493 (611)
.++|.+.+.||+|+||.||+|.+. +++. ||+|.++.. ....+.+.+|+.+++.++||||++++++|... ..+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SEE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-Cce
Confidence 467999999999999999999854 5554 577777543 34568899999999999999999999999875 478
Q ss_pred EEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccc
Q 007254 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (611)
Q Consensus 494 lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~ 573 (611)
+||||+.+|+|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+.
T Consensus 93 ~v~~~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 9999999999999997653 358999999999999999999999 8999999999999999999999999999998
Q ss_pred cCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 574 ASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
..............||+.|+|||... ..|+.++|||||
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 205 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSY 205 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHH
Confidence 76554444444567889999999876 889999999996
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-31 Score=274.79 Aligned_cols=180 Identities=20% Similarity=0.354 Sum_probs=159.2
Q ss_pred cCCCccceeecccCceEEEEEEe--cCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCC------eeeEEEEEEeCCeE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCL--PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKN------IISLLGFCFEDNNL 492 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~--~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~Hpn------Iv~l~~~~~~~~~~ 492 (611)
.++|.+.+.||+|+||.||+|.. .+++.||||+++........+.+|++++..++|++ |+++++++.+.+.+
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 46799999999999999999986 36889999999987777788999999999987654 99999999999999
Q ss_pred EEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcC-------------
Q 007254 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD------------- 559 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~------------- 559 (611)
|+||||+ +++|.+++..... ..+++.++..++.|++.||.|||+ ++|+||||||+|||++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEcCC-CCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCcccc
Confidence 9999999 8899999976542 358899999999999999999999 89999999999999987
Q ss_pred ------CCcEEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 560 ------DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 560 ------~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
++.+||+|||+++...... ....||+.|+|||+.. ..++.++|||||
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 220 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSI 220 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHH
T ss_pred ccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHH
Confidence 6689999999998765432 3468999999999876 789999999996
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-31 Score=273.15 Aligned_cols=185 Identities=25% Similarity=0.378 Sum_probs=156.9
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh-----hHHHHHHHHHHHHHhcCCCCeeeEEEEEE--eCCeE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-----DVIKEFVLEIEIITTLHHKNIISLLGFCF--EDNNL 492 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~~ 492 (611)
.++|.+.+.||+|+||.||++... +++.||||+++... .....+.+|+++++.++||||+++++++. +.+.+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 478999999999999999999964 78899999997642 34678999999999999999999999984 45689
Q ss_pred EEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccc
Q 007254 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~ 572 (611)
|+||||+.+| |.+.+..... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPE--KRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTT--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHhCcc--cccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999876 7777765432 458999999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCceeecCCccCCCcccceecc---CCCcCcceEEeC
Q 007254 573 WASTSSSHITCTDVAGTFGYVVLILNP---IAFLFMFNCWFF 611 (611)
Q Consensus 573 ~~~~~~~~~~~~~~~GT~~Y~aPE~~~---~~~~~~sDiWSL 611 (611)
...............||+.|+|||+.. ..++.++|||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~sl 199 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSA 199 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHH
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHH
Confidence 876544444555678999999999875 234789999996
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=274.51 Aligned_cols=184 Identities=26% Similarity=0.405 Sum_probs=154.4
Q ss_pred CCCccceeecccCceEEEEEEecC----CCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-CCeEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLPD----GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFE-DNNLLL 494 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~~----g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~l 494 (611)
.+|.+.+.||+|+||.||+|.+.+ +..+|+|.++.. ....+.+.+|+.+++.++||||++++++|.. .+..|+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 457888999999999999998542 236899999763 3456789999999999999999999999754 567899
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccccc
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~ 574 (611)
||||+++|+|.+++.... ..+++.++..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+|+..
T Consensus 105 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEECCTTCBHHHHHHCTT---CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEeCCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccccc
Confidence 999999999999997543 358899999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCC--ceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 575 STSSS--HITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 575 ~~~~~--~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
..... ........||+.|+|||... ..++.++|||||
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 218 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 218 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHH
Confidence 54321 12234567889999999875 789999999996
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-31 Score=282.07 Aligned_cols=178 Identities=24% Similarity=0.307 Sum_probs=146.2
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC------
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN------ 490 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------ 490 (611)
.++|.+.+.||+|+||.||+|... +++.||||+++.. ....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 478999999999999999999864 7899999999753 345678899999999999999999999997654
Q ss_pred eEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecc
Q 007254 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (611)
Q Consensus 491 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGl 570 (611)
.+|+||||+.+ +|.+.+.. .+++..+..++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCCC-CHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeec
Confidence 78999999975 78888852 38899999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 571 AKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 571 A~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
|+...... ......||+.|+|||+.. ..|+.++|||||
T Consensus 174 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 212 (371)
T 2xrw_A 174 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSV 212 (371)
T ss_dssp -------------------CTTCCHHHHTTCCCCTTHHHHHH
T ss_pred cccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHH
Confidence 98765432 234568999999999876 779999999996
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=278.74 Aligned_cols=185 Identities=19% Similarity=0.313 Sum_probs=156.0
Q ss_pred HhcCCCccc-eeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCeE
Q 007254 419 SATSNFLAE-NLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNL 492 (611)
Q Consensus 419 ~~~~~f~~~-~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~ 492 (611)
...+.|.+. +.||+|+||.||+|... +|+.||||+++.. ......+.+|+.++..+. ||||++++++|.+.+.+
T Consensus 25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~ 104 (327)
T 3lm5_A 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI 104 (327)
T ss_dssp HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence 334566666 89999999999999865 6899999999763 244678899999999995 69999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcC---CCcEEEEeec
Q 007254 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSDFG 569 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~---~~~vKL~DFG 569 (611)
|+||||+.+|+|.+++.... ...+++.++..++.|++.||.|||+ ++|+||||||+||||+. ++.+||+|||
T Consensus 105 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL~Dfg 179 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLPEL--AEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFG 179 (327)
T ss_dssp EEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred EEEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEEeeCc
Confidence 99999999999999986532 2458999999999999999999999 89999999999999998 7899999999
Q ss_pred cccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 570 LAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 570 lA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+++....... .....||+.|+|||+.. ..++.++|||||
T Consensus 180 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 219 (327)
T 3lm5_A 180 MSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNI 219 (327)
T ss_dssp GCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred cccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHH
Confidence 9998765432 23468999999999876 889999999996
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=274.68 Aligned_cols=180 Identities=26% Similarity=0.418 Sum_probs=156.4
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
.++|.+.+.||+|+||.||++... +|+.||||+++... .....+.+|+.+++.++||||+++++++.+.+..|+||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 457889999999999999999865 79999999998654 3446788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE---cCCCcEEEEeeccccccC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl---~~~~~vKL~DFGlA~~~~ 575 (611)
+++|+|.+.+.... .+++..+..++.|++.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++...
T Consensus 88 ~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 88 VSGGELFDRILERG----VYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred CCCccHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 99999999987543 48899999999999999999999 899999999999999 788999999999997654
Q ss_pred CCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 576 TSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
... .....||+.|+|||+.. ..++.++|||||
T Consensus 161 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 193 (304)
T 2jam_A 161 NGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSI 193 (304)
T ss_dssp CBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHH
T ss_pred CCc----cccccCCCCccChHHhccCCCCchhhHHHH
Confidence 322 23457999999999876 778999999996
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=272.73 Aligned_cols=183 Identities=23% Similarity=0.374 Sum_probs=155.5
Q ss_pred CCccceeecccCceEEEEEEec-CC---CEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeE-EEE
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP-DG---KELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL-LLV 495 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~-~g---~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~-~lV 495 (611)
.|...+.||+|+||.||+|.+. ++ ..||+|+++... ...+.+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4556799999999999999853 22 379999997643 4567899999999999999999999999876655 999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
|||+.+|+|.+++.... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 99999999999997632 458999999999999999999999 899999999999999999999999999998665
Q ss_pred CCC--CceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 576 TSS--SHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~--~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
... .........||+.|+|||... ..++.++|||||
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 214 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSF 214 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHH
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhH
Confidence 432 112234567899999999876 788999999996
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=268.48 Aligned_cols=178 Identities=19% Similarity=0.287 Sum_probs=154.7
Q ss_pred cCCCccceeecccCceEEEEEEecCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CeEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLLV 495 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lV 495 (611)
.++|.+.+.||+|+||.||+|.+ +++.||||+++.. ....+.|.+|+.+++.++||||++++++|.+. +.+++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 46788999999999999999998 5889999999864 34567899999999999999999999999876 788999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEecCCCCCCEEEcCCCcEEEEeeccccc
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR--VIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~--IvHrDLKp~NILl~~~~~vKL~DFGlA~~ 573 (611)
|||+++|+|.+++..... ..+++.++..++.|++.||.|||+ ++ |+||||||+|||++.++.++|+|||++..
T Consensus 88 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp EECCTTCBHHHHHHSCSS--CCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred ecccCCCcHHHHHhhccc--CCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceee
Confidence 999999999999986432 358999999999999999999998 77 99999999999999999999999998765
Q ss_pred cCCCCCceeecCCccCCCcccceecc-C---CCcCcceEEeC
Q 007254 574 ASTSSSHITCTDVAGTFGYVVLILNP-I---AFLFMFNCWFF 611 (611)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~Y~aPE~~~-~---~~~~~sDiWSL 611 (611)
... ....||+.|+|||... . .++.++|||||
T Consensus 163 ~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~sl 197 (271)
T 3kmu_A 163 FQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSF 197 (271)
T ss_dssp TSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHH
T ss_pred ecc-------cCccCCccccChhhhccCCCCCCCchhhHHHH
Confidence 332 2357899999999865 3 33448999996
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-31 Score=268.99 Aligned_cols=182 Identities=23% Similarity=0.384 Sum_probs=152.0
Q ss_pred hcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 494 (611)
..++|.+.+.||+|+||.||+|... +|+.||||+++... .....+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 3568999999999999999999975 79999999997542 345688999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccccc
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~ 574 (611)
||||+++++|.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++...
T Consensus 89 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHG----RVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp EEECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred EEeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeeccccccc
Confidence 999999999999997643 48899999999999999999999 89999999999999999999999999999877
Q ss_pred CCCCCceeecCCccCCCcccceecc-CCC-cCcceEEeC
Q 007254 575 STSSSHITCTDVAGTFGYVVLILNP-IAF-LFMFNCWFF 611 (611)
Q Consensus 575 ~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~-~~~sDiWSL 611 (611)
..... .....||+.|+|||... ..+ +.++|||||
T Consensus 162 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 197 (276)
T 2h6d_A 162 SDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSC 197 (276)
T ss_dssp CC----------------CCTGGGTTSCCCHHHHHHHHH
T ss_pred CCCcc---eecccCCccccCHHHHcCCCCCCccchHHHH
Confidence 65332 23467999999999876 333 789999996
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-31 Score=273.17 Aligned_cols=182 Identities=25% Similarity=0.404 Sum_probs=155.7
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 499 (611)
.++|.+.+.||+|+||.||+|... +|+.||||+++... ....+.+|+.++..++||||+++++++...+.+|+||||+
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC 106 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence 467889999999999999999875 68999999997654 3467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~ 579 (611)
++|+|.+++.... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++........
T Consensus 107 ~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 107 GAGSVSDIIRLRN---KTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp TTEEHHHHHHHHT---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred CCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 9999999986332 358999999999999999999999 8999999999999999999999999999987655322
Q ss_pred ceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 580 HITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 580 ~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......||+.|+|||+.. ..++.++|||||
T Consensus 181 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 211 (314)
T 3com_A 181 --KRNTVIGTPFWMAPEVIQEIGYNCVADIWSL 211 (314)
T ss_dssp --CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHH
T ss_pred --ccCccCCCCCccChhhcCCCCCCccccHHHH
Confidence 223568999999999876 778999999996
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=273.35 Aligned_cols=184 Identities=21% Similarity=0.275 Sum_probs=142.5
Q ss_pred cCCCccceeecccCceEEEEEEe-cCCCEEEEEEecCCh--h-HHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE--D-VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~~--~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
.++|.+.+.||+|+||.||+|.. .+|+.||||+++... . ....+.++...++.++||||+++++++.+.+..|+||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 56789999999999999999986 478999999997642 2 2333445555688899999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC-CeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ-RVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~-~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
||++ |+|.+++.........+++..+..++.|++.||.|||+ + +|+||||||+|||++.++.+||+|||+++...
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9997 48888776432233469999999999999999999998 7 99999999999999999999999999998776
Q ss_pred CCCCceeecCCccCCCcccceec-----cCCCcCcceEEeC
Q 007254 576 TSSSHITCTDVAGTFGYVVLILN-----PIAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~-----~~~~~~~sDiWSL 611 (611)
.... .....||+.|+|||+. ...++.++|||||
T Consensus 162 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~sl 199 (290)
T 3fme_A 162 DDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSL 199 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHH
T ss_pred cccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHH
Confidence 5432 2335799999999984 2678999999996
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-31 Score=276.29 Aligned_cols=182 Identities=29% Similarity=0.397 Sum_probs=157.2
Q ss_pred HhcCCCccceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHh--cCCCCeeeEEEEEEeCC----eE
Q 007254 419 SATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITT--LHHKNIISLLGFCFEDN----NL 492 (611)
Q Consensus 419 ~~~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~~~----~~ 492 (611)
...++|.+.+.||+|+||.||+|.. +|+.||||+++... ...+.+|++++.. ++||||+++++++...+ .+
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~ 115 (342)
T 1b6c_B 39 TIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 115 (342)
T ss_dssp HHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred cccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh--HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence 3456899999999999999999988 68999999997543 3567889999988 79999999999998775 89
Q ss_pred EEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCCeEecCCCCCCEEEcCCCcEE
Q 007254 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH--------SGSAQRVIHRDVKSSNILLSDDFEPQ 564 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH--------~~~~~~IvHrDLKp~NILl~~~~~vK 564 (611)
|+||||+++|+|.+++... .+++.++..++.|++.||.||| + .+|+||||||+||||+.++.+|
T Consensus 116 ~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~NIll~~~~~~k 187 (342)
T 1b6c_B 116 WLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKNILVKKNGTCC 187 (342)
T ss_dssp EEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGGEEECTTSCEE
T ss_pred EEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHHEEECCCCCEE
Confidence 9999999999999999754 3899999999999999999999 6 8999999999999999999999
Q ss_pred EEeeccccccCCCCCce--eecCCccCCCcccceeccC-------CCcCcceEEeC
Q 007254 565 LSDFGLAKWASTSSSHI--TCTDVAGTFGYVVLILNPI-------AFLFMFNCWFF 611 (611)
Q Consensus 565 L~DFGlA~~~~~~~~~~--~~~~~~GT~~Y~aPE~~~~-------~~~~~sDiWSL 611 (611)
|+|||+++......... ......||+.|+|||+... .++.++|||||
T Consensus 188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~sl 243 (342)
T 1b6c_B 188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM 243 (342)
T ss_dssp ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHH
T ss_pred EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHH
Confidence 99999998876544322 2345689999999998753 34478999996
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-31 Score=278.38 Aligned_cols=185 Identities=25% Similarity=0.410 Sum_probs=151.6
Q ss_pred cCCCccceeecccCceEEEEEEecC-----CCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLPD-----GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~~-----g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 493 (611)
.++|...+.||+|+||.||+|.+.. +..||||+++.. ......+.+|+.++..++||||+++++++.+.+.++
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3567788999999999999998642 236999999864 345668999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccc
Q 007254 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (611)
Q Consensus 494 lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~ 573 (611)
+||||+++|+|.+++.... ..+++.++..++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+++.
T Consensus 123 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 9999999999999997643 358999999999999999999999 8999999999999999999999999999988
Q ss_pred cCCCCCc-eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 574 ASTSSSH-ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 574 ~~~~~~~-~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
....... .......||+.|+|||+.. ..++.++|||||
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 236 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSF 236 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHH
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHH
Confidence 7643221 2223345788999999875 789999999996
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-31 Score=280.43 Aligned_cols=182 Identities=24% Similarity=0.357 Sum_probs=157.1
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----CeE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NNL 492 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~ 492 (611)
.++|.+.+.||+|+||.||+|... +++.||||+++... .....+.+|+++|..++||||+++++++... ..+
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 457999999999999999999865 78899999997543 4557899999999999999999999999764 468
Q ss_pred EEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccc
Q 007254 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~ 572 (611)
|+||||+. |+|.+++... .+++.++..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++
T Consensus 106 ~iv~e~~~-~~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEcccC-cCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceE
Confidence 99999996 5999998753 38999999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCCce-eecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 573 WASTSSSHI-TCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 573 ~~~~~~~~~-~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
......... ......||+.|+|||+.. ..++.++|||||
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl 218 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 218 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHH
Confidence 776433221 234568999999999753 668999999996
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=277.79 Aligned_cols=180 Identities=26% Similarity=0.422 Sum_probs=152.2
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh---------hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN 490 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~---------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 490 (611)
.++|.+.+.||+|+||.||+|... +++.||||+++... .....+.+|+++|+.++||||+++++++...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 87 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 87 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-
Confidence 457899999999999999999865 68899999997532 2234588999999999999999999998665
Q ss_pred eEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCc---EEEEe
Q 007254 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE---PQLSD 567 (611)
Q Consensus 491 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~---vKL~D 567 (611)
..|+||||+++|+|.+.+... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++. +||+|
T Consensus 88 ~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 DYYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp SEEEEEECCTTEETHHHHSTT----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred ceEEEEecCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 489999999999999998654 358999999999999999999999 89999999999999987654 99999
Q ss_pred eccccccCCCCCceeecCCccCCCcccceec----cCCCcCcceEEeC
Q 007254 568 FGLAKWASTSSSHITCTDVAGTFGYVVLILN----PIAFLFMFNCWFF 611 (611)
Q Consensus 568 FGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~----~~~~~~~sDiWSL 611 (611)
||+++...... ......||+.|+|||+. ...++.++|||||
T Consensus 161 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~sl 205 (322)
T 2ycf_A 161 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSL 205 (322)
T ss_dssp CTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHH
T ss_pred Cccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHH
Confidence 99998775432 22346799999999975 3678999999996
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-32 Score=292.06 Aligned_cols=181 Identities=13% Similarity=0.220 Sum_probs=150.3
Q ss_pred cCCCccceeecccCceEEEEEEe-cCCCEEEEEEecC----ChhHHHHHHHHH---HHHHhcCCCCeeeEE-------EE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP----SEDVIKEFVLEI---EIITTLHHKNIISLL-------GF 485 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~----~~~~~~~~~~Ei---~il~~l~HpnIv~l~-------~~ 485 (611)
.++|.+.+.||+|+||.||+|.. .+|+.||||+++. .....+.|.+|+ ++|+.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 45788899999999999999996 4799999999964 334668899999 555566899999998 66
Q ss_pred EEeCC-----------------eEEEEEEcCCCCCHHHHHhcCCCC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCe
Q 007254 486 CFEDN-----------------NLLLVYDFLSRGSLEENLHGNKKD---PAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545 (611)
Q Consensus 486 ~~~~~-----------------~~~lV~Ey~~~gsL~~~L~~~~~~---~~~l~~~~~~~ia~qia~aL~yLH~~~~~~I 545 (611)
+.+.+ ..||||||+ +|+|.+++...... ...++|..+..|+.||+.||.|||+ ++|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 66553 289999999 68999999754221 1235578889999999999999999 899
Q ss_pred EecCCCCCCEEEcCCCcEEEEeeccccccCCCCCceeecCCccCCCcccceecc-C-----------CCcCcceEEeC
Q 007254 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-I-----------AFLFMFNCWFF 611 (611)
Q Consensus 546 vHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~-----------~~~~~sDiWSL 611 (611)
|||||||+||||+.++.+||+|||+|+.... ......| +.|+|||+.. . .|+.++|||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSl 299 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWAL 299 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHH
Confidence 9999999999999999999999999986433 2345678 9999999876 5 79999999996
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-31 Score=269.24 Aligned_cols=183 Identities=23% Similarity=0.326 Sum_probs=154.9
Q ss_pred CCccceeecccCceEEEEEEec-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 500 (611)
+|....+||+|+||.||+|... +++.||||+++... ...+.+.+|+.+++.++||||+++++++.+.+.+++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 4555678999999999999964 78899999997653 456789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcC-CCcEEEEeeccccccCCCCC
Q 007254 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWASTSSS 579 (611)
Q Consensus 501 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~-~~~vKL~DFGlA~~~~~~~~ 579 (611)
+++|.+++.... ....+++..+..++.|++.||.|||+ .+|+||||||+|||++. ++.+||+|||+++.......
T Consensus 103 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 103 GGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp EEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 999999997653 23457899999999999999999999 89999999999999987 89999999999987654322
Q ss_pred ceeecCCccCCCcccceecc---CCCcCcceEEeC
Q 007254 580 HITCTDVAGTFGYVVLILNP---IAFLFMFNCWFF 611 (611)
Q Consensus 580 ~~~~~~~~GT~~Y~aPE~~~---~~~~~~sDiWSL 611 (611)
......||+.|+|||+.. ..++.++|||||
T Consensus 179 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~sl 211 (295)
T 2clq_A 179 --CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSL 211 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHH
T ss_pred --cccccCCCccccChhhhcCCCCCCCcHHHHHHH
Confidence 223568999999999875 348999999996
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=282.74 Aligned_cols=183 Identities=20% Similarity=0.255 Sum_probs=150.1
Q ss_pred cCCCccceeecccCceEEEEEEec----CCCEEEEEEecCChh------------HHHHHHHHHHHHHhcCCCCeeeEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPSED------------VIKEFVLEIEIITTLHHKNIISLLG 484 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~----~g~~vAVK~lk~~~~------------~~~~~~~Ei~il~~l~HpnIv~l~~ 484 (611)
.++|.+.+.||+|+||.||+|... ++..+|||++..... ....+.+|+.++..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 357889999999999999999975 578899999876431 1234678889999999999999999
Q ss_pred EEEe----CCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCC
Q 007254 485 FCFE----DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD 560 (611)
Q Consensus 485 ~~~~----~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~ 560 (611)
++.. .+.+|+||||+ +++|.+++.... .+++.++..++.||+.||.|||+ .+|+||||||+||||+.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG----BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccC
Confidence 9988 67899999999 999999997653 58999999999999999999999 899999999999999988
Q ss_pred C--cEEEEeeccccccCCCCCc-----eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 561 F--EPQLSDFGLAKWASTSSSH-----ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 561 ~--~vKL~DFGlA~~~~~~~~~-----~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+ .+||+|||+|+.+...... .......||+.|+|||+.. ..++.++|||||
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 246 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEIL 246 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHH
Confidence 7 9999999999877543211 1124568999999999876 678999999996
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=276.89 Aligned_cols=188 Identities=24% Similarity=0.320 Sum_probs=156.4
Q ss_pred cCCCccceeecccCceEEEEEEe-cCCCEEEEEEecCC-hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe----CCeEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFE----DNNLLL 494 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~l 494 (611)
.++|.+.+.||+|+||.||++.. .+|+.||||++... ....+.+.+|+++++.++||||+++++++.. .+..|+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46799999999999999999986 57899999988654 4566789999999999999999999999973 347899
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccccc
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~ 574 (611)
||||+.+|+|.+++.........+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 999999999999997643334569999999999999999999999 89999999999999999999999999998865
Q ss_pred CCCCCc-------eeecCCccCCCcccceecc----CCCcCcceEEeC
Q 007254 575 STSSSH-------ITCTDVAGTFGYVVLILNP----IAFLFMFNCWFF 611 (611)
Q Consensus 575 ~~~~~~-------~~~~~~~GT~~Y~aPE~~~----~~~~~~sDiWSL 611 (611)
...... .......||+.|+|||+.. ..++.++|||||
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~sl 232 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSL 232 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHH
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHH
Confidence 421110 0112356899999999875 237899999996
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=286.07 Aligned_cols=183 Identities=26% Similarity=0.423 Sum_probs=145.3
Q ss_pred CCccceeecccCceEEEEEEec--CC--CEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-CCeEEEE
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP--DG--KELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFE-DNNLLLV 495 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~--~g--~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lV 495 (611)
.|.+.+.||+|+||.||+|.+. ++ ..||||.++.. ....++|.+|+.+++.++||||++++++|.+ .+..|+|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4667889999999999999864 22 36899999753 3567889999999999999999999999764 4578999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
|||+++|+|.+++.... ..+++.++..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++...
T Consensus 170 ~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EECCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeecccccccc
Confidence 99999999999997543 358899999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCc--eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 576 TSSSH--ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~--~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
..... .......||+.|+|||+.. ..++.++|||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSl 282 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 282 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHH
Confidence 43221 1223467889999999876 889999999996
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-31 Score=271.33 Aligned_cols=183 Identities=25% Similarity=0.375 Sum_probs=154.8
Q ss_pred cCCCccce-eecccCceEEEEEEec---CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEE
Q 007254 421 TSNFLAEN-LIGKGGSSQVYKGCLP---DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (611)
Q Consensus 421 ~~~f~~~~-~IG~G~fG~Vyk~~~~---~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 493 (611)
.++|.+.+ .||+|+||.||+|.+. +++.||||+++... ...+.+.+|+++++.++||||+++++++ ..+.+|
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 45677777 9999999999999642 46889999998642 3467899999999999999999999999 667889
Q ss_pred EEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccc
Q 007254 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (611)
Q Consensus 494 lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~ 573 (611)
+||||+++++|.+++.... .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 94 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEECCTTEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEeCCCCCHHHHHHhCc----CCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 9999999999999998653 48999999999999999999999 8999999999999999999999999999988
Q ss_pred cCCCCCcee-ecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 574 ASTSSSHIT-CTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 574 ~~~~~~~~~-~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......... .....||+.|+|||+.. ..++.++|||||
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 206 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSF 206 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHH
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHH
Confidence 765443322 22345789999999876 778999999996
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-31 Score=277.42 Aligned_cols=185 Identities=26% Similarity=0.456 Sum_probs=154.9
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEE--EEEEecCC--hhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKEL--AVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLL 494 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~v--AVK~lk~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l 494 (611)
.++|.+.+.||+|+||.||+|... +|..+ |||.++.. ......+.+|++++..+ +||||+++++++.+.+.+|+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 367889999999999999999864 56644 99998753 34556789999999999 89999999999999999999
Q ss_pred EEEcCCCCCHHHHHhcCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCc
Q 007254 495 VYDFLSRGSLEENLHGNK------------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE 562 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~------------~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~ 562 (611)
||||+++|+|.+++.... .....+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCe
Confidence 999999999999997653 223468999999999999999999999 99999999999999999999
Q ss_pred EEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 563 PQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 563 vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+||+|||+++...... ......+|+.|+|||+.. ..++.++|||||
T Consensus 181 ~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 227 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSY 227 (327)
T ss_dssp EEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHH
T ss_pred EEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHH
Confidence 9999999998543322 122346789999999876 778999999996
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-31 Score=269.81 Aligned_cols=184 Identities=23% Similarity=0.380 Sum_probs=154.8
Q ss_pred hcCCCccceeecccCceEEEEEEecC----CCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEE
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLPD----GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~~----g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 493 (611)
..++|.+.+.||+|+||.||+|.+.. +..||||+++.. ......+.+|+.+++.++||||+++++++.+ +..|
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 35678999999999999999998542 336999999864 3456789999999999999999999999864 5679
Q ss_pred EEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccc
Q 007254 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (611)
Q Consensus 494 lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~ 573 (611)
+||||+++++|.+++.... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNK---NSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEEecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 9999999999999997543 358999999999999999999999 8999999999999999999999999999987
Q ss_pred cCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 574 ASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
...... .......||+.|+|||+.. ..++.++|||||
T Consensus 163 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 200 (281)
T 3cc6_A 163 IEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMF 200 (281)
T ss_dssp C----------CCCCCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred cccccc-cccccCCCCcceeCchhhccCCCCchhccHHH
Confidence 765332 1233467889999999876 889999999996
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-31 Score=275.91 Aligned_cols=184 Identities=27% Similarity=0.431 Sum_probs=158.9
Q ss_pred CCCccceeecccCceEEEEEEe-----cCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC--eEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN--NLL 493 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~-----~~g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~~ 493 (611)
++|.+.+.||+|+||.||+|.+ .+|+.||||+++... ...+.+.+|+++++.++||||+++++++...+ .++
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 4688899999999999999984 368899999997653 55678999999999999999999999987644 789
Q ss_pred EEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccc
Q 007254 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (611)
Q Consensus 494 lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~ 573 (611)
+||||+++|+|.+++.... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 121 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEECCCTTCBHHHHHHHST---TSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEECCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 9999999999999997653 358999999999999999999999 8999999999999999999999999999998
Q ss_pred cCCCCCcee-ecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 574 ASTSSSHIT-CTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 574 ~~~~~~~~~-~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......... .....||..|+|||... ..++.++|||||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 234 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSF 234 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHH
Confidence 765543322 23456788899999875 778999999996
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=288.63 Aligned_cols=180 Identities=23% Similarity=0.289 Sum_probs=148.5
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC------CeEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED------NNLLL 494 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~~~~l 494 (611)
.+|.+.+.||+|+||.||+|.+. +|+.||||++..... .+.+|+++|+.++||||++++++|... .++++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 35788899999999999999975 699999999976542 234699999999999999999998642 24789
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCC-CcEEEEeeccccc
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDFGLAKW 573 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~-~~vKL~DFGlA~~ 573 (611)
||||+++ +|.+.+.........+++..+..++.||+.||.|||+ ++|+||||||+||||+.+ +.+||+|||+|+.
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 9999976 6666654322223468999999999999999999999 999999999999999965 5789999999997
Q ss_pred cCCCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 574 ASTSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
+..... .....||+.|+|||++. ..|+.++|||||
T Consensus 207 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSl 243 (420)
T 1j1b_A 207 LVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSA 243 (420)
T ss_dssp CCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHH
T ss_pred cccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHH
Confidence 754432 23468999999999875 579999999996
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-31 Score=301.05 Aligned_cols=183 Identities=23% Similarity=0.389 Sum_probs=151.3
Q ss_pred CCCccce-eecccCceEEEEEEec---CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 007254 422 SNFLAEN-LIGKGGSSQVYKGCLP---DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 422 ~~f~~~~-~IG~G~fG~Vyk~~~~---~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 495 (611)
+++.+.+ .||+|+||.||+|.+. ++..||||+++.. ....+.|.+|+++|+.++||||++++++|.. +.+|||
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 3444444 7999999999999864 4567999999864 2457889999999999999999999999976 679999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
|||+.+|+|.+++.... ..+++.++..++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+.+.
T Consensus 414 ~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp EECCTTCBHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred EEeCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 99999999999997542 458999999999999999999999 899999999999999999999999999999875
Q ss_pred CCCCce-eecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 576 TSSSHI-TCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~-~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
...... ......||+.|+|||++. ..++.++|||||
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSl 525 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSY 525 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHHHHHHHH
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHH
Confidence 433221 122345678999999876 889999999996
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=274.56 Aligned_cols=183 Identities=24% Similarity=0.422 Sum_probs=154.4
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
.++|.+.+.||+|+||.||+|... +++.||+|++.... .....+.+|++++..++||||+++++++...+.+|+||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 467899999999999999999975 68999999997643 4567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
+++++|.+++.... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 98 ~~~~~l~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 98 CPGGAVDAIMLELD---RGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp CTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred CCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 99999999887532 348999999999999999999999 899999999999999999999999999986543211
Q ss_pred CceeecCCccCCCcccceec------cCCCcCcceEEeC
Q 007254 579 SHITCTDVAGTFGYVVLILN------PIAFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~~~~~~~GT~~Y~aPE~~------~~~~~~~sDiWSL 611 (611)
. ......||+.|+|||+. ...++.++|||||
T Consensus 172 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~sl 208 (302)
T 2j7t_A 172 Q--KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSL 208 (302)
T ss_dssp H--C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHH
T ss_pred c--ccccccCChhhcCCeeeccccCCCCCCchhhhHHHH
Confidence 1 12245799999999976 3678999999996
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=274.29 Aligned_cols=190 Identities=26% Similarity=0.408 Sum_probs=142.8
Q ss_pred HhcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 007254 419 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 419 ~~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 495 (611)
...++|.+.+.||+|+||.||+|... +++.||||+++... ....++.+|+.++..++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 34678999999999999999999854 78999999987642 4457788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhcC----CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccc
Q 007254 496 YDFLSRGSLEENLHGN----KKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~----~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA 571 (611)
|||+++|+|.+++... ......+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 9999999999988631 1123458999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCC---ceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 572 KWASTSSS---HITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 572 ~~~~~~~~---~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
........ ........||+.|+|||+.. ..++.++|||||
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 213 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSF 213 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHH
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHH
Confidence 87654321 11223467999999999875 578999999996
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.6e-31 Score=275.90 Aligned_cols=182 Identities=23% Similarity=0.367 Sum_probs=155.1
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----CeE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NNL 492 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~ 492 (611)
.++|.+.+.||+|+||.||+|... +|+.||||+++.. ......+.+|+.+++.++||||+++++++... +..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 568999999999999999999965 7899999999753 34567788999999999999999999998754 678
Q ss_pred EEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccc
Q 007254 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~ 572 (611)
|+||||+. |+|.+.+... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 90 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeccC-ccHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 99999996 5999988753 48999999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCCc--------eeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 573 WASTSSSH--------ITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 573 ~~~~~~~~--------~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
........ .......||+.|+|||+.. ..++.++|||||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~sl 209 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSC 209 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHH
Confidence 77543211 1123468999999999653 778999999996
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=275.54 Aligned_cols=191 Identities=21% Similarity=0.309 Sum_probs=155.0
Q ss_pred cChHHHHHhcCCCccceeecccCceEEEEEEecCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcC--CCCeeeEEEEE
Q 007254 412 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLH--HKNIISLLGFC 486 (611)
Q Consensus 412 ~~~~~l~~~~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~ 486 (611)
+.++.+....++|.+.+.||+|+||.||++...+++.||||+++.. ......+.+|+.++..++ ||||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 3344444556779999999999999999999888999999999653 356678999999999997 59999999999
Q ss_pred EeCCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEE
Q 007254 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 566 (611)
Q Consensus 487 ~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~ 566 (611)
.+.+.+|+||| +.+++|.+++.... .+++.++..++.|++.||.|||+ .+|+||||||+|||+++ +.+||+
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~ 168 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLI 168 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEEC
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEe
Confidence 99999999999 55889999997653 48899999999999999999999 89999999999999965 799999
Q ss_pred eeccccccCCCCCceeecCCccCCCcccceecc------------CCCcCcceEEeC
Q 007254 567 DFGLAKWASTSSSHITCTDVAGTFGYVVLILNP------------IAFLFMFNCWFF 611 (611)
Q Consensus 567 DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~------------~~~~~~sDiWSL 611 (611)
|||+++...............||+.|+|||+.. ..++.++|||||
T Consensus 169 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~sl 225 (313)
T 3cek_A 169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 225 (313)
T ss_dssp CCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHH
T ss_pred eccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHH
Confidence 999999876554433344568999999999864 378999999996
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=282.32 Aligned_cols=180 Identities=17% Similarity=0.235 Sum_probs=153.6
Q ss_pred CCCccceeecccCceEEEEEEecC---------CCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeee-----------
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLPD---------GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS----------- 481 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~~---------g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~----------- 481 (611)
++|.+.+.||+|+||.||+|.... ++.||||+++.. ..+.+|+++++.++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence 678999999999999999998753 789999999865 45778999999999999987
Q ss_pred ----EEEEEEe-CCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEE
Q 007254 482 ----LLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 556 (611)
Q Consensus 482 ----l~~~~~~-~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NIL 556 (611)
+++++.. .+.+|+||||+ +|+|.+++.... ...+++.++..++.||+.||.|||+ ++|+||||||+|||
T Consensus 118 ~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIl 191 (352)
T 2jii_A 118 AIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIF 191 (352)
T ss_dssp SCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGEE
T ss_pred CccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEE
Confidence 6778776 78899999999 999999998652 1359999999999999999999999 89999999999999
Q ss_pred EcCCC--cEEEEeeccccccCCCCCc-----eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 557 LSDDF--EPQLSDFGLAKWASTSSSH-----ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 557 l~~~~--~vKL~DFGlA~~~~~~~~~-----~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
++.++ .+||+|||+++.+...... .......||+.|+|||+.. ..++.++|||||
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 254 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSL 254 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHH
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHH
Confidence 99998 8999999999877543221 1223468999999999876 689999999996
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.1e-31 Score=274.34 Aligned_cols=186 Identities=23% Similarity=0.300 Sum_probs=142.3
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC-hhHHHHHHHHHHHHHhcC-CCCeeeEEEEEE--------eC
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS-EDVIKEFVLEIEIITTLH-HKNIISLLGFCF--------ED 489 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~-~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~--------~~ 489 (611)
..+|.+.+.||+|+||.||+|... +|+.||||++... ......+.+|+.++..+. ||||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 457888999999999999999964 7899999988654 355678899999999996 999999999994 33
Q ss_pred CeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEecCCCCCCEEEcCCCcEEEEe
Q 007254 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR--VIHRDVKSSNILLSDDFEPQLSD 567 (611)
Q Consensus 490 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~--IvHrDLKp~NILl~~~~~vKL~D 567 (611)
..+++||||+. |+|.+++..... ...+++.++..++.||+.||.|||+ .+ |+||||||+||||+.++.+||+|
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEec
Confidence 45899999995 699998865221 2359999999999999999999999 77 99999999999999999999999
Q ss_pred eccccccCCCCCce----------eecCCccCCCcccceec----cCCCcCcceEEeC
Q 007254 568 FGLAKWASTSSSHI----------TCTDVAGTFGYVVLILN----PIAFLFMFNCWFF 611 (611)
Q Consensus 568 FGlA~~~~~~~~~~----------~~~~~~GT~~Y~aPE~~----~~~~~~~sDiWSL 611 (611)
||+++......... ......||+.|+|||+. ...++.++|||||
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~sl 239 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWAL 239 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHH
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHH
Confidence 99998876533211 11245699999999986 3678999999996
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-31 Score=300.94 Aligned_cols=177 Identities=24% Similarity=0.374 Sum_probs=148.6
Q ss_pred ceeecccCceEEEEEEec---CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 007254 427 ENLIGKGGSSQVYKGCLP---DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (611)
Q Consensus 427 ~~~IG~G~fG~Vyk~~~~---~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 500 (611)
.+.||+|+||.||+|.+. +++.||||+++... ...++|.+|+++|..++||||++++++|. .+.++|||||++
T Consensus 374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~ 452 (635)
T 4fl3_A 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAE 452 (635)
T ss_dssp EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCT
T ss_pred CCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccC
Confidence 357999999999999653 56789999998643 34688999999999999999999999996 456899999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCc
Q 007254 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (611)
Q Consensus 501 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~ 580 (611)
+|+|.+++.... .+++.++..++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+.+......
T Consensus 453 ~g~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 453 LGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp TEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred CCCHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 999999997653 48999999999999999999999 89999999999999999999999999999987654322
Q ss_pred -eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 581 -ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 581 -~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.......||+.|+|||++. ..|+.++|||||
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSl 558 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSF 558 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred cccccCCCCceeeeChhhhcCCCCCcHHHHHHH
Confidence 2233456789999999886 789999999996
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-31 Score=281.85 Aligned_cols=177 Identities=23% Similarity=0.342 Sum_probs=137.9
Q ss_pred cCCCccceeecccCceEEEEEEe-cCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC------C
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED------N 490 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~ 490 (611)
.++|.+.+.||+|+||.||+|.. .+|+.||||++... ....+.+.+|+.+|+.++||||+++++++... +
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 47899999999999999999985 47899999999753 34567889999999999999999999999754 5
Q ss_pred eEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecc
Q 007254 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (611)
Q Consensus 491 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGl 570 (611)
.+|+||||+ +++|.+++... .+++..+..++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC-----C-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 689999999 78998888642 48999999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 571 AKWASTSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 571 A~~~~~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
|+..... .+...||+.|+|||+.. ..|+.++|||||
T Consensus 179 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 216 (367)
T 2fst_X 179 ARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 216 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHH
T ss_pred ccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHH
Confidence 9876543 23468999999999765 678999999996
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=278.72 Aligned_cols=184 Identities=23% Similarity=0.308 Sum_probs=159.1
Q ss_pred HhcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHHHhcC-CC-----CeeeEEEEEEeCCe
Q 007254 419 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLH-HK-----NIISLLGFCFEDNN 491 (611)
Q Consensus 419 ~~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~-Hp-----nIv~l~~~~~~~~~ 491 (611)
...++|.+.+.||+|+||.||+|... +++.||||+++.......++..|+.++..++ |+ +|+.+++++...+.
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 34678999999999999999999865 6889999999987777788889999999885 44 49999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEc--CCCcEEEEeec
Q 007254 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS--DDFEPQLSDFG 569 (611)
Q Consensus 492 ~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~--~~~~vKL~DFG 569 (611)
+||||||+. |+|.+++..... ..+++..+..++.|++.||.|||.. ..+||||||||+||||+ .++.+||+|||
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred eEEEEecCC-CCHHHHHhhcCc--CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 999999995 599999976532 3489999999999999999999952 27899999999999995 47789999999
Q ss_pred cccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 570 LAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 570 lA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+|+...... ....||+.|+|||+.. ..|+.++|||||
T Consensus 207 ~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSl 244 (382)
T 2vx3_A 207 SSCQLGQRI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSL 244 (382)
T ss_dssp TCEETTCCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred Cceeccccc-----ccccCCccccChHHHcCCCCCcHHHHHHH
Confidence 998875432 3468999999999876 789999999996
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-31 Score=284.11 Aligned_cols=180 Identities=21% Similarity=0.273 Sum_probs=147.8
Q ss_pred CCCccceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC------eEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN------NLLLV 495 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------~~~lV 495 (611)
.+|.+.+.||+|+||.||+|....+..+|+|++...... ..+|+++|+.++||||++++++|...+ ++|+|
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~---~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv 116 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF---KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch---HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence 468889999999999999999877777999988654322 236999999999999999999996544 38999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEc-CCCcEEEEeecccccc
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKWA 574 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~-~~~~vKL~DFGlA~~~ 574 (611)
|||++++ +...+.........+++..+..++.||+.||.|||+ .+|+||||||+||||+ .++.+||+|||+|+..
T Consensus 117 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 117 LEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred eeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 9999774 444333211222468999999999999999999999 8999999999999999 7999999999999987
Q ss_pred CCCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 575 STSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 575 ~~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
..... .....||+.|+|||+.. ..|+.++|||||
T Consensus 193 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSl 228 (394)
T 4e7w_A 193 IAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWST 228 (394)
T ss_dssp CTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHH
T ss_pred cCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHH
Confidence 55432 23468999999999774 569999999996
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=270.91 Aligned_cols=179 Identities=30% Similarity=0.482 Sum_probs=148.5
Q ss_pred cCCCccceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-CeEEEEEEcC
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED-NNLLLVYDFL 499 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-~~~~lV~Ey~ 499 (611)
.++|.+.+.||+|+||.||++.. +|+.||||+++... ..+.+.+|+++++.++||||+++++++.+. +.+|+||||+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 46788999999999999999987 58899999998654 457889999999999999999999997654 4789999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~ 579 (611)
++|+|.+++..... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 98 ~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 171 (278)
T 1byg_A 98 AKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 171 (278)
T ss_dssp TTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence 99999999975421 237899999999999999999999 899999999999999999999999999998665432
Q ss_pred ceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 580 HITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 580 ~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
....||+.|+|||... ..++.++|||||
T Consensus 172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 200 (278)
T 1byg_A 172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSF 200 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHH
T ss_pred ----cCCCccccccCHHHhCCCCCCchhcHHHH
Confidence 2346899999999875 788999999996
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-30 Score=271.13 Aligned_cols=180 Identities=19% Similarity=0.312 Sum_probs=156.8
Q ss_pred cCCCccceeecccCceEEEEEEec-CC-CEEEEEEecCChhHHHHHHHHHHHHHhcCCCC------eeeEEEEEEeCCeE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DG-KELAVKILKPSEDVIKEFVLEIEIITTLHHKN------IISLLGFCFEDNNL 492 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g-~~vAVK~lk~~~~~~~~~~~Ei~il~~l~Hpn------Iv~l~~~~~~~~~~ 492 (611)
.++|.+.+.||+|+||.||+|... ++ +.||||+++........+.+|+.+++.++|++ ++.+++++...+.+
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 467999999999999999999864 44 68999999987777788899999999997766 99999999999999
Q ss_pred EEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE---------------
Q 007254 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL--------------- 557 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl--------------- 557 (611)
|+||||+ +++|.+.+..... ..+++.++..++.||+.||.|||+ ++|+||||||+||||
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENNF--QPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEecc-CCChHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecccccccccccccc
Confidence 9999999 6677777765432 358999999999999999999999 899999999999999
Q ss_pred ----cCCCcEEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 558 ----SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 558 ----~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+.++.+||+|||+++...... ....||+.|+|||+.. ..++.++|||||
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 225 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSI 225 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred cccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHH
Confidence 567899999999998755432 3468999999999875 789999999996
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.1e-31 Score=301.73 Aligned_cols=175 Identities=19% Similarity=0.294 Sum_probs=152.9
Q ss_pred cCCCccceeecccCceEEEEEEec--CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCe-----
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP--DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN----- 491 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~--~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~----- 491 (611)
.++|.+.+.||+|+||.||+|.+. +|+.||||++... ......+.+|++++..++||||++++++|...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 367999999999999999999975 6899999998753 3456788999999999999999999999987665
Q ss_pred EEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccc
Q 007254 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (611)
Q Consensus 492 ~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA 571 (611)
.||||||++|++|.+.+.. .++|.++..++.||+.||.|||+ ++||||||||+||||+.+ .+||+|||++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccc
Confidence 7999999999999887643 48999999999999999999999 899999999999999886 8999999999
Q ss_pred cccCCCCCceeecCCccCCCcccceeccCCCcCcceEEeC
Q 007254 572 KWASTSSSHITCTDVAGTFGYVVLILNPIAFLFMFNCWFF 611 (611)
Q Consensus 572 ~~~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~~~~sDiWSL 611 (611)
+..... ....||++|+|||+....++.++|||||
T Consensus 229 ~~~~~~------~~~~gt~~y~aPE~~~~~~~~~sDi~sl 262 (681)
T 2pzi_A 229 SRINSF------GYLYGTPGFQAPEIVRTGPTVATDIYTV 262 (681)
T ss_dssp EETTCC------SCCCCCTTTSCTTHHHHCSCHHHHHHHH
T ss_pred hhcccC------CccCCCccccCHHHHcCCCCCceehhhh
Confidence 887653 3467999999999887667999999996
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=277.38 Aligned_cols=176 Identities=24% Similarity=0.384 Sum_probs=150.8
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeE----
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL---- 492 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~---- 492 (611)
.++|.+.+.||+|+||.||+|... +|+.||||+++.. ....+.+.+|+.+++.++||||++++++|...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468899999999999999999865 7899999999763 34567899999999999999999999999876654
Q ss_pred --EEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecc
Q 007254 493 --LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (611)
Q Consensus 493 --~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGl 570 (611)
|+||||+. |+|.+.+.. .+++..+..++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM------EFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999997 588887742 38999999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 571 AKWASTSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 571 A~~~~~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
++..... .....||+.|+|||+.. ..++.++|||||
T Consensus 191 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 228 (371)
T 4exu_A 191 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSV 228 (371)
T ss_dssp C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHH
T ss_pred ccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHH
Confidence 9876543 23568999999999765 688999999996
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-31 Score=282.22 Aligned_cols=179 Identities=13% Similarity=0.086 Sum_probs=136.9
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhc--CCCCeeeEE-------EEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTL--HHKNIISLL-------GFC 486 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l--~HpnIv~l~-------~~~ 486 (611)
..+|.+.+.||+|+||.||+|.+. +|+.||||+++... .....+.+|+.++..| +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345788999999999999999965 78999999998743 4456777885555444 699988865 454
Q ss_pred EeC-----------------CeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHH------HHHHHHHHHHHHHHHcCCCC
Q 007254 487 FED-----------------NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER------YKVAMGVAEALEYLHSGSAQ 543 (611)
Q Consensus 487 ~~~-----------------~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~------~~ia~qia~aL~yLH~~~~~ 543 (611)
... .++||||||++ |+|.+++..... .+.+..+ ..++.||+.||.|||+ +
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~ 213 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQS---K 213 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHH---T
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHH---C
Confidence 433 34899999998 899999975422 2455555 7788999999999999 8
Q ss_pred CeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCceeecCCccCCCcccceecc---CCCcCcceEEeC
Q 007254 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP---IAFLFMFNCWFF 611 (611)
Q Consensus 544 ~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~---~~~~~~sDiWSL 611 (611)
+||||||||+||||+.++.+||+|||+|+...... ....||+.|+|||+.. ..|+.++|||||
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSl 279 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQL 279 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHH
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHH
Confidence 99999999999999999999999999998765321 1456789999999875 578999999996
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-30 Score=267.14 Aligned_cols=181 Identities=23% Similarity=0.382 Sum_probs=159.3
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
.++|.+.+.||+|+||.||+|... +++.||||+++... .....+.+|+++++.++||||+++++++.+.+.+|+||
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 467899999999999999999975 78999999996532 35678999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCC---CcEEEEeeccccc
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD---FEPQLSDFGLAKW 573 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~---~~vKL~DFGlA~~ 573 (611)
||+++++|.+.+.... .+++.++..++.|++.||.|||+ .+|+||||||+|||++.+ +.+||+|||++..
T Consensus 101 e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 101 ELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp CCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 9999999999887543 48999999999999999999999 899999999999999754 4699999999987
Q ss_pred cCCCCCceeecCCccCCCcccceeccCCCcCcceEEeC
Q 007254 574 ASTSSSHITCTDVAGTFGYVVLILNPIAFLFMFNCWFF 611 (611)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~~~~sDiWSL 611 (611)
...... .....||+.|+|||.....++.++|||||
T Consensus 174 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~Di~sl 208 (287)
T 2wei_A 174 FQQNTK---MKDRIGTAYYIAPEVLRGTYDEKCDVWSA 208 (287)
T ss_dssp BCCCSS---CSCHHHHHTTCCHHHHTTCCCTHHHHHHH
T ss_pred ecCCCc---cccccCcccccChHHhcCCCCCchhhHhH
Confidence 765432 23457999999999888779999999996
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-30 Score=265.53 Aligned_cols=184 Identities=24% Similarity=0.313 Sum_probs=152.0
Q ss_pred hcCCCccceeecccCceEEEEEEe-cCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEE-EeCCeEEEEEE
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC-FEDNNLLLVYD 497 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-~~~~~~~lV~E 497 (611)
..++|.+.+.||+|+||.||+|.. .+++.||||++..... ...+.+|+.++..++|++++..++.+ ...+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 357899999999999999999986 5789999998765432 24578899999999988877666665 56778999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE---cCCCcEEEEeecccccc
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWA 574 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl---~~~~~vKL~DFGlA~~~ 574 (611)
|+ +|+|.+++.... ..+++.++..++.|++.||.|||+ .+|+||||||+|||| +.++.+||+|||+|+..
T Consensus 86 ~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 86 LL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp CC-CCBHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred cc-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 99 999999997543 358999999999999999999999 899999999999999 78899999999999987
Q ss_pred CCCCCc-----eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 575 STSSSH-----ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 575 ~~~~~~-----~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
...... .......||+.|+|||+.. ..++.++|||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 201 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESL 201 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHH
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHH
Confidence 654321 1233578999999999876 789999999996
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-30 Score=271.15 Aligned_cols=183 Identities=25% Similarity=0.390 Sum_probs=154.6
Q ss_pred hcCCCccceeecccCceEEEEEEe--cCCCEEEEEEecCCh---hHHHHHHHHHHHHHhc---CCCCeeeEEEEEE----
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCL--PDGKELAVKILKPSE---DVIKEFVLEIEIITTL---HHKNIISLLGFCF---- 487 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~--~~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~---- 487 (611)
..++|.+.+.||+|+||.||+|.. .+|+.||||+++... .....+.+|+.+++.+ +||||++++++|.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999997 368899999986532 2233566777777766 8999999999997
Q ss_pred -eCCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEE
Q 007254 488 -EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 566 (611)
Q Consensus 488 -~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~ 566 (611)
..+.+++||||+. |+|.+++..... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEe
Confidence 4567999999997 699999976532 348999999999999999999999 899999999999999999999999
Q ss_pred eeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 567 DFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 567 DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
|||+++...... ......||+.|+|||+.. ..++.++|||||
T Consensus 163 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 205 (326)
T 1blx_A 163 DFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSV 205 (326)
T ss_dssp SCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHH
T ss_pred cCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHH
Confidence 999998765432 234568999999999875 778999999996
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-30 Score=268.19 Aligned_cols=182 Identities=24% Similarity=0.359 Sum_probs=148.0
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCCCeeeEEEEEE-----------
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCF----------- 487 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~----------- 487 (611)
.++|.+.+.||+|+||.||+|... +|+.||||++.... ...+.+.+|+++++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 467899999999999999999976 58999999987653 56678999999999999999999999873
Q ss_pred ---eCCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEc-CCCcE
Q 007254 488 ---EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-DDFEP 563 (611)
Q Consensus 488 ---~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~-~~~~v 563 (611)
+.+.+|+||||+. |+|.+++... .+++..+..++.|++.||.|||+ ++|+||||||+|||++ +++.+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG-----PLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC-----CccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeE
Confidence 3467899999997 5999998642 48899999999999999999999 8999999999999997 56799
Q ss_pred EEEeeccccccCCCCCc-eeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 564 QLSDFGLAKWASTSSSH-ITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 564 KL~DFGlA~~~~~~~~~-~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
||+|||+++........ .......||..|+|||... ..++.++|||||
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 211 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAA 211 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhH
Confidence 99999999876543221 2233457899999999763 778999999996
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-30 Score=280.97 Aligned_cols=183 Identities=24% Similarity=0.377 Sum_probs=137.7
Q ss_pred Ccc-ceeecccCceEEEEEEec---CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CCeEEEEEE
Q 007254 424 FLA-ENLIGKGGSSQVYKGCLP---DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLLVYD 497 (611)
Q Consensus 424 f~~-~~~IG~G~fG~Vyk~~~~---~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lV~E 497 (611)
|.+ .++||+|+||.||+|... +++.||||+++... ....+.+|+.+|+.++||||++++++|.. ...+|||||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e 100 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 100 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEe
Confidence 444 468999999999999865 57899999997653 23467899999999999999999999965 678999999
Q ss_pred cCCCCCHHHHHhcCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE----cCCCcEEEEee
Q 007254 498 FLSRGSLEENLHGNK-----KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL----SDDFEPQLSDF 568 (611)
Q Consensus 498 y~~~gsL~~~L~~~~-----~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl----~~~~~vKL~DF 568 (611)
|+. |+|.+++.... .....+++..+..++.||+.||.|||+ .+||||||||+|||| +.++.+||+||
T Consensus 101 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 176 (405)
T 3rgf_A 101 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADM 176 (405)
T ss_dssp CCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECCT
T ss_pred CCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEEC
Confidence 996 48888775221 122358999999999999999999999 899999999999999 67789999999
Q ss_pred ccccccCCCCC-ceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 569 GLAKWASTSSS-HITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 569 GlA~~~~~~~~-~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
|+|+....... .......+||+.|+|||++. ..|+.++|||||
T Consensus 177 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl 222 (405)
T 3rgf_A 177 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAI 222 (405)
T ss_dssp TCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHH
T ss_pred CCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHH
Confidence 99988764322 12334578999999999775 458999999996
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-30 Score=264.33 Aligned_cols=183 Identities=24% Similarity=0.316 Sum_probs=155.1
Q ss_pred cCCCccceeecccCceEEEEEEe-cCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEE-EeCCeEEEEEEc
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC-FEDNNLLLVYDF 498 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-~~~~~~~lV~Ey 498 (611)
.++|.+.+.||+|+||.||+|.. .+|+.||||++..... ...+.+|+.+++.++|++++..+.++ ...+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEe
Confidence 46899999999999999999996 5799999999876432 24688999999999988866666555 567788999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE---cCCCcEEEEeeccccccC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl---~~~~~vKL~DFGlA~~~~ 575 (611)
+ +++|.+++.... ..+++.++..++.|++.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++...
T Consensus 87 ~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 87 L-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp C-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred c-CCCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 9 999999997443 358999999999999999999999 899999999999999 488899999999999876
Q ss_pred CCCCce-----eecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 576 TSSSHI-----TCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~-----~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
...... ......||+.|+|||+.. ..++.++|||||
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 201 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESL 201 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHH
Confidence 543321 224578999999999876 778999999996
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.6e-31 Score=268.38 Aligned_cols=184 Identities=27% Similarity=0.454 Sum_probs=148.4
Q ss_pred cCCCccceeecccCceEEEEEEec--CCC--EEEEEEecCC----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP--DGK--ELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 492 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~--~g~--~vAVK~lk~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 492 (611)
.++|.+.+.||+|+||.||+|.+. +++ .||||+++.. ....+.+.+|+++++.++||||+++++++.+.+ .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 357889999999999999999853 333 6899999753 345678999999999999999999999997654 8
Q ss_pred EEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccc
Q 007254 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~ 572 (611)
++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHhcc---CCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccc
Confidence 99999999999999997542 348899999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCce-eecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 573 WASTSSSHI-TCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 573 ~~~~~~~~~-~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......... ......||+.|+|||+.. ..++.++|||||
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 210 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMF 210 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHH
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHH
Confidence 876554332 223467899999999876 778999999996
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-30 Score=274.23 Aligned_cols=182 Identities=20% Similarity=0.312 Sum_probs=158.8
Q ss_pred cCCCccceeecccCceEEEEEEecCCCEEEEEEecCChh------------------HHHHHHHHHHHHHhcCCCCeeeE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSED------------------VIKEFVLEIEIITTLHHKNIISL 482 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~------------------~~~~~~~Ei~il~~l~HpnIv~l 482 (611)
.++|.+.+.||+|+||.||+|.. +|+.||||++..... ....+.+|+.++..++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 57899999999999999999999 999999999975321 12789999999999999999999
Q ss_pred EEEEEeCCeEEEEEEcCCCCCHHHH------HhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEE
Q 007254 483 LGFCFEDNNLLLVYDFLSRGSLEEN------LHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 556 (611)
Q Consensus 483 ~~~~~~~~~~~lV~Ey~~~gsL~~~------L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NIL 556 (611)
++++.+.+.+|+||||+++|+|.++ +... ....+++..+..++.|++.||.|||+ ..+|+||||||+|||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEE
Confidence 9999999999999999999999988 5432 13569999999999999999999996 268999999999999
Q ss_pred EcCCCcEEEEeeccccccCCCCCceeecCCccCCCcccceecc-C-CCcC-cceEEeC
Q 007254 557 LSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-I-AFLF-MFNCWFF 611 (611)
Q Consensus 557 l~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~-~~~~-~sDiWSL 611 (611)
++.++.+||+|||++...... ......||+.|+|||+.. . .++. ++|||||
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~sl 238 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSL 238 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHH
T ss_pred EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHH
Confidence 999999999999999876543 334578999999999876 3 5655 9999996
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-30 Score=275.20 Aligned_cols=180 Identities=18% Similarity=0.282 Sum_probs=157.0
Q ss_pred cCCCccceeecccCceEEEEEEe-cCCCEEEEEEecCChhHHHHHHHHHHHHHhcC-----------CCCeeeEEEEEEe
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLH-----------HKNIISLLGFCFE 488 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~-----------HpnIv~l~~~~~~ 488 (611)
.++|.+.+.||+|+||.||+|.. .+++.||||+++........+.+|+.++..++ ||||+++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 46799999999999999999986 47899999999987767788899999999886 8999999999986
Q ss_pred CC----eEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC-CeEecCCCCCCEEEc-----
Q 007254 489 DN----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ-RVIHRDVKSSNILLS----- 558 (611)
Q Consensus 489 ~~----~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~-~IvHrDLKp~NILl~----- 558 (611)
.+ .+++||||+ +++|.+++..... ..+++..+..++.||+.||.|||+ + +|+||||||+||||+
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEH--RGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhc--cCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCC
Confidence 54 789999999 8899999976433 348999999999999999999999 7 999999999999994
Q ss_pred -CCCcEEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 559 -DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 559 -~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
..+.+||+|||+|+...... ....||+.|+|||+.. ..++.++|||||
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 221 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWST 221 (373)
T ss_dssp TTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHH
T ss_pred cCcceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCCCCCchHhHHHH
Confidence 44589999999998776532 3458999999999875 778999999996
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.9e-30 Score=270.28 Aligned_cols=179 Identities=23% Similarity=0.329 Sum_probs=134.3
Q ss_pred cCCCccc-eeecccCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe----CCeEEE
Q 007254 421 TSNFLAE-NLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE----DNNLLL 494 (611)
Q Consensus 421 ~~~f~~~-~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~l 494 (611)
.++|.+. ++||+|+||.||+|... +|+.||||++........++ ...+..+.||||+++++++.. .+.+|+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~---~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 103 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEV---DHHWQASGGPHIVCILDVYENMHHGKRCLLI 103 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHH---HHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHH---HHHHHhcCCCChHHHHHHHhhccCCCceEEE
Confidence 4678874 57999999999999976 79999999998765433332 234667799999999999976 456899
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcC---CCcEEEEeeccc
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSDFGLA 571 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~---~~~vKL~DFGlA 571 (611)
||||+++|+|.+++..... ..+++.++..++.||+.||.|||+ .+|+||||||+||||+. ++.+||+|||++
T Consensus 104 v~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 104 IMECMEGGELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEECCTTEEHHHHHHTC-C--CCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 9999999999999986532 469999999999999999999999 89999999999999986 455999999999
Q ss_pred cccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 572 KWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 572 ~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+...... .....||+.|+|||+.. ..++.++|||||
T Consensus 179 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 215 (336)
T 3fhr_A 179 KETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSL 215 (336)
T ss_dssp EEC--------------------------CHHHHHHHHHHH
T ss_pred eeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHH
Confidence 8765432 23468899999999875 788999999996
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-30 Score=292.34 Aligned_cols=171 Identities=18% Similarity=0.085 Sum_probs=126.4
Q ss_pred eecccCceEEEEEE-ecCCCEEEEEEecCC-----------hhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEE
Q 007254 429 LIGKGGSSQVYKGC-LPDGKELAVKILKPS-----------EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 429 ~IG~G~fG~Vyk~~-~~~g~~vAVK~lk~~-----------~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV 495 (611)
.++.|++|.+..+. .-.|+.+|||++.+. +...++|.+|+++|+++ .|+||+++++++.+++.+|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35667777666654 336899999999653 23456799999999999 799999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
|||++||+|.+.|.... .++.. +|+.||+.||.|||+ +|||||||||+||||++++.+||+|||+|+...
T Consensus 321 MEyv~G~~L~d~i~~~~----~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE----EIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EECCCSEEHHHHHHTTC----CCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EecCCCCcHHHHHHhCC----CCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 99999999999997653 35543 589999999999999 999999999999999999999999999999876
Q ss_pred CCCCceeecCCccCCCcccceeccCCCcCcceEEeC
Q 007254 576 TSSSHITCTDVAGTFGYVVLILNPIAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~~~~~~~~sDiWSL 611 (611)
...+ ...+.+||++|||||+....+.+++|+||+
T Consensus 391 ~~~~--~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~ 424 (569)
T 4azs_A 391 QDCS--WPTNLVQSFFVFVNELFAENKSWNGFWRSA 424 (569)
T ss_dssp ---C--CSHHHHHHHHHHHHHHC-------------
T ss_pred CCCc--cccCceechhhccHHHhCCCCCCccccccc
Confidence 5443 234578999999999998888999999985
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.96 E-value=6e-30 Score=282.50 Aligned_cols=183 Identities=24% Similarity=0.306 Sum_probs=156.0
Q ss_pred cCCCccceeecccCceEEEEEEe-cCCCEEEEEEecCChhHHHHHHHHHHHHHhcCC-CCeeeEEEEEEeCCeEEEEEEc
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHH-KNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~lV~Ey 498 (611)
.++|.+.+.||+|+||.||+|.. .+++.||||+++.... ..++..|++++..++| ++|..+..++.+.+..||||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 46799999999999999999986 4799999999875432 2357889999999987 5666777777788899999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE---cCCCcEEEEeeccccccC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl---~~~~~vKL~DFGlA~~~~ 575 (611)
+ +++|.+++.... ..+++.++..|+.||+.||.|||+ ++||||||||+|||| +.++.+||+|||+|+.+.
T Consensus 85 ~-g~sL~~ll~~~~---~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 85 L-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp C-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred C-CCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 9 999999997543 359999999999999999999999 899999999999999 688999999999999876
Q ss_pred CCCCce-----eecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 576 TSSSHI-----TCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~-----~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
...... ......||+.|+|||+.. ..++.++|||||
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSl 199 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESL 199 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHH
Confidence 544321 223578999999999876 789999999996
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.8e-30 Score=271.52 Aligned_cols=176 Identities=24% Similarity=0.378 Sum_probs=149.9
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCe-----
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN----- 491 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~----- 491 (611)
.++|.+.+.||+|+||.||+|... +|+.||||++... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 467999999999999999999864 7899999999753 3456788999999999999999999999987654
Q ss_pred -EEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecc
Q 007254 492 -LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (611)
Q Consensus 492 -~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGl 570 (611)
+|+||||+. |+|.+.+.. .+++.++..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999997 588776632 38999999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 571 AKWASTSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 571 A~~~~~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
++..... .....||+.|+|||+.. ..++.++|||||
T Consensus 173 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~sl 210 (353)
T 3coi_A 173 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSV 210 (353)
T ss_dssp TTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHH
T ss_pred ccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHH
Confidence 9876543 23468999999999764 678999999996
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-30 Score=280.67 Aligned_cols=183 Identities=23% Similarity=0.282 Sum_probs=141.8
Q ss_pred CCccceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 007254 423 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 501 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 501 (611)
.|...+.||+|+||+||.+...+|+.||||++.... ...+.+|+.+|..+ +||||+++++++.+.+.+||||||+.
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~- 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN- 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG--HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-
Confidence 355678999999999987766689999999987543 35678899999876 89999999999999999999999995
Q ss_pred CCHHHHHhcCCCCCCC---CCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCC-------------CcEEE
Q 007254 502 GSLEENLHGNKKDPAA---FGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-------------FEPQL 565 (611)
Q Consensus 502 gsL~~~L~~~~~~~~~---l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~-------------~~vKL 565 (611)
|+|.+++......... ..+..+..++.||+.||.|||+ ++||||||||+||||+.+ +.+||
T Consensus 93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 6999999865432221 2334567899999999999999 899999999999999754 48999
Q ss_pred EeeccccccCCCCCce--eecCCccCCCcccceecc--------CCCcCcceEEeC
Q 007254 566 SDFGLAKWASTSSSHI--TCTDVAGTFGYVVLILNP--------IAFLFMFNCWFF 611 (611)
Q Consensus 566 ~DFGlA~~~~~~~~~~--~~~~~~GT~~Y~aPE~~~--------~~~~~~sDiWSL 611 (611)
+|||+|+......... ......||++|+|||+.. ..++.++|||||
T Consensus 170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSl 225 (434)
T 2rio_A 170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSM 225 (434)
T ss_dssp CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHH
T ss_pred cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhH
Confidence 9999999876543221 233568999999999763 568999999996
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.3e-30 Score=293.15 Aligned_cols=184 Identities=23% Similarity=0.365 Sum_probs=154.9
Q ss_pred hcCCCccceeecccCceEEEEEEec----CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEE
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~----~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 493 (611)
..++|.+.+.||+|+||.||+|.+. .+..||||.++.. ....+.|.+|+.+++.++||||+++++++. .+.+|
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 3467889999999999999999864 2457999998763 345678999999999999999999999984 56789
Q ss_pred EEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccc
Q 007254 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (611)
Q Consensus 494 lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~ 573 (611)
+||||+++|+|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+|+.
T Consensus 467 lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp EEEECCTTCBHHHHHHHTT---TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred EEEEcCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCee
Confidence 9999999999999997543 358999999999999999999999 8999999999999999999999999999998
Q ss_pred cCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 574 ASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
...... .......||+.|+|||+.. ..++.++|||||
T Consensus 541 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl 578 (656)
T 2j0j_A 541 MEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMF 578 (656)
T ss_dssp CCC-----------CCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred cCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHH
Confidence 765432 2233456789999999876 889999999996
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.2e-30 Score=267.18 Aligned_cols=184 Identities=22% Similarity=0.315 Sum_probs=136.8
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC--hhHHHHHHHHHH-HHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIE-IITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~--~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
.++|.+.+.||+|+||.||+|... +|+.||||+++.. .....++..|+. +++.++||||+++++++.+.+..|+||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 467888999999999999999975 7899999999764 344556666776 677789999999999999999999999
Q ss_pred EcCCCCCHHHHHhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC-CeEecCCCCCCEEEcCCCcEEEEeecccccc
Q 007254 497 DFLSRGSLEENLHGN-KKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ-RVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~-~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~-~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~ 574 (611)
||+.+ +|.+++... ......+++..+..++.|++.||.|||+ . +|+||||||+|||++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99975 887777531 1112458999999999999999999999 7 9999999999999999999999999999877
Q ss_pred CCCCCceeecCCccCCCcccceec-----cCCCcCcceEEeC
Q 007254 575 STSSSHITCTDVAGTFGYVVLILN-----PIAFLFMFNCWFF 611 (611)
Q Consensus 575 ~~~~~~~~~~~~~GT~~Y~aPE~~-----~~~~~~~sDiWSL 611 (611)
..... .....||+.|+|||+. ...++.++|||||
T Consensus 177 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~sl 215 (327)
T 3aln_A 177 VDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSL 215 (327)
T ss_dssp --------------------------------CCSHHHHHHH
T ss_pred ccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHH
Confidence 55432 2335799999999986 2668999999996
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-30 Score=267.88 Aligned_cols=181 Identities=24% Similarity=0.333 Sum_probs=148.6
Q ss_pred hcCCCccceeecccCceEEEEEEe-cCCCEEEEEEecCChh-------HHHHHHHHHHHHHhc----CCCCeeeEEEEEE
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSED-------VIKEFVLEIEIITTL----HHKNIISLLGFCF 487 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~~~-------~~~~~~~Ei~il~~l----~HpnIv~l~~~~~ 487 (611)
..++|.+.+.||+|+||.||+|.. .+++.||||+++.... ....+.+|+.++..+ +||||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 356899999999999999999986 4789999999976431 233456799999999 8999999999999
Q ss_pred eCCeEEEEEEc-CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEc-CCCcEEE
Q 007254 488 EDNNLLLVYDF-LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-DDFEPQL 565 (611)
Q Consensus 488 ~~~~~~lV~Ey-~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~-~~~~vKL 565 (611)
..+..++|||| +.+++|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++ .++.+||
T Consensus 109 ~~~~~~~v~e~~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 109 TQEGFMLVLERPLPAQDLFDYITEKG----PLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp ----CEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEEE
T ss_pred cCCeEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEEE
Confidence 98999999999 78999999997643 48999999999999999999999 8999999999999999 8899999
Q ss_pred EeeccccccCCCCCceeecCCccCCCcccceecc-CCC-cCcceEEeC
Q 007254 566 SDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAF-LFMFNCWFF 611 (611)
Q Consensus 566 ~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~-~~~sDiWSL 611 (611)
+|||+++...... .....||+.|+|||+.. ..+ +.++|||||
T Consensus 182 ~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 225 (312)
T 2iwi_A 182 IDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSL 225 (312)
T ss_dssp CCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHH
T ss_pred EEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHH
Confidence 9999998876533 23567999999999875 444 669999996
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-30 Score=269.46 Aligned_cols=182 Identities=23% Similarity=0.281 Sum_probs=156.5
Q ss_pred HhcCCCccceeecccCceEEEEEEe-cCCCEEEEEEecCCh-------hHHHHHHHHHHHHHhcC--CCCeeeEEEEEEe
Q 007254 419 SATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-------DVIKEFVLEIEIITTLH--HKNIISLLGFCFE 488 (611)
Q Consensus 419 ~~~~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~~-------~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~ 488 (611)
...++|.+.+.||+|+||.||+|.. .+++.||||+++... .....+.+|+.+++.++ ||||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 3457899999999999999999985 478999999997542 12355778999999996 5999999999999
Q ss_pred CCeEEEEEEcCCC-CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEc-CCCcEEEE
Q 007254 489 DNNLLLVYDFLSR-GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-DDFEPQLS 566 (611)
Q Consensus 489 ~~~~~lV~Ey~~~-gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~-~~~~vKL~ 566 (611)
.+..++||||+.+ ++|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+||||+ +++.+||+
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEEC
T ss_pred CCcEEEEEEcCCCCccHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEe
Confidence 9999999999976 89999997643 48899999999999999999999 8999999999999999 78899999
Q ss_pred eeccccccCCCCCceeecCCccCCCcccceecc-CC-CcCcceEEeC
Q 007254 567 DFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IA-FLFMFNCWFF 611 (611)
Q Consensus 567 DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~-~~~~sDiWSL 611 (611)
|||+++...... .....||+.|+|||+.. .. ++.++|||||
T Consensus 193 Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~sl 235 (320)
T 3a99_A 193 DFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL 235 (320)
T ss_dssp CCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHH
T ss_pred eCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhH
Confidence 999998776432 23467999999999775 44 4789999996
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-29 Score=276.81 Aligned_cols=182 Identities=21% Similarity=0.284 Sum_probs=143.8
Q ss_pred cCCCccceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEEEEcC
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFL 499 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~ 499 (611)
..+|.+.+.||+|+||+||.....+|+.||||++..... ..+.+|+.+|+.+ +||||+++++++.+.+.+||||||+
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 346888899999999997655556899999999976432 2356799999999 7999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcC-----CCcEEEEeecccccc
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-----DFEPQLSDFGLAKWA 574 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~-----~~~vKL~DFGlA~~~ 574 (611)
. |+|.+++..... .+.+.++..++.||+.||.|||+ .+||||||||+||||+. ...+||+|||+|+..
T Consensus 101 ~-g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 101 A-ATLQEYVEQKDF---AHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp S-EEHHHHHHSSSC---CCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred C-CCHHHHHHhcCC---CccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 6 599999976542 24444567899999999999999 89999999999999953 235889999999987
Q ss_pred CCCCC-ceeecCCccCCCcccceecc----CCCcCcceEEeC
Q 007254 575 STSSS-HITCTDVAGTFGYVVLILNP----IAFLFMFNCWFF 611 (611)
Q Consensus 575 ~~~~~-~~~~~~~~GT~~Y~aPE~~~----~~~~~~sDiWSL 611 (611)
..... ........||+.|+|||++. ..+++++|||||
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSl 215 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSA 215 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHH
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHH
Confidence 64322 22344578999999999874 567889999996
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=260.70 Aligned_cols=181 Identities=21% Similarity=0.292 Sum_probs=135.7
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh--hH-HHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DV-IKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~--~~-~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
.++|.+.+.||+|+||.||+|... +|+.||||+++... .. ...+.++..+++.++||||+++++++.+.+.+|+||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 567888999999999999999975 78999999997643 22 333444556788889999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC-CeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ-RVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~-~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
||+ ++.+..++.... ..+++..+..++.|++.||.|||+ . +|+||||||+|||++.++.+||+|||++....
T Consensus 104 e~~-~~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQ---GPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CCC-SEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecc-CCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999 556665554322 358999999999999999999998 6 89999999999999999999999999998765
Q ss_pred CCCCceeecCCccCCCcccceec------cCCCcCcceEEeC
Q 007254 576 TSSSHITCTDVAGTFGYVVLILN------PIAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~------~~~~~~~sDiWSL 611 (611)
.... .....||+.|+|||+. ...+++++|||||
T Consensus 177 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~sl 215 (318)
T 2dyl_A 177 DDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSL 215 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHH
T ss_pred CCcc---ccccCCCccccChhhcccccccccCCccccchhhH
Confidence 5332 2346799999999986 2678999999996
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-30 Score=269.86 Aligned_cols=185 Identities=21% Similarity=0.344 Sum_probs=152.0
Q ss_pred HHhcCCCccceeecccCceEEEEEEecCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 007254 418 LSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (611)
Q Consensus 418 ~~~~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 494 (611)
....++|.+.+.||+|+||.||+|.... .+|+|+++.. ....+.+.+|+.+++.++||||+++++++.+.+.+++
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i 106 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI 106 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence 3446789999999999999999998743 4999999753 2334567789999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccccc
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~ 574 (611)
||||+++++|.+++.... ..+++.++..++.||+.||.|||+ .+|+||||||+|||++ ++.+||+|||+++..
T Consensus 107 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 107 ITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179 (319)
T ss_dssp ECBCCCSEEHHHHTTSSC---CCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred EeecccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence 999999999999997543 358899999999999999999999 8999999999999998 679999999998865
Q ss_pred CCCC---CceeecCCccCCCcccceecc----------CCCcCcceEEeC
Q 007254 575 STSS---SHITCTDVAGTFGYVVLILNP----------IAFLFMFNCWFF 611 (611)
Q Consensus 575 ~~~~---~~~~~~~~~GT~~Y~aPE~~~----------~~~~~~sDiWSL 611 (611)
.... .........||+.|+|||+.. ..++.++|||||
T Consensus 180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~sl 229 (319)
T 2y4i_B 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFAL 229 (319)
T ss_dssp --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHH
T ss_pred ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHH
Confidence 4221 112233467999999999764 357899999996
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-29 Score=286.39 Aligned_cols=184 Identities=25% Similarity=0.407 Sum_probs=157.7
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe------CCe
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFE------DNN 491 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------~~~ 491 (611)
.++|.+.+.||+|+||.||+|... +|+.||||+++.. ......+.+|+++++.++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 478999999999999999999864 7899999999764 3556789999999999999999999999765 667
Q ss_pred EEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCc---EEEEee
Q 007254 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE---PQLSDF 568 (611)
Q Consensus 492 ~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~---vKL~DF 568 (611)
.|+||||+++|+|.+++..... ...+++..+..++.|++.||.|||+ .+|+||||||+|||++.++. +||+||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEccc
Confidence 8999999999999999986532 2358889999999999999999999 89999999999999997765 999999
Q ss_pred ccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 569 GLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 569 GlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
|++........ .....||+.|+|||+.. ..++.++|||||
T Consensus 169 G~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSL 209 (676)
T 3qa8_A 169 GYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSF 209 (676)
T ss_dssp CCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHH
T ss_pred ccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHH
Confidence 99998765432 24578999999999876 889999999996
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.95 E-value=7.6e-28 Score=247.53 Aligned_cols=153 Identities=14% Similarity=0.086 Sum_probs=134.7
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
++|.+.+.||+|+||.||+|... +|+.||||+++.. ......|.+|+.++..++||||+++++++.+.+..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 57889999999999999999975 5899999999864 345688999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
||++|++|.+++... ....++..++.|++.||.|||+ ++|+||||||+||||+.++.+||+++
T Consensus 111 e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~-------- 173 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYP-------- 173 (286)
T ss_dssp ECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSC--------
T ss_pred EecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEec--------
Confidence 999999999999532 2445788899999999999999 89999999999999999999999744
Q ss_pred CCCceeecCCccCCCcccceeccCCCcCcceEEeC
Q 007254 577 SSSHITCTDVAGTFGYVVLILNPIAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~~~~~~~~~GT~~Y~aPE~~~~~~~~~sDiWSL 611 (611)
+|++| ++.++|||||
T Consensus 174 --------------~~~~~------~~~~~Di~sl 188 (286)
T 3uqc_A 174 --------------ATMPD------ANPQDDIRGI 188 (286)
T ss_dssp --------------CCCTT------CCHHHHHHHH
T ss_pred --------------cccCC------CCchhHHHHH
Confidence 34443 6889999986
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3e-27 Score=243.52 Aligned_cols=159 Identities=24% Similarity=0.387 Sum_probs=136.2
Q ss_pred cCCCccc-eeecccCceEEEEEEe-cCCCEEEEEEecCChhHHHHHHHHHHHH-HhcCCCCeeeEEEEEEe----CCeEE
Q 007254 421 TSNFLAE-NLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEII-TTLHHKNIISLLGFCFE----DNNLL 493 (611)
Q Consensus 421 ~~~f~~~-~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~~~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~----~~~~~ 493 (611)
.++|.+. +.||+|+||.||++.. .+++.||||+++.. ..+.+|++++ +.++||||+++++++.. .+.+|
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 3566666 7899999999999986 47899999999754 3466788887 66699999999999987 67899
Q ss_pred EEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcC---CCcEEEEeecc
Q 007254 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSDFGL 570 (611)
Q Consensus 494 lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~---~~~vKL~DFGl 570 (611)
+||||+++|+|.+++..... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++. ++.+||+|||+
T Consensus 92 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 99999999999999986532 358999999999999999999999 89999999999999998 78999999999
Q ss_pred ccccCCCCCceeecCCccCCCcccceeccCCCcCcceEEeC
Q 007254 571 AKWASTSSSHITCTDVAGTFGYVVLILNPIAFLFMFNCWFF 611 (611)
Q Consensus 571 A~~~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~~~~sDiWSL 611 (611)
|+.... ..|+.++|||||
T Consensus 167 a~~~~~-----------------------~~~~~~~Diwsl 184 (299)
T 3m2w_A 167 AKETTG-----------------------EKYDKSCDMWSL 184 (299)
T ss_dssp CEECTT-----------------------CGGGGHHHHHHH
T ss_pred cccccc-----------------------ccCCchhhHHHH
Confidence 865432 446778899985
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-28 Score=264.50 Aligned_cols=181 Identities=15% Similarity=0.227 Sum_probs=139.1
Q ss_pred cCCCccceeecccCceEEEEEEe-cCCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCC-CCe---------------
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----DVIKEFVLEIEIITTLHH-KNI--------------- 479 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~H-pnI--------------- 479 (611)
+.+|...+.||+|+||.||+|.+ .+|+.||||+++... ...+.|.+|+.++..++| .|.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 34577789999999999999995 479999999998432 335778999999999987 211
Q ss_pred ------eeEEEEEEe-----CCeEEEEEEcCCCCCHHHHHhcC---CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCe
Q 007254 480 ------ISLLGFCFE-----DNNLLLVYDFLSRGSLEENLHGN---KKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545 (611)
Q Consensus 480 ------v~l~~~~~~-----~~~~~lV~Ey~~~gsL~~~L~~~---~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~I 545 (611)
..+..++.. ....+++|+++ +++|.+++... ......++|..++.++.||+.||.|||+ ++|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCc
Confidence 111111111 23467888876 67999888421 1223458899999999999999999999 999
Q ss_pred EecCCCCCCEEEcCCCcEEEEeeccccccCCCCCceeecCCccCCCcccceec----------c-CCCcCcceEEeC
Q 007254 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILN----------P-IAFLFMFNCWFF 611 (611)
Q Consensus 546 vHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~----------~-~~~~~~sDiWSL 611 (611)
|||||||+||||+.++.+||+|||+|+..... ....+| +.|+|||++ . ..|+.++|||||
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSl 303 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL 303 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHH
Confidence 99999999999999999999999999876543 345678 999999977 3 458889999996
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.3e-28 Score=269.91 Aligned_cols=168 Identities=17% Similarity=0.243 Sum_probs=132.8
Q ss_pred ccceeecccCceEEEEEEecCCCEEEEEEecCCh---------hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 007254 425 LAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE---------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 425 ~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~---------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 495 (611)
...+.||+|+||.||+|.. .++.+++|.+.... ...++|.+|+++|+.++||||+.+..++...++.|||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999954 67889999864321 1245689999999999999999666666677788999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
|||+++|+|.+++.. +..++.|++.||.|||+ ++|+||||||+|||++. .+||+|||+|+...
T Consensus 418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 999999999999964 35789999999999999 89999999999999998 99999999999876
Q ss_pred CCCCce-----eecCCccCCCcccceecc---CCCcCcceEEe
Q 007254 576 TSSSHI-----TCTDVAGTFGYVVLILNP---IAFLFMFNCWF 610 (611)
Q Consensus 576 ~~~~~~-----~~~~~~GT~~Y~aPE~~~---~~~~~~sDiWS 610 (611)
...... ......||+.|||||+.. ..|+..+|+||
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws 523 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWE 523 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHH
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHH
Confidence 532211 123578999999999875 77888899997
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=8.7e-25 Score=224.70 Aligned_cols=161 Identities=14% Similarity=0.074 Sum_probs=128.0
Q ss_pred HHHHhcCCCccceeecccCceEEEEEEecCCCEEEEEEecCCh-------------------hHHHHHHHHHHHHHhcCC
Q 007254 416 DLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-------------------DVIKEFVLEIEIITTLHH 476 (611)
Q Consensus 416 ~l~~~~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~-------------------~~~~~~~~Ei~il~~l~H 476 (611)
.+......|.+.+.||+|+||.||+|...+|+.||||+++... .....+.+|+++|+.++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 3444555677889999999999999999779999999997532 13567899999999999
Q ss_pred CCeeeEEEEEEeCCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEE
Q 007254 477 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 556 (611)
Q Consensus 477 pnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NIL 556 (611)
| +++.+++.. +..|+||||++||+|.+ +.. .+...++.|++.||.|||+ .+||||||||+|||
T Consensus 163 -~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NIL 225 (282)
T 1zar_A 163 -G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVL 225 (282)
T ss_dssp -T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEE
T ss_pred -C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEE
Confidence 4 556665533 56699999999999988 521 1234699999999999999 99999999999999
Q ss_pred EcCCCcEEEEeeccccccCCCCCceeecCCccCCCcccceecc-----------CCCcCcceEEe
Q 007254 557 LSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-----------IAFLFMFNCWF 610 (611)
Q Consensus 557 l~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-----------~~~~~~sDiWS 610 (611)
|+ ++.+||+|||+|+. +..|+|||+.. ..|...+|+|.
T Consensus 226 l~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVE---------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp EE-TTEEEECCCTTCEE---------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred EE-CCcEEEEECCCCeE---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 99 99999999999863 44578888742 45666777664
|
| >1mjh_A Protein (ATP-binding domain of protein MJ0577); hypothetical protein, structural genomics, functional assignment; HET: ATP; 1.70A {Methanocaldococcus jannaschii} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.84 E-value=3.7e-20 Score=173.13 Aligned_cols=138 Identities=15% Similarity=0.092 Sum_probs=115.5
Q ss_pred CCCEEEEEeCCCHhHHHHHHHHHHHccCCCCEEEEEEEeeCC-----CcccC------C-Cc------hhHHHHHHHHHH
Q 007254 15 AGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANN-----AIVDR------D-GK------SSLLSLVKAFDS 76 (611)
Q Consensus 15 ~~~~IlVaVD~s~~S~~AL~WAl~~~~~~g~~vvlvHV~~~~-----~~~~~------~-~~------~~~~~~~~~~~~ 76 (611)
.-++||||||+|+.|..||+||+..+...|++|++|||.++. ..... . .. .......+..++
T Consensus 4 ~~~~ILv~vD~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (162)
T 1mjh_A 4 MYKKILYPTDFSETAEIALKHVKAFKTLKAEEVILLHVIDEREIKKRDIFSLLLGVAGLNKSVEEFENELKNKLTEEAKN 83 (162)
T ss_dssp CCCEEEEECCSCHHHHHHHHHHHHTCCSSCCEEEEEEEEEGGGTC-----------------CHHHHHHHHHHHHHHHHH
T ss_pred ccceEEEEeCCCHHHHHHHHHHHHHHhhcCCeEEEEEEecCccccccccccccccccccccchhhhHHHHHHHHHHHHHH
Confidence 357899999999999999999999999999999999999854 11010 0 11 123344566778
Q ss_pred HHHHHHhhhhhcCCcEEEEEEECCchhHHHHHHHHhcCCCEEEEccCCCCceeec-ccchhHHHHhcCCCCcEEEEEeCC
Q 007254 77 VLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRS-TTSLAKYCAKKLSKDCSVLAVNNG 155 (611)
Q Consensus 77 ll~~~~~~C~~k~V~~~~~v~~g~~~~~~Iv~~a~~~~ad~LVlG~~g~~~~~R~-~gsva~~v~k~ap~~C~VlvV~kg 155 (611)
.|+.+...+...|++++.++..| ++.++|+++|++.++|+||||++|++++.|+ +|||+++|+++++ |||+||+.+
T Consensus 84 ~l~~~~~~~~~~g~~~~~~v~~G-~~~~~I~~~a~~~~~dlIV~G~~g~~~~~~~~~GSv~~~vl~~~~--~pVlvv~~~ 160 (162)
T 1mjh_A 84 KMENIKKELEDVGFKVKDIIVVG-IPHEEIVKIAEDEGVDIIIMGSHGKTNLKEILLGSVTENVIKKSN--KPVLVVKRK 160 (162)
T ss_dssp HHHHHHHHHHHTTCEEEEEEEEE-CHHHHHHHHHHHTTCSEEEEESCCSSCCTTCSSCHHHHHHHHHCC--SCEEEECCC
T ss_pred HHHHHHHHHHHcCCceEEEEcCC-CHHHHHHHHHHHcCCCEEEEcCCCCCCccceEecchHHHHHHhCC--CCEEEEeCC
Confidence 89999999999999999888886 7899999999999999999999999999885 9999999999998 999999754
|
| >3s3t_A Nucleotide-binding protein, universal stress PROT family; structural genomics, PSI-biology, midwest center for structu genomics, MCSG; HET: ATP; 1.90A {Lactobacillus plantarum} SCOP: c.26.2.0 | Back alignment and structure |
|---|
Probab=99.84 E-value=3.4e-20 Score=170.01 Aligned_cols=136 Identities=15% Similarity=0.178 Sum_probs=117.4
Q ss_pred CCCEEEEEeCCCHhHHHHHHHHHHHccCCCCEEEEEEEeeCCCcccCC----CchhHHHHHHHHHHHHHHHHhhhhhcCC
Q 007254 15 AGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRD----GKSSLLSLVKAFDSVLAVYEGFCNLKQV 90 (611)
Q Consensus 15 ~~~~IlVaVD~s~~S~~AL~WAl~~~~~~g~~vvlvHV~~~~~~~~~~----~~~~~~~~~~~~~~ll~~~~~~C~~k~V 90 (611)
+-++|+||+|+|+.|..||+||+..+...|.+|++|||.++....... .........+..++.|+.+...+...|+
T Consensus 4 ~~~~ILv~~D~s~~s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~g~ 83 (146)
T 3s3t_A 4 RYTNILVPVDSSDAAQAAFTEAVNIAQRHQANLTALYVVDDSAYHTPALDPVLSELLDAEAAHAKDAMRQRQQFVATTSA 83 (146)
T ss_dssp CCCEEEEECCSSHHHHHHHHHHHHHHHHHTCEEEEEEEEECCCCCCGGGHHHHHHHHHHHHHHHHHHHHHHHHHHTTSSC
T ss_pred ccceEEEEcCCCHHHHHHHHHHHHHHHhcCCEEEEEEEecCccccccccccccHHHHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 457999999999999999999999999899999999999875432211 1122345567778899999999999999
Q ss_pred -cEEEEEEECCchhHHHHH-HHHhcCCCEEEEccCCCCceeec-ccchhHHHHhcCCCCcEEEEEe
Q 007254 91 -DLKLKICRGTSIRKILVR-EAQSYSATKFIVGTAKNHHTIRS-TTSLAKYCAKKLSKDCSVLAVN 153 (611)
Q Consensus 91 -~~~~~v~~g~~~~~~Iv~-~a~~~~ad~LVlG~~g~~~~~R~-~gsva~~v~k~ap~~C~VlvV~ 153 (611)
+++..+..| ++.+.|++ +|++.++|+||||++|++++.++ +||++++|+++++ |||+||+
T Consensus 84 ~~~~~~~~~g-~~~~~I~~~~a~~~~~dliV~G~~~~~~~~~~~~Gs~~~~vl~~~~--~pVlvV~ 146 (146)
T 3s3t_A 84 PNLKTEISYG-IPKHTIEDYAKQHPEIDLIVLGATGTNSPHRVAVGSTTSYVVDHAP--CNVIVIR 146 (146)
T ss_dssp CCCEEEEEEE-CHHHHHHHHHHHSTTCCEEEEESCCSSCTTTCSSCHHHHHHHHHCS--SEEEEEC
T ss_pred cceEEEEecC-ChHHHHHHHHHhhcCCCEEEECCCCCCCcceEEEcchHHHHhccCC--CCEEEeC
Confidence 999888887 78999999 99999999999999999998885 9999999999998 9999985
|
| >3fg9_A Protein of universal stress protein USPA family; APC60691, nucleotide- binding, lactobacillus plantarum WCFS1, structural genomics PSI-2; 1.47A {Lactobacillus plantarum} | Back alignment and structure |
|---|
Probab=99.83 E-value=4.3e-20 Score=171.76 Aligned_cols=138 Identities=15% Similarity=0.188 Sum_probs=117.3
Q ss_pred CCCCEEEEEeC--CCHhHHHHHHHHHHHccCCCCEEEEEEEeeCCCcccC--CCchhHHHHHHHHHHHHHHHHhhhhhcC
Q 007254 14 GAGRTVVVGVK--LDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDR--DGKSSLLSLVKAFDSVLAVYEGFCNLKQ 89 (611)
Q Consensus 14 ~~~~~IlVaVD--~s~~S~~AL~WAl~~~~~~g~~vvlvHV~~~~~~~~~--~~~~~~~~~~~~~~~ll~~~~~~C~~k~ 89 (611)
..-++|||||| +|+.|..||+||+..+...|.+|++|||.++...... ..........+..++.|..+...+...|
T Consensus 13 ~~~~~ILv~vD~~~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~g 92 (156)
T 3fg9_A 13 LVYRRILLTVDEDDNTSSERAFRYATTLAHDYDVPLGICSVLESEDINIFDSLTPSKIQAKRKHVEDVVAEYVQLAEQRG 92 (156)
T ss_dssp CCCC-EEEECCSCCCHHHHHHHHHHHHHHHHHTCCEEEEEEECCCCTTCCCSSHHHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred ccCceEEEEECCCCCHHHHHHHHHHHHHHHhcCCEEEEEEEEeCCCccccccCCHHHHHHHHHHHHHHHHHHHHHHHHcC
Confidence 35689999999 9999999999999999989999999999986542211 1122344566777889999999999999
Q ss_pred C-cEEEEEEECCchhHHHHHH-HHhcCCCEEEEccCCCCceeecccchhHHHHhcCCCCcEEEEEe
Q 007254 90 V-DLKLKICRGTSIRKILVRE-AQSYSATKFIVGTAKNHHTIRSTTSLAKYCAKKLSKDCSVLAVN 153 (611)
Q Consensus 90 V-~~~~~v~~g~~~~~~Iv~~-a~~~~ad~LVlG~~g~~~~~R~~gsva~~v~k~ap~~C~VlvV~ 153 (611)
+ .++..+..++++.++|+++ |++.++|+||||++|++++.+++||++++|+++++ |||+||+
T Consensus 93 ~~~~~~~v~~~g~~~~~I~~~~a~~~~~DlIV~G~~g~~~~~~~~Gs~~~~vl~~a~--~PVlvV~ 156 (156)
T 3fg9_A 93 VNQVEPLVYEGGDVDDVILEQVIPEFKPDLLVTGADTEFPHSKIAGAIGPRLARKAP--ISVIVVR 156 (156)
T ss_dssp CSSEEEEEEECSCHHHHHHHTHHHHHCCSEEEEETTCCCTTSSSCSCHHHHHHHHCS--SEEEEEC
T ss_pred CCceEEEEEeCCCHHHHHHHHHHHhcCCCEEEECCCCCCccceeecchHHHHHHhCC--CCEEEeC
Confidence 9 5898888856899999999 99999999999999999987779999999999998 9999985
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.5e-20 Score=190.34 Aligned_cols=137 Identities=20% Similarity=0.203 Sum_probs=108.1
Q ss_pred CccceeecccCceEEEEEEe-cCCCE--EEEEEecCChh-------------------------HHHHHHHHHHHHHhcC
Q 007254 424 FLAENLIGKGGSSQVYKGCL-PDGKE--LAVKILKPSED-------------------------VIKEFVLEIEIITTLH 475 (611)
Q Consensus 424 f~~~~~IG~G~fG~Vyk~~~-~~g~~--vAVK~lk~~~~-------------------------~~~~~~~Ei~il~~l~ 475 (611)
|.+.+.||+|+||.||+|.. .+|+. ||||+++.... ....+.+|+.+|..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56789999999999999997 68999 99999865321 1236788999999998
Q ss_pred CCCe--eeEEEEEEeCCeEEEEEEcCCC-C----CHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCCeEe
Q 007254 476 HKNI--ISLLGFCFEDNNLLLVYDFLSR-G----SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH-SGSAQRVIH 547 (611)
Q Consensus 476 HpnI--v~l~~~~~~~~~~~lV~Ey~~~-g----sL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH-~~~~~~IvH 547 (611)
|++| +.++.+ +..+|||||+.+ | .|.+.+.. +++..+..++.|++.||.||| . .+|||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~---~givH 194 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQE---AELVH 194 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHT---SCEEC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHH---CCEEe
Confidence 8754 444442 245999999942 3 67666532 123456789999999999999 8 89999
Q ss_pred cCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 548 RDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 548 rDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
|||||+|||++. .++|+|||+|.....
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~~~ 221 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTLRH 221 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEETTS
T ss_pred CCCCHHHEEEcC--cEEEEECcccccCCC
Confidence 999999999988 999999999987643
|
| >3hgm_A Universal stress protein TEAD; rossman fold, signaling protein; HET: ATP; 1.90A {Halomonas elongata} SCOP: c.26.2.0 | Back alignment and structure |
|---|
Probab=99.82 E-value=4e-20 Score=169.58 Aligned_cols=134 Identities=15% Similarity=0.093 Sum_probs=114.8
Q ss_pred CCEEEEEeCCCHhHHHHHHHHHHHccCCCCEEEEEEEeeCCC-ccc-------CCCchhHHHHHHHHHHHHHHHHhhhhh
Q 007254 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNA-IVD-------RDGKSSLLSLVKAFDSVLAVYEGFCNL 87 (611)
Q Consensus 16 ~~~IlVaVD~s~~S~~AL~WAl~~~~~~g~~vvlvHV~~~~~-~~~-------~~~~~~~~~~~~~~~~ll~~~~~~C~~ 87 (611)
-++|+||+|+|+.|.+||+||+..+...|++|++|||.++.. ... ...........+..++.++.+...+..
T Consensus 2 ~~~ILv~vD~s~~s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 81 (147)
T 3hgm_A 2 FNRIMVPVDGSKGAVKALEKGVGLQQLTGAELYILCVFKHHSLLEASLSMARPEQLDIPDDALKDYATEIAVQAKTRATE 81 (147)
T ss_dssp CSEEEEECCSBHHHHHHHHHHHHHHHHHCCEEEEEEEECCHHHHHHTBSSCCCGGGCCCTTHHHHHHHHHHHHHHHHHHH
T ss_pred CceEEEEeCCCHHHHHHHHHHHHHHHhcCCEEEEEEEecCcccccccccccChhhhhhHHHHHHHHHHHHHHHHHHHHHh
Confidence 378999999999999999999999998999999999998542 100 011112445567788999999999999
Q ss_pred cCCcE---EEEEEECCchhHHHHHHHHhcCCCEEEEccCCCCceeec-ccchhHHHHhcCCCCcEEEEE
Q 007254 88 KQVDL---KLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRS-TTSLAKYCAKKLSKDCSVLAV 152 (611)
Q Consensus 88 k~V~~---~~~v~~g~~~~~~Iv~~a~~~~ad~LVlG~~g~~~~~R~-~gsva~~v~k~ap~~C~VlvV 152 (611)
.|+++ +..+..| ++.++|+++|++.++|+||||++|++++.++ +||++++|+++++ |||+||
T Consensus 82 ~g~~~~~~~~~~~~g-~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~Gs~~~~vl~~~~--~pVlvV 147 (147)
T 3hgm_A 82 LGVPADKVRAFVKGG-RPSRTIVRFARKRECDLVVIGAQGTNGDKSLLLGSVAQRVAGSAH--CPVLVV 147 (147)
T ss_dssp TTCCGGGEEEEEEES-CHHHHHHHHHHHTTCSEEEECSSCTTCCSCCCCCHHHHHHHHHCS--SCEEEC
T ss_pred cCCCccceEEEEecC-CHHHHHHHHHHHhCCCEEEEeCCCCccccceeeccHHHHHHhhCC--CCEEEC
Confidence 99988 8888876 7899999999999999999999999999885 9999999999998 999986
|
| >3idf_A USP-like protein; universal, stress, PSI, MCSG, structural genomics, midwest center for structural genomics structure initiative; 2.00A {Wolinella succinogenes} | Back alignment and structure |
|---|
Probab=99.82 E-value=8.9e-20 Score=165.74 Aligned_cols=132 Identities=14% Similarity=0.154 Sum_probs=112.9
Q ss_pred CEEEEEeCCCHhHHHHHHHHHHHc-cCCCCEEEEEEEeeCCCcccC---CCchhHHHHH-HHHHHHHHHHHhhhhhcCCc
Q 007254 17 RTVVVGVKLDTHSRELLTWALVKV-AQPGDTVIALHVLANNAIVDR---DGKSSLLSLV-KAFDSVLAVYEGFCNLKQVD 91 (611)
Q Consensus 17 ~~IlVaVD~s~~S~~AL~WAl~~~-~~~g~~vvlvHV~~~~~~~~~---~~~~~~~~~~-~~~~~ll~~~~~~C~~k~V~ 91 (611)
++|+||+|+|+.|..||+||+..+ ...|..|++|||.++...... .......... +..++.++.+...+...|++
T Consensus 2 ~~ILv~~D~s~~s~~al~~a~~la~~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~g~~ 81 (138)
T 3idf_A 2 KKLLFAIDDTEACERAAQYILDMFGKDADCTLTLIHVKPEFMLYGEAVLAAYDEIEMKEEEKAKLLTQKFSTFFTEKGIN 81 (138)
T ss_dssp EEEEEECCSSHHHHHHHHHHHHHHTTCTTEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred ceEEEEeCCCHHHHHHHHHHHHHhccCCCCEEEEEEEecCCCcccccccCcHHHHHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 589999999999999999999999 899999999999986532111 0112233444 67788999999999999999
Q ss_pred EEEEEEECCchhHHHHHHHHhcCCCEEEEccCCCCceeecccchhHHHHhcCCCCcEEEEEe
Q 007254 92 LKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTSLAKYCAKKLSKDCSVLAVN 153 (611)
Q Consensus 92 ~~~~v~~g~~~~~~Iv~~a~~~~ad~LVlG~~g~~~~~R~~gsva~~v~k~ap~~C~VlvV~ 153 (611)
++..+..| ++.++|+++|+ ++|+||||++|++++.+++||++++|+++++ |||+||+
T Consensus 82 ~~~~v~~g-~~~~~I~~~a~--~~dliV~G~~~~~~~~~~~Gs~~~~vl~~~~--~pVlvv~ 138 (138)
T 3idf_A 82 PFVVIKEG-EPVEMVLEEAK--DYNLLIIGSSENSFLNKIFASHQDDFIQKAP--IPVLIVK 138 (138)
T ss_dssp CEEEEEES-CHHHHHHHHHT--TCSEEEEECCTTSTTSSCCCCTTCHHHHHCS--SCEEEEC
T ss_pred eEEEEecC-ChHHHHHHHHh--cCCEEEEeCCCcchHHHHhCcHHHHHHhcCC--CCEEEeC
Confidence 99988887 78999999999 9999999999999988844999999999998 9999984
|
| >2dum_A Hypothetical protein PH0823; conserved hypothetical protein, putative universal protein A structural genomics, NPPSFA; 2.75A {Pyrococcus horikoshii} | Back alignment and structure |
|---|
Probab=99.81 E-value=3e-19 Score=168.46 Aligned_cols=138 Identities=14% Similarity=0.026 Sum_probs=114.5
Q ss_pred CCCEEEEEeCCCHhHHHHHHHHHHHccCCCCEEEEEEEeeCCCcccC-------------CCchhHHHHHHHHHHHHHHH
Q 007254 15 AGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDR-------------DGKSSLLSLVKAFDSVLAVY 81 (611)
Q Consensus 15 ~~~~IlVaVD~s~~S~~AL~WAl~~~~~~g~~vvlvHV~~~~~~~~~-------------~~~~~~~~~~~~~~~ll~~~ 81 (611)
.-++||||||+|+.|..||+||+..+...|++|++|||.++...... ..........+..++.|+.+
T Consensus 4 m~~~ILv~vD~s~~s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 83 (170)
T 2dum_A 4 MFRKVLFPTDFSEGAYRAVEVFEKRNKMEVGEVILLHVIDEGTLEELMDGYSFFYDNAEIELKDIKEKLKEEASRKLQEK 83 (170)
T ss_dssp CCSEEEEECCSSHHHHHHHHHHHHHCCSCCSEEEEEEEEETTGGGCCC------------CCTTSHHHHHHHHHHHHHHH
T ss_pred ccceEEEEecCCHHHHHHHHHHHHHHHhcCCEEEEEEEecCccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 35789999999999999999999999999999999999986432100 11122344556777889999
Q ss_pred HhhhhhcCCcEEE--EEEECCchhHHHHHHHHhcCCCEEEEccCCCCceeec-ccchhHHHHhcCCCCcEEEEEeCC
Q 007254 82 EGFCNLKQVDLKL--KICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRS-TTSLAKYCAKKLSKDCSVLAVNNG 155 (611)
Q Consensus 82 ~~~C~~k~V~~~~--~v~~g~~~~~~Iv~~a~~~~ad~LVlG~~g~~~~~R~-~gsva~~v~k~ap~~C~VlvV~kg 155 (611)
...+...+++++. .+..| ++.++|+++|++.++|+||||++|++++.++ +||++++|+++++ |||+||+.+
T Consensus 84 ~~~~~~~g~~~~~~~~~~~g-~~~~~I~~~a~~~~~DlIV~G~~g~~~~~~~~~Gsv~~~vl~~~~--~PVlvv~~~ 157 (170)
T 2dum_A 84 AEEVKRAFRAKNVRTIIRFG-IPWDEIVKVAEEENVSLIILPSRGKLSLSHEFLGSTVMRVLRKTK--KPVLIIKEV 157 (170)
T ss_dssp HHHHHHHTTCSEEEEEEEEE-CHHHHHHHHHHHTTCSEEEEESCCCCC--TTCCCHHHHHHHHHCS--SCEEEECCC
T ss_pred HHHHHHcCCceeeeeEEecC-ChHHHHHHHHHHcCCCEEEECCCCCCccccceechHHHHHHHhCC--CCEEEEccC
Confidence 8888888999887 77775 7899999999999999999999999998885 9999999999998 999999853
|
| >1tq8_A Hypothetical protein RV1636; MTCY01B2.28, structural target, NYSGXRC, PSI, protein structure initiative; 2.40A {Mycobacterium tuberculosis} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.81 E-value=1.4e-19 Score=170.49 Aligned_cols=138 Identities=16% Similarity=0.092 Sum_probs=109.4
Q ss_pred CCCCEEEEEeCCCHhHHHHHHHHHHHccCCCCEEEEE--EEeeCCCc-ccCC--CchhHHHHHHHHHHHHHHHHhhhhhc
Q 007254 14 GAGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIAL--HVLANNAI-VDRD--GKSSLLSLVKAFDSVLAVYEGFCNLK 88 (611)
Q Consensus 14 ~~~~~IlVaVD~s~~S~~AL~WAl~~~~~~g~~vvlv--HV~~~~~~-~~~~--~~~~~~~~~~~~~~ll~~~~~~C~~k 88 (611)
..-++||||||+|+.|..||+||++.+. .|..|++| ||.++... .... .........+..++.|+.+...+...
T Consensus 15 ~~~~~ILv~vD~s~~s~~al~~A~~lA~-~~a~l~ll~a~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 93 (163)
T 1tq8_A 15 SAYKTVVVGTDGSDSSMRAVDRAAQIAG-ADAKLIIASAYLPQHEDARAADILKDESYKVTGTAPIYEILHDAKERAHNA 93 (163)
T ss_dssp CCCCEEEEECCSSHHHHHHHHHHHHHHT-TTSEEEEEEECCC--------------------CCTHHHHHHHHHHHHHTT
T ss_pred ccCCEEEEEcCCCHHHHHHHHHHHHHhC-CCCEEEEEEeeeccCcccccccccccHHHHHHHHHHHHHHHHHHHHHHHHc
Confidence 4568999999999999999999999999 99999999 88764321 1100 11111223345667888888888888
Q ss_pred CCc-EEEEEEECCchhHHHHHHHHhcCCCEEEEccCCCCceeec-ccchhHHHHhcCCCCcEEEEEeCC
Q 007254 89 QVD-LKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRS-TTSLAKYCAKKLSKDCSVLAVNNG 155 (611)
Q Consensus 89 ~V~-~~~~v~~g~~~~~~Iv~~a~~~~ad~LVlG~~g~~~~~R~-~gsva~~v~k~ap~~C~VlvV~kg 155 (611)
+++ ++..+..| ++.++|+++|++.++|+||||++|++++.|+ +||++++|+++++ |||+||+..
T Consensus 94 gv~~v~~~v~~G-~~~~~I~~~a~~~~~DLIV~G~~g~~~~~~~~lGSva~~vl~~a~--~PVlvV~~~ 159 (163)
T 1tq8_A 94 GAKNVEERPIVG-APVDALVNLADEEKADLLVVGNVGLSTIAGRLLGSVPANVSRRAK--VDVLIVHTT 159 (163)
T ss_dssp TCCEEEEEEECS-SHHHHHHHHHHHTTCSEEEEECCCCCSHHHHHTBBHHHHHHHHTT--CEEEEECCC
T ss_pred CCCeEEEEEecC-CHHHHHHHHHHhcCCCEEEECCCCCCcccceeeccHHHHHHHhCC--CCEEEEeCC
Confidence 998 98888876 7899999999999999999999999999885 9999999999998 999999753
|
| >3dlo_A Universal stress protein; unknown function, structural genomics, PSI-2, protein struct initiative, midwest center for structural genomics; HET: MSE; 1.97A {Archaeoglobus fulgidus} PDB: 3qtb_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=3.3e-19 Score=166.51 Aligned_cols=130 Identities=17% Similarity=0.146 Sum_probs=113.0
Q ss_pred CCCEEEEEeCC-CHhHHHHHHHHHHHccCCCCEEEEEEEeeCCCcccCCCchhHHHHHHHHHHHHHHHHhhhhhcCCcEE
Q 007254 15 AGRTVVVGVKL-DTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLK 93 (611)
Q Consensus 15 ~~~~IlVaVD~-s~~S~~AL~WAl~~~~~~g~~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~C~~k~V~~~ 93 (611)
+-++||||||+ |+.|..||+||+..+...|+.|++|||.+.... ......+..++.|+.+...+...+++++
T Consensus 23 m~~~ILv~vD~~s~~s~~al~~A~~la~~~~a~l~llhV~~~~~~-------~~~~~~~~~~~~l~~~~~~~~~~g~~~~ 95 (155)
T 3dlo_A 23 IYMPIVVAVDKKSDRAERVLRFAAEEARLRGVPVYVVHSLPGGGR-------TKDEDIIEAKETLSWAVSIIRKEGAEGE 95 (155)
T ss_dssp CCCCEEEECCSSSHHHHHHHHHHHHHHHHHTCCEEEEEEECCSTT-------SCHHHHHHHHHHHHHHHHHHHHTTCCEE
T ss_pred ccCeEEEEECCCCHHHHHHHHHHHHHHHhcCCEEEEEEEEcCCCc-------ccHHHHHHHHHHHHHHHHHHHhcCCCce
Confidence 45789999999 999999999999999989999999999975421 1134456677888999999988999888
Q ss_pred EEE-EECCchhHHHHHHHHhcCCCEEEEccCCCCceeec-ccchhHHHHhcCCCCcEEEEEe
Q 007254 94 LKI-CRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRS-TTSLAKYCAKKLSKDCSVLAVN 153 (611)
Q Consensus 94 ~~v-~~g~~~~~~Iv~~a~~~~ad~LVlG~~g~~~~~R~-~gsva~~v~k~ap~~C~VlvV~ 153 (611)
..+ +..+++.++|+++|++.++|+||||++|++++.++ +||++++|+++++ |||+||+
T Consensus 96 ~~~~v~~G~~~~~I~~~a~~~~~DLIV~G~~g~~~~~~~~lGSv~~~vl~~a~--~PVLvVr 155 (155)
T 3dlo_A 96 EHLLVRGKEPPDDIVDFADEVDAIAIVIGIRKRSPTGKLIFGSVARDVILKAN--KPVICIK 155 (155)
T ss_dssp EEEEESSSCHHHHHHHHHHHTTCSEEEEECCEECTTSCEECCHHHHHHHHHCS--SCEEEEC
T ss_pred EEEEecCCCHHHHHHHHHHHcCCCEEEECCCCCCCCCCEEeccHHHHHHHhCC--CCEEEeC
Confidence 654 45678999999999999999999999999998885 9999999999998 9999985
|
| >2z08_A Universal stress protein family; uncharacterized conserved protein, structural genomics, unknown function, NPPSFA; HET: ATP; 1.55A {Thermus thermophilus} SCOP: c.26.2.4 PDB: 1wjg_A* 2z09_A* 2z3v_A | Back alignment and structure |
|---|
Probab=99.79 E-value=4.3e-19 Score=161.31 Aligned_cols=131 Identities=16% Similarity=0.153 Sum_probs=103.2
Q ss_pred CEEEEEeCCCHhHHHHHHHHHHHccCCCCEEEEEEEeeCCCcccC-C-CchhHHHHHHHHHHHHHHHHhhhhhcCC-cEE
Q 007254 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDR-D-GKSSLLSLVKAFDSVLAVYEGFCNLKQV-DLK 93 (611)
Q Consensus 17 ~~IlVaVD~s~~S~~AL~WAl~~~~~~g~~vvlvHV~~~~~~~~~-~-~~~~~~~~~~~~~~ll~~~~~~C~~k~V-~~~ 93 (611)
++||||+|+|+.|..||+||+..+...|..|++|||.++...... . .........+..++.|+.+... .|+ +++
T Consensus 3 ~~ILv~~D~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~---~g~~~~~ 79 (137)
T 2z08_A 3 KTILLAYDGSEHARRAAEVAKAEAEAHGARLIVVHAYEPVPDYLGEPFFEEALRRRLERAEGVLEEARAL---TGVPKED 79 (137)
T ss_dssp SEEEEECCSSHHHHHHHHHHHHHHHHHTCEEEEEEEECC--------------CHHHHHHHHHHHHHHHH---HCCCGGG
T ss_pred ceEEEEeCCCHHHHHHHHHHHHHHhhcCCEEEEEEEecCCCccccccchHHHHHHHHHHHHHHHHHHHHH---cCCCccE
Confidence 689999999999999999999999988999999999975321000 0 0111223344555666655433 688 888
Q ss_pred EEEEECCchhHHHHHHHHhcCCCEEEEccCCCCceeec-ccchhHHHHhcCCCCcEEEEEe
Q 007254 94 LKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRS-TTSLAKYCAKKLSKDCSVLAVN 153 (611)
Q Consensus 94 ~~v~~g~~~~~~Iv~~a~~~~ad~LVlG~~g~~~~~R~-~gsva~~v~k~ap~~C~VlvV~ 153 (611)
..+..| ++.++|+++|++.++|+||||++|++++.++ +||++++|+++++ |||+||+
T Consensus 80 ~~~~~g-~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~Gs~~~~vl~~~~--~pVlvv~ 137 (137)
T 2z08_A 80 ALLLEG-VPAEAILQAARAEKADLIVMGTRGLGALGSLFLGSQSQRVVAEAP--CPVLLVR 137 (137)
T ss_dssp EEEEES-SHHHHHHHHHHHTTCSEEEEESSCTTCCSCSSSCHHHHHHHHHCS--SCEEEEC
T ss_pred EEEEec-CHHHHHHHHHHHcCCCEEEECCCCCchhhhhhhccHHHHHHhcCC--CCEEEeC
Confidence 877776 7899999999999999999999999998885 9999999999998 9999984
|
| >2gm3_A Unknown protein; AT3G01520, putative ethylene-responsive protein, USP domain, nucleotide binding domain, AMP; HET: MSE AMP; 2.46A {Arabidopsis thaliana} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.79 E-value=4e-19 Score=168.57 Aligned_cols=138 Identities=17% Similarity=0.265 Sum_probs=104.5
Q ss_pred CCCEEEEEeCCCH---------hHHHHHHHHHHHccC---CCCEEEEEEEeeCCCcccC------CCchh----HHHHHH
Q 007254 15 AGRTVVVGVKLDT---------HSRELLTWALVKVAQ---PGDTVIALHVLANNAIVDR------DGKSS----LLSLVK 72 (611)
Q Consensus 15 ~~~~IlVaVD~s~---------~S~~AL~WAl~~~~~---~g~~vvlvHV~~~~~~~~~------~~~~~----~~~~~~ 72 (611)
.-++||||||+|+ .|..||.||+.++.+ .|..|++|||.++...... ..... .....+
T Consensus 4 ~~~~ILv~vD~s~~~~~~~~~~~s~~al~~a~~la~~~~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (175)
T 2gm3_A 4 EPTKVMVAVNASTIKDYPNPSISCKRAFEWTLEKIVRSNTSDFKILLLHVQVVDEDGFDDVDSIYASPEDFRDMRQSNKA 83 (175)
T ss_dssp -CEEEEEECCBCSSSCTTCBCHHHHHHHHHHHHHTTTTCTTSEEEEEEEEEC----------CCCCSHHHHHHHTTSHHH
T ss_pred CccEEEEEECCCcccccccccHHHHHHHHHHHHHhhcccCCCCEEEEEEEeecccccccccccccCCHHHHHHHHHHHHH
Confidence 4579999999999 999999999999865 4889999999864321000 00111 112334
Q ss_pred HHHHHHHHHHhhhhhcCCcEEEEEEECCchhHHHHHHHHhcCCCEEEEccCCCCceeec-ccchhHHHHhcCCCCcEEEE
Q 007254 73 AFDSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRS-TTSLAKYCAKKLSKDCSVLA 151 (611)
Q Consensus 73 ~~~~ll~~~~~~C~~k~V~~~~~v~~g~~~~~~Iv~~a~~~~ad~LVlG~~g~~~~~R~-~gsva~~v~k~ap~~C~Vlv 151 (611)
..++.|..+...+...+++++.++..| ++.+.|+++|++.++|+||||++|++++.++ +||++++|+++++ |||+|
T Consensus 84 ~~~~~l~~~~~~~~~~g~~~~~~v~~G-~~~~~I~~~a~~~~~DLIVmG~~g~~~~~~~~~Gsva~~vl~~a~--~pVlv 160 (175)
T 2gm3_A 84 KGLHLLEFFVNKCHEIGVGCEAWIKTG-DPKDVICQEVKRVRPDFLVVGSRGLGRFQKVFVGTVSAFCVKHAE--CPVMT 160 (175)
T ss_dssp HHHHHHHHHHHHHHHHTCEEEEEEEES-CHHHHHHHHHHHHCCSEEEEEECCCC--------CHHHHHHHHCS--SCEEE
T ss_pred HHHHHHHHHHHHHHHCCCceEEEEecC-CHHHHHHHHHHHhCCCEEEEeCCCCChhhhhhcCchHHHHHhCCC--CCEEE
Confidence 566788888888888999999888886 7899999999999999999999999999885 9999999999998 99999
Q ss_pred EeCC
Q 007254 152 VNNG 155 (611)
Q Consensus 152 V~kg 155 (611)
|+.+
T Consensus 161 v~~~ 164 (175)
T 2gm3_A 161 IKRN 164 (175)
T ss_dssp EECC
T ss_pred EcCC
Confidence 9853
|
| >3fdx_A Putative filament protein / universal stress PROT; structural genomics, APC60640.1, universal protein F, PSI-2; HET: MSE ATP; 1.58A {Klebsiella pneumoniae subsp} PDB: 3fh0_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=1e-18 Score=159.52 Aligned_cols=133 Identities=14% Similarity=0.177 Sum_probs=105.0
Q ss_pred CEEEEEeCCCHh--HHHHHHHHHHHccCCCCEEEEEEEeeCCCcccCC---CchhHHHHHHHHHHHHHHHHhhhhhcCC-
Q 007254 17 RTVVVGVKLDTH--SRELLTWALVKVAQPGDTVIALHVLANNAIVDRD---GKSSLLSLVKAFDSVLAVYEGFCNLKQV- 90 (611)
Q Consensus 17 ~~IlVaVD~s~~--S~~AL~WAl~~~~~~g~~vvlvHV~~~~~~~~~~---~~~~~~~~~~~~~~ll~~~~~~C~~k~V- 90 (611)
++|+||||+|+. |..||+||+..+...|++|++|||.++....... .........+..++.+..++.++.+.++
T Consensus 2 k~ILv~vD~s~~~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 81 (143)
T 3fdx_A 2 NAILVPIDISDKEFTERIISHVESEARIDDAEVHFLTVIPSLPYYASLGMAYTAELPGMDELREGSETQLKEIAKKFSIP 81 (143)
T ss_dssp CEEEEECCTTCSSCCTTHHHHHHHHHHHHTCEEEEEEEECC----------------CHHHHHHHHHHHHHHHHTTSCCC
T ss_pred CEEEEEecCChHhhHHHHHHHHHHHHHhcCCeEEEEEEecCCcccccccccccchhhhHHHHHHHHHHHHHHHHHHcCCC
Confidence 789999999999 9999999999999899999999999864321110 1111122344556677777778877654
Q ss_pred --cEEEEEEECCchhHHHHHHHHhcCCCEEEEccCCCCceeec-ccchhHHHHhcCCCCcEEEEEe
Q 007254 91 --DLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRS-TTSLAKYCAKKLSKDCSVLAVN 153 (611)
Q Consensus 91 --~~~~~v~~g~~~~~~Iv~~a~~~~ad~LVlG~~g~~~~~R~-~gsva~~v~k~ap~~C~VlvV~ 153 (611)
+++..+..| ++.++|+++|++.++|+||||+++ +++.++ +||++++|+++++ |||+||+
T Consensus 82 ~~~v~~~~~~g-~~~~~I~~~a~~~~~dliV~G~~~-~~~~~~~~Gs~~~~v~~~~~--~pVlvv~ 143 (143)
T 3fdx_A 82 EDRMHFHVAEG-SPKDKILALAKSLPADLVIIASHR-PDITTYLLGSNAAAVVRHAE--CSVLVVR 143 (143)
T ss_dssp GGGEEEEEEES-CHHHHHHHHHHHTTCSEEEEESSC-TTCCSCSSCHHHHHHHHHCS--SEEEEEC
T ss_pred CCceEEEEEec-ChHHHHHHHHHHhCCCEEEEeCCC-CCCeeeeeccHHHHHHHhCC--CCEEEeC
Confidence 568888887 889999999999999999999996 778775 9999999999998 9999985
|
| >3tnj_A Universal stress protein (USP); structural genomics, PSI-biology, midwest center for structu genomics, MCSG, chaperone; HET: AMP; 2.00A {Nitrosomonas europaea} PDB: 2pfs_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=1.2e-18 Score=160.46 Aligned_cols=134 Identities=19% Similarity=0.215 Sum_probs=98.6
Q ss_pred CCCEEEEEeCCCHhHHHHHHHHHHHccCCCCEEEEEEEeeCCCcc----c----CCCchhHHHHHHHHHHHHHHHHhhhh
Q 007254 15 AGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIV----D----RDGKSSLLSLVKAFDSVLAVYEGFCN 86 (611)
Q Consensus 15 ~~~~IlVaVD~s~~S~~AL~WAl~~~~~~g~~vvlvHV~~~~~~~----~----~~~~~~~~~~~~~~~~ll~~~~~~C~ 86 (611)
.-++||||||+|+.|..||+||+..+...|+.|++|||.++.... . ...........+..++.|..+ ++
T Consensus 5 ~~~~ILv~vD~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~---~~ 81 (150)
T 3tnj_A 5 VYHHILLAVDFSSEDSQVVQKVRNLASQIGARLSLIHVLDNIPMPDTPYGTAIPLDTETTYDAMLDVEKQKLSQI---GN 81 (150)
T ss_dssp CCSEEEEECCCSTTHHHHHHHHHHHHHHHTCEEEEEEEEC--------CTTCCCSSSCCCHHHHHHHHHHHHHHH---HH
T ss_pred ccceEEEEeCCCHHHHHHHHHHHHHHhhcCCEEEEEEEEcCccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HH
Confidence 358999999999999999999999999999999999999864321 0 011223344445555555554 44
Q ss_pred hcCCc-EEEEEEECCchhHHHHHHHHhcCCCEEEEccCCCCceeec-ccchhHHHHhcCCCCcEEEEEeCC
Q 007254 87 LKQVD-LKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRS-TTSLAKYCAKKLSKDCSVLAVNNG 155 (611)
Q Consensus 87 ~k~V~-~~~~v~~g~~~~~~Iv~~a~~~~ad~LVlG~~g~~~~~R~-~gsva~~v~k~ap~~C~VlvV~kg 155 (611)
+.++. ++..+..| ++.++|+++|++.++|+||||++|++++. + +||++++|+++++ |||+||+..
T Consensus 82 ~~~~~~~~~~~~~g-~~~~~I~~~a~~~~~dliV~G~~~~~~~~-~~~Gs~~~~vl~~~~--~pVlvv~~~ 148 (150)
T 3tnj_A 82 TLGIDPAHRWLVWG-EPREEIIRIAEQENVDLIVVGSHGRHGLA-LLLGSTANSVLHYAK--CDVLAVRLR 148 (150)
T ss_dssp HHTCCGGGEEEEES-CHHHHHHHHHHHTTCSEEEEEEC---------CCCHHHHHHHHCS--SEEEEEECC
T ss_pred HcCCCcceEEEecC-CHHHHHHHHHHHcCCCEEEEecCCCCCcC-eEecchHHHHHHhCC--CCEEEEeCC
Confidence 55777 46666665 78999999999999999999999999887 6 9999999999998 999999853
|
| >1jmv_A USPA, universal stress protein A; chaperone; 1.85A {Haemophilus influenzae} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.72 E-value=7.2e-18 Score=153.63 Aligned_cols=132 Identities=13% Similarity=0.080 Sum_probs=98.8
Q ss_pred CCEEEEEeCCCHhHHHHHHHHHHHccCCCCEEEEEEEeeCCCc-ccCCCch----hHHHHHHHHHHHHHHHHhhhhhcCC
Q 007254 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAI-VDRDGKS----SLLSLVKAFDSVLAVYEGFCNLKQV 90 (611)
Q Consensus 16 ~~~IlVaVD~s~~S~~AL~WAl~~~~~~g~~vvlvHV~~~~~~-~~~~~~~----~~~~~~~~~~~ll~~~~~~C~~k~V 90 (611)
-++||||+|+|+.|..||+||+..+...|..|++|||.+.... ....... ......+..++.|.. ++...++
T Consensus 2 ~~~ILv~~D~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~---~~~~~~~ 78 (141)
T 1jmv_A 2 YKHILVAVDLSEESPILLKKAVGIAKRHDAKLSIIHVDVNFSDLYTGLIDVNMSSMQDRISTETQKALLD---LAESVDY 78 (141)
T ss_dssp CSEEEEEECCSTTHHHHHHHHHHHHHHHTCEEEEEEEEECCGGGCCCCEEHHHHHHTTCCCCHHHHHHHH---HHHHSSS
T ss_pred CceEEEEecCchhhHHHHHHHHHHHHhcCCEEEEEEEecCchhhhccccccchHHHHHHHHHHHHHHHHH---HHHHcCC
Confidence 3689999999999999999999999988999999999854211 1110000 001111233344443 3445577
Q ss_pred cE-EEEEEECCchhHHHHHHHHhcCCCEEEEccCCCCceeecccchhHHHHhcCCCCcEEEEEeCC
Q 007254 91 DL-KLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTSLAKYCAKKLSKDCSVLAVNNG 155 (611)
Q Consensus 91 ~~-~~~v~~g~~~~~~Iv~~a~~~~ad~LVlG~~g~~~~~R~~gsva~~v~k~ap~~C~VlvV~kg 155 (611)
.+ +..+.. +++.++|+++|++.++|+||||++ ++++.|+ ||++++|+++++ |||+||+.+
T Consensus 79 ~~~~~~~~~-g~~~~~I~~~a~~~~~dliV~G~~-~~~~~~l-gs~~~~vl~~~~--~pVlvv~~~ 139 (141)
T 1jmv_A 79 PISEKLSGS-GDLGQVLSDAIEQYDVDLLVTGHH-QDFWSKL-MSSTRQVMNTIK--IDMLVVPLR 139 (141)
T ss_dssp CCCCEEEEE-ECHHHHHHHHHHHTTCCEEEEEEC-CCCHHHH-HHHHHHHHTTCC--SEEEEEECC
T ss_pred CceEEEEec-CCHHHHHHHHHHhcCCCEEEEeCC-Cchhhhh-cchHHHHHhcCC--CCEEEeeCC
Confidence 76 445555 578999999999999999999999 8888775 999999999998 999999864
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.68 E-value=5.4e-17 Score=173.00 Aligned_cols=136 Identities=15% Similarity=0.158 Sum_probs=100.3
Q ss_pred CCccceeecccCceEEEEEEecCCCEEEEEEecCCh-------------------hHH----HHHHHHHHHHHhcCCCCe
Q 007254 423 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-------------------DVI----KEFVLEIEIITTLHHKNI 479 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~-------------------~~~----~~~~~Ei~il~~l~HpnI 479 (611)
-|.+...||+|+||.||+|...+|+.||||+++... ... -....|...|..+.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 388999999999999999999899999999986421 000 112356777777765544
Q ss_pred eeEEEEEEeCCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcC
Q 007254 480 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD 559 (611)
Q Consensus 480 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~ 559 (611)
.-..-+.... .+|||||++|+.|...+.. .....++.|++.+|.|||+ .+||||||||.||||++
T Consensus 176 ~vp~p~~~~~--~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 176 PVPEPIAQSR--HTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAK---HGLIHGDFNEFNILIRE 240 (397)
T ss_dssp SCCCEEEEET--TEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEE
T ss_pred CCCeeeeccC--ceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeC
Confidence 3222222222 2899999999888543311 1235678999999999999 89999999999999988
Q ss_pred CC----------cEEEEeeccccc
Q 007254 560 DF----------EPQLSDFGLAKW 573 (611)
Q Consensus 560 ~~----------~vKL~DFGlA~~ 573 (611)
++ .+.|+||+-+-.
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCcccccccccceEEEEeCCccc
Confidence 76 389999997654
|
| >1q77_A Hypothetical protein AQ_178; structural genomics, universal stress protein, PSI, protein structure initiative; 2.70A {Aquifex aeolicus} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.67 E-value=2.2e-16 Score=143.32 Aligned_cols=126 Identities=13% Similarity=-0.003 Sum_probs=100.0
Q ss_pred CCCEEEEEeCCCHhHHHHHHHHHHHccCCCCEEEEEEEe-eC-C--C-cc--c-CCCchhHHHHHHHHHHHHHHHHhhh-
Q 007254 15 AGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVL-AN-N--A-IV--D-RDGKSSLLSLVKAFDSVLAVYEGFC- 85 (611)
Q Consensus 15 ~~~~IlVaVD~s~~S~~AL~WAl~~~~~~g~~vvlvHV~-~~-~--~-~~--~-~~~~~~~~~~~~~~~~ll~~~~~~C- 85 (611)
.-++||||+|+|+.|..||.||+..+...|..|++|||. +. . . .. . ...........+..++.|..+ ..|
T Consensus 3 ~~~~ILv~~D~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~ 81 (138)
T 1q77_A 3 AMKVLLVLTDAYSDCEKAITYAVNFSEKLGAELDILAVLEDVYNLERANVTFGLPFPPEIKEESKKRIERRLREV-WEKL 81 (138)
T ss_dssp CCEEEEEEESTTCCCHHHHHHHHHHHTTTCCEEEEEEECHHHHHHHHHHHHHCCCCCTHHHHHHHHHHHHHHHHH-HHHH
T ss_pred cccEEEEEccCCHhHHHHHHHHHHHHHHcCCeEEEEEEecccccccccccccCCCCChHHHHHHHHHHHHHHHHH-HHHh
Confidence 347899999999999999999999999999999999998 63 1 1 00 0 101223344556667788887 663
Q ss_pred -hhcCCcEEEEEEECCchhHHHHHHHHhcCCCEEEEccCCCCceeecccchhHHHHhcCCCCcEEEEEe
Q 007254 86 -NLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTSLAKYCAKKLSKDCSVLAVN 153 (611)
Q Consensus 86 -~~k~V~~~~~v~~g~~~~~~Iv~~a~~~~ad~LVlG~~g~~~~~R~~gsva~~v~k~ap~~C~VlvV~ 153 (611)
...+ +++..+..| ++.+.|+++|++.++|+||||++|+ |++++|+++++ |||+||+
T Consensus 82 ~~~~~-~~~~~~~~g-~~~~~I~~~a~~~~~dliV~G~~g~--------sv~~~vl~~a~--~PVlvv~ 138 (138)
T 1q77_A 82 TGSTE-IPGVEYRIG-PLSEEVKKFVEGKGYELVVWACYPS--------AYLCKVIDGLN--LASLIVK 138 (138)
T ss_dssp HSCCC-CCCEEEECS-CHHHHHHHHHTTSCCSEEEECSCCG--------GGTHHHHHHSS--SEEEECC
T ss_pred hccCC-cceEEEEcC-CHHHHHHHHHHhcCCCEEEEeCCCC--------chHHHHHHhCC--CceEeeC
Confidence 5556 777766664 7899999999999999999999976 89999999998 9999984
|
| >3ab8_A Putative uncharacterized protein TTHA0350; tandem-type universal stress protein, unknown function; HET: ATP; 1.70A {Thermus thermophilus} PDB: 3ab7_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=3.2e-16 Score=158.48 Aligned_cols=134 Identities=12% Similarity=0.040 Sum_probs=111.1
Q ss_pred CEEEEEeCCCHhHHHHHHHHHHHccCCCCEEEEEEEeeCCCcc--cC-----CCchh-------HHHHHHHHHHHHHHHH
Q 007254 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIV--DR-----DGKSS-------LLSLVKAFDSVLAVYE 82 (611)
Q Consensus 17 ~~IlVaVD~s~~S~~AL~WAl~~~~~~g~~vvlvHV~~~~~~~--~~-----~~~~~-------~~~~~~~~~~ll~~~~ 82 (611)
++|+|++|+|+.|..||+||+..+...|..|+++||.++.... .. ..... .....+..++.|+.+.
T Consensus 1 k~ILv~vD~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 80 (268)
T 3ab8_A 1 MRILLATDGSPQARGAEALAEWLAYKLSAPLTVLFVVDTRLARIPELLDFGALTVPVPVLRTELERALALRGEAVLERVR 80 (268)
T ss_dssp CCEEEECCSCGGGHHHHHHHHHHHHHHTCCEEEEEEEEHHHHTHHHHC-------CHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CcEEEEcCCCHHHHHHHHHHHHHHHHhCCcEEEEEEeccCCcccccccCchHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 4799999999999999999999999889999999998753210 00 00011 2334566778999999
Q ss_pred hhhhhcCCcEEEEEEECCchhHHHHHHHHhcCCCEEEEccCCCC-ceeec-ccchhHHHHhcCCCCcEEEEEeCC
Q 007254 83 GFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNH-HTIRS-TTSLAKYCAKKLSKDCSVLAVNNG 155 (611)
Q Consensus 83 ~~C~~k~V~~~~~v~~g~~~~~~Iv~~a~~~~ad~LVlG~~g~~-~~~R~-~gsva~~v~k~ap~~C~VlvV~kg 155 (611)
..+...|++++..+..| ++.+.|+++ +.++|+||||++|++ ++.++ +||++++|+++++ |||++|+.+
T Consensus 81 ~~~~~~g~~~~~~~~~g-~~~~~I~~~--~~~~dliV~G~~g~~~~~~~~~~Gs~~~~v~~~a~--~PVlvv~~~ 150 (268)
T 3ab8_A 81 QSALAAGVAVEAVLEEG-VPHEAILRR--ARAADLLVLGRSGEAHGDGFGGLGSTADRVLRASP--VPVLLAPGE 150 (268)
T ss_dssp HHHHHTTCCEEEEEEEE-CHHHHHHHH--HTTCSEEEEESSCTTSCTTCCSCCHHHHHHHHHCS--SCEEEECSS
T ss_pred HHHHhCCCCeEEEEecC-CHHHHHHhh--ccCCCEEEEeccCCCccccccccchhHHHHHHhCC--CCEEEECCC
Confidence 99999999999888876 789999999 889999999999998 88885 9999999999998 999999854
|
| >3mt0_A Uncharacterized protein PA1789; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: MSE; 1.58A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=99.65 E-value=5.8e-16 Score=158.77 Aligned_cols=134 Identities=14% Similarity=0.174 Sum_probs=102.4
Q ss_pred CCCEEEEEeCCCHh-------HHHHHHHHHHHccCCCCEEEEEEEeeCCCcccCCCc-hhHHHHHHHHHHHHHHHHhhhh
Q 007254 15 AGRTVVVGVKLDTH-------SRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGK-SSLLSLVKAFDSVLAVYEGFCN 86 (611)
Q Consensus 15 ~~~~IlVaVD~s~~-------S~~AL~WAl~~~~~~g~~vvlvHV~~~~~~~~~~~~-~~~~~~~~~~~~ll~~~~~~C~ 86 (611)
..++|+||+|+|+. |.+||+||+..+...|..|++|||.++......... .......+...+.+.. ++.
T Consensus 133 ~~~~Ilva~D~s~~~~~~~~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~l~~---~~~ 209 (290)
T 3mt0_A 133 TGGKILAAVDVGNNDGEHRSLHAGIISHAYDIAGLAKATLHVISAHPSPMLSSADPTFQLSETIEARYREACRT---FQA 209 (290)
T ss_dssp TTCEEEEEECTTCCSHHHHHHHHHHHHHHHHHHHHTTCEEEEEEEEC---------CHHHHHHHHHHHHHHHHH---HHH
T ss_pred CCCeEEEEECCCCcchhhhHHHHHHHHHHHHHHHHcCCeEEEEEEecCccccccCchhHHHHHHHHHHHHHHHH---HHH
Confidence 56899999999998 999999999999999999999999986432111110 1122223333344443 444
Q ss_pred hcCCc-EEEEEEECCchhHHHHHHHHhcCCCEEEEccCCCCceeec-ccchhHHHHhcCCCCcEEEEEeC
Q 007254 87 LKQVD-LKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRS-TTSLAKYCAKKLSKDCSVLAVNN 154 (611)
Q Consensus 87 ~k~V~-~~~~v~~g~~~~~~Iv~~a~~~~ad~LVlG~~g~~~~~R~-~gsva~~v~k~ap~~C~VlvV~k 154 (611)
+.+++ .+..+..| ++.++|+++|++.++|+||||++|++++.++ +||++++|+++++ |||+||+.
T Consensus 210 ~~g~~~~~~~v~~g-~~~~~I~~~a~~~~~dLiVmG~~g~~~~~~~~~Gsv~~~vl~~~~--~pVLvv~~ 276 (290)
T 3mt0_A 210 EYGFSDEQLHIEEG-PADVLIPRTAQKLDAVVTVIGTVARTGLSGALIGNTAEVVLDTLE--SDVLVLKP 276 (290)
T ss_dssp HHTCCTTTEEEEES-CHHHHHHHHHHHHTCSEEEEECCSSCCGGGCCSCHHHHHHHTTCS--SEEEEECC
T ss_pred HcCCCcceEEEecc-CHHHHHHHHHHhcCCCEEEECCCCCcCCcceecchHHHHHHhcCC--CCEEEECC
Confidence 55774 55667776 8999999999999999999999999999985 9999999999998 99999974
|
| >3cis_A Uncharacterized protein; alpha/beta hydrolase, ATP, universal stress protein, unknown function; HET: ATP; 2.90A {Mycobacterium tuberculosis} PDB: 2jax_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=7.6e-16 Score=159.36 Aligned_cols=137 Identities=11% Similarity=0.107 Sum_probs=112.2
Q ss_pred CCCCEEEEEeCCCHhHHHHHHHHHHHccCCCCEEEEEEEeeCCCcc--cC-CCchhHHHHHHHHHHHHHHHHhhhhhc--
Q 007254 14 GAGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIV--DR-DGKSSLLSLVKAFDSVLAVYEGFCNLK-- 88 (611)
Q Consensus 14 ~~~~~IlVaVD~s~~S~~AL~WAl~~~~~~g~~vvlvHV~~~~~~~--~~-~~~~~~~~~~~~~~~ll~~~~~~C~~k-- 88 (611)
..-++|||++|+|+.|..||+||+..+...|..|++|||.++.... .. ..........+..++.|+.+...+...
T Consensus 17 ~~~~~ILv~~D~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 96 (309)
T 3cis_A 17 NSSLGIIVGIDDSPAAQVAVRWAARDAELRKIPLTLVHAVSPEVATWLEVPLPPGVLRWQQDHGRHLIDDALKVVEQASL 96 (309)
T ss_dssp -CTTEEEEECCSSHHHHHHHHHHHHHHHHHTCCEEEEEECCCCCCCTTCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHCS
T ss_pred CCCCeEEEEECCCHHHHHHHHHHHHHHHhcCCcEEEEEEecCcccccccCCCCchhhHHHHHHHHHHHHHHHHHHHHhcc
Confidence 3568999999999999999999999999899999999998743211 00 111223344566778888888888765
Q ss_pred ---CCcEEEEEEECCchhHHHHHHHHhcCCCEEEEccCCCCceeec-ccchhHHHHhcCCCCcEEEEEeCC
Q 007254 89 ---QVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRS-TTSLAKYCAKKLSKDCSVLAVNNG 155 (611)
Q Consensus 89 ---~V~~~~~v~~g~~~~~~Iv~~a~~~~ad~LVlG~~g~~~~~R~-~gsva~~v~k~ap~~C~VlvV~kg 155 (611)
+++++..+..| ++.++|+++|+ ++|+||||++|++++.++ +||++++|+++++ |||+||+.+
T Consensus 97 ~~~~~~~~~~~~~g-~~~~~I~~~a~--~~DliV~G~~g~~~~~~~~~Gs~~~~vl~~~~--~PVlvv~~~ 162 (309)
T 3cis_A 97 RAGPPTVHSEIVPA-AAVPTLVDMSK--DAVLMVVGCLGSGRWPGRLLGSVSSGLLRHAH--CPVVIIHDE 162 (309)
T ss_dssp SSCCSCEEEEEESS-CHHHHHHHHGG--GEEEEEEESSCTTCCTTCCSCHHHHHHHHHCS--SCEEEECTT
T ss_pred cCCCceEEEEEecC-CHHHHHHHHhc--CCCEEEECCCCCccccccccCcHHHHHHHhCC--CCEEEEcCC
Confidence 89999887775 78999999997 799999999999988885 9999999999998 999999854
|
| >3olq_A Universal stress protein E; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: UNL; 1.82A {Proteus mirabilis} | Back alignment and structure |
|---|
Probab=99.64 E-value=8.9e-16 Score=159.09 Aligned_cols=139 Identities=10% Similarity=0.050 Sum_probs=113.6
Q ss_pred CCCEEEEEeCCCHhHHHHHHHHHHHccCCCCEEEEEEEeeCCCcccC--CCc----hhHHHHHHHHHHHHHHHHhhhhhc
Q 007254 15 AGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDR--DGK----SSLLSLVKAFDSVLAVYEGFCNLK 88 (611)
Q Consensus 15 ~~~~IlVaVD~s~~S~~AL~WAl~~~~~~g~~vvlvHV~~~~~~~~~--~~~----~~~~~~~~~~~~ll~~~~~~C~~k 88 (611)
.-++|||++|+|+.|..||.||+..+...|.+|++|||......... ... .......+..++.|..+...+...
T Consensus 6 ~~k~ILv~~D~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 85 (319)
T 3olq_A 6 KYQNLLVVIDPNQDDQPALRRAVYIVQRNGGRIKAFLPVYDLSYDMTTLLSPDERNAMRKGVINQKTAWIKQQARYYLEA 85 (319)
T ss_dssp CSCEEEEECCTTCSCCHHHHHHHHHHHHHCCEEEEEEEECCGGGGCTTTSCHHHHHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred ccceEEEEECCCcccHHHHHHHHHHHHHcCCeEEEEEEecccchhhccccChhhHHHHHHHHHHHHHHHHHHHHHHHhhc
Confidence 34789999999999999999999999999999999999864321111 111 112233456677888888888889
Q ss_pred CCcEEEEEEECCchhHHHHHHHHhcCCCEEEEccCCCCceeec-ccchhHHHHhcCCCCcEEEEEeCC
Q 007254 89 QVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRS-TTSLAKYCAKKLSKDCSVLAVNNG 155 (611)
Q Consensus 89 ~V~~~~~v~~g~~~~~~Iv~~a~~~~ad~LVlG~~g~~~~~R~-~gsva~~v~k~ap~~C~VlvV~kg 155 (611)
++.++..+...+++.+.|+++|++.++|+||||++|++++.++ +||++.+++++++ |||+||+.+
T Consensus 86 ~v~~~~~~~~~g~~~~~i~~~a~~~~~DLiV~G~~g~~~~~~~~~Gs~~~~vl~~~~--~PVlvv~~~ 151 (319)
T 3olq_A 86 GIQIDIKVIWHNRPYEAIIEEVITDKHDLLIKMAHQHDKLGSLIFTPLDWQLLRKCP--APVWMVKDK 151 (319)
T ss_dssp TCCEEEEEEECSCHHHHHHHHHHHHTCSEEEEEEBCC--CCSCBCCHHHHHHHHHCS--SCEEEEESS
T ss_pred CCeEEEEEEecCChHHHHHHHHHhcCCCEEEEecCcCchhhcccccccHHHHHhcCC--CCEEEecCc
Confidence 9999998885568999999999999999999999999988885 9999999999998 999999864
|
| >3loq_A Universal stress protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: AMP; 2.32A {Archaeoglobus fulgidus} | Back alignment and structure |
|---|
Probab=99.64 E-value=3.5e-16 Score=160.66 Aligned_cols=138 Identities=9% Similarity=0.003 Sum_probs=116.6
Q ss_pred CCCCEEEEEeCCCHhHHHHHHHHHHHccCCCCEEEEEEEeeCCCccc----CCCchhHHHHHHHHHHHHHHHHhhhhhcC
Q 007254 14 GAGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVD----RDGKSSLLSLVKAFDSVLAVYEGFCNLKQ 89 (611)
Q Consensus 14 ~~~~~IlVaVD~s~~S~~AL~WAl~~~~~~g~~vvlvHV~~~~~~~~----~~~~~~~~~~~~~~~~ll~~~~~~C~~k~ 89 (611)
.+-++|||++|+|+.|..||+||+..+...|.+|++|||.+...... ...........+..++.|..+...+...|
T Consensus 20 ~m~~~ILv~vD~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~g 99 (294)
T 3loq_A 20 FQSNAMLLPTDLSENSFKVLEYLGDFKKVGVEEIGVLFVINLTKLSTVSGGIDIDHYIDEMSEKAEEVLPEVAQKIEAAG 99 (294)
T ss_dssp STTCEEEEECCSCTGGGGGGGGHHHHHHTTCCEEEEECCEECTTC-----CCCTTHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HhhccEEEecCCCHHHHHHHHHHHHHHhhcCCEEEEEEEecCcccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHcC
Confidence 35689999999999999999999999999999999999998653221 12233445566778899999999999999
Q ss_pred CcEEE-EEEECCchhHHHHHHHHhcCCCEEEEccCCCCceeec-ccchhHHHHhcCCCCcEEEEEeCC
Q 007254 90 VDLKL-KICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRS-TTSLAKYCAKKLSKDCSVLAVNNG 155 (611)
Q Consensus 90 V~~~~-~v~~g~~~~~~Iv~~a~~~~ad~LVlG~~g~~~~~R~-~gsva~~v~k~ap~~C~VlvV~kg 155 (611)
++++. .+.+.+++.++| ++++.++|+||||++|++++.++ +||++.+++++++ |||+||+.+
T Consensus 100 ~~~~~~~v~~~g~~~~~I--~a~~~~~DliV~G~~g~~~~~~~~~Gs~~~~vl~~~~--~PVlvv~~~ 163 (294)
T 3loq_A 100 IKAEVIKPFPAGDPVVEI--IKASENYSFIAMGSRGASKFKKILLGSVSEGVLHDSK--VPVYIFKHD 163 (294)
T ss_dssp CEEEECSSCCEECHHHHH--HHHHTTSSEEEEECCCCCHHHHHHHCCHHHHHHHHCS--SCEEEECCC
T ss_pred CCcceeEeeccCChhHhe--eeccCCCCEEEEcCCCCccccceeeccHHHHHHhcCC--CCEEEecCc
Confidence 99998 677234788999 99999999999999999988885 8999999999998 999999754
|
| >3loq_A Universal stress protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: AMP; 2.32A {Archaeoglobus fulgidus} | Back alignment and structure |
|---|
Probab=99.61 E-value=1.5e-15 Score=155.89 Aligned_cols=123 Identities=16% Similarity=0.250 Sum_probs=107.2
Q ss_pred CCCCEEEEEeCCCHhHHHHHHHHHHHccCCCCEEEEEEEeeCCCcccCCCchhHHHHHHHHHHHHHHHHhhhhhcCCcEE
Q 007254 14 GAGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLK 93 (611)
Q Consensus 14 ~~~~~IlVaVD~s~~S~~AL~WAl~~~~~~g~~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~C~~k~V~~~ 93 (611)
...++|+||+|+++.|..||.||+..+...|..|++|||.++.. .++.++.+...+...+++++
T Consensus 168 ~~~~~Ilv~~d~s~~s~~al~~a~~la~~~~~~l~ll~v~~~~~----------------~~~~l~~~~~~l~~~~~~~~ 231 (294)
T 3loq_A 168 SLFDRVLVAYDFSKWADRALEYAKFVVKKTGGELHIIHVSEDGD----------------KTADLRVMEEVIGAEGIEVH 231 (294)
T ss_dssp CTTSEEEEECCSSHHHHHHHHHHHHHHHHHTCEEEEEEECSSSC----------------CHHHHHHHHHHHHHTTCCEE
T ss_pred ccCCEEEEEECCCHHHHHHHHHHHHHhhhcCCEEEEEEEccCch----------------HHHHHHHHHHHHHHcCCcEE
Confidence 45689999999999999999999999988899999999987532 23445566666667789988
Q ss_pred EEEEECCchhHHHHHHHHhcCCCEEEEccCCCCceeec-ccchhHHHHhcCCCCcEEEEEeCC
Q 007254 94 LKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRS-TTSLAKYCAKKLSKDCSVLAVNNG 155 (611)
Q Consensus 94 ~~v~~g~~~~~~Iv~~a~~~~ad~LVlG~~g~~~~~R~-~gsva~~v~k~ap~~C~VlvV~kg 155 (611)
..+..| ++.++|+++|++.++|+||||++|++++.++ +||++++++++++ |||++|+.+
T Consensus 232 ~~~~~g-~~~~~I~~~a~~~~~dLlV~G~~~~~~~~~~~~Gs~~~~vl~~~~--~pvLvv~~~ 291 (294)
T 3loq_A 232 VHIESG-TPHKAILAKREEINATTIFMGSRGAGSVMTMILGSTSESVIRRSP--VPVFVCKRG 291 (294)
T ss_dssp EEEECS-CHHHHHHHHHHHTTCSEEEEECCCCSCHHHHHHHCHHHHHHHHCS--SCEEEECSC
T ss_pred EEEecC-CHHHHHHHHHHhcCcCEEEEeCCCCCCccceeeCcHHHHHHhcCC--CCEEEECCC
Confidence 877775 8999999999999999999999999999885 9999999999998 999999864
|
| >3cis_A Uncharacterized protein; alpha/beta hydrolase, ATP, universal stress protein, unknown function; HET: ATP; 2.90A {Mycobacterium tuberculosis} PDB: 2jax_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=3.1e-15 Score=154.80 Aligned_cols=134 Identities=17% Similarity=0.163 Sum_probs=105.1
Q ss_pred CCCEEEEEeCCCHhHHHHHHHHHHHccCCCCEEEEEEEeeCCCcccCCCchhHHHHHHHHHHHHHHHHhhhhh--cCCcE
Q 007254 15 AGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNL--KQVDL 92 (611)
Q Consensus 15 ~~~~IlVaVD~s~~S~~AL~WAl~~~~~~g~~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~C~~--k~V~~ 92 (611)
..++|+||+|+|+.|..||.||+..+...|..|++|||.++........ .......+..++.+..+...+.. .++++
T Consensus 170 ~~~~Ilv~~D~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~-~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 248 (309)
T 3cis_A 170 QQAPVLVGVDGSSASELATAIAFDEASRRNVDLVALHAWSDVDVSEWPG-IDWPATQSMAEQVLAERLAGWQERYPNVAI 248 (309)
T ss_dssp CCCCEEEECCSSHHHHHHHHHHHHHHHHTTCCEEEEEESCSSCCTTCSS-CCHHHHHHHHHHHHHHHHTTHHHHCTTSCE
T ss_pred CCCeEEEEeCCChHHHHHHHHHHHHHHhcCCEEEEEEEeecccccCCCc-ccHHHHHHHHHHHHHHHHHHHHhhCCCCcE
Confidence 3578999999999999999999999988899999999987543211111 11122334444555555444333 58888
Q ss_pred EEEEEECCchhHHHHHHHHhcCCCEEEEccCCCCceeec-ccchhHHHHhcCCCCcEEEEEeC
Q 007254 93 KLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRS-TTSLAKYCAKKLSKDCSVLAVNN 154 (611)
Q Consensus 93 ~~~v~~g~~~~~~Iv~~a~~~~ad~LVlG~~g~~~~~R~-~gsva~~v~k~ap~~C~VlvV~k 154 (611)
+..+..| ++.++|+++|+ ++|+||||++|++++.++ +||++++|+++++ |||+||+.
T Consensus 249 ~~~~~~g-~~~~~I~~~a~--~adliV~G~~~~~~~~~~l~Gsv~~~vl~~~~--~pVlvv~~ 306 (309)
T 3cis_A 249 TRVVVRD-QPARQLVQRSE--EAQLVVVGSRGRGGYAGMLVGSVGETVAQLAR--TPVIVARE 306 (309)
T ss_dssp EEEEESS-CHHHHHHHHHT--TCSEEEEESSCSSCCTTCSSCHHHHHHHHHCS--SCEEEECC
T ss_pred EEEEEcC-CHHHHHHHhhC--CCCEEEECCCCCCCccccccCcHHHHHHhcCC--CCEEEeCC
Confidence 8877765 78999999998 899999999999999885 9999999999998 99999974
|
| >3mt0_A Uncharacterized protein PA1789; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: MSE; 1.58A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=99.60 E-value=1.3e-15 Score=156.18 Aligned_cols=122 Identities=13% Similarity=0.068 Sum_probs=106.1
Q ss_pred CCCEEEEEeCCCHhHHHHHHHHHHHccCCCCEEEEEEEeeCCCcccCCCchhHHHHHHHHHHHHHHHHhhhhhcCCcEEE
Q 007254 15 AGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKL 94 (611)
Q Consensus 15 ~~~~IlVaVD~s~~S~~AL~WAl~~~~~~g~~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~C~~k~V~~~~ 94 (611)
.-++|||++|+|+.|..||.||+..+...|.+|+++||.++ +..++.|..+...+...+++++.
T Consensus 6 ~~~~ILv~~D~s~~s~~al~~A~~la~~~~a~l~ll~v~~~----------------~~~~~~l~~~~~~~~~~~~~~~~ 69 (290)
T 3mt0_A 6 AIRSILVVIEPDQLEGLALKRAQLIAGVTQSHLHLLVCEKR----------------RDHSAALNDLAQELREEGYSVST 69 (290)
T ss_dssp TCCEEEEECCSSCSCCHHHHHHHHHHHHHCCEEEEEEECSS----------------SCCHHHHHHHHHHHHHTTCCEEE
T ss_pred hhceEEEEeCCCccchHHHHHHHHHHHhcCCeEEEEEeeCc----------------HHHHHHHHHHHHHHhhCCCeEEE
Confidence 45799999999999999999999999999999999999863 11223444555555678999999
Q ss_pred EEEECCchhHHHHHHHHhcCCCEEEEccCCCCceeec-ccchhHHHHhcCCCCcEEEEEeC
Q 007254 95 KICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRS-TTSLAKYCAKKLSKDCSVLAVNN 154 (611)
Q Consensus 95 ~v~~g~~~~~~Iv~~a~~~~ad~LVlG~~g~~~~~R~-~gsva~~v~k~ap~~C~VlvV~k 154 (611)
.+..++++.++|+++|++.++|+||||++|++++.++ +||++.+++++++ |||++|+.
T Consensus 70 ~~~~~g~~~~~i~~~a~~~~~dliV~G~~~~~~~~~~~~gs~~~~vl~~~~--~PVlvv~~ 128 (290)
T 3mt0_A 70 NQAWKDSLHQTIIAEQQAEGCGLIIKQHFPDNPLKKAILTPDDWKLLRFAP--CPVLMTKT 128 (290)
T ss_dssp EEECSSSHHHHHHHHHHHHTCSEEEEECCCSCTTSTTSCCHHHHHHHHHCS--SCEEEECC
T ss_pred EEEeCCCHHHHHHHHHHhcCCCEEEEecccCCchhhcccCHHHHHHHhcCC--CCEEEecC
Confidence 8887788999999999999999999999999988885 9999999999998 99999984
|
| >3olq_A Universal stress protein E; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: UNL; 1.82A {Proteus mirabilis} | Back alignment and structure |
|---|
Probab=99.57 E-value=6.8e-15 Score=152.38 Aligned_cols=134 Identities=13% Similarity=0.076 Sum_probs=103.4
Q ss_pred CCCEEEEEeCCCH-------hHHHHHHHHHHHccCC--CCEEEEEEEeeCCCcccC---CC---chhHHHHHHHHHHHHH
Q 007254 15 AGRTVVVGVKLDT-------HSRELLTWALVKVAQP--GDTVIALHVLANNAIVDR---DG---KSSLLSLVKAFDSVLA 79 (611)
Q Consensus 15 ~~~~IlVaVD~s~-------~S~~AL~WAl~~~~~~--g~~vvlvHV~~~~~~~~~---~~---~~~~~~~~~~~~~ll~ 79 (611)
..++|+||+|+|. .|..||.||+..+... |..|++|||.+....... .. ........+...+.|.
T Consensus 155 ~~~~Ilva~D~s~~~~~~~~~s~~al~~a~~la~~~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (319)
T 3olq_A 155 EYGTIVVAANLSNEESYHDALNLKLIELTNDLSHRIQKDPDVHLLSAYPVAPINIAIELPDFDPNLYNNALRGQHLIAMK 234 (319)
T ss_dssp TTCEEEEECCCSCCSTHHHHHHHHHHHHHHHHHHHHCSSCCEEEEEEECCCSCSCCTTCTTCCHHHHHHHHHHHHHHHHH
T ss_pred cCCeEEEEECCCCcchhHHHHHHHHHHHHHHHHHhccCCCeEEEEEeecCcchhhhccCCcccHHHHHHHHHHHHHHHHH
Confidence 4689999999999 6799999999999876 999999999986532210 00 1122233333444444
Q ss_pred HHHhhhhhcCCc-EEEEEEECCchhHHHHHHHHhcCCCEEEEccCCCCceeec-ccchhHHHHhcCCCCcEEEEEeC
Q 007254 80 VYEGFCNLKQVD-LKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRS-TTSLAKYCAKKLSKDCSVLAVNN 154 (611)
Q Consensus 80 ~~~~~C~~k~V~-~~~~v~~g~~~~~~Iv~~a~~~~ad~LVlG~~g~~~~~R~-~gsva~~v~k~ap~~C~VlvV~k 154 (611)
. ++.+.++. ++..+..| ++.++|+++|++.++|+||||++|++++.++ +|||+++|+++++ |||+||+.
T Consensus 235 ~---~~~~~~~~~~~~~v~~g-~~~~~I~~~a~~~~~dLiV~G~~g~~~~~~~~~Gsv~~~vl~~~~--~pVLvv~~ 305 (319)
T 3olq_A 235 E---LRQKFSIPEEKTHVKEG-LPEQVIPQVCEELNAGIVVLGILGRTGLSAAFLGNTAEQLIDHIK--CDLLAIKP 305 (319)
T ss_dssp H---HHHHTTCCGGGEEEEES-CHHHHHHHHHHHTTEEEEEEECCSCCSTHHHHHHHHHHHHHTTCC--SEEEEECC
T ss_pred H---HHHHhCCCcccEEEecC-CcHHHHHHHHHHhCCCEEEEeccCccCCccccccHHHHHHHhhCC--CCEEEECC
Confidence 4 44555663 45566665 7899999999999999999999999999885 9999999999998 99999975
|
| >3ab8_A Putative uncharacterized protein TTHA0350; tandem-type universal stress protein, unknown function; HET: ATP; 1.70A {Thermus thermophilus} PDB: 3ab7_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=2.7e-13 Score=136.84 Aligned_cols=115 Identities=14% Similarity=0.057 Sum_probs=96.5
Q ss_pred CCCEEEEEeCCCHhHHHHHHHHHHHccCCCCEEEEEEEeeCCCcccCCCchhHHHHHHHHHHHHHHHHhhhhhcCCcEEE
Q 007254 15 AGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKL 94 (611)
Q Consensus 15 ~~~~IlVaVD~s~~S~~AL~WAl~~~~~~g~~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~C~~k~V~~~~ 94 (611)
..++|+||+|+|+.|..||.||...+...|..|+++||.++. +..++.++.+...+...|++++.
T Consensus 153 ~~~~ilv~~d~s~~~~~al~~a~~la~~~~a~l~ll~v~~~~---------------~~~~~~l~~~~~~l~~~~~~~~~ 217 (268)
T 3ab8_A 153 ELEGALLGYDASESAVRALHALAPLARALGLGVRVVSVHEDP---------------ARAEAWALEAEAYLRDHGVEASA 217 (268)
T ss_dssp CCCEEEEECCSCHHHHHHHHHHHHHHHHHTCCEEEEEECSSH---------------HHHHHHHHHHHHHHHHTTCCEEE
T ss_pred CCCEEEEEECCCHHHHHHHHHHHHhhhcCCCEEEEEEEcCcH---------------HHHHHHHHHHHHHHHHcCCceEE
Confidence 457999999999999999999999988889999999998642 12344556666666677999988
Q ss_pred EEEECCchhHHHHHHHHhcCCCEEEEccCCCCceeec-ccchhHHHHhcCCCCcEEEEEe
Q 007254 95 KICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRS-TTSLAKYCAKKLSKDCSVLAVN 153 (611)
Q Consensus 95 ~v~~g~~~~~~Iv~~a~~~~ad~LVlG~~g~~~~~R~-~gsva~~v~k~ap~~C~VlvV~ 153 (611)
.+..| ++.++|+++|++. |+||||+ ++.++ +||++++++++++ |||++|+
T Consensus 218 ~~~~g-~~~~~i~~~a~~~--dliV~G~----~~~~~~~Gs~~~~vl~~~~--~pvlvv~ 268 (268)
T 3ab8_A 218 LVLGG-DAADHLLRLQGPG--DLLALGA----PVRRLVFGSTAERVIRNAQ--GPVLTAR 268 (268)
T ss_dssp EEECS-CHHHHHHHHCCTT--EEEEEEC----CCSCCSSCCHHHHHHHHCS--SCEEEEC
T ss_pred EEeCC-ChHHHHHHHHHhC--CEEEECC----cccccEeccHHHHHHhcCC--CCEEEeC
Confidence 77764 7899999999998 9999999 45554 8999999999998 9999984
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=2.6e-12 Score=129.00 Aligned_cols=147 Identities=18% Similarity=0.134 Sum_probs=115.4
Q ss_pred HhcCCCccceeecccCceEEEEEEecCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCeEEEEE
Q 007254 419 SATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 419 ~~~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~ 496 (611)
.....|.+...++.|+.+.||++.. .++.+++|+..... .....+.+|+.++..+. +..+.++++++...+..|+||
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 3445787888889899999999875 46889999987522 22245788999999985 678889999999989999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC------------------------------------
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG------------------------------------ 540 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~------------------------------------ 540 (611)
||++|.+|.+.+... .....++.+++.+|..||+.
T Consensus 90 e~i~G~~l~~~~~~~---------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 90 SEADGVLCSEEYEDE---------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp ECCSSEEHHHHCCTT---------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EecCCeehhhccCCc---------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 999999998764211 12346788999999999981
Q ss_pred --------------------CCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 541 --------------------SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 541 --------------------~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
.+..++|+|++|.|||++++..+.|+||+.+.+.+
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~gd 215 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRAD 215 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEEE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccCC
Confidence 11458999999999999876566799999987654
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.31 E-value=3.1e-12 Score=127.29 Aligned_cols=140 Identities=16% Similarity=0.085 Sum_probs=103.5
Q ss_pred CCccceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCC--eeeEEEEEEeCCeEEEEEEcCC
Q 007254 423 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKN--IISLLGFCFEDNNLLLVYDFLS 500 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~~~~~~~lV~Ey~~ 500 (611)
+|.+..+.+.|..+.||++...+|+.+++|+.... ....+..|+.+++.+.+.+ +.++++++...+..++||||++
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~ 98 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 98 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecC
Confidence 34443333455669999998777888999998754 2245778999999886544 5678998888888999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC---------------------------------------
Q 007254 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS--------------------------------------- 541 (611)
Q Consensus 501 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~--------------------------------------- 541 (611)
|.+|. ... .. ...++.+++..|..||...
T Consensus 99 G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 99 GQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp SEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred CcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 98873 211 11 1256778888888888622
Q ss_pred ----------------CCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 542 ----------------AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 542 ----------------~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
+..++|+|++|.|||+++++.+.|+|||.|.+.+.
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g~~ 217 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVADR 217 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEEET
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccCCh
Confidence 12399999999999998876677999999987653
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.11 E-value=2.5e-10 Score=120.23 Aligned_cols=143 Identities=14% Similarity=0.257 Sum_probs=108.6
Q ss_pred cceeecccCceEEEEEEecCCCEEEEEEec--CCh--hHHHHHHHHHHHHHhcC--CCCeeeEEEEEEeC---CeEEEEE
Q 007254 426 AENLIGKGGSSQVYKGCLPDGKELAVKILK--PSE--DVIKEFVLEIEIITTLH--HKNIISLLGFCFED---NNLLLVY 496 (611)
Q Consensus 426 ~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk--~~~--~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~---~~~~lV~ 496 (611)
..+.|+.|.++.||+.... +..+++|+.. ... .....+.+|+.+++.|. +..+++++.++.+. +..|+||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 4577899999999998774 4678888776 432 22456788999999997 45688999998776 4579999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----------------------------------
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS----------------------------------- 541 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~----------------------------------- 541 (611)
||++|..+.+.. ...++..++..++.+++..|..||...
T Consensus 121 e~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 121 EFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp ECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 999987764311 123678888899999999999999720
Q ss_pred --------------------CCCeEecCCCCCCEEEcCCCc--EEEEeeccccccC
Q 007254 542 --------------------AQRVIHRDVKSSNILLSDDFE--PQLSDFGLAKWAS 575 (611)
Q Consensus 542 --------------------~~~IvHrDLKp~NILl~~~~~--vKL~DFGlA~~~~ 575 (611)
...++|+|++|.|||++.++. +.|+||++|.+.+
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g~ 250 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLGH 250 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEEC
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccCC
Confidence 357999999999999997753 6899999998654
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.61 E-value=9.2e-08 Score=98.12 Aligned_cols=139 Identities=20% Similarity=0.207 Sum_probs=101.0
Q ss_pred ceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcC-CCC--eeeEEEEEEeCC---eEEEEEEcCC
Q 007254 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKN--IISLLGFCFEDN---NLLLVYDFLS 500 (611)
Q Consensus 427 ~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~-Hpn--Iv~l~~~~~~~~---~~~lV~Ey~~ 500 (611)
.+.++.|.+..||+.. ..+++|+-... .....+.+|.++|+.+. +.. +..++......+ ..|+||++++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 3568999999999852 56889986543 44567889999998884 322 445555543332 3488999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC----------------------------------------
Q 007254 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG---------------------------------------- 540 (611)
Q Consensus 501 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~---------------------------------------- 540 (611)
|..|...... .++..++..++.+++..|..||+.
T Consensus 100 G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 100 GVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CeECCccccc------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9888654321 256677778888888888888851
Q ss_pred ---------------CCCCeEecCCCCCCEEEcC--CCcEEEEeeccccccCC
Q 007254 541 ---------------SAQRVIHRDVKSSNILLSD--DFEPQLSDFGLAKWAST 576 (611)
Q Consensus 541 ---------------~~~~IvHrDLKp~NILl~~--~~~vKL~DFGlA~~~~~ 576 (611)
.+..++|+|++|.|||+++ +..+.|+||+.+...+.
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~ 226 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDP 226 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCCh
Confidence 1235899999999999998 45678999999987643
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.56 E-value=5.2e-07 Score=92.92 Aligned_cols=139 Identities=20% Similarity=0.200 Sum_probs=97.1
Q ss_pred ceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCC---CeeeEEEEEE-eCCeEEEEEEcCCCC
Q 007254 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK---NIISLLGFCF-EDNNLLLVYDFLSRG 502 (611)
Q Consensus 427 ~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~~~~~-~~~~~~lV~Ey~~~g 502 (611)
...++.|....||+. |..+++|+-. .......+..|.++|..|.+. .+..++.++. ..+..|+||||++|.
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~-~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK-SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES-SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC-CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 456788888899987 5678888853 334567788999999999753 3567777764 455678999999998
Q ss_pred CHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC------------------------------------------
Q 007254 503 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG------------------------------------------ 540 (611)
Q Consensus 503 sL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~------------------------------------------ 540 (611)
.|...... .++..++..++.+++..|..||+.
T Consensus 99 ~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 99 ILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp ECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred ECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 87663211 123344444455555555555431
Q ss_pred ---------------CCCCeEecCCCCCCEEEcC---CCc-EEEEeeccccccCC
Q 007254 541 ---------------SAQRVIHRDVKSSNILLSD---DFE-PQLSDFGLAKWAST 576 (611)
Q Consensus 541 ---------------~~~~IvHrDLKp~NILl~~---~~~-vKL~DFGlA~~~~~ 576 (611)
.+..++|+|++|.|||++. ++. +.|+||+.+...+.
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd~ 227 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISDP 227 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEECG
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCCH
Confidence 2346799999999999987 455 48999999987654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=1.9e-06 Score=86.23 Aligned_cols=137 Identities=19% Similarity=0.139 Sum_probs=96.8
Q ss_pred ecccCce-EEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCeEEEEEEcCCCCCHHH
Q 007254 430 IGKGGSS-QVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDFLSRGSLEE 506 (611)
Q Consensus 430 IG~G~fG-~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 506 (611)
+..|..| .||+.... ++..+.+|+-... ....+..|..+|+.|. +--+.++++++.+.+..|+|||+++|.++.+
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~ 109 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ 109 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence 4445444 68987754 4667899986644 3456778999998885 3346788999999999999999999988776
Q ss_pred HHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC----------------------------------------------
Q 007254 507 NLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG---------------------------------------------- 540 (611)
Q Consensus 507 ~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~---------------------------------------------- 540 (611)
...... .....++.+++..|.-||..
T Consensus 110 ~~~~~~--------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 110 VLEEYP--------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHCG--------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred cccCCH--------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 543211 12233455555556666541
Q ss_pred ---------CCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 541 ---------SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 541 ---------~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
.+..++|+|+.+.|||+++++.+-|+||+.+.+.+.
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~gdp 226 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADR 226 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEEET
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccCCH
Confidence 111379999999999999887778999999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.25 E-value=4.3e-06 Score=86.25 Aligned_cols=144 Identities=18% Similarity=0.277 Sum_probs=83.5
Q ss_pred eeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcC--CCCeeeEEE------EEEeCCeEEEEEEcC
Q 007254 428 NLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLH--HKNIISLLG------FCFEDNNLLLVYDFL 499 (611)
Q Consensus 428 ~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~------~~~~~~~~~lV~Ey~ 499 (611)
..|+.|..+.||+....+| .+++|+...... ++..|..++..|. .-.+..++. +....+..++||+|+
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~~---~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRPEK---KALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSCHH---HHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCCHH---HHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 4566677899999887555 589999987442 2334455555442 112333332 123467789999999
Q ss_pred CCCCHH--------------HHHhcCCC-C--C-------CCCCHHHHH-------------------------------
Q 007254 500 SRGSLE--------------ENLHGNKK-D--P-------AAFGWSERY------------------------------- 524 (611)
Q Consensus 500 ~~gsL~--------------~~L~~~~~-~--~-------~~l~~~~~~------------------------------- 524 (611)
+|..+. -.||.... . + ....|...+
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 986532 12221100 0 0 112443211
Q ss_pred HHHHHHHHHHHHHHc----------CCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 525 KVAMGVAEALEYLHS----------GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 525 ~ia~qia~aL~yLH~----------~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
.+...+..++.+|+. ..+..++|+|+++.|||++.++.+.|+||+.+.+.+
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~g~ 254 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSFDL 254 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEECC
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcccCC
Confidence 011123445666653 124789999999999999888899999999987654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=4.4e-06 Score=88.87 Aligned_cols=74 Identities=16% Similarity=0.121 Sum_probs=50.4
Q ss_pred ceeecccCceEEEEEEec-CCCEEEEEEecCChh--------HHHHHHHHHHHHHhcCC--C-CeeeEEEEEEeCCeEEE
Q 007254 427 ENLIGKGGSSQVYKGCLP-DGKELAVKILKPSED--------VIKEFVLEIEIITTLHH--K-NIISLLGFCFEDNNLLL 494 (611)
Q Consensus 427 ~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~--------~~~~~~~Ei~il~~l~H--p-nIv~l~~~~~~~~~~~l 494 (611)
.+.||.|.++.||++... +++.++||...+... ...++..|.++|..+.. + .+..++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 567999999999999754 568899998754221 23456779999887742 3 44566654 3445689
Q ss_pred EEEcCCCC
Q 007254 495 VYDFLSRG 502 (611)
Q Consensus 495 V~Ey~~~g 502 (611)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.19 E-value=1.6e-06 Score=90.61 Aligned_cols=78 Identities=13% Similarity=0.097 Sum_probs=55.4
Q ss_pred ceee-cccCceEEEEEEec-------CCCEEEEEEecCChh----HHHHHHHHHHHHHhcCC---CCeeeEEEEEEeC--
Q 007254 427 ENLI-GKGGSSQVYKGCLP-------DGKELAVKILKPSED----VIKEFVLEIEIITTLHH---KNIISLLGFCFED-- 489 (611)
Q Consensus 427 ~~~I-G~G~fG~Vyk~~~~-------~g~~vAVK~lk~~~~----~~~~~~~Ei~il~~l~H---pnIv~l~~~~~~~-- 489 (611)
.+.| +.|....+|+.... ++..+++|+-..... ....+..|+.+|+.|.. ..+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88888999987754 266788998765331 12456778888888742 3577888887654
Q ss_pred -CeEEEEEEcCCCCCH
Q 007254 490 -NNLLLVYDFLSRGSL 504 (611)
Q Consensus 490 -~~~~lV~Ey~~~gsL 504 (611)
+..|+||||++|..+
T Consensus 105 ~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVP 120 (357)
T ss_dssp TSSCEEEEECCCCBCC
T ss_pred cCCceEEEEecCCCCh
Confidence 356899999988654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.75 E-value=0.00014 Score=77.89 Aligned_cols=34 Identities=24% Similarity=0.435 Sum_probs=30.2
Q ss_pred CCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 542 ~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
+..++|+|++|.|||++.++ ++|+||+++.+.+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p 264 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPM 264 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCch
Confidence 47899999999999998876 99999999987763
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00011 Score=74.99 Aligned_cols=142 Identities=13% Similarity=0.101 Sum_probs=79.1
Q ss_pred ceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCe-eeEEEEEEeCCeEEEEEEcC-CCCCH
Q 007254 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI-ISLLGFCFEDNNLLLVYDFL-SRGSL 504 (611)
Q Consensus 427 ~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV~Ey~-~~gsL 504 (611)
.+.|+.|....+|+. ..+.+|+........-....|+.+++.+....+ .++++++.+ .-++|+||+ +|..|
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTRYIAGAQTM 95 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEECCTTCEEC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEeecCCCccC
Confidence 577888999999998 568889886543222223457777776642222 466665433 337899999 65444
Q ss_pred HH------------------HHhcCCC-CCCCCC-HHHHHHHHH--------------HHHHHHH----HHHc-CCCCCe
Q 007254 505 EE------------------NLHGNKK-DPAAFG-WSERYKVAM--------------GVAEALE----YLHS-GSAQRV 545 (611)
Q Consensus 505 ~~------------------~L~~~~~-~~~~l~-~~~~~~ia~--------------qia~aL~----yLH~-~~~~~I 545 (611)
.. .||.... ....+. +.....+.. .+...+. .|.. ..+..+
T Consensus 96 ~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~l 175 (301)
T 3dxq_A 96 SPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLAA 175 (301)
T ss_dssp CHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCEE
T ss_pred CHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCcee
Confidence 21 1222111 001111 111111111 0111111 1211 234568
Q ss_pred EecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 546 vHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
+|+|+.+.||| ..++.+.|+||..|.+.+.
T Consensus 176 ~HgDl~~~Nil-~~~~~~~lID~e~a~~g~~ 205 (301)
T 3dxq_A 176 CHCDPLCENFL-DTGERMWIVDWEYSGMNDP 205 (301)
T ss_dssp ECSCCCGGGEE-ECSSCEEECCCTTCEEECT
T ss_pred eccCCCcCCEE-ECCCCEEEEecccccCCCH
Confidence 99999999999 5667889999999886553
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00069 Score=69.50 Aligned_cols=146 Identities=17% Similarity=0.239 Sum_probs=85.6
Q ss_pred eeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCC--CCeeeEEEE-----EEeCCeEEEEEEcCC
Q 007254 428 NLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH--KNIISLLGF-----CFEDNNLLLVYDFLS 500 (611)
Q Consensus 428 ~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~-----~~~~~~~~lV~Ey~~ 500 (611)
..|+ |....||+....+|+.+++|+.++.......+..|..++..|.. -.++.++.. ....+..++||+|++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 4566 78889999877678789999997543233456668888777642 123444432 223456789999998
Q ss_pred CCCHH-----H---------HHhcCC---C--CCCCCCHHHHH----HH---------------HHHHHHHHHHHHc---
Q 007254 501 RGSLE-----E---------NLHGNK---K--DPAAFGWSERY----KV---------------AMGVAEALEYLHS--- 539 (611)
Q Consensus 501 ~gsL~-----~---------~L~~~~---~--~~~~l~~~~~~----~i---------------a~qia~aL~yLH~--- 539 (611)
|..+. . .++... . ....+.+.... .+ ...+-..+..|..
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 74431 1 122110 0 01123332210 01 0111122333321
Q ss_pred -CCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 540 -GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 540 -~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
..+..++|+|+++.|||++ + .+.|+||+.+.+.+.
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g~~ 226 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNGPA 226 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEECT
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcCcH
Confidence 1346789999999999998 5 899999999876653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.53 E-value=0.0002 Score=73.32 Aligned_cols=147 Identities=17% Similarity=0.147 Sum_probs=82.8
Q ss_pred ceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCC--eeeEEEE------EEeCCeEEEEEEc
Q 007254 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKN--IISLLGF------CFEDNNLLLVYDF 498 (611)
Q Consensus 427 ~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~------~~~~~~~~lV~Ey 498 (611)
.+.|+.|....+|+....+| .+++|+..... ....+..|+.++..|.... +..++.. ....+..++||+|
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~-~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKD-PLILTLYEKRV-EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eeccCCCcccceEEEEeCCc-cEEEEEeCCCC-CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 35577788899999887555 68899887631 1123445777776663211 2333321 1234667999999
Q ss_pred CCCCCHH--------------HHHhcCC-CCC-C---C---CCHHHHHH------------HHHHHHHHHHHHHc----C
Q 007254 499 LSRGSLE--------------ENLHGNK-KDP-A---A---FGWSERYK------------VAMGVAEALEYLHS----G 540 (611)
Q Consensus 499 ~~~gsL~--------------~~L~~~~-~~~-~---~---l~~~~~~~------------ia~qia~aL~yLH~----~ 540 (611)
++|..+. -.++... ... . . ..|...+. +...+...+.+|.. .
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 9886431 1122211 000 0 0 12433111 01124455566653 2
Q ss_pred CCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 541 ~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
.+..++|+|+.+.|||++.+..+.|+||+.+.+.+
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~g~ 219 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFACNDL 219 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCEEEE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhccCch
Confidence 34679999999999999987666899999887643
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.51 E-value=0.0015 Score=67.36 Aligned_cols=143 Identities=15% Similarity=0.221 Sum_probs=96.4
Q ss_pred cceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcC---CCCeeeEEEEEEeCCeEEEEEEcCCCC
Q 007254 426 AENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLH---HKNIISLLGFCFEDNNLLLVYDFLSRG 502 (611)
Q Consensus 426 ~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~lV~Ey~~~g 502 (611)
..+.|+.|.+..+|+... ++..+.+|+.... ....|..|...|+.|. ...+++++.++...+..++||||+++.
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 346789999999999876 5678889987643 2566788999888884 367889999988888899999999987
Q ss_pred CHH-----------HHHhcCCC-C-----------------CCCCCHHHHHH---HHH----------------HHHHH-
Q 007254 503 SLE-----------ENLHGNKK-D-----------------PAAFGWSERYK---VAM----------------GVAEA- 533 (611)
Q Consensus 503 sL~-----------~~L~~~~~-~-----------------~~~l~~~~~~~---ia~----------------qia~a- 533 (611)
.+. -.|+.... . ...-+|...+. +.. .++..
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 541 13343321 0 00125655431 111 11111
Q ss_pred HHHHHc-CCCCCeEecCCCCCCEEEcCCCcEEEEeeccccc
Q 007254 534 LEYLHS-GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (611)
Q Consensus 534 L~yLH~-~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~ 573 (611)
...|.. .....+||+|+.+.|++++.++ +.|+||+ +.+
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~-~~~ 235 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA-CYW 235 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC-CEE
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc-ccc
Confidence 123421 2246799999999999999887 8999984 443
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00061 Score=68.88 Aligned_cols=78 Identities=21% Similarity=0.204 Sum_probs=56.6
Q ss_pred CCccceeecccCceEEEEEEecCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCC---CCeeeEEEEEEeCCeEEEEEEc
Q 007254 423 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-DVIKEFVLEIEIITTLHH---KNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~H---pnIv~l~~~~~~~~~~~lV~Ey 498 (611)
.......+|.|..+.||+..+.+|+.|.+|+-.... .....|..|...|+.|.. -.+.+++++. .. ++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~~--~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--DR--TLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--TT--EEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc--Cc--eEEEEe
Confidence 344567899999999999999999999999875433 223456789999998842 2355666543 23 889999
Q ss_pred CCCCCH
Q 007254 499 LSRGSL 504 (611)
Q Consensus 499 ~~~gsL 504 (611)
++++..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987643
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00075 Score=69.57 Aligned_cols=145 Identities=14% Similarity=0.123 Sum_probs=77.0
Q ss_pred eeecccCceE-EEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcC--CCCeeeEEEEEEeCCeEEEEEEcCCCCCH
Q 007254 428 NLIGKGGSSQ-VYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLH--HKNIISLLGFCFEDNNLLLVYDFLSRGSL 504 (611)
Q Consensus 428 ~~IG~G~fG~-Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 504 (611)
..|+.|+... +|+....+|..+.+|...+... ..+..|+.++..+. .-.+.+++.+....+ ++|||++.+..+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~--~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l 99 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG--GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALF 99 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT--CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBH
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC--ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcch
Confidence 3455554444 6676554467787876654320 22334666666663 234566777654444 789999977666
Q ss_pred HHHHhcC---------------------CCC-CCCCCHHHHH---------H-----------HHHHHHHHHHHHH---c
Q 007254 505 EENLHGN---------------------KKD-PAAFGWSERY---------K-----------VAMGVAEALEYLH---S 539 (611)
Q Consensus 505 ~~~L~~~---------------------~~~-~~~l~~~~~~---------~-----------ia~qia~aL~yLH---~ 539 (611)
.+.+... ... -..+...... . ....+...+..|- .
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~ 179 (333)
T 3csv_A 100 TEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQL 179 (333)
T ss_dssp HHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHC
T ss_pred HHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcc
Confidence 5433211 100 0112211100 0 0011122222331 1
Q ss_pred CCCCCeEecCCCCCCEEEcCC----CcEEEEeeccccccCC
Q 007254 540 GSAQRVIHRDVKSSNILLSDD----FEPQLSDFGLAKWAST 576 (611)
Q Consensus 540 ~~~~~IvHrDLKp~NILl~~~----~~vKL~DFGlA~~~~~ 576 (611)
..+..++|+|+.+.|||++.+ +.+.|+||+.+.+.+.
T Consensus 180 ~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~~ 220 (333)
T 3csv_A 180 EGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGHR 220 (333)
T ss_dssp CSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEECT
T ss_pred cCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCCC
Confidence 234789999999999999875 6899999999987654
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.21 E-value=0.00085 Score=71.14 Aligned_cols=145 Identities=18% Similarity=0.233 Sum_probs=86.8
Q ss_pred ceeecccCceEEEEEEec--------CCCEEEEEEecCChhHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCeEEEEEE
Q 007254 427 ENLIGKGGSSQVYKGCLP--------DGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 427 ~~~IG~G~fG~Vyk~~~~--------~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E 497 (611)
.+.|..|-...+|+.... +++.+.+|+.-........+.+|..+++.|. +.-..++++++.+ .+|||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 355667778889998864 2478999986443233456678999988874 3233567776643 38999
Q ss_pred cCCCCCHH--------------H---HHhcCCC-CCCCC--CHHHHHHHHHHHHH-------------------HHHHHH
Q 007254 498 FLSRGSLE--------------E---NLHGNKK-DPAAF--GWSERYKVAMGVAE-------------------ALEYLH 538 (611)
Q Consensus 498 y~~~gsL~--------------~---~L~~~~~-~~~~l--~~~~~~~ia~qia~-------------------aL~yLH 538 (611)
|++|..|. + .||.... ..... -|.+..++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 99875442 1 1222211 11112 24555555443321 233332
Q ss_pred c-----CCCCCeEecCCCCCCEEEcCC----CcEEEEeeccccccC
Q 007254 539 S-----GSAQRVIHRDVKSSNILLSDD----FEPQLSDFGLAKWAS 575 (611)
Q Consensus 539 ~-----~~~~~IvHrDLKp~NILl~~~----~~vKL~DFGlA~~~~ 575 (611)
. ..+..++|+|+.+.|||++.+ +.+.|+||.+|.+.+
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~~ 256 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYNY 256 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcCC
Confidence 2 234679999999999999876 789999999987654
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.14 E-value=0.00036 Score=73.23 Aligned_cols=144 Identities=16% Similarity=0.237 Sum_probs=79.6
Q ss_pred ceeecccCceEEEEEEecC---------CCEEEEEEecCChhHHHHHHHHHHHHHhcCCCC-eeeEEEEEEeCCeEEEEE
Q 007254 427 ENLIGKGGSSQVYKGCLPD---------GKELAVKILKPSEDVIKEFVLEIEIITTLHHKN-IISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 427 ~~~IG~G~fG~Vyk~~~~~---------g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~lV~ 496 (611)
...|+.|....+|+....+ +..+.+|+.........+...|..++..+...+ ..++++.+ .+ ++||
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v~ 113 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRIE 113 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--CC--cEEE
Confidence 4567788888999987643 268899987654332223456888888775333 44676554 33 7899
Q ss_pred EcCCCCCHH--------------H---HHhcC---CCCCCCCC-----HHHHHHHH--------------------HHHH
Q 007254 497 DFLSRGSLE--------------E---NLHGN---KKDPAAFG-----WSERYKVA--------------------MGVA 531 (611)
Q Consensus 497 Ey~~~gsL~--------------~---~L~~~---~~~~~~l~-----~~~~~~ia--------------------~qia 531 (611)
||++|..+. . .||.. ...+..+. |.....+. ..+.
T Consensus 114 e~i~G~~l~~~~~~~~~~~~~~a~~La~lH~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (369)
T 3c5i_A 114 EWLYGDPLRIDDLKNPTILIGIANVLGKFHTLSRKRHLPEHWDRTPCIFKMMEKWKNQLFKYKNIEKYNCDIHKYIKESD 193 (369)
T ss_dssp ECCCSEECCGGGGGCHHHHHHHHHHHHHHHTHHHHSCCCTTSCCSCHHHHHHHHHHHHHTTCSSGGGC-CCHHHHHHHHH
T ss_pred EEecCCcCChhhcCChHHHHHHHHHHHHHHcCcccccCcccCCCCCcHHHHHHHHHHHHhhhhhHHHHHhhHHHHHHHHH
Confidence 999875331 1 11210 00011111 11111111 1112
Q ss_pred HHHHHHHc-------CCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 532 EALEYLHS-------GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 532 ~aL~yLH~-------~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
..+.+|.. ..+..++|+|+.+.|||++++. +.|+||..|.+..
T Consensus 194 ~l~~~l~~~~~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~g~ 243 (369)
T 3c5i_A 194 KFIKFMKVYSKSDNLANTIVFCHNDLQENNIINTNKC-LRLIDFEYSGFNF 243 (369)
T ss_dssp HHHHHHHHHTTSSCGGGCEEEECSCCCGGGEEECC-C-EEECCCTTCEEEE
T ss_pred HHHHHHHHhhhhcccCCCeEEEeCCCCcccEEecCCc-EEEEEecCCCCCc
Confidence 22334421 1235799999999999998664 8999999887544
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.11 E-value=0.0017 Score=70.00 Aligned_cols=72 Identities=15% Similarity=0.214 Sum_probs=49.8
Q ss_pred ceeecccCceEEEEEEecC--------CCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCe-eeEEEEEEeCCeEEEEEE
Q 007254 427 ENLIGKGGSSQVYKGCLPD--------GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI-ISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 427 ~~~IG~G~fG~Vyk~~~~~--------g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV~E 497 (611)
.+.|+.|-...||++...+ ++.+.+|+.... .....+..|..++..|...++ .++++.+. + .+|||
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e 152 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEE 152 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEEC
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEE
Confidence 4678888889999998653 578999988542 112455679988888753333 67777653 2 38999
Q ss_pred cCCCCC
Q 007254 498 FLSRGS 503 (611)
Q Consensus 498 y~~~gs 503 (611)
|++|..
T Consensus 153 ~l~G~~ 158 (429)
T 1nw1_A 153 YIPSRP 158 (429)
T ss_dssp CCCEEE
T ss_pred EeCCcc
Confidence 998633
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.94 E-value=0.0045 Score=67.25 Aligned_cols=74 Identities=22% Similarity=0.181 Sum_probs=48.4
Q ss_pred ceeecccCceEEEEEEecC-CCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCe-eeEEEEEEeCCeEEEEEEcCCCCCH
Q 007254 427 ENLIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI-ISLLGFCFEDNNLLLVYDFLSRGSL 504 (611)
Q Consensus 427 ~~~IG~G~fG~Vyk~~~~~-g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV~Ey~~~gsL 504 (611)
.+.|+.|-...+|+....+ +..+.+|+........-+...|..++..|...++ .++++++. + .+||||++|..|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 4668888889999988754 4788899875432111122478999998865444 57777762 3 359999987443
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.67 E-value=0.0025 Score=66.22 Aligned_cols=140 Identities=16% Similarity=0.199 Sum_probs=80.7
Q ss_pred cccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcC---CCCeeeEEEE------EEeCCeEEEEEEcCCC
Q 007254 431 GKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLH---HKNIISLLGF------CFEDNNLLLVYDFLSR 501 (611)
Q Consensus 431 G~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~------~~~~~~~~lV~Ey~~~ 501 (611)
|.|....||+....+| .+++|+...... ..|+.++..|. -|+++..+.. ....+..++||+|++|
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~-----~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G 105 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD-----EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA 105 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC-----CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc-----hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence 3333678999887667 899998876541 34556665553 1224444432 2335778999999998
Q ss_pred CCHH----------------HHHhcCCCC----------CCCCCHHHHH-HHH---------------------------
Q 007254 502 GSLE----------------ENLHGNKKD----------PAAFGWSERY-KVA--------------------------- 527 (611)
Q Consensus 502 gsL~----------------~~L~~~~~~----------~~~l~~~~~~-~ia--------------------------- 527 (611)
..+. -.|+..... .....|.... .+.
T Consensus 106 ~~~~~~~~~~~~~~~lg~~La~LH~~~~~~~~~~~~~~~~~~~~w~~~i~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l 185 (339)
T 3i1a_A 106 PNGFTQNLTGKQWKQLGKVLRQIHETSVPISIQQQLRKEIYSPKWREIVRSFYNQIEFDNSDDKLTAAFKSFFNQNSAAI 185 (339)
T ss_dssp CBTTTSCCCHHHHHHHHHHHHHHHTCCCCHHHHTTSEECCCCCHHHHHHHHHGGGGSCCTTCCHHHHHHHHHHHHTHHHH
T ss_pred CcCcccCCCHHHHHHHHHHHHHHhCcCCCCCCccCccccccCcchHHHHHHHHHhhhccccCCcHHHHHHHHHHHhHHHH
Confidence 6551 122322110 0011121111 000
Q ss_pred HHHHHHHH----HHHc-CCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 528 MGVAEALE----YLHS-GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 528 ~qia~aL~----yLH~-~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
..++..+. .|.. ..+..++|+|+.+.|||++.++.+.|+||+.+.+.+.
T Consensus 186 ~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~~ 239 (339)
T 3i1a_A 186 HRLVDTSEKLSKKIQPDLDKYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAPK 239 (339)
T ss_dssp HHHHHHHHHHHHHCCCCGGGCEEECSCCCGGGEEECGGGCEEECCCSSCEEECT
T ss_pred HHHHHHHHHHHHHHhhCCCCceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCCH
Confidence 11121222 2221 1236799999999999999888899999998887653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.68 E-value=0.019 Score=61.69 Aligned_cols=144 Identities=13% Similarity=0.165 Sum_probs=86.6
Q ss_pred ceeecccCceEEEEEEecC--------CCEEEEEEecCChhHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCeEEEEEE
Q 007254 427 ENLIGKGGSSQVYKGCLPD--------GKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 427 ~~~IG~G~fG~Vyk~~~~~--------g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E 497 (611)
.+.|..|-...+|+....+ ++.+.+|+........-+..+|..+++.+. +.-..++++.+ .+ ++|||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~e 150 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIEE 150 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEEE
Confidence 3567777788899988653 578999987553322223356888887774 22345666543 33 78999
Q ss_pred cCCCCCHH--------------H---HHhcCCC---------CCCCCCHHHHHHHHHHH-------------------HH
Q 007254 498 FLSRGSLE--------------E---NLHGNKK---------DPAAFGWSERYKVAMGV-------------------AE 532 (611)
Q Consensus 498 y~~~gsL~--------------~---~L~~~~~---------~~~~l~~~~~~~ia~qi-------------------a~ 532 (611)
|++|..|. . .||.... ...+..|.+..++..++ ..
T Consensus 151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 230 (424)
T 3mes_A 151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE 230 (424)
T ss_dssp CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence 99986531 0 1111100 11122344444333222 22
Q ss_pred HHHHHHc---------------------CCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 533 ALEYLHS---------------------GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 533 aL~yLH~---------------------~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
.+.+|.. ..+..++|+|+.+.||| +.++.+.|+||..|.+..
T Consensus 231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~~~ 293 (424)
T 3mes_A 231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAINF 293 (424)
T ss_dssp HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEEEE
T ss_pred HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCcCC
Confidence 3333321 12357899999999999 788899999999987644
|
| >3a2k_A TRNA(Ile)-lysidine synthase; ligase, pseudo-knot, ligase/RNA complex; 3.65A {Geobacillus kaustophilus} | Back alignment and structure |
|---|
Probab=93.20 E-value=0.34 Score=52.39 Aligned_cols=97 Identities=21% Similarity=0.160 Sum_probs=68.0
Q ss_pred CCCEEEEEeCCCHhHHHHHHHHHHHccCCCCEEEEEEEeeCCCcccCCCchhHHHHHHHHHHHHHHHHhhhhhcCCcEEE
Q 007254 15 AGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKL 94 (611)
Q Consensus 15 ~~~~IlVaVD~s~~S~~AL~WAl~~~~~~g~~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~C~~k~V~~~~ 94 (611)
.+.+|+||+.|-..|.-+|.++.......|-.|+++||..... + ...+.-....+.+|+..||++..
T Consensus 17 ~~~~vlVa~SGG~DS~~Ll~ll~~~~~~~~~~v~avhvdhglr-----g--------~~s~~~~~~v~~~~~~lgi~~~v 83 (464)
T 3a2k_A 17 EGAAVIVGVSGGPDSLALLHVFLSLRDEWKLQVIAAHVDHMFR-----G--------RESEEEMEFVKRFCVERRILCET 83 (464)
T ss_dssp CSSBEEEECCSSHHHHHHHHHHHHHHHTTTCBCEEEEEECTTC-----T--------HHHHHHHHHHHHHHHHTTCEEEE
T ss_pred CCCEEEEEEcCcHHHHHHHHHHHHHHHHcCCeEEEEEEECCCC-----c--------cccHHHHHHHHHHHHHcCCcEEE
Confidence 3568999999999999888777665555688999999975321 0 11222345567889999998875
Q ss_pred EEEEC--------Cch--------hHHHHHHHHhcCCCEEEEccCC
Q 007254 95 KICRG--------TSI--------RKILVREAQSYSATKFIVGTAK 124 (611)
Q Consensus 95 ~v~~g--------~~~--------~~~Iv~~a~~~~ad~LVlG~~g 124 (611)
+-+.. ..+ -..+.++|++.+++.|++|.+.
T Consensus 84 ~~~~~~~~~~~~~~~~e~~aR~~Ry~~l~~~a~~~g~~~IatgH~~ 129 (464)
T 3a2k_A 84 AQIDVPAFQRSAGLGAQEAARICRYRFFAELMEKHQAGYVAVGHHG 129 (464)
T ss_dssp EECCCHHHHTTTTCCSHHHHHHHHHHHHHHHHHTTTCCEEECCCCH
T ss_pred EEechhhhhhccCCCHHHHHHHHHHHHHHHHHHHcCcCEEEEeCCh
Confidence 54431 011 1456778889999999999874
|
| >1wy5_A TILS, hypothetical UPF0072 protein AQ_1887; N-type ATP-ppase, structural genomics, translation, NPPSFA; 2.42A {Aquifex aeolicus} SCOP: c.26.2.5 d.229.1.1 PDB: 2e21_A* 2e89_A* | Back alignment and structure |
|---|
Probab=92.73 E-value=0.66 Score=47.42 Aligned_cols=96 Identities=13% Similarity=-0.012 Sum_probs=64.1
Q ss_pred CCCEEEEEeCCCHhHHHHHHHHHHHccCCCCE-EEEEEEeeCCCcccCCCchhHHHHHHHHHHHHHHHHhhhhhcCCcEE
Q 007254 15 AGRTVVVGVKLDTHSRELLTWALVKVAQPGDT-VIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLK 93 (611)
Q Consensus 15 ~~~~IlVaVD~s~~S~~AL~WAl~~~~~~g~~-vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~C~~k~V~~~ 93 (611)
.+.+|+||+.|-..|.-+|.++.......|-. |+++||..... .....-....+.+|+..||++.
T Consensus 23 ~~~~vlva~SGG~DS~~Ll~ll~~~~~~~g~~~v~av~vd~g~r--------------~~s~~~~~~v~~~a~~lgi~~~ 88 (317)
T 1wy5_A 23 GERRVLIAFSGGVDSVVLTDVLLKLKNYFSLKEVALAHFNHMLR--------------ESAERDEEFCKEFAKERNMKIF 88 (317)
T ss_dssp SCCEEEEECCSSHHHHHHHHHHHHSTTTTTCSEEEEEEEECCSS--------------THHHHHHHHHHHHHHHHTCCEE
T ss_pred CCCEEEEEecchHHHHHHHHHHHHHHHHcCCCEEEEEEEECCCC--------------cccHHHHHHHHHHHHHcCCcEE
Confidence 45689999999999997776665544445777 99999965321 1112234456678888889876
Q ss_pred EEEEE--------CCchh--------HHHHHHHHhcCCCEEEEccCC
Q 007254 94 LKICR--------GTSIR--------KILVREAQSYSATKFIVGTAK 124 (611)
Q Consensus 94 ~~v~~--------g~~~~--------~~Iv~~a~~~~ad~LVlG~~g 124 (611)
.+-+. +.++. ..+.+.|++.+++.|++|.+.
T Consensus 89 v~~~~~~~~~~~~~~~~e~~ar~~Ry~~l~~~a~~~g~~~i~~Gh~~ 135 (317)
T 1wy5_A 89 VGKEDVRAFAKENRMSLEEAGRFLRYKFLKEILESEGFDCIATAHHL 135 (317)
T ss_dssp EEECCHHHHHHHTTCCHHHHHHHHHHHHHHHHHHHTTCSEEECCCCH
T ss_pred EEEEechhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCEEEEeCch
Confidence 54432 11111 256677889999999999874
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=89.77 E-value=0.63 Score=49.06 Aligned_cols=33 Identities=30% Similarity=0.418 Sum_probs=27.0
Q ss_pred CCeEecCCCCCCEEE------cCCCcEEEEeeccccccC
Q 007254 543 QRVIHRDVKSSNILL------SDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 543 ~~IvHrDLKp~NILl------~~~~~vKL~DFGlA~~~~ 575 (611)
..++|.|+.+.|||+ +++..+.++||-+|....
T Consensus 244 ~vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n~ 282 (401)
T 3g15_A 244 VVFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYNY 282 (401)
T ss_dssp EEEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEEE
T ss_pred eeeEEecCCCCeEEEecCcccCcCCeEEEechHhccCCC
Confidence 346799999999999 456679999999887644
|
| >1ni5_A Putative cell cycle protein MESJ; structural genomics, ATPase, PP-type, putative cell cycle PR PSI, protein structure initiative; 2.65A {Escherichia coli} SCOP: b.153.1.2 c.26.2.5 d.229.1.1 | Back alignment and structure |
|---|
Probab=87.37 E-value=0.92 Score=48.55 Aligned_cols=68 Identities=24% Similarity=0.257 Sum_probs=47.3
Q ss_pred CCEEEEEeCCCHhHHHHHHHHHHHccC-CCCEEEEEEEeeCCCcccCCCchhHHHHHHHHHHHHHHHHhhhhhcCCcEEE
Q 007254 16 GRTVVVGVKLDTHSRELLTWALVKVAQ-PGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKL 94 (611)
Q Consensus 16 ~~~IlVaVD~s~~S~~AL~WAl~~~~~-~g~~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~C~~k~V~~~~ 94 (611)
+.+|+||+-|-..|.-+|.++...... .|-.|+++||..... . ..++-....+.+|+..||++..
T Consensus 13 ~~~vlVa~SGG~DS~~Ll~ll~~~~~~~~g~~v~avhvdhglr-----~---------~s~~~~~~v~~~~~~lgi~~~v 78 (433)
T 1ni5_A 13 SRQILVAFSGGLDSTVLLHQLVQWRTENPGVALRAIHVHHGLS-----A---------NADAWVTHCENVCQQWQVPLVV 78 (433)
T ss_dssp CSEEEEECCSBHHHHHHHHHHHHHHTTSTTCEEEEEEECCSCC-----S---------SHHHHHHHHHHHHHHTTCCEEE
T ss_pred CCEEEEEEcchHHHHHHHHHHHHHHHhcCCCeEEEEEEECCCC-----c---------ccHHHHHHHHHHHHHcCCcEEE
Confidence 468999999999999877666555444 688999999975321 0 1112234567788888998765
Q ss_pred EEE
Q 007254 95 KIC 97 (611)
Q Consensus 95 ~v~ 97 (611)
+-+
T Consensus 79 ~~~ 81 (433)
T 1ni5_A 79 ERV 81 (433)
T ss_dssp ECC
T ss_pred EEe
Confidence 433
|
| >1k92_A Argininosuccinate synthase, argininosuccinate SY; N-type ATP pyrophosphatase, ligase; 1.60A {Escherichia coli} SCOP: c.26.2.1 d.210.1.1 PDB: 1k97_A* 1kp2_A* 1kp3_A* | Back alignment and structure |
|---|
Probab=86.85 E-value=3.8 Score=43.94 Aligned_cols=37 Identities=16% Similarity=0.222 Sum_probs=32.1
Q ss_pred CCCEEEEEeCCCHhHHHHHHHHHHHccCCCCEEEEEEEeeC
Q 007254 15 AGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLAN 55 (611)
Q Consensus 15 ~~~~IlVaVD~s~~S~~AL~WAl~~~~~~g~~vvlvHV~~~ 55 (611)
.+.+|+||+-|-..|--+|.|+.+. |..|+++|+...
T Consensus 9 ~~~KVvVA~SGGlDSSvll~~L~e~----G~eViavtvd~G 45 (455)
T 1k92_A 9 VGQRIGIAFSGGLDTSAALLWMRQK----GAVPYAYTANLG 45 (455)
T ss_dssp TTSEEEEECCSSHHHHHHHHHHHHT----TCEEEEEEEECC
T ss_pred CCCeEEEEEcChHHHHHHHHHHHHc----CCEEEEEEEEcC
Confidence 3568999999999999999999763 889999999764
|
| >2nz2_A Argininosuccinate synthase; amino-acid biosynthesis, aspartate, citrulline, ST genomics, structural genomics consortium, SGC, ligase; HET: CIR; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.67 E-value=2.7 Score=44.62 Aligned_cols=88 Identities=19% Similarity=0.134 Sum_probs=59.7
Q ss_pred CCEEEEEeCCCHhHHHHHHHHHHHccCCCCEEEEEEEeeCCCcccCCCchhHHHHHHHHHHHHHHHHhhhhhcCCc-EEE
Q 007254 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVD-LKL 94 (611)
Q Consensus 16 ~~~IlVaVD~s~~S~~AL~WAl~~~~~~g~~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~C~~k~V~-~~~ 94 (611)
+.+|+||+-|-..|--++.|+.+. |..|+++|+..... . . +...+.+|..-|+. +..
T Consensus 5 ~~kVvvalSGGlDSsvll~lL~e~----G~eV~av~vd~g~~----~---e-----------~e~a~~~A~~lGi~~~~v 62 (413)
T 2nz2_A 5 KGSVVLAYSGGLDTSCILVWLKEQ----GYDVIAYLANIGQK----E---D-----------FEEARKKALKLGAKKVFI 62 (413)
T ss_dssp CEEEEEECCSSHHHHHHHHHHHHT----TEEEEEEEEESSCC----C---C-----------HHHHHHHHHHHTCSEEEE
T ss_pred CCeEEEEEcChHHHHHHHHHHHHc----CCEEEEEEEECCcH----H---H-----------HHHHHHHHHHhCCCEEEE
Confidence 468999999999999999998763 78999999975421 0 0 12333344444443 322
Q ss_pred EEE------------------------ECCc-----hhHHHHHHHHhcCCCEEEEccCCC
Q 007254 95 KIC------------------------RGTS-----IRKILVREAQSYSATKFIVGTAKN 125 (611)
Q Consensus 95 ~v~------------------------~g~~-----~~~~Iv~~a~~~~ad~LVlG~~g~ 125 (611)
+-+ .+.. +.+.++++|++.+++.|+.|.++.
T Consensus 63 vd~~~ef~~~~~~~~i~~~a~~e~~y~~g~~~aRp~i~~~l~~~A~~~Ga~~IatGh~~~ 122 (413)
T 2nz2_A 63 EDVSREFVEEFIWPAIQSSALYEDRYLLGTSLARPCIARKQVEIAQREGAKYVSHGATGK 122 (413)
T ss_dssp EECHHHHHHHTHHHHHHTTCCBTTTBCCTTTTHHHHHHHHHHHHHHHHTCSEEECCCCTT
T ss_pred EeChHHHHHHHHHHHHHhCcccccccccccccchHHHHHHHHHHHHHcCCCEEEECCcCc
Confidence 211 1111 247888999999999999999975
|
| >3bl5_A Queuosine biosynthesis protein QUEC; PREQ1 biosynthesis, RNA modification, tRNA, hydrolase; 2.95A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=81.94 E-value=6.5 Score=37.05 Aligned_cols=36 Identities=22% Similarity=0.207 Sum_probs=29.5
Q ss_pred CCEEEEEeCCCHhHHHHHHHHHHHccCCCCEEEEEEEeeC
Q 007254 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLAN 55 (611)
Q Consensus 16 ~~~IlVaVD~s~~S~~AL~WAl~~~~~~g~~vvlvHV~~~ 55 (611)
..+|+|++-|-..|--++.|+.+. |..|+++|+...
T Consensus 3 ~~~v~v~lSGG~DS~~ll~ll~~~----~~~v~~~~~~~~ 38 (219)
T 3bl5_A 3 KEKAIVVFSGGQDSTTCLLWALKE----FEEVETVTFHYN 38 (219)
T ss_dssp CCEEEEECCSSHHHHHHHHHHHHH----CSEEEEEEEESS
T ss_pred CCCEEEEccCcHHHHHHHHHHHHc----CCceEEEEEeCC
Confidence 357999999999999888887664 478999999753
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=81.64 E-value=3.1 Score=40.17 Aligned_cols=89 Identities=11% Similarity=0.063 Sum_probs=64.8
Q ss_pred cCCCCeeeEEEEEEeCCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHH-HHHcCCCCCeEecCCCC
Q 007254 474 LHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE-YLHSGSAQRVIHRDVKS 552 (611)
Q Consensus 474 l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~-yLH~~~~~~IvHrDLKp 552 (611)
..||++ -..+-.+.+.+.|.|+.-+++.=...+. .++..++++++..|+.... +++. -+|--|.|
T Consensus 47 ~~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P 112 (219)
T 4ano_A 47 EVDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCP 112 (219)
T ss_dssp GSCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCG
T ss_pred ccCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeC
Confidence 367887 3344467788888888764543333443 2667889999988887666 5543 67889999
Q ss_pred CCEEEcCCCcEEEEeeccccccCC
Q 007254 553 SNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 553 ~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
+||+++.++.++|.-.|+-..+++
T Consensus 113 ~NL~f~~~~~p~i~hRGi~~~lpP 136 (219)
T 4ano_A 113 ENLMFNRALEPFFLHVGVKESLPP 136 (219)
T ss_dssp GGEEECTTCCEEESCCEETTTBSS
T ss_pred ceEEEeCCCcEEEEEcCCcccCCC
Confidence 999999999999999997665554
|
| >1kor_A Argininosuccinate synthetase; ligase, riken structural genomics/proteomics initiative, RSGI, structural genomics; HET: ANP ARG; 1.95A {Thermus thermophilus} SCOP: c.26.2.1 d.210.1.1 PDB: 1j1z_A* 1j21_A* 1kh1_A 1kh2_A* 1kh3_A* 1j20_A* | Back alignment and structure |
|---|
Probab=80.26 E-value=4.6 Score=42.60 Aligned_cols=88 Identities=19% Similarity=0.132 Sum_probs=59.0
Q ss_pred CEEEEEeCCCHhHHHHHHHHHHHccCCCCEEEEEEEeeCCCcccCCCchhHHHHHHHHHHHHHHHHhhhhhcCC-cEEEE
Q 007254 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQV-DLKLK 95 (611)
Q Consensus 17 ~~IlVaVD~s~~S~~AL~WAl~~~~~~g~~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~C~~k~V-~~~~~ 95 (611)
.+|+||+-|-..|--+|.|+.+.. |..|+++||-.... +-+...+.+|..-|+ ++..+
T Consensus 1 ~kVvva~SGG~DSsvll~ll~~~~---g~~V~av~vd~g~~------------------~e~e~a~~~A~~lGi~~~~vv 59 (400)
T 1kor_A 1 MKIVLAYSGGLDTSIILKWLKETY---RAEVIAFTADIGQG------------------EEVEEAREKALRTGASKAIAL 59 (400)
T ss_dssp CEEEEECCSSHHHHHHHHHHHHHH---TCEEEEEEEESSCS------------------SCHHHHHHHHHHHTCSEEEEE
T ss_pred CcEEEEEeChHHHHHHHHHHHHhh---CCcEEEEEEeCCCH------------------HHHHHHHHHHHHhCCCeEEEE
Confidence 379999999999999999987653 67899999975420 002223334444455 33322
Q ss_pred EEE------------------------CCc-----hhHHHHHHHHhcCCCEEEEccCCC
Q 007254 96 ICR------------------------GTS-----IRKILVREAQSYSATKFIVGTAKN 125 (611)
Q Consensus 96 v~~------------------------g~~-----~~~~Iv~~a~~~~ad~LVlG~~g~ 125 (611)
-+. |.. ..+.++++|++.+++.|+.|.++.
T Consensus 60 d~~~ef~~~~~~~~i~~~~~~e~~y~~g~~~~R~~~~~~L~~~A~~~G~~~IatG~~~d 118 (400)
T 1kor_A 60 DLKEEFVRDFVFPMMRAGAVYEGYYLLGTSIARPLIAKHLVRIAEEEGAEAIAHGATGK 118 (400)
T ss_dssp ECHHHHHHHTHHHHHHTTCCBTTTBCCTTTTHHHHHHHHHHHHHHHHTCSEEECCCCTT
T ss_pred eCcHHHHHHhhHHHHHcCCccccccccCCccchHHHHHHHHHHHHHcCCCEEEECCCCC
Confidence 111 111 135789999999999999999986
|
| >2pg3_A Queuosine biosynthesis protein QUEC; YP_049261.1, hypothetical protein, structural genomics, JOIN for structural genomics; 2.40A {Pectobacterium atrosepticum SCRI1043} SCOP: c.26.2.1 | Back alignment and structure |
|---|
Probab=80.17 E-value=7.4 Score=37.31 Aligned_cols=34 Identities=24% Similarity=0.078 Sum_probs=29.0
Q ss_pred CEEEEEeCCCHhHHHHHHHHHHHccCCCCEEEEEEEee
Q 007254 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLA 54 (611)
Q Consensus 17 ~~IlVaVD~s~~S~~AL~WAl~~~~~~g~~vvlvHV~~ 54 (611)
.+|+|++-|-..|--++.|+.+. +..|++||+..
T Consensus 3 ~kvvv~lSGG~DS~~~l~ll~~~----~~~v~av~~~~ 36 (232)
T 2pg3_A 3 KRAVVVFSGGQDSTTCLIQALQD----YDDVHCITFDY 36 (232)
T ss_dssp CEEEEECCSSHHHHHHHHHHHHH----CSEEEEEEEES
T ss_pred CCEEEEecCcHHHHHHHHHHHHc----CCCEEEEEEEC
Confidence 57999999999999999888775 46899999864
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 611 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-43 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-43 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-42 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-40 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-40 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-40 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-40 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-40 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-39 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-39 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-39 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-39 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 8e-39 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-39 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-38 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-38 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-38 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-37 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-37 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-37 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-36 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-36 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-35 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-35 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-35 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-34 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-34 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-33 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-33 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-33 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-33 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-32 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-32 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-32 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-32 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-31 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-31 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-31 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-31 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-30 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-30 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-30 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-30 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-29 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-29 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-29 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-29 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-28 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-28 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-27 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-27 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-26 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-26 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-26 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-26 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-26 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-26 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-25 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-24 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-22 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-21 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-20 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-19 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 1e-43
Identities = 48/175 (27%), Positives = 82/175 (46%), Gaps = 12/175 (6%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILK---PSEDVIKEFVLEIEIITTLHHKN 478
IG G VYKG ++AVK+L P+ ++ F E+ ++ H N
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
I+ +G+ L +V + SL +LH + F + +A A+ ++YLH
Sbjct: 66 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLH 121
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYV 593
+ + +IHRD+KS+NI L +D ++ DFGLA S S ++G+ ++
Sbjct: 122 A---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 2e-43
Identities = 35/172 (20%), Positives = 72/172 (41%), Gaps = 7/172 (4%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 481
+G G +V+ G ++AVK LK F+ E ++ L H+ ++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
L + ++ +++ GSL + L ++ +A +AE + ++
Sbjct: 73 LYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEE-- 127
Query: 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYV 593
+ IHRD++++NIL+SD +++DFGLA+ + +
Sbjct: 128 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWT 177
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 2e-42
Identities = 41/177 (23%), Positives = 78/177 (44%), Gaps = 13/177 (7%)
Query: 420 ATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPS--EDVIKEFVLEIEIITTLHH 476
+F + +G G V+K P G +A K++ + + + E++++ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 477 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
I+ G + D + + + + GSL++ L + KV++ V + L Y
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTY 119
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYV 593
L +++HRDVK SNIL++ E +L DFG++ S + GT Y+
Sbjct: 120 LR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYM 170
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (368), Expect = 2e-40
Identities = 37/171 (21%), Positives = 78/171 (45%), Gaps = 7/171 (4%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 481
+ +G G V G ++A+K++K EF+ E +++ L H+ ++
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
L G C + + ++ ++++ G L L + F + ++ V EA+EYL S
Sbjct: 64 LYGVCTKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLES-- 118
Query: 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 592
++ +HRD+ + N L++D ++SDFGL+++ + +
Sbjct: 119 -KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRW 167
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (368), Expect = 2e-40
Identities = 39/171 (22%), Positives = 73/171 (42%), Gaps = 7/171 (4%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 481
S IG G V+ G + ++A+K ++ ++F+ E E++ L H ++
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
L G C E + LV++F+ G L + L F + + V E + YL
Sbjct: 65 LYGVCLEQAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEE-- 119
Query: 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 592
VIHRD+ + N L+ ++ ++SDFG+ ++ + +
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFPVKW 168
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 146 bits (370), Expect = 3e-40
Identities = 50/195 (25%), Positives = 87/195 (44%), Gaps = 21/195 (10%)
Query: 412 FNYQDLLSATSNFLAE---------NLIGKGGSSQVYKGCLPDGKEL----AVKILKP-- 456
F ++D A F E +IG G +V G L + A+K LK
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 457 SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPA 516
+E ++F+ E I+ H N+I L G + ++++ +F+ GSL+ L N
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ-- 124
Query: 517 AFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576
F + + G+A ++YL +HRD+ + NIL++ + ++SDFGL+++
Sbjct: 125 -FTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 577 SSSHITCTDVAGTFG 591
+S T T G
Sbjct: 181 DTSDPTYTSALGGKI 195
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 147 bits (371), Expect = 3e-40
Identities = 44/171 (25%), Positives = 73/171 (42%), Gaps = 18/171 (10%)
Query: 428 NLIGKGGSSQVYKG-CLPDGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISL 482
IG G VY + + + +A+K + S + ++ + E+ + L H N I
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
G ++ LV ++ + + K E V G + L YLHS
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAVTHGALQGLAYLHS--- 133
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYV 593
+IHRDVK+ NILLS+ +L DFG A + ++S + GT ++
Sbjct: 134 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPYWM 178
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 6e-40
Identities = 36/171 (21%), Positives = 78/171 (45%), Gaps = 7/171 (4%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 481
+ E +G+G +V+ G +A+K LKP + F+ E +++ L H+ ++
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
L + + +V +++S+GSL + L G + +A +A + Y+
Sbjct: 77 LYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVER-- 131
Query: 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 592
+HRD++++NIL+ ++ +++DFGLA+ + +
Sbjct: 132 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKW 180
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 1e-39
Identities = 44/185 (23%), Positives = 84/185 (45%), Gaps = 14/185 (7%)
Query: 415 QDLLSATSNFLAENL-IGKGGSSQVYKGCL---PDGKELAVKILKP--SEDVIKEFVLEI 468
+ L N L ++ +G G V +G ++A+K+LK + +E + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 469 EIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM 528
+I+ L + I+ L+G C + L+LV + G L + L G +++ S ++
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLH 116
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD-VA 587
V+ ++YL + +HRD+ + N+LL + ++SDFGL+K S+ T
Sbjct: 117 QVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 588 GTFGY 592
+
Sbjct: 174 WPLKW 178
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 2e-39
Identities = 44/167 (26%), Positives = 86/167 (51%), Gaps = 10/167 (5%)
Query: 428 NLIGKGGSSQVYKG-CLPDGKELAVKILKP-SEDVIKEFVLEIEIITTLHHKNIISLLGF 485
+G G +VYK A K++ SE+ ++++++EI+I+ + H NI+ LL
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
+ +NNL ++ +F + G+++ + ++ S+ V +AL YLH ++
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLHD---NKI 131
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 592
IHRD+K+ NIL + D + +L+DFG++ + + GT +
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR--RDSFIGTPYW 176
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 3e-39
Identities = 43/194 (22%), Positives = 82/194 (42%), Gaps = 26/194 (13%)
Query: 422 SNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPSEDV--IKEFVLEIEIITT 473
+ +G G +V + +AVK+LKPS + + + E+++++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 474 L-HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK--------------DPAAF 518
L +H NI++LLG C L++ ++ G L L + D A
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 519 GWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578
+ + VA+ + +L S + IHRD+ + NILL+ ++ DFGLA+ S
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 579 SHITCTDVAGTFGY 592
+++ + +
Sbjct: 200 NYVVKGNARLPVKW 213
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 4e-39
Identities = 51/177 (28%), Positives = 78/177 (44%), Gaps = 16/177 (9%)
Query: 422 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPS----EDVIKEFVLEIEIITTLHH 476
+F +GKG VY LA+K+L + V + E+EI + L H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 477 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
NI+ L G+ + + L+ ++ G++ L K F +A AL Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSY 121
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYV 593
HS +RVIHRD+K N+LL E +++DFG + A +S C GT Y+
Sbjct: 122 CHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYL 171
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 8e-39
Identities = 41/199 (20%), Positives = 84/199 (42%), Gaps = 31/199 (15%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPD------GKELAVKILKPSED--VIKEFVLEIEIITT 473
N ++G G +V ++AVK+LK D + + E++++T
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 474 L-HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK------------------- 513
L H+NI++LLG C + L++++ G L L ++
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 514 DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573
D + + A VA+ +E+L + +HRD+ + N+L++ ++ DFGLA+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 574 ASTSSSHITCTDVAGTFGY 592
+ S+++ + +
Sbjct: 214 IMSDSNYVVRGNARLPVKW 232
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 9e-39
Identities = 45/183 (24%), Positives = 73/183 (39%), Gaps = 10/183 (5%)
Query: 419 SATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKP---SEDVIKEFVLEIEIITTL 474
S ++ IG G + K DGK L K L +E + V E+ ++ L
Sbjct: 1 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60
Query: 475 HHKNIISLLGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE 532
H NI+ + + L +V ++ G L + K+ +V +
Sbjct: 61 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 533 ALEYLHSGS--AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 590
AL+ H S V+HRD+K +N+ L +L DFGLA+ + +S GT
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKAFVGTP 178
Query: 591 GYV 593
Y+
Sbjct: 179 YYM 181
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (355), Expect = 2e-38
Identities = 41/174 (23%), Positives = 73/174 (41%), Gaps = 10/174 (5%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNI 479
++ +G+G +V + +AVKI+ + D + EI I L+H+N+
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 480 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 539
+ G E N L ++ S G L + + + + + + + YLH
Sbjct: 66 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQLMAGVVYLHG 121
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYV 593
+ HRD+K N+LL + ++SDFGLA ++ + GT YV
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 2e-38
Identities = 50/164 (30%), Positives = 83/164 (50%), Gaps = 8/164 (4%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 481
IGKG V G G ++AVK +K ++ + F+ E ++T L H N++
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIK-NDATAQAFLAEASVMTQLRHSNLVQ 64
Query: 482 LLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
LLG E+ L +V +++++GSL + L + G K ++ V EA+EYL
Sbjct: 65 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEG- 121
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 584
+HRD+ + N+L+S+D ++SDFGL K AS++
Sbjct: 122 --NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP 163
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 6e-38
Identities = 52/178 (29%), Positives = 79/178 (44%), Gaps = 17/178 (9%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
+ IGKG +V++G G+E+AVKI E+ EI L H+NI+ +
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 487 FEDNN----LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS--- 539
+DN L LV D+ GSL + L+ K+A+ A L +LH
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT-----VEGMIKLALSTASGLAHLHMEIV 121
Query: 540 --GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW--ASTSSSHITCTDVAGTFGYV 593
+ HRD+KS NIL+ + ++D GLA ++T + I GT Y+
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (350), Expect = 1e-37
Identities = 40/181 (22%), Positives = 83/181 (45%), Gaps = 7/181 (3%)
Query: 413 NYQDLLSATSNFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFVLEIEII 471
NY ++ ++ +G G +VY+G +AVK LK ++EF+ E ++
Sbjct: 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 67
Query: 472 TTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVA 531
+ H N++ LLG C + ++ +F++ G+L + L + +A ++
Sbjct: 68 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQIS 125
Query: 532 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG 591
A+EYL + IHRD+ + N L+ ++ +++DFGL++ + +
Sbjct: 126 SAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIK 181
Query: 592 Y 592
+
Sbjct: 182 W 182
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 138 bits (349), Expect = 2e-37
Identities = 43/199 (21%), Positives = 85/199 (42%), Gaps = 31/199 (15%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKP--SEDVIKEFVLEIEIITT 473
+N IG+G +V++ P +AVK+LK S D+ +F E ++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 474 LHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD------------------- 514
+ NI+ LLG C + L++++++ G L E L
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 515 -PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573
P +E+ +A VA + YL ++ +HRD+ + N L+ ++ +++DFGL++
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 574 ASTSSSHITCTDVAGTFGY 592
++ + + A +
Sbjct: 190 IYSADYYKADGNDAIPIRW 208
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 4e-37
Identities = 41/176 (23%), Positives = 72/176 (40%), Gaps = 15/176 (8%)
Query: 425 LAENLIGKGGSSQVYKGCLPD---GKELAVKILKP---SEDVIKEFVLEIEIITTLHHKN 478
L + +G G V KG K +AVKILK + E + E ++ L +
Sbjct: 10 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 69
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
I+ ++G C E + +LV + G L + L N+ ++ V+ ++YL
Sbjct: 70 IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLE 124
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD-VAGTFGYV 593
+HRD+ + N+LL ++SDFGL+K ++ +
Sbjct: 125 E---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 177
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 1e-36
Identities = 48/175 (27%), Positives = 75/175 (42%), Gaps = 12/175 (6%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKP----SEDVIKEFVLEIEIITTLHHK 477
+F ++G+G S V L +E A+KIL+ E+ + E ++++ L H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 478 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
+ L +D L + G L + + F + + ALEYL
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEYL 124
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 592
H + +IHRD+K NILL++D Q++DFG AK S S GT Y
Sbjct: 125 HG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 176
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (337), Expect = 9e-36
Identities = 49/167 (29%), Positives = 82/167 (49%), Gaps = 12/167 (7%)
Query: 428 NLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGF 485
IG+G S VY + G+E+A++ + + KE ++ EI ++ + NI++ L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
+ L +V ++L+ GSL + + D + V +ALE+LHS +V
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCMD-----EGQIAAVCRECLQALEFLHS---NQV 137
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 592
IHRD+KS NILL D +L+DFG + S + + GT +
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYW 182
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 4e-35
Identities = 45/189 (23%), Positives = 84/189 (44%), Gaps = 24/189 (12%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPDGKEL---AVKILKP--SEDVIKEFVLEIEIITTL-H 475
++ +++IG+G QV K + A+K +K S+D ++F E+E++ L H
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 476 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGN------------KKDPAAFGWSER 523
H NII+LLG C L L ++ G+L + L + + +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 524 YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 583
A VA ++YL ++ IHRD+ + NIL+ +++ +++DFGL++
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 186
Query: 584 TDVAGTFGY 592
+
Sbjct: 187 R---LPVRW 192
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 5e-35
Identities = 41/176 (23%), Positives = 73/176 (41%), Gaps = 18/176 (10%)
Query: 427 ENLIGKGGSSQVYKG-CLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISL 482
+ IG+G VYKG E+A L+ ++ + F E E++ L H NI+
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 483 LGFCFE----DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
++LV + ++ G+L+ L K + + L++LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLH 129
Query: 539 SGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYV 593
+ + +IHRD+K NI ++ ++ D GLA S + V GT ++
Sbjct: 130 TRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA----KAVIGTPEFM 180
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 133 bits (335), Expect = 7e-35
Identities = 43/178 (24%), Positives = 77/178 (43%), Gaps = 19/178 (10%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPS-------EDVIKEFVLEIEIITTL 474
+F +IG+GG +VY GK A+K L E + + + +++T
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 475 HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL 534
I+ + + L + D ++ G L +L + ++ A + L
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS----EADMRFYAAEIILGL 120
Query: 535 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 592
E++H+ + V++RD+K +NILL + ++SD GLA S H + GT GY
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGY 171
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 131 bits (330), Expect = 3e-34
Identities = 37/166 (22%), Positives = 67/166 (40%), Gaps = 10/166 (6%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL-KPSEDVIKEFVLEIEIITTLHHKNII 480
++ +G G V++ G A K + P E + EI+ ++ L H ++
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
+L +DN ++++Y+F+S G L E + E + V + L ++H
Sbjct: 87 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHE- 142
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQ--LSDFGLAKWASTSSSHITCT 584
+H D+K NI+ + + L DFGL S T
Sbjct: 143 --NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT 186
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (326), Expect = 3e-34
Identities = 43/193 (22%), Positives = 80/193 (41%), Gaps = 25/193 (12%)
Query: 422 SNFLAENLIGKGGSSQVYKGC------LPDGKELAVKILKPS--EDVIKEFVLEIEIIT- 472
+G+G QV + + +AVK+LK + + E++I+
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 473 TLHHKNIISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPA------------AFG 519
HH N+++LLG C + L+++ +F G+L L + +
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 520 WSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579
+ VA+ +E+L S ++ IHRD+ + NILLS+ ++ DFGLA+
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 580 HITCTDVAGTFGY 592
++ D +
Sbjct: 190 YVRKGDARLPLKW 202
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 1e-33
Identities = 39/172 (22%), Positives = 79/172 (45%), Gaps = 14/172 (8%)
Query: 428 NLIGKGGSSQVYKG-CLPDGKEL----AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 480
++G G VYKG +P+G+++ A+K L+ S KE + E ++ ++ + ++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
LLG C + + L+ + G L + + +K + G + +A+ + YL
Sbjct: 75 RLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED- 129
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 592
+R++HRD+ + N+L+ +++DFGLAK +
Sbjct: 130 --RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 4e-33
Identities = 45/172 (26%), Positives = 77/172 (44%), Gaps = 16/172 (9%)
Query: 430 IGKGGSSQVYKGCLP----DGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIIS 481
+G G V +G +AVK LKP + + +F+ E+ + +L H+N+I
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
L G + +V + GSL + L ++ F + A+ VAE + YL S
Sbjct: 76 LYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGYLES-- 129
Query: 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD-VAGTFGY 592
+R IHRD+ + N+LL+ ++ DFGL + + H + F +
Sbjct: 130 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 5e-33
Identities = 41/179 (22%), Positives = 79/179 (44%), Gaps = 14/179 (7%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPDGKE-----LAVKILKP--SEDVIKEFVLEIEIITTL 474
S + +IG G +VYKG L +A+K LK +E +F+ E I+
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 475 HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL 534
H NII L G + ++++ +++ G+ ++ F + + G+A +
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGA---LDKFLREKDGEFSVLQLVGMLRGIAAGM 123
Query: 535 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI-TCTDVAGTFGY 592
+YL + +HRD+ + NIL++ + ++SDFGL++ T + +
Sbjct: 124 KYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 6e-33
Identities = 46/179 (25%), Positives = 81/179 (45%), Gaps = 17/179 (9%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGK----ELAVKILKPSEDV--IKEFVLEIEIITTLHH 476
+F +IG+G VY G L D AVK L D+ + +F+ E I+ H
Sbjct: 30 HF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 477 KNIISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 535
N++SLLG C + + L+V ++ G L + +P + + VA+ ++
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPT---VKDLIGFGLQVAKGMK 144
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS--SHITCTDVAGTFGY 592
+L S ++ +HRD+ + N +L + F +++DFGLA+ S T +
Sbjct: 145 FLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 200
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 126 bits (318), Expect = 1e-32
Identities = 37/168 (22%), Positives = 64/168 (38%), Gaps = 13/168 (7%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFC 486
+G G V++ G+ K + + K V EI I+ LHH +I+L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
+ ++L+ +FLS G L + + +E E L+++H ++
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDY---KMSEAEVINYMRQACEGLKHMHE---HSIV 149
Query: 547 HRDVKSSNILLSDDFEPQ--LSDFGLAKWASTSSSHITCTDVAGTFGY 592
H D+K NI+ + DFGLA + T T +
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEF 194
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 123 bits (310), Expect = 3e-32
Identities = 49/182 (26%), Positives = 81/182 (44%), Gaps = 22/182 (12%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPS----------EDVIKEFVLEIEII 471
N+ + ++G+G SS V + P KE AVKI+ + +++ + + E++I+
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 472 TTLH-HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGV 530
+ H NII L + LV+D + +G L + L E K+ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMRAL 119
Query: 531 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 590
E + LH ++HRD+K NILL DD +L+DFG + +V GT
Sbjct: 120 LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTP 173
Query: 591 GY 592
Y
Sbjct: 174 SY 175
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 4e-32
Identities = 38/172 (22%), Positives = 78/172 (45%), Gaps = 14/172 (8%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKE----LAVKILKP--SEDVIKEFVLEIEIITTLHHKNII 480
IG+G V++G + +A+K K S+ V ++F+ E + H +I+
Sbjct: 12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
L+G +N + ++ + + G L + + + A ++ AL YL S
Sbjct: 72 KLIGVI-TENPVWIIMELCTLGEL---RSFLQVRKYSLDLASLILYAYQLSTALAYLES- 126
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 592
+R +HRD+ + N+L+S + +L DFGL+++ S+ + + +
Sbjct: 127 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKW 175
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 5e-32
Identities = 34/185 (18%), Positives = 78/185 (42%), Gaps = 17/185 (9%)
Query: 422 SNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKP--SEDVIKEFVLEIEIITT 473
+G+G VY+G +A+K + S EF+ E ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 474 LHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFG------WSERYKVA 527
+ +++ LLG + L++ + ++RG L+ L + A S+ ++A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 528 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 587
+A+ + YL++ + +HRD+ + N ++++DF ++ DFG+ + + +
Sbjct: 140 GEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 588 GTFGY 592
+
Sbjct: 197 LPVRW 201
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 1e-31
Identities = 41/176 (23%), Positives = 76/176 (43%), Gaps = 15/176 (8%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPS----EDVIKEFVLEIEIIT-TLHH 476
+F+ ++GKG +V+ + A+K LK +D ++ ++E +++ H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 477 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
+ + NL V ++L+ G L ++ K F S A + L++
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQF 118
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 592
LHS + +++RD+K NILL D +++DFG+ K GT Y
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNTFCGTPDY 169
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 120 bits (301), Expect = 5e-31
Identities = 41/177 (23%), Positives = 78/177 (44%), Gaps = 17/177 (9%)
Query: 427 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIIS 481
++G GG S+V+ L +++AVK+L+ F E + L+H I++
Sbjct: 12 GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 71
Query: 482 LLGFCFEDNN----LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
+ + +V +++ +L + +H +V +AL +
Sbjct: 72 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALNFS 127
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT-CTDVAGTFGYV 593
H +IHRDVK +NI++S ++ DFG+A+ + S + +T V GT Y+
Sbjct: 128 HQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (303), Expect = 8e-31
Identities = 33/167 (19%), Positives = 62/167 (37%), Gaps = 12/167 (7%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCF 487
+G+G V++ K K +K EI I+ H+NI+ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 547
L+++++F+S + E ++ + + E V EAL++LHS + H
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFE---LNEREIVSYVHQVCEALQFLHS---HNIGH 125
Query: 548 RDVKSSNILLSDDFEPQ--LSDFGLAKWASTSSSHITCTDVAGTFGY 592
D++ NI+ + +FG A+ + Y
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---TAPEY 169
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 8e-31
Identities = 47/173 (27%), Positives = 79/173 (45%), Gaps = 16/173 (9%)
Query: 428 NLIGKGGSSQVYKG-CLPDGKELAVKILKPS------EDVIKEFVLEIEIITTLHHKNII 480
+ +G+G + VYK + +A+K +K + + + + EI+++ L H NII
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
LL +N+ LV+DF+ + S + + LEYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV----LTPSHIKAYMLMTLQGLEYLHQ- 118
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYV 593
++HRD+K +N+LL ++ +L+DFGLAK S S + T T Y
Sbjct: 119 --HWILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRAYTHQVVTRWYR 167
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 1e-30
Identities = 40/180 (22%), Positives = 68/180 (37%), Gaps = 16/180 (8%)
Query: 421 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSED--VIKEFVLEIEIITTLHHK 477
+ + IG+G V + +A+K + P E + + EI+I+ H+
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 478 NIISLLGFC----FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 533
NII + E + + L L + L +
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-----LSNDHICYFLYQILRG 121
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK-WASTSSSHITCTDVAGTFGY 592
L+Y+HS V+HRD+K SN+LL+ + ++ DFGLA+ T+ T Y
Sbjct: 122 LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 1e-30
Identities = 48/194 (24%), Positives = 88/194 (45%), Gaps = 26/194 (13%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLP--------DGKELAVKILKP--SEDVIKEFVLEIEII 471
+ +G+G QV ++AVK+LK +E + + + E+E++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 472 TTL-HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAA------------F 518
+ HKNII+LLG C +D L ++ ++ S+G+L E L +
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 519 GWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578
+ A VA +EYL S ++ IHRD+ + N+L+++D +++DFGLA+
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 579 SHITCTDVAGTFGY 592
+ T+ +
Sbjct: 190 YYKKTTNGRLPVKW 203
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 119 bits (300), Expect = 1e-30
Identities = 43/173 (24%), Positives = 76/173 (43%), Gaps = 16/173 (9%)
Query: 427 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLL 483
+++G G S+V K +A+K + E EI ++ + H NI++L
Sbjct: 14 RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALD 73
Query: 484 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
+L L+ +S G L + + + + ++ V +A++YLH
Sbjct: 74 DIYESGGHLYLIMQLVSGGELFDRIVEKGF----YTERDASRLIFQVLDAVKYLHD---L 126
Query: 544 RVIHRDVKSSNILLS---DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYV 593
++HRD+K N+L +D + +SDFGL+K S + GT GYV
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYV 176
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 118 bits (297), Expect = 2e-30
Identities = 39/173 (22%), Positives = 71/173 (41%), Gaps = 11/173 (6%)
Query: 428 NLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLG 484
IG+G VYK G+ A+K ++ E + + EI I+ L H NI+ L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 544
L+LV++ L + + + + + Y H +R
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGG----LESVTAKSFLLQLLNGIAYCHD---RR 120
Query: 545 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLIL 597
V+HRD+K N+L++ + E +++DFGLA+ ++ + +L
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK-YTHEIVTLWYRAPDVL 172
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 117 bits (294), Expect = 1e-29
Identities = 44/176 (25%), Positives = 78/176 (44%), Gaps = 17/176 (9%)
Query: 422 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPS----EDVIKEFVLEIEIITTLHH 476
+F +G G +V+ +G+ A+K+LK ++ E +++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 477 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
II + G + + ++ D++ G L L +++ P A V ALEY
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP----NPVAKFYAAEVCLALEY 119
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 592
LHS + +I+RD+K NILL + +++DFG AK+ + GT Y
Sbjct: 120 LHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDY 167
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 4e-29
Identities = 39/169 (23%), Positives = 68/169 (40%), Gaps = 15/169 (8%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 481
++ +IG G VY+ G+ +A+K + + E++I+ L H NI+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKLDHCNIVR 77
Query: 482 LLGFCFE------DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 535
L F + + L LV D++ H ++ + +L
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ-TLPVIYVKLYMYQLFRSLA 136
Query: 536 YLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITC 583
Y+HS + HRD+K N+LL D +L DFG AK +++
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 182
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 5e-29
Identities = 48/186 (25%), Positives = 86/186 (46%), Gaps = 21/186 (11%)
Query: 422 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHK 477
S + IG+G +V+K G+++A+K + E + EI+I+ L H+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 478 NIISLLGFCFE--------DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG 529
N+++L+ C ++ LV+DF + K F SE +V
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQM 125
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS--SSHITCTDVA 587
+ L Y+H +++HRD+K++N+L++ D +L+DFGLA+ S + S T+
Sbjct: 126 LLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 588 GTFGYV 593
T Y
Sbjct: 183 VTLWYR 188
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (290), Expect = 5e-29
Identities = 37/172 (21%), Positives = 68/172 (39%), Gaps = 13/172 (7%)
Query: 427 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
++G G + +V + ++ A+K+L+ +E L +I+ ++
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRA---SQCPHIVRIVDV 73
Query: 486 C----FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
LL+V + L G L + F E ++ + EA++YLHS
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA--FTEREASEIMKSIGEAIQYLHS-- 129
Query: 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYV 593
+ HRDVK N+L + + +A ++SH + T T YV
Sbjct: 130 -INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYV 180
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 1e-28
Identities = 45/166 (27%), Positives = 74/166 (44%), Gaps = 10/166 (6%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKN 478
NF IG+G VYK G+ +A+K ++ +E V + EI ++ L+H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
I+ LL +N L LV++FL + + + + L + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG---IPLPLIKSYLFQLLQGLAFCH 119
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 584
S RV+HRD+K N+L++ + +L+DFGLA+ T
Sbjct: 120 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE 162
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 113 bits (282), Expect = 2e-28
Identities = 41/175 (23%), Positives = 71/175 (40%), Gaps = 16/175 (9%)
Query: 427 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
IG G +Y G + G+E+A+K+ + +E +I + I + +
Sbjct: 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRW 70
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
C + + ++ L SLE+ + + F +A + +EY+HS +
Sbjct: 71 CGAEGDYNVMVMELLGPSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYIHS---KNF 124
Query: 546 IHRDVKSSNILLSD---DFEPQLSDFGLAKWASTSSSHITC-----TDVAGTFGY 592
IHRDVK N L+ + DFGLAK + +H ++ GT Y
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 6e-27
Identities = 44/176 (25%), Positives = 77/176 (43%), Gaps = 14/176 (7%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKP----SEDVIKEFVLEIEIITTLHHK 477
+F L+GKG +V G+ A+KIL+ ++D + V E ++ H
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 478 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
+ +L + L V ++ + G L +L + F + ALEYL
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV----FTEERARFYGAEIVSALEYL 121
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYV 593
HS + V++RD+K N++L D +++DFGL K + + + GT Y+
Sbjct: 122 HS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYL 172
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 6e-27
Identities = 39/159 (24%), Positives = 65/159 (40%), Gaps = 7/159 (4%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLG 484
+G G V G ++A+K L SE K E+ ++ + H+N+I LL
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 544
D L DF G G + + + L Y+H+
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA---AG 141
Query: 545 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 583
+IHRD+K N+ +++D E ++ DFGLA+ A + +
Sbjct: 142 IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVV 180
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 107 bits (269), Expect = 1e-26
Identities = 31/182 (17%), Positives = 69/182 (37%), Gaps = 18/182 (9%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 481
++ IG+G +++G L + +++A+K D + E L I
Sbjct: 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-PQLRDEYRTYKLLAGCTGIP 64
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
+ + ++ ++ L SLE+ L + F A + ++ +H
Sbjct: 65 NVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK---FSVKTVAMAAKQMLARVQSIHE-- 119
Query: 542 AQRVIHRDVKSSNILLSDDFEPQ-----LSDFGLAKWASTSSSH-----ITCTDVAGTFG 591
+ +++RD+K N L+ + DFG+ K+ + +++GT
Sbjct: 120 -KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178
Query: 592 YV 593
Y+
Sbjct: 179 YM 180
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 108 bits (271), Expect = 2e-26
Identities = 36/149 (24%), Positives = 65/149 (43%), Gaps = 12/149 (8%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLG 484
+G G +V G A+KIL I+ + E I+ ++ ++ L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 544
+++NL +V ++++ G + +L + F A + EYLHS
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHS---LD 161
Query: 545 VIHRDVKSSNILLSDDFEPQLSDFGLAKW 573
+I+RD+K N+L+ Q++DFG AK
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 3e-26
Identities = 38/175 (21%), Positives = 67/175 (38%), Gaps = 21/175 (12%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILKPSE-------DVIKEFVLEIEIITTLH--HKN 478
L+G GG VY G + D +A+K ++ +E+ ++ +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
+I LL + ++ +L+ + + + A V EA+ + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCH 127
Query: 539 SGSAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 592
+ V+HRD+K NIL+ + E +L DFG + TD GT Y
Sbjct: 128 N---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVY 175
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 3e-26
Identities = 39/160 (24%), Positives = 69/160 (43%), Gaps = 11/160 (6%)
Query: 428 NLIGKGGSSQVYKG-CLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLL 483
IG+G V+K + +A+K ++ E V + EI ++ L HKNI+ L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 484 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
D L LV++F + + N + + L + HS +
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD----PEIVKSFLFQLLKGLGFCHS---R 120
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 583
V+HRD+K N+L++ + E +L++FGLA+ +
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 4e-26
Identities = 43/186 (23%), Positives = 78/186 (41%), Gaps = 22/186 (11%)
Query: 420 ATSNFLAENLIGKGGSSQVYKG--CLPDGKELAVKILKPS---EDVIKEFVLEIEIITTL 474
A + IG+G +V+K G+ +A+K ++ E + + E+ ++ L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 475 ---HHKNIISLLGFCF-----EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKV 526
H N++ L C + L LV++ + + + +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP---GVPTETIKDM 121
Query: 527 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV 586
+ L++LHS RV+HRD+K NIL++ + +L+DFGLA+ S + T V
Sbjct: 122 MFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSV 175
Query: 587 AGTFGY 592
T Y
Sbjct: 176 VVTLWY 181
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 7e-26
Identities = 39/177 (22%), Positives = 72/177 (40%), Gaps = 22/177 (12%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILKPS-------EDVIKEFVLEIEIITTLHHKNII 480
+G G + V K G + A K +K ++ E+ I+ + H N+I
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
+L +++L+ + ++ G L + L + E + + + YLHS
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKES----LTEEEATEFLKQILNGVYYLHS- 131
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFGYV 593
++ H D+K NI+L D P+ + DFGLA + ++ GT +V
Sbjct: 132 --LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFV 183
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 104 bits (259), Expect = 5e-25
Identities = 37/175 (21%), Positives = 78/175 (44%), Gaps = 20/175 (11%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNII 480
++ +G+G S+V++ + + +++ VKILKP + K+ EI+I+ L NII
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPNII 93
Query: 481 SLLGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
+L + LV++ ++ ++ + + +AL+Y H
Sbjct: 94 TLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCH 146
Query: 539 SGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 592
S ++HRDVK N+++ + + +L D+GLA++ + +
Sbjct: 147 S---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYF 195
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 3e-24
Identities = 40/171 (23%), Positives = 72/171 (42%), Gaps = 17/171 (9%)
Query: 423 NFLAENLIGKGGSSQVYKG----CLPDGKELAVKILKPS-----EDVIKEFVLEIEIITT 473
NF ++G G +V+ GK A+K+LK + + E +++
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 474 L-HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE 532
+ +++L + L L+ D+++ G L +L ++ F E +
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVL 140
Query: 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 583
ALE+LH +I+RD+K NILL + L+DFGL+K +
Sbjct: 141 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY 188
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.3 bits (236), Expect = 6e-22
Identities = 39/161 (24%), Positives = 63/161 (39%), Gaps = 7/161 (4%)
Query: 428 NLIGKGGSSQVYKG-CLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLL 483
+ +G G V G +AVK L S K E+ ++ + H+N+I LL
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 484 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
+L D L N + + L+Y+HS
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 140
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 584
+IHRD+K SN+ +++D E ++ DFGLA+ + T
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 181
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.3 bits (228), Expect = 7e-21
Identities = 43/175 (24%), Positives = 70/175 (40%), Gaps = 23/175 (13%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLG 484
IG G V + +A+K L ++ K E+ ++ ++HKNIISLL
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 485 FCF------EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
E ++ LV + + + + + +++LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-------HERMSYLLYQMLCGIKHLH 136
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYV 593
S +IHRD+K SNI++ D ++ DFGLA+ A TS T T Y
Sbjct: 137 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYR 185
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 87.9 bits (217), Expect = 1e-20
Identities = 23/156 (14%), Positives = 45/156 (28%), Gaps = 22/156 (14%)
Query: 428 NLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIK-----------EFVLEIEIITTLHH 476
L+G+G S V+ E VK K K F +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 477 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
+ + L G Y + L E + + + + E +
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEV--LDMILEEVAK 118
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+ + ++H D+ N+L+ + + DF +
Sbjct: 119 FYH---RGIVHGDLSQYNVLV-SEEGIWIIDFPQSV 150
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 87.0 bits (214), Expect = 4e-19
Identities = 33/181 (18%), Positives = 64/181 (35%), Gaps = 16/181 (8%)
Query: 427 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
+G G S V+ + + +A+KI++ + + EI+++ ++ +
Sbjct: 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 486 C----------FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEA 533
F V+ + L ENL K G Y +++ +
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 534 LEYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 592
L+Y+H +IH D+K N+L+ D L +A + T+ T Y
Sbjct: 138 LDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195
Query: 593 V 593
Sbjct: 196 R 196
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 611 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.98 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.98 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.95 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d2gm3a1 | 171 | Putative ethylene-responsive protein AT3g01520/F4P | 99.89 | |
| d1mjha_ | 160 | "Hypothetical" protein MJ0577 {Archaeon Methanococ | 99.88 | |
| d2z3va1 | 135 | Hypothetical protein TTHA0895 {Thermus thermophilu | 99.85 | |
| d1tq8a_ | 147 | Hypothetical protein Rv1636 {Mycobacterium tubercu | 99.81 | |
| d1jmva_ | 140 | Universal stress protein A, UspA {Haemophilus infl | 99.77 | |
| d1q77a_ | 138 | Hypothetical protein Aq_178 {Aquifex aeolicus [Tax | 99.69 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.45 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.01 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.66 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.19 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.58 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.06 | |
| d1wy5a1 | 216 | TilS-like protein Aq_1887 {Aquifex aeolicus [TaxId | 94.51 | |
| d1ni5a1 | 227 | tRNA-Ile-lysidine synthetase, TilS, N-terminal dom | 91.3 | |
| d2c5sa1 | 218 | Thiamine biosynthesis protein ThiI, C-terminal dom | 89.18 | |
| d1np7a2 | 204 | Cryptochrome {Synechocystis sp., pcc 6803 [TaxId: | 82.03 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-42 Score=350.46 Aligned_cols=184 Identities=23% Similarity=0.324 Sum_probs=161.0
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 497 (611)
.++|.+.+.||+|+||+||+|... +|+.||||+++... +..+++.+|+++|+.++||||+++++++.+.+.+|||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 467999999999999999999864 79999999997643 345678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCC
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~ 577 (611)
|+++|+|.++|.... .+++.++..++.||+.||.|||+ ++||||||||+||||++++.+||+|||+|+.+...
T Consensus 84 y~~gg~L~~~l~~~~----~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 84 YCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp CCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ccCCCcHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 999999999986543 59999999999999999999999 89999999999999999999999999999987655
Q ss_pred CCceeecCCccCCCcccceecc-CC-CcCcceEEeC
Q 007254 578 SSHITCTDVAGTFGYVVLILNP-IA-FLFMFNCWFF 611 (611)
Q Consensus 578 ~~~~~~~~~~GT~~Y~aPE~~~-~~-~~~~sDiWSL 611 (611)
......+..+||+.|||||++. .. ++.++|||||
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSl 192 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC 192 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHH
T ss_pred CccccccceeeCcCccCHhHhcCCCCCCCceeeeHh
Confidence 4444456789999999999775 44 4789999996
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-40 Score=342.00 Aligned_cols=180 Identities=27% Similarity=0.400 Sum_probs=161.7
Q ss_pred CCCccceeecccCceEEEEEEe-cCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 007254 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 499 (611)
++|.+.+.||+|+||+||+|.. .+|+.||||+++... ...+.+.+|+++|+.++|||||+++++|.+.+++|||||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4799999999999999999986 479999999997543 44677999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~ 579 (611)
+||+|.+++... .+++.++..++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+.+.....
T Consensus 100 ~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 100 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp TTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 999999988653 38999999999999999999999 8999999999999999999999999999998765432
Q ss_pred ceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 580 HITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 580 ~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.....+||+.|+|||+.. ..|+.++|||||
T Consensus 172 --~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 202 (293)
T d1yhwa1 172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 202 (293)
T ss_dssp --CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHH
T ss_pred --cccccccCCCccChhhhcCCCCCchhceehH
Confidence 234578999999999876 779999999996
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-41 Score=340.72 Aligned_cols=184 Identities=23% Similarity=0.423 Sum_probs=155.2
Q ss_pred cCCCccceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 500 (611)
.++|.+.+.||+|+||+||+|.+.+++.||||+++......++|.+|+++++.++|||||+++|+|.+.+.+|+||||++
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 35788899999999999999999888999999998876667889999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCc
Q 007254 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (611)
Q Consensus 501 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~ 580 (611)
+|+|.+++.... ..++|..+..++.||+.||.|||+ .+|+||||||+||||++++.+||+|||+|+........
T Consensus 84 ~g~L~~~l~~~~---~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 84 HGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp TCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred CCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 999999987543 458999999999999999999999 89999999999999999999999999999987654322
Q ss_pred eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 581 ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 581 ~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......||+.|+|||++. ..|+.++|||||
T Consensus 158 -~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~ 188 (263)
T d1sm2a_ 158 -SSTGTKFPVKWASPEVFSFSRYSSKSDVWSF 188 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHH
T ss_pred -eecceecCcccCChHHhcCCCCCchhhhcch
Confidence 233468999999999876 889999999996
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-41 Score=348.24 Aligned_cols=186 Identities=22% Similarity=0.415 Sum_probs=167.1
Q ss_pred hcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
..++|.+.+.||+|+||+||+|.+. +|+.||||+++.+....++|.+|+++|+.++|||||+++++|.+.+.+||||||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 3567888999999999999999975 688999999988776678899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
+++|+|.++|..... ..++|..+..|+.||+.||.|||+ ++||||||||+||||++++.+||+|||+|+......
T Consensus 95 ~~~g~l~~~l~~~~~--~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 95 MTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp CTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred ccCcchHHHhhhccc--cchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 999999999976433 468999999999999999999999 899999999999999999999999999999876644
Q ss_pred CceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 579 SHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
. .......||+.|+|||++. ..|+.++|||||
T Consensus 170 ~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~ 202 (287)
T d1opja_ 170 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF 202 (287)
T ss_dssp S-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHH
T ss_pred c-eeeccccccccccChHHHcCCCCCchhhhhhH
Confidence 3 3345567999999999775 889999999996
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-41 Score=338.93 Aligned_cols=179 Identities=28% Similarity=0.424 Sum_probs=161.6
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
++|.+.+.||+|+||+||+|... +|+.||||++++. ......+.+|+++|+.++|||||++++++.+.+.+||||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999975 7899999999753 234677899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
|||++|+|.+++.... .+++.++..++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+....
T Consensus 86 Ey~~~g~L~~~l~~~~----~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 9999999999997653 48999999999999999999999 9999999999999999999999999999988765
Q ss_pred CCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 577 SSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
... ....||+.|||||+.. ..|+.++|||||
T Consensus 159 ~~~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSl 190 (263)
T d2j4za1 159 SRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSL 190 (263)
T ss_dssp CCC----EETTEEGGGCCHHHHTTCCCCTTHHHHHH
T ss_pred Ccc----cccCCCCcccCHHHHcCCCCCchhhhhhH
Confidence 432 3468999999999876 778999999996
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-41 Score=345.37 Aligned_cols=183 Identities=27% Similarity=0.379 Sum_probs=159.7
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
++|.+.+.||+|+||+||+|... +|+.||||++++. ....+.+.+|+++|+.++||||++++++|.+.+++||||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999864 7999999999753 234577999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
||++||+|.+++...+ .+++.++..++.|++.||.|||+ ++||||||||+||||++++.+||+|||+|+.+..
T Consensus 88 Ey~~gg~L~~~~~~~~----~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhccC----CCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceeccc
Confidence 9999999999987653 48999999999999999999999 9999999999999999999999999999998876
Q ss_pred CCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 577 SSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
..........+||+.|+|||++. ..|+.++|||||
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSl 196 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWAL 196 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHH
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehh
Confidence 55444556678999999999875 789999999996
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-41 Score=343.34 Aligned_cols=184 Identities=21% Similarity=0.372 Sum_probs=163.3
Q ss_pred cCCCccceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 500 (611)
.++|.+.+.||+|+||.||+|.+++++.||||+++......+.|.+|+++|+.++|||||+++|+|. .+.+||||||++
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~ 90 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME 90 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCC
Confidence 4678889999999999999999988899999999887666788999999999999999999999885 466799999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCc
Q 007254 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (611)
Q Consensus 501 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~ 580 (611)
+|+|.+++..... ..++|.++..|+.||+.||.|||+ ++||||||||+||||++++.+||+|||+|+.+.... .
T Consensus 91 ~g~L~~~~~~~~~--~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~-~ 164 (272)
T d1qpca_ 91 NGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-Y 164 (272)
T ss_dssp TCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-E
T ss_pred CCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCc-c
Confidence 9999998764322 348999999999999999999999 899999999999999999999999999999876543 2
Q ss_pred eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 581 ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 581 ~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.......||+.|||||++. ..|+.++|||||
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~ 196 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSF 196 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHH
T ss_pred ccccccCCcccccChHHHhCCCCCchhhhhhh
Confidence 2345678999999999876 889999999996
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-41 Score=342.54 Aligned_cols=189 Identities=24% Similarity=0.326 Sum_probs=149.9
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CCeEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLL 494 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~l 494 (611)
.++|.+.+.||+|+||+||+|... +|+.||||+++.. +...+.|.+|+++|+.++|||||+++++|.+ .+.+||
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 367999999999999999999864 7999999999764 3456778999999999999999999999965 467899
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCeEecCCCCCCEEEcCCCcEEEEeecccc
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS--AQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~--~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~ 572 (611)
|||||++|+|.+++.........+++.+++.++.||+.||.|||+.+ ..+||||||||+||||+.++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 99999999999998754333456999999999999999999999821 2359999999999999999999999999999
Q ss_pred ccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 573 WASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 573 ~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.+..... .....+||+.|||||++. ..|+.++|||||
T Consensus 163 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSl 200 (269)
T d2java1 163 ILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSL 200 (269)
T ss_dssp HC-------------CCCSCCCHHHHTTCCCCHHHHHHHH
T ss_pred ecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhh
Confidence 8765432 234578999999999875 789999999996
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-41 Score=351.95 Aligned_cols=182 Identities=23% Similarity=0.369 Sum_probs=161.0
Q ss_pred hcCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
..++|.+.+.||+|+||+||+|... +|+.||+|+++.. .....++.+|+.+|+.++|||||+++++|.+.+++||||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3578999999999999999999964 7899999999754 345678999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
|||+||+|.+++.+.. .+++..+..++.|++.||.|||+. .+||||||||+||||++++.+||+|||+|+.+..
T Consensus 84 Ey~~gg~L~~~l~~~~----~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EcCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 9999999999997653 489999999999999999999960 3899999999999999999999999999998754
Q ss_pred CCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 577 SSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.. ..+.+||+.|+|||++. ..|+.++|||||
T Consensus 158 ~~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSl 189 (322)
T d1s9ja_ 158 SM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSM 189 (322)
T ss_dssp HT----C---CCSSCCCCHHHHHCSCCCTTHHHHHH
T ss_pred Cc----cccccCCccccCchHHcCCCCCcHHHHHHH
Confidence 32 23568999999999876 789999999996
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-40 Score=338.70 Aligned_cols=182 Identities=27% Similarity=0.450 Sum_probs=153.2
Q ss_pred cCCCccceeecccCceEEEEEEecCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 497 (611)
.++|.+.+.||+|+||+||+|.++ ..||||+++.. ....+.|.+|+++|..++|||||++++++. .+.+|||||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEe
Confidence 567889999999999999999864 36999999753 456788999999999999999999999885 467899999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCC
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~ 577 (611)
||++|+|.++|...+ ..++|.++..|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+.....
T Consensus 84 y~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CCCEEEHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred cCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 999999999997543 359999999999999999999999 89999999999999999999999999999988765
Q ss_pred CCceeecCCccCCCcccceecc----CCCcCcceEEeC
Q 007254 578 SSHITCTDVAGTFGYVVLILNP----IAFLFMFNCWFF 611 (611)
Q Consensus 578 ~~~~~~~~~~GT~~Y~aPE~~~----~~~~~~sDiWSL 611 (611)
..........||+.|||||++. ..|+.++|||||
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~ 195 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAF 195 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHH
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhh
Confidence 5444556789999999999763 458999999996
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-40 Score=340.42 Aligned_cols=182 Identities=24% Similarity=0.410 Sum_probs=160.3
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCC-hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 499 (611)
+.|.+.+.||+|+||.||+|... +|+.||||+++.. ....+.|.+|+++|+.++|||||+++++|.+.+.+|||||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 45888999999999999999965 7899999999754 455678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~ 579 (611)
++|+|.+++.... ..+++.++..++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+......
T Consensus 92 ~~g~L~~~~~~~~---~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~- 164 (288)
T d2jfla1 92 AGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI- 164 (288)
T ss_dssp TTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-
T ss_pred CCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCc-
Confidence 9999999876532 358999999999999999999999 899999999999999999999999999998765421
Q ss_pred ceeecCCccCCCcccceec------cCCCcCcceEEeC
Q 007254 580 HITCTDVAGTFGYVVLILN------PIAFLFMFNCWFF 611 (611)
Q Consensus 580 ~~~~~~~~GT~~Y~aPE~~------~~~~~~~sDiWSL 611 (611)
.......||+.|||||++ ...|+.++|||||
T Consensus 165 -~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSl 201 (288)
T d2jfla1 165 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSL 201 (288)
T ss_dssp -HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHH
T ss_pred -ccccccccccccCCHHHHhhcccCCCCCChhhhHHHH
Confidence 123457899999999975 2668999999996
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-40 Score=342.51 Aligned_cols=182 Identities=25% Similarity=0.338 Sum_probs=163.9
Q ss_pred cCCCccceeecccCceEEEEEEe-cCCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 495 (611)
.++|.+.+.||+|+||.||+|.. .+|+.||||++++. ....+.+.+|+.+|+.++||||++++++|.+.+++|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 46899999999999999999986 47999999999764 23467889999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
||||+||+|.+++.... .+++..+..++.||+.||+|||+ ++||||||||+||||+.+|.+||+|||+|+...
T Consensus 84 ~ey~~gg~L~~~~~~~~----~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eeccCCCchhhhhhccc----CCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccc
Confidence 99999999999998654 48899999999999999999999 999999999999999999999999999999765
Q ss_pred CCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 576 TSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.... .....+||+.|||||++. ..|+.++|||||
T Consensus 157 ~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSl 191 (337)
T d1o6la_ 157 SDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 191 (337)
T ss_dssp CTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHH
T ss_pred cCCc--ccccceeCHHHhhhhhccCCCCChhhcccch
Confidence 4332 344679999999999886 889999999996
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-39 Score=329.41 Aligned_cols=176 Identities=24% Similarity=0.337 Sum_probs=153.8
Q ss_pred ccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe----CCeEEEEE
Q 007254 425 LAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE----DNNLLLVY 496 (611)
Q Consensus 425 ~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~lV~ 496 (611)
...+.||+|+||+||+|... +++.||+|+++.. ....+.|.+|+++|+.++|||||+++++|.+ .+.+||||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45678999999999999865 7889999998653 3456789999999999999999999999875 35689999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEecCCCCCCEEEc-CCCcEEEEeeccccc
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR--VIHRDVKSSNILLS-DDFEPQLSDFGLAKW 573 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~--IvHrDLKp~NILl~-~~~~vKL~DFGlA~~ 573 (611)
||+++|+|.+++.+.. .+++.++..++.||+.||.|||+ ++ ||||||||+||||+ +++.+||+|||+|+.
T Consensus 92 E~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eCCCCCcHHHHHhccc----cccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 9999999999997653 48999999999999999999998 55 99999999999996 578999999999987
Q ss_pred cCCCCCceeecCCccCCCcccceeccCCCcCcceEEeC
Q 007254 574 ASTSSSHITCTDVAGTFGYVVLILNPIAFLFMFNCWFF 611 (611)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~~~~sDiWSL 611 (611)
..... ....+||+.|||||+....|+.++|||||
T Consensus 165 ~~~~~----~~~~~GT~~Y~aPE~~~~~~~~~~DIwSl 198 (270)
T d1t4ha_ 165 KRASF----AKAVIGTPEFMAPEMYEEKYDESVDVYAF 198 (270)
T ss_dssp CCTTS----BEESCSSCCCCCGGGGGTCCCTHHHHHHH
T ss_pred ccCCc----cCCcccCccccCHHHhCCCCCCcCchhhH
Confidence 55432 23578999999999988889999999996
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.9e-40 Score=338.36 Aligned_cols=184 Identities=26% Similarity=0.437 Sum_probs=147.4
Q ss_pred CCCccceeecccCceEEEEEEec-CCC---EEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGK---ELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~---~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 495 (611)
++|.+.+.||+|+||+||+|.+. +|+ .||||.+... ....++|.+|+++|+.++|||||+++|+|.+.+.+|+|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 45777899999999999999864 333 6899998753 45667899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
||||++|+|.+++.... ..++|.++..++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+.+.
T Consensus 106 ~Ey~~~g~L~~~~~~~~---~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EECCTTEEHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEecCCCcceeeecccc---CCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEcc
Confidence 99999999999887543 358999999999999999999999 899999999999999999999999999999876
Q ss_pred CCCCce---eecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 576 TSSSHI---TCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~---~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
...... ......||+.|||||+.. ..|+.++|||||
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~ 219 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSY 219 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHH
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccc
Confidence 543322 222356899999999875 889999999996
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-39 Score=337.05 Aligned_cols=176 Identities=26% Similarity=0.326 Sum_probs=156.7
Q ss_pred CCccceeecccCceEEEEEEec-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 497 (611)
.|...+.||+|+||.||+|... +|+.||||+++.. ....+.+.+|+++|+.++|||||+++++|.+.+++|||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4888999999999999999864 7899999999753 2456789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCC
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~ 577 (611)
||.+|+|..++.... .+++.++..++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+.....
T Consensus 96 ~~~~g~l~~~~~~~~----~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp CCSEEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 999999987765443 58999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCceeecCCccCCCcccceecc----CCCcCcceEEeC
Q 007254 578 SSHITCTDVAGTFGYVVLILNP----IAFLFMFNCWFF 611 (611)
Q Consensus 578 ~~~~~~~~~~GT~~Y~aPE~~~----~~~~~~sDiWSL 611 (611)
....||+.|||||++. ..|+.++|||||
T Consensus 169 ------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSl 200 (309)
T d1u5ra_ 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 200 (309)
T ss_dssp ------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHH
T ss_pred ------CccccCccccCHHHHhccCCCCcCchhhhhhH
Confidence 2468999999999763 568999999996
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.3e-39 Score=336.42 Aligned_cols=179 Identities=26% Similarity=0.379 Sum_probs=161.5
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 495 (611)
.++|.+.+.||+|+||+||+|... +|+.||||++++. ....+.+.+|+.+|+.++|||||++++++.+.+.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 357999999999999999999964 7999999999753 23467899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
||||.||+|...+.... .+++..+..++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+...
T Consensus 83 mE~~~gg~l~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~ 155 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 155 (316)
T ss_dssp ECCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred eeecCCccccccccccc----cccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEec
Confidence 99999999999987654 47889999999999999999999 999999999999999999999999999999876
Q ss_pred CCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 576 TSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
... ...+||+.|||||++. ..|+.++|||||
T Consensus 156 ~~~-----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSl 187 (316)
T d1fota_ 156 DVT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSF 187 (316)
T ss_dssp SCB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHH
T ss_pred ccc-----ccccCcccccCHHHHcCCCCCchhhcccc
Confidence 532 3578999999999876 779999999996
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-39 Score=337.17 Aligned_cols=181 Identities=24% Similarity=0.394 Sum_probs=144.1
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 497 (611)
.+.|.+.+.||+|+||+||+|... +|+.||||++.+.. .....+.+|+.+|+.++|||||++++++.+.+++|||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 456899999999999999999865 78999999997643 344678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEc---CCCcEEEEeecccccc
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS---DDFEPQLSDFGLAKWA 574 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~---~~~~vKL~DFGlA~~~ 574 (611)
||+||+|.++|.... .+++.++..++.||+.||.|||+ ++||||||||+|||+. +++.+||+|||+|+..
T Consensus 88 ~~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 88 LVSGGELFDRIVEKG----FYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCSCBHHHHHHTCS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ccCCCcHHHhhhccc----CCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 999999999997643 59999999999999999999999 9999999999999995 5789999999999977
Q ss_pred CCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 575 STSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 575 ~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
..... ..+.+||+.|||||++. ..|+.++|||||
T Consensus 161 ~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSl 195 (307)
T d1a06a_ 161 DPGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSI 195 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHH
T ss_pred cCCCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhh
Confidence 65432 34578999999999876 779999999996
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-39 Score=327.59 Aligned_cols=184 Identities=22% Similarity=0.385 Sum_probs=166.2
Q ss_pred cCCCccceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 500 (611)
.++|.+.+.||+|+||.||+|.+++++.||||++++.....++|.+|+.++..++||||++++|+|.+.+.+++||||++
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 36889999999999999999999888899999999877667889999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCc
Q 007254 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (611)
Q Consensus 501 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~ 580 (611)
+|+|..++.... ..+++..+.+++.|++.||.|||+ .+|+||||||+||||++++.+||+|||+|+........
T Consensus 83 ~g~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 83 NGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp TEEHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred CCcHHHhhhccc---cCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 999999976543 358899999999999999999999 89999999999999999999999999999877654332
Q ss_pred eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 581 ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 581 ~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......||+.|+|||+.. ..|+.++|||||
T Consensus 157 -~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~ 187 (258)
T d1k2pa_ 157 -SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAF 187 (258)
T ss_dssp -CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred -eecccCCCCCcCCcHHhcCCCCCcceeeccc
Confidence 334567999999999876 889999999996
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-39 Score=337.22 Aligned_cols=188 Identities=22% Similarity=0.385 Sum_probs=162.2
Q ss_pred cCCCccceeecccCceEEEEEEecC-C-----CEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCe
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLPD-G-----KELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNN 491 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~~-g-----~~vAVK~lk~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 491 (611)
.++|.+.+.||+|+||+||+|.+.. + ..||||.+... ......|.+|+.+|..+ +|||||+++++|.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 4678899999999999999998642 2 36999998754 34456789999999998 89999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhcCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCC
Q 007254 492 LLLVYDFLSRGSLEENLHGNKK-------------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKS 552 (611)
Q Consensus 492 ~~lV~Ey~~~gsL~~~L~~~~~-------------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp 552 (611)
+|||||||++|+|.++|+.... ....++|.++..|+.||+.||.|||+ ++||||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCch
Confidence 9999999999999999976532 12358999999999999999999999 8999999999
Q ss_pred CCEEEcCCCcEEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 553 SNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 553 ~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+|||++.++.+||+|||+|+...............||+.|||||++. ..|+.++|||||
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~ 252 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSY 252 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccch
Confidence 99999999999999999999887766666666788999999999775 889999999996
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.1e-39 Score=337.83 Aligned_cols=182 Identities=21% Similarity=0.338 Sum_probs=161.9
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
.++|.+.+.||+|+||.||+|... +|+.||||+++... ...+.+.+|+.+|+.++|||||+++++|.+.+++||||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 458999999999999999999864 79999999997654 4567789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcC--CCcEEEEeeccccccCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD--DFEPQLSDFGLAKWAST 576 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~--~~~vKL~DFGlA~~~~~ 576 (611)
|+||+|.+++.... ..+++.++..|+.||+.||.|||+ ++||||||||+||||+. ++.+||+|||+|+.+..
T Consensus 105 ~~gg~L~~~l~~~~---~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 105 MSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCSCBHHHHHTCTT---SCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 99999999996442 359999999999999999999999 99999999999999964 57899999999998766
Q ss_pred CCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 577 SSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
... .....||+.|||||++. ..|+.++|||||
T Consensus 179 ~~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSl 211 (350)
T d1koaa2 179 KQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSV 211 (350)
T ss_dssp TSC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHH
T ss_pred ccc---cceecCcccccCHHHHcCCCCChhHhhhhh
Confidence 443 23468999999999876 789999999996
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-39 Score=329.11 Aligned_cols=185 Identities=25% Similarity=0.412 Sum_probs=152.6
Q ss_pred cCCCccceeecccCceEEEEEEecCC-----CEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLPDG-----KELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~~g-----~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 493 (611)
.+.|...++||+|+||.||+|.+++. ..||||+++.. .....+|.+|+++|+.++|||||+++|+|.+.+.++
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 45688899999999999999987532 37999999764 345668999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccc
Q 007254 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (611)
Q Consensus 494 lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~ 573 (611)
+||||+.+|+|.+.+.... ..++|.++..++.||+.||.|||+ .+||||||||+||||+.++.+||+|||+|+.
T Consensus 86 ~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEecccCcchhhhhccc---ccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhc
Confidence 9999999999999886543 359999999999999999999999 8999999999999999999999999999998
Q ss_pred cCCCCCc-eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 574 ASTSSSH-ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 574 ~~~~~~~-~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+...... .......||+.|||||++. ..|+.++|||||
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~ 199 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSF 199 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHH
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCccccccc
Confidence 7654322 2334467999999999765 889999999996
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-39 Score=327.93 Aligned_cols=184 Identities=24% Similarity=0.401 Sum_probs=158.4
Q ss_pred cCCCcccee-ecccCceEEEEEEec---CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 007254 421 TSNFLAENL-IGKGGSSQVYKGCLP---DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (611)
Q Consensus 421 ~~~f~~~~~-IG~G~fG~Vyk~~~~---~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 494 (611)
.++|.+.+. ||+|+||.||+|.++ ++..||||+++.. ....++|.+|+++|+.++|||||+++|+|.+ +.+||
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 456777774 999999999999864 3557999999764 3556889999999999999999999999864 56899
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccccc
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~ 574 (611)
|||||++|+|.+++...+ ..+++.++..++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+.+
T Consensus 86 vmE~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcc
Confidence 999999999999986543 358999999999999999999999 89999999999999999999999999999988
Q ss_pred CCCCCc-eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 575 STSSSH-ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 575 ~~~~~~-~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
...... .......||+.|||||+.. ..|+.++|||||
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~ 198 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSY 198 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHH
T ss_pred cccccccccccccccCccccChHHHhCCCCCccchhhcc
Confidence 654432 2233567999999999876 889999999996
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-38 Score=326.44 Aligned_cols=181 Identities=22% Similarity=0.317 Sum_probs=161.0
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh-------hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 492 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~-------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 492 (611)
.++|.+.+.||+|+||+||+|... +|+.||||++++.. ...+.|.+|+.+|+.++|||||+++++|.+.+++
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 357899999999999999999964 79999999996421 2467899999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCC----cEEEEee
Q 007254 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF----EPQLSDF 568 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~----~vKL~DF 568 (611)
|||||||++|+|.++|.... .+++.++..++.|++.||.|||+ ++||||||||+|||++.++ .+||+||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~----~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCccccchhcccc----ccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecch
Confidence 99999999999999997653 48999999999999999999999 9999999999999998776 4999999
Q ss_pred ccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 569 GLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 569 GlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
|+|+...... ......||+.|+|||++. ..|+.++|||||
T Consensus 162 G~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSl 202 (293)
T d1jksa_ 162 GLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSI 202 (293)
T ss_dssp TTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred hhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhh
Confidence 9999876543 234578999999999876 779999999996
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.5e-38 Score=335.00 Aligned_cols=181 Identities=20% Similarity=0.283 Sum_probs=161.6
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 499 (611)
++|.+.+.||+|+||.||+|... +|+.||||+++... .....+.+|+++|+.++|||||+++++|.+.+++|||||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 56899999999999999999964 79999999997654 44567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEc--CCCcEEEEeeccccccCCC
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS--DDFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~--~~~~vKL~DFGlA~~~~~~ 577 (611)
+||+|.+.+.... ..+++.++..|+.||+.||.|||+ ++||||||||+||||+ .++.+||+|||+|+.+...
T Consensus 109 ~gg~L~~~~~~~~---~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 109 SGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCChHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 9999999886542 359999999999999999999999 9999999999999998 6789999999999988765
Q ss_pred CCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 578 SSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 578 ~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.. .....||+.|+|||++. ..|++++|||||
T Consensus 183 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 214 (352)
T d1koba_ 183 EI---VKVTTATAEFAAPEIVDREPVGFYTDMWAI 214 (352)
T ss_dssp SC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHH
T ss_pred Cc---eeeccCcccccCHHHHcCCCCCCccchHHH
Confidence 43 33468999999999876 789999999996
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-39 Score=331.01 Aligned_cols=184 Identities=21% Similarity=0.400 Sum_probs=155.8
Q ss_pred cCCCccceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 500 (611)
.++|.+.+.||+|+||+||+|.+++++.||||+++......+.|.+|+.+|+.++|||||+++|+|. .+.+|+||||++
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~ 94 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 94 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecC
Confidence 3578899999999999999999988889999999887766788999999999999999999999985 466899999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCc
Q 007254 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (611)
Q Consensus 501 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~ 580 (611)
+|+|..++..... ..++|.++..|+.||+.||.|||+ .+|+||||||+||||++++.+||+|||+|+.+.....
T Consensus 95 ~g~l~~~~~~~~~--~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~- 168 (285)
T d1fmka3 95 KGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY- 168 (285)
T ss_dssp TCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCchhhhhhhccc--ccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCc-
Confidence 9999998875322 359999999999999999999999 8999999999999999999999999999998765432
Q ss_pred eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 581 ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 581 ~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.......||+.|+|||++. ..++.++|||||
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~ 200 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 200 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred eeeccccccccccChHHHhCCCCCcHHhhhcc
Confidence 2334578999999999876 889999999996
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-39 Score=325.79 Aligned_cols=176 Identities=24% Similarity=0.373 Sum_probs=151.0
Q ss_pred eeecccCceEEEEEEec---CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 007254 428 NLIGKGGSSQVYKGCLP---DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (611)
Q Consensus 428 ~~IG~G~fG~Vyk~~~~---~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 501 (611)
+.||+|+||+||+|.+. +++.||||+++.. ....++|.+|+++|+.++|||||+++|+|.. +.+||||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999864 3568999999753 2456789999999999999999999999954 567999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCCce
Q 007254 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (611)
Q Consensus 502 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~ 581 (611)
|+|.+++.... .++|.++..++.||+.||.|||+ .+||||||||+||||+.++.+||+|||+|+.+.......
T Consensus 92 g~L~~~l~~~~----~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhhcc----CCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 99999997653 49999999999999999999999 899999999999999999999999999999876554332
Q ss_pred -eecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 582 -TCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 582 -~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
......||+.|||||.+. ..|+.++|||||
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~ 196 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSF 196 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHH
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccc
Confidence 233467999999999775 889999999996
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-38 Score=334.76 Aligned_cols=178 Identities=22% Similarity=0.294 Sum_probs=161.4
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 496 (611)
++|.+.+.||+|+||.||+|..+ +|+.||||++++.. ...+.+.+|+.+|+.++|||||++++++.+.+.+|+||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999864 79999999997532 34577899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 497 Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
||+.+|+|...+...+ .+++.++..++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+.+..
T Consensus 121 e~~~~g~l~~~l~~~~----~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 9999999999997654 48999999999999999999999 9999999999999999999999999999998764
Q ss_pred CCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 577 SSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
. .....||+.|||||++. ..|+.++|||||
T Consensus 194 ~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSl 224 (350)
T d1rdqe_ 194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWAL 224 (350)
T ss_dssp C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred c-----cccccCccccCCHHHHcCCCCCccccccch
Confidence 3 23578999999999876 789999999996
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.7e-38 Score=332.76 Aligned_cols=180 Identities=24% Similarity=0.324 Sum_probs=156.1
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh----hHHHHHH---HHHHHHHhcCCCCeeeEEEEEEeCCeE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFV---LEIEIITTLHHKNIISLLGFCFEDNNL 492 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~----~~~~~~~---~Ei~il~~l~HpnIv~l~~~~~~~~~~ 492 (611)
.++|.+.++||+|+||.||+|... +|+.||||++.+.. .....+. .|+.+++.++|||||+++++|.+.+.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 478999999999999999999865 79999999996532 1223333 446677778899999999999999999
Q ss_pred EEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccc
Q 007254 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (611)
Q Consensus 493 ~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~ 572 (611)
|||||||+||+|.++|.... .+++.++..++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEEecCCCcHHHHHHhcc----cccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceee
Confidence 99999999999999997653 48899999999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 573 WASTSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 573 ~~~~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
.+..... ...+||+.|+|||++. ..|+.++|||||
T Consensus 156 ~~~~~~~----~~~~GT~~y~APE~~~~~~~~~~~~DiwSl 192 (364)
T d1omwa3 156 DFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSL 192 (364)
T ss_dssp ECSSSCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHH
T ss_pred ecCCCcc----cccccccccchhHHhhcCCCCCcccchhHH
Confidence 8765432 3568999999999764 568999999996
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-38 Score=327.49 Aligned_cols=190 Identities=23% Similarity=0.391 Sum_probs=164.3
Q ss_pred HhcCCCccceeecccCceEEEEEEec------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 007254 419 SATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN 490 (611)
Q Consensus 419 ~~~~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 490 (611)
...++|.+.+.||+|+||+||+|.+. +++.||||+++.. ....++|.+|+++|+.++||||++++++|.+.+
T Consensus 10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 89 (301)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence 34678999999999999999999853 4578999999764 345778999999999999999999999999999
Q ss_pred eEEEEEEcCCCCCHHHHHhcCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCC
Q 007254 491 NLLLVYDFLSRGSLEENLHGNKK--------------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDV 550 (611)
Q Consensus 491 ~~~lV~Ey~~~gsL~~~L~~~~~--------------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDL 550 (611)
.+++||||+++|+|.++|..... ....++|.++..|+.|++.||+|||+ ++||||||
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDl 166 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDL 166 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCC
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEeeEE
Confidence 99999999999999999975421 12358999999999999999999999 99999999
Q ss_pred CCCCEEEcCCCcEEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 551 KSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 551 Kp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
||+||||+.++.+||+|||+|+...............||+.|+|||+.. ..|+.++|||||
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~ 228 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAY 228 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred cccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccc
Confidence 9999999999999999999999776554444555688999999999876 889999999997
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-38 Score=326.32 Aligned_cols=190 Identities=24% Similarity=0.380 Sum_probs=154.7
Q ss_pred HhcCCCccceeecccCceEEEEEEec------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC
Q 007254 419 SATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED 489 (611)
Q Consensus 419 ~~~~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 489 (611)
...++|.+.+.||+|+||.||+|.+. +++.||||+++.. ....+.+.+|..++..+ +|+||+.+++++.+.
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 34568999999999999999999853 3568999999764 34567788888888777 689999999998764
Q ss_pred -CeEEEEEEcCCCCCHHHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEE
Q 007254 490 -NNLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 556 (611)
Q Consensus 490 -~~~~lV~Ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NIL 556 (611)
+.+++|||||++|+|.++|..... ....++|.++..++.||+.||.|||+ ++||||||||+|||
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NIL 166 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNIL 166 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEE
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCcccee
Confidence 468999999999999999975432 12458999999999999999999999 89999999999999
Q ss_pred EcCCCcEEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 557 LSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 557 l~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
|++++.+||+|||+|+...............||+.|||||++. ..|+.++|||||
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~ 222 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 222 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeeh
Confidence 9999999999999999887666555666789999999999776 889999999996
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-37 Score=324.41 Aligned_cols=182 Identities=19% Similarity=0.244 Sum_probs=162.0
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 499 (611)
.++|.+.+.||+|+||+||+|... +|+.||||+++........+.+|+++|+.++|||||+++++|.+.+++|||||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 467999999999999999999865 7889999999887666667889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCC--CcEEEEeeccccccCCC
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD--FEPQLSDFGLAKWASTS 577 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~--~~vKL~DFGlA~~~~~~ 577 (611)
+||+|.+++.... ..+++.++..++.||+.||.|||+ ++||||||||+||||+.+ +.+||+|||+++.....
T Consensus 84 ~gg~L~~~i~~~~---~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 84 SGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 9999999997543 358999999999999999999999 999999999999999854 58999999999877554
Q ss_pred CCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 578 SSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 578 ~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
. ......||+.|+|||... ..|+.++|||||
T Consensus 158 ~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSl 189 (321)
T d1tkia_ 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSL 189 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHH
T ss_pred C---cccccccccccccchhccCCCCCchhhcccH
Confidence 3 233468999999999875 788999999996
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-38 Score=325.57 Aligned_cols=183 Identities=22% Similarity=0.425 Sum_probs=153.7
Q ss_pred CCCccceeecccCceEEEEEEec-CCC----EEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGK----ELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~----~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 494 (611)
.+|.+.+.||+|+||+||+|.+. +|+ .||||.++.. ....++|.+|+++|+.++|||||+++|+|.+. ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46999999999999999999864 454 5899988753 34578899999999999999999999999764 5688
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccccc
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~ 574 (611)
+|||+.+|+|.+.+.... ..++|..+..++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+..
T Consensus 88 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHHTS---SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCcccccccccc---cCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceec
Confidence 899999999999887653 368999999999999999999999 89999999999999999999999999999988
Q ss_pred CCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 575 STSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 575 ~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.............||+.|||||++. ..|+.++|||||
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~ 199 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSY 199 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHH
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhH
Confidence 7665555555678999999999775 889999999996
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-38 Score=325.04 Aligned_cols=181 Identities=23% Similarity=0.407 Sum_probs=159.7
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCC----hhHHHHHHHHHHHHH-hcCCCCeeeEEEEEEeCCeEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIIT-TLHHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~----~~~~~~~~~Ei~il~-~l~HpnIv~l~~~~~~~~~~~lV 495 (611)
++|.+.+.||+|+||+||+|... +|+.||||+++++ ......+..|+.++. .++|||||++++++.+.+++|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 68999999999999999999865 7999999999753 234556777777765 68999999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
||||++|+|.+++.... .+++.++..++.||+.||.|||+ ++||||||||+|||+++++.+||+|||+|+...
T Consensus 82 mEy~~~g~L~~~i~~~~----~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhcc
Confidence 99999999999997653 48899999999999999999999 899999999999999999999999999998766
Q ss_pred CCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 576 TSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 576 ~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.... ..+...||+.|+|||++. ..|+.++|||||
T Consensus 155 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 189 (320)
T d1xjda_ 155 LGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSF 189 (320)
T ss_dssp CTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred cccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhh
Confidence 4332 344578999999999876 889999999996
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.7e-37 Score=316.52 Aligned_cols=180 Identities=28% Similarity=0.439 Sum_probs=159.8
Q ss_pred CCCccceeecccCceEEEEEEe-cCCCEEEEEEecCCh----------hHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeC
Q 007254 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----------DVIKEFVLEIEIITTLH-HKNIISLLGFCFED 489 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~~----------~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~ 489 (611)
++|.+.+.||+|+||+||+|.. .+|+.||||++++.. ...+.+.+|+.+|+.++ ||||+++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6799999999999999999986 479999999996531 23456889999999997 99999999999999
Q ss_pred CeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeec
Q 007254 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569 (611)
Q Consensus 490 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFG 569 (611)
+++|||||||++|+|.++|.... .+++.++..++.||+.||.|||+ ++||||||||+|||++.++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcCCCchHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccch
Confidence 99999999999999999997543 48999999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCCceeecCCccCCCcccceecc-------CCCcCcceEEeC
Q 007254 570 LAKWASTSSSHITCTDVAGTFGYVVLILNP-------IAFLFMFNCWFF 611 (611)
Q Consensus 570 lA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-------~~~~~~sDiWSL 611 (611)
+|+....... .....||+.|+|||+.. ..++.++|||||
T Consensus 156 ~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~Diwsl 201 (277)
T d1phka_ 156 FSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWST 201 (277)
T ss_dssp TCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHH
T ss_pred heeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEccc
Confidence 9998876432 34578999999999752 457899999996
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.6e-37 Score=315.99 Aligned_cols=184 Identities=22% Similarity=0.300 Sum_probs=152.4
Q ss_pred cCCCccceeecccCceEEEEEEe-cCCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC----e
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN----N 491 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~ 491 (611)
.++|.+.+.||+|+||.||+|.. .+|+.||||++++. ......|.+|+++|+.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 35799999999999999999986 47999999999753 345678999999999999999999999998654 3
Q ss_pred EEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccc
Q 007254 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (611)
Q Consensus 492 ~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA 571 (611)
+||||||++||+|.+.+...+ .+++.++..++.||+.||.|||+ ++||||||||+||||+.++.++|+|||++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~----~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhcccC----CCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhh
Confidence 899999999999999887653 48999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCC-CceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 572 KWASTSS-SHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 572 ~~~~~~~-~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+...... ........+||+.|+|||+.. ..|++++|||||
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSl 200 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 200 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHH
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccc
Confidence 8765432 223445678999999999876 779999999996
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-37 Score=320.72 Aligned_cols=176 Identities=27% Similarity=0.339 Sum_probs=149.9
Q ss_pred ceeecccCceEEEEEEec-CCCEEEEEEecCCh------hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 007254 427 ENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (611)
Q Consensus 427 ~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 499 (611)
+++||+|+||+||+|... +|+.||||+++... ...+.+.+|+++|+.++|||||+++++|.+.+++||||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 578999999999999964 79999999997542 12356889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~ 579 (611)
.++++...+... ..+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+.......
T Consensus 83 ~~~~~~~~~~~~----~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 83 ETDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp SEEHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred cchHHhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 887776665433 358888999999999999999999 9999999999999999999999999999988765432
Q ss_pred ceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 580 HITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 580 ~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
.....+||+.|+|||++. ..|+.++|||||
T Consensus 156 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl 187 (299)
T d1ua2a_ 156 --AYTHQVVTRWYRAPELLFGARMYGVGVDMWAV 187 (299)
T ss_dssp --CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHH
T ss_pred --cccceecChhhccHHHHccCCCCChhhhhhhc
Confidence 233568999999999764 568999999996
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-37 Score=319.03 Aligned_cols=184 Identities=28% Similarity=0.337 Sum_probs=151.1
Q ss_pred CCCccceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC----eEEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN----NLLLVYD 497 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~~lV~E 497 (611)
++|.+.+.||+|+||.||+|.+ +|+.||||+++........+..|+..+..++||||++++++|.+.+ .+|||||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 4677889999999999999987 7899999999765543222334455556789999999999998654 5899999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-----CCCCeEecCCCCCCEEEcCCCcEEEEeecccc
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG-----SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~-----~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~ 572 (611)
||++|+|.++|++. .++|.++..++.|++.||.|||.. ..++||||||||+||||+.++.+||+|||+++
T Consensus 82 y~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 82 YHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp CCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999999999864 389999999999999999999972 12699999999999999999999999999999
Q ss_pred ccCCCCCc--eeecCCccCCCcccceeccC-------CCcCcceEEeC
Q 007254 573 WASTSSSH--ITCTDVAGTFGYVVLILNPI-------AFLFMFNCWFF 611 (611)
Q Consensus 573 ~~~~~~~~--~~~~~~~GT~~Y~aPE~~~~-------~~~~~sDiWSL 611 (611)
........ .......||+.|+|||+... .++.++|||||
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~ 204 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM 204 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHH
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhh
Confidence 87654332 23446789999999998752 26789999996
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-37 Score=320.54 Aligned_cols=179 Identities=24% Similarity=0.335 Sum_probs=153.6
Q ss_pred cCCCccc-eeecccCceEEEEEEe-cCCCEEEEEEecCChhHHHHHHHHHHHHHh-cCCCCeeeEEEEEEe----CCeEE
Q 007254 421 TSNFLAE-NLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITT-LHHKNIISLLGFCFE----DNNLL 493 (611)
Q Consensus 421 ~~~f~~~-~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~----~~~~~ 493 (611)
.++|.+. ++||+|+||+||+|.. .+|+.||||+++.. ..+.+|++++.+ ++|||||+++++|.+ .+++|
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 4678776 5699999999999986 57999999999764 346679998654 589999999999875 46799
Q ss_pred EEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcC---CCcEEEEeecc
Q 007254 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSDFGL 570 (611)
Q Consensus 494 lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~---~~~vKL~DFGl 570 (611)
||||||+||+|.++|..... ..|++.++..|+.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+
T Consensus 86 ivmEy~~gg~L~~~i~~~~~--~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSC--CCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEECCCCCcHHHHHHhcCC--CCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccce
Confidence 99999999999999976432 469999999999999999999999 99999999999999985 46799999999
Q ss_pred ccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 571 AKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 571 A~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
|+....... ....+||+.|||||++. ..|+.++|||||
T Consensus 161 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSl 199 (335)
T d2ozaa1 161 AKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 199 (335)
T ss_dssp CEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHH
T ss_pred eeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhh
Confidence 998765442 34578999999999876 789999999996
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-37 Score=314.18 Aligned_cols=183 Identities=23% Similarity=0.369 Sum_probs=147.0
Q ss_pred cCCCccceeecccCceEEEEEEecC----CCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLPD----GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~~----g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 494 (611)
.++|.+.+.||+|+||.||+|.+.. +..||||.++.. ....+.|.+|+++|+.++|||||+++++|. .+.+|+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 4578899999999999999998642 346899998753 345678999999999999999999999995 567899
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecccccc
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~ 574 (611)
||||+++|+|.+++.... ..+++..+..++.||+.||.|||+ ++||||||||+|||+++++.+||+|||+|+..
T Consensus 85 v~E~~~~g~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEeccCCcHHhhhhccC---CCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheec
Confidence 999999999999886543 358999999999999999999999 99999999999999999999999999999987
Q ss_pred CCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 575 STSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 575 ~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
..... .......||+.|+|||++. ..|+.++|||||
T Consensus 159 ~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSl 195 (273)
T d1mp8a_ 159 EDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMF 195 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHH
T ss_pred cCCcc-eeccceecCcccchhhHhccCCCCCccccccc
Confidence 65432 2334578999999999876 889999999996
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-37 Score=316.61 Aligned_cols=182 Identities=27% Similarity=0.403 Sum_probs=155.2
Q ss_pred CCCccceeecccCceEEEEEEe-cCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 497 (611)
++|.+.+.||+|+||+||+|.. .+|+.||||+++... ....++.+|+++|+.++|||||+++++|.+.+++|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999986 479999999997643 335788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCC
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~ 577 (611)
|+.+ .+.+++..... ..+++.++..++.||+.||.|||+ ++||||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~-~~~~~~~~~~~--~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSE-EHHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCC-chhhhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCC
Confidence 9966 45455443322 459999999999999999999999 99999999999999999999999999999987653
Q ss_pred CCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 578 SSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 578 ~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
.. ......||+.|+|||+.. ..+++++|||||
T Consensus 156 ~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSl 189 (298)
T d1gz8a_ 156 VR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSL 189 (298)
T ss_dssp SB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHH
T ss_pred cc--cceeecccceeeehhhhccccCCCcccccccc
Confidence 32 344578999999999754 556899999996
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-37 Score=317.70 Aligned_cols=188 Identities=24% Similarity=0.394 Sum_probs=167.0
Q ss_pred cCCCccceeecccCceEEEEEEe------cCCCEEEEEEecCCh--hHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCe
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPSE--DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNN 491 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~------~~g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 491 (611)
.++|.+.+.||+|+||.||+|.+ .+++.||||+++... .....|.+|+.++..+ +|||||+++++|.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 45788899999999999999985 246789999998643 4566899999999999 69999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhcCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE
Q 007254 492 LLLVYDFLSRGSLEENLHGNKK--------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557 (611)
Q Consensus 492 ~~lV~Ey~~~gsL~~~L~~~~~--------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl 557 (611)
+|+|||||++|+|.++|+.... ....+++..+..++.||+.||.|||+ ++||||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccccccccc
Confidence 9999999999999999976542 22458999999999999999999999 999999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 558 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 558 ~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+.++.+||+|||+++...............||+.|+|||+.. ..++.++|||||
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~ 233 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSY 233 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccch
Confidence 999999999999999988777666777789999999999876 888999999997
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-37 Score=312.31 Aligned_cols=179 Identities=30% Similarity=0.477 Sum_probs=148.9
Q ss_pred cCCCccceeecccCceEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-CCeEEEEEEcC
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE-DNNLLLVYDFL 499 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lV~Ey~ 499 (611)
.++|.+.+.||+|+||.||+|.+ .|+.||||+++.+. ..+.|.+|+++++.++||||++++|+|.+ .+.+|+||||+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 35678889999999999999998 57899999997654 45789999999999999999999999965 45689999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~ 579 (611)
++|+|.++|..... ..++|..+..++.||+.||.|||+ .+||||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~- 157 (262)
T d1byga_ 84 AKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 157 (262)
T ss_dssp TTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCCC-
Confidence 99999999975422 248999999999999999999999 899999999999999999999999999998765432
Q ss_pred ceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 580 HITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 580 ~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
....||+.|+|||+.. ..++.++|||||
T Consensus 158 ----~~~~~~~~y~aPE~l~~~~~t~~sDIwSf 186 (262)
T d1byga_ 158 ----DTGKLPVKWTAPEALREKKFSTKSDVWSF 186 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHH
T ss_pred ----ccccccccCCChHHHhCCCCChHHHHHhH
Confidence 2357899999999875 889999999997
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-37 Score=317.69 Aligned_cols=189 Identities=20% Similarity=0.344 Sum_probs=165.0
Q ss_pred hcCCCccceeecccCceEEEEEEec------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCe
Q 007254 420 ATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 491 (611)
Q Consensus 420 ~~~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 491 (611)
..++|.+.+.||+|+||.||+|.+. +++.||||+++.. ......|.+|+++++.++||||++++++|...+.
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence 3467888999999999999999863 3578999999764 3445679999999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHhcCC------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEE
Q 007254 492 LLLVYDFLSRGSLEENLHGNK------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQL 565 (611)
Q Consensus 492 ~~lV~Ey~~~gsL~~~L~~~~------~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL 565 (611)
.++||||+++|+|.+++.... .....++|..+.+|+.|++.||.|||+ ++||||||||+||||+.++.+||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEE
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEE
Confidence 999999999999999886432 122457999999999999999999999 89999999999999999999999
Q ss_pred EeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 566 SDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 566 ~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+|||+|+.+.............||+.|+|||... ..++.++|||||
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~ 221 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 221 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccH
Confidence 9999999887666555556678999999999876 889999999996
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-36 Score=311.80 Aligned_cols=188 Identities=26% Similarity=0.419 Sum_probs=160.2
Q ss_pred cCCCccceeecccCceEEEEEEecC--------CCEEEEEEecCCh--hHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLPD--------GKELAVKILKPSE--DVIKEFVLEIEIITTL-HHKNIISLLGFCFED 489 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~~--------g~~vAVK~lk~~~--~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 489 (611)
.++|.+.+.||+|+||.||+|.... +..||||+++++. ....++.+|..++..+ +|||||+++++|.+.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 4578889999999999999998532 3479999997643 4567889999999888 899999999999999
Q ss_pred CeEEEEEEcCCCCCHHHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEE
Q 007254 490 NNLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557 (611)
Q Consensus 490 ~~~~lV~Ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl 557 (611)
+.+++||||+++|+|.++|..... ....+++.++..++.||+.||+|||+ .+||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceee
Confidence 999999999999999999976532 12458999999999999999999999 999999999999999
Q ss_pred cCCCcEEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 558 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 558 ~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+.++.+||+|||+++...............||+.|+|||+.. ..|+.++|||||
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~ 223 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 223 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHh
Confidence 999999999999999887766655666788999999999775 899999999996
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-36 Score=314.73 Aligned_cols=184 Identities=26% Similarity=0.462 Sum_probs=155.6
Q ss_pred CCCccceeecccCceEEEEEEec-CCC--EEEEEEecCC--hhHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGK--ELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLV 495 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~--~vAVK~lk~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV 495 (611)
++|.+.+.||+|+||.||+|.+. +|. .||||.++.. .+..+.|.+|+++|..+ +|||||+++|+|.+.+.+|+|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 67888999999999999999865 454 4788887643 34567899999999999 799999999999999999999
Q ss_pred EEcCCCCCHHHHHhcCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcE
Q 007254 496 YDFLSRGSLEENLHGNK------------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 563 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~------------~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~v 563 (611)
|||+++|+|.++|+... .....++|..+..++.||+.||.|||+ ++||||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCce
Confidence 99999999999997542 223569999999999999999999999 899999999999999999999
Q ss_pred EEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 564 QLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 564 KL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
||+|||+|+....... .....||..|+|||.+. ..|+.++|||||
T Consensus 167 kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSf 212 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSY 212 (309)
T ss_dssp EECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHH
T ss_pred EEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehh
Confidence 9999999986654332 22457999999999875 889999999996
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-36 Score=311.03 Aligned_cols=179 Identities=26% Similarity=0.438 Sum_probs=154.8
Q ss_pred ceeecccCceEEEEEEecCC----CEEEEEEecC--ChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-CCeEEEEEEcC
Q 007254 427 ENLIGKGGSSQVYKGCLPDG----KELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFE-DNNLLLVYDFL 499 (611)
Q Consensus 427 ~~~IG~G~fG~Vyk~~~~~g----~~vAVK~lk~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lV~Ey~ 499 (611)
.++||+|+||+||+|.+.++ ..||||.++. .....++|.+|+++|++++||||++++|+|.+ .+.+++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 57899999999999987532 2689999975 34567889999999999999999999999876 46899999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCCC
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~ 579 (611)
++|+|.+++.... ..+++..+.+++.|++.||.|||+ .+|+||||||+||||++++.+||+|||+++.+.....
T Consensus 112 ~~g~l~~~~~~~~---~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhcccc---ccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 9999999987543 357889999999999999999999 8999999999999999999999999999998765432
Q ss_pred c--eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 580 H--ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 580 ~--~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
. .......||+.|+|||+.. ..++.++|||||
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~Sf 220 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 220 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhh
Confidence 2 2333568999999999875 889999999997
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-37 Score=310.68 Aligned_cols=183 Identities=27% Similarity=0.449 Sum_probs=148.9
Q ss_pred CCCccceeecccCceEEEEEEec--CC--CEEEEEEecCC----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP--DG--KELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~--~g--~~vAVK~lk~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 493 (611)
++|.+.+.||+|+||.||+|.+. ++ ..||||++++. ....++|.+|+.+|+.++||||++++|+|.+ +.++
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 56889999999999999999853 23 37899998763 3556789999999999999999999999965 5779
Q ss_pred EEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccc
Q 007254 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (611)
Q Consensus 494 lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~ 573 (611)
+||||+++|+|.+.+.... ..++|..+..++.|++.||.|||+ ++|+||||||+||||+.++.+||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeeeecCcchhhhhhccc---CCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhh
Confidence 9999999999999886542 358999999999999999999999 8999999999999999999999999999998
Q ss_pred cCCCCCcee-ecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 574 ASTSSSHIT-CTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 574 ~~~~~~~~~-~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
+........ .....||+.|+|||++. ..++.++|||||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~ 200 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMF 200 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHH
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhh
Confidence 876554433 33467889999999876 889999999996
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.6e-36 Score=309.81 Aligned_cols=181 Identities=23% Similarity=0.336 Sum_probs=155.6
Q ss_pred CCCccceeecccCceEEEEEEecCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 498 (611)
++|.+.+.||+|+||+||+|.+++|+.||||+++... ...+++.+|+.+|+.++||||++++++|...+..|++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5789999999999999999999899999999997642 3467899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCCC
Q 007254 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (611)
Q Consensus 499 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~ 578 (611)
+.++.+..+.... ..+++.++..++.||+.||+|||+ .+||||||||+||||+.++.+||+|||+|.......
T Consensus 82 ~~~~~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHHhhc----CCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 9887666665443 359999999999999999999999 899999999999999999999999999998876543
Q ss_pred CceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 579 SHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 579 ~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
. ......||+.|+|||... ..+++++|||||
T Consensus 155 ~--~~~~~~~~~~y~~pE~~~~~~~~~~~~Diwsl 187 (286)
T d1ob3a_ 155 R--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSV 187 (286)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHH
T ss_pred c--ccceecccchhhhHHHHhCCCCCCcceeehhc
Confidence 2 234567999999999764 667999999996
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-37 Score=309.96 Aligned_cols=179 Identities=23% Similarity=0.272 Sum_probs=153.5
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCCh-------hHHHHHHHHHHHHHhcC--CCCeeeEEEEEEeCCe
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-------DVIKEFVLEIEIITTLH--HKNIISLLGFCFEDNN 491 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~-------~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~ 491 (611)
++|.+.+.||+|+||.||+|... +|+.||||++++.. ....++.+|+.+|+.++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999864 79999999987532 12345678999999997 8999999999999999
Q ss_pred EEEEEEcCCC-CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcC-CCcEEEEeec
Q 007254 492 LLLVYDFLSR-GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFG 569 (611)
Q Consensus 492 ~~lV~Ey~~~-gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~-~~~vKL~DFG 569 (611)
+|+||||+.+ +++.+++.... .+++.++..++.||+.||.|||+ ++||||||||+||||+. ++.+||+|||
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~----~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEeccCcchHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccc
Confidence 9999999976 57888876543 48999999999999999999999 99999999999999985 4799999999
Q ss_pred cccccCCCCCceeecCCccCCCcccceecc-CC-CcCcceEEeC
Q 007254 570 LAKWASTSSSHITCTDVAGTFGYVVLILNP-IA-FLFMFNCWFF 611 (611)
Q Consensus 570 lA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~-~~~~sDiWSL 611 (611)
+|+...... .++..||+.|+|||+.. .. ++.++|||||
T Consensus 157 ~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSl 196 (273)
T d1xwsa_ 157 SGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL 196 (273)
T ss_dssp TCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHH
T ss_pred cceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccc
Confidence 998765432 34578999999999875 44 5788999996
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-35 Score=307.96 Aligned_cols=183 Identities=22% Similarity=0.314 Sum_probs=152.2
Q ss_pred cCCCccceeecccCceEEEEEEe-cCCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC----eEE
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN----NLL 493 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~~ 493 (611)
.++|.+.+.||+|+||+||+|.. .+|+.||||++++. ....+.+.+|+++|+.++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45799999999999999999985 48999999999764 345678999999999999999999999997543 224
Q ss_pred EEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccc
Q 007254 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (611)
Q Consensus 494 lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~ 573 (611)
++++|+.+|+|.+++... .+++.++..++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+.
T Consensus 87 ~l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 445566699999999754 38999999999999999999999 8999999999999999999999999999987
Q ss_pred cCCCCCc-eeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 574 ASTSSSH-ITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 574 ~~~~~~~-~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
....... ......+||+.|+|||++. ..|+.++|||||
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSl 199 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 199 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhcc
Confidence 7543222 2234578999999999864 677999999996
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-35 Score=304.61 Aligned_cols=182 Identities=24% Similarity=0.360 Sum_probs=150.7
Q ss_pred cCCCccceeecccCceEEEEEEec-C-CCEEEEEEecCC---hhHHHHHHHHHHHHHhc---CCCCeeeEEEEEEe----
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-D-GKELAVKILKPS---EDVIKEFVLEIEIITTL---HHKNIISLLGFCFE---- 488 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~-g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~---- 488 (611)
.++|.+.+.||+|+||+||+|... + ++.||||+++.. +.....+.+|+.+|+.| +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999863 4 667999998653 22234566777777665 89999999999863
Q ss_pred -CCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEe
Q 007254 489 -DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSD 567 (611)
Q Consensus 489 -~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~D 567 (611)
..++|++|||+.+|.+........ ..+++..+..++.|++.||+|||+ ++||||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhccC---CCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecc
Confidence 347899999998877765544332 458999999999999999999999 9999999999999999999999999
Q ss_pred eccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 568 FGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 568 FGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
||+++...... ......||+.|+|||++. ..|+.++|||||
T Consensus 160 fg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSl 201 (305)
T d1blxa_ 160 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSV 201 (305)
T ss_dssp CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHH
T ss_pred hhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhch
Confidence 99998665432 334678999999999775 889999999996
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-35 Score=302.58 Aligned_cols=184 Identities=26% Similarity=0.347 Sum_probs=152.4
Q ss_pred cCCCccceeecccCceEEEEEEe-cCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--------
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE-------- 488 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-------- 488 (611)
.++|.+.+.||+|+||+||+|.. .+|+.||||+++.. +....++.+|+++|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 47899999999999999999996 47999999998654 2345778999999999999999999999865
Q ss_pred CCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEee
Q 007254 489 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568 (611)
Q Consensus 489 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DF 568 (611)
.+++|+||||+.++.+....... ..++...+..++.|++.||.|||+ ++||||||||+||||+.++.+||+||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~----~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTT----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCCCccchhhhcc----cccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeec
Confidence 35689999999887665554332 358889999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCC--ceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 569 GLAKWASTSSS--HITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 569 GlA~~~~~~~~--~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
|+|+....... .......+||+.|+|||+.. ..|++++|||||
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSl 208 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGA 208 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHH
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccC
Confidence 99987764321 12233468999999999764 578999999996
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-35 Score=309.17 Aligned_cols=179 Identities=24% Similarity=0.301 Sum_probs=147.9
Q ss_pred CCccceeecccCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC------CeEEEE
Q 007254 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED------NNLLLV 495 (611)
Q Consensus 423 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~~~~lV 495 (611)
+|...++||+|+||+||+|... +|+.||||+++..... +.+|+++|+.++||||++++++|... .++|||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence 4677899999999999999975 7999999999775432 23699999999999999999999643 358999
Q ss_pred EEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCC-cEEEEeecccccc
Q 007254 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKWA 574 (611)
Q Consensus 496 ~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~-~vKL~DFGlA~~~ 574 (611)
||||++|.+...... ......+++.++..++.||+.||+|||+ ++||||||||+||||+.++ .+||+|||+|+..
T Consensus 98 ~Ey~~~~~~~~l~~~-~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 98 LDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EECCSEEHHHHHHHH-HHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EeccCCccHHHHHhh-hhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 999977644333321 1222469999999999999999999999 9999999999999999775 8999999999987
Q ss_pred CCCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 575 STSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 575 ~~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
..... ..+..||..|+|||... ..|+.++|||||
T Consensus 174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSl 209 (350)
T d1q5ka_ 174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSA 209 (350)
T ss_dssp CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHH
T ss_pred cCCcc---cccccccccccChHHhhcccCCCcceeeccc
Confidence 65432 23568999999999654 678999999996
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.5e-35 Score=303.07 Aligned_cols=175 Identities=22% Similarity=0.376 Sum_probs=152.3
Q ss_pred CCCccceeecccCceEEEEEEe-cCCCEEEEEEecCChhHHHHHHHHHHHHHhcC-CCCeeeEEEEEEe--CCeEEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFE--DNNLLLVYD 497 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~--~~~~~lV~E 497 (611)
++|.+.+.||+|+||+||+|.. .+|+.||||++++.. .+++.+|+++|+.++ ||||++++++|.. .+.+++|||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 5799999999999999999986 479999999998654 467889999999995 9999999999974 456999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCC-cEEEEeeccccccCC
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKWAST 576 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~-~vKL~DFGlA~~~~~ 576 (611)
||.+|+|.... ..+++.++..++.||+.||.|||+ ++||||||||+||||+.++ .+||+|||+|+....
T Consensus 113 ~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 113 HVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp CCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred ecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccC
Confidence 99999986653 248899999999999999999999 9999999999999998655 699999999998765
Q ss_pred CCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 577 SSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
... ....+||+.|+|||... ..|++++|||||
T Consensus 183 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 216 (328)
T d3bqca1 183 GQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSL 216 (328)
T ss_dssp TCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHH
T ss_pred CCc---ccccccCccccCcccccCCCCCCcccchhhh
Confidence 432 24568999999999765 568999999996
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-35 Score=305.99 Aligned_cols=177 Identities=24% Similarity=0.366 Sum_probs=149.6
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC------
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN------ 490 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------ 490 (611)
.++|.+.+.||+|+||+||+|... +|+.||||++++. ....+.+.+|+++|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 568999999999999999999964 7999999999753 345678999999999999999999999997654
Q ss_pred eEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecc
Q 007254 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (611)
Q Consensus 491 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGl 570 (611)
++||||||+ +++|...+... .+++..+..++.||+.||.|||+ ++||||||||+|||++.++.+||+|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccc
Confidence 579999999 66887777543 48999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 571 AKWASTSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 571 A~~~~~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
|+...... +...||+.|+|||.+. ..+++++|||||
T Consensus 168 a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSl 205 (346)
T d1cm8a_ 168 ARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSV 205 (346)
T ss_dssp CEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHH
T ss_pred eeccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcc
Confidence 98776532 4578999999999764 567999999996
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-34 Score=293.90 Aligned_cols=181 Identities=23% Similarity=0.282 Sum_probs=159.7
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 497 (611)
++|.+.+.||+|+||+||+|... +|+.||||+++.. .....++.+|+.+|+.++||||++++++|.+.++.++|||
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999964 7899999999653 3457889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccccccCCC
Q 007254 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (611)
Q Consensus 498 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~ 577 (611)
|+.+++|..++...+ .+++..+..++.|++.||+|||+ ++||||||||+||||+.++.+||+|||+|+.....
T Consensus 82 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG----DLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ecccccccccccccc----ccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 999999988876543 48899999999999999999999 99999999999999999999999999999987654
Q ss_pred CCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 578 SSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 578 ~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
... .....+++.|+|||+.. ..++.++|||||
T Consensus 155 ~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSl 188 (292)
T d1unla_ 155 VRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSA 188 (292)
T ss_dssp CSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHH
T ss_pred Ccc--ceeeccccchhhhhHhccCCCCCchhhcccc
Confidence 432 23456788999999765 457999999996
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.9e-34 Score=295.80 Aligned_cols=182 Identities=19% Similarity=0.218 Sum_probs=155.9
Q ss_pred CCCccceeecccCceEEEEEEec-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCC-CCeeeEEEEEEeCCeEEEEEEcC
Q 007254 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHH-KNIISLLGFCFEDNNLLLVYDFL 499 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~lV~Ey~ 499 (611)
++|.+.+.||+|+||+||+|... +|+.||||+++.... ...+.+|++++..+.| +||+.+++++.+.+..|+||||+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 57999999999999999999964 789999999865432 2456778999999976 89999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcC-----CCcEEEEeecccccc
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-----DFEPQLSDFGLAKWA 574 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~-----~~~vKL~DFGlA~~~ 574 (611)
+|+|.+++.... ..+++.++..++.|++.||+|||+ ++||||||||+||||+. ++.+||+|||+|+..
T Consensus 84 -~~~l~~~~~~~~---~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 84 -GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp -CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred -CCCHHHHHHhhc---cchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 789999987653 358999999999999999999999 99999999999999974 578999999999987
Q ss_pred CCCCCc-----eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 575 STSSSH-----ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 575 ~~~~~~-----~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
...... ......+||+.|||||... ..+++++|||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSl 199 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEAL 199 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHH
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHh
Confidence 643221 2234578999999999776 779999999996
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-33 Score=290.04 Aligned_cols=182 Identities=23% Similarity=0.261 Sum_probs=150.0
Q ss_pred CCCccceeecccCceEEEEEEe-cCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCe-eeEEEEEEeCCeEEEEEEcC
Q 007254 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI-ISLLGFCFEDNNLLLVYDFL 499 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV~Ey~ 499 (611)
++|.+.+.||+|+||.||+|.+ .+|+.||||+++.... ..++..|+++++.++|+|+ +.+..++.+.+..++||||+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 4699999999999999999986 4789999999876432 2457889999999987765 45556667788899999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcC---CCcEEEEeeccccccCC
Q 007254 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSDFGLAKWAST 576 (611)
Q Consensus 500 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~---~~~vKL~DFGlA~~~~~ 576 (611)
+|+|...+.... ..+++..+..++.|++.||+|||+ ++||||||||+|||++. +..+||+|||+|+.+..
T Consensus 86 -~~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 86 -GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp -CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred -CCchhhhhhhcc---CCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 567777665433 358999999999999999999999 99999999999999864 45799999999998765
Q ss_pred CCCc-----eeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 577 SSSH-----ITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 577 ~~~~-----~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.... .......||+.|||||... ..|++++|||||
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 199 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESL 199 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEec
Confidence 4322 2344678999999999876 779999999996
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-34 Score=299.28 Aligned_cols=183 Identities=25% Similarity=0.320 Sum_probs=156.6
Q ss_pred cCCCccceeecccCceEEEEEEec----CCCEEEEEEecCC-----hhHHHHHHHHHHHHHhcCC-CCeeeEEEEEEeCC
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPS-----EDVIKEFVLEIEIITTLHH-KNIISLLGFCFEDN 490 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~----~g~~vAVK~lk~~-----~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~ 490 (611)
.++|.+.+.||+|+||+||+|... +|+.||||++++. ....+.+.+|+++|++++| |||+++++++.+.+
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 367999999999999999999742 5889999999753 2345678899999999977 89999999999999
Q ss_pred eEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecc
Q 007254 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (611)
Q Consensus 491 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGl 570 (611)
.+++||||+.+|+|.+.+.... .++...+..++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~----~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGL 175 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred ceeeeeecccccHHHHHHHhcc----cccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccc
Confidence 9999999999999999997664 36788899999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCceeecCCccCCCcccceecc---CCCcCcceEEeC
Q 007254 571 AKWASTSSSHITCTDVAGTFGYVVLILNP---IAFLFMFNCWFF 611 (611)
Q Consensus 571 A~~~~~~~~~~~~~~~~GT~~Y~aPE~~~---~~~~~~sDiWSL 611 (611)
|+.+...... ......||+.|++||... ..++.++|||||
T Consensus 176 a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSl 218 (322)
T d1vzoa_ 176 SKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSL 218 (322)
T ss_dssp EEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHH
T ss_pred hhhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHH
Confidence 9887553322 234578999999999764 457889999996
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=9.8e-34 Score=296.67 Aligned_cols=178 Identities=22% Similarity=0.308 Sum_probs=150.2
Q ss_pred cCCCccceeecccCceEEEEEEe-cCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----Ce
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NN 491 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~ 491 (611)
.++|.+.+.||+|+||+||+|.. .+|+.||||++++. ....+++.+|+++|+.++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 56899999999999999999985 47999999999764 24556789999999999999999999998643 34
Q ss_pred EEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeeccc
Q 007254 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (611)
Q Consensus 492 ~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA 571 (611)
.+++|+|+.+|+|.+++... .+++.++..++.||+.||.|||+ ++||||||||+|||++.++.+||+|||+|
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~-----~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhcccc-----cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchh
Confidence 46667778899999998643 48999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCceeecCCccCCCcccceecc--CCCcCcceEEeC
Q 007254 572 KWASTSSSHITCTDVAGTFGYVVLILNP--IAFLFMFNCWFF 611 (611)
Q Consensus 572 ~~~~~~~~~~~~~~~~GT~~Y~aPE~~~--~~~~~~sDiWSL 611 (611)
...... .....||+.|+|||... ..+++++|||||
T Consensus 169 ~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSl 205 (348)
T d2gfsa1 169 RHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 205 (348)
T ss_dssp -CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHH
T ss_pred cccCcc-----cccccccccccCchhhcCCccCCcccchhhh
Confidence 866442 34578999999999754 557999999996
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=3.6e-33 Score=293.88 Aligned_cols=178 Identities=25% Similarity=0.304 Sum_probs=143.5
Q ss_pred cCCCccceeecccCceEEEEEEec-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEEe------CC
Q 007254 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE------DN 490 (611)
Q Consensus 421 ~~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------~~ 490 (611)
.++|.+.+.||+|+||+||+|.+. +|+.||||+++.. ....+++.+|+.+|+.++||||++++++|.. .+
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 367999999999999999999965 7999999999754 3456788999999999999999999999964 36
Q ss_pred eEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEEEeecc
Q 007254 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (611)
Q Consensus 491 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL~DFGl 570 (611)
++|+|||||.+ ++.+.+.. .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~iv~Ey~~~-~l~~~~~~------~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 96 DVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp EEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred eeEEEEeccch-HHHHhhhc------CCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhh
Confidence 89999999966 45555532 38899999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 571 AKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 571 A~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
++...... ..+..+||+.|+|||++. ..++.++|||||
T Consensus 166 ~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSl 204 (355)
T d2b1pa1 166 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSV 204 (355)
T ss_dssp ------------------CCTTCCHHHHTTCCCCTTHHHHHH
T ss_pred hhcccccc---ccccccccccccChhhhcCCCCCCCcccccc
Confidence 98766543 334568999999999875 889999999996
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.95 E-value=3.8e-29 Score=262.37 Aligned_cols=182 Identities=19% Similarity=0.218 Sum_probs=147.9
Q ss_pred CCCccceeecccCceEEEEEEe-cCCCEEEEEEecCChhHHHHHHHHHHHHHhcC-----------CCCeeeEEEEEEe-
Q 007254 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLH-----------HKNIISLLGFCFE- 488 (611)
Q Consensus 422 ~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~-----------HpnIv~l~~~~~~- 488 (611)
++|.+.+.||+|+||+||+|.. .+|+.||||++++.....+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 3589999999999999999996 47999999999988766778889999998875 5789999998864
Q ss_pred -CCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCC------
Q 007254 489 -DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF------ 561 (611)
Q Consensus 489 -~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~------ 561 (611)
....+++|+++..+......... .....+++..+..++.||+.||.|||+ ..+|+||||||+||||+.++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred cccceeeeeeeccccccccccccc-ccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccc
Confidence 35677777777665443332222 223468899999999999999999996 27899999999999998665
Q ss_pred cEEEEeeccccccCCCCCceeecCCccCCCcccceecc-CCCcCcceEEeC
Q 007254 562 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYVVLILNP-IAFLFMFNCWFF 611 (611)
Q Consensus 562 ~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~sDiWSL 611 (611)
.+||+|||.|....... ...+||+.|+|||+.. ..|+.++|||||
T Consensus 170 ~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 215 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWST 215 (362)
T ss_dssp EEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHH
T ss_pred eeeEeeccccccccccc-----ccccccccccChhhccccCCCccccccch
Confidence 39999999998765432 3468999999999765 889999999996
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=1.4e-25 Score=214.72 Aligned_cols=158 Identities=15% Similarity=0.136 Sum_probs=120.6
Q ss_pred ccceeecccCceEEEEEEecCCCEEEEEEecCCh-------------------hHHHHHHHHHHHHHhcCCCCeeeEEEE
Q 007254 425 LAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-------------------DVIKEFVLEIEIITTLHHKNIISLLGF 485 (611)
Q Consensus 425 ~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~-------------------~~~~~~~~Ei~il~~l~HpnIv~l~~~ 485 (611)
.+.+.||+|+||.||+|...+|+.||||+++... .....+..|...+..+.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 4678999999999999998899999999976421 112344568889999999999998876
Q ss_pred EEeCCeEEEEEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCEEEcCCCcEEE
Q 007254 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQL 565 (611)
Q Consensus 486 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IvHrDLKp~NILl~~~~~vKL 565 (611)
. .+ +++|||++++.+.. +++.....++.|++.+|.|||+ .+|+||||||+|||++++ .++|
T Consensus 83 ~--~~--~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 83 E--GN--AVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp E--TT--EEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEE
T ss_pred c--CC--EEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEE
Confidence 3 22 89999998765432 2233456789999999999999 999999999999999865 5899
Q ss_pred EeeccccccCCCCCceeecCCccCCCccc------ceeccCCCcCcceEEeC
Q 007254 566 SDFGLAKWASTSSSHITCTDVAGTFGYVV------LILNPIAFLFMFNCWFF 611 (611)
Q Consensus 566 ~DFGlA~~~~~~~~~~~~~~~~GT~~Y~a------PE~~~~~~~~~sDiWSL 611 (611)
+|||+|......... .|+. .++....|+..+|+||+
T Consensus 144 iDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f~r~y~~~~d~~s~ 185 (191)
T d1zara2 144 IDFPQSVEVGEEGWR----------EILERDVRNIITYFSRTYRTEKDINSA 185 (191)
T ss_dssp CCCTTCEETTSTTHH----------HHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred EECCCcccCCCCCcH----------HHHHHHHHHHHHHHcCCCCCcccHHHH
Confidence 999999765432211 1111 13334788999999984
|
| >d2gm3a1 c.26.2.4 (A:5-175) Putative ethylene-responsive protein AT3g01520/F4P13_7 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Putative ethylene-responsive protein AT3g01520/F4P13 7 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.89 E-value=2.3e-23 Score=195.68 Aligned_cols=136 Identities=17% Similarity=0.282 Sum_probs=107.5
Q ss_pred CEEEEEeCCCH---------hHHHHHHHHHHHccCCCC---EEEEEEEeeCCCcccC-----C-C----chhHHHHHHHH
Q 007254 17 RTVVVGVKLDT---------HSRELLTWALVKVAQPGD---TVIALHVLANNAIVDR-----D-G----KSSLLSLVKAF 74 (611)
Q Consensus 17 ~~IlVaVD~s~---------~S~~AL~WAl~~~~~~g~---~vvlvHV~~~~~~~~~-----~-~----~~~~~~~~~~~ 74 (611)
+||+||||+|. .|++||+||++++.+.|+ .|+++||......... . . ........+..
T Consensus 2 ~ki~vavd~s~~~~~~~~~~~S~~Al~wal~~~~~~~~~~~~L~~vhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (171)
T d2gm3a1 2 TKVMVAVNASTIKDYPNPSISCKRAFEWTLEKIVRSNTSDFKILLLHVQVVDEDGFDDVDSIYASPEDFRDMRQSNKAKG 81 (171)
T ss_dssp EEEEEECCBCSSSCTTCBCHHHHHHHHHHHHHTTTTCTTSEEEEEEEEEC----------CCCCSHHHHHHHTTSHHHHH
T ss_pred CEEEEEEcCCcccCCCCCCHHHHHHHHHHHHHHHHCCCCCcEEEEEEeccccccccccccccccCHHHHHHHHHHHHHHH
Confidence 68999999986 899999999999999998 4999999875422110 0 0 11233455677
Q ss_pred HHHHHHHHhhhhhcCCcEEEEEEECCchhHHHHHHHHhcCCCEEEEccCCCCceeec-ccchhHHHHhcCCCCcEEEEEe
Q 007254 75 DSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRS-TTSLAKYCAKKLSKDCSVLAVN 153 (611)
Q Consensus 75 ~~ll~~~~~~C~~k~V~~~~~v~~g~~~~~~Iv~~a~~~~ad~LVlG~~g~~~~~R~-~gsva~~v~k~ap~~C~VlvV~ 153 (611)
+++|+.+...|..++++++.++.+| ++.++|+++|++.++|+||||++|++++.|+ +|||++||++|++ |||+||+
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~v~~G-~~~~~I~~~a~~~~~dlIV~G~~g~~~~~~~~lGSv~~~vi~~~~--cpVlvV~ 158 (171)
T d2gm3a1 82 LHLLEFFVNKCHEIGVGCEAWIKTG-DPKDVICQEVKRVRPDFLVVGSRGLGRFQKVFVGTVSAFCVKHAE--CPVMTIK 158 (171)
T ss_dssp HHHHHHHHHHHHHHTCEEEEEEEES-CHHHHHHHHHHHHCCSEEEEEECCCC--------CHHHHHHHHCS--SCEEEEE
T ss_pred HHHHHHHHHHHHhcCCceEEEEEeC-ChHHHHHHHHhhcCCcEEEeccCCccccccCccCcHHHHHHhCCC--CCEEEEe
Confidence 8999999999999999999988886 7899999999999999999999999999985 9999999999998 9999998
Q ss_pred CC
Q 007254 154 NG 155 (611)
Q Consensus 154 kg 155 (611)
.+
T Consensus 159 ~~ 160 (171)
T d2gm3a1 159 RN 160 (171)
T ss_dssp CC
T ss_pred CC
Confidence 64
|
| >d1mjha_ c.26.2.4 (A:) "Hypothetical" protein MJ0577 {Archaeon Methanococcus jannaschii [TaxId: 2190]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: "Hypothetical" protein MJ0577 species: Archaeon Methanococcus jannaschii [TaxId: 2190]
Probab=99.88 E-value=2.4e-22 Score=185.87 Aligned_cols=137 Identities=16% Similarity=0.104 Sum_probs=117.8
Q ss_pred CCEEEEEeCCCHhHHHHHHHHHHHccCCCCEEEEEEEeeCCCcccC------C--------C----chhHHHHHHHHHHH
Q 007254 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDR------D--------G----KSSLLSLVKAFDSV 77 (611)
Q Consensus 16 ~~~IlVaVD~s~~S~~AL~WAl~~~~~~g~~vvlvHV~~~~~~~~~------~--------~----~~~~~~~~~~~~~l 77 (611)
-++||||||+|+.|++||+||++.+...|++|+++||+++...... . . ........+++++.
T Consensus 3 ~~~ILvavD~s~~s~~al~~a~~la~~~~a~l~llhV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (160)
T d1mjha_ 3 YKKILYPTDFSETAEIALKHVKAFKTLKAEEVILLHVIDEREIKKRDIFSLLLGVAGLNKSVEEFENELKNKLTEEAKNK 82 (160)
T ss_dssp CCEEEEECCSCHHHHHHHHHHHHTCCSSCCEEEEEEEEEGGGTC-----------------CHHHHHHHHHHHHHHHHHH
T ss_pred cCeEEEEECCCHHHHHHHHHHHHHHHhcCCEEEEEEecccccccccccccccccccccchhHHHHHHHHHHHHHHHHHHH
Confidence 3799999999999999999999999999999999999976432110 0 0 01233445677789
Q ss_pred HHHHHhhhhhcCCcEEEEEEECCchhHHHHHHHHhcCCCEEEEccCCCCceeec-ccchhHHHHhcCCCCcEEEEEeCC
Q 007254 78 LAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRS-TTSLAKYCAKKLSKDCSVLAVNNG 155 (611)
Q Consensus 78 l~~~~~~C~~k~V~~~~~v~~g~~~~~~Iv~~a~~~~ad~LVlG~~g~~~~~R~-~gsva~~v~k~ap~~C~VlvV~kg 155 (611)
|+.+...|...||+++.++..| ++++.|+++|++.++|+||||++|++++.++ +||++++|+++++ |||+||++.
T Consensus 83 l~~~~~~~~~~gv~~~~~~~~G-~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~GS~a~~vl~~s~--~pVlvV~~~ 158 (160)
T d1mjha_ 83 MENIKKELEDVGFKVKDIIVVG-IPHEEIVKIAEDEGVDIIIMGSHGKTNLKEILLGSVTENVIKKSN--KPVLVVKRK 158 (160)
T ss_dssp HHHHHHHHHHTTCEEEEEEEEE-CHHHHHHHHHHHTTCSEEEEESCCSSCCTTCSSCHHHHHHHHHCC--SCEEEECCC
T ss_pred HHHHHHHHHhcCCeEEEEEEec-cHHHHHhhhhhccccceEEeccCCCCcccccccCcHHHHHHhcCC--CCEEEEcCC
Confidence 9999999999999999999987 7999999999999999999999999999996 8999999999998 999999864
|
| >d2z3va1 c.26.2.4 (A:2-136) Hypothetical protein TTHA0895 {Thermus thermophilus [TaxId: 274]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein TTHA0895 species: Thermus thermophilus [TaxId: 274]
Probab=99.85 E-value=1.6e-21 Score=175.11 Aligned_cols=133 Identities=16% Similarity=0.110 Sum_probs=105.7
Q ss_pred CEEEEEeCCCHhHHHHHHHHHHHccCCCCEEEEEEEeeCCCcccCCCchhHHHHHHHHHHHHHHHHhhhhhcCCcEEEEE
Q 007254 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKI 96 (611)
Q Consensus 17 ~~IlVaVD~s~~S~~AL~WAl~~~~~~g~~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~C~~k~V~~~~~v 96 (611)
++||||||+|+.|++|++||++++...|++|+++||+++..... ..........+..+++.+.++.++...++.....+
T Consensus 2 k~Ilv~~D~s~~s~~a~~~a~~~a~~~~~~l~ll~V~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 80 (135)
T d2z3va1 2 KTILLAYDGSEHARRAAEVAKAEAEAHGARLIVVHAYEPVPDYL-GEPFFEEALRRRLERAEGVLEEARALTGVPKEDAL 80 (135)
T ss_dssp CEEEEECCSSHHHHHHHHHHHHHHHHHTCEEEEEEEECCCCTTC-CTTHHHHHHHHHHHHHHHHHHHHHHHHCCCGGGEE
T ss_pred CEEEEEECCCHHHHHHHHHHHHHHHHcCCEEEEEEEecCCcccc-ccchhHHHHHHHHHHHHHHHHHHHHhcCCCeEEEE
Confidence 68999999999999999999999999999999999998643211 11122222333333444444455556677666566
Q ss_pred EECCchhHHHHHHHHhcCCCEEEEccCCCCceeec-ccchhHHHHhcCCCCcEEEEE
Q 007254 97 CRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRS-TTSLAKYCAKKLSKDCSVLAV 152 (611)
Q Consensus 97 ~~g~~~~~~Iv~~a~~~~ad~LVlG~~g~~~~~R~-~gsva~~v~k~ap~~C~VlvV 152 (611)
+.++++.++|+++|++.++|+||||+++++++.|+ +||++++|+++++ |||++|
T Consensus 81 ~~~g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~Gs~~~~ll~~~~--~pVlvV 135 (135)
T d2z3va1 81 LLEGVPAEAILQAARAEKADLIVMGTRGLGALGSLFLGSQSQRVVAEAP--CPVLLV 135 (135)
T ss_dssp EEESCHHHHHHHHHHHTTCSEEEEESSCSSSCBCSSCBHHHHHHHHHCS--SCEEEE
T ss_pred EEcCChHHHHHHHhhhhheeeEEeccCCCCcccccccCcHHHHHHHhCC--CCEEeC
Confidence 66678999999999999999999999999999996 9999999999998 999997
|
| >d1tq8a_ c.26.2.4 (A:) Hypothetical protein Rv1636 {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Rv1636 species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.81 E-value=9e-20 Score=165.65 Aligned_cols=137 Identities=15% Similarity=0.032 Sum_probs=103.3
Q ss_pred CCCEEEEEeCCCHhHHHHHHHHHHHccCCCCEEEEEEEeeCC-CcccC----CCchhHHHHHHHHHHHHHHHHhhhhhcC
Q 007254 15 AGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANN-AIVDR----DGKSSLLSLVKAFDSVLAVYEGFCNLKQ 89 (611)
Q Consensus 15 ~~~~IlVaVD~s~~S~~AL~WAl~~~~~~g~~vvlvHV~~~~-~~~~~----~~~~~~~~~~~~~~~ll~~~~~~C~~k~ 89 (611)
.-++||||||+|+.|++||+||+..+...++.+ ++|+..+. ..... ..........+..++.++.++..|.+.+
T Consensus 4 ~yk~ILv~vD~s~~s~~al~~A~~la~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 82 (147)
T d1tq8a_ 4 AYKTVVVGTDGSDSSMRAVDRAAQIAGADAKLI-IASAYLPQHEDARAADILKDESYKVTGTAPIYEILHDAKERAHNAG 82 (147)
T ss_dssp CCCEEEEECCSSHHHHHHHHHHHHHHTTTSEEE-EEEECCC--------------------CCTHHHHHHHHHHHHHTTT
T ss_pred CCCEEEEEECCCHHHHHHHHHHHHHHhcCCCEE-EEEEEecccccccccccchhhhHHHHHHHHHHHHHHHHHHHHHHcC
Confidence 458999999999999999999999886555444 55554432 21111 1122233344566788999999999999
Q ss_pred CcEEEEEEECCchhHHHHHHHHhcCCCEEEEccCCCCceeec-ccchhHHHHhcCCCCcEEEEEeC
Q 007254 90 VDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRS-TTSLAKYCAKKLSKDCSVLAVNN 154 (611)
Q Consensus 90 V~~~~~v~~g~~~~~~Iv~~a~~~~ad~LVlG~~g~~~~~R~-~gsva~~v~k~ap~~C~VlvV~k 154 (611)
+......+..+++.+.|+++|+++++|+||||+++++++.|+ +||++++|+++++ |||+||+.
T Consensus 83 ~~~~~~~~~~G~~~~~i~~~a~~~~~dlIv~g~~~~~~~~~~l~Gs~~~~ll~~~~--~pVlvV~~ 146 (147)
T d1tq8a_ 83 AKNVEERPIVGAPVDALVNLADEEKADLLVVGNVGLSTIAGRLLGSVPANVSRRAK--VDVLIVHT 146 (147)
T ss_dssp CCEEEEEEECSSHHHHHHHHHHHTTCSEEEEECCCCCSHHHHHTBBHHHHHHHHTT--CEEEEECC
T ss_pred CCcEEEEEEecChHHHHHHhhhccceeEEEecCCCCCcccccccccHHHHHHHhCC--CCEEEEec
Confidence 875444555568999999999999999999999999999885 9999999999998 99999974
|
| >d1jmva_ c.26.2.4 (A:) Universal stress protein A, UspA {Haemophilus influenzae [TaxId: 727]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Universal stress protein A, UspA species: Haemophilus influenzae [TaxId: 727]
Probab=99.77 E-value=2.5e-19 Score=161.31 Aligned_cols=135 Identities=13% Similarity=0.145 Sum_probs=102.9
Q ss_pred CCEEEEEeCCCHhHHHHHHHHHHHccCCCCEEEEEEEeeCCCcccCCC-chhHHHHH-HHHHHHHHHHHhhhhhcCCcEE
Q 007254 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDG-KSSLLSLV-KAFDSVLAVYEGFCNLKQVDLK 93 (611)
Q Consensus 16 ~~~IlVaVD~s~~S~~AL~WAl~~~~~~g~~vvlvHV~~~~~~~~~~~-~~~~~~~~-~~~~~ll~~~~~~C~~k~V~~~ 93 (611)
-++||||||+++.|+.||.||+.++.+.|+.|+++||.++........ ........ +..+++...+...+...++...
T Consensus 2 yk~ILv~vD~s~~s~~al~~A~~~a~~~~~~v~~lhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (140)
T d1jmva_ 2 YKHILVAVDLSEESPILLKKAVGIAKRHDAKLSIIHVDVNFSDLYTGLIDVNMSSMQDRISTETQKALLDLAESVDYPIS 81 (140)
T ss_dssp CSEEEEEECCSTTHHHHHHHHHHHHHHHTCEEEEEEEEECCGGGCCCCEEHHHHHHTTCCCCHHHHHHHHHHHHSSSCCC
T ss_pred CCeEEEEECCCHHHHHHHHHHHHHHHHcCCeEEEEEEeeecccccccccccchHHHHHHHHHHHHHHHHHHHHhcCCceE
Confidence 479999999999999999999999999999999999998664322211 11111111 1112344445555656666666
Q ss_pred EEEEECCchhHHHHHHHHhcCCCEEEEccCCCCceeecccchhHHHHhcCCCCcEEEEEeC
Q 007254 94 LKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTSLAKYCAKKLSKDCSVLAVNN 154 (611)
Q Consensus 94 ~~v~~g~~~~~~Iv~~a~~~~ad~LVlG~~g~~~~~R~~gsva~~v~k~ap~~C~VlvV~k 154 (611)
..++.++++.++|+++|+++++|+||||++|+++.. +||++++++++++ |||++|+-
T Consensus 82 ~~~~~~~~~~~~I~~~a~~~~~dliV~G~~~~~~~~--lgs~~~~li~~~~--~pVliVp~ 138 (140)
T d1jmva_ 82 EKLSGSGDLGQVLSDAIEQYDVDLLVTGHHQDFWSK--LMSSTRQVMNTIK--IDMLVVPL 138 (140)
T ss_dssp CEEEEEECHHHHHHHHHHHTTCCEEEEEECCCCHHH--HHHHHHHHHTTCC--SEEEEEEC
T ss_pred EEEEEecCHHHHHHHhhhhchhhEEEeccCCCCCCC--cccHHHHHHhccC--CCEEEEec
Confidence 666777789999999999999999999999887543 6999999999998 99999974
|
| >d1q77a_ c.26.2.4 (A:) Hypothetical protein Aq_178 {Aquifex aeolicus [TaxId: 63363]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Aq 178 species: Aquifex aeolicus [TaxId: 63363]
Probab=99.69 E-value=2e-17 Score=147.94 Aligned_cols=127 Identities=10% Similarity=-0.033 Sum_probs=100.6
Q ss_pred CCCEEEEEeCCCHhHHHHHHHHHHHccCCCCEEEEEEEeeCCCccc--------CCCchhHHHHHHHHHHHHHHHHhhhh
Q 007254 15 AGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVD--------RDGKSSLLSLVKAFDSVLAVYEGFCN 86 (611)
Q Consensus 15 ~~~~IlVaVD~s~~S~~AL~WAl~~~~~~g~~vvlvHV~~~~~~~~--------~~~~~~~~~~~~~~~~ll~~~~~~C~ 86 (611)
+=++||||+|+|+.|++||.||++.+...|++|+++||+++..... .......+...+...+.+..+...+.
T Consensus 3 ~mk~ILv~~D~S~~s~~al~~A~~~a~~~~a~l~llhv~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~l~~~~~~~~ 82 (138)
T d1q77a_ 3 AMKVLLVLTDAYSDCEKAITYAVNFSEKLGAELDILAVLEDVYNLERANVTFGLPFPPEIKEESKKRIERRLREVWEKLT 82 (138)
T ss_dssp CCEEEEEEESTTCCCHHHHHHHHHHHTTTCCEEEEEEECHHHHHHHHHHHHHCCCCCTHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCEEEEEEeCCHHHHHHHHHHHHhhhhccceEEEEEEccCcccccccccccccchhhhhhhhhhhhccccchhhccccc
Confidence 3479999999999999999999999999999999999997432110 12223344455666677777777777
Q ss_pred hcCCcEEEEEEECCchhHHHHHHHHhcCCCEEEEccCCCCceeec-ccchhHHHHhcCCCCcEEEEEe
Q 007254 87 LKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRS-TTSLAKYCAKKLSKDCSVLAVN 153 (611)
Q Consensus 87 ~k~V~~~~~v~~g~~~~~~Iv~~a~~~~ad~LVlG~~g~~~~~R~-~gsva~~v~k~ap~~C~VlvV~ 153 (611)
..++.++.++..| ++.+.|+++|++.++|+||||++|++.+.|+ +|+ . ||+|||+
T Consensus 83 ~~~~~~~~~v~~G-~~~~~I~~~a~~~~~DLIV~Gs~g~~~l~r~l~g~---------~--~~~livk 138 (138)
T d1q77a_ 83 GSTEIPGVEYRIG-PLSEEVKKFVEGKGYELVVWACYPSAYLCKVIDGL---------N--LASLIVK 138 (138)
T ss_dssp SCCCCCCEEEECS-CHHHHHHHHHTTSCCSEEEECSCCGGGTHHHHHHS---------S--SEEEECC
T ss_pred ccceeEEEeeecc-hhHHHHHHhhhhccCCEEEEecCCCcHHHHHhcCC---------C--CCEEEeC
Confidence 7788888888775 7899999999999999999999999877764 554 3 9999885
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.45 E-value=4.3e-07 Score=88.13 Aligned_cols=149 Identities=18% Similarity=0.131 Sum_probs=99.6
Q ss_pred HHHhcCCCccceeecccCceEEEEEEecCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCeEEE
Q 007254 417 LLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLL 494 (611)
Q Consensus 417 l~~~~~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAVK~lk~~~-~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~l 494 (611)
+......|...+..+-++.+.||+... +++.+.+|+..... .....+.+|..++..+. +--+.+++.++...+..++
T Consensus 9 l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l 87 (263)
T d1j7la_ 9 LKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence 334445565555544444578998765 56677888876543 22335667888888774 4446788888888899999
Q ss_pred EEEcCCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC---------------------------------
Q 007254 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS--------------------------------- 541 (611)
Q Consensus 495 V~Ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~--------------------------------- 541 (611)
||++++|..+.+..... .. ...++.+++..|..||+..
T Consensus 88 v~~~l~G~~~~~~~~~~------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 88 LMSEADGVLCSEEYEDE------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEECCSSEEHHHHTTTC------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEeccccccccccccc------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 99999998876554211 11 1224455555555565411
Q ss_pred -----------------------CCCeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 542 -----------------------AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 542 -----------------------~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
...++|+|+.|.|||+++++.+-|+||+.+.+.+
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g~ 215 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRAD 215 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccCC
Confidence 1137999999999999987667799999988654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.01 E-value=4.7e-06 Score=80.08 Aligned_cols=144 Identities=20% Similarity=0.120 Sum_probs=87.1
Q ss_pred ecccCc-eEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcC--CCCeeeEEEEEEeCCeEEEEEEcCCCCCHHH
Q 007254 430 IGKGGS-SQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLH--HKNIISLLGFCFEDNNLLLVYDFLSRGSLEE 506 (611)
Q Consensus 430 IG~G~f-G~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 506 (611)
+..|.. ..||+....++..+.+|.-..... ..+..|...|+.+. .-.+.+++.++.+.+..++||+|++|.++.+
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~--~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~ 95 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL--NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLS 95 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTT--SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCH--hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccc
Confidence 444443 679998887788889998766542 24566777777664 3346778888888889999999998765421
Q ss_pred -----------------HHhcCCCCCCCC--CHHHHHHHHH--------------------HHHHHHHHHHcC----CCC
Q 007254 507 -----------------NLHGNKKDPAAF--GWSERYKVAM--------------------GVAEALEYLHSG----SAQ 543 (611)
Q Consensus 507 -----------------~L~~~~~~~~~l--~~~~~~~ia~--------------------qia~aL~yLH~~----~~~ 543 (611)
.|+........+ .+.....-.. .....+..+... .+.
T Consensus 96 ~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (255)
T d1nd4a_ 96 SHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDL 175 (255)
T ss_dssp SCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCE
T ss_pred ccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccCCc
Confidence 111111000001 1110000000 011222333321 112
Q ss_pred CeEecCCCCCCEEEcCCCcEEEEeeccccccC
Q 007254 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (611)
Q Consensus 544 ~IvHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 575 (611)
.++|+|+.|.|||++++..+-|+||+.+.+.+
T Consensus 176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~~g~ 207 (255)
T d1nd4a_ 176 VVTHGDACLPNIMVENGRFSGFIDCGRLGVAD 207 (255)
T ss_dssp EEECSSCCGGGEEEETTEEEEECCCTTCEEEE
T ss_pred eEEeCCCCCcceEEeCCceEEEEEchhcccCC
Confidence 47999999999999988677899999987754
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.66 E-value=6.1e-05 Score=77.73 Aligned_cols=75 Identities=17% Similarity=0.078 Sum_probs=49.2
Q ss_pred ceeecccCceEEEEEEec-CCCEEEEEEecCC-----h---hHHHHHHHHHHHHHhcC---CCCeeeEEEEEEeCCeEEE
Q 007254 427 ENLIGKGGSSQVYKGCLP-DGKELAVKILKPS-----E---DVIKEFVLEIEIITTLH---HKNIISLLGFCFEDNNLLL 494 (611)
Q Consensus 427 ~~~IG~G~fG~Vyk~~~~-~g~~vAVK~lk~~-----~---~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~l 494 (611)
.+.||.|....||+.... +++.+.||.-.+. + ....+...|.+.|..+. ...+++++.+.. ...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~--~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT--EMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET--TTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC--CCCEE
Confidence 456899999999999865 4678999965431 1 12344556888887663 245667776643 44589
Q ss_pred EEEcCCCCC
Q 007254 495 VYDFLSRGS 503 (611)
Q Consensus 495 V~Ey~~~gs 503 (611)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.19 E-value=0.00049 Score=68.66 Aligned_cols=139 Identities=16% Similarity=0.225 Sum_probs=82.1
Q ss_pred eEEEEEEecCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCCCe--eeEE-----EEEEeCCeEEEEEEcCCCCCHH---
Q 007254 436 SQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI--ISLL-----GFCFEDNNLLLVYDFLSRGSLE--- 505 (611)
Q Consensus 436 G~Vyk~~~~~g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~HpnI--v~l~-----~~~~~~~~~~lV~Ey~~~gsL~--- 505 (611)
-.||++...+|+.+++|+.++......++..|...+..|....| +..+ ..+...+..+.+++++.|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~ 115 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADN 115 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCC
Confidence 57999999899999999998865555677788888887742222 1111 1223456788999998763321
Q ss_pred --H---------HHhc----CC-CCCCCCCHH-------------------HHHHHHHHHHHHHHHHH----cCCCCCeE
Q 007254 506 --E---------NLHG----NK-KDPAAFGWS-------------------ERYKVAMGVAEALEYLH----SGSAQRVI 546 (611)
Q Consensus 506 --~---------~L~~----~~-~~~~~l~~~-------------------~~~~ia~qia~aL~yLH----~~~~~~Iv 546 (611)
. .++. .. .....+++. .+-.+...+...+..+. ...+.++|
T Consensus 116 ~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~li 195 (325)
T d1zyla1 116 IDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRL 195 (325)
T ss_dssp HHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEEC
T ss_pred HHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceee
Confidence 0 1111 00 000111111 11111222222333332 23456899
Q ss_pred ecCCCCCCEEEcCCCcEEEEeeccccccCC
Q 007254 547 HRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (611)
Q Consensus 547 HrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 576 (611)
|+|+.+.|||++++ ..++||+.|...+.
T Consensus 196 HgDlh~~NvL~~~~--~~~IDFdd~~~g~~ 223 (325)
T d1zyla1 196 HGDCHAGNILWRDG--PMFVDLDDARNGPA 223 (325)
T ss_dssp CSSCSGGGEEESSS--EEECCCTTCCEECT
T ss_pred cCCCCcccEEEeCC--ceEEechhcccCcH
Confidence 99999999999744 45899999986553
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.58 E-value=0.0011 Score=67.89 Aligned_cols=73 Identities=18% Similarity=0.172 Sum_probs=50.1
Q ss_pred ceeecccCceEEEEEEecC--------CCEEEEEEecCChhHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCeEEEEEE
Q 007254 427 ENLIGKGGSSQVYKGCLPD--------GKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYD 497 (611)
Q Consensus 427 ~~~IG~G~fG~Vyk~~~~~--------g~~vAVK~lk~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E 497 (611)
.+.|+-|-.-.+|+....+ .+.|.+++.-.... .-...+|..+++.+. +.-..+++++|. + .+|||
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~--~--g~I~e 121 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET-ESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEE 121 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC-HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEEC
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcch-hhHHHHHHHHHHHHHhCCCCCeEEEEcC--C--ceEEE
Confidence 4678888889999988653 34677777653332 234567888888885 333457888774 3 78999
Q ss_pred cCCCCCH
Q 007254 498 FLSRGSL 504 (611)
Q Consensus 498 y~~~gsL 504 (611)
|++|..|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.06 E-value=0.0054 Score=60.06 Aligned_cols=34 Identities=29% Similarity=0.276 Sum_probs=29.7
Q ss_pred CCCCCeEecCCCCCCEEEcCCCcEEEEeeccccc
Q 007254 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (611)
Q Consensus 540 ~~~~~IvHrDLKp~NILl~~~~~vKL~DFGlA~~ 573 (611)
..+.++||+|+.++||+++.+...-|+||+.|..
T Consensus 180 ~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 180 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp SSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccccccccCCcchhhhhcccccceeEeccccccc
Confidence 3457899999999999999887778999999864
|
| >d1wy5a1 c.26.2.5 (A:1-216) TilS-like protein Aq_1887 {Aquifex aeolicus [TaxId: 63363]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: PP-loop ATPase domain: TilS-like protein Aq 1887 species: Aquifex aeolicus [TaxId: 63363]
Probab=94.51 E-value=0.087 Score=48.63 Aligned_cols=97 Identities=13% Similarity=-0.002 Sum_probs=63.0
Q ss_pred CCCEEEEEeCCCHhHHHHHHHHHHHccC-CCCEEEEEEEeeCCCcccCCCchhHHHHHHHHHHHHHHHHhhhhhcCCcEE
Q 007254 15 AGRTVVVGVKLDTHSRELLTWALVKVAQ-PGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLK 93 (611)
Q Consensus 15 ~~~~IlVaVD~s~~S~~AL~WAl~~~~~-~g~~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~C~~k~V~~~ 93 (611)
++.+|+||+-|-..|.-+|.++...... ....|.++||-..-. +..+.-....+.+|+..+|++.
T Consensus 23 ~~~kv~Va~SGG~DS~~Ll~lL~~~~~~~~~~~i~~~~vdh~~r--------------~~s~~~~~~~~~~~~~l~i~~~ 88 (216)
T d1wy5a1 23 GERRVLIAFSGGVDSVVLTDVLLKLKNYFSLKEVALAHFNHMLR--------------ESAERDEEFCKEFAKERNMKIF 88 (216)
T ss_dssp SCCEEEEECCSSHHHHHHHHHHHHSTTTTTCSEEEEEEEECCSS--------------THHHHHHHHHHHHHHHHTCCEE
T ss_pred CCCeEEEEeCCcHHHHHHHHHHHHHHHhcCCCcEEEEEeecccc--------------cchhhhhhHHHHHHHhhhhhhh
Confidence 4679999999999998666554443333 334799999964311 0111112345778888888876
Q ss_pred EEEEEC--------Cc-------h-hHHHHHHHHhcCCCEEEEccCCC
Q 007254 94 LKICRG--------TS-------I-RKILVREAQSYSATKFIVGTAKN 125 (611)
Q Consensus 94 ~~v~~g--------~~-------~-~~~Iv~~a~~~~ad~LVlG~~g~ 125 (611)
..-+.. .. . .+.+.+.|++.+++.|++|.+..
T Consensus 89 i~~~~~~~~~~~~~~~~~~~~R~~Ry~~l~~~a~~~~~~~ia~GH~~d 136 (216)
T d1wy5a1 89 VGKEDVRAFAKENRMSLEEAGRFLRYKFLKEILESEGFDCIATAHHLN 136 (216)
T ss_dssp EEECCHHHHHHHTTCCHHHHHHHHHHHHHHHHHHHTTCSEEECCCCHH
T ss_pred hhccchhhhccCCccchHHHHHHHHHHHhhhhccccccceeEeeeecc
Confidence 432211 10 1 24678899999999999998853
|
| >d1ni5a1 c.26.2.5 (A:0-226) tRNA-Ile-lysidine synthetase, TilS, N-terminal domain {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: PP-loop ATPase domain: tRNA-Ile-lysidine synthetase, TilS, N-terminal domain species: Escherichia coli [TaxId: 562]
Probab=91.30 E-value=0.15 Score=47.07 Aligned_cols=95 Identities=17% Similarity=0.156 Sum_probs=60.0
Q ss_pred CCCEEEEEeCCCHhHHHHHHHHHHHcc-CCCCEEEEEEEeeCCCcccCCCchhHHHHHHHHHHHHHHHHhhhhhcCCcEE
Q 007254 15 AGRTVVVGVKLDTHSRELLTWALVKVA-QPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLK 93 (611)
Q Consensus 15 ~~~~IlVaVD~s~~S~~AL~WAl~~~~-~~g~~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~C~~k~V~~~ 93 (611)
.+++|+||+-|-..|.-+|..+.+... .+|-.|+++||-..-. ...+.-......+|...+|.+.
T Consensus 12 ~~kkvlva~SGG~DS~~Ll~ll~~~~~~~~~~~l~~~~vdh~~r--------------~~s~~~~~~~~~~~~~~~i~~~ 77 (227)
T d1ni5a1 12 TSRQILVAFSGGLDSTVLLHQLVQWRTENPGVALRAIHVHHGLS--------------ANADAWVTHCENVCQQWQVPLV 77 (227)
T ss_dssp TCSEEEEECCSBHHHHHHHHHHHHHHTTSTTCEEEEEEECCSCC--------------SSHHHHHHHHHHHHHHTTCCEE
T ss_pred CCCcEEEEecCcHHHHHHHHHHHHHHHhCCCceEEEEEeCCCCC--------------cchhhhHHHHHHHHhhccCcce
Confidence 457999999999999987776665544 3688999999975321 0112233446778888898876
Q ss_pred EEEEECCch----------hHHHHHHHHhcCCCEEEEccC
Q 007254 94 LKICRGTSI----------RKILVREAQSYSATKFIVGTA 123 (611)
Q Consensus 94 ~~v~~g~~~----------~~~Iv~~a~~~~ad~LVlG~~ 123 (611)
..-...... .......+...+++.|++|-+
T Consensus 78 i~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~i~~gH~ 117 (227)
T d1ni5a1 78 VERVQLAQEGLGIEAQARQARYQAFARTLLPGEVLVTAQH 117 (227)
T ss_dssp EECCCCCCSSSTTTTHHHHHHHHHHHHTCCTTEEEECCCC
T ss_pred eeeccccccccchhhHHHHHHHHHHHHHhhhhHHHHHHHH
Confidence 543321111 122233445667777777755
|
| >d2c5sa1 c.26.2.6 (A:174-391) Thiamine biosynthesis protein ThiI, C-terminal domain {Bacillus anthracis [TaxId: 1392]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: ThiI-like domain: Thiamine biosynthesis protein ThiI, C-terminal domain species: Bacillus anthracis [TaxId: 1392]
Probab=89.18 E-value=1.3 Score=39.48 Aligned_cols=36 Identities=22% Similarity=0.158 Sum_probs=29.0
Q ss_pred CCEEEEEeCCCHhHHHHHHHHHHHccCCCCEEEEEEEeeC
Q 007254 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLAN 55 (611)
Q Consensus 16 ~~~IlVaVD~s~~S~~AL~WAl~~~~~~g~~vvlvHV~~~ 55 (611)
..||+||+-|-..|.-++.|+.+ .|..|++||+...
T Consensus 4 ~gKvvv~~SGG~DS~vla~ll~k----~g~~v~av~~~~~ 39 (218)
T d2c5sa1 4 GGKVMVLLSGGIDSPVAAYLTMK----RGVSVEAVHFHSP 39 (218)
T ss_dssp TEEEEEECCSSSHHHHHHHHHHH----BTEEEEEEEEECT
T ss_pred CCEEEEEecCcHHHHHHHHHHHH----cCCeEEEEEEeCC
Confidence 34899999999999877776654 3889999999753
|
| >d1np7a2 c.28.1.1 (A:1-204) Cryptochrome {Synechocystis sp., pcc 6803 [TaxId: 1143]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Cryptochrome/photolyase, N-terminal domain superfamily: Cryptochrome/photolyase, N-terminal domain family: Cryptochrome/photolyase, N-terminal domain domain: Cryptochrome species: Synechocystis sp., pcc 6803 [TaxId: 1143]
Probab=82.03 E-value=2.1 Score=38.09 Aligned_cols=119 Identities=14% Similarity=0.068 Sum_probs=66.7
Q ss_pred CCEEEEEeCCCHh--HHHHHHHHHHHccCCCCEEEEEEEeeCCCcccC-CC-chhHHHHHHHHHHHHHHHHhhhhhcCCc
Q 007254 16 GRTVVVGVKLDTH--SRELLTWALVKVAQPGDTVIALHVLANNAIVDR-DG-KSSLLSLVKAFDSVLAVYEGFCNLKQVD 91 (611)
Q Consensus 16 ~~~IlVaVD~s~~--S~~AL~WAl~~~~~~g~~vvlvHV~~~~~~~~~-~~-~~~~~~~~~~~~~ll~~~~~~C~~k~V~ 91 (611)
.++|+|=...|-- =-.||..|+ +.|+.|+.|+|.++...... .+ .........-..+-|..++.-.++.|+.
T Consensus 5 p~~~lvWfr~DLRl~DN~aL~~A~----~~~~~vi~vyi~dp~~~~~~~~~~~~~~~~r~~fl~~sL~~L~~~L~~~g~~ 80 (204)
T d1np7a2 5 PPTVLVWFRNDLRLHDHEPLHRAL----KSGLAITAVYCYDPRQFAQTHQGFAKTGPWRSNFLQQSVQNLAESLQKVGNK 80 (204)
T ss_dssp CCEEEEEESSCCCSTTCHHHHHHH----HTTSEEEEEEEECGGGGSBCTTSCBSSCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred CCcEEEEeCCCCccccHHHHHHHH----hcCCcEEEEEEECchHhcCcccccccccHHHHHHHHHHHHHHHHHHHhccch
Confidence 3566665555421 124666665 45789999999987532211 11 0001111122334455555555566777
Q ss_pred EEEEEEECCchhHHHHHHHHhcCCCEEEEccCCCCceee-cccchhHHHHhc
Q 007254 92 LKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIR-STTSLAKYCAKK 142 (611)
Q Consensus 92 ~~~~v~~g~~~~~~Iv~~a~~~~ad~LVlG~~g~~~~~R-~~gsva~~v~k~ 142 (611)
+ .+..| ++.++|.+++++++|+.|..-.. -+...+ --..|.+.|-++
T Consensus 81 L--~v~~G-~~~~~l~~l~~~~~i~~V~~n~~-~~~~e~~rd~~v~~~l~~~ 128 (204)
T d1np7a2 81 L--LVTTG-LPEQVIPQIAKQINAKTIYYHRE-VTQEELDVERNLVKQLTIL 128 (204)
T ss_dssp E--EEEES-CHHHHHHHHHHHTTEEEEEEECC-CSHHHHHHHHHHHHHHHHH
T ss_pred h--hhhhh-hhHHHHHHHHHHhhhhheeeecc-ccHHHHHHHHHHhhhhccc
Confidence 5 46675 67899999999999999876332 222221 124456666444
|